Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,embryonic skeletal system development (GO:0048706),-0.7187889992213927,-2.1592611099429306,0.0,0.0009816663821256863,0.001,14/35,5.68%,SULF1;COL1A1;PDGFRA;HOXC4;OSR1;HOXB3;PCSK5;HOXA3;HOXB4;SULF2;RBP4;DYNC2I1;WNT9A;SIX1
prerank,collagen fibril organization (GO:0030199),-0.5955755995209818,-2.116502230348549,0.0,0.005399165101691275,0.011,41/88,8.48%,COL1A2;COL3A1;COL5A2;COL4A5;ADAMTS2;COL1A1;COL5A1;COL4A6;COL8A1;COL12A1;COL22A1;COL25A1;COL4A3;LOXL1;COL6A2;COL4A4;PLOD2;COL6A3;COL26A1;COL6A1;COL8A2;COL18A1;COL13A1;COL23A1;COL11A1;COL15A1;LOXL3;TGFBR1;P4HA1;SERPINH1;CYP1B1;COL20A1;COL27A1;TLL1;COL16A1;LOX;ATP7A;COL9A2;LUM;COL5A3;DPT
prerank,dermatan sulfate metabolic process (GO:0030205),-0.8850734601102352,-2.0939612457900276,0.0,0.005562776165378889,0.017,5/13,5.48%,UST;DSE;DCN;BGN;CSPG4
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.6313047528869511,-2.071248741615954,0.0,0.008344164248068334,0.033,20/50,10.29%,ZIC1;GLI3;FGFR2;GPC3;DCDC2;TULP3;GAS1;SMO;FBXL17;IFT81;SUFU;RORA;GLIS2;GLI1;MGRN1;IFT122;EVC;FUZ;ARMC9;BTRC
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.8916596103345111,-2.0565782146940683,0.0,0.009031330715556316,0.043,5/12,5.48%,UST;DSE;DCN;BGN;CSPG4
prerank,skeletal system development (GO:0001501),-0.5204865015570616,-2.03207695081211,0.0,0.012270829776571079,0.068,51/148,14.60%,BMP6;COL1A2;SULF1;IGF1;SOX5;FBN1;COL1A1;GLI2;BMP5;BMP7;EXT1;CDH11;FGFR2;ITGB8;PCSK5;PKD1;MMP14;NPR3;COL13A1;MMP16;GJA1;SULF2;WWOX;CREB3L2;RBP4;SH3PXD2B;TGFBR1;SUFU;TNFRSF11B;PRELP;PAPSS2;AKAP13;IGF2;TLL1;GNAS;ATP7A;COL9A2;PTH1R;MYOC;SOX6;EVC;PAPSS1;CHRD;PTHLH;PKDCC;BMP2;CMKLR1;P3H1;COMP;WNT11;DDRGK1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.8001446090905687,-2.017742190437525,0.0,0.013322615185991458,0.083,10/17,12.08%,ATP1A2;CACNA1C;ANK2;CACNA2D1;KCNJ2;CACNA1G;SLC8A1;CACNA1D;TRPM4;CACNB2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.8410329142612312,1.9909134539902607,0.0,0.0566460806942394,0.051,5/19,6.45%,SLCO1C1;PDGFB;APP;KLF2;KLF4
prerank,mesonephric tubule development (GO:0072164),-0.8206817919411953,-1.9834175937446656,0.0,0.019633327642513725,0.134,13/15,14.40%,BMP7;FGFR2;BMP4;OSR1;SLIT2;PKD1;SALL1;FOXC1;PKD2;SIX1;ROBO2;NPNT;WNT11
prerank,retinoid metabolic process (GO:0001523),-0.5773255181593653,-1.983010425364902,0.0,0.017451846793345535,0.134,17/71,8.01%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;GPC3;RBP1;CYP26B1;ABCA4;RBP4;DHRS3;GPC4;AKR1B1;CYP1B1;SCPEP1;SDC4;APOE
prerank,ureteric bud development (GO:0001657),-0.7925903013335067,-1.9737925217183099,0.0,0.017669994878262357,0.149,14/17,14.40%,BMP7;FGFR2;GPC3;BMP4;OSR1;SLIT2;SALL1;FOXC1;PKD2;SIX1;ROBO2;BMP2;NPNT;WNT11
prerank,establishment of endothelial barrier (GO:0061028),0.7994305570127319,1.9700153698373148,0.0,0.05361146922847657,0.09,15/29,8.79%,PECAM1;TJP1;PPP1R16B;ROBO4;PDE2A;RAPGEF2;TJP2;F11R;RAPGEF1;RAPGEF3;PDE4D;MARVELD2;SOX18;RAP1B;MSN
prerank,eye development (GO:0001654),-0.5848485751356896,-1.9181225283293368,0.0,0.04542438077290676,0.36,14/54,6.50%,CACNA1C;PBX1;FBN1;COL5A2;SMOC1;COL5A1;EFEMP1;LAMA1;RBP4;SH3PXD2B;FOXC1;PBX4;MEIS1;PBX3
prerank,positive regulation of developmental growth (GO:0048639),0.6923856590787617,1.9067335442744986,0.0,0.18612283656678658,0.365,15/49,12.62%,PLCB1;SEMA7A;INSR;MACF1;NTN1;NEDD4L;AGRN;ITSN2;DBNL;RASAL1;TWF2;SMURF1;CPNE5;SYT4;CPNE6
prerank,ceramide biosynthetic process (GO:0046513),0.7112778380684383,1.904998028740462,0.0,0.14464981320136133,0.375,7/40,2.43%,SGMS1;ST8SIA4;ST6GALNAC3;ST8SIA6;SGMS2;DEGS2;CERS4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.7039988912011501,-1.9046109259298023,0.0,0.052600956975568026,0.43,12/22,20.69%,TIMP2;TIMP3;PTPN3;ADAM9;APOE;SNX9;SNX33;NRDC;PACSIN3;ADRA2A;TIMP4;ADAM8
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.7707959898510216,-1.904574481250683,0.0,0.048554729515908945,0.43,7/16,8.16%,IGF1;IGFBP2;IGFBP5;BMP5;IGFBP6;IGFBP4;IGFBP3
prerank,hemopoiesis (GO:0030097),0.6311211430921237,1.9039518338189856,0.0,0.1177429248715976,0.38,18/87,5.83%,FLT1;MECOM;KITLG;TEK;PDGFB;KDR;CD34;TGFB2;NOTCH4;RASGRP4;TIRAP;FLT4;SNRK;ZFPM1;ZBTB16;TAL1;PLD4;ETV6
prerank,angiogenesis involved in wound healing (GO:0060055),0.8987508029527848,1.8891694889074306,0.0,0.13655751595932714,0.473,6/11,4.52%,NDNF;KDR;ADIPOR2;CD34;PRCP;GATA2
prerank,glycerolipid catabolic process (GO:0046503),0.8209660783381515,1.8884482652312016,0.0,0.11849435247264363,0.476,5/19,5.89%,GPCPD1;ABHD2;PLA2G4B;PNPLA6;GDPD1
prerank,regulation of cell junction assembly (GO:1901888),0.7565136679750225,1.8866413414577101,0.0016420361247947454,0.106717169879326,0.481,11/27,7.23%,PRKCH;OCLN;TJP1;CLDN5;RAPGEF2;F11R;MEF2C;RAPGEF1;APLNR;SNAI2;RAP1B
prerank,relaxation of cardiac muscle (GO:0055119),-0.7687045359957335,-1.88373288929917,0.0,0.06429914802923245,0.543,6/13,7.24%,ATP1A2;GSN;CAMK2D;KCNJ2;P2RX4;SLC8A1
prerank,membrane lipid biosynthetic process (GO:0046467),0.664190708414686,1.8750186159418076,0.0014749262536873156,0.11947377733725491,0.559,15/58,5.12%,SGMS1;CERT1;SGPP2;ELOVL7;ST8SIA6;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD1;PRKD2;PRKD3;ACER1
prerank,bile acid and bile salt transport (GO:0015721),0.7819550822397728,1.8740825015636982,0.0,0.10904370533641083,0.567,6/24,7.18%,SLCO1C1;ABCC4;SLCO2B1;NCOA1;ABCB11;NCOA2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.7632490305192476,-1.87045390390879,0.002304147465437788,0.07290508997920098,0.613,9/16,12.61%,FOXD1;BMP4;FGF1;SALL1;PKD2;FGF2;SIX1;BMP2;NPNT
prerank,sphingolipid metabolic process (GO:0006665),0.6023412794472783,1.8660754854797026,0.0,0.11246454007963438,0.615,34/108,13.92%,SGMS1;ST6GALNAC3;CERT1;SGPP2;ELOVL7;ESYT2;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD1;PRKD2;PRKD3;ACER1;NEU4;ESYT1;GAL3ST1;SPTLC2;CERKL;ELOVL5;ENPP2;GLB1;ORMDL1;GLTP;ORMDL3;ELOVL6;B4GALNT1;CERK;HACD2;DEGS1;SPTLC1;NEU2
prerank,relaxation of muscle (GO:0090075),-0.7575646460789693,-1.864405835197928,0.0,0.07454529089266931,0.644,6/13,7.24%,ATP1A2;GSN;CAMK2D;KCNJ2;P2RX4;SLC8A1
prerank,extracellular structure organization (GO:0043062),-0.4641546607500998,-1.8641108348466724,0.0,0.07056448935044639,0.646,78/204,8.12%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;COL4A5;SMOC1;THSD4;ADAMTS2;COL1A1;ADAMTS12;ADAMTSL3;DCN;ITGA9;COL5A1;COL4A6;COL8A1;ADAMTS10;COL22A1;NID1;VTN;COL4A3;LOXL1;ADAMTS6;COL6A2;COL4A4;BGN;COL6A3;ELN;ADAMTSL5;LAMA1;COL6A1;ITGB5;COL8A2;ITGB8;VIT;MFAP5;MMP14;ITGA10;COL18A1;LAMC3;SMOC2;COL13A1;MMP16;COL23A1;COL11A1;FBLN5;THBS1;COL15A1;DDR1;CDH1;DAG1;TGFBR1;SH3PXD2A;ECM2;ADAMTS5;NID2;ADAMTS17;ITGA11;FGF2;ADAMTSL4;ST7;TNC;SPP1;COL27A1;ADAMTS15;ADAMTSL1;COL16A1;MMP2;SPARC;LOX;ATP7A;TGFBI;ITGA5;ADAMTS16;COL9A2;LUM;ADAM19
prerank,extracellular matrix organization (GO:0030198),-0.4499140162005225,-1.855759860040882,0.0,0.07553377440244864,0.685,99/276,9.26%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;COL4A5;SMOC1;THSD4;ADAMTS2;COL1A1;ADAMTS12;ADAMTSL3;DCN;ITGA9;COL5A1;COL4A6;GSN;COL8A1;COL12A1;TIMP2;ADAMTS10;COL22A1;NID1;VTN;COL25A1;COL4A3;LOXL1;ADAMTS6;COL6A2;COL4A4;BGN;PLOD2;COL6A3;COL26A1;ELN;ADAMTSL5;LAMA1;COL6A1;ITGB5;COL8A2;ITGB8;VIT;MFAP5;MMP14;ITGA10;COL18A1;LAMC3;SMOC2;COL13A1;MMP16;COL23A1;COL11A1;FBLN5;THBS1;SH3PXD2B;COL15A1;DDR1;CDH1;LOXL3;DAG1;TGFBR1;P4HA1;SH3PXD2A;ECM2;ADAMTS5;NID2;ADAMTS17;ITGA11;SERPINH1;FGF2;ADAMTSL4;SCUBE1;CYP1B1;ST7;TNC;SPP1;COL20A1;CTSL;COL27A1;ADAMTS15;TLL1;ADAMTSL1;COL16A1;MMP2;SPARC;LOX;ATP7A;TGFBI;ITGA5;ADAMTS16;COL9A2;LUM;ADAM19;COL5A3;DPT;KLK2;LAMB1;CREB3L1;ITGB4
prerank,external encapsulating structure organization (GO:0045229),-0.46097020096848296,-1.8533592747405023,0.0,0.07414164517633473,0.695,77/205,8.12%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;COL4A5;SMOC1;THSD4;ADAMTS2;COL1A1;ADAMTS12;ADAMTSL3;DCN;ITGA9;COL5A1;COL4A6;COL8A1;ADAMTS10;COL22A1;NID1;VTN;COL4A3;LOXL1;ADAMTS6;COL6A2;COL4A4;BGN;COL6A3;ELN;ADAMTSL5;LAMA1;COL6A1;ITGB5;COL8A2;ITGB8;VIT;MFAP5;MMP14;ITGA10;COL18A1;LAMC3;SMOC2;COL13A1;MMP16;COL23A1;COL11A1;FBLN5;THBS1;COL15A1;DDR1;CDH1;DAG1;SH3PXD2A;ECM2;ADAMTS5;NID2;ADAMTS17;ITGA11;FGF2;ADAMTSL4;ST7;TNC;SPP1;COL27A1;ADAMTS15;ADAMTSL1;COL16A1;MMP2;SPARC;LOX;ATP7A;TGFBI;ITGA5;ADAMTS16;COL9A2;LUM;ADAM19
prerank,monocyte chemotaxis (GO:0002548),0.7280474748620978,1.8526303066849386,0.0,0.13369149401944,0.713,4/32,2.32%,FLT1;PDGFB;IL6R;TNFRSF11A
prerank,organic anion transport (GO:0015711),0.6256138975154264,1.848984993140052,0.001455604075691412,0.13274479898952252,0.74,9/76,2.53%,SLCO1C1;ABCC4;ABCG2;CA4;ABCC6;SLCO2B1;SLC39A8;SLC16A2;LRRC8C
prerank,maintenance of blood-brain barrier (GO:0035633),0.7310342328949995,1.8455606709646197,0.001644736842105263,0.1312108195672688,0.756,12/30,3.99%,OCLN;SLC1A1;MFSD2A;PECAM1;ESAM;TJP1;CLDN5;JAM2;TJP2;F11R;ACTB;LSR
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.8375396012635897,1.8442656503365011,0.0,0.11784407858712304,0.76,2/14,1.07%,ABCG2;SLCO2B1
prerank,heme catabolic process (GO:0042167),0.8375396012635897,1.8442656503365011,0.0,0.11784407858712304,0.76,2/14,1.07%,ABCG2;SLCO2B1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7033348519907168,1.843203429438289,0.0,0.11299465046046282,0.766,11/34,5.17%,FLT1;SEMA6A;KDR;DAB2IP;FLT4;PRKD1;NOTCH1;PRKD2;RAMP2;DLL4;GAB1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.5672405545631604,-1.8363257012844811,0.0,0.08898805753969347,0.777,20/55,12.24%,GPC6;DCN;SDC2;OGN;CEMIP;FMOD;GPC3;BGN;CEMIP2;GPC4;FGF2;PRELP;CSPG4;SDC4;LUM;OMD;ARSB;SLC9A1;HEXA;GNS
prerank,diterpenoid metabolic process (GO:0016101),-0.5487940128153391,-1.832059894208747,0.0,0.08993933900999146,0.793,13/55,8.01%,GPC6;ALDH1A1;LRP1;SDC2;GPC3;RBP1;ABCA4;RBP4;DHRS3;GPC4;AKR1B1;SDC4;APOE
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.5465735262618213,-1.8211359524740842,0.0,0.09990686498088236,0.845,13/53,12.85%,EYA2;EYA1;EGFR;EYA4;DDX5;PLA2R1;PRKCD;FBH1;ATM;FXR2;SPRED1;TMEM161A;FMR1
prerank,kidney development (GO:0001822),-0.5310816145752905,-1.8165583669447778,0.0,0.10213598488812033,0.861,19/65,8.22%,SULF1;GLI2;WNT4;BMP7;BMP4;KANK2;OSR1;PCSK5;PKD1;GREB1L;SULF2;SALL1;FOXC1;TGFBR1;ARL3;PYGO1;SIX1;ACE;AGTR1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.704506978583442,-1.816111048476746,0.0,0.09861656863770957,0.863,8/20,10.27%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1;PRKACA;SLC9A1
prerank,ganglioside biosynthetic process (GO:0001574),0.8049926724378595,1.8156054639666876,0.0035587188612099642,0.1746025522986129,0.896,5/15,2.10%,ST8SIA4;ST6GALNAC3;ST8SIA6;ST3GAL1;B4GALT5
prerank,organic hydroxy compound transport (GO:0015850),0.7023358372571247,1.8148990375122702,0.0,0.16748925739104992,0.896,7/36,7.18%,SLCO1C1;ABCC4;SLCO2B1;NCOA1;OSBP;ABCB11;NCOA2
prerank,dendritic spine organization (GO:0097061),0.7210572771314806,1.81118178057233,0.008305647840531562,0.16791516777220963,0.904,6/26,6.12%,IGF1R;SHANK3;INSR;WNT7A;DIP2A;FYN
prerank,neutral amino acid transport (GO:0015804),0.7273087968594671,1.806640427972666,0.0033112582781456954,0.1738880538318063,0.917,5/28,2.87%,SLC6A6;SLC7A5;SLC1A1;SLC38A5;SLC43A2
prerank,cardiac muscle cell action potential (GO:0086001),-0.6276477708491288,-1.8045003128776806,0.002544529262086514,0.11179216759647316,0.893,9/30,7.86%,ATP1A2;CACNA1C;ANK2;DMD;CACNA2D1;KCNJ2;CACNA1G;SLC8A1;CACNA1D
prerank,response to interleukin-4 (GO:0070670),0.8795141973795959,1.8035535947329502,0.0,0.17467407512777228,0.927,3/10,5.83%,LEF1;JAK3;TCF7
prerank,sulfur compound catabolic process (GO:0044273),-0.6016634978062286,-1.8033984874328992,0.0,0.10907823761388877,0.894,12/38,12.24%,DCN;OGN;FMOD;BGN;PRELP;CSPG4;GGT5;LUM;OMD;ARSB;HEXA;GNS
prerank,regulation of JNK cascade (GO:0046328),0.5861913028103654,1.8016546059656164,0.0,0.17231315540374995,0.933,19/101,5.25%,IGF1R;MECOM;PLCB1;MFHAS1;DAB2IP;MAP4K2;TNFRSF19;APP;ANKRD6;TIRAP;SH3RF1;FLT4;PHLPP1;TPD52L1;NOD2;MEN1;DUSP3;WNT7A;CCR7
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.7331316127117553,-1.801530607118674,0.002320185614849188,0.10761972189229747,0.901,7/16,10.12%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1;PRKACA
prerank,cellular response to interleukin-4 (GO:0071353),0.8810288477200101,1.800274627553084,0.0018115942028985507,0.16880026278305713,0.937,3/10,5.83%,LEF1;JAK3;TCF7
prerank,regulation of interleukin-4 production (GO:0032673),0.7735790072190755,1.8001173699050355,0.0,0.16249332862004673,0.938,5/21,8.41%,LEF1;SLC7A5;ZFPM1;LGALS9;FOXP3
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.7610222906937628,1.7986052964179542,0.0017543859649122807,0.15997849163098377,0.942,7/19,5.99%,PRKCH;OCLN;TJP1;CLDN5;F11R;IKBKB;SNAI2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.8665810436045446,1.7959667262244914,0.001941747572815534,0.1609093363635967,0.948,3/10,3.20%,NAMPT;KDR;NOD2
prerank,endodermal cell differentiation (GO:0035987),-0.6160129978604535,-1.7951207603556234,0.0,0.1127864554035119,0.916,12/31,10.36%,COL8A1;COL12A1;VTN;COL6A1;ITGB5;MMP14;COL11A1;CTR9;MMP2;ITGA5;LAMB1;ITGAV
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.6406128058828281,-1.789361300368433,0.0026455026455026454,0.11735990851137086,0.929,7/23,13.30%,ATP1A2;ANK2;CAMK2D;CACNA2D1;DIAPH1;PTK2B;CACNB1
prerank,sphingolipid biosynthetic process (GO:0030148),0.6084927368832523,1.7888655254662915,0.005681818181818182,0.17420114866557548,0.961,17/71,7.79%,SGMS1;CERT1;SGPP2;ELOVL7;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD1;PRKD2;PRKD3;ACER1;TLCD3B;SPTLC2;ELOVL5
prerank,amide transport (GO:0042886),0.7231282594934538,1.7888050284919974,0.0031645569620253164,0.16840349605405652,0.961,5/26,1.98%,CERT1;ABCG2;PLTP;AQP11;SLC38A5
prerank,activation of adenylate cyclase activity (GO:0007190),-0.5982300423024581,-1.7828537494096073,0.0025380710659898475,0.1242789639771119,0.942,7/35,4.82%,LGR4;ADCY5;ADCY1;ADCY9;EDNRA;ADCY2;ADCY7
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.645797899766428,-1.7773552704268918,0.0049261083743842365,0.13002329564542156,0.951,11/23,15.15%,GLI3;ENPP1;GPC3;TULP3;SUFU;GLIS2;MGRN1;IFT122;BTRC;KIF7;PTCH2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.7366029367129543,-1.7731288519240527,0.004123711340206186,0.13243293036364337,0.959,6/14,10.18%,SULF1;SULF2;THBS1;FGF2;CREB3L1;FUZ
prerank,vascular transport (GO:0010232),0.5986229877739849,1.7698557835258444,0.0,0.2180199748624714,0.985,16/81,3.10%,SLCO1C1;SLC6A6;SLC7A5;TFRC;ABCC4;SLC7A1;ABCG2;SLC1A1;SLC2A1;MFSD2A;ATP8A1;INSR;SLCO2B1;SLC16A2;SLC38A5;SLC22A8
prerank,myeloid cell differentiation (GO:0030099),0.6408308014858831,1.76762610449577,0.0014925373134328358,0.21810046276514752,0.988,13/47,7.67%,MFHAS1;RASGRP4;TIRAP;SNRK;JAK3;ZFPM1;LYN;ZBTB16;KLF1;SLC25A5;TAL1;CDKN2B;KAT6A
prerank,amino acid import (GO:0043090),0.7352829468637564,1.7669993387835334,0.005042016806722689,0.2136556135113639,0.988,6/21,1.67%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SH3BP4;SLC16A2
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.7555927775348841,-1.7668074625534302,0.0,0.13895041426997215,0.97,5/13,11.96%,DCN;BGN;CSPG4;ARSB;HEXA
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.7170118947818915,1.766009952408052,0.0016286644951140066,0.2101545071643427,0.989,5/23,7.37%,PIK3R6;CADM1;LGALS9;PVR;CD160
prerank,regulation of protein import into nucleus (GO:0042306),-0.5859897598616244,-1.7649503137200062,0.0,0.13809736193256347,0.976,13/36,14.13%,ZIC1;SMAD3;BMP4;MDFIC;APOD;CDH1;PRKCD;SUFU;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,regulation of epithelial cell migration (GO:0010632),0.6397314769462945,1.7647620092194434,0.0015408320493066256,0.20822789851837262,0.99,17/51,8.63%,PTPRG;DAB2IP;MACF1;BMPR2;TGFB2;DOCK1;MCC;PTK2;EVL;VIL1;PLCG1;RREB1;INSL3;RAB11A;PTPRR;PTN;ENPP2
prerank,protein targeting to ER (GO:0045047),0.5790047492313425,1.7595417757359062,0.0,0.21765389474914126,0.994,70/99,32.25%,SEC62;RPL38;RPL13;RPS29;RPL36A;ZFAND2A;RPL3;RPL27;RPSA;SRP14;SGTB;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;GET3;RPS9;SPCS2;RPL11;EDEM1;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;SPCS1;RPL18A;RPS21;RPL10A;RPL24;SRPRA;RPL7A;ZFAND2B;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;SEC63;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,cardiac muscle cell contraction (GO:0086003),-0.6841707412649691,-1.758308081215064,0.0,0.14666095748957755,0.98,7/19,7.86%,CACNA1C;GSN;CAMK2D;CACNA2D1;KCNJ2;CACNA1G;CACNA1D
prerank,transport across blood-brain barrier (GO:0150104),0.5945077595179894,1.7565062780359493,0.0,0.2216952265265619,0.995,16/83,3.10%,SLCO1C1;SLC6A6;SLC7A5;TFRC;ABCC4;SLC7A1;ABCG2;SLC1A1;SLC2A1;MFSD2A;ATP8A1;INSR;SLCO2B1;SLC16A2;SLC38A5;SLC22A8
prerank,cardiac conduction system development (GO:0003161),-0.6265977971916873,-1.756344404597901,0.004640371229698376,0.14572292072443524,0.982,7/24,5.68%,NOTCH2;BMPR1A;GJB6;BMP4;GJA1;CACNA1G;TBX18
prerank,positive regulation of neuron migration (GO:2001224),0.8527578892407183,1.7547887718407418,0.0037174721189591076,0.2211438932122116,0.996,4/11,2.67%,SEMA6A;DAB2IP;RAPGEF2;ARHGEF2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5998476179713548,1.750482758512298,0.0014124293785310734,0.23065709079679714,0.996,39/70,21.61%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;ACTB;LYN;ELMO2;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;NCKAP1;WIPF2;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;MAPK1;NCK1;ACTR2;PRKCE;CRK;MYO1C;FCGR3A;PLCG2;ARPC1B;VAV1;WIPF1;ARPC2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7262413515076651,1.749628188500388,0.006644518272425249,0.22738836513113403,0.996,7/21,11.53%,SLC39A10;PRKCH;LYN;CD19;ELF2;CBFB;PRKCB
prerank,glycerophospholipid catabolic process (GO:0046475),0.7126592151629084,1.7484038249752822,0.0047694753577106515,0.22537047819065242,0.996,9/27,14.91%,GPCPD1;PLA2G4B;PNPLA6;INPP5F;GDPD1;ENPP2;LIPC;PNPLA8;PRDX6
prerank,lipid transport (GO:0006869),0.5687986822844193,1.7476672030510085,0.0013192612137203166,0.222168099586945,0.997,20/97,7.36%,SLCO1C1;ABCC4;CERT1;MFSD2A;PLTP;ATP8A1;SLCO2B1;SPNS2;PPARD;NCOA1;SCARB1;OSBP;ABCG1;PITPNC1;PRELID2;PITPNA;ABCA3;ABCB11;NCOA2;CHKA
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7350250006424418,1.7448811164035036,0.008928571428571428,0.225837712019508,0.997,3/21,3.43%,SLC39A10;PRKCH;PRKD2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5934906263086258,1.7418402887176356,0.001392757660167131,0.23008941664051308,0.997,39/71,21.61%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;ACTB;LYN;ELMO2;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;NCKAP1;WIPF2;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;MAPK1;NCK1;ACTR2;PRKCE;CRK;MYO1C;FCGR3A;PLCG2;ARPC1B;VAV1;WIPF1;ARPC2
prerank,membrane depolarization during action potential (GO:0086010),-0.6228008436107934,-1.7409859397606215,0.002336448598130841,0.17120792334748794,0.994,7/26,7.86%,ATP1A2;CACNA1C;SCN7A;KCNJ2;CACNA1G;SLC8A1;CACNA1D
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6540581266756484,1.7387920565670025,0.0032626427406199023,0.2343547672877745,0.997,11/34,5.25%,FLT1;TEK;PDGFB;DAB2IP;PTK2;PIK3R3;NOD2;PIK3IP1;PRKD1;CD19;CCR7
prerank,positive regulation of lymphocyte migration (GO:2000403),0.8112499416532581,1.7383625190415526,0.003795066413662239,0.2304281639669238,0.997,3/12,1.57%,CXCL12;JAM2;APP
prerank,positive regulation of JNK cascade (GO:0046330),0.5933416408482975,1.737040580678074,0.002793296089385475,0.2294869946137742,0.997,14/70,5.25%,PLCB1;MFHAS1;DAB2IP;MAP4K2;TNFRSF19;APP;ANKRD6;TIRAP;SH3RF1;FLT4;TPD52L1;NOD2;WNT7A;CCR7
prerank,purine ribonucleotide transport (GO:0015868),0.7759261885779538,1.7370200484668972,0.007155635062611807,0.22462581466784823,0.997,3/16,2.53%,ABCC4;ABCC6;LRRC8C
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7607746185746445,-1.7364885949919007,0.002188183807439825,0.17589911568141575,0.995,6/13,9.50%,BMP6;BMPR1A;BMP4;TGFBR1;DAB2;TGFB3
prerank,positive regulation of axon extension (GO:0045773),0.7227179260723008,1.7361259851194124,0.006622516556291391,0.22285427951695744,0.997,5/22,8.14%,SEMA7A;MACF1;NTN1;DBNL;TWF2
prerank,renal system development (GO:0072001),-0.5360005391742075,-1.7345065280749108,0.0,0.17524003467587254,0.998,18/52,8.22%,SULF1;GLI2;WNT4;BMP4;PCSK5;PKD1;GREB1L;SULF2;RBP4;SALL1;FOXC1;TGFBR1;ARL3;PYGO1;SIX1;TBX18;ACE;AGTR1
prerank,embryonic eye morphogenesis (GO:0048048),-0.7744162691438614,-1.7340854085171553,0.002288329519450801,0.17191432516976082,0.998,10/11,22.61%,FBN1;EFEMP1;MFAP5;KDM2B;FBN2;LRP6;MFAP2;TBX2;RARG;ALDH1A3
prerank,blood vessel morphogenesis (GO:0048514),0.6245028565201735,1.7337844980079749,0.002861230329041488,0.22464382292810245,0.997,20/54,9.09%,FLT1;SLC1A1;EGFL7;KDR;ENG;RASIP1;CAV1;TBX1;SOX17;FLT4;ID1;APLNR;CDH2;RAMP2;SMAD7;COL4A1;SOX18;TGFB1;LRP5;CCM2
prerank,cellular component maintenance (GO:0043954),0.8278262669994801,1.7336650316738589,0.009208103130755065,0.22063648430406246,0.998,3/12,6.12%,IGF1R;INSR;FYN
prerank,cell junction assembly (GO:0034329),0.5648600114998297,1.731945378522465,0.001303780964797914,0.22111012170146388,0.998,25/100,9.63%,SPOCK2;DNM3;ITGA6;SHANK3;TJP1;CLDN5;LIMS2;ADGRL3;GJC1;PLXND1;CDH2;ACTB;CDH20;CTNND1;CDH8;DBNL;DCHS1;CDH19;PKP4;SLITRK1;GPM6A;OPHN1;NRXN1;DNER;ACTG1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6480131182534197,-1.725765667141005,0.00702576112412178,0.18388287352988467,1.0,10/20,9.01%,IGF1;LRP1;BMPR1A;PDGFRB;IGFBP5;VTN;SLIT2;ACE;IGFBP3;CCN4
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5857504526700141,1.7253259568538837,0.0014044943820224719,0.23724436818232952,0.998,39/73,21.61%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;ACTB;LYN;ELMO2;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;NCKAP1;WIPF2;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;MAPK1;NCK1;ACTR2;PRKCE;CRK;MYO1C;FCGR3A;PLCG2;ARPC1B;VAV1;WIPF1;ARPC2
prerank,regulation of acrosome reaction (GO:0060046),0.8344361053741788,1.7237654960960773,0.011342155009451797,0.23752037541772547,0.998,1/10,0.22%,PLCB1
prerank,negative regulation of blood pressure (GO:0045776),0.807194801844245,1.7232351884467623,0.00539568345323741,0.2345642270017413,0.999,5/13,4.86%,BMPR2;NOS3;PRCP;NOS2;NPPA
prerank,positive regulation of vasculature development (GO:1904018),0.561270517437568,1.7164237873835355,0.0,0.2507692565798552,1.0,18/94,5.30%,FLT1;TEK;ETS1;PIK3R6;KDR;TIE1;CD34;NOS3;CD40;APLNR;PRKD1;PRKD2;RAMP2;RAPGEF3;PLCG1;GATA2;GAB1;RHOB
prerank,adenine nucleotide transport (GO:0051503),0.7645325400002201,1.7083437269559583,0.0071174377224199285,0.27291633712030067,1.0,4/17,5.07%,ABCC4;ABCC6;LRRC8C;SLC25A5
prerank,regulation of angiogenesis (GO:0045765),0.51558226142264,1.7064222796655353,0.0,0.2748541659750563,1.0,40/192,7.37%,FLT1;TEK;PTPRM;ETS1;SEMA6A;CLDN5;PIK3R6;KDR;PPP1R16B;TIE1;DAB2IP;CD34;TGFB2;NOS3;STAB1;RGCC;COL4A2;PLXND1;SP100;CD40;AMOT;APLNR;PRKD1;PRKD2;RAMP2;VASH1;RAPGEF3;PLCG1;HHEX;SARS1;CTNNB1;GATA2;TSPAN12;FGF16;GAB1;RHOB;KLF4;STAT1;GTF2I;CD160
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6694249099146203,1.702260148047833,0.006329113924050633,0.2845733062462759,1.0,12/33,10.12%,HIP1;HIP1R;BCAR3;PLAUR;AFAP1L2;CCDC88A;FBXW7;TGFA;SHKBP1;ADAM17;CNOT9;PTK6
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7044765889074981,-1.7020802536808166,0.014457831325301205,0.2335197339004222,1.0,4/14,7.08%,ANK2;ACTN2;ATP1B3;ATP1B2
prerank,phospholipid catabolic process (GO:0009395),0.71494196109283,1.7011981874394215,0.003278688524590164,0.283230403471197,1.0,5/24,8.63%,GPCPD1;PLA2G4B;PNPLA6;GDPD1;ENPP2
prerank,ceramide transport (GO:0035627),0.805806369803586,1.6992187654815112,0.01092896174863388,0.2852703367342931,1.0,2/12,0.53%,CERT1;PLTP
prerank,hematopoietic stem cell proliferation (GO:0071425),0.8240212315836614,1.6983824913185859,0.007619047619047619,0.28371129818435065,1.0,3/11,5.83%,MECOM;CD34;ETV6
prerank,skeletal system morphogenesis (GO:0048705),-0.5507099427307173,-1.6968394535941391,0.01643835616438356,0.24082787593125268,1.0,18/42,16.73%,PDGFRA;HOXC4;FGFR2;HOXB3;CYP26B1;HOXA3;HOXB4;WWOX;DYNC2I1;TGFBR1;SIX1;SFRP4;FUZ;FBN2;SKI;HOXA9;LRP6;RFLNA
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.533674355815599,1.6960661881210561,0.0012903225806451613,0.2869176195532529,1.0,33/138,9.30%,PTPRG;FLT1;IGF1R;TEK;MPZL1;KDR;INSR;TIE1;BMPR2;RASGRP4;FES;FLT4;NEDD9;PTK2;MTSS1;JAK3;RAPGEF1;ZAP70;MERTK;LYN;NPPA;CD4;EPHA4;FYN;RET;YES1;EPHB4;HCK;PTN;SHC3;CD8B;NPR1;LIFR
prerank,ureteric bud morphogenesis (GO:0060675),-0.7021811255013485,-1.6951286729656876,0.00909090909090909,0.23972739263501136,1.0,9/16,17.88%,BMP4;SALL1;PKD2;FGF2;SIX1;BMP2;NPNT;WNT11;PAX2
prerank,nuclear migration (GO:0007097),-0.7161204522204703,-1.6943590201053051,0.004662004662004662,0.23651615366681536,1.0,7/13,17.32%,DOCK7;SYNE2;CLMN;SYNE3;PCM1;FBXW11;SUN2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.43541060017734456,-1.6895525247298537,0.0,0.24373069022298832,1.0,36/152,13.00%,RNF220;WLS;SULF1;ZEB2;EGFR;LGR4;COL1A1;PTK7;FGFR2;GPC3;WNT5B;RSPO3;LRRK1;KANK1;SULF2;SALL1;LYPD6;TBL1XR1;DAAM2;PLEKHA4;RSPO2;SFRP4;DACT1;TNKS2;PSME4;UBR5;SMURF2;AXIN1;PPM1B;TRPM4;PSME3;LRRK2;CAPRIN2;BMP2;SCEL;SKI
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.5597133917023186,1.689458235228817,0.001364256480218281,0.30461718903943025,1.0,16/93,5.25%,PLCB1;MFHAS1;DAB2IP;TGFB2;MAP4K2;TNFRSF19;APP;XDH;ANKRD6;TIRAP;SH3RF1;FLT4;TPD52L1;NOD2;WNT7A;CCR7
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6029460315369535,1.6874271351081422,0.0045662100456621,0.3078075952902657,1.0,25/54,14.66%,ETS1;PDGFB;KDR;NOS3;RGCC;MEF2C;CD40;ACVRL1;PRKD1;PRKD2;VASH1;TMSB4X;PLCG1;PRCP;GATA2;TGFB1;ADAM17;AGTR2;HSPB1;HIF1A;ATP5F1A;PPARG;CSNK2B;SP1;NUS1
prerank,chordate embryonic development (GO:0043009),-0.5146482801925326,-1.6852750832045649,0.0,0.2501996083294382,1.0,16/55,6.93%,SULF1;ALDH1A2;COL1A1;BMP5;BMP7;FGFR2;ARNT2;PCSK5;PKD1;SULF2;RBP4;TGFBR1;PKD2;IGF2;DACT1;ZNF568
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.8050763163044203,1.6826718924190682,0.007352941176470588,0.31998810748212925,1.0,4/11,2.47%,TJP1;RAPGEF2;TJP2;F11R
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.7973139789023657,1.6824651617125885,0.0055658627087198514,0.316013403093756,1.0,4/12,8.62%,IGF1R;INSR;IRGM;FYCO1
prerank,modified amino acid transport (GO:0072337),-0.6684042807321772,-1.6818536845263952,0.015283842794759825,0.2535766973328413,1.0,4/15,6.32%,SLC6A13;SLC16A12;PDPN;SLC5A6
prerank,digestive tract development (GO:0048565),-0.5761003472272869,-1.6811766342907926,0.01,0.2498841792704834,1.0,13/32,7.73%,GLI3;CLMP;RARB;GLI2;FGFR2;PCSK5;COBL;PKD1;SMO;SALL1;KIT;GLI1;CHD8
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.582958950112838,1.6788350215133268,0.0014749262536873156,0.3239938410709961,1.0,17/67,6.86%,FLT1;IGF1R;TEK;PDGFB;KDR;INSR;FES;FLT4;PTK2;JAK3;ZAP70;LYN;EPHA4;FYN;MAPK3;AATK;HCK
prerank,phospholipid transport (GO:0015914),0.6049898024365565,1.6763464873920715,0.007564296520423601,0.32794629595199626,1.0,15/52,9.75%,ATP10A;MFSD2A;PLTP;ATP8A1;ATP11B;SCARB1;ABCG1;PITPNC1;ATP11A;PRELID2;PITPNA;ABCA3;ABCA7;ATP11C;ATP10B
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6637894836404437,-1.6752920585676805,0.015873015873015872,0.2599845246421668,1.0,8/15,20.69%,ADAM9;APOE;SNX9;SNX33;NRDC;PACSIN3;ADRA2A;ADAM8
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7759270168210952,1.6752432087827909,0.016885553470919325,0.3270490202401104,1.0,6/13,7.04%,KDR;ENG;NOTCH4;CTNNB1;DLL4;COL4A1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6946088577055166,-1.675179231078069,0.017429193899782137,0.25517551427137697,1.0,5/13,3.44%,FSTL1;FBN1;NBL1;LTBP1;GREM2
prerank,positive regulation of cellular component movement (GO:0051272),0.6896578277456148,1.674602885209955,0.01487603305785124,0.3247467784289903,1.0,6/24,6.03%,SPOCK2;ETS1;NTN1;LYN;CCR7;ACTN4
prerank,negative regulation of cell junction assembly (GO:1901889),-0.6029953701001434,-1.674398575487024,0.009615384615384616,0.25251479860217657,1.0,11/25,13.57%,PHLDB2;ARHGAP6;ROCK2;APOD;THBS1;ACE;ITGB1BP1;ROBO2;DMTN;BCAS3;PTEN
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6700037196010835,1.6729510308083457,0.015228426395939087,0.3260996330509168,1.0,7/26,11.43%,OCLN;FES;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1
prerank,lung development (GO:0030324),-0.5642927607375617,-1.6727364720725004,0.012468827930174564,0.25204747411257244,1.0,11/33,6.13%,GLI2;ERRFI1;PDPN;FGFR2;BMP4;FGF1;PKD1;RBP4;LOXL3;FGF2;RCN3
prerank,tight junction assembly (GO:0120192),0.6156895168239913,1.6722985371052954,0.0030349013657056147,0.32412741262321354,1.0,10/49,6.92%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;LSR;MARVELD2;CLDN14
prerank,aminoglycan biosynthetic process (GO:0006023),-0.5187932335640799,-1.6708353147930872,0.0058823529411764705,0.2520337541072318,1.0,14/49,9.24%,GPC6;SDC2;B3GALT1;EXT1;GPC3;HS3ST3A1;HS2ST1;GPC4;PXYLP1;HS3ST3B1;HS6ST1;SDC4;HS6ST2;NDST2
prerank,organic acid transport (GO:0015849),0.5584186044198968,1.6707638818585921,0.0041265474552957355,0.3250914136906924,1.0,11/94,2.87%,SLCO1C1;SLC6A6;ABCC4;SLC7A1;ABCG2;MFSD2A;SLCO2B1;PPARD;SLC38A5;NCOA1;SLC43A2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7231337011188042,-1.6697201879602337,0.019650655021834062,0.25068189703555027,1.0,3/11,2.31%,EGFR;BMP4;DDX5
prerank,ceramide metabolic process (GO:0006672),0.6089986219735595,1.668154555636507,0.006125574272588055,0.33017119524340205,1.0,16/49,15.00%,SGMS1;ST6GALNAC3;SGMS2;DEGS2;ACER2;CERS4;ACER1;TLCD3B;SPTLC2;ORMDL1;ORMDL3;CERK;DEGS1;SPTLC1;CLN8;FA2H
prerank,neurotransmitter uptake (GO:0001504),-0.7298278405116656,-1.6677464149990213,0.008791208791208791,0.251289064067352,1.0,2/12,0.90%,ATP1A2;SLC1A3
prerank,endothelial cell development (GO:0001885),0.684526358374059,1.6674363634456613,0.008051529790660225,0.32858772951279863,1.0,12/25,8.79%,PECAM1;PPP1R16B;ROBO4;PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;PDE4D;MARVELD2;SOX18;RAP1B;MSN
prerank,peptide catabolic process (GO:0043171),-0.6152968574203026,-1.6668552092120936,0.015748031496062992,0.24913659445316103,1.0,8/23,13.45%,CPQ;ANPEP;GGT5;ACE;ENPEP;NPEPPS;IDE;CTSH
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.7490123488156414,1.6660927221075994,0.0166358595194085,0.329175485838799,1.0,2/16,0.95%,IGF1R;INSR
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6912388006401151,-1.6658716067270993,0.016913319238900635,0.24741377886057386,1.0,6/15,10.98%,IGF1;ROCK2;CAMK2D;PRKCA;SLC9A1;PARP1
prerank,embryonic organ morphogenesis (GO:0048562),-0.5273187669515407,-1.6657766680244537,0.008426966292134831,0.2434532627671702,1.0,13/42,5.68%,FBN1;PDGFRA;EFEMP1;HOXC4;FGFR2;HOXB3;HOXA3;MFAP5;HOXB4;RBP4;DYNC2I1;RBPMS2;SIX1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5165711263394304,1.665773502362721,0.0,0.3260302483000077,1.0,36/151,13.84%,SGMS1;CERT1;MFSD2A;SGPP2;ELOVL7;SGMS2;DEGS2;ACER2;SPNS2;B4GALT5;GCH1;CERS4;ALAS1;PPM1L;PRKD1;PRKD2;PRKD3;SLC44A5;MGST2;ACER1;GSTA4;SPTLC2;GPHN;CHKA;ELOVL5;HPGDS;LPCAT3;GSTK1;SLC25A15;ELOVL6;CEPT1;CSNK2B;LPIN3;HACD2;DEGS1;SPTLC1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.660152896614896,1.6645164364612908,0.014263074484944533,0.3267394695721981,1.0,9/30,12.47%,DACH1;BMPR2;ACVRL1;MEN1;TERF2;HNRNPC;ACD;DCP2;TERF1
prerank,positive regulation of angiogenesis (GO:0045766),0.5320076925088959,1.664049680245335,0.0,0.32426808173182925,1.0,19/108,5.30%,FLT1;TEK;ETS1;TJP1;PIK3R6;KDR;TIE1;CD34;NOS3;CD40;APLNR;PRKD1;PRKD2;RAMP2;RAPGEF3;PLCG1;GATA2;GAB1;RHOB
prerank,carboxylic acid transport (GO:0046942),0.5972791947711067,1.6637084817126273,0.0015220700152207,0.32123891207987637,1.0,7/55,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC16A4;SLC16A2;SLC38A5
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.7465731651126377,-1.6636605574470162,0.02127659574468085,0.24440220693655837,1.0,7/10,18.63%,HOXB4;ACE;MLLT3;LMBR1L;SFRP1;BATF;SP7
prerank,negative regulation of reproductive process (GO:2000242),-0.6779947611826377,-1.6625373427696473,0.009029345372460496,0.242938290238842,1.0,3/17,3.09%,SULF1;IGF1;GJA1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.745040950071169,-1.662520831106016,0.01910828025477707,0.23906743070509254,1.0,5/10,8.52%,PID1;APPL2;ENPP1;SELENOS;GRB10
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6474524941424452,1.6618743867005967,0.0144,0.3239791162810081,1.0,6/36,4.52%,LEF1;PLCB1;FZD6;FZD4;CALM1;CTNNB1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.6225657857998289,-1.6596442410514722,0.007537688442211055,0.24219112027586578,1.0,6/21,7.24%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1
prerank,T-helper cell differentiation (GO:0042093),0.7818439877202175,1.6596370139514849,0.01303538175046555,0.32791073976791624,1.0,2/14,3.19%,LEF1;ZFPM1
prerank,alanine transport (GO:0032328),0.8115251821453416,1.6595459134700066,0.021937842778793418,0.3243256238027321,1.0,1/10,0.07%,SLC6A6
prerank,cartilage development (GO:0051216),-0.508339000531223,-1.656652489721923,0.0058309037900874635,0.24541659553142156,1.0,15/49,9.46%,SULF1;SOX5;WNT5B;BMP4;OSR1;ITGB8;PKD1;SULF2;CREB3L2;SLC39A14;FGF2;RUNX2;ATP7A;CCN3;SOX6
prerank,bicellular tight junction assembly (GO:0070830),0.6178941999551059,1.6563092167674995,0.007739938080495356,0.3316035552885353,1.0,9/46,6.92%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;MARVELD2;CLDN14
prerank,epithelial cell morphogenesis (GO:0003382),-0.6494771927969027,-1.6550544463613754,0.012958963282937365,0.24564313392729675,1.0,6/17,13.60%,COL22A1;COL18A1;COL15A1;MET;DACT2;RILPL2
prerank,protein localization to cilium (GO:0061512),-0.5584086539688824,-1.6545467388888555,0.010526315789473684,0.24312604063979498,1.0,12/32,17.78%,TULP3;WDR35;INVS;ARL3;ZNF423;IFT122;EHD1;BBS9;RAB29;WDR19;SNX10;TULP1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.5574287305693222,1.654256017679008,0.0014064697609001407,0.335378118933835,1.0,13/75,4.52%,TEK;EGFL7;JCAD;PDGFB;KDR;PPP1R16B;BMPR2;FLT4;APLNR;PRKD1;PRKD2;PLCG1;GATA2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.6769746045784992,-1.652934051889957,0.011961722488038277,0.2432481384485171,1.0,4/14,13.99%,MOXD1;DAGLA;SLC5A7;SLC22A2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.8055106731451891,1.6526281118169304,0.013618677042801557,0.33733587921735586,1.0,2/10,1.56%,PRKCH;TRIM16
prerank,apical junction assembly (GO:0043297),0.5920063322611413,1.6520122550354739,0.007385524372230428,0.33563267885890985,1.0,10/53,6.92%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;MARVELD2;PKN2;CLDN14
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.6458235364577041,-1.6474545882373504,0.026378896882494004,0.25166750058231013,1.0,10/19,9.61%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBP4;TGFBR1;RBPJ;FGF2;GLI1;VGLL4
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.7053069301245862,-1.647091787625757,0.0091324200913242,0.24887376844238596,1.0,4/12,11.14%,ANK2;ANXA6;DIAPH1;PTK2B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5530980200529203,1.6469095300429972,0.008426966292134831,0.35014128734318717,1.0,62/87,32.25%,RPL38;RPL13;RPS29;RPL36A;RPL3;RPL27;RPSA;SRP14;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPL18A;RPS21;RPL10A;RPL24;RPL7A;ZFAND2B;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;SEC63;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,smooth muscle contraction (GO:0006939),-0.7045745728765425,-1.645703435465309,0.01834862385321101,0.24872621361973105,1.0,7/14,9.85%,ROCK2;MYLK;EDNRA;SLC8A1;MYH11;BDKRB2;ACTA2
prerank,insulin receptor signaling pathway (GO:0008286),0.559171494679185,1.6447023454810321,0.007246376811594203,0.3540607355110244,1.0,17/69,10.31%,IGF1R;GRB14;NAMPT;INSR;BCAR3;FOXO1;PIK3R3;ATP6V0A1;GRB2;GAB1;BAIAP2;SOS1;SORBS1;AP3S1;CAV2;PIK3C2A;GRB7
prerank,positive regulation of cell motility (GO:2000147),0.49698961568927624,1.6426365413887192,0.0,0.3576121022875613,1.0,33/205,6.46%,LEF1;SPOCK2;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;PECAM1;SEMA6A;TJP1;PDGFB;KDR;INSR;PODXL;CXCL12;PDGFD;CAV1;NTN1;NEDD9;SEMA6B;PTK2;PIK3R3;TIAM1;NOTCH1;VIL1;RIPOR1;SEMA4F;CCR7;SNAI2;ACTN4;FAM107A;ADAM10;RET
prerank,positive regulation of isotype switching (GO:0045830),0.7411135538776933,1.6424987996464553,0.018211920529801324,0.3541269306823152,1.0,4/15,8.09%,TFRC;CD40;SHLD1;TGFB1
prerank,ameboidal-type cell migration (GO:0001667),0.5865831267185815,1.6424293199568416,0.013846153846153847,0.35040966454297545,1.0,15/51,9.46%,SEMA3C;SEMA7A;SEMA6A;SRGAP2;TBX1;SEMA6B;PKN3;AMOT;SEMA4F;PKN1;NANOS1;PKN2;SEMA6D;SEMA4C;PHACTR4
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.7030018413168856,-1.641102152527722,0.017130620985010708,0.25656058291160894,1.0,2/12,3.28%,NUPR1;IL18
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7669771907508416,1.640147415060389,0.013409961685823755,0.35496252754541135,1.0,3/13,3.20%,NAMPT;KDR;NOD2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.4330711858313775,-1.6397156727850872,0.0,0.25662395339402316,1.0,27/129,11.53%,RNF220;WLS;ZEB2;EGFR;LGR4;COL1A1;PTK7;FGFR2;GPC3;LRRK1;KANK1;LYPD6;TBL1XR1;DAAM2;PLEKHA4;SFRP4;DACT1;TNKS2;PSME4;UBR5;SMURF2;AXIN1;PPM1B;TRPM4;PSME3;LRRK2;CAPRIN2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.7081601807486136,1.6368373307578352,0.015437392795883362,0.3637552176495772,1.0,6/20,12.39%,PLCB1;AGRN;GNAQ;LYPD1;CHRM3;GNB1
prerank,regulation of cardiac conduction (GO:1903779),-0.4950268458580069,-1.6365561048682216,0.009771986970684038,0.2610829151913726,1.0,14/54,10.47%,ATP1A2;ANK2;ITPR1;STIM1;SLC8A3;DMPK;ASPH;ABCC9;ATP1B3;TMEM65;ATP1B2;SLC8A1;PRKACA;ITPR2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.5968739742344252,1.635561300273697,0.012269938650306749,0.36468576386798857,1.0,22/47,16.28%,IGF1R;DAB2IP;TGFB2;FAS;PHLPP1;FOXO1;NOD2;PPIA;MAPK3;LGALS9;GREM1;SEMA4C;AGER;PDCD10;ARL6IP5;MID1;MAP4K4;EPHB1;INAVA;MAPK1;KLHDC10;COPS5
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7087787661290723,1.6297964618014043,0.023450586264656615,0.38350956083114424,1.0,9/17,16.13%,TGFB2;NOD2;LYN;SEMA4C;PDCD10;ARL6IP5;MID1;INAVA;KLHDC10
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.729677095882347,1.6293529317155524,0.015789473684210527,0.3812869382222892,1.0,3/15,4.02%,PLTP;SCARB1;ABCG1
prerank,positive regulation of cell adhesion (GO:0045785),0.5541952305593013,1.6291519648080441,0.005578800557880056,0.37811878171867197,1.0,16/74,6.46%,NDNF;FRMD5;PDGFB;TGFB2;CXCL12;MAGI1;STX3;ADGRG1;PTPRJ;PRKD2;TGM2;SMAD7;CCR7;EPHA4;RSU1;RET
prerank,cellular response to fatty acid (GO:0071398),-0.6979278859655592,-1.628889470666494,0.016203703703703703,0.27684318552136417,1.0,2/12,2.41%,PID1;IRS1
prerank,mesoderm development (GO:0007498),0.7068728805713951,1.6285519072568424,0.012455516014234875,0.3763939972248179,1.0,5/18,6.86%,TIE1;TBX1;TBX3;MESD;HCK
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6296261843559695,-1.6281313562787185,0.024282560706401765,0.2748927647653822,1.0,4/18,6.13%,IGF1;IGFBP2;IL18;IGF2
prerank,carbohydrate derivative transport (GO:1901264),0.7004665228294373,1.6278614809648868,0.020942408376963352,0.37509820791139026,1.0,5/18,6.50%,MFSD2A;PLTP;SCARB1;ABCG1;SLC10A7
prerank,positive regulation of T cell activation (GO:0050870),0.5625619789232535,1.6276028894986416,0.008915304606240713,0.3724459775207522,1.0,17/62,17.12%,TFRC;SLC7A1;JAK3;NOD2;ZAP70;CD6;CCR7;CCDC88B;LGALS9;PNP;TNFSF11;CYRIB;IL15;NCKAP1L;VCAM1;NCK1;CCR2
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.5342105165913509,-1.6270735787914492,0.0076726342710997444,0.2738849206130665,1.0,17/40,12.43%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;WNT6;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;CEBPB;FBN2;PKDCC;BMP2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6654541378325158,-1.626973997752381,0.02522935779816514,0.270557454045082,1.0,8/16,6.56%,IGF1;TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6273101126286086,1.6257556883251272,0.02030456852791878,0.3757563020841615,1.0,9/31,11.85%,PLCB1;TIRAP;CD40;CCR7;TLR3;LGALS9;IRF5;AGER;SYK
prerank,regulation of endothelial cell proliferation (GO:0001936),0.5380095435781255,1.6255997281392855,0.004070556309362279,0.37265814459493896,1.0,16/88,3.62%,TEK;PTPRM;EGFL7;PDGFB;KDR;PPP1R16B;TIE1;BMPR2;XDH;CAV1;FLT4;RGCC;ACVRL1;PRKD1;PRKD2;VASH1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.67141874685007,-1.6238933725342048,0.017699115044247787,0.2748665869951922,1.0,7/16,10.98%,IGF1;ROCK2;CAMK2D;TRPC3;PRKCA;SLC9A1;PARP1
prerank,regulation of gastrulation (GO:0010470),-0.6712824057944125,-1.6235234330407642,0.016091954022988506,0.27233165102109547,1.0,4/14,7.49%,PHLDB2;OSR1;DAG1;PHLDB1
prerank,regulation of transmembrane transport (GO:0034762),0.6324504812950748,1.6217911728078422,0.01730103806228374,0.38310024491495553,1.0,5/31,3.87%,OCLN;SLC2A1;CTTNBP2NL;NEDD4L;ACTB
prerank,regulation of GTPase activity (GO:0043087),0.49459476568906036,1.6215240367693917,0.0012254901960784314,0.3804246735603435,1.0,45/177,11.60%,CHN2;ITGA6;DOCK9;FGD5;LRCH1;SRGAP2;DAB2IP;RASIP1;RAPGEF2;SH3BP4;ARHGAP27;NET1;BCAR3;F11R;AGRN;PTK2;PLXND1;RAPGEF1;CD40;SNX13;RAPGEF3;PRKG1;TGM2;TBC1D2;USP6NL;MAPRE2;EPHA4;OCRL;RSU1;RAP1GDS1;RASGRP2;STMN3;PKP4;FICD;ARHGEF5;PIN1;CAV2;ARHGEF7;FGD6;FERMT2;TBC1D10B;CCL1;PLXNB3;HRAS;TBC1D30
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5861273683552745,1.6212554620133093,0.010447761194029851,0.3777804990774173,1.0,11/48,12.52%,SLC7A5;IL1R1;ZFPM1;PDE4D;TLR3;LGALS9;TLR7;PDE4B;EBI3;TLR8;CYRIB
prerank,vesicle transport along actin filament (GO:0030050),0.6948292936653836,1.6205879866821244,0.02631578947368421,0.3768023171413541,1.0,6/19,10.03%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4;MYO1F
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6429350156989065,1.6200058110007265,0.020134228187919462,0.37519598983639807,1.0,12/28,21.14%,OCLN;FES;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1;GIT1;CKAP5;DCTN1;MECP2;CLASP1
prerank,cardiac muscle contraction (GO:0060048),-0.5449501880553211,-1.619070625978758,0.005390835579514825,0.2795417731400658,1.0,7/34,10.13%,ATP1A2;GSN;TPM1;DMD;CAMK2D;SLC8A1;GAA
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5676765287019591,1.6186516167205567,0.010057471264367816,0.37652382568928155,1.0,9/63,6.19%,TFRC;SLC7A1;TIRAP;MEF2C;JAK3;CD40;CD6;CD38;CCDC88B
prerank,eye morphogenesis (GO:0048592),-0.6319528887300732,-1.6179825727405202,0.01990049751243781,0.27851450774852343,1.0,9/19,13.29%,FBN1;COL5A2;COL5A1;EFEMP1;MFAP5;IFT122;FBN2;SKI;NF1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.7041252615359062,-1.6179057591216075,0.020876826722338204,0.2753095340212733,1.0,8/12,16.33%,PARP8;PARP3;TNKS2;PARP11;PARP6;PARP1;PARP12;TIPARP
prerank,neural crest cell development (GO:0014032),0.5907896352712219,1.6174940663058386,0.012307692307692308,0.37711944306343465,1.0,15/44,14.26%,SEMA3C;SEMA7A;SEMA6A;TBX1;SEMA6B;CDH2;SEMA4F;SNAI2;SEMA6D;SEMA4C;PHACTR4;SOX10;SOX11;PDCD6;SEMA3G
prerank,monocarboxylic acid transport (GO:0015718),0.5842338560604632,1.616299152514238,0.011782032400589101,0.3785882844854378,1.0,7/51,2.80%,SLCO1C1;ABCC4;ABCG2;SLCO2B1;SLC16A4;SLC16A2;NCOA1
prerank,cellular zinc ion homeostasis (GO:0006882),0.653310322117457,1.6159993690239038,0.021487603305785124,0.3762195691006435,1.0,11/26,13.52%,SLC39A10;SLC39A8;SLC30A1;MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6172435716539376,-1.6142961350646785,0.016706443914081145,0.28107592254478236,1.0,7/21,9.50%,BMP6;BMPR1A;BMP4;TGFBR1;DAB2;CCN3;TGFB3
prerank,cAMP biosynthetic process (GO:0006171),-0.7404626713063094,-1.6140709852361486,0.018867924528301886,0.27817386778259184,1.0,5/10,4.82%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.57009010974941,-1.6134485998434966,0.005509641873278237,0.2765180963204154,1.0,11/27,24.43%,EGFR;BMP4;DDX5;AGO2;TNRC6B;FMR1;LIMD1;EIF4G1;MAP2K1;AJUBA;STAT3
prerank,sulfation (GO:0051923),-0.711765233039459,-1.6133060854418733,0.03111111111111111,0.27363379665484827,1.0,1/11,0.06%,UST
prerank,zinc ion transmembrane transport (GO:0071577),0.6668659043094632,1.6132513649004532,0.029605263157894735,0.3825311261546985,1.0,3/22,3.02%,SLC39A10;SLC39A8;SLC30A1
prerank,clathrin coat assembly (GO:0048268),0.7236391003263392,1.6129829608098254,0.01592920353982301,0.3800185375897376,1.0,5/15,12.19%,HIP1;HIP1R;FCHO2;PIK3C2A;EPS15
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.5829978478770363,-1.6123929270114874,0.024271844660194174,0.27284683662277265,1.0,6/24,10.91%,PID1;LEPR;PPARGC1A;GFPT1;GFPT2;COQ10A
prerank,regulation of plasminogen activation (GO:0010755),-0.6938149624820533,-1.611757756011276,0.024444444444444446,0.2714642205571429,1.0,6/12,19.06%,THBS1;CLEC3B;SERPINE2;CTSZ;RUNX1;SERPINE1
prerank,regulation of cell projection organization (GO:0031344),0.7534342529654138,1.6105263968806023,0.02819548872180451,0.38538686017661566,1.0,3/13,3.39%,MFSD2A;MACF1;NTNG2
prerank,respiratory tube development (GO:0030323),-0.5583382435670612,-1.6104522945110316,0.0199501246882793,0.2717009886618206,1.0,9/28,4.69%,GLI2;PDPN;FGFR2;BMP4;FGF1;PCSK5;RBP4;LOXL3;FGF2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.6147729341770337,1.6099345830013114,0.025806451612903226,0.3840353130810195,1.0,7/36,6.54%,SGMS1;DAB2IP;FAS;TPD52L1;PTPMT1;PPIA;CRADD
prerank,innate immune response (GO:0045087),0.4785689399924442,1.6097185104026208,0.0,0.3815742935653626,1.0,45/217,13.35%,MFHAS1;PGLYRP1;APP;FES;GCH1;TRIM25;TRIM14;B2M;PTK2;SERINC3;SP100;ADAM15;CD40;DEFA6;NOD2;IFIH1;NLRC5;ZAP70;LYN;SERINC5;IKBKB;ADAR;NOS2;CFD;TLR3;NRROS;FYN;YES1;HCK;IRF5;BST2;SHMT2;IRGM;MALT1;PTK6;AGER;CYBB;TLR8;SYK;TNK2;RNF187;SLPI;PPARG;CYLD;TRIM39
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5863777728377974,1.6092998717793547,0.00764525993883792,0.3797721953565668,1.0,20/48,11.99%,ETS1;JCAD;PDGFB;KDR;NOS3;CD40;PRKD1;PRKD2;HDAC9;HDAC7;TMSB4X;PLCG1;GATA2;TGFB1;MAP3K3;ADAM17;PIK3C2A;HSPB1;HIF1A;ATP5F1A
prerank,embryonic hemopoiesis (GO:0035162),0.77046466732796,1.6086518611672964,0.022058823529411766,0.3789609197945049,1.0,4/12,5.20%,KITLG;KDR;ZFPM1;TAL1
prerank,retinoic acid metabolic process (GO:0042573),-0.6738298770015112,-1.6084963854643053,0.024943310657596373,0.27328501337954525,1.0,3/14,6.81%,ALDH1A2;CYP26B1;SCPEP1
prerank,cellular response to drug (GO:0035690),0.6512360263244369,1.6081016850769245,0.0361247947454844,0.3777332622008276,1.0,7/25,8.10%,TFRC;ACER2;MEF2C;KCNQ1;AIM2;KCNH2;PDE4B
prerank,response to axon injury (GO:0048678),-0.628845451220621,-1.6080120067794583,0.02112676056338028,0.271500873685047,1.0,6/18,22.37%,DPYSL3;APOD;P2RX4;SARM1;GAP43;TYROBP
prerank,odontogenesis (GO:0042476),-0.5288222274385279,-1.6078326445518876,0.014204545454545454,0.2688912264083402,1.0,9/35,3.85%,COL1A2;GLI2;EDA;FGFR2;BMP4;OSR1;WNT6;FOXC1;BCOR
prerank,negative regulation of epithelial cell migration (GO:0010633),0.6253411580518837,1.6063646246621388,0.019704433497536946,0.3809983954604428,1.0,9/33,5.01%,PTPRG;PTPRM;DAB2IP;MCC;SP100;ACVRL1;VASH1;EVL;DLL4
prerank,regulation of T cell proliferation (GO:0042129),0.5576663425060959,1.606294614720675,0.008823529411764706,0.378074448708522,1.0,12/61,16.16%,TFRC;SLC7A1;JAK3;TNFRSF21;CD6;CCDC88B;FOXP3;PNP;IL15;NCKAP1L;VCAM1;NCK1
prerank,regulation of protein neddylation (GO:2000434),0.7848748482008707,1.605693768976199,0.02976190476190476,0.37717177684086833,1.0,6/10,13.34%,EPAS1;DCUN1D3;COPS9;HIF1A;DCUN1D1;RPL11
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.680877845215299,-1.605415125366024,0.021413276231263382,0.2716893656939037,1.0,9/13,21.31%,ADHFE1;IDH2;D2HGDH;GOT1;PHYH;GPT2;L2HGDH;IDH1;GOT2
prerank,regulation of neuron projection arborization (GO:0150011),0.7360790303186531,1.6053828517586144,0.025878003696857672,0.375231339253114,1.0,4/15,3.39%,MFSD2A;MACF1;FZD4;NTNG2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.6743749374379039,1.6053375160057548,0.02821869488536155,0.37239133448392975,1.0,6/20,16.94%,FAR2;FASN;ACSL3;SLC25A1;HSD17B8;DGAT1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.7587437245513703,1.603461538796589,0.029906542056074768,0.3758342216129276,1.0,3/12,0.97%,PROM1;MYO1E;PODXL
prerank,oligosaccharide metabolic process (GO:0009311),0.5923934752661428,1.6020673496907716,0.0091324200913242,0.3777653207602756,1.0,14/46,14.38%,ST8SIA4;ST6GALNAC3;ST3GAL6;ST8SIA6;FUT8;NEU4;FUT9;B3GALT4;ST6GALNAC4;MAN1B1;B3GALT2;MANBA;NEU2;MAN2B1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5535600937929317,1.6002629809982387,0.0091324200913242,0.38100969426776843,1.0,24/67,12.15%,FLT1;KDR;DAB2IP;WASF2;DOCK1;ELMO1;FLT4;PTK2;PRKD1;PRKD2;PXN;ELMO2;BAIAP2;FYN;NCKAP1;PGF;CYFIP1;HSPB1;SHB;CYBB;CLEC14A;RAC1;NCF4;PIK3CB
prerank,calcium ion transmembrane transport (GO:0070588),-0.4525982522234936,-1.5971156166542682,0.0,0.28865168938248903,1.0,25/86,12.34%,SLC24A3;TRPM3;CACNA1C;NALCN;MCU;PKD1;SLC8A3;ANO6;CACNA2D1;PKD2;TRPC3;CACNA1G;TRPM6;SLC35G1;SLC8B1;P2RX4;SLC8A1;CACNA1D;TRPC6;ITGAV;TRPM4;SLC24A5;AFG3L2;TRPC4;TRPC4AP
prerank,histone H3 acetylation (GO:0043966),0.6020194395903123,1.5949354970259164,0.019969278033794162,0.39652256485967574,1.0,12/40,14.76%,LEF1;TRIM16;YEATS2;BRCA2;KAT6A;JADE2;NAA60;BRD1;BRPF1;PHF14;BRPF3;POLE3
prerank,heart morphogenesis (GO:0003007),0.5807198168218601,1.5945233911195198,0.016152716593245228,0.3950208212368752,1.0,11/50,3.41%,INSR;ENG;TGFB2;NOS3;TBX1;SOX17;TBX3;PTK2;ACVRL1;ZFPM1;NOTCH1
prerank,regulation of cell communication (GO:0010646),-0.5184854532089933,-1.5930243791140348,0.017994858611825194,0.2962875807862085,1.0,9/35,8.25%,ANK2;CXADR;GRK5;GRK3;CAMK2D;ANXA1;TBX18;SLC8A1;TSPYL2
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.48589362076288845,-1.5923620214609846,0.009554140127388535,0.2950111992117297,1.0,19/54,15.37%,GPC6;SDC2;EXT1;GPC3;HS3ST3A1;HS2ST1;GPC4;PXYLP1;HS3ST3B1;HS6ST1;SDC4;HS6ST2;NDST2;HEXA;GNS;NDST1;HGSNAT;B3GAT1;HPSE2
prerank,regulation of vasculogenesis (GO:2001212),0.7485551635615632,1.5921073585146008,0.027079303675048357,0.40049149690395586,1.0,4/14,1.74%,KDR;CD34;RAPGEF2;XDH
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5440412953497449,1.5920346794859006,0.007342143906020558,0.397725681021607,1.0,11/72,5.17%,FLT1;IGF1R;TEK;PDGFB;KDR;INSR;TGFB2;PDGFD;PTK2;LYN;GAB1
prerank,mesonephros development (GO:0001823),-0.7062277225506637,-1.590340322480005,0.026373626373626374,0.297535996231909,1.0,4/11,2.26%,BMP7;BMP4;OSR1;FGF1
prerank,peptidyl-tyrosine modification (GO:0018212),0.5635869331427527,1.5886533102267049,0.010510510510510511,0.40698018582565043,1.0,15/56,6.86%,FLT1;TEK;PDGFB;KDR;INSR;FES;FLT4;PTK2;JAK3;ZAP70;LYN;EPHA4;TPST2;FYN;HCK
prerank,cotranslational protein targeting to membrane (GO:0006613),0.5277443825180481,1.588398643881773,0.00819672131147541,0.4047884841507461,1.0,64/91,32.25%,SEC62;RPL38;RPL13;RPS29;RPL36A;RPL3;RPL27;RPSA;SRP14;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPL18A;RPS21;RPL10A;RPL24;SRPRA;RPL7A;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;SEC63;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;SSR1;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.6077907048356593,1.586417064187697,0.01779935275080906,0.4090506398491954,1.0,13/36,12.15%,NOSTRIN;NOS3;CAV1;DDAH1;GCH1;SCARB1;CALM1;DNM2;TERF2;LYPLA1;AGTR2;HIF1A;PIK3CB
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.632217233714478,1.5863947003623196,0.02671118530884808,0.40614704338099217,1.0,8/27,5.25%,FLT1;TEK;PDGFB;PTK2;NOD2;PRKD1;CD19;CCR7
prerank,positive regulation of tissue remodeling (GO:0034105),-0.7230038319029068,-1.5862607591975832,0.018218623481781375,0.30505783674750664,1.0,2/10,3.28%,ROCK2;IL18
prerank,regulation of vasculature development (GO:1901342),0.6400003453257719,1.5860865482090858,0.032590051457975985,0.4043047558205371,1.0,6/26,4.57%,ETS1;PLXND1;SP100;VASH1;CTNNB1;TSPAN12
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5461099961956978,-1.5846332109465187,0.030470914127423823,0.3061807530027974,1.0,10/31,5.68%,PDGFRA;HOXC4;FGFR2;OSR1;HOXB3;HOXA3;HOXB4;DYNC2I1;TGFBR1;SIX1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.6138701290888777,1.584584568031093,0.021875,0.40692380560826863,1.0,8/29,5.25%,FLT1;TEK;PDGFB;PTK2;NOD2;PRKD1;CD19;CCR7
prerank,positive regulation of cell migration (GO:0030335),0.46971052040772454,1.5837621436353133,0.0011750881316098707,0.40681986755524985,1.0,53/253,10.41%,LEF1;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;PECAM1;SEMA6A;TJP1;PDGFB;KDR;INSR;PODXL;DAB2IP;BMPR2;TGFB2;CXCL12;RAPGEF2;PDGFD;DOCK1;CAV1;NEDD9;SEMA6B;ARHGEF2;PTK2;PIK3R3;TIAM1;NOTCH1;VIL1;RIPOR1;PLCG1;RREB1;SEMA4F;GAB1;SNAI2;ACTN4;FAM107A;INSL3;ADAM10;RET;SEMA6D;RAB11A;SPAG9;TGFB1;ARHGEF7;ENPP2;PAK1;SEMA4C;ACTG1;ADAM17;CBLL1;GRB7;PDCD10
prerank,ganglioside metabolic process (GO:0001573),0.6815483083226405,1.5835584295902438,0.036585365853658534,0.4046076368363153,1.0,3/20,1.09%,ST8SIA4;ST6GALNAC3;ST8SIA6
prerank,regulation of muscle contraction (GO:0006937),-0.5658462355539159,-1.5820818201482876,0.02608695652173913,0.309941526828543,1.0,7/26,8.94%,ATP1A2;PLCE1;TPM1;PPP1R12B;ANXA6;KCNB2;MYL9
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6620578682934186,-1.5815221221121822,0.024229074889867842,0.3085348280613643,1.0,4/13,12.43%,BMP5;DKK3;APOE;BMP2
prerank,synaptic membrane adhesion (GO:0099560),-0.6503356370140454,-1.5810178221175226,0.04415011037527594,0.3067803685944939,1.0,4/14,4.60%,GPC6;PTPRF;PTPRS;GPC4
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7363861025190075,1.5801666459815547,0.05565529622980251,0.4136254342080885,1.0,5/12,7.16%,CAV1;GJD3;CALM1;PDE4D;SRI
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5252609317463297,1.5790325649999988,0.006858710562414266,0.4146589986433193,1.0,9/91,4.15%,SLC39A10;TFRC;SLC40A1;ABCG2;SLC39A8;APP;ATOX1;SLC30A1;SLC31A1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.661127645863828,1.578502462678765,0.0288135593220339,0.4138460228542053,1.0,7/20,9.32%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,filopodium assembly (GO:0046847),0.6996210544038404,1.5784454501356533,0.031413612565445025,0.41117580448370644,1.0,5/16,3.96%,DNM3;FGD5;SRGAP2;SPATA13;PPP1R9B
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4899535622430605,1.5782491834542558,0.005154639175257732,0.4090865539397651,1.0,31/149,11.71%,TFRC;PRKCH;APP;CAV1;TIRAP;NFKBIA;TRIM25;TNFRSF11A;TRIM14;ARHGEF2;NOD1;CD40;NOD2;PRKD1;PRKD2;IKBKB;PPIA;RPS6KA5;LGALS9;AIM2;CRNN;PIDD1;IRAK2;MALT1;UBE2V1;AGER;LAMTOR5;S100A8;TNFSF11;PRKCB;ZBTB7A
prerank,synapse assembly (GO:0007416),0.5483518378888849,1.576862624696311,0.017316017316017316,0.4111621402641435,1.0,14/67,9.29%,SPOCK2;DNM3;SHANK3;ADGRL3;PLXND1;FGF13;CDH2;WNT7A;GRID2;DBNL;SLITRK1;GPM6A;NRXN1;DNER
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7077569414659092,1.5758636877791827,0.04092526690391459,0.41186077111179664,1.0,5/16,5.21%,NDNF;NOS3;DDAH1;NOS2;KCNC2
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.6581329530379609,-1.574079782745958,0.015590200445434299,0.3215862821911156,1.0,5/15,8.93%,LRP1;PDPN;DDR1;FAP;DPP4
prerank,regulation of actomyosin structure organization (GO:0110020),-0.6650965903797375,-1.5739803090670017,0.0367170626349892,0.31879615759531665,1.0,6/13,10.27%,ROCK2;ASAP3;ALMS1;AKAP13;FHOD1;SLC9A1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6928831689179397,1.5734992199859057,0.02866779089376054,0.41750512612069346,1.0,5/18,12.39%,PLCB1;AGRN;GNAQ;CHRM3;GNB1
prerank,regulation of B cell proliferation (GO:0030888),0.5826315727773193,1.5728940582019604,0.01775147928994083,0.4168890847641243,1.0,7/44,5.65%,TFRC;TIRAP;MEF2C;CD40;LYN;TNFRSF21;CD38
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5050847755331616,-1.5693441956914076,0.008670520231213872,0.3280635557027651,1.0,16/43,12.04%,IGF1;BMPR1A;PDGFRB;IGFBP5;BMP4;GJA1;IL18;THBS1;FGF2;RBPMS2;MMP2;FOXJ2;CCN4;CDH13;ADAMTS1;MFN2
prerank,neural crest cell migration (GO:0001755),0.5982107586737647,1.5692882211333823,0.02321981424148607,0.4268956538414441,1.0,9/36,9.46%,SEMA3C;SEMA7A;SEMA6A;TBX1;SEMA6B;SEMA4F;SEMA6D;SEMA4C;PHACTR4
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.6963275414156278,1.569256176567648,0.04212454212454213,0.424142218443208,1.0,3/16,1.09%,ST8SIA4;ST6GALNAC3;ST8SIA6
prerank,receptor internalization (GO:0031623),0.5959202509504764,1.5682158349072794,0.01951951951951952,0.425098489495609,1.0,12/44,8.20%,TFRC;DNM3;CAV1;RAB31;RAMP2;CALCRL;GRB2;RAMP3;GTF2H2;DNM2;AP2M1;CXCR2
prerank,metanephros development (GO:0001656),-0.5683131767469345,-1.5677900840250691,0.028871391076115485,0.32923793915990823,1.0,12/26,17.88%,FOXD1;BMP7;BMP4;OSR1;PKD1;PKD2;SIX1;ROBO2;NF1;CTSH;SIX4;PAX2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.567607872939569,-1.56765404001682,0.021447721179624665,0.3264545315437224,1.0,8/25,8.56%,ANK2;ACTN2;SLC6A9;DMD;WNK4;ATP1B3;ATP1B2;TRPC6
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.7045225370753249,-1.567625698343504,0.036170212765957444,0.3235045204281047,1.0,7/10,25.66%,SETD7;SETD4;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4460836957991291,1.567275409068162,0.0,0.4257050812210638,1.0,94/390,12.50%,PTPRG;FLT1;IGF1R;GRB14;TEK;PLCB1;MPZL1;NAMPT;PDGFB;KDR;INSR;TIE1;WASF2;RAPGEF2;PDGFD;DOCK1;RASGRP4;FES;ELMO1;ANKS1A;FLT4;BCAR3;NEDD9;PTPRJ;PTK2;MTSS1;COL4A2;KALRN;ARPC4;FOXO1;RAPGEF1;PIK3R3;TIAM1;PRKD1;PRKD2;ATP6V0A1;ZAP70;MERTK;PXN;ACTB;LYN;ELMO2;STMN1;SOCS2;GRB2;FGF16;SORT1;GAB1;CD4;EPHA4;BAIAP2;FYN;SOS1;MAPK3;RET;YES1;NCKAP1;EPHB4;HCK;SORBS1;ANKS1B;EFNA1;TIAL1;AP2M1;AP3S1;CAV2;ARHGEF7;SHC3;CD8B;ARPC3;PAK1;PGF;PLAT;ACTG1;PTK6;DDIT4;CYFIP1;PIK3C2A;GRB7;SHB;CYBB;APH1A;GRIN2B;RAC1;NCBP2;HRAS;GSK3A;SYK;NCF4;PIK3CB;TNK2;AP2B1;GDF15;EPHB1
prerank,regulation of interleukin-13 production (GO:0032656),0.7540169913742942,1.5662589453082214,0.040892193308550186,0.42680299528644333,1.0,3/13,6.44%,LEF1;TNFRSF21;LGALS9
prerank,positive regulation of locomotion (GO:0040017),0.6441024830790446,1.5657679479136821,0.02866779089376054,0.42580493399274627,1.0,6/27,8.09%,SPOCK2;PDGFB;NTN1;STX3;CCR7;TGFB1
prerank,regulation of striated muscle contraction (GO:0006942),-0.5469765369875705,-1.5649203492661143,0.025906735751295335,0.3281827794922937,1.0,6/27,10.12%,ATP1A2;ANK2;SLC8A3;DMD;P2RX4;PRKACA
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.6450355759920913,1.564545945086901,0.030252100840336135,0.427335542819729,1.0,3/22,5.61%,SLC7A5;NOD2;TRIL
prerank,negative regulation of wound healing (GO:0061045),-0.5475585897574264,-1.5640691210898936,0.022277227722772276,0.3274303596381039,1.0,9/28,8.01%,PHLDB2;TFPI;VTN;CASK;SLC12A2;FGF2;THBD;CD109;APOE
prerank,glucose transmembrane transport (GO:1904659),0.6902633914372378,1.5640171416200728,0.023423423423423424,0.4264112327783037,1.0,3/18,5.10%,SLC2A1;PPARD;SORT1
prerank,zinc ion homeostasis (GO:0055069),0.6255676794878307,1.5635020114996803,0.030944625407166124,0.42569068688080536,1.0,11/28,13.52%,SLC39A10;SLC39A8;SLC30A1;MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,positive regulation of vasculogenesis (GO:2001214),0.7722975343987291,1.5634840374357015,0.04251012145748988,0.42307700565232575,1.0,3/10,1.44%,KDR;CD34;RAPGEF2
prerank,cytoplasmic translation (GO:0002181),0.5225032483906716,1.5633748038893893,0.016238159675236806,0.4207804902641173,1.0,63/91,32.25%,RPL38;RPL13;RPS29;RPL36A;RPL3;RPL27;RPSA;RPS7;RPL9;RPL18;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPL22L1;RPS15;RPL37;RPS28;RPS10;EIF3M;RPS25;RPL37A;EIF4A1;RPL15;RWDD1;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPL18A;RPS21;RPL10A;RPL24;RPL7A;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;DRG1;RPL36;RPS3;RPS26;RPL27A
prerank,positive regulation of B cell proliferation (GO:0030890),0.6238326280811117,1.5632080674370907,0.02388535031847134,0.4187009882015863,1.0,5/29,5.65%,TFRC;TIRAP;MEF2C;CD40;CD38
prerank,adherens junction organization (GO:0034332),0.5655538425481124,1.562420880163438,0.016442451420029897,0.4189012634055481,1.0,15/48,7.00%,TJP1;CADM1;CDH2;RAMP2;ACTB;NECTIN4;CDH20;SMAD7;CTNND1;CTNNB1;CDH8;PIP5K1C;PVR;DCHS1;CDH19
prerank,regulation of neuron migration (GO:2001222),0.6417330600813255,1.5623052348087836,0.034722222222222224,0.4166974562199926,1.0,7/26,3.39%,SEMA6A;SRGAP2;DAB2IP;RAPGEF2;ADGRG1;ARHGEF2;NTNG2
prerank,intraciliary retrograde transport (GO:0035721),-0.6702885305758979,-1.562104046310177,0.033542976939203356,0.3297868413465481,1.0,6/12,14.69%,WDR35;DYNC2I1;DYNC2H1;IFT122;WDR19;DYNC2I2
prerank,respiratory system development (GO:0060541),-0.5296401384940277,-1.56209770700794,0.0199501246882793,0.32685984573420623,1.0,8/32,4.69%,GLI2;PDPN;FGFR2;BMP4;FGF1;RBP4;LOXL3;FGF2
prerank,cellular response to copper ion (GO:0071280),0.6835806747287749,1.5603170981323682,0.05197132616487455,0.42158278109015207,1.0,11/16,25.24%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;DAXX;SNCA;AOC1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6495311110541582,1.5602114598427905,0.02572347266881029,0.41941395720949065,1.0,5/24,4.52%,TEK;NDNF;KDR;RAMP2;GATA2
prerank,L-amino acid transport (GO:0015807),0.6312392737486195,1.560092736909891,0.02586206896551724,0.4174418844620127,1.0,5/28,5.02%,SLC7A5;SLC7A1;SLC1A1;SLC38A5;SLC1A2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6269944132771,1.559263764678382,0.0449438202247191,0.41798290103372304,1.0,7/27,3.77%,DACH1;PDGFB;BMPR2;RGCC;ACVRL1;PRKD2;HMBOX1
prerank,embryonic digestive tract development (GO:0048566),-0.6074171934463422,-1.5592133080354396,0.026726057906458798,0.3319943580470375,1.0,8/18,5.56%,GLI3;RARB;GLI2;PDGFRA;FGFR2;PCSK5;SALL1;RBPMS2
prerank,cellular response to increased oxygen levels (GO:0036295),0.7467430249766673,1.5587636647601129,0.043875685557586835,0.41707844490752155,1.0,3/11,2.99%,CAV1;FAS;FOXO1
prerank,regulation of blood circulation (GO:1903522),-0.5173893211755579,-1.558012898032337,0.011019283746556474,0.33211323706862694,1.0,10/34,10.36%,CELF2;TPM1;DMPK;CAMK2D;KCNMB2;PER2;ACE;BDKRB2;AGTR1;DES
prerank,early endosome to Golgi transport (GO:0034498),-0.6839673483236529,-1.5576600688255164,0.03508771929824561,0.3299252666883285,1.0,7/11,23.00%,STX5;SNX8;RAB6A;LMAN1;TRAPPC10;SURF4;TMED9
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5883300239139216,-1.5575506065279592,0.0182648401826484,0.3273857384389164,1.0,6/20,9.03%,SULF1;SMOC2;SULF2;THBS1;FGF2;CREB3L1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6591969013036778,-1.5567993139572016,0.046875,0.3265005606328116,1.0,7/13,6.56%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1
prerank,receptor metabolic process (GO:0043112),0.570663453551426,1.5549704223374166,0.013177159590043924,0.42769466843697906,1.0,16/53,11.87%,TFRC;DNM3;CAV1;RAB31;RAMP2;CALCRL;GRB2;RAMP3;REP15;DNM2;AP2M1;TGFB1;CXCR2;SMURF1;SYK;SH3GLB1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.4007136673258529,-1.5548783523487133,0.0,0.3287667267391949,1.0,27/142,12.11%,ATP1A2;CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;SMAD3;CD55;CCR9;EDNRA;ADRA1B;TRPC3;SLC35G1;SLC8B1;DLG4;SLC8A1;BDKRB2;AGTR1;PTGDR;TRPC6;PTGFR;PRKACA;TRPM4;CLN3;TRPC4;ABL1;ESR1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.7027508218852345,-1.5538728217440978,0.019027484143763214,0.32863550698422767,1.0,7/11,16.33%,PARP8;PARP3;PARP4;PARP11;PARP6;PARP12;TIPARP
prerank,sodium-independent organic anion transport (GO:0043252),0.7638462158666076,1.5529990989595668,0.04905660377358491,0.4319918176977389,1.0,3/10,1.67%,SLCO1C1;SLCO2B1;SLC16A2
prerank,phospholipid biosynthetic process (GO:0008654),0.5945111918402329,1.5529111382300025,0.03145695364238411,0.42976723627797414,1.0,3/36,1.83%,SGMS1;SGMS2;MBOAT1
prerank,cardiac muscle tissue development (GO:0048738),-0.4764874429421925,-1.552686846941642,0.0029239766081871343,0.3289809463098707,1.0,13/50,6.00%,NOTCH2;BMPR1A;GJB6;BMP5;SGCD;BMP7;BMP4;GJA1;RBP4;CACNA1G;NDUFV2;TBX18;AKAP13
prerank,amino acid import across plasma membrane (GO:0089718),0.6520670357422033,1.5522809669203412,0.023728813559322035,0.42948573785502586,1.0,6/24,1.92%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC16A2;SLC6A5
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.7145188727957572,1.551824692231594,0.04498269896193772,0.42858186094209877,1.0,2/14,6.58%,TFRC;SHLD1
prerank,cellular response to sterol (GO:0036315),-0.6589026999069468,-1.5511828661147495,0.03728070175438596,0.3302942293314128,1.0,8/13,20.36%,INSIG2;SMO;RORA;GRAMD1B;GRAMD1C;LRP6;GRAMD1A;PTCH1
prerank,neuron remodeling (GO:0016322),0.7545145009794639,1.5502261638438548,0.058287795992714025,0.431565932514117,1.0,3/10,2.06%,APP;SCARF1;ANKS1A
prerank,vasculogenesis (GO:0001570),0.6123279427659342,1.5490217743241614,0.024429967426710098,0.4334060996464045,1.0,12/32,9.09%,EGFL7;KDR;ENG;RASIP1;CAV1;SOX17;APLNR;NOTCH1;RAMP2;SOX18;TGFB1;CCM2
prerank,positive regulation of bone mineralization (GO:0030501),-0.5197035788531067,-1.5472060541680428,0.014527845036319613,0.3375242600903784,1.0,15/35,12.43%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;FBN2;PKDCC;BMP2
prerank,negative regulation of interleukin-10 production (GO:0032693),0.6808264035223317,1.5470256367731707,0.04262877442273535,0.4380875461483059,1.0,6/16,11.81%,JAK3;TNFRSF21;FOXP3;TRIB2;AGER;VSIR
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.6438599385505536,1.546300619842232,0.038523274478330656,0.4382641884866657,1.0,9/25,10.12%,HIP1;HIP1R;BCAR3;PLAUR;AFAP1L2;CCDC88A;SHKBP1;CNOT9;PTK6
prerank,negative regulation of angiogenesis (GO:0016525),0.5146954413167775,1.5457661003559728,0.012838801711840228,0.43791034632999526,1.0,20/84,7.37%,TEK;PTPRM;SEMA6A;CLDN5;DAB2IP;EPN2;TGFB2;STAB1;RGCC;COL4A2;AMOT;VASH1;KLF2;HHEX;SARS1;CTNNB1;KLF4;STAT1;GTF2I;CD160
prerank,regulation of interleukin-2 production (GO:0032663),0.5699077304540959,1.5450473536184919,0.03153153153153153,0.4378430099949789,1.0,11/43,11.08%,SPTBN1;CD34;PRKD2;HDAC7;HOMER2;PDE4D;CD4;PDE4B;FOXP3;MALT1;PNP
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6960105650201757,-1.5440994723564307,0.031042128603104215,0.3426255104443554,1.0,1/10,0.02%,ATP1A2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5784674413161657,1.544089064893978,0.019490254872563718,0.4387991982984419,1.0,8/39,4.52%,TEK;NDNF;KDR;RGCC;CD40;RAMP2;PLCG1;GATA2
prerank,myelination (GO:0042552),0.5577218492848368,1.5434074452822242,0.0350609756097561,0.4385656257380068,1.0,20/46,19.06%,MPZ;CMTM8;MAL;B4GALT5;PLLP;PARD3;TNFRSF21;BCAS1;GAL3ST1;NFASC;EIF2B2;ABCD1;SOX10;DEGS1;MBP;PMP22;ARHGEF10;MAL2;TPPP;ABCD2
prerank,modulation by symbiont of entry into host (GO:0052372),0.6874936688688345,1.5429287744829994,0.04570383912248629,0.4376954618163991,1.0,3/16,2.37%,CAV1;TRIM25;TRIM14
prerank,positive regulation of hydrolase activity (GO:0051345),0.4874320697064688,1.5427020648363625,0.003861003861003861,0.4359393487619612,1.0,26/137,8.52%,ITGA6;DOCK9;SRGAP2;RAPGEF2;ARHGAP27;NET1;CD200;BCAR3;F11R;AGRN;RAPGEF1;CD40;SNX13;RAPGEF3;TGM2;TBC1D2;CALM1;USP6NL;MAPRE2;RSU1;RAP1GDS1;RASGRP2;PKP4;PIN1;CAV2;ARHGEF7
prerank,glycolipid metabolic process (GO:0006664),0.5605953028352685,1.5425981935064355,0.027607361963190184,0.43401540941855704,1.0,12/47,13.92%,ST6GALNAC3;ST3GAL6;ST8SIA6;ESYT2;NEU4;ESYT1;GLB1;GLTP;ST6GALNAC4;B4GALNT1;CERK;NEU2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5014595665713071,1.5421579114449337,0.009446693657219974,0.4332714363216432,1.0,17/100,6.20%,FLT1;IGF1R;TEK;PDGFB;KDR;PPP1R16B;INSR;DAB2IP;TGFB2;PDGFD;PTK2;PIK3IP1;LYN;GAB1;PIP5K1C;MAPK3;ENTPD5
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7090664576488838,1.540689121998388,0.05075187969924812,0.43607040460703644,1.0,4/13,4.35%,DAB2IP;EPN2;MMRN2;HHEX
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7577800644956154,1.5403799463141374,0.06340579710144928,0.4347229680169255,1.0,2/10,1.57%,SHANK3;APP
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5032118179788134,1.540070075587121,0.003968253968253968,0.4334382905096735,1.0,72/110,32.25%,RPL38;RPL13;RPS29;RPL36A;RPL3;RNPS1;RPL27;RPSA;EIF3E;RPS7;RPL9;RPL18;RPLP2;MAGOHB;RPL13A;HELZ2;RPS11;RPL8;NCBP2;RPS27;RPL19;RPS9;RPL11;PNRC2;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RBM8A;RPS18;UPF2;RPL21;RPS4X;RPL18A;NCBP1;RPS21;RPL10A;PABPC1;RPL24;RPL7A;RPL32;RPL4;UPF3B;UPF1;RPS2;RPS20;RPL6;RPS13;RPS19;PPP2R1A;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,regulation of monooxygenase activity (GO:0032768),0.6447145093949057,1.5391193067323896,0.043402777777777776,0.4346130936107057,1.0,7/23,8.87%,NOSTRIN;NOS3;CAV1;DDAH1;CALM1;DNM2;LYPLA1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.6214808202362236,-1.5390562941206902,0.02666666666666667,0.3510988715655445,1.0,8/16,13.57%,PHLDB2;ARHGAP6;APOD;THBS1;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.6214808202362236,-1.5390562941206902,0.02666666666666667,0.3510988715655445,1.0,8/16,13.57%,PHLDB2;ARHGAP6;APOD;THBS1;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,keratan sulfate catabolic process (GO:0042340),-0.6989176650948342,-1.5388899696995348,0.041666666666666664,0.3488187877819939,1.0,7/11,12.24%,OGN;FMOD;PRELP;LUM;OMD;HEXA;GNS
prerank,regulation of T cell migration (GO:2000404),0.6751943213484867,1.5387903011875945,0.032667876588021776,0.43360338741939164,1.0,4/18,2.13%,LRCH1;CXCL12;APP;CD200
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6692604084638362,1.537917004811144,0.041353383458646614,0.43428838399118486,1.0,4/15,6.88%,MFSD2A;SCARB1;FBXW7;NR1H2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5614567933468848,-1.537860681702307,0.023752969121140142,0.348684807068423,1.0,6/23,5.68%,WNT5B;BMP4;GJA1;SMO;FGF2;SIX1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.642111621674552,-1.535439217403806,0.05429864253393665,0.3523108614225764,1.0,8/13,22.68%,DDO;ASPA;ACOT8;GOT1;GLUL;QPRT;GOT2;MTHFS
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.4229825257860969,-1.5349376112591635,0.007751937984496124,0.3509571463353064,1.0,27/95,9.29%,GPC6;UST;DSE;DCN;ANGPT1;SDC2;OGN;CEMIP;EXT1;FMOD;GPC3;BGN;HS3ST3A1;ST3GAL4;HS2ST1;CHST15;GPC4;PRELP;PXYLP1;CSPG4;HS3ST3B1;HS6ST1;SDC4;LUM;HS6ST2;NDST2;OMD
prerank,intestinal absorption (GO:0050892),0.7097792603983638,1.5330142247754266,0.049910873440285206,0.44926474434535574,1.0,3/13,5.16%,TJP2;F11R;KCNQ1
prerank,negative regulation of axon extension (GO:0030517),0.5975768519977868,1.5320952516818245,0.03166666666666667,0.450249338841601,1.0,7/30,6.97%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;DIP2B;SEMA4F;SEMA6D
prerank,amino acid transmembrane transport (GO:0003333),0.5560526954430302,1.5311828796891302,0.02735562310030395,0.4509787197538801,1.0,5/45,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;SLC38A5
prerank,bone development (GO:0060348),-0.49712254766978087,-1.5309260647222376,0.0213903743315508,0.3594484727351138,1.0,10/39,6.60%,RANBP3L;SULF1;FGFR2;CYP26B1;GJA1;SULF2;SH3PXD2B;AKAP13;SFRP4;GNAS
prerank,eye photoreceptor cell differentiation (GO:0001754),0.7275864477101497,1.530826678180548,0.05605786618444846,0.4498902276968859,1.0,2/12,2.21%,PROM1;NKD1
prerank,regulation of phospholipase activity (GO:0010517),-0.6917233289192887,-1.5306382696478602,0.027426160337552744,0.35751390400636923,1.0,3/10,9.06%,LRP1;FGFR2;PDPK1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.6221681817118155,1.5302187988356435,0.05387205387205387,0.4496643918374986,1.0,9/24,12.23%,TEK;KDR;PTPRJ;DUSP3;MAPRE2;IQSEC1;FERMT2;RAC1;MAP4K4
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5328905774870266,1.5301995623297704,0.020348837209302327,0.44743831324293154,1.0,21/65,12.42%,HIP1;DAB2IP;ITGA1;HIP1R;BCAR3;PLAUR;AFAP1L2;PTPRJ;RHBDF2;PTPN12;DUSP3;GRB2;CCDC88A;TGFA;ARHGEF7;SHKBP1;CNOT9;PTK6;CEACAM1;EPS15;HGS
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.634596293350244,1.52972019037043,0.025466893039049237,0.4468950716819341,1.0,7/24,9.32%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,regulation of cell-cell adhesion (GO:0022407),0.5610409458357659,1.5291599836347445,0.044233807266982623,0.44635728983511747,1.0,8/39,8.09%,PTPRG;PODXL;MAGI1;PTK2;SMAD7;FUT9;PTPRR;TGFB1
prerank,N-glycan processing (GO:0006491),0.6664786484081746,1.5281950315012385,0.0425531914893617,0.44756472971380645,1.0,3/18,1.96%,ST8SIA4;ST8SIA6;FUT8
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6237679053504096,-1.527988463221491,0.04888888888888889,0.36219771067172196,1.0,5/14,2.27%,LRP1;BMPR1A;IGFBP5;TPM1;SLIT2
prerank,regulation of chemokine production (GO:0032642),0.5885046815125894,1.5267784338361867,0.03184713375796178,0.45028500978296643,1.0,10/36,11.82%,APP;IL6R;SIGIRR;TLR3;SNAI2;LGALS9;TLR7;ADAM17;AGER;HIF1A
prerank,granulocyte differentiation (GO:0030851),0.6619284738390331,1.52606726913431,0.05299145299145299,0.45054465808186944,1.0,2/18,5.20%,LEF1;TAL1
prerank,positive regulation of ruffle assembly (GO:1900029),0.6999553405672677,1.5255467325865508,0.07806691449814127,0.44996461407200133,1.0,6/13,15.74%,EPS8;EPS8L2;PLEKHM1;HRAS;FAM98A;NLGN1
prerank,limb development (GO:0060173),-0.5393647359032256,-1.5253215791091776,0.04081632653061224,0.3666560841990646,1.0,11/28,20.36%,SMOC1;GLI3;PCSK5;SALL1;RSPO2;IFT122;IQCE;COMP;INTU;KREMEN1;PTCH1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5389509299299189,-1.5249664250759325,0.021333333333333333,0.3648502300672057,1.0,7/26,7.86%,ANK2;ACTN2;FHL1;DLG1;ATP1B3;ATP1B2;CACNA1D
prerank,positive regulation of DNA repair (GO:0045739),-0.48797663437565497,-1.5244165882037526,0.02359882005899705,0.3635655983223709,1.0,4/46,2.10%,EYA2;EYA1;EGFR;EYA4
prerank,secondary palate development (GO:0062009),0.682049481017531,1.5231822721894361,0.04918032786885246,0.45611400374127326,1.0,3/14,4.25%,LEF1;TGFB2;WNT7A
prerank,regulation of trophoblast cell migration (GO:1901163),-0.6400344798462041,-1.5228279073479456,0.047520661157024795,0.3648983868794105,1.0,7/14,20.08%,GJA1;SYDE1;AGO2;SMURF2;ACVR1B;C1QBP;ARHGDIB
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6726460722378961,1.5226204698611994,0.04521739130434783,0.45587265707137536,1.0,2/17,6.44%,SLC7A5;LGALS9
prerank,regulation of leukocyte activation (GO:0002694),0.7143274363352001,1.5224753919462548,0.05985915492957746,0.4541212582146886,1.0,3/14,3.88%,MFHAS1;CD200;LYN
prerank,camera-type eye morphogenesis (GO:0048593),-0.7079347423177145,-1.5221114251294514,0.03411513859275053,0.36431287493734504,1.0,6/10,19.44%,KDM2B;IFT122;SKI;NF1;LRP6;TBX2
prerank,positive regulation of cell junction assembly (GO:1901890),0.5343236638528612,1.5216853315443661,0.027777777777777776,0.4546346414310953,1.0,15/56,13.19%,TEK;CLDN5;KDR;CAV1;PTPRJ;WNT7A;CLSTN1;GRID2;NRXN1;LRRC4B;FERMT2;RAC1;MAP4K4;EPHB1;CNTNAP2
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.624109452749914,-1.5206725500168203,0.033112582781456956,0.3658841330770629,1.0,6/16,14.60%,ANK2;GBF1;SEC16B;LRRK2;SEC16A;DDRGK1
prerank,cellular response to BMP stimulus (GO:0071773),-0.44305905784664557,-1.5206439118312935,0.006349206349206349,0.3633013095633781,1.0,15/66,6.76%,BMP6;TGFBR3;BMPR1A;ADAMTS12;SMAD3;BMP5;BMP7;BMP4;DDX5;SMAD6;RGMA;RGMB;RUNX2;TMEM100;SMAD9
prerank,cellular response to exogenous dsRNA (GO:0071360),0.724159374944814,1.5203256855416074,0.05605786618444846,0.45697649936431944,1.0,4/12,6.97%,CAV1;IFIH1;ZCCHC3;RALB
prerank,hemidesmosome assembly (GO:0031581),0.7236161251390241,1.5202943074090858,0.07074569789674952,0.4549110062041139,1.0,1/11,0.31%,ITGA6
prerank,diol metabolic process (GO:0034311),0.6592612165335631,1.52023351210298,0.06896551724137931,0.45304822446400395,1.0,5/19,4.35%,SGPP2;DEGS2;NOS3;GCH1;CALM1
prerank,positive regulation of integrin activation (GO:0033625),0.7244422365267639,1.5174135785438596,0.0675422138836773,0.46035966798463274,1.0,4/11,10.91%,RASIP1;PIEZO1;RAP1B;FERMT2
prerank,regulation of cell migration (GO:0030334),0.43567186219145837,1.5173250437681802,0.0,0.45851261543073013,1.0,58/382,6.48%,LEF1;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;LIMCH1;DACH1;PECAM1;FRMD5;SEMA6A;TJP1;CLDN5;PDGFB;KDR;SRGAP3;SRGAP2;INSR;PODXL;MACF1;ROBO4;SRGAP1;ENG;CXCL12;PDGFD;PRR5L;CAV1;NKD1;NEDD9;SEMA6B;SPATA13;PTPRJ;PTK2;PLXND1;ADAM15;PIK3R3;AMOT;ACVRL1;TIAM1;NTNG2;NOTCH1;DUSP3;VIL1;RIPOR1;TMSB4X;SMAD7;GNA12;FGF16;SEMA4F;RHOB;EPHA4;SNAI2;ACTN4;FAM107A;KIF2A;ADAM10;RET;RFFL
prerank,protein glycosylation (GO:0006486),0.4766762218228625,1.5163041041158993,0.01366120218579235,0.4598647365816547,1.0,36/125,17.29%,ST8SIA4;ST3GAL6;EOGT;AQP11;ST8SIA6;SLC39A8;ST3GAL1;GALNT18;FUT8;B4GALT5;ST6GALNAC2;B3GNT2;OGA;STT3B;FUT9;ENTPD5;GAL3ST1;COG3;PLOD3;NPC1;B3GALT4;MGAT4B;B3GALT2;PLOD1;DPAGT1;SERP2;NUS1;POFUT1;DAD1;GCNT2;DPM3;MGAT2;B3GNT3;POGLUT1;DOLPP1;POMGNT1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6336541992705336,1.5160131632276952,0.05098684210526316,0.4586848318164466,1.0,8/23,13.45%,FAR2;ELOVL7;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;HACD2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.690363087095496,-1.515998768531545,0.04329896907216495,0.3729771299859251,1.0,3/10,6.35%,BMP4;SALL1;FZD7
prerank,fat cell differentiation (GO:0045444),-0.4542257597557337,-1.5150953429202825,0.020771513353115726,0.37287309523053463,1.0,17/57,14.77%,PID1;WNT5B;SMAD6;OSBPL8;PPARGC1A;FAM120B;PER2;ATF5;C1QTNF3;CLIP3;BBS9;MKKS;MAFB;NR4A1;EP300;METRNL;TMEM120A
prerank,actin filament organization (GO:0007015),0.4645527718636327,1.5148523316983427,0.011464968152866241,0.46023999599273924,1.0,27/151,7.03%,FLII;HIP1;MYO1D;MYO1E;RHOBTB1;SHROOM4;NEBL;SHROOM1;ELMO1;HIP1R;NEDD9;ARHGEF2;ARPC4;CD2AP;EVL;PLS3;ELMO2;VIL1;PPP1R9B;MYO6;RFLNB;EPS8;RHOB;TPM3;BAIAP2;ARHGAP25;ACTN1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.6296684133676229,-1.5148424404951133,0.05043859649122807,0.37099384786461237,1.0,7/13,18.21%,NUPR1;TMEM39A;LRRK2;SCFD1;PHF23;FEZ1;SMCR8
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.6003845607384889,-1.513787966222504,0.042316258351893093,0.3712827012396346,1.0,4/16,5.34%,APPL2;APOD;ADCY7;PPARA
prerank,skin development (GO:0043588),-0.4531502078621976,-1.5129116722260598,0.015337423312883436,0.37085856148624624,1.0,22/65,14.74%,COL1A2;COL3A1;COL5A2;COL1A1;COL5A1;ERRFI1;PKD1;ADAM9;ANXA1;ATP7A;TXNIP;JAG1;MET;COL5A3;ITGB4;CLDN1;GATA6;SCEL;DACT2;BCR;SLC2A10;CASP3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5652012350482217,1.512602251764804,0.037520391517128875,0.4659112038846877,1.0,12/45,11.01%,TRIM16;APP;NOD2;GBP5;LGALS9;AIM2;P2RX7;MALT1;AGER;CASP8;HSPB1;TLR8
prerank,glycoprotein metabolic process (GO:0009100),0.5486670788090212,1.5117152158266527,0.023183925811437404,0.46693394149615425,1.0,8/53,5.56%,ST8SIA4;ST6GALNAC3;ST8SIA6;FUT8;B4GALT5;OGA;NEU4;STT3B
prerank,catecholamine biosynthetic process (GO:0042423),0.7326479368958921,1.5114076009224797,0.04621072088724584,0.4658592607815319,1.0,4/11,7.04%,DDC;TGFB2;GCH1;INSM1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.5297847943668489,-1.5112811191502478,0.022727272727272728,0.37280304136643483,1.0,9/28,14.13%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,regulation of interleukin-10 production (GO:0032653),0.5527764305822814,1.5102136513997855,0.027565084226646247,0.4680969016533755,1.0,10/44,11.85%,CD34;JAK3;NOD2;TNFRSF21;LGALS9;FOXP3;TRIB2;AGER;VSIR;SYK
prerank,neuron maturation (GO:0042551),0.6522024171379517,1.5101429492806684,0.07078039927404718,0.46628644329909896,1.0,4/18,2.10%,APP;SCARF1;ANKS1A;B4GALT5
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.6185026381378336,-1.509363422871172,0.060133630289532294,0.3751915464999686,1.0,5/14,9.96%,SEC24D;SEC24A;SAR1A;SEC31A;SEC23A
prerank,glycoprotein biosynthetic process (GO:0009101),0.5064145088922691,1.5092384841021311,0.025495750708215296,0.46720658426506834,1.0,11/79,7.12%,ST8SIA4;CSGALNACT1;ST3GAL6;ST8SIA6;BMPR2;B4GALT5;ST6GALNAC2;CHST11;B3GNT2;FUT9;COG3
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.6321867668631668,-1.5090078051727074,0.050239234449760764,0.37357414341831985,1.0,5/14,10.23%,IRS1;PPARGC1A;IRS2;NNMT;SLC45A3
prerank,L-serine metabolic process (GO:0006563),0.7437478468653635,1.5089535395243077,0.06702898550724638,0.4660406836782094,1.0,4/10,9.59%,SERINC3;SERINC5;SHMT2;CBS
prerank,protein secretion (GO:0009306),-0.45113903412302475,-1.506886823001515,0.0060790273556231,0.3769333592124223,1.0,10/56,9.51%,WLS;PCSK5;STEAP3;ABCA1;TANGO2;ANXA1;RCN3;ARFGAP3;TANGO6;CANX
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5975474846406884,1.5060868898774435,0.04530201342281879,0.47374866382023195,1.0,7/29,11.88%,LEF1;MEN1;CTNNB1;TCF7;TLE4;AXIN2;TLE1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5071415265904334,1.5058839162499262,0.023943661971830985,0.47239236729461803,1.0,18/75,7.37%,TEK;PTPRM;SEMA6A;CLDN5;DAB2IP;TGFB2;STAB1;RGCC;COL4A2;AMOT;VASH1;HHEX;SARS1;CTNNB1;KLF4;STAT1;GTF2I;CD160
prerank,cell-cell junction organization (GO:0045216),0.5021245391054853,1.5050105237008875,0.032520325203252036,0.4732735084796801,1.0,19/79,8.09%,OCLN;TJP1;CLDN5;CADM1;LIMS2;TGFB2;GJC1;TJP2;CDH2;NECTIN4;CDH20;CTNND1;CDH8;MARVELD2;PVR;DCHS1;CDH19;PKP4;TGFB1
prerank,glycerophospholipid metabolic process (GO:0006650),0.5102802107568857,1.503707882429916,0.03626220362622036,0.4756865368286243,1.0,10/75,6.36%,GPCPD1;PLCB1;DGKH;PLA2G4B;PLCG1;SERINC5;PNPLA6;GDPD1;ABCA3;PIGM
prerank,anterior/posterior pattern specification (GO:0009952),-0.45977667598036165,-1.5032089582190278,0.026239067055393587,0.38464851266875133,1.0,23/53,20.30%,WLS;HOXC4;HOXC6;HOXB3;PCSK5;HOXA3;HOXA5;HOXB4;HOXB6;TGFBR1;HOXA7;HEYL;BMP2;HOXB5;SKI;HOXC5;HOXA9;HOXA6;DDIT3;HEY2;ATP6AP2;HOXD3;HES6
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5956957524690769,1.5028692037918194,0.0343213728549142,0.47626912402456784,1.0,8/30,10.45%,BCL2L1;NOS3;FAS;TNFSF10;ARHGEF2;RFFL;FAIM;CASP8
prerank,cellular response to peptide (GO:1901653),0.5342685808203519,1.5022231486891535,0.03188405797101449,0.47638963446005933,1.0,12/56,6.25%,IGF1R;CACNA1A;APP;CAV1;ARHGEF2;NOD1;NOD2;CYP11B1;CYP11A1;EPHA4;FYN;ATP1A3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7199905892540102,1.5021305289020446,0.061068702290076333,0.4746715401904994,1.0,2/11,0.22%,IGF1R;PLCB1
prerank,phospholipid translocation (GO:0045332),0.6026434060125577,1.5019182135937674,0.05834683954619125,0.4733070309187383,1.0,9/28,9.75%,ATP10A;MFSD2A;ATP8A1;ATP11B;ATP11A;ABCA7;P2RX7;ATP11C;ATP10B
prerank,Rap protein signal transduction (GO:0032486),0.7399262934820514,1.5018695396865913,0.06439393939393939,0.4714157248870085,1.0,4/10,7.23%,RAPGEF2;RAPGEF1;RAPGEF3;RAP1B
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.7064606609264199,1.5013863628724324,0.052346570397111915,0.47105366887655753,1.0,4/12,11.60%,MFSD2A;ACSL3;LPCAT3;MTTP
prerank,negative regulation of anoikis (GO:2000811),0.6946111266098219,1.500592829397358,0.0661764705882353,0.47145011748857496,1.0,7/14,11.88%,CAV1;PTK2;NOTCH1;SNAI2;MCL1;PTRH2;TLE1
prerank,positive regulation of lipid localization (GO:1905954),-0.6707288366019675,-1.5004684358475882,0.05063291139240506,0.3894401426743548,1.0,2/11,3.91%,LRP1;IKBKE
prerank,amino acid transport (GO:0006865),0.5512488404310878,1.500369600887083,0.04090909090909091,0.47012269992531375,1.0,6/49,2.87%,SLC6A6;SLC7A5;SLC7A1;SH3BP4;SLC38A5;SLC43A2
prerank,sulfate transport (GO:0008272),-0.639846270891637,-1.4993040064411007,0.045146726862302484,0.3898255713337916,1.0,3/14,2.84%,SLC13A4;SLC26A7;SLC26A2
prerank,lung epithelium development (GO:0060428),-0.6876767403369031,-1.4991405044025763,0.06557377049180328,0.38782926258572104,1.0,4/10,6.13%,ERRFI1;BMP4;PKD1;RCN3
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.5971332729942616,1.4988356799536184,0.04084967320261438,0.4734639548603999,1.0,5/29,3.73%,KANK3;SHANK3;TJP1;HIP1R;SSH2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6106822731654614,-1.4987576123348152,0.07009345794392523,0.38635950674812064,1.0,7/15,16.37%,PIEZO2;ADGRV1;COL11A1;KIT;MKKS;TMEM120A;PDZD7
prerank,receptor-mediated endocytosis (GO:0006898),0.47188683325494885,1.4984420749593332,0.014230271668822769,0.47273074545468,1.0,31/132,12.31%,TFRC;DNM3;INSR;STAB1;ARHGAP27;CAV1;SCARF1;FNBP1L;HIP1R;RAB31;SCARB1;RAMP2;CALCRL;DNAJC13;GRB2;PIKFYVE;RAMP3;PIP5K1C;INPP5F;LRP1B;DNM2;FCHO2;AP2M1;CXCR2;CAV2;LRP2;AMN;CD163;SYK;EPS15;AP2B1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6082054639803267,1.4984223383300534,0.04590163934426229,0.47081292656581886,1.0,5/27,1.98%,SLC7A5;SLC7A1;SLC1A1;SLC6A5;SLC38A5
prerank,endothelial cell proliferation (GO:0001935),0.6462596448811768,1.497253842915157,0.06394316163410302,0.4728723693008009,1.0,4/17,3.18%,TEK;CD34;BMPR2;ACVRL1
prerank,regulation of interleukin-17 production (GO:0032660),0.5898349145509811,1.4959492672177412,0.055284552845528454,0.47518545007957513,1.0,9/31,14.70%,SLC7A5;NOD2;TGFB1;FOXP3;CCL1;VSIR;IL15;RFTN1;NCKAP1L
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6431613204670033,-1.495914036994299,0.05482456140350877,0.39202273269056875,1.0,5/13,7.08%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;ATP1B2
prerank,microtubule depolymerization (GO:0007019),0.6577299117445657,1.494683965614529,0.06281833616298811,0.4775340467811025,1.0,7/17,15.68%,STMN1;NCKAP5;KIF2A;STMN3;STMN4;NCKAP5L;CKAP5
prerank,response to progesterone (GO:0032570),0.6495287837542015,1.4930965794934175,0.05244755244755245,0.480899873706467,1.0,3/18,1.75%,ABHD2;TGFB2;CAV1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.6285753663616428,-1.4924360495966216,0.06315789473684211,0.3991708842982944,1.0,4/12,15.15%,PKD2;ABCC9;TRPM4;KCNJ8
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6428650121040047,1.492386488543809,0.05514705882352941,0.4815920036354402,1.0,3/16,6.88%,MFSD2A;SCARB1;NR1H2
prerank,cellular response to dsRNA (GO:0071359),0.6785701949842547,1.492198130529333,0.06642728904847396,0.48020541025916835,1.0,5/15,10.56%,CAV1;IFIH1;ZCCHC3;RALB;PDE12
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5969315164103987,-1.4918279986640617,0.05133928571428571,0.39824191448209095,1.0,6/17,6.33%,FSTL1;SULF1;SLIT2;CASK;TWSG1;SFRP4
prerank,positive regulation of cellular component organization (GO:0051130),0.477092768241479,1.4917048909963042,0.012295081967213115,0.4798375739135494,1.0,13/107,5.96%,IGF1R;ATP10A;TFRC;SHANK3;INSR;DAB2IP;TGFB2;TIRAP;NEDD4L;RAPGEF3;FNIP2;TAL1;BIK
prerank,muscle cell differentiation (GO:0042692),0.579455709966071,1.4914860857548653,0.050381679389312976,0.47859745102008283,1.0,7/32,2.75%,SYNE1;NEBL;TMEM204;MRTFB;TBX1;MRTFA;MEF2C
prerank,positive regulation of cellular metabolic process (GO:0031325),0.48236893634590416,1.4910493957602238,0.017663043478260868,0.47811578344386507,1.0,19/98,8.89%,SLCO1C1;PDGFB;INSR;XDH;FASN;PPARD;NFKBIA;IFNAR1;IL10RB;WNT7A;GRB2;RAMP3;INPP5F;TBC1D5;KLF4;ACACB;NR1H2;TGFB1;GREM1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.5442219938565998,-1.4908206763134042,0.04187192118226601,0.39849402462187417,1.0,7/23,15.29%,PLCE1;AGMO;MOGAT3;GK;LPGAT1;GPAT3;PNPLA3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7199617837959429,1.4898502021798476,0.08270676691729323,0.4802835747237069,1.0,3/11,3.88%,MFHAS1;TIRAP;LYN
prerank,regulation of glucose import (GO:0046324),-0.517264844580863,-1.4888556991137805,0.03713527851458886,0.40158853338655615,1.0,12/30,8.52%,PID1;IGF1;PRKAG2;APPL2;ENPP1;IRS1;RHOQ;OSBPL8;PRKCI;IRS2;SELENOS;GRB10
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.6090279935400719,1.4885347017044397,0.043697478991596636,0.48281321024902835,1.0,8/26,13.79%,NOD1;NOD2;IFIH1;IRAK2;UBE2V1;CASP8;CYLD;TNFAIP3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.528938281131645,1.4880875457109184,0.04585798816568047,0.4823041655438094,1.0,5/49,2.65%,SGMS1;BCL2L1;CAV1;PLAUR;PTPMT1
prerank,regulation of developmental growth (GO:0048638),0.5904165830877763,1.488064298745054,0.03980891719745223,0.48043968725957037,1.0,4/29,1.57%,PLCB1;MFSD2A;INSR;APP
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7215455529421825,1.486559613111613,0.07532956685499058,0.4836195409527251,1.0,3/10,1.74%,SEMA6A;DAB2IP;XDH
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.6804839675721563,-1.486203338058834,0.06172839506172839,0.4065642322601168,1.0,6/10,24.38%,EMC8;EMC7;EMC1;EMC2;EMC3;EMC4
prerank,positive regulation by host of viral transcription (GO:0043923),0.6686241942678416,1.4859363003355894,0.06866197183098592,0.4837837006456785,1.0,3/15,8.95%,LEF1;JUN;CHD1
prerank,regulation of BMP signaling pathway (GO:0030510),-0.429839513274955,-1.4856518442289486,0.018461538461538463,0.4056000074347805,1.0,17/73,6.76%,FSTL1;SULF1;BMPR1A;FOXD1;NBL1;CRIM1;BMP4;BMPER;SMAD6;HTRA3;TWSG1;RBPJ;ZNF423;RBPMS2;SFRP4;CCN1;SMAD9
prerank,divalent inorganic cation homeostasis (GO:0072507),0.6038900040449389,1.4854533326549617,0.07178631051752922,0.4834587858235056,1.0,2/25,1.75%,TMTC2;CAV1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5886519693227463,-1.485360804074753,0.07061503416856492,0.404056321805621,1.0,4/17,5.34%,PID1;NUPR1;HDAC4;PPARA
prerank,spinal cord development (GO:0021510),-0.6439244820024931,-1.4848934614015772,0.06995884773662552,0.4029740498625942,1.0,5/12,4.66%,GLI2;PKD1;VIT;LOXL3;PKD2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7325589896362846,1.4833394971148182,0.08646616541353383,0.48873970803710876,1.0,3/10,4.03%,DGKH;PARD3;PRKD3
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5572185060808353,1.4826328590946902,0.054313099041533544,0.4890286294107726,1.0,11/39,6.17%,EPN2;TGFB2;NOS3;NOTCH4;JAG2;TSPAN5;NOD2;TSPAN14;NOTCH1;DLL4;MAML2
prerank,striated muscle cell development (GO:0055002),0.6893604659309902,1.4825669060458557,0.06810035842293907,0.4873554403478995,1.0,2/14,1.54%,FLII;PGM5
prerank,ATP transport (GO:0015867),0.7297209031046302,1.4823638320603418,0.09523809523809523,0.48621481658704707,1.0,2/10,5.07%,ABCC6;SLC25A5
prerank,regulation of potassium ion transport (GO:0043266),-0.5157016485588393,-1.4814807755682584,0.03814713896457766,0.41004746805772685,1.0,8/31,11.14%,ANK2;ACTN2;FHL1;KCNIP3;CD63;DLG1;CACNA1D;PTK2B
prerank,prostanoid biosynthetic process (GO:0046457),-0.6046754064001936,-1.480709414227004,0.05263157894736842,0.40972599912501967,1.0,4/15,5.75%,PTGDS;PTGIS;PTGS1;PTGES
prerank,type I interferon signaling pathway (GO:0060337),0.553210971108634,1.4806713109928649,0.0487062404870624,0.48825219098113193,1.0,12/41,10.15%,IFNAR1;SP100;IFNAR2;IRF2;ADAR;SAMHD1;XAF1;IRF9;STAT1;IRF5;BST2;OASL
prerank,cellular response to type I interferon (GO:0071357),0.553210971108634,1.4806713109928649,0.0487062404870624,0.48825219098113193,1.0,12/41,10.15%,IFNAR1;SP100;IFNAR2;IRF2;ADAR;SAMHD1;XAF1;IRF9;STAT1;IRF5;BST2;OASL
prerank,neutrophil migration (GO:1990266),0.5233555208858965,1.480590514643976,0.03235294117647059,0.48661940117267,1.0,11/58,11.85%,BSG;PECAM1;TGFB2;PIKFYVE;PIP5K1C;PPIA;PDE4B;CXCR2;CCL1;S100A8;SYK
prerank,regulation of anoikis (GO:2000209),0.6399788600031528,1.480327449940321,0.07295373665480427,0.4856230981903109,1.0,7/19,11.88%,CAV1;PTK2;NOTCH1;SNAI2;MCL1;PTRH2;TLE1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.6081451763174297,-1.4803087377312545,0.05092592592592592,0.40841486141686056,1.0,7/15,21.31%,GGT5;ALDH4A1;PRODH;GGACT;SARDH;ABHD16A;GOT2
prerank,peptide metabolic process (GO:0006518),-0.42824263816952546,-1.4801466971794661,0.009900990099009901,0.406486759687791,1.0,18/75,15.69%,CPQ;AEBP1;MGAT3;PCSK5;DMD;ANPEP;GSTT1;BACE2;ACE;ENPEP;NPEPPS;CPXM1;CPXM2;IDE;PSEN1;GSTA3;GSTM2;HM13
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.46491647209702175,1.4792018555413706,0.010540184453227932,0.4875956562920921,1.0,32/140,8.84%,CHN2;MCF2L;ARHGAP31;ARHGEF3;ARAP3;SRGAP3;SRGAP2;SRGAP1;ARAP2;RASGRF2;NET1;PLEKHG5;ARHGEF2;KALRN;FAM13A;TIAM1;ABR;CD2AP;STARD13;TGM2;RHOB;OCRL;DEPDC7;ARHGAP23;SOS1;ARHGAP25;ARHGEF12;ARHGEF5;PREX1;ARHGEF7;OPHN1;ARHGAP4
prerank,defense response to symbiont (GO:0140546),0.48997540116809163,1.478479809196927,0.023676880222841225,0.4880109082514379,1.0,23/92,11.42%,BCL2L1;SERINC3;IFNAR2;CD40;IFIH1;NLRC5;IRF2;SERINC5;SAMHD1;NT5C3A;TLR3;STAT1;BST2;TLR7;RTP4;AGBL5;BNIP3L;ZMYND11;OASL;DDIT4;PDE12;TLR8;RNASE1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.4740429452676004,-1.4775844473056983,0.03412073490813648,0.41121240575809814,1.0,18/46,15.49%,ALDH1A1;LGR4;DOCK7;PLCL1;NPR3;FOXC2;ADAMTS5;RBPJ;ZNF423;ACOT11;TLE3;NOVA1;PLCL2;STK11;RHEB;PCTP;TLR4;NRDC
prerank,regulation of protein localization to nucleus (GO:1900180),0.54531329311653,1.4774252476411123,0.046296296296296294,0.489426888357594,1.0,10/43,12.05%,TFRC;MFHAS1;WWTR1;CARD10;LIMK2;PIN1;TGFB1;LAMTOR5;FERMT2;ORMDL3
prerank,acylglycerol metabolic process (GO:0006639),0.5587822542999693,1.4772498180198668,0.049441786283891544,0.48808385445622027,1.0,6/37,7.90%,ABHD2;DGKH;CAV1;DGKI;DGKE;AWAT2
prerank,regulation of establishment of cell polarity (GO:2000114),-0.6023163791564405,-1.476757797174446,0.06682027649769585,0.4112480950833679,1.0,6/16,12.47%,ROCK2;GSN;KANK1;RIPOR2;PTK2B;BCAS3
prerank,calcium ion transport (GO:0006816),-0.402378773852239,-1.4767024017438475,0.008264462809917356,0.40897150867646864,1.0,30/113,13.70%,SLC24A3;TRPM3;CACNA1C;ANK2;NALCN;ITPR1;PKD1;STIM1;SLC8A3;ANO6;CACNA2D1;RAMP1;PKD2;TRPC3;CACNA1G;TRPM6;P2RX4;SLC8A1;CACNA1D;TRPC6;ITGAV;TRPM4;SLC24A5;TRPC4;CACNB2;TRPC4AP;PSEN1;PANX1;ORAI2;CRACR2A
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.6631906335289548,1.475616770345713,0.07894736842105263,0.491504382629548,1.0,5/15,8.41%,TGFB2;JAK3;SMAD7;TGFB1;FOXP3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.577788299528284,1.475561692416904,0.04669887278582931,0.48987569985076407,1.0,14/32,10.41%,JCAD;KDR;MMRN2;NOTCH1;HDAC9;HDAC7;STARD13;GATA2;DLL4;CARD10;KLF4;MAP3K3;PIK3C2A;PDCD10
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5909009883344805,1.4752651132225962,0.0594059405940594,0.48900650111040517,1.0,10/29,14.31%,ELOVL7;FASN;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;SLC25A1;HACD2;HSD17B8
prerank,cardiac atrium morphogenesis (GO:0003209),0.6513683681542772,1.4749748253182133,0.06537102473498234,0.48812120264718095,1.0,6/16,5.01%,ENG;BMPR2;TGFB2;ZFPM1;NOTCH1;DLL4
prerank,positive regulation of MAPK cascade (GO:0043410),0.4392114355525079,1.4745639486659214,0.0035294117647058825,0.4876545696802692,1.0,34/245,6.46%,FLT1;IGF1R;TEK;SEMA7A;MFHAS1;PIK3R6;JCAD;PDGFB;KDR;INSR;DAB2IP;TGFB2;RAPGEF2;PDGFD;APP;TBX1;TIRAP;PDE8A;FLT4;BCAR3;TPD52L1;PTPRJ;CD40;NOD2;NOTCH1;PRKD2;RAMP3;CCR7;CD4;MAPK3;ADRA2B;FBXW7;LGALS9;RET
prerank,amino sugar metabolic process (GO:0006040),0.7260511884238658,1.474464762488887,0.06653620352250489,0.48616118029669203,1.0,3/10,8.00%,CSGALNACT1;ST3GAL1;ST6GAL1
prerank,camera-type eye development (GO:0043010),-0.534928533347465,-1.4738500617464507,0.05063291139240506,0.4147193993993216,1.0,9/25,13.29%,CACNA1C;FBN1;EFEMP1;LAMA1;CYP1B1;IFT122;FBN2;SKI;NF1
prerank,regulation of axon extension (GO:0030516),0.5513679762187575,1.4736121930221668,0.06595092024539877,0.48721877126534213,1.0,7/37,8.14%,SEMA7A;MACF1;NTN1;DIP2B;DBNL;DNM2;TWF2
prerank,smoothened signaling pathway (GO:0007224),-0.5038077559027451,-1.4731216812864973,0.03684210526315789,0.4144067317339586,1.0,13/32,23.62%,GLI3;GLI2;CC2D2A;SMO;EVC2;GLI1;DYRK2;PTCH2;STIL;TMEM231;PTCH1;TMEM17;STK36
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.564206843114124,-1.4709296369494662,0.07242990654205607,0.4180357799929994,1.0,3/18,2.31%,EGFR;BMP4;DDX5
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7117947004853029,1.4708379986557443,0.07312614259597806,0.4945527425760214,1.0,3/11,4.35%,NOS3;GCH1;CALM1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5162525115928919,1.470586003859984,0.037900874635568516,0.4936633574370689,1.0,11/59,6.91%,HMCN1;PTPRM;BSG;PECAM1;CADM1;ROBO4;CDH2;DSCAML1;NECTIN4;PVR;CNTN2
prerank,regulation of macrophage cytokine production (GO:0010935),0.6704741120802971,1.4692128406255804,0.08084358523725835,0.49628955490317284,1.0,2/13,1.32%,SEMA7A;TGFB2
prerank,negative regulation of DNA binding (GO:0043392),0.5941720417694876,1.4691986729434685,0.05152979066022544,0.4945463791873237,1.0,10/28,17.92%,LEF1;NFKBIA;SP100;JUN;SOX11;HEY1;HMGA2;SUMO1;SIN3A;CPNE1
prerank,chondrocyte differentiation (GO:0002062),-0.4994976470965148,-1.4684961770627827,0.05026455026455026,0.42254779659752234,1.0,11/32,9.46%,SULF1;SOX5;WNT5B;BMP4;OSR1;SULF2;CREB3L2;SLC39A14;RUNX2;CCN3;SOX6
prerank,membrane organization (GO:0061024),0.43831185038378284,1.467633803671295,0.0036363636363636364,0.4978917341474137,1.0,59/227,16.46%,TFRC;DNM3;CERT1;HIP1;SPTBN1;EPN2;REEP1;FNBP1L;HIP1R;AGFG1;DYSF;FZD4;ARPC4;ATP2C1;ACTB;SNX3;GRB2;CD4;PIP5K1C;OCRL;CCDC88A;CNTN2;DNM2;CHRNB1;GRIN3B;FCHO2;CHMP1B;AP2M1;TGFA;RTP4;ARPC3;NPC1;ACTG1;ATP10B;LPCAT3;PIK3C2A;LEMD3;HSPA8;LRP2;SH3GLB1;GLTP;EPS15;SNAP29;AP2B1;HGS;MITD1;IL7R;SUN1;SGCZ;M6PR;AMPH;RTP3;PLEKHA3;SH3KBP1;SYNJ1;REEP3;PDCD6IP;ANK3;SPAST
prerank,nitrogen compound transport (GO:0071705),0.4616398552675581,1.4672729738923806,0.008894536213468869,0.49732333396762246,1.0,24/141,10.98%,SLC6A6;SLC7A5;SLC7A1;CERT1;ABCG2;SLC6A2;SLC38A5;ATP11B;SLC43A2;RAMP2;CALCRL;RAMP3;SLC52A2;CMTM6;SEC14L1;LRP1B;SCAMP1;CHMP1B;SLC3A2;SLC52A3;SLC18A1;ARL6IP5;LRP2;AMN
prerank,response to exogenous dsRNA (GO:0043330),0.6407340702512933,1.4670236835447334,0.06216696269982238,0.49633481534050083,1.0,6/18,8.98%,CAV1;IFIH1;TLR3;ZCCHC3;RALB;SLC3A2
prerank,oogenesis (GO:0048477),0.6532449235773821,1.4666732657381376,0.0695970695970696,0.49560624184952934,1.0,4/15,8.49%,NANOS3;NANOS2;NANOS1;PTN
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.5193349348438896,-1.46600804682006,0.06569343065693431,0.42677099698791693,1.0,11/25,15.71%,ERRFI1;SLC6A9;CBLB;SNX6;PPARA;TSG101;EPHB2;CNRIP1;ZFYVE28;ACE2;GPRC5A
prerank,regulation of heart contraction (GO:0008016),-0.4056322779956052,-1.4659258054923092,0.020491803278688523,0.42457351503045115,1.0,16/90,7.24%,ATP1A2;CELF2;ANK2;ITPR1;TPM1;STIM1;SLC8A3;DMPK;ASPH;CAMK2D;ABCC9;ATP1B3;TMEM65;ATP1B2;P2RX4;SLC8A1
prerank,regulation of glucose metabolic process (GO:0010906),-0.49084154863062357,-1.4656122224741914,0.06201550387596899,0.4230647447967802,1.0,8/34,10.23%,PDK1;IRS1;OGT;RORA;IRS2;PRKN;SELENOS;SLC45A3
prerank,axon extension (GO:0048675),-0.5378348859278179,-1.4652511670767199,0.05092592592592592,0.42166176101837105,1.0,11/23,21.59%,ALCAM;AUTS2;SLIT2;ULK2;SPG11;PPP3CB;USP9X;MAP1B;SEMA5A;SEMA3F;CDK5
prerank,positive regulation of GTPase activity (GO:0043547),0.4435510714473497,1.4651599733918932,0.009876543209876543,0.4988390081471927,1.0,38/188,8.52%,ITGA6;DOCK9;TBC1D4;SRGAP2;RAPGEF2;ARHGAP27;ARHGEF15;NET1;BCAR3;F11R;TBC1D14;AGRN;TBC1D22A;RAPGEF1;SIPA1L2;CD40;SIPA1;TIAM1;ABR;RALGAPA1;TBC1D12;SNX13;RAPGEF3;TGM2;TBC1D2;CCR7;USP6NL;MAPRE2;RSU1;TBC1D5;RAP1GDS1;RASGRP2;ARHGAP25;PKP4;ARHGEF5;PIN1;CAV2;ARHGEF7
prerank,transition metal ion transport (GO:0000041),0.5621200692940366,1.4645204046288176,0.05672609400324149,0.4992043471515512,1.0,6/35,4.15%,TFRC;SLC39A8;ATOX1;SLC30A1;ATP2C1;SLC31A1
prerank,glucose import (GO:0046323),0.6876450844830597,1.46442650285169,0.07235621521335807,0.49771917241995506,1.0,2/13,5.10%,SLC2A1;SORT1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5718370371237854,1.4636754263393188,0.05608974358974359,0.49841000099771726,1.0,4/33,5.26%,LEF1;FES;CTNNBIP1;CD4
prerank,regulation of integrin activation (GO:0033623),0.6652637489033716,1.4636582527285809,0.07553956834532374,0.49669313725525954,1.0,4/15,10.91%,RASIP1;PIEZO1;RAP1B;FERMT2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6664887599504102,1.4628364270355871,0.07913669064748201,0.497502975068294,1.0,5/14,4.16%,PTK2;JAK3;PXN;LYN;SOCS2
prerank,cAMP metabolic process (GO:0046058),-0.6279010157391379,-1.46282508018689,0.06277056277056277,0.42613696449702054,1.0,7/13,12.33%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PTHLH;ADCY6
prerank,lamellipodium assembly (GO:0030032),0.5883428972653897,1.462280996374643,0.08739495798319327,0.4975106279589815,1.0,9/26,11.43%,PARVB;ABLIM1;SRGAP2;S1PR1;SPATA13;CCDC88A;ARHGEF7;CYFIP1;RAC1
prerank,endocrine system development (GO:0035270),-0.5492585493200387,-1.4611481196389173,0.06407322654462243,0.4284507603551354,1.0,11/21,19.53%,GLI2;WNT4;DKK3;SALL1;TGFBR1;SIX1;FOXE1;NF1;WNT11;MDK;HOXD3
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6276195862365425,1.4604423420755395,0.08710801393728224,0.5017575518240112,1.0,2/18,0.45%,OCLN;SLC2A1
prerank,regulation of Notch signaling pathway (GO:0008593),0.4922910941153071,1.4599232864878924,0.02575107296137339,0.5017889314488533,1.0,16/76,6.44%,EGFL7;EPN2;TGFB2;NOS3;NOTCH4;JAG2;TSPAN5;NOD2;PRAG1;TSPAN14;NOTCH1;MFNG;GATA2;DLL4;MAML2;FBXW7
prerank,xenobiotic transport (GO:0042908),0.644259622103756,1.4597613756102583,0.08196721311475409,0.5005992739578725,1.0,2/16,0.38%,SLC7A5;ABCG2
prerank,negative regulation of protein processing (GO:0010955),-0.6192428876051475,-1.459057083628656,0.07918552036199095,0.431933208135302,1.0,7/12,19.06%,GAS1;THBS1;SNX12;LRRK2;SERPINE2;CTSZ;SERPINE1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.48589692391130845,1.4584514382177882,0.03159340659340659,0.5031858556121754,1.0,20/94,11.35%,PLCB1;IL1R1;NFKBIA;NOD1;NOD2;PELI1;MAP3K8;IKBKB;ST18;MAPK3;RPS6KA5;PSMB3;PSMD11;PSMC6;IRAK2;MAP3K3;PSME2;UBE2V1;TOLLIP;PSMD8
prerank,regulation of endothelial cell migration (GO:0010594),0.48102628867511676,1.457980674020503,0.02556818181818182,0.5031462021938242,1.0,17/85,5.30%,TEK;PTPRM;ETS1;KDR;DAB2IP;BMPR2;FLT4;PTK2;SP100;SCARB1;ACVRL1;PRKD1;PRKD2;VASH1;PRCP;DLL4;RHOB
prerank,negative regulation of defense response to virus (GO:0050687),-0.6669994423653767,-1.4576430950006984,0.0625,0.4335385852022036,1.0,5/10,20.58%,PPM1B;PCBP2;C1QBP;MUL1;TARBP2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.680558834896455,1.4573153862113113,0.0671785028790787,0.5036246712332367,1.0,3/11,6.88%,MFSD2A;SCARB1;NR1H2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5445354938328436,-1.4567270135833457,0.05238095238095238,0.4335783083910621,1.0,7/22,10.98%,IGF1;ROCK2;CAMK2D;P2RX4;PRKCA;SLC9A1;PARP1
prerank,amide biosynthetic process (GO:0043604),0.5245956581148501,1.4565744026131482,0.06092124814264487,0.5043544899713227,1.0,11/47,15.00%,SGMS1;SGMS2;DEGS2;CERS4;TLCD3B;SPTLC2;SLC25A15;DEGS1;SPTLC1;CLN8;FA2H
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6536235121061268,1.455785030316,0.08941605839416059,0.5053331023094516,1.0,4/15,10.08%,ENTPD1;AK4;ENTPD5;CMPK1
prerank,copper ion homeostasis (GO:0055070),0.6532421727624734,1.4553776497070972,0.0965391621129326,0.5049723338529001,1.0,4/17,5.15%,APP;ATOX1;SLC31A1;XIAP
prerank,organic substance transport (GO:0071702),0.4683895613666047,1.455320650646437,0.022788203753351208,0.5034628178489989,1.0,24/120,10.98%,ABCG2;MFSD2A;PLTP;ATP8A1;SLCO2B1;SPNS2;SLC6A2;RAMP2;CALCRL;ABCG1;RAMP3;CMTM6;ABCA3;LRP1B;CHKA;SCAMP1;CHMP1B;ABCA7;TAP2;SLC18A1;ARL6IP5;LRP2;ABCD1;AMN
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.44762243216049064,-1.453221341798088,0.03278688524590164,0.4420610011924238,1.0,11/51,6.76%,FSTL1;FBN1;BMPR1A;NBL1;CRIM1;BMPER;SMAD6;HTRA3;GREM2;RBPMS2;SMAD9
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5529829740998818,1.4529411855417411,0.081377151799687,0.5096450052489508,1.0,9/35,6.71%,FLT1;PTPRM;XDH;CAV1;RGCC;MEF2C;VASH1;DLL4;STAT1
prerank,positive regulation of cytokine production (GO:0001819),0.4207038326617054,1.4520950653395137,0.005733944954128441,0.5108600940774977,1.0,52/292,13.02%,SLC7A5;PLCB1;SPTBN1;CADM1;CD34;APP;IL1R1;TIRAP;IL6R;FLT4;CD200;AFAP1L2;ARHGEF2;RGCC;NOD1;LRRFIP1;CD40;ZFPM1;NOD2;PRKD2;IFIH1;GBP5;NOS2;CTNNB1;PDE4D;POU2AF1;CD6;HYAL2;CCR7;CD4;TLR3;MRE11;CCDC88B;LGALS9;IRF5;TLR7;TGFB1;PDE4B;MALT1;EBI3;ADAM17;AGER;LAMTOR5;CCL1;TLR8;PNP;HIF1A;SYK;C1QTNF4;CYRIB;IL15;RAB1A
prerank,JNK cascade (GO:0007254),0.5583551156863635,1.4518067883050636,0.049689440993788817,0.5101047002326607,1.0,6/40,3.20%,SH2D3C;MAP4K2;TNFRSF19;MAP4K3;NOD1;NOD2
prerank,heart contraction (GO:0060047),-0.4693792259397205,-1.4512963464805326,0.03508771929824561,0.4450683311396142,1.0,7/41,10.13%,ATP1A2;SGCD;TPM1;DMD;SLC8A1;ACE;GAA
prerank,negative regulation of metabolic process (GO:0009892),-0.4498994381210708,-1.450373841137029,0.03867403314917127,0.4454218348561857,1.0,18/54,15.49%,ALDH1A1;LGR4;DOCK7;PLCL1;NPR3;FOXC2;ADAMTS5;RBPJ;ZNF423;ACOT11;TLE3;NOVA1;PLCL2;STK11;RHEB;PCTP;TLR4;NRDC
prerank,lipid modification (GO:0030258),0.5541294603709004,1.4501991896769542,0.057750759878419454,0.5137802207438358,1.0,9/37,11.93%,SGPP2;DGKH;MBOAT1;CYP2E1;PLPP6;DGKI;DGKE;LPCAT3;DGKZ
prerank,stabilization of membrane potential (GO:0030322),-0.5844292338398307,-1.4499333752596113,0.05811138014527845,0.4443201489893288,1.0,2/16,3.08%,KCNK2;KCNK5
prerank,response to molecule of bacterial origin (GO:0002237),0.4981491675206574,1.4492608418291963,0.045779685264663805,0.5153279386903683,1.0,19/69,15.03%,NOS3;TIRAP;GCH1;IFNAR1;TNFRSF11A;PELI1;NOS2;NOCT;PALM3;CD6;LGALS9;IRF5;ADAM17;S100A8;CYRIB;SLPI;HMGB2;TNFAIP3;INAVA
prerank,positive regulation of interleukin-17 production (GO:0032740),0.6144905480454952,1.4476384815872696,0.07903780068728522,0.5188050548260414,1.0,6/22,14.29%,SLC7A5;NOD2;TGFB1;CCL1;IL15;RFTN1
prerank,iron ion transmembrane transport (GO:0034755),0.703965007238714,1.447338816840678,0.0933572710951526,0.5181199786807685,1.0,2/10,1.24%,SLC40A1;SLC39A8
prerank,regulation of dendrite extension (GO:1903859),0.6353343546341337,1.4468790168118686,0.10398613518197573,0.5179534547038726,1.0,10/18,20.25%,NEDD4L;ITSN2;RASAL1;SMURF1;CPNE5;SYT4;CPNE6;RIMS2;UNC13A;PLAA
prerank,B cell activation (GO:0042113),0.49766756121039285,1.4467034511124803,0.043923865300146414,0.5168392898263093,1.0,22/68,16.54%,TPD52;PTPRJ;MEF2C;JAK3;CD40;HDAC9;ZAP70;HHEX;SLC25A5;CD79A;KLF6;MALT1;ADAM17;CASP8;PRKCB;ZBTB7A;VCAM1;HDAC5;DNAJB9;MSH2;LAT2;ITGA4
prerank,regulation of microtubule polymerization (GO:0031113),0.5329950782427519,1.4465147308256256,0.06260032102728733,0.5157620375355616,1.0,10/40,13.45%,OCLN;FES;STMN1;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1;MAPRE3;CDH5
prerank,heart looping (GO:0001947),0.5533552754618022,1.4461726691479708,0.056910569105691054,0.5152303910826166,1.0,7/39,3.41%,ENG;ZIC3;SOX17;TBX3;MEF2C;APLNR;NOTCH1
prerank,response to muramyl dipeptide (GO:0032495),0.6790520164863213,1.4460307052131072,0.09306569343065693,0.5140180068544539,1.0,4/12,7.15%,ARHGEF2;NOD1;NOD2;IRF5
prerank,positive regulation of dendrite extension (GO:1903861),0.6424310765079353,1.4437618945650885,0.10350877192982456,0.5198322071082533,1.0,10/17,20.25%,NEDD4L;ITSN2;RASAL1;SMURF1;CPNE5;SYT4;CPNE6;RIMS2;UNC13A;PLAA
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4458967086862211,1.4435847899607754,0.012578616352201259,0.5187103986585097,1.0,19/150,6.46%,IGF1R;KITLG;TEK;HIP1;MFHAS1;PDGFB;INSR;ENG;PTPRJ;PTK2;GRB2;CD19;FGF16;RAMP3;HSP90AB1;GAB1;CCR7;FYN;RET
prerank,protein localization to cell-cell junction (GO:0150105),0.6631973243724775,1.4423121468913884,0.09269162210338681,0.5213274456017055,1.0,5/15,3.99%,TJP1;TJP2;F11R;ACTB;LSR
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3903427425081628,-1.4421590394194694,0.011811023622047244,0.46498964240399415,1.0,37/108,13.23%,TRABD2B;WLS;SULF1;LRP1;PTK7;FGFR2;GPC3;RNF43;DCDC2;MDFIC;RSPO3;KANK1;SULF2;WWOX;SALL1;DAAM2;RSPO2;SFRP4;FZD7;DACT1;CTNND2;PRKN;FOXL1;GRB10;NXN;AXIN1;VGLL4;CDK14;BTRC;LRRK2;CXXC4;ESR1;PSEN1;BMP2;EMD;SKI;NKD2
prerank,negative regulation of GTPase activity (GO:0034260),0.5964595081245349,1.4416609166007448,0.0799347471451876,0.5219596356074054,1.0,7/22,11.49%,LRCH1;DAB2IP;SH3BP4;F11R;FICD;PLXNB3;HRAS
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6032989805741118,1.441079644380915,0.07504363001745201,0.5222012242161568,1.0,4/22,3.88%,MFHAS1;DAB2IP;TIRAP;LYN
prerank,MAPK cascade (GO:0000165),0.4195590766101051,1.4409527375354225,0.006888633754305396,0.5210443942860091,1.0,50/295,9.52%,KITLG;TEK;RASGRP3;SHANK3;RASAL2;SPTBN1;PDGFB;KDR;BCL2L1;DAB2IP;RAPGEF2;RASGRF2;RASGRP4;PTK2;MEF2C;DUSP7;JAK3;FGF13;MEN1;MAP3K8;IKBKB;CALM1;GRB2;FGF16;CAMKK2;ZDHHC9;IL17RD;FYN;SOS1;MAPK3;ABHD17A;LGALS9;RET;PSMB3;LRRC7;RGL2;RASAL1;PSMD11;TGFB1;TGFA;SPTAN1;MARK3;SHC3;PSMC6;LYPLA1;CCM2;PAK1;MAP3K3;PPP1CB;PSME2
prerank,smooth muscle cell differentiation (GO:0051145),0.6878674890035901,1.440144929775862,0.10071942446043165,0.5221644425297083,1.0,5/12,3.28%,TMEM204;MRTFB;MRTFA;MEF2C;APLNR
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5691015442765491,-1.4396505471926844,0.053738317757009345,0.4700354399989783,1.0,4/16,5.34%,PRKAG2;APPL2;PPARGC1A;PPARA
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5529186325956343,-1.4395952479559397,0.0625,0.46769910605761666,1.0,8/20,10.27%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;LACC1;ATP1B2;SLC8A1;SLC9A1
prerank,fatty acid biosynthetic process (GO:0006633),0.501711281005416,1.4391615606663604,0.04591104734576758,0.5237592605335211,1.0,12/63,14.31%,ABHD2;ELOVL7;TECRL;CYP2E1;ELOVL5;LIPC;ABCD1;ELOVL6;LTA4H;HACD2;DEGS1;HSD17B8
prerank,cellular response to insulin stimulus (GO:0032869),0.45319430671903727,1.4387803231559613,0.022818791946308724,0.5234259447617804,1.0,30/124,14.06%,IGF1R;GRB14;TBC1D4;NAMPT;INSR;BCAR3;RAB31;FOXO1;PIK3R3;HDAC9;ATP6V0A1;GRB2;GAB1;BAIAP2;DENND4C;SOS1;SLC25A33;SORBS1;PKM;AP3S1;CAV2;PIK3C2A;GRB7;GSK3A;CEACAM1;ZFP36L1;PPARG;LPIN3;SH2B2;PDE3B
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.48155234340467395,1.438246233098543,0.03380281690140845,0.5235196277685588,1.0,17/73,10.41%,TFRC;SH2D3C;APP;CAV1;BCAR3;PRKD1;PRKD2;RAPGEF3;FNIP2;RAMP3;HSP90AB1;TGFB1;IRGM;PAK1;CNOT9;AKAP9;PDCD10
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5436055504754493,1.4380685828666229,0.06818181818181818,0.522515839653816,1.0,9/38,10.45%,BCL2L1;NOS3;FAS;TNFSF10;ARHGEF2;SP100;RFFL;FAIM;CASP8
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.4605341515807132,-1.4378295603400373,0.020895522388059702,0.4705901969303777,1.0,15/46,12.49%,IGF1;PDGFRB;OGN;IGFBP5;BMP4;ELN;APOD;IL18;THBS1;RBPMS2;IGFBP3;CCN4;CDH13;MFN2;XRCC5
prerank,positive regulation of proteolysis (GO:0045862),-0.4377983611728526,-1.437499666606978,0.031055900621118012,0.46912345913562375,1.0,21/55,20.69%,CCBE1;CYFIP2;ASPH;OGT;ADAM9;RCN3;APOE;SNX9;PERP;BTRC;TBC1D10A;NKD2;CTSH;FBXW11;ATP5IF1;SNX33;NRDC;PACSIN3;CLN6;ADRA2A;ADAM8
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.640153515324696,-1.4368239312374216,0.07191011235955057,0.4686690047789117,1.0,3/10,3.84%,ATP1A2;OSR1;CAMK2D
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6707913342831588,1.4359597934396922,0.0984182776801406,0.5276789135787977,1.0,3/13,4.35%,NOS3;GCH1;CALM1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6154439825740223,-1.4353131037455298,0.09411764705882353,0.47073700517797995,1.0,7/12,19.36%,DMD;WNK4;ATP1B3;ATP1B2;FXYD1;WNK1;WNK3
prerank,regulation of calcium ion import (GO:0090279),0.6054896458847389,1.4348792371404298,0.09443507588532883,0.5295082865782448,1.0,5/21,6.12%,PDGFB;CXCL12;SLC30A1;CTNNB1;FYN
prerank,Golgi to plasma membrane transport (GO:0006893),0.5207070929484292,1.4348693359384848,0.046476761619190406,0.5279096540594834,1.0,10/47,11.21%,SPTBN1;MACF1;EXOC6B;EXOC6;RAB31;STXBP6;RAB34;AMN;EXOC4;EXOC2
prerank,positive regulation of B cell activation (GO:0050871),0.5168355631524716,1.4343696943967426,0.061855670103092786,0.5278163411777723,1.0,7/50,6.58%,TFRC;TIRAP;MEF2C;CD40;NOD2;CD38;SHLD1
prerank,dendrite self-avoidance (GO:0070593),0.6387773340201097,1.4335173447088105,0.08833922261484099,0.5287538142165307,1.0,4/16,6.91%,BSG;ROBO4;DSCAML1;CNTN2
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.6280362440696151,1.4332542406843494,0.1099476439790576,0.5279479260497066,1.0,6/16,11.65%,BMPR2;DDAH1;PRCP;NPPA;KLK1;GSK3A
prerank,lipid translocation (GO:0034204),0.6175020379466536,1.4319961433901007,0.07876712328767123,0.5305311309231939,1.0,7/21,9.75%,ATP10A;ATP8A1;ATP11B;ATP11A;ABCA7;ATP11C;ATP10B
prerank,glutamate receptor signaling pathway (GO:0007215),0.5516683885499349,1.431167132614266,0.054878048780487805,0.5318588347413178,1.0,12/37,14.46%,PLCB1;APP;GNAQ;HOMER2;GRID2;HOMER1;GRIN3B;GRIA4;GRIN2B;GRIK2;GRIK1;GRM7
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6077644106103295,1.4311004250585784,0.10499139414802065,0.5304482394667303,1.0,6/19,12.23%,TEK;KDR;PTPRJ;FERMT2;RAC1;MAP4K4
prerank,regulation of cellular component biogenesis (GO:0044087),0.5376502839002826,1.4309589123823552,0.06132075471698113,0.52930061017528,1.0,11/39,10.71%,TJP1;TIE1;DAB2IP;RAPGEF2;RAPGEF1;NOTCH1;INSM1;RAP1B;IRGM;MSN;HSPA8
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5378496328031346,-1.4301949421179325,0.07565011820330969,0.48403236829182805,1.0,9/21,12.04%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;MMP2;FOXJ2;ADAMTS1;MFN2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5163540572485114,1.4299598594620604,0.05829596412556054,0.5310875665433964,1.0,15/49,14.07%,TIRAP;AFAP1L2;NOD1;NOD2;PRKD2;NOS2;HYAL2;TLR3;LGALS9;TLR7;LAMTOR5;TLR8;SYK;RAB1A;BCL10
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.6338283714739379,-1.4296810981135353,0.06828193832599119,0.48331715050636287,1.0,5/11,19.17%,WNT4;BMP5;BMP2;NR1H4;STAR
prerank,positive regulation of blood coagulation (GO:0030194),-0.5578438907461942,-1.4290506096509226,0.08857808857808858,0.48287468146489565,1.0,6/17,12.29%,ST3GAL4;THBS1;F3;ANO6;THBD;DMTN
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.6815249526471794,1.4287319999543422,0.08949416342412451,0.533555381410026,1.0,5/11,12.15%,RAPGEF2;MEF2C;LYN;LGALS9;PIK3CB
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6427012180734768,1.4285397519146041,0.08333333333333333,0.5326001322588522,1.0,5/16,5.01%,JCAD;PPP1R16B;APLNR;GATA2;DLL4
prerank,determination of heart left/right asymmetry (GO:0061371),0.5352066679194878,1.4285091403383183,0.06581059390048154,0.5310933491607789,1.0,7/42,3.41%,ENG;ZIC3;SOX17;TBX3;MEF2C;APLNR;NOTCH1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.5492043477755919,-1.4282244688033843,0.05733944954128441,0.48300477539624687,1.0,7/21,8.15%,SULF1;EXT1;SULF2;HS2ST1;HS3ST3B1;HS6ST1;HS6ST2
prerank,anion transmembrane transport (GO:0098656),0.48986803908397336,1.4277272763384707,0.040345821325648415,0.5321047778305039,1.0,10/67,5.07%,SLC7A5;SLC7A1;SLC1A1;SLC39A8;SLC6A5;SLC38A5;LRRC8B;LRRC8C;SLC1A2;SLC25A5
prerank,negative regulation of immune effector process (GO:0002698),-0.6005284236841469,-1.4276649978577296,0.09719222462203024,0.482211383797608,1.0,4/13,16.97%,CD55;ENPP3;CD300A;GRN
prerank,BMP signaling pathway (GO:0030509),-0.4255590345250429,-1.4270653322354951,0.02875399361022364,0.48152462592178197,1.0,14/62,6.76%,BMP6;TGFBR3;BMPR1A;SMAD3;BMP5;BMP7;BMP4;DDX5;SMAD6;RGMA;RGMB;RUNX2;TMEM100;SMAD9
prerank,response to lipid (GO:0033993),0.4635392769884551,1.4263798636975076,0.025815217391304348,0.5349737024578568,1.0,26/105,13.76%,NOS3;ACER2;TRIM16;PPARD;TIRAP;GCH1;IFNAR1;TNFRSF11A;FOXO1;PELI1;ABCG1;SOCS2;NOS2;CTNNB1;NOCT;PALM3;CD6;LGALS9;TGFB1;ADAM17;S100A8;PAQR7;SLPI;PPARG;SOX9;HMGB2
prerank,Rac protein signal transduction (GO:0016601),0.6319866922056666,1.42627265245201,0.07513416815742398,0.5336924059812339,1.0,7/18,11.43%,ELMO1;TIAM1;EPS8;DBNL;NCKAP1;CYFIP1;RAC1
prerank,actin filament-based transport (GO:0099515),0.6021560311680005,1.4260747439893398,0.09233449477351917,0.5327778167578173,1.0,5/21,6.03%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4
prerank,response to copper ion (GO:0046688),0.6070974706995469,1.4258795781178242,0.08727272727272728,0.5319342688201307,1.0,12/20,25.24%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;LOXL2;DAXX;SNCA;AOC1
prerank,B cell proliferation (GO:0042100),0.625381599002212,1.4252319104033562,0.09671848013816926,0.5325445611485742,1.0,4/17,8.21%,MEF2C;CD40;CD19;CD79A
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6175370825693824,-1.4244028077602386,0.08951965065502183,0.48725992543190566,1.0,5/11,24.43%,XPO5;FMR1;LIMD1;AJUBA;STAT3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6432979846699112,1.4242607657680644,0.08604206500956023,0.5341924750513207,1.0,2/15,1.56%,PRKCH;TRIM16
prerank,negative regulation of complement activation (GO:0045916),-0.6423611050225475,-1.424146543596887,0.08739837398373984,0.48560740484953724,1.0,2/10,1.85%,SERPING1;CD55
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5579670058917907,1.4239541397701927,0.06976744186046512,0.5336302150613341,1.0,5/33,4.52%,TEK;NDNF;KDR;RAMP2;GATA2
prerank,cellular response to growth factor stimulus (GO:0071363),0.43610969939528876,1.4236203947366515,0.008894536213468869,0.5331508589289915,1.0,28/151,5.07%,FLT1;NDNF;SEMA6A;PDGFB;KDR;DAB2IP;BMPR2;PDE2A;RAPGEF2;TBX1;PDE8A;FLT4;MEF2C;RAPGEF1;PTPN12;ACVRL1;PRKD1;NOTCH1;PRKD2;RAMP2;DUSP3;VIL1;PLCG1;WNT7A;SMAD7;CTNNB1;DLL4;HYAL2
prerank,positive regulation of macrophage activation (GO:0043032),-0.5643092539397072,-1.4228211969954045,0.06921241050119331,0.4869405436762953,1.0,4/17,14.75%,LBP;THBS1;TNIP2;TLR4
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.43885468335295363,1.4215124226563853,0.024906600249066,0.5383553647042534,1.0,26/159,7.00%,MPZ;HMCN1;PTPRM;BSG;PECAM1;CLDN5;CADM1;ROBO4;TGFB2;ADGRL3;CDH2;DSCAML1;ATP2C1;NECTIN4;CDH20;PCDHGB4;CD6;CDH8;GRID2;PVR;SLITRK3;FAT4;CNTN2;CLDN14;DCHS1;CDH19
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5374256680421685,1.421095019939442,0.09105180533751962,0.538143630578783,1.0,11/36,19.12%,SHANK3;ADRA2B;FBXW7;BUD31;TGFA;GREM1;ADAM17;HIF1A;EDN1;CCR2;NRP1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.6231115513937343,1.4206890020418772,0.0979381443298969,0.5378483383340887,1.0,3/16,7.37%,CADM1;PVR;CD160
prerank,cellular response to mechanical stimulus (GO:0071260),0.5243139423061324,1.4201674950955012,0.07078313253012049,0.5379074742746255,1.0,14/46,14.07%,PDE2A;FAS;F11R;CD40;MAP3K1;PIEZO1;TLR3;MAPK3;CRADD;TLR7;CASP8;TLR8;SOX9;BCL10
prerank,carbohydrate transport (GO:0008643),0.6780668744864936,1.420098054813922,0.10622710622710622,0.5365565131111987,1.0,2/11,4.59%,AQP11;AQP7
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6385621662240394,1.4199262721016839,0.0984182776801406,0.5354886406356686,1.0,3/14,1.75%,NOTCH4;XDH;CAV1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5644362510060391,-1.4193660623976923,0.07948717948717948,0.49493394521083617,1.0,2/17,1.85%,BMP6;CD55
prerank,protein O-linked glycosylation (GO:0006493),0.46143583458301557,1.4190300834621974,0.04061624649859944,0.5368343287180752,1.0,11/96,4.42%,TMTC2;EOGT;ST8SIA6;ST3GAL1;GALNT18;B4GALT5;ST6GALNAC2;MUC3B;MUC3A;B3GNT2;OGA
prerank,defense response to bacterium (GO:0042742),0.45517720431728564,1.4179205637535879,0.040376850605652756,0.5388611165268093,1.0,20/105,13.76%,PGLYRP1;STAB1;TIRAP;IL6R;NOD1;DEFA6;NOD2;GBP7;GBP4;NOS2;TLR3;IRGM;PPP1R11;ADAM17;S100A8;SYK;LPO;SLPI;RAB1A;HMGB2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5322371326016393,1.4178537227613701,0.0673076923076923,0.5375687769454437,1.0,7/43,3.41%,ENG;ZIC3;SOX17;TBX3;MEF2C;APLNR;NOTCH1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.5549428762829675,-1.4177498686943009,0.07209302325581396,0.4975075600432762,1.0,9/19,21.62%,DDO;ASPA;ALDH7A1;GOT1;PHYKPL;HYKK;PIPOX;GOT2;AASS
prerank,positive regulation of transferase activity (GO:0051347),0.44547301531587896,1.4172964838009785,0.030729833546734954,0.5377394559307407,1.0,24/142,8.09%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;CD200;DCUN1D3;HMBOX1;MERTK;SERINC5;CTNNB1;HSP90AB1;CD4;EPHA4;MRE11;MAPK3;FBXW7;KLF4;RET;EPHB4;PIN1;TGFB1
prerank,defense response to virus (GO:0051607),0.464735637671032,1.416345760508498,0.03333333333333333,0.5392293123390797,1.0,23/100,11.42%,BCL2L1;SERINC3;IFNAR2;CD40;IFIH1;NLRC5;IRF2;SERINC5;SAMHD1;NT5C3A;TLR3;STAT1;BST2;TLR7;RTP4;AGBL5;BNIP3L;ZMYND11;OASL;DDIT4;PDE12;TLR8;RNASE1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5527965435008667,-1.415524021937203,0.07194244604316546,0.5016937732807019,1.0,3/17,4.57%,ANK2;SNTA1;CACNA2D1
prerank,regulation of DNA repair (GO:0006282),-0.4557783129133579,-1.4153590314508697,0.0521978021978022,0.49975873054692765,1.0,4/44,2.10%,EYA2;EYA1;EGFR;EYA4
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5761570125367165,1.4152022795978794,0.09661016949152543,0.5412521612732825,1.0,5/25,9.05%,SLC7A5;B2M;NOD2;CD160;MALT1
prerank,endoderm formation (GO:0001706),-0.476334759478682,-1.4146722128202018,0.05191256830601093,0.49941684396935276,1.0,11/35,10.36%,COL8A1;COL12A1;VTN;COL6A1;ITGB5;MMP14;COL11A1;MMP2;ITGA5;LAMB1;ITGAV
prerank,positive regulation of T cell migration (GO:2000406),0.6034213502745016,1.4141276703199237,0.08741258741258741,0.5432295491295879,1.0,4/20,9.89%,CXCL12;APP;ADAM10;ADAM17
prerank,sodium ion transport (GO:0006814),-0.3981946940849765,-1.4137084544410923,0.01694915254237288,0.5001354239434669,1.0,17/85,7.24%,ATP1A2;SLC24A3;NALCN;SLC6A13;SCN7A;SLC6A12;SLC8A3;SLC6A9;SLC12A2;ANO6;PKD2;ATP1B3;SLC5A5;SLC6A1;SLC5A6;SLC9B2;SLC8A1
prerank,carboxylic acid metabolic process (GO:0019752),0.5525203493924254,1.4127824564084794,0.09175738724727839,0.5461875622761634,1.0,6/33,9.51%,CSGALNACT1;SLC2A1;ST3GAL1;GLYAT;ST6GAL1;TBXAS1
prerank,energy reserve metabolic process (GO:0006112),-0.5601120311992781,-1.4120570899415752,0.07126948775055679,0.5026554603633712,1.0,8/19,10.73%,PID1;PRKAG2;LEPR;PHKB;PYGM;GFPT1;GFPT2;PPP1R3C
prerank,stress-activated MAPK cascade (GO:0051403),0.4960833357922415,1.4120082424814144,0.06484149855907781,0.5472246478558824,1.0,13/61,9.77%,SH2D3C;MAP4K2;TNFRSF19;MAP4K3;NOD1;NOD2;MAP3K8;IKBKB;MAPK3;LGALS9;IRAK2;CCM2;UBE2V1
prerank,cell-cell junction assembly (GO:0007043),0.4898561641515172,1.411266904955999,0.05891016200294551,0.5481714262327686,1.0,17/63,7.09%,TJP1;CLDN5;GJD3;GJC1;CDH2;RAMP2;ACTB;CDH20;SMAD7;CTNND1;CTNNB1;CDH8;PIP5K1C;PKN2;DCHS1;CDH19;PKP4
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5782891214614728,1.411225199472463,0.10684474123539232,0.5467526913675231,1.0,3/24,3.18%,DACH1;BMPR2;ACVRL1
prerank,cellular copper ion homeostasis (GO:0006878),0.646056690464117,1.4107307157638682,0.1125,0.5467820661076273,1.0,3/14,4.15%,APP;ATOX1;SLC31A1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.558421955659509,1.410667710987849,0.07462686567164178,0.5454923682323717,1.0,15/33,12.99%,MMRN2;RGCC;MEF2C;ACVRL1;NOTCH1;VASH1;STARD13;DLL4;CARD10;KLF4;TGFB1;AGTR2;PDCD10;PPARG;CSNK2B
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.6102209771595623,-1.4099572365207258,0.0935412026726058,0.506661392824165,1.0,2/12,6.03%,INSIG2;KDELR3
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6129829576005764,1.4095614918711605,0.0981067125645439,0.5476233657040498,1.0,3/17,7.37%,CADM1;PVR;CD160
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6712060587547022,1.409377659367179,0.12384473197781885,0.5466163376411005,1.0,2/12,0.85%,DDC;MAOA
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3949220873686328,1.4092079783237783,0.0010799136069114472,0.5456536262255471,1.0,87/509,12.33%,FLT1;IGF1R;TFRC;KITLG;TEK;HIP1;MFHAS1;JCAD;PDGFB;KDR;INSR;BCL2L1;DAB2IP;ENG;TGFB2;RAPGEF2;TNFRSF19;PDGFD;APP;CAV1;TBX1;TIRAP;FLT4;PLEKHG5;TRIM25;BCAR3;TNFSF10;TRIM14;PTPRJ;PTK2;NOD1;CD40;NOD2;PELI1;PRKD1;PRKD2;ATP2C1;VWF;LYN;TGM2;IKBKB;GRB2;CD19;FGF16;RAMP3;HSP90AB1;GAB1;CCR7;CD4;WDR59;TLR3;ACTN4;FYN;ZCCHC3;ADRA2B;LGALS9;RET;BST2;TLR7;BIRC3;TGFB1;TGFA;IQGAP1;CAV2;MALT1;MAP3K3;NDFIP2;SCHIP1;UBE2V1;OASL;SHARPIN;AGER;CASP8;BRD4;LRP2;LAMTOR5;FERMT2;S100A8;RAC1;TNFSF11;HRAS;PRKCB;GPR89A;C1QTNF4;PIK3CB;RPTOR;GDF15
prerank,hippo signaling (GO:0035329),0.5727773908776533,1.4089978104977021,0.09012131715771231,0.5448343636640751,1.0,7/26,6.99%,TJP1;TEAD4;TJP2;AMOT;WWTR1;FAT4;DCHS1
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6419448046565809,-1.4087280689658785,0.09333333333333334,0.5081309901564133,1.0,2/10,1.89%,GLI3;BMP4
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5655651481973689,1.4087196328396732,0.10576923076923077,0.5442014770627386,1.0,7/25,11.08%,SPTBN1;PRKD2;PDE4D;CD4;PDE4B;MALT1;PNP
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5763226326529172,1.408387178839316,0.09895833333333333,0.543756195794567,1.0,10/24,14.18%,DAB2IP;EPN2;TMEM204;MMRN2;PRKD2;HHEX;PRKCB;HIF1A;HGS;PDCD6
prerank,T cell homeostasis (GO:0043029),0.6811879835895757,1.4075684243800233,0.11645101663585952,0.5449389147854797,1.0,4/10,14.70%,FAS;JAK3;FOXP3;NCKAP1L
prerank,regulation of MAPK cascade (GO:0043408),0.4379209299214452,1.4072647630011628,0.029639175257731958,0.544390159768427,1.0,37/157,12.68%,FLT1;IGF1R;TEK;JCAD;PDGFB;KDR;INSR;DAB2IP;CAV1;FAS;TBX1;FLT4;BCAR3;PHLPP1;PTPRJ;DUSP3;LYN;CD4;PAK5;MAPK3;ADRA2B;RET;ARHGEF5;ABCA7;IQGAP1;CAV2;P2RX7;GREM1;PAK1;DUSP1;HRAS;SYK;CEACAM1;MAP4K4;GDF15;EPHB1;WWC1
prerank,triglyceride biosynthetic process (GO:0019432),-0.5408115974187022,-1.406627629595916,0.08933002481389578,0.5118325167370884,1.0,6/18,15.29%,AGMO;MOGAT3;GK;LPGAT1;GPAT3;PNPLA3
prerank,lipid phosphorylation (GO:0046834),0.6938358340498161,1.4066225034118747,0.12432432432432433,0.5449240630357807,1.0,4/10,11.93%,DGKH;DGKI;DGKE;DGKZ
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5952803524677417,-1.404926547076942,0.07816091954022988,0.5145084032927946,1.0,7/13,24.90%,DDX5;PLA2R1;ATM;SPRED1;HIC1;ATR;MSX1
prerank,positive regulation of phosphorylation (GO:0042327),0.4106994427150417,1.4042008956331606,0.020737327188940093,0.5514400240240481,1.0,47/240,10.36%,FLT1;IGF1R;TFRC;TEK;ITGA6;LIMCH1;PECAM1;KDR;INSR;TIE1;ENG;APP;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;MERTK;LYN;FGF16;CD4;CAMKK2;EPHA4;MRE11;LIMK2;PPIA;MAPK3;ENTPD5;RET;EPHB4;RALB;EFNA1;PIN1;TGFB1;IRGM;P2RX7;PAK1;PGF;PFKFB3;CCND3;ADAM17;AXIN2;AGER
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.5321791265207668,1.403585636737962,0.07395498392282958,0.5519223332444899,1.0,11/35,11.43%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;PLXND1;SEMA4F;SEMA6D;SEMA4C;ARHGDIA;PLXNB3;RAC1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5070194185254459,1.4033681870001486,0.07575757575757576,0.5511660405975733,1.0,8/46,7.63%,TEK;PARVB;SRGAP2;LAMA5;NTNG2;PXN;PARVG;EFNA1
prerank,organophosphate ester transport (GO:0015748),0.5688004755962208,1.4030472984525475,0.09612141652613827,0.550640365834217,1.0,6/24,6.01%,PLTP;SCARB1;PITPNC1;PRELID2;PITPNA;ABCA3
prerank,membrane repolarization (GO:0086009),-0.5649485286552894,-1.4026335325373787,0.10440835266821345,0.5194483073791984,1.0,4/15,7.08%,ATP1A2;KCNJ2;ATP1B3;ATP1B2
prerank,positive regulation of secretion (GO:0051047),0.6662603063386913,1.4024297274639779,0.12932604735883424,0.5510241042911997,1.0,4/11,17.40%,ABCB11;ACSL3;NPR1;TRH
prerank,regulation of interleukin-12 production (GO:0032655),0.5063515105198788,1.4022551883823333,0.09841269841269841,0.5501447394593668,1.0,11/47,11.85%,PLCB1;TIRAP;JAK3;CD40;CCR7;TLR3;LGALS9;IRF5;AGER;TLR8;SYK
prerank,negative regulation of chemotaxis (GO:0050922),0.5409967339942228,1.4022336868035803,0.09508716323296355,0.5487428505801226,1.0,8/31,6.97%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;NOTCH1;DUSP3;SEMA4F;SEMA6D
prerank,defense response to protozoan (GO:0042832),0.6575202968847409,1.401698926935943,0.13310580204778158,0.5489390617596912,1.0,3/12,3.22%,CD40;GBP7;GBP4
prerank,acylglycerol catabolic process (GO:0046464),0.5547007702212379,1.4008645209128292,0.09863945578231292,0.5501138341255084,1.0,4/30,10.76%,ABHD2;LIPE;FABP5;LIPC
prerank,positive regulation of chromatin organization (GO:1905269),0.6568795732064857,1.4005933998836875,0.13818181818181818,0.5494930012751233,1.0,6/12,21.77%,TAL1;TERF2;ACD;TERF1;SIN3A;DAXX
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6964480732573388,1.399932521979514,0.1274131274131274,0.5501702923373565,1.0,5/10,6.44%,CXCL12;RAPGEF2;LYN;CCR7;LGALS9
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.6319264998080671,1.399295525761418,0.10460992907801418,0.5507331208861558,1.0,6/14,19.50%,DAB2IP;FICD;DNAJB9;COPS5;BFAR;BAK1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.6072412242381529,-1.3990591137878892,0.09360730593607305,0.5278808237352516,1.0,7/13,15.12%,LARGE1;MGAT3;RENBP;PGM3;CHST3;CHST1;NAGK
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5113216651312891,1.3988809567240146,0.08,0.5506370994121533,1.0,12/51,11.01%,TRIM16;APP;NOD2;GBP5;LGALS9;AIM2;P2RX7;MALT1;AGER;CASP8;HSPB1;TLR8
prerank,cell-matrix adhesion (GO:0007160),-0.38131914179728876,-1.398466791361425,0.030927835051546393,0.5273911742934868,1.0,21/95,7.16%,ITGBL1;COL3A1;ADAMTS12;VTN;ACTN2;ITGB5;ITGB8;PKD1;ITGA10;COL13A1;FBLN5;DDR1;VCL;ECM2;CD63;ADAM9;NID2;ITGA11;THBS3;EMILIN1;MSLN
prerank,positive regulation of calcium ion import (GO:0090280),0.6394913056371353,1.3980737450911258,0.12477064220183487,0.55158464233707,1.0,3/12,4.91%,PDGFB;CXCL12;RAMP3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6193052570398421,-1.3979969253399147,0.11883408071748879,0.52633603791502,1.0,5/11,8.27%,PDK1;MAP3K5;PRKCD;CYP1B1;PRODH
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.6608208679864376,1.3969828547302499,0.11669658886894076,0.5536488764966992,1.0,5/13,13.45%,ELOVL7;TECRL;ELOVL5;ELOVL6;HACD2
prerank,positive regulation of cholesterol transport (GO:0032376),0.55371484730968,1.3968761751443581,0.07142857142857142,0.552576348625312,1.0,7/27,10.00%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7;LPCAT3
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.5142335029459474,-1.3958765630347465,0.09290953545232274,0.5308383476628643,1.0,7/26,15.92%,IGF1;FHL2;EFHB;SLC9A1;STIMATE;DYRK2;HOMER3
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.5412194491455733,-1.3947851062108132,0.1066350710900474,0.5316776845511045,1.0,10/18,22.94%,ASPA;NAALAD2;ASPG;MTHFR;MTHFD1;GOT1;SLC25A12;NIT2;GOT2;NAT8L
prerank,positive regulation of cell differentiation (GO:0045597),0.410727457946463,1.3936133125425025,0.01770956316410862,0.5614735116382665,1.0,30/237,5.03%,LEF1;SLC6A6;PRKCH;KITLG;PLCB1;KDR;CD34;BMPR2;TGFB2;RAPGEF2;ZHX3;FES;PPARD;IL6R;CTNNBIP1;ARHGEF2;RGCC;MEF2C;RPS6KA1;ACVRL1;TIAM1;CDH2;PRKD1;MMD;ZBTB16;CTNNB1;NOCT;CREB1;WWTR1;HSP90AB1
prerank,regulation of kinase activity (GO:0043549),0.4613449728958117,1.3935586277113954,0.062162162162162166,0.5601705540412112,1.0,15/89,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;NLRC5;MERTK;CD4;CAMKK2;EPHA4;MRE11;RET;EPHB4
prerank,cyclooxygenase pathway (GO:0019371),-0.627762184600311,-1.3934508411993327,0.11086474501108648,0.5332991863296166,1.0,4/10,5.75%,PTGDS;PTGIS;PTGS1;PTGES
prerank,phosphatidylcholine metabolic process (GO:0046470),0.48679968746776153,1.3934184611719078,0.050872093023255814,0.559188114164617,1.0,14/70,13.32%,MFSD2A;MBOAT1;PLA2G4B;SLC44A5;ABCA3;NR1H2;CHKA;ENPP2;LPCAT3;LIPC;CEPT1;PNPLA8;CSNK2B;LPIN3
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5493223139914658,1.3929023688407602,0.1018363939899833,0.5594783548144368,1.0,11/31,17.11%,PPP1R13B;HIP1R;PPP3CC;YWHAH;YWHAQ;CASP8;ZNF205;GSK3A;PPP3R1;YWHAZ;YWHAB
prerank,regulation of isotype switching (GO:0045191),0.648187983821397,1.3927176423093237,0.10787671232876712,0.5586291353449534,1.0,2/14,6.58%,TFRC;SHLD1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5248303469316313,1.3926911920057234,0.09032258064516129,0.5572694604248036,1.0,9/39,12.15%,EFR3B;ITPKB;PIK3R3;SOCS2;SOCS5;PIK3C3;PIK3C2A;PIP4K2A;PIK3CB
prerank,regulation of interferon-gamma production (GO:0032649),0.4814278988111056,1.3926749785659378,0.05202312138728324,0.5559269568205455,1.0,14/71,12.52%,SLC7A5;IL1R1;ZFPM1;PDE4D;CCR7;TLR3;LGALS9;TLR7;PDE4B;FOXP3;EBI3;TLR8;VSIR;CYRIB
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5756549310876505,1.3925607817528907,0.10641891891891891,0.5548575794728823,1.0,11/24,18.48%,FGF13;STMN1;NCKAP5;KIF2A;STMN3;STMN4;PIN1;NCKAP5L;CKAP5;TRPV4;TPPP
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6218200348401172,1.3919890117256168,0.1366120218579235,0.5552112876703237,1.0,2/15,1.32%,STOX2;TGFB2
prerank,endocardial cushion development (GO:0003197),0.5909553998489059,1.390890269661463,0.1012216404886562,0.5571939035830493,1.0,7/21,4.36%,ENG;BMPR2;TGFB2;NOS3;ACVRL1;NOTCH1;FOXF1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.4610661864541766,1.3902941230177157,0.05706134094151213,0.5577000818816866,1.0,15/84,5.30%,TEK;ETS1;PDGFB;KDR;BMPR2;NOS3;FLT4;SCARB1;CD40;PRKD1;PRKD2;TMSB4X;PLCG1;GATA2;RHOB
prerank,positive regulation of interleukin-6 production (GO:0032755),0.48535957372583227,1.3889149145999171,0.05997001499250375,0.5605690466696848,1.0,16/68,12.10%,APP;TIRAP;IL6R;ARHGEF2;NOD2;IFIH1;NOS2;POU2AF1;HYAL2;TLR3;LGALS9;TLR7;AGER;TLR8;SYK;C1QTNF4
prerank,regulation of protein dephosphorylation (GO:0035304),0.5285543709146548,1.3883417084460434,0.11251980982567353,0.5609858620895802,1.0,11/37,13.64%,MFHAS1;PPP1R16B;CALM1;PPIA;PPP1R2;PPP2R5A;PIN1;TGFB1;NSMF;CDH5;PPP1R8
prerank,wound healing (GO:0042060),-0.4094947761335016,-1.387861611043212,0.050473186119873815,0.548116311713942,1.0,13/62,6.35%,IGF1;COL3A1;PDGFRA;SMAD3;TPM1;FGF1;DCBLD2;MYOF;TGFBR1;AHNAK2;FGF2;ANXA6;FZD7
prerank,positive regulation of potassium ion transport (GO:0043268),-0.4585150292577964,-1.3876546261412934,0.07258064516129033,0.5463371389387063,1.0,7/38,6.15%,ANK2;ACTN2;FHL1;KCNMB2;KCNJ2;DLG1;FLNA
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5489539543565799,1.387177566116726,0.10749185667752444,0.5631688967488607,1.0,5/30,8.09%,FLT1;KDR;FLT4;PLD4;TGFB1
prerank,negative regulation of cytokine production (GO:0001818),0.4262946993849423,1.3864439573044718,0.026348808030112924,0.5640703584411711,1.0,35/163,12.02%,LEF1;CD34;CD200;TRIM25;RGCC;SRGN;JAK3;ZFPM1;IFIH1;SIGIRR;HDAC9;HDAC7;NLRC5;RNF125;TMSB4X;SARS1;HOMER2;TNFRSF21;CCR7;RPS6KA5;ATP2B1;LGALS9;KLF4;N4BP1;PIN1;CD200R1;FOXP3;PPP1R11;TRIB2;AGER;ABCD1;TLR8;RAC1;VSIR;CEACAM1
prerank,protein oxidation (GO:0018158),-0.5959251898537385,-1.3855849593046012,0.11328976034858387,0.5501381663991536,1.0,3/11,6.71%,LOXL1;LOXL3;LOX
prerank,positive regulation of cholesterol efflux (GO:0010875),0.5772439573373831,1.385379838015164,0.09768211920529801,0.566169644882817,1.0,6/21,8.30%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7
prerank,positive regulation of ion transport (GO:0043270),-0.4330954526430041,-1.3853203427394662,0.061946902654867256,0.5486112695536692,1.0,12/48,13.70%,ANK2;ACTN2;FHL1;MYLK;ANO6;DLG1;P2RX4;CACNA1D;TRPC6;GPD1L;CACNB2;CRACR2A
prerank,regulation of inflammatory response (GO:0050727),0.4183561846390101,1.3851939483407043,0.024390243902439025,0.5653616366177487,1.0,35/190,13.79%,TEK;ETS1;SEMA7A;MFHAS1;PDE2A;APP;IL1R1;PPARD;NFKBIA;CD200;BCL6B;NOD2;TMSB4X;HYAL2;MGST2;XIAP;TLR3;KLF4;HCK;TLR7;BIRC3;NLRP6;CD200R1;LPCAT3;SHARPIN;BRD4;CCL1;S100A8;USP18;IL15;DDT;PPARG;CYLD;CDH5;TNFAIP3
prerank,cellular response to ketone (GO:1901655),-0.46016657148085577,-1.3851780866359227,0.08,0.5466747378398505,1.0,7/35,8.86%,ROCK2;ADCY5;ADCY1;ADCY2;AR;SPP1;PTGFR
prerank,positive regulation of cellular process (GO:0048522),0.38481712695970677,1.3847641681577683,0.0021321961620469083,0.5653393743924947,1.0,90/565,12.69%,LEF1;FLT1;IGF1R;SLC6A6;KITLG;ETS1;MFSD2A;FRMD5;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;TGFB2;CXCL12;ACER2;PDGFD;CAV1;FASN;TBX1;IL6R;FLT4;CNOT6L;TBX3;TNFRSF11A;STX3;ADGRG1;GNAI2;PTPRJ;PTK2;RPS6KA1;TIAM1;PARD3;NOTCH1;PRKD2;MERTK;LYN;TGM2;GATA2;OSMR;FGF16;RAMP3;WWTR1;HSP90AB1;SLC25A5;TAL1;CCR7;EPHA4;ACTN4;SLC25A33;ADAM10;ACACB;HCK;INSM1;TGFB1;TGFA;CXCR2;CST7;ABCA7;PTN;P2RX7;LRP5;COPS9;GREM1;PAK1;PGF;LIFR;ADAM17;PTK6;AXIN2;CDCA7L;PDCD10;CNTF;CDC6;S100A8;PPP3CA;RAC1;HRAS;BRAT1;CNOT6;RNF187;RPTOR;TGFBR2;RPS9;ZFP36L1;SOX11;IL15;DERL2
prerank,positive regulation of protein import (GO:1904591),-0.4784368353861801,-1.3846518387784286,0.052109181141439205,0.5459845983807629,1.0,9/30,14.13%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,spliceosomal complex assembly (GO:0000245),-0.43719785703455705,-1.3836969313001353,0.0676056338028169,0.5464811338169988,1.0,9/46,12.49%,CELF2;SRSF5;LUC7L3;DDX1;SRSF6;GCFC2;RBM5;LUC7L2;PRPF19
prerank,positive regulation of MAP kinase activity (GO:0043406),0.48118429327342416,1.3832764513201599,0.06119402985074627,0.5688426530518104,1.0,9/66,3.20%,FLT1;PIK3R6;PDGFB;DAB2IP;PDGFD;TPD52L1;TNFRSF11A;CD40;NOD2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.47026657518280646,-1.3829196881036299,0.08033240997229917,0.5464824804881699,1.0,12/37,14.69%,WDR35;IFT80;DYNC2I1;IFT81;IFT74;DYNC2H1;IFT122;IFT57;CLUAP1;PCM1;WDR19;DYNC2I2
prerank,cell junction organization (GO:0034330),0.47753646574077235,1.382234110068513,0.0764872521246459,0.5708747872562308,1.0,17/71,10.91%,OCLN;TJP1;APBB2;LIMS2;TGFB2;APP;TJP2;AGRN;PPFIBP1;ACTB;MARVELD2;PIN1;TGFB1;OPHN1;ACTG1;ELFN1;FERMT2
prerank,membrane lipid metabolic process (GO:0006643),0.5833342485097808,1.3821756386741932,0.12265758091993186,0.5696739249649664,1.0,9/22,13.84%,ST3GAL6;B4GALT4;MGST2;ACER1;GAL3ST1;CERKL;ST6GALNAC4;CERK;SPTLC1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4832556253291781,-1.3819136179620273,0.09397590361445783,0.5474140407470218,1.0,12/27,19.83%,ANK2;DMD;CAMK2D;CACNB4;PRKACA;CACNB2;JPH1;CACNB1;AHNAK;JPH2;ADRA2A;CACNB3
prerank,negative regulation of lipid catabolic process (GO:0050995),0.603788063244014,1.3808628977173045,0.13468634686346864,0.5726141185371926,1.0,1/17,0.46%,MFSD2A
prerank,cellular response to lipid (GO:0071396),-0.34142786692220134,-1.380266034351985,0.010810810810810811,0.5502581520990864,1.0,27/191,8.17%,ATP1A2;PID1;EGFR;ROCK2;ADCY5;EPHA3;TFPI;PTK7;AXL;ADCY1;WNT5B;IRS1;LBP;WNT6;ADCY2;WNT9A;ADAM9;RORA;AR;CTR9;SPP1;FZD7;PABPN1;LCOR;SELENOS;ATM;TNIP2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6121059519418196,1.3801005885902515,0.12897526501766785,0.5735465013567604,1.0,3/16,5.99%,BCL2L1;CXCL12;SNAI2
prerank,protein modification process (GO:0036211),0.46901266883993714,1.3799152144738105,0.06111111111111111,0.5727293839118164,1.0,23/76,19.23%,ST8SIA4;ST3GAL6;ST3GAL1;STK38;YES1;LCMT1;PLAT;FBXL2;CHRM3;DUSP12;UBA3;MANBA;FBXW2;MAN2B1;UBE2D3;LOXL2;MMP15;MCRS1;SEPHS1;FBXO2;ERO1A;CPE;USP25
prerank,positive regulation of protein modification process (GO:0031401),0.4144367010424486,1.37917519869841,0.022167487684729065,0.5737576235089369,1.0,40/203,10.36%,TFRC;TEK;LIMCH1;PECAM1;KDR;PPP1R16B;INSR;ENG;APP;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;RAPGEF3;LYN;CALM1;FGF16;CD4;CAMKK2;LIMK2;PPIA;MAPK3;PPP2R5A;RALB;EFNA1;PIN1;TGFB1;IRGM;ASPSCR1;PAK1;PGF;CCND3;ADAM17;AXIN2;AGER
prerank,modulation by host of symbiont process (GO:0051851),0.5504907782944025,1.3789050289378113,0.08877721943048576,0.5732354117158402,1.0,1/31,0.03%,LEF1
prerank,neuron migration (GO:0001764),0.5116580536542429,1.3782509064176347,0.07164179104477612,0.5738934060396971,1.0,15/48,11.43%,NDNF;RAPGEF2;ADGRL3;SH3RF1;NAV1;MEF2C;FGF13;GPM6A;SPOCK1;DNER;DISC1;DDIT4;DCX;CEP85L;RAC1
prerank,regulation of cellular component organization (GO:0051128),0.4301049356957898,1.3780488813852623,0.043758043758043756,0.5730565166824374,1.0,21/135,9.03%,TFRC;HIP1;TJP1;DAB2IP;LTBP4;RAPGEF2;NET1;HIP1R;RAPGEF1;SOCS2;PAK5;WFDC1;FAM107A;RASGRP2;INSM1;EGLN2;RAP1B;MARK4;IRGM;OPHN1;SPOCK1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.44967930785600857,1.377426632701057,0.05212620027434842,0.5735464301885741,1.0,21/93,10.41%,TFRC;SH2D3C;APP;CAV1;CNKSR3;BCAR3;PRKD1;PRKD2;RAPGEF3;FNIP2;SMAD7;PDE4D;RAMP3;HSP90AB1;TGFB1;IRGM;PAK1;CNOT9;AKAP9;DDIT4;PDCD10
prerank,endoderm development (GO:0007492),0.6364859078182692,1.3767317546476574,0.11172161172161173,0.5743178065727743,1.0,4/13,16.13%,SOX17;SOX7;DUSP1;LHX1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5300227144340615,1.37634737920563,0.0933786078098472,0.5741828525462609,1.0,7/33,8.09%,ETS1;PDGFB;TGFB2;GATA2;KLF4;JUN;TGFB1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.4023088366583514,-1.3762243735006132,0.04956268221574344,0.56092247089141,1.0,21/65,14.36%,FBN1;LDLRAD4;LTBP1;SMAD3;SMAD6;HTRA3;SNX6;TGFBR1;PPARA;ASPN;EMILIN1;TGFB1I1;CD109;SMURF2;PDPK1;SPRED1;FBN2;VASN;SKI;HTRA4;SLC2A10
prerank,negative regulation of binding (GO:0051100),0.4663699404727398,1.3756125916031114,0.06693989071038252,0.5752194150551923,1.0,12/81,8.04%,LEF1;PDGFB;CAV1;NFKBIA;CTNNBIP1;NES;SP100;ZFPM1;ACTB;RALB;JUN;PIN1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5240967681561133,1.3751665877944543,0.09609120521172639,0.5752370959751238,1.0,11/39,13.02%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4;KIF1A;MYO1F;BICDL1;SYT4;F8A1;RAB1A
prerank,negative regulation of neuron projection development (GO:0010977),-0.42351412933977883,-1.3751258372798476,0.04504504504504504,0.5621055554616581,1.0,13/56,13.57%,DPYSL3;LPAR1;PTPN9;EFNB2;KANK1;PTPRS;APOE;CBFA2T2;STX1B;MYLIP;RAB29;ADCY6;PTEN
prerank,positive regulation of epithelial cell migration (GO:0010634),0.44826598364373677,1.375115631955839,0.05548037889039242,0.5740485369573417,1.0,27/92,14.36%,TEK;ETS1;KDR;BMPR2;TGFB2;DOCK1;FLT4;SCARB1;PRKD1;PRKD2;VIL1;PLCG1;RREB1;RHOB;MAPRE2;INSL3;RAB11A;IQSEC1;ENPP2;RAC1;HIF1A;PIK3CB;MAP4K4;RIN2;SOX9;PDCD6;NRP2
prerank,positive regulation of developmental process (GO:0051094),0.4217940972378183,1.374992877950565,0.030456852791878174,0.5730453864814543,1.0,25/164,9.33%,SLC6A6;TFRC;PLCB1;SHANK3;PDGFB;KDR;INSR;DAB2IP;BMPR2;B4GALT5;LRP8;FZD4;RPS6KA1;RAPGEF3;VIL1;ZBTB16;RREB1;HSP90AB1;SHLD1;INSM1;PTN;ARHGEF7;ENPP2;NRXN1;RBM19
prerank,protein autophosphorylation (GO:0046777),0.43006153204194386,1.3740197463939394,0.038510911424903725,0.5745124513909545,1.0,25/157,10.12%,FLT1;IGF1R;TEK;KDR;INSR;FES;FLT4;PTK2;PRKD1;STK10;PRKD2;LYN;PIKFYVE;CAMKK2;EPHA4;MAPK3;AATK;EPHB4;HCK;MARK3;PAK1;MAP3K3;EIF2AK4;STK33;PTK6
prerank,cellular response to interleukin-15 (GO:0071350),0.6382895504389803,1.3738860805794817,0.12059369202226346,0.5722063379842383,1.0,4/13,5.26%,PLCB1;JAK3;GRB2;CD4
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.6382895504389803,1.3738860805794817,0.12059369202226346,0.5722063379842383,1.0,4/13,5.26%,PLCB1;JAK3;GRB2;CD4
prerank,nucleoside catabolic process (GO:0009164),-0.5988278760463204,-1.3728936834669871,0.12210526315789473,0.5667037842358876,1.0,6/11,15.13%,DPYD;NT5E;UPB1;UPP2;DERA;NT5C1A
prerank,regulation of ossification (GO:0030278),0.5188793067688799,1.3727165666446814,0.10114192495921696,0.5744652476709436,1.0,8/36,4.55%,SGMS2;BMPR2;TGFB2;S1PR1;MEF2C;NOTCH1;ZBTB16;NOTUM
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5255777176088229,1.3723005452459793,0.09888357256778309,0.5745341526686388,1.0,12/42,13.54%,NDNF;PDGFB;FZD4;CORO2B;PTK2;NOTCH1;RSU1;ATXN3;SPOCK1;RAC1;PIK3CB;MINK1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5595248762420962,-1.371830080746358,0.09744779582366589,0.5677345861515012,1.0,6/15,6.43%,GPC3;WNT5B;RSPO3;DAAM2;SFRP4;DACT1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3947705471036821,1.3713363393073743,0.009142857142857144,0.5762712993056194,1.0,65/348,10.41%,TFRC;TEK;LIMCH1;PECAM1;PDGFB;SH2D3C;KDR;INSR;ENG;BMPR2;TGFB2;RAPGEF2;PDGFD;APP;CAV1;FAS;TBX1;PDE8A;IL6R;FLT4;BCAR3;LRP8;PLAUR;PTPRJ;ARHGEF2;PTK2;NIBAN1;CD40;PIK3R3;ACVRL1;APLNR;PRKD1;PRKD2;MMD;RAPGEF3;LYN;FNIP2;CALM1;FGF16;RAMP3;HSP90AB1;CCR7;CD4;CAMKK2;MRE11;LIMK2;PPIA;MAPK3;RPS6KA5;RALB;EFNA1;PIN1;TGFB1;IRGM;IQGAP1;ENPP2;PAK1;PGF;CCND3;ADAM17;CNOT9;AKAP9;AXIN2;AGER;PDCD10
prerank,somite development (GO:0061053),-0.6107972578311025,-1.371113644196514,0.10572687224669604,0.5676203886638405,1.0,4/11,8.72%,MEOX2;SMO;LOXL3;MTHFD1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5280516904077703,1.3709117779769042,0.088,0.5762059889066501,1.0,11/35,11.49%,TEK;ESAM;TJP1;FES;F11R;RAPGEF3;BAIAP2;HCK;ARHGDIA;ABI3;HRAS
prerank,regulation of hydrolase activity (GO:0051336),0.46803355504142297,1.3708708618897656,0.08166189111747851,0.5749859479903974,1.0,17/71,11.16%,CHN2;FGD5;DAB2IP;RASIP1;ARHGAP27;CAV1;PTK2;PLXND1;PRKG1;EPHA4;OCRL;STMN3;CFAP100;ARHGEF5;FGD6;TBC1D10B;PLXNB3
prerank,retinal metabolic process (GO:0042574),-0.5821557589761401,-1.3707705566337185,0.12933025404157045,0.5662717567672138,1.0,7/12,34.22%,ABCA4;CYP1B1;RDH10;ALDH1A3;RDH13;ALDH8A1;DHRS13
prerank,embryonic limb morphogenesis (GO:0030326),-0.45995987366856816,-1.3706596187833444,0.08529411764705883,0.5642262147965352,1.0,7/34,4.36%,CACNA1C;GLI3;AFF3;OSR1;CYP26B1;SALL1;WDPCP
prerank,regulation of osteoblast differentiation (GO:0045667),-0.39290015578448634,-1.3699040989466629,0.038461538461538464,0.564231314045728,1.0,29/82,13.13%,BMP6;RANBP3L;IGF1;BMPR1A;SMOC1;WNT4;CRIM1;BMP7;FGFR2;BMP4;DDX5;SMAD6;SUFU;RUNX2;CCN1;TMEM64;YAP1;CCN4;LRP3;TWIST2;PRKACA;TRPM4;FBN2;CHRD;IFITM1;BMP2;NPNT;SKI;TWIST1
prerank,base conversion or substitution editing (GO:0016553),0.6619116503017375,1.369629051823478,0.12287334593572778,0.5775266948473218,1.0,5/11,23.34%,ADAR;ADAD1;NUDT16;METTL3;ADARB2
prerank,regulation of metal ion transport (GO:0010959),-0.558483369915102,-1.3691638752078938,0.10218978102189781,0.5640967193388927,1.0,7/16,7.38%,ANK2;SLC30A10;STIM1;IL16;CACNA2D1;DLG1;BCL2
prerank,activation of phospholipase C activity (GO:0007202),-0.483126659285926,-1.3685607868330316,0.09921671018276762,0.5636728366165691,1.0,4/29,2.82%,ARHGAP6;LPAR1;EGFR;EDNRA
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5031823722103035,-1.3682766497197003,0.08783783783783784,0.5622789518200404,1.0,7/22,15.64%,AEBP1;MAP1S;AKAP13;APOE;EFEMP2;ABL1;MAP2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4363916479885037,1.3671479107934579,0.04699738903394256,0.5838653339678684,1.0,39/113,22.15%,TFRC;DAB2IP;RASIP1;UNC13B;TIRAP;GBP5;FNIP2;PIEZO1;TAL1;BIK;GTF2H2;RAP1B;TGFB1;PSMC6;CAPG;MMP1;FERMT2;GTF2H4;SYK;SH3GLB1;TERF1;CDH5;FSCN1;RBX1;MPP7;SUMO1;IL5;SLF1;RPA1;TPPP;SKAP1;BAK1;GTF2H3;DDB1;ERCC4;PSMC3;HRK;RACK1;SNCA
prerank,epithelial tube morphogenesis (GO:0060562),0.5326940327797995,1.3668415277334227,0.10823909531502424,0.5834607050458243,1.0,12/32,9.22%,PODXL;RASIP1;SOX17;MTSS1;MEF2C;ACVRL1;PRKD2;CTNNB1;RHOB;COL4A1;CCM2;PAK1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5796578840109639,-1.3664826677232216,0.11004784688995216,0.5654073843231681,1.0,6/13,15.71%,ERRFI1;CBLB;SNX6;TSG101;ZFYVE28;GPRC5A
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5579999134723304,1.3662040156124016,0.12207357859531773,0.5841557149670263,1.0,7/24,10.05%,PDE2A;RAPGEF2;APLNR;PEX5L;PDE4D;PRKAR2B;PRKAR2A
prerank,positive regulation of kinase activity (GO:0033674),0.44448581427832484,1.3656109481599037,0.05665349143610013,0.5846638249914295,1.0,17/107,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;RAPGEF2;FLT4;PTK2;MMD;MERTK;CCR7;CD4;EPHA4;MRE11;RET;EPHB4
prerank,regulation of activated T cell proliferation (GO:0046006),-0.47695726844293773,-1.3651752833509456,0.08816120906801007,0.5673789301925448,1.0,4/30,6.13%,IGF1;IGFBP2;IL18;IGF2
prerank,regulation of lymphocyte migration (GO:2000401),0.671290016135401,1.3649581368391142,0.16068052930056712,0.5853436071869228,1.0,3/10,8.79%,JAM2;STK10;MSN
prerank,nitric oxide metabolic process (GO:0046209),0.624842181609386,1.3648372438812744,0.14620938628158844,0.5843930228274165,1.0,3/14,4.51%,NOS3;GCH1;NOS2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5461043899923493,-1.3644894533373206,0.12009237875288684,0.567234193507789,1.0,8/17,13.39%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6;CYSLTR2
prerank,cellular macromolecule catabolic process (GO:0044265),0.48891944898462475,1.3641425312776225,0.08602150537634409,0.5852227426713568,1.0,18/49,21.62%,DAB2IP;DENND3;OGA;NEU4;STT3B;UBE2G1;DFFB;FBXO6;MANBA;PPP1R8;NEU2;SND1;UBE2G2;FBXO2;RNASEH2C;XRN2;NCBP1;RNASE6
prerank,regulation of protein kinase B signaling (GO:0051896),0.4111862066703227,1.3634220461568929,0.030413625304136254,0.5861823251925564,1.0,23/193,6.46%,IGF1R;KITLG;TEK;HIP1;MFHAS1;PDGFB;INSR;ENG;XDH;PHLPP1;PTPRJ;PTK2;GRB2;CD19;FGF16;RAMP3;HSP90AB1;HYAL2;GAB1;CCR7;FYN;PLEKHA1;RET
prerank,neuron projection organization (GO:0106027),0.6225041384296018,1.3632144541810616,0.12259194395796848,0.5855673644362991,1.0,4/15,10.97%,INSR;APP;ATP1A3;ABCD1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6280310649978049,1.3631526642925518,0.1322463768115942,0.5844574521127455,1.0,4/14,10.05%,RAPGEF2;PKIG;PRKAR2B;PRKAR2A
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.4672740274578263,-1.3630151717428909,0.10204081632653061,0.5696990661623529,1.0,7/30,4.90%,CACNA1C;ANK2;SNTA1;GJA1;CACNA2D1;KCNJ2;CACNA1G
prerank,hepaticobiliary system development (GO:0061008),-0.5357405108869889,-1.3629462496410474,0.09579439252336448,0.5675947135285737,1.0,5/20,8.05%,TGFBR3;WNT4;COBL;PKD2;MET
prerank,regulation of interleukin-6 production (GO:0032675),0.4508537894557315,1.3627271191302095,0.05931034482758621,0.5845334515465637,1.0,24/96,15.03%,APP;TIRAP;IL6R;CD200;AFAP1L2;ARHGEF2;NOD2;IFIH1;NOS2;POU2AF1;HYAL2;TLR3;LGALS9;TLR7;CD200R1;AGER;TLR8;SYK;C1QTNF4;TNFAIP3;FOXJ1;BCL10;NCKAP1L;INAVA
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.5241858247632387,-1.3619326873626985,0.11031175059952038,0.5684961172697988,1.0,6/19,17.85%,IRS1;PRKCD;PPARA;IRS2;TWIST1;ANGPTL3
prerank,cell-substrate junction assembly (GO:0007044),0.5223534976536577,1.3617019158536208,0.1404399323181049,0.5864700622279317,1.0,6/33,10.91%,ITGA6;THSD1;ACTN1;SORBS1;ARHGEF7;FERMT2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3371144630424157,-1.3613252181942175,0.020689655172413793,0.5680483770149631,1.0,62/248,14.40%,RNF220;BICC1;RBMS3;WLS;ZEB2;EGFR;LGR4;GLI3;COL1A1;IGFBP2;PTK7;DKK3;FGFR2;GPC3;IGFBP6;LRRK1;KANK1;INVS;AMFR;LYPD6;DAB2;IGFBP4;TBL1XR1;DAAM2;PLEKHA4;SFRP4;FZD7;DACT1;GLI1;CTNND2;PFDN5;TNKS2;TMEM64;CHD8;PRKN;TLE3;APOE;PSME4;UBR5;SMURF2;MLLT3;AXIN1;CUL3;CDK14;STK11;PPM1B;FUZ;BTRC;TRPM4;PSME3;LRRK2;CAPRIN2;PSEN1;BMP2;SCEL;EMD;NKD2;DVL2;WNK1;DDX3X;LMBR1L;WNT11
prerank,C4-dicarboxylate transport (GO:0015740),0.6189569840561296,1.3599377909863912,0.14513274336283186,0.590744533379005,1.0,2/14,5.02%,SLC1A1;SLC1A2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5484736652134865,1.3598726240593582,0.14238952536824878,0.5896193250047098,1.0,4/26,5.43%,MFHAS1;CAV1;TIRAP;TLR3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5555668691015994,-1.3597795850134946,0.11802575107296137,0.5705571170843116,1.0,5/15,5.48%,UST;DSE;DCN;BGN;CSPG4
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.46458047698484245,1.359309297155508,0.09248554913294797,0.5900709006334186,1.0,18/66,8.51%,PTPRM;AQP11;DAB2IP;TGFB2;XDH;CAV1;MCC;B2M;RGCC;MTSS1;VASH1;SNAI2;FBXW7;CDKN2B;STAT1;BRCA2;TGFB1;CAV2
prerank,visual system development (GO:0150063),-0.4467046487615118,-1.3591456563577442,0.08648648648648649,0.5702185880525832,1.0,8/37,6.50%,PBX1;SMOC1;RBP4;SH3PXD2B;FOXC1;PBX4;MEIS1;PBX3
prerank,melanocyte differentiation (GO:0030318),-0.6080601144437053,-1.358292377915995,0.13238770685579196,0.5706806048376559,1.0,5/11,11.17%,LRMDA;ENPP1;KIT;MITF;SLC24A5
prerank,cell chemotaxis (GO:0060326),0.4709675201867824,1.3574476723799966,0.08575581395348837,0.594530397264036,1.0,7/60,5.25%,LEF1;DOCK4;PDGFB;CXCL12;PLEKHG5;ELMO2;CCR7
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5630099613278068,1.3571284978596916,0.12627986348122866,0.5941561523583513,1.0,9/23,15.05%,MYO10;CCDC88A;CCDC88B;KIF1A;MAP6D1;TUBB;HOOK1;F8A1;TUBA1A
prerank,retinol metabolic process (GO:0042572),-0.5648961060237205,-1.356418019439912,0.13169642857142858,0.5743254750632394,1.0,3/14,5.39%,RBP4;DHRS3;CYP1B1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.46214832398397543,1.3559391270929266,0.08931185944363104,0.5966311979962141,1.0,11/70,8.64%,TEK;PARVB;SRGAP2;MEF2C;LAMA5;NTNG2;PXN;PARVG;ACTN1;EFNA1;OPHN1
prerank,dephosphorylation (GO:0016311),0.41715911051156224,1.3555823357414332,0.06273525721455459,0.5963798281344703,1.0,15/147,4.61%,PTPRG;PTPRM;PTPRB;SGPP2;CTTNBP2NL;PTPRJ;DUSP23;PPM1L;DUSP7;PTPN12;SSH2;DUSP3;PLPP6;PPP3CC;PPP4R1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4434775473581923,1.3555306602698618,0.06490066225165562,0.5952593370387684,1.0,23/101,12.53%,FLT1;PIK3R6;PDGFB;DAB2IP;RAPGEF2;PDGFD;CCNY;TPD52L1;RGCC;CD40;NOD2;CALM1;RALB;TGFB1;IRGM;CCND3;ADAM17;PDCD10;FERMT2;TNFSF11;HRAS;RPTOR;MAPRE3
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5228081451281328,1.355346825656301,0.1056782334384858,0.5944750151491927,1.0,12/33,15.74%,CACNA1A;LRP8;ABR;BTBD9;GRID2;PXK;FABP5;GRIK5;GRIK2;GRIK1;LRRC4C;NLGN1
prerank,regulation of cholesterol efflux (GO:0010874),0.5366255188793931,1.3549983453273016,0.11323763955342903,0.5942881270942235,1.0,8/30,12.84%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7;NAXE;PPARG
prerank,development of primary male sexual characteristics (GO:0046546),0.5211661440151292,1.3548396728049608,0.11022364217252396,0.5934960312636613,1.0,7/34,10.83%,KITLG;TGFB2;LHFPL2;BIK;COL9A3;NCOA4;LRP2
prerank,innate immune response in mucosa (GO:0002227),0.6724925342666871,1.3537487301332671,0.16387337057728119,0.5956308707096276,1.0,2/10,4.51%,DEFA6;NOS2
prerank,lipid oxidation (GO:0034440),0.6424774855552449,1.3537201094482922,0.1522491349480969,0.5944244854054102,1.0,3/12,11.57%,ADIPOR2;ACOX1;ADIPOR1
prerank,metal ion homeostasis (GO:0055065),0.49840597031184847,1.3532251556629327,0.10935023771790808,0.5946753892575498,1.0,6/40,9.14%,TMTC2;CAV1;SLC12A6;SLC12A9;KCNH2;LETM1
prerank,metanephric mesenchyme development (GO:0072075),-0.6262235349486693,-1.352815790928645,0.12747252747252746,0.5834939613060981,1.0,4/10,5.68%,WNT4;OSR1;PKD2;SIX1
prerank,negative chemotaxis (GO:0050919),0.5167283923375237,1.3519530106828186,0.11414790996784566,0.5973391933345555,1.0,7/33,6.97%,SEMA3C;SEMA7A;SEMA6A;NTN1;SEMA6B;SEMA4F;SEMA6D
prerank,negative regulation of glycolytic process (GO:0045820),-0.611626031768022,-1.3511540147629624,0.15250544662309368,0.5841569417902585,1.0,3/10,5.34%,NUPR1;HDAC4;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.611626031768022,-1.3511540147629624,0.15250544662309368,0.5841569417902585,1.0,3/10,5.34%,NUPR1;HDAC4;PPARA
prerank,histone lysine demethylation (GO:0070076),-0.47497965355108146,-1.3510900360530653,0.09653465346534654,0.5820783143545647,1.0,12/25,23.80%,KDM7A;KDM2A;KDM3B;KDM5B;KDM6B;KDM2B;KDM1A;PHF8;RIOX2;PHF2;KDM4D;HR
prerank,regulation of p38MAPK cascade (GO:1900744),0.5230607059971768,1.3510338810041096,0.11605723370429252,0.5990371516678158,1.0,9/35,13.54%,MFHAS1;DAB2IP;XDH;PHLPP1;LGALS9;AGER;DUSP1;CYLD;MINK1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.49166109448069983,-1.3507589484257172,0.10199004975124377,0.5808332817073778,1.0,6/25,5.68%,CACNA1C;ANK2;CXADR;CAMK2D;DLG1;TBX18
prerank,cellular response to interleukin-1 (GO:0071347),0.4210998887430409,1.3507001933861411,0.06583850931677018,0.5988233989290834,1.0,25/143,11.82%,PLCB1;DAB2IP;IL1R1;NFKBIA;NOD1;CD40;NOD2;PELI1;MAP3K8;IKBKB;HYAL2;ST18;MAPK3;RPS6KA5;PSMB3;PSMD11;PSMC6;IRAK2;MAP3K3;PSME2;UBE2V1;TOLLIP;CCL1;PSMD8;HIF1A
prerank,iron ion homeostasis (GO:0055072),0.4752601618753987,1.3506479355987886,0.09985734664764621,0.5976670573155529,1.0,4/58,2.47%,TFRC;SLC40A1;ABCG2;B2M
prerank,positive regulation of protein sumoylation (GO:0033235),-0.603569206257726,-1.3500977736865278,0.15301724137931033,0.5807013239288377,1.0,5/10,24.79%,HDAC4;PIAS1;MUL1;UBA2;RWDD3
prerank,regulation of neuroinflammatory response (GO:0150077),-0.5158449475021246,-1.3496478788398671,0.11165048543689321,0.5798502437678774,1.0,4/19,5.22%,IGF1;NUPR1;IL18;DAGLA
prerank,amino sugar biosynthetic process (GO:0046349),-0.5840971598243391,-1.349580212752276,0.11652542372881355,0.5778163837990415,1.0,8/12,28.38%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.4735112436621669,1.3490461945664023,0.08801213960546282,0.6014507967218713,1.0,15/55,14.07%,BCL2L1;DAB2IP;CAV1;FAS;TPD52L1;TNFSF10;HYAL2;CRADD;DEDD2;AGTR2;S100A8;TNFSF12;CYLD;TRIM39;BCL10
prerank,regulation of phospholipid metabolic process (GO:1903725),0.6484707135319473,1.3486557848141782,0.16287878787878787,0.6014101803173456,1.0,4/10,15.12%,MFSD2A;ABCA3;DNAJC19;MTMR2
prerank,nitric oxide biosynthetic process (GO:0006809),0.6306516314514345,1.348117988275466,0.17304189435336975,0.6018144665259253,1.0,3/13,4.51%,NOS3;GCH1;NOS2
prerank,regulation of bone mineralization (GO:0030500),-0.41285058356427745,-1.3480888854771973,0.061971830985915494,0.5803453681824187,1.0,21/55,13.13%,BMP6;BMPR1A;WNT4;BMP7;ENPP1;BMP4;OSR1;ADGRV1;ANO6;BCOR;KL;ECM1;CCN1;SLC8A1;TGFB3;TRPM4;FBN2;PTK2B;PKDCC;BMP2;TWIST1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.49547047188671384,1.3479561587788713,0.09451219512195122,0.6010466762572062,1.0,11/47,13.85%,NANOS3;APP;NFKBIA;WNT7A;KLF4;NR1H2;TGFB1;CYFIP1;EIF4E;PUM3;SSH1
prerank,regulation of cell motility (GO:2000145),0.42806999162829684,1.34754853932279,0.06275579809004093,0.6011026984889668,1.0,28/121,12.52%,SPOCK2;FRMD5;MACF1;ROBO4;FES;NTN1;SPATA13;PLXND1;AMOT;PRAG1;TMSB4X;FGF16;CCR7;RHOB;PKN1;INPP5F;KIF2A;PKN2;TMSB10;PIN1;TGFB1;ENPP2;ABI3;PLXNB3;RAC1;SLK;CEACAM1;CYRIB
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5126440252684278,1.3467553609195044,0.112,0.6022978138667664,1.0,15/36,14.21%,PTPRM;DAB2IP;RGCC;MEF2C;SP100;ACVRL1;NOTCH1;VASH1;DLL4;TGFB1;AGTR2;PPARG;CSNK2B;DNAJA4;SYNJ2BP
prerank,calcium-mediated signaling (GO:0019722),-0.3730332708398792,-1.3467473383071369,0.05019305019305019,0.5822817841488799,1.0,23/93,12.29%,CACNA1C;ANK2;EGFR;PLCE1;MCU;NUDT4;CCR9;ADGRL1;DMPK;P2RX4;SLC8A1;AGTR1;PTGFR;PDPK1;PRKACA;SLC9A1;TRPM4;STIMATE;LRRK2;PPP3CB;SPHK1;RCAN3;DMTN
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6145292815573538,1.34654124182835,0.1545138888888889,0.6016398213417927,1.0,1/15,0.16%,PRKCH
prerank,hexose transmembrane transport (GO:0008645),0.570256746481612,1.3464662430771712,0.11965811965811966,0.6005424916488504,1.0,2/21,1.88%,SLC2A1;PPARD
prerank,sister chromatid segregation (GO:0000819),-0.46633687864094875,-1.3464127144377611,0.10426540284360189,0.5813331268081641,1.0,15/31,27.22%,TOP2B;KLHL22;ZWINT;SMC4;CENPK;TUBG1;LATS1;KIF18A;NUSAP1;TOP2A;KNSTRN;KIFC1;NSL1;SGO1;CDCA8
prerank,regulation of histone methylation (GO:0031060),-0.5827614860294937,-1.3456397157650264,0.11850311850311851,0.5815146231117035,1.0,10/13,33.38%,CTR9;MTHFR;NNMT;PAF1;NSD1;AASS;TET1;TTLL12;PIH1D1;JARID2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5474893728993234,1.3454316152742334,0.13682432432432431,0.6025576179379784,1.0,6/26,6.96%,NOS3;ACER2;GCH1;NOS2;ACER1;SPTLC2
prerank,actin filament depolymerization (GO:0030042),-0.6020885438360836,-1.3452660148174367,0.13596491228070176,0.5804685927545233,1.0,3/11,1.66%,MICAL3;GSN;MICAL2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6666104642494065,1.3452152881591628,0.15942028985507245,0.6019999085244486,1.0,4/10,8.89%,FAS;LYN;MAPK3;GREM1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.588050404529209,1.3450588554256033,0.1386481802426343,0.601215251956713,1.0,7/18,10.26%,JCAD;KDR;HDAC9;HDAC7;GATA2;MAP3K3;PIK3C2A
prerank,cellular iron ion homeostasis (GO:0006879),0.4782718519182946,1.3449804126245533,0.09393063583815028,0.6001965334204831,1.0,3/55,0.38%,TFRC;SLC40A1;ABCG2
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5841417272905733,-1.344775839144294,0.13232104121475055,0.5797588795729955,1.0,5/11,8.15%,ITGB5;KIT;VCL;PLEKHA7;CCN3
prerank,regulation of intracellular signal transduction (GO:1902531),0.38430303543449534,1.3445452621666425,0.006600660066006601,0.6003110228846794,1.0,88/420,13.66%,SGMS1;CHN2;MCF2L;TEK;ARHGAP31;ARHGEF3;ARAP3;SRGAP3;SRGAP2;PPP1R16B;DAB2IP;SRGAP1;PPP1R13B;PDE2A;ARAP2;RASGRF2;NET1;NFKBIA;PLEKHG5;PHLPP1;PTPMT1;ARHGEF2;KALRN;FAM13A;TIAM1;ABR;PRKD2;VWF;STARD13;MOB3B;LYN;TMSB4X;PEX5L;GNA12;XIAP;RHOB;PIP5K1C;PHF20;OCRL;DEPDC7;MRE11;ARHGAP23;PAK5;SOS1;MAPK3;ENTPD5;ARHGAP25;RFFL;ARHGEF12;JMY;PRKAR2B;KAT6A;BIRC3;CRNN;ARHGEF5;PIN1;PIDD1;PREX1;ARHGEF7;OPHN1;ARHGAP4;PAK1;ARHGDIA;DNA2;PRKAR2A;DDIT4;ARHGAP17;AGER;PRKAB1;FBXL2;HSPB1;IER3;RAC1;TNFSF11;PIP4K2A;CEACAM1;MAP4K4;WWC1;TMEM127;HIPK2;CSNK2B;FGD2;CYLD;BRPF1;RPL11;STK3;MINK1;AKAP6
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.424409449964552,1.344195804629107,0.06040268456375839,0.6001950386821475,1.0,26/124,12.16%,PTPRM;FRY;RAPGEF2;APP;FRYL;STX3;MAP4;LYN;PPP1R9B;STMN1;CCR7;TBC1D24;PLEKHA1;STMN3;RAB11A;STMN4;MARK4;GPM6A;OPHN1;TBC1D23;BICDL1;CYFIP1;AGER;CEP78;RAC1;BTG2
prerank,icosanoid secretion (GO:0032309),0.6355415226994686,1.3440622317997395,0.1518987341772152,0.5993463898784441,1.0,2/12,4.51%,ABCC4;NOS2
prerank,carnitine shuttle (GO:0006853),-0.5982521273340422,-1.343973010129442,0.1346153846153846,0.5802457182048453,1.0,2/11,1.34%,PRKAG2;PRKAA2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5039494769107642,1.3434826370301909,0.11290322580645161,0.599854256803587,1.0,7/40,9.89%,PGLYRP1;TIRAP;DEFA6;GBP7;GBP4;PPP1R11;ADAM17
prerank,import into cell (GO:0098657),0.5078509739973991,1.3433858014963327,0.11181102362204724,0.5988850167599797,1.0,5/41,2.53%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;LRRC8C
prerank,telomere maintenance via recombination (GO:0000722),-0.5865926763762118,-1.3430630332238853,0.1346153846153846,0.5808058453320717,1.0,6/11,19.24%,SMC6;TEP1;ERCC1;RAD50;NSMCE2;TPRKB
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.35201617323490964,-1.343008774136601,0.017167381974248927,0.5787890391743423,1.0,23/128,7.28%,BMP6;COL1A2;COL3A1;TGFBR3;BMPR1A;APPL2;SMAD3;BMP5;BMP7;BMP4;ITGB5;DDX5;SMAD6;RGMA;RGMB;TGFBR1;TWSG1;ADAM9;RUNX2;TMEM100;ARHGEF18;SMAD9;TGFB1I1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.47052360032374074,-1.3429622971839728,0.09476309226932668,0.5767762649172393,1.0,11/29,21.31%,DDO;ACADSB;ALDH4A1;PRODH;THNSL2;KYAT1;SARDH;FAH;KMO;KYNU;GOT2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.46299883647791973,1.3427625494490694,0.09423347398030943,0.5995902326034149,1.0,15/70,12.48%,BCL2L1;DAB2IP;TGFB2;FAS;IL6R;SORT1;TLR3;CRADD;MCL1;TGFB1;P2RX7;DEDD2;CASP8;GSK3A;TNFSF12
prerank,positive regulation of histone deacetylation (GO:0031065),0.6327730091827024,1.340711547513641,0.17117117117117117,0.6046969114110055,1.0,3/12,3.43%,APLNR;PRKD1;PRKD2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.591142924409413,-1.340504859850265,0.13655462184873948,0.5819615348825328,1.0,8/11,28.38%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5546391979064944,-1.3402344343463066,0.14137214137214138,0.5806628831625061,1.0,8/13,28.38%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.46229192665934127,-1.3402095969214134,0.09547738693467336,0.5785934464553688,1.0,13/32,13.57%,PHLDB2;ARHGAP6;APOD;CASK;THBS1;HOXA7;JAG1;MYOC;SEMA3E;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,renal water homeostasis (GO:0003091),-0.5031215834484444,-1.3395079687213738,0.12679425837320574,0.5786529222988462,1.0,8/23,12.33%,ADCY5;ADCY1;ADCY9;ADCY2;RAB11FIP2;ADCY7;PRKACA;ADCY6
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.627475011385394,1.3390621986879083,0.15283018867924528,0.6085584176989014,1.0,2/13,5.93%,ETS1;FUT9
prerank,heart development (GO:0007507),-0.3534074191950214,-1.3389962468477454,0.043478260869565216,0.5780801294102391,1.0,38/150,8.99%,CACNA1C;COL3A1;TGFBR3;FBN1;NTRK3;PLCE1;GLI2;CXADR;BMP5;SGCD;MICAL2;BMP7;ADAP2;GPC3;BMP4;ZFPM2;OSR1;PCSK5;PKD1;PDLIM7;RBP4;SH3PXD2B;SALL1;FOXC2;FOXC1;BCOR;TGFBR1;PKD2;SCUBE1;NDUFV2;PDLIM2;AKAP13;PDLIM4;FOXL1;KDM6B;POU6F1;MTHFD1;IFT122
prerank,microtubule bundle formation (GO:0001578),0.494928040208961,1.338965908697128,0.11295180722891567,0.6075938530896631,1.0,15/42,18.48%,NAV1;CLIP1;RP1;NCKAP5;MARK4;TTLL3;CDK5RAP2;RSPH4A;DCX;RSPH1;FOXJ1;NCKAP5L;SPAST;CCDC66;TPPP
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.504363158599165,1.3387913446750812,0.11904761904761904,0.6069055389139686,1.0,5/42,5.25%,TEK;UTRN;KDR;PTPRJ;CCR7
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.5176572307185411,-1.3384888393736316,0.11576354679802955,0.5775008169079757,1.0,8/21,13.67%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;GUCY1A1;ADCY6;GUCY1B1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5891446154399348,1.3381105505236717,0.15213675213675212,0.6077499144614092,1.0,7/18,13.45%,ELOVL7;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;HACD2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.538133329434817,1.3377842589558864,0.13258785942492013,0.6075313010893365,1.0,7/27,11.65%,EFHC2;MBOAT1;NTNG2;CCDC88A;HOMER1;DISC1;GSK3A
prerank,cellular defense response (GO:0006968),-0.43835111634753116,-1.3373893211816286,0.08522727272727272,0.5788500367901844,1.0,7/40,11.14%,DCDC2;LBP;CCR9;LSP1;ADORA2A;ZNF148;PTK2B
prerank,negative regulation of JNK cascade (GO:0046329),0.5198254689583377,1.3372283034352095,0.13643926788685523,0.6079359116599906,1.0,8/31,15.14%,MECOM;MEN1;DUSP3;NPPA;ZMYND11;CYLD;DNAJA1;HIPK3
prerank,regulation of synapse maturation (GO:0090128),0.641365810598753,1.3369079244677315,0.16477272727272727,0.607624345634035,1.0,7/10,19.95%,DAB2IP;ARHGEF15;NRXN1;CAMK2B;YWHAZ;NEUROD2;ANAPC2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.4508231200408281,-1.3366168358762458,0.1,0.5791690407580092,1.0,14/33,19.26%,APPL2;PKD1;STXBP4;GLI1;PSME3;MN1;PTEN;PAF1;TCIM;PLK5;DDRGK1;ID2;PTPN6;EZH2
prerank,negative regulation of cartilage development (GO:0061037),-0.5659560366855297,-1.3364230780735278,0.15401785714285715,0.5777018695872198,1.0,4/13,4.34%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.44262603462348316,-1.3362566533392302,0.10704225352112676,0.5761750591832127,1.0,14/37,13.57%,IGF1;BMPR1A;IGFBP5;TPM1;GJA1;FGF2;MMP2;FOXJ2;SOD2;EFEMP2;TGFB3;ADAMTS1;MFN2;PTEN
prerank,positive regulation of defense response (GO:0031349),0.4389701673406794,1.33604110346971,0.07386363636363637,0.6090925378278749,1.0,15/89,12.73%,ETS1;PDE2A;APP;NFKBIA;MEF2C;GBP5;HYAL2;MGST2;TLR3;TLR7;CCL1;TLR8;S100A8;IL15;DDT
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5010697528936627,1.3357034976326427,0.12025316455696203,0.608879172802607,1.0,8/36,13.08%,MECOM;FOXO1;MEN1;DUSP3;PPIA;ZMYND11;DUSP1;CYLD
prerank,cellular response to alcohol (GO:0097306),-0.4328279839465783,-1.3356847241642575,0.08163265306122448,0.575937727486202,1.0,19/42,25.65%,ADCY5;ADCY1;SMO;CDH1;ADCY2;ADCY7;GRAMD1B;PTGFR;GRAMD1C;ADCY6;LRP6;SFRP1;GRAMD1A;BRCA1;PTCH1;KLF9;MLC1;SPIDR;AHR
prerank,histone H4 acetylation (GO:0043967),0.49181846919038663,1.3350875707938992,0.11922503725782414,0.6095584828408501,1.0,10/47,16.38%,LEF1;TRIM16;PHF20;BRCA2;JADE2;NAA60;TRRAP;MCRS1;HCFC1;MSL2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.37349480879020874,-1.3347084149533541,0.05660377358490566,0.5768473564385296,1.0,14/86,4.67%,BMP6;SULF1;ZEB2;BMPR1A;FOXD1;BMP5;BMP7;BMP4;THBS1;TGFBR1;TWSG1;RBPJ;ZNF423;DAB2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6455178946543426,1.3340806999445778,0.1682600382409178,0.6114773005869176,1.0,2/10,3.94%,PODXL;PIEZO1
prerank,artery development (GO:0060840),0.5595728830390536,1.3340803374777241,0.1497504159733777,0.6102344605450742,1.0,7/23,4.31%,ENG;BMPR2;PDE2A;TBX1;ACVRL1;APLNR;SMAD7
prerank,sodium ion homeostasis (GO:0055078),-0.4982514571611554,-1.3340096825139602,0.11666666666666667,0.5770082367559471,1.0,6/21,10.27%,ATP1A2;SLC12A2;ATP1B3;ATP1B2;SLC8A1;SLC9A1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5844711799746215,-1.3336217257027312,0.11244979919678715,0.574057833606425,1.0,5/12,12.29%,FBLN1;EFNA5;KANK1;ITGB1BP1;DMTN
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5844711799746215,-1.3336217257027312,0.11244979919678715,0.574057833606425,1.0,5/12,12.29%,FBLN1;EFNA5;KANK1;ITGB1BP1;DMTN
prerank,regulation of protein phosphorylation (GO:0001932),0.3909108865590752,1.3334661442546294,0.024822695035460994,0.6109561309765605,1.0,48/256,10.75%,TFRC;TEK;OCLN;LIMCH1;PECAM1;KDR;INSR;DAB2IP;ENG;APP;PRR5L;XDH;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;MEN1;LYN;FNIP2;FGF16;WWTR1;CD4;CAMKK2;CCDC88A;LIMK2;PPIA;FYN;MAPK3;PPP2R5A;RALB;INSM1;EFNA1;PIN1;TGFB1;IRGM;PAK1;PGF;CCND3;ADAM17;AXIN2;AGER;BRD4;HSPB1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.6239859411083648,1.3330300189483801,0.18503937007874016,0.6110544429082393,1.0,1/12,1.02%,DAB2IP
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5873652681304518,1.3325707219597223,0.15753424657534246,0.6111870972798694,1.0,13/18,26.46%,UNC13B;CDH8;GRID2;GRIK5;GRIK2;GRIK1;SLC17A6;UNC13A;GRIA2;GRIK3;GRID1;SLC17A8;NAPB
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5805836578559743,1.3324995527147074,0.15213675213675212,0.6101649223397712,1.0,4/18,8.41%,CD34;HDAC7;HOMER2;FOXP3
prerank,cellular response to fluid shear stress (GO:0071498),0.6527494737458144,1.332337849493563,0.13883677298311445,0.6094623301138473,1.0,4/12,6.45%,MTSS1;MEF2C;KLF2;KLF4
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.608110915573244,-1.3323066776232249,0.13856812933025403,0.5760974379103403,1.0,4/10,10.23%,IRS1;IRS2;PTH1R;SLC45A3
prerank,positive regulation of chemokine production (GO:0032722),0.5006526179672699,1.3322718543756653,0.1140625,0.60841725569527,1.0,10/44,11.85%,APP;TIRAP;IL6R;TLR3;LGALS9;TLR7;ADAM17;AGER;HIF1A;SYK
prerank,polyol metabolic process (GO:0019751),0.4889998070267575,1.3318970673004693,0.1060842433697348,0.608367635821295,1.0,13/46,12.48%,PLCB1;PLCB4;ITPKB;INPP5D;PLCG1;CALM1;PLD4;OCRL;PLCH2;NUDT3;IPMK;PLCH1;INPP1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.3448318460822784,-1.331494966429316,0.03902439024390244,0.576552846820515,1.0,24/140,13.00%,CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;CD55;CCR9;EDNRA;ADRA1B;CACNA2D1;TRPC3;DLG4;P2RX4;SLC8A1;BDKRB2;AGTR1;PTGDR;PTGFR;TRPM4;ABL1;ESR1;JPH1;LPAR4;CMKLR1
prerank,transferrin transport (GO:0033572),0.518574458270132,1.3312800651111998,0.12225705329153605,0.6090323596584253,1.0,5/33,7.03%,TFRC;ATP6V0A1;MCOLN1;REP15;DNM2
prerank,heme biosynthetic process (GO:0006783),0.5584618935764637,1.3312371688436124,0.1480865224625624,0.607925754162867,1.0,3/22,8.34%,ABCG2;ALAS1;CPOX
prerank,positive regulation of cell growth (GO:0030307),0.4362144351293367,1.3311946912567287,0.09795918367346938,0.6068336325254111,1.0,24/96,13.66%,SEMA7A;MFSD2A;MACF1;TGFB2;NTN1;NEDD4L;ITSN2;RPS6KA1;SLC25A33;DBNL;ADAM10;RASAL1;TWF2;SMURF1;ADAM17;CPNE5;S100A8;SYT4;BRAT1;RPTOR;CPNE6;DERL2;SDCBP;AKAP6
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5752979592602381,-1.3311356441591662,0.13938053097345132,0.5756655275848712,1.0,2/12,0.75%,NOTCH2;DOCK11
prerank,axon guidance (GO:0007411),0.3960749009747377,1.3311186499543652,0.03916768665850673,0.6058524367577434,1.0,39/201,9.32%,SEMA3C;PTPRM;SEMA7A;BSG;SHANK3;SEMA6A;SPTBN1;ROBO4;CXCL12;NTN1;SEMA6B;KLF7;PTK2;LAMA5;PLXND1;TMEFF1;NOTCH1;DSCAML1;EVL;PLCG1;GRB2;SEMA4F;GAB1;EPHA4;DOK4;FYN;SOS1;MAPK3;RPS6KA5;RET;EPHB4;CNTN2;SEMA6D;EFNA1;SPTAN1;SHC3;OPHN1;NRXN1;SEMA4C
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5376434098974139,-1.330723473591301,0.14014251781472684,0.5748930455904014,1.0,6/16,15.13%,DPYSL3;DPYD;NT5E;UPB1;UPP2;NT5C1A
prerank,protein localization to cell junction (GO:1902414),0.5521676505116784,1.330389115185049,0.1455160744500846,0.606912258061739,1.0,3/22,1.89%,TJP1;HEG1;TJP2
prerank,neuron projection development (GO:0031175),0.40391656318456315,1.3301464508647034,0.062103929024081114,0.6064315474039762,1.0,31/168,10.36%,PTPRM;FRY;SHANK3;SRGAP2;DAB2IP;RAPGEF2;APP;FRYL;STX3;MAP4;LYN;PPP1R9B;STMN1;WNT7A;TBC1D24;EPHA4;DIP2A;DBNL;NCKAP1;STMN3;DNM2;RAB11A;STMN4;GPM6A;OPHN1;PAK1;SLC9A6;ZPR1;TBC1D23;BICDL1;AGER
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5205175490893674,1.3301379167086833,0.11827956989247312,0.6052690496201633,1.0,7/32,13.32%,MFSD2A;SLC44A5;CHKA;LPCAT3;CEPT1;CSNK2B;LPIN3
prerank,negative regulation of vascular permeability (GO:0043116),0.6148308919669214,1.3296625941958142,0.1752767527675277,0.6055815575148313,1.0,5/12,3.52%,CLDN5;PDE2A;DDAH1;PTPRJ;RAMP2
prerank,cytosolic calcium ion transport (GO:0060401),-0.4699933360114288,-1.3295456795248217,0.13541666666666666,0.5763871087933418,1.0,13/28,20.43%,CACNA1C;MCU;CACNA2D1;SLC35G1;SLC8A1;AFG3L2;JPH1;ATP2A3;ATP2B3;JPH2;ATP2A2;CACNB3;MICU1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5517915062251323,1.3291973558460541,0.13036303630363036,0.6058669492701145,1.0,7/24,13.79%,NOD1;NOD2;IRAK2;UBE2V1;CASP8;CYLD;TNFAIP3
prerank,sulfur compound transport (GO:0072348),0.5306556285673731,1.3285211232622984,0.1361344537815126,0.6066301596322852,1.0,2/27,0.38%,SLC6A6;ABCG2
prerank,mesenchyme morphogenesis (GO:0072132),0.5785110555327044,1.3284963260728055,0.15412186379928317,0.6055259751970766,1.0,5/17,3.41%,ENG;TGFB2;NOS3;ACVRL1;NOTCH1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5738347173101455,-1.3282632157348844,0.14725274725274726,0.5784241450556041,1.0,2/12,2.85%,DPYSL3;DPYD
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5868660264242177,1.3282353785585281,0.13978494623655913,0.6050872736947944,1.0,4/17,6.46%,PODXL;TGFB2;PIEZO1;RET
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6471667652536965,1.3281688464514394,0.1760154738878143,0.6040971014884758,1.0,3/11,3.96%,SEMA6A;EPN2;KLF2
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5763677410859648,1.3279016530418446,0.16129032258064516,0.6037062754133452,1.0,5/18,10.15%,RNF125;SEC14L1;ZCCHC3;BIRC3;OASL
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.40618977237726017,-1.327781444689567,0.07430340557275542,0.5779493587341545,1.0,11/56,4.67%,BMP6;BMPR1A;LDLRAD4;BMP5;BMP7;BMP4;BMPER;SMAD6;TGFBR1;TWSG1;DAB2
prerank,myotube cell development (GO:0014904),-0.6028846005344985,-1.327564875227224,0.1787941787941788,0.5765899580146829,1.0,3/10,13.00%,IGF1;SIX1;SKI
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4154398629615634,1.3273833997595421,0.05625,0.6040608631452892,1.0,24/151,8.30%,TEK;SEMA7A;MFHAS1;PDGFB;KDR;RAPGEF2;PDGFD;APP;TIRAP;PDE8A;FLT4;TNFRSF11A;NOD2;NOTCH1;PRKD2;RAMP3;CCR7;CD4;MAPK3;FBXW7;LGALS9;HTR2A;TGFB1;ABCA7
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.6356589056042844,1.326971233452008,0.15105162523900573,0.6042019456573666,1.0,4/11,9.66%,JAK3;SMAD7;FOXP3;SOCS5
prerank,sodium ion transmembrane transport (GO:0035725),-0.3793981909050271,-1.3263554936633926,0.05821917808219178,0.5783450761279184,1.0,16/84,7.24%,ATP1A2;SLC24A3;NALCN;SLC6A13;SCN7A;SLC6A12;SLC8A3;SLC6A9;SLC12A2;ANO6;PKD2;SLC9A2;ATP1B3;SLC6A1;ATP1B2;SLC8A1
prerank,adipose tissue development (GO:0060612),0.6484015523418828,1.326205997944182,0.1622103386809269,0.6054481149728145,1.0,3/11,8.59%,NAMPT;SPTLC2;LRP5
prerank,negative regulation of calcium ion transport (GO:0051926),-0.533833008443768,-1.3260204377741158,0.12745098039215685,0.5774361320622363,1.0,1/15,0.02%,ATP1A2
prerank,mitochondrion morphogenesis (GO:0070584),-0.5808524812597006,-1.32597179176579,0.1506849315068493,0.5755980932951081,1.0,1/11,0.14%,PID1
prerank,regulation of fibrinolysis (GO:0051917),-0.5523914223856214,-1.3257775068334279,0.14508928571428573,0.5742781388175404,1.0,3/13,7.12%,THBS1;FAP;THBD
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5703148576339462,-1.3253425915919628,0.15011037527593818,0.5735599959431196,1.0,5/12,13.13%,IRS1;PPARGC1A;PPARA;IRS2;TWIST1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.578817181699092,1.3248218213583913,0.15970961887477314,0.6082977488975237,1.0,2/18,1.49%,SLC39A8;JAM2
prerank,cilium-dependent cell motility (GO:0060285),0.5486933844539539,1.3247776419631194,0.1636060100166945,0.6072581703546956,1.0,6/22,12.40%,EFHC2;DNAH3;DRC1;CFAP54;DNAAF2;DNAH8
prerank,heterochromatin organization (GO:0070828),0.6123831431844836,1.3244713209320391,0.15808823529411764,0.6070119476981173,1.0,1/14,0.11%,MECOM
prerank,positive regulation of immune system process (GO:0002684),0.5945854157346424,1.3244297563962262,0.16936936936936936,0.6060021833940356,1.0,5/16,14.70%,TGFB2;LGALS9;PIK3CB;IL15;NCKAP1L
prerank,atrioventricular valve development (GO:0003171),0.5896128565425963,1.3243804748809747,0.1863468634686347,0.6049962953444801,1.0,5/14,3.41%,BMPR2;TGFB2;ZFPM1;APLNR;NOTCH1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5871631844561517,-1.3236237170318639,0.16891891891891891,0.5769801616333979,1.0,6/10,30.54%,ADGRV1;PDZD7;TSKU;PLS1;IFT88;WHRN
prerank,aminoglycan catabolic process (GO:0006026),-0.4638045655278151,-1.3234843409061134,0.0948509485094851,0.5754299276531611,1.0,5/28,7.96%,GPC6;SDC2;GPC3;GPC4;SDC4
prerank,nucleotide catabolic process (GO:0009166),0.5891683531055516,1.3233801056665933,0.1669724770642202,0.6068331538630215,1.0,5/16,11.08%,XDH;SAMHD1;NT5C2;NUDT3;PNP
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5853248210020554,-1.3226121258195909,0.15550755939524838,0.5760750988024413,1.0,1/10,2.78%,TUT4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5370092331577442,1.3214310607586615,0.12459546925566344,0.6114190883456169,1.0,11/26,13.39%,DAB2IP;PDE8A;PTPN12;DUSP3;VIL1;PLCG1;SNAI2;IQGAP1;ZPR1;ZFP36L1;SOX9
prerank,natural killer cell activation (GO:0030101),-0.48279289189912106,-1.320243290295042,0.13157894736842105,0.581192005931485,1.0,3/23,7.34%,PBX1;AXL;ELF4
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6047698687767533,1.3201940396492344,0.18850987432675045,0.6140628960863159,1.0,4/15,6.75%,IGF1R;KDR;MAPK3;AATK
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5233839905728208,-1.3201830581448535,0.13716814159292035,0.579477989351097,1.0,7/17,17.63%,FGFR2;NPR3;CCN1;MN1;BMP2;SFRP1;TMEM119
prerank,protein localization to cell surface (GO:0034394),-0.4702216601956072,-1.3201795390499238,0.12562814070351758,0.577575040920278,1.0,7/26,10.34%,ANK2;ANGPT1;FBLN5;VCL;FLNA;GGA2;PRRT1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.593163147836654,1.3201546969838134,0.17902350813743217,0.6130223438831078,1.0,6/17,12.02%,PTPRJ;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1
prerank,carbohydrate biosynthetic process (GO:0016051),0.553685050244017,1.320046572727124,0.15033783783783783,0.6121626710006027,1.0,4/21,5.93%,ST3GAL6;ST8SIA6;FUT8;FUT9
prerank,actin filament polymerization (GO:0030041),-0.45747626402626723,-1.3196630014041246,0.11734693877551021,0.5772101769549973,1.0,4/29,2.45%,ARHGAP6;GAS7;GSN;COBL
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.4909593866737162,1.3190820868048723,0.12615384615384614,0.6137803998996684,1.0,6/41,4.31%,TJP1;PODXL;MAGI1;PLAUR;PIEZO1;SMAD7
prerank,positive regulation of protein processing (GO:0010954),-0.5072105683899674,-1.3187292864800713,0.13381995133819952,0.5780090154676909,1.0,3/19,3.29%,GSN;CCBE1;CLEC3B
prerank,positive regulation of growth (GO:0045927),0.4571520768383431,1.3183988776973914,0.09883720930232558,0.6146620850223137,1.0,16/64,14.29%,PLCB1;MFSD2A;INSR;TGFB2;RPS6KA1;SLC25A33;ADAM10;ZPR1;ADAM17;S100A8;BRAT1;RPTOR;DERL2;SDCBP;AKAP6;RFTN1
prerank,regulation of MAP kinase activity (GO:0043405),0.43940055464163064,1.3182192883704633,0.0811554332874828,0.6140068775764158,1.0,14/92,5.07%,FLT1;PIK3R6;PDGFB;DAB2IP;PDGFD;TPD52L1;STK38;PTPRJ;DUSP7;CD40;NOD2;LYN;FGF16;HYAL2
prerank,regulation of cytokine production (GO:0001817),0.41834894750811863,1.3182143428854671,0.08047493403693931,0.6128598253978406,1.0,23/126,10.63%,CADM1;AFAP1L2;BCL6B;RGCC;SRGN;IFIH1;HDAC9;LYN;NOS2;MOG;CCR7;PLD4;TRIL;SNAI2;CCDC88B;RPS6KA5;ATP2B1;LGALS9;N4BP1;FOXP3;PPP1R11;CASP8;NLRP4
prerank,connective tissue development (GO:0061448),-0.4384746874323106,-1.317663251406218,0.09686609686609686,0.579058458649911,1.0,10/35,10.20%,SULF1;SOX5;ITGB8;PKD1;SULF2;CREB3L2;SH3PXD2B;ATP7A;SOX6;SLC39A13
prerank,protein ADP-ribosylation (GO:0006471),-0.4648374217879975,-1.3176508754474117,0.11407766990291263,0.5772198326899036,1.0,11/28,16.33%,PARP8;PARP3;SIRT3;TNKS2;PARP4;PARP11;PARP6;PARP1;SIRT2;PARP12;TIPARP
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6043026258382431,-1.3173750653734002,0.14955357142857142,0.5742590002147826,1.0,5/10,18.79%,PRKCD;SMPD3;SIRT3;NSMAF;PLA2G6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6043026258382431,-1.3173750653734002,0.14955357142857142,0.5742590002147826,1.0,5/10,18.79%,PRKCD;SMPD3;SIRT3;NSMAF;PLA2G6
prerank,I-kappaB phosphorylation (GO:0007252),0.6435824989446124,1.3173627314007845,0.188212927756654,0.6141916449123583,1.0,3/10,7.61%,DAB2IP;TLR3;TLR7
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5578421953389016,-1.3171907474183049,0.12669683257918551,0.5728891372677928,1.0,4/13,10.27%,ATP1A2;ATP1B3;ATP1B2;SLC9A1
prerank,regulated exocytosis (GO:0045055),0.40112052404428167,1.3171195077143203,0.05562422744128554,0.6137862952775047,1.0,28/173,10.32%,ABCC4;PECAM1;RAB11FIP1;PDGFB;TGFB2;APP;LHFPL2;RAB31;STX1A;SRGN;SELENOP;VWF;LYN;TMSB4X;CALM1;CFD;PIP5K1C;SYT7;ACTN4;CTSW;STXBP1;ACTN1;TGFB1;QSOX1;SCG3;CDC37L1;DNAJC5;ARHGAP17
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.39164431051682314,-1.3170167713208236,0.06646525679758308,0.5715752509926809,1.0,8/61,6.27%,EYA2;EYA1;EGFR;PDGFRB;EYA4;SMOC2;FGF2;PARP3
prerank,actin cytoskeleton reorganization (GO:0031532),-0.39325553159528814,-1.3170057420376846,0.08459214501510574,0.5697742224944838,1.0,19/63,12.32%,AUTS2;PARVA;GSN;CXADR;PTK7;MCU;SIPA1L1;NRK;KIT;DTNBP1;ANXA1;FLNA;SYDE1;PHACTR1;PDLIM4;EZR;EFS;DMTN;S1PR2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.49837348828724914,-1.3168590628660009,0.11282051282051282,0.5683598246423106,1.0,5/21,7.86%,ANK2;SNTA1;CACNA2D1;FLNA;CACNA1D
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5343709956399298,1.3168297085490919,0.1478405315614618,0.6135229052088019,1.0,11/25,18.87%,HSP90AB1;EPHA4;EFNA1;RPS7;OPHN1;HIPK2;F8A1;RPL11;TRIM39;PRKCG;RPL23
prerank,transepithelial transport (GO:0070633),0.5923373739558124,1.316576671852014,0.1637323943661972,0.6131146432659099,1.0,3/15,5.02%,ABCG2;SLC1A1;SLC1A2
prerank,inositol phosphate metabolic process (GO:0043647),0.48341505576004284,1.3165522224845119,0.11975116640746501,0.6120253562965486,1.0,13/46,12.48%,PLCB1;PLCB4;ITPKB;INPP5D;PLCG1;CALM1;PLD4;OCRL;PLCH2;NUDT3;IPMK;PLCH1;INPP1
prerank,neural tube development (GO:0021915),-0.5346783198183124,-1.3160482757022294,0.16166281755196305,0.5689021578521466,1.0,4/15,6.43%,ALDH1A2;PKD1;PKD2;DACT1
prerank,neuron development (GO:0048666),0.40770453136342943,1.3159665554122044,0.07692307692307693,0.6126650311440551,1.0,25/141,10.39%,PTPRM;FRY;TGFB2;RAPGEF2;APP;FRYL;B4GALT5;STX3;MEF2C;MAP4;LYN;PPP1R9B;STMN1;TBC1D24;RP1;STMN3;INSM1;RAB11A;STMN4;GPM6A;OPHN1;TBC1D23;BICDL1;AGER;DCX
prerank,neutrophil chemotaxis (GO:0030593),0.4756611242819821,1.3158723325795407,0.11411411411411411,0.6118500048809544,1.0,10/53,11.85%,BSG;TGFB2;PIKFYVE;PIP5K1C;PPIA;PDE4B;CXCR2;CCL1;S100A8;SYK
prerank,purine nucleotide catabolic process (GO:0006195),0.6185288273328122,1.3154814926503389,0.1776061776061776,0.6118934906218816,1.0,4/13,11.08%,XDH;HINT1;NT5C2;PNP
prerank,regulation of stress fiber assembly (GO:0051492),-0.37688375180122063,-1.3154796877056898,0.07317073170731707,0.5688073245797886,1.0,24/74,10.27%,PHLDB2;ARHGAP6;LPAR1;ROCK2;ARHGAP28;PPM1E;CCN2;ARHGEF10L;ASAP3;ARAP1;TPM1;CARMIL1;TGFBR1;S100A10;ALMS1;CGNL1;ARHGEF18;FHOD1;MET;PFN2;MYOC;TGFB3;ITGB1BP1;SLC9A1
prerank,regulation of protein localization to membrane (GO:1905475),-0.46831855461582705,-1.3153581199557947,0.12853470437017994,0.5673938786505194,1.0,9/28,11.08%,GPC6;GSN;GPC3;MMP14;GPC4;AR;PRKN;SLC5A3;CLN3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.600793024138914,1.3152290889518587,0.1871559633027523,0.6114882855435364,1.0,7/14,19.69%,KDR;FLT4;GAB1;PGF;NUS1;NRP1;MYO1C
prerank,negative regulation of dephosphorylation (GO:0035305),0.5792948350410471,1.3141384922535748,0.14768683274021352,0.6136583813197767,1.0,2/18,0.95%,MFHAS1;PPP1R16B
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.5947708860562071,1.3139881884213787,0.17537313432835822,0.6129672092762933,1.0,3/13,15.81%,PRR5L;GTPBP1;ZC3HAV1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.39732501019470856,1.3133182522284983,0.04567307692307692,0.6138332195103262,1.0,53/224,17.53%,MPZ;SLC1A1;CACNA1A;HCRTR1;SLC6A5;SLC6A2;UNC13B;RPS6KA1;CALM1;PDE7B;SLC1A2;CAMKK2;SYPL1;SLC12A6;PRKACB;ATXN3;HOMER1;CHRNB1;GABRB1;HTR2A;PRKAR2B;HCRTR2;GRIA4;KCNQ3;APBA2;NRXN1;AKAP9;PRKAR2A;NPY5R;CHRM3;EXOC4;GRIN2B;GABRQ;PCDHB14;CPNE6;GRIK2;CPLX1;SDCBP;MINK1;GRIK1;MYCBPAP;SYNJ2BP;GABRG1;HTR4;GRM7;AMPH;NLGN1;MAPK1;GABRG3;MBP;PMP22;GABRA1;SST
prerank,potassium ion homeostasis (GO:0055075),-0.4910487247157665,-1.313019456320495,0.1295843520782396,0.5724257198237364,1.0,6/23,7.08%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;SLC12A7;ATP1B2
prerank,maintenance of protein location in nucleus (GO:0051457),0.5605351274855704,1.3127828279780536,0.1646655231560892,0.6142880719957977,1.0,3/20,2.92%,SYNE1;ARL2BP;SP100
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5182713661358259,1.3127565594045536,0.1423785594639866,0.6132258059399032,1.0,8/28,12.58%,SHANK3;APP;EPHA4;FAM107A;PTN;EIF2AK4;AGER;CALB2
prerank,positive regulation of ossification (GO:0045778),-0.4330282776393931,-1.3124138894270656,0.09319899244332494,0.5725761506503184,1.0,15/39,12.43%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;FBN2;PKDCC;BMP2
prerank,phagosome-lysosome fusion (GO:0090385),0.632971232292983,1.3111232099615695,0.17567567567567569,0.6171230421530741,1.0,4/10,7.82%,PIKFYVE;SYT7;RAB34;RAB39A
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.4149371317464639,-1.3107051523556559,0.10674157303370786,0.5758915153665898,1.0,15/48,15.28%,ADCY5;AMPD3;ADCY1;ADCY9;SLC26A2;ADCY2;ADCY7;PAPSS2;GUCY1A1;DCAKD;PAPSS1;ADCY6;GUCY1B1;IMPDH2;GMPS
prerank,cellular response to hexose stimulus (GO:0071331),0.538124762871338,1.3106142928785742,0.1611295681063123,0.6174341279857385,1.0,2/23,2.00%,IGF1R;UNC13B
prerank,vasodilation (GO:0042311),0.610525776431588,1.3106099815145509,0.17667238421955403,0.6163238560361349,1.0,3/13,10.36%,NOS3;KLF2;AGTR2
prerank,negative regulation of cell adhesion (GO:0007162),0.4440577354071919,1.31015268598909,0.10930576070901034,0.6165411254810869,1.0,20/72,11.99%,SEMA6A;PODXL;ACER2;FZD4;CORO2B;PTK2;PLXND1;SIPA1;ACVRL1;NOTCH1;SNAI2;ADAM10;NEXMIF;TGFB1;SPOCK1;ARHGDIA;CBLL1;DUSP1;PLXNB3;RND1
prerank,protein hydroxylation (GO:0018126),-0.5319189070813872,-1.3096549810352835,0.15765765765765766,0.577253472347858,1.0,7/15,13.28%,PLOD2;ASPH;P3H3;EGLN3;P3H2;OGFOD1;P3H1
prerank,mRNA splice site selection (GO:0006376),-0.44824241115080465,-1.309474282274545,0.11917098445595854,0.5759759821187629,1.0,6/30,13.96%,CELF2;SRSF5;LUC7L3;SRSF6;LUC7L2;PSIP1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.3963213738006906,-1.309171929233253,0.10461538461538461,0.5751531666222706,1.0,22/52,22.68%,ME1;ADHFE1;ME2;ACOT8;IDH2;MTHFR;MTHFD1;MDH2;ALDH18A1;D2HGDH;GOT1;PHYH;GCLC;GPT2;MTHFD1L;L2HGDH;MTHFD2;NIT2;IDH1;GOT2;FPGS;MTHFS
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5176768227921436,-1.3088523818703615,0.14084507042253522,0.5742536247019373,1.0,3/16,4.19%,AUTS2;ARHGAP24;OGT
prerank,positive regulation of cell population proliferation (GO:0008284),0.3696121997928237,1.3087234000771653,0.023076923076923078,0.6197093020004059,1.0,52/423,9.30%,LEF1;FLT1;IGF1R;PRKCH;KITLG;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;TGFB2;ACER2;PDGFD;TBX1;IL6R;FLT4;CNOT6L;TBX3;TNFRSF11A;STX3;GNAI2;PTK2;NES;MEF2C;NOD2;TIAM1;NOTCH1;LYN;OSMR;FGF16;DLL4;WWTR1;SLC25A5;SLC25A33;ADAM10;STAT1;HCK;INSM1;BST2;TGFB1;TGFA;CXCR2;PTN;LRP5;COPS9;GREM1;PAK1;PGF;MAP3K3;LIFR
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5904670699552125,1.3084737835826932,0.18165784832451498,0.6193586826868002,1.0,2/16,6.92%,CLDN5;CLDN14
prerank,regulation of sprouting angiogenesis (GO:1903670),0.5118741650681736,1.308294073817257,0.15321252059308071,0.6188073957716506,1.0,11/33,12.15%,SEMA6A;TJP1;PPP1R16B;EPN2;KLF2;FGF16;KLF4;PKM;SMAD1;CEACAM1;PIK3CB
prerank,muscle contraction (GO:0006936),-0.3446303836297066,-1.3072613102681976,0.05357142857142857,0.5770416224851485,1.0,30/126,13.21%,CALD1;ROCK2;ACTN2;MYLK;TPM1;SNTA1;ITGB5;SNTB1;EDNRA;MYOF;DMD;VCL;ASPH;PABPN1;GNAO1;SLC8A1;MYH11;BDKRB2;MYL9;LMOD1;ACTA2;TPM2;TMOD3;DES;ARHGEF11;DTNA;TLN1;MYOM1;EMD;FXYD1
prerank,photoreceptor cell development (GO:0042461),0.5852884842685517,1.30706876571533,0.18617021276595744,0.6213312001303989,1.0,3/14,10.39%,MFSD2A;RP1;DCX
prerank,response to lipopolysaccharide (GO:0032496),0.40733128928312373,1.3068843736251905,0.07012987012987013,0.6208130945214636,1.0,25/138,14.07%,DAB2IP;NOS3;TIRAP;GCH1;IFNAR1;TNFRSF11A;MEF2C;SCARB1;DEFA6;NOD2;PELI1;NOS2;NOCT;PALM3;CD6;LGALS9;PDE4B;IRGM;ADAM17;S100A8;SLPI;HMGB2;TNFAIP3;GIT1;BCL10
prerank,erythrocyte differentiation (GO:0030218),0.4831536372795039,1.3060365987903124,0.12042682926829268,0.6222943713296151,1.0,8/44,5.20%,MFHAS1;ALAS1;JAK3;ZFPM1;LYN;KLF1;SLC25A5;TAL1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.41947239983208884,1.305547608544743,0.08433734939759036,0.622645772500995,1.0,20/124,12.39%,LEF1;PLCB1;FZD6;FZD4;TIAM1;WNT7A;CALM1;CTNNB1;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;PSMD8;PPP3CA;RAC1;PPP3R1;AP2B1;GNB1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.5123127393323141,-1.3048454271586836,0.1543942992874109,0.5826701889833008,1.0,6/17,1.46%,IGF1;DOCK5;PDGFRB;DOCK7;IGFBP5;VTN
prerank,regulation of macrophage migration (GO:1905521),0.6457205986106463,1.3036183024134702,0.18029739776951673,0.6274477647093613,1.0,3/10,8.06%,MTUS1;CD200;CD200R1
prerank,regulation of cell population proliferation (GO:0042127),0.36080806980150043,1.3034597304347597,0.007306889352818371,0.626778930954271,1.0,85/691,9.30%,LEF1;FLT1;IGF1R;TFRC;KITLG;ETS1;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;DAB2IP;ENG;BMPR2;TGFB2;NOS3;RAPGEF2;ACER2;PDGFD;SH3BP4;APP;JAG2;FES;TBX1;DDAH1;ITGA1;IL6R;FLT4;CNOT6L;CD200;TBX3;TNFRSF11A;STX3;ADGRG1;GNAI2;BCL6B;PTPRJ;ARHGEF2;RGCC;PTK2;SMARCA2;ACVRL1;TIAM1;NOTCH1;MEN1;LYN;PPP1R9B;HHEX;CTNNB1;SOX7;OSMR;FGF16;DLL4;WWTR1;SLC25A5;XIAP;IGFBP7;BTG4;ST18;CCDC88A;SLC25A33;ADAM10;KLF4;CDKN2B;STAT1;HCK;INSM1;JUN;TGFB1;TGFA;CXCR2;TMEM115;CDCA7;FOXP3;PTN;LRP5;ADAMTS8;COPS9;GREM1;HMGA1;PAK1;PGF;LIFR
prerank,lamellipodium organization (GO:0097581),0.5177494984004495,1.303249881067737,0.15577889447236182,0.6263644723462963,1.0,8/29,11.43%,PARVB;ABLIM1;S1PR1;SPATA13;CCDC88A;ARHGEF7;CYFIP1;RAC1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.5186626529172818,-1.3028303584022483,0.15473441108545036,0.5867212825352485,1.0,7/17,14.67%,BMP4;FGF2;TMEM100;SFRP4;ATOH8;NKX6-1;AHI1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.5417971034951317,-1.302703546833823,0.16375545851528384,0.5852736870627702,1.0,4/16,11.52%,AUTS2;BCOR;CTR9;KDM1A
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.41197715751693104,-1.3026093643678598,0.10743801652892562,0.5837304589689256,1.0,9/44,7.08%,ANK2;ACTN2;ANO6;WNK4;KCNMB2;KCNJ2;ATP1B3;FLNA;ATP1B2
prerank,peptidyl-lysine methylation (GO:0018022),-0.45806271409347044,-1.3025220804171582,0.115,0.5822620281980947,1.0,13/26,28.73%,EHMT2;SMYD3;SETD7;SETD4;EEF2KMT;TRMT112;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2;ANTKMT;METTL21C
prerank,positive regulation of vascular permeability (GO:0043117),0.6050736809074431,1.3023145080471017,0.18962432915921287,0.6280596196472432,1.0,4/12,1.89%,OCLN;TJP1;PDE2A;TJP2
prerank,regulation of cell growth (GO:0001558),0.3903859308495122,1.302177054693242,0.06367041198501873,0.6273408931579119,1.0,40/204,12.22%,TFRC;MFSD2A;APBB2;LTBP4;BMPR2;TGFB2;SH3BP4;NET1;SOX17;DCUN1D3;PTPRJ;SMARCA2;ADAM15;SIPA1;RPS6KA1;ACVRL1;CCDC85B;PPP1R9B;SOCS2;KIF26A;HYAL2;PAK5;WFDC1;FAM107A;SLC25A33;ADAM10;RASGRP2;EGLN2;BST2;TGFB1;NPR1;SPOCK1;ADAM17;BTG1;AGTR2;S100A8;BRAT1;NAIF1;CEACAM1;RPTOR
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.568725284218059,1.3019207835883988,0.1813380281690141,0.6269889544731083,1.0,4/17,6.86%,TEK;FES;BAIAP2;HCK
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.39886781093699597,1.3012817995635166,0.06944444444444445,0.6277344001386951,1.0,48/163,20.06%,INPP5D;PTPRJ;MEF2C;PRKD2;ZAP70;PLCG1;IKBKB;PDE4D;TNFRSF21;MOG;CD19;CD4;CD38;FYN;PLEKHA1;PSMB3;PSMD11;PDE4B;CD79A;PSMC6;MALT1;PAK1;PSME2;EIF2B1;EIF2B2;DENND1B;PSMD8;PRKCB;SYK;PIK3CB;SH2B2;PSMB10;BCL10;RFTN1;LCP2;NCKAP1L;CARD11;PSMA8;NCK1;LAT2;PAK2;SKP1;PSMD9;SPPL3;SKAP1;RBCK1;FYB2;PLCG2
prerank,error-prone translesion synthesis (GO:0042276),0.554026480158612,1.3005054559861455,0.15332197614991483,0.6290754958599987,1.0,1/21,0.28%,POLK
prerank,activation of protein kinase A activity (GO:0034199),-0.5319187103421769,-1.2998054717091956,0.16972477064220184,0.5884096431423513,1.0,7/16,12.33%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6
prerank,positive regulation of T cell proliferation (GO:0042102),0.46267379992088303,1.2994579580355288,0.14157973174366617,0.6311059225877576,1.0,15/55,17.12%,TFRC;SLC7A1;JAK3;CD6;CCDC88B;EBI3;AGER;PNP;SYK;IL27RA;IL15;NCKAP1L;VCAM1;NCK1;CCR2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5131445425572052,-1.2992140212850132,0.14180929095354522,0.5884528163817574,1.0,4/18,5.75%,PTGDS;PTGIS;PTGS1;PTGES
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5677726073718588,1.2989823988349998,0.17889087656529518,0.6314229762846972,1.0,3/18,4.11%,FLT1;MEF2C;PLCG1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.42901240867607127,-1.2987396868550865,0.12078651685393259,0.5880535382584078,1.0,9/40,4.69%,ARHGAP6;LPAR1;NTRK3;EGFR;PDGFRB;PDGFRA;EDNRA;KIT;FGF2
prerank,positive regulation of protein secretion (GO:0050714),-0.38073632724212825,-1.298429167662553,0.08278145695364239,0.5872246002490529,1.0,13/69,9.52%,BMP6;WLS;IGF1;MCU;FRMD4A;NLGN2;RBP4;ADAM9;IRS2;NNAT;C1QTNF3;TGFB3;EZR
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5614418282549165,1.2981233851551637,0.19337979094076654,0.6328898459190748,1.0,5/16,15.66%,FASN;DIP2A;SLC25A1;HSD17B8;ACAT1
prerank,response to interferon-gamma (GO:0034341),0.4450770976016481,1.298014567671494,0.12011577424023155,0.6321054650812588,1.0,12/67,11.00%,GCH1;SP100;CD40;GBP7;GBP4;GBP5;LGALS9;STAT1;BST2;RPL13A;PDE12;CCL1
prerank,retina homeostasis (GO:0001895),0.540836065911444,1.2979143109157691,0.1694915254237288,0.6312757625154208,1.0,6/23,10.75%,B2M;POTEF;ACTB;POC1B;ACTG1;HSPB1
prerank,positive regulation of cellular senescence (GO:2000774),0.6281759017672756,1.297821860336999,0.19887429643527205,0.6304240878669085,1.0,4/10,16.58%,B2M;HMGA1;ABI3;HMGA2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5289630541343118,-1.2976932427448304,0.16585365853658537,0.5875405162655652,1.0,4/15,3.79%,GLI2;EDA;WNT6;FOXC1
prerank,axonogenesis (GO:0007409),0.38337930006442444,1.297406247826832,0.053462940461725394,0.6305691924398688,1.0,46/237,9.42%,SEMA3C;SEMA7A;BSG;SHANK3;SEMA6A;SPTBN1;ROBO4;CXCL12;APP;B4GALT5;SEMA6B;KLF7;PTK2;LAMA5;PARD3;NTNG2;NOTCH1;DSCAML1;EVL;ACTB;PLCG1;WNT7A;GRB2;HSP90AB1;SEMA4F;GAB1;EPHA4;BAIAP2;DOK4;FYN;SOS1;MAPK3;RPS6KA5;RET;EPHB4;SLITRK3;CNTN2;SEMA6D;EFNA1;SLITRK1;SPTAN1;SHC3;OPHN1;NRXN1;SEMA4C;SLC9A6
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5791411557359495,1.2968822186883098,0.1657754010695187,0.6310273475685806,1.0,5/15,4.90%,KDR;PRKD1;PRKD2;TMSB4X;FGF16
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.49790721733477844,1.2967732650088402,0.16006600660066006,0.6302353951066159,1.0,11/33,14.70%,TGFB2;ACER2;PTK2;LYN;SNAI2;RET;NEXMIF;EFNA1;SYK;PDE3B;NCKAP1L
prerank,iron ion transport (GO:0006826),0.47507941452003927,1.2965375749101038,0.1437216338880484,0.6298310499828176,1.0,6/47,7.03%,TFRC;SLC40A1;ATP6V0A1;MCOLN1;REP15;DNM2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.5568394667467528,-1.2963428863269906,0.17248908296943233,0.5896980979222215,1.0,7/12,29.97%,ANO1;TRPM4;PPP3CB;STX4;PLA2G6;BAIAP3;GPLD1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.48964108869047784,1.2963090160071133,0.15217391304347827,0.6293911062701468,1.0,8/37,6.99%,HMCN1;CADM1;NECTIN4;CD6;GRID2;PVR;FAT4;DCHS1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.49566052039929553,1.295902523575186,0.15873015873015872,0.6294857288974194,1.0,8/38,7.63%,PDGFB;APP;CAV1;LRP8;NEDD9;HYAL2;EPHA4;EFNA1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.49585264113577,-1.2957323000621503,0.14903846153846154,0.5897513720842795,1.0,6/20,14.60%,IGF1;FOXC1;NIBAN2;TWIST1;EP300;DDRGK1
prerank,apoptotic DNA fragmentation (GO:0006309),0.5801334165361783,1.295710995877305,0.2049335863377609,0.6289530806745526,1.0,8/16,19.18%,FOXL2;CECR2;DFFB;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5792261407882365,-1.2952217511863127,0.17002237136465326,0.5876648788265624,1.0,3/12,10.68%,IGF1;SLC9A1;STIMATE
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5792261407882365,-1.2952217511863127,0.17002237136465326,0.5876648788265624,1.0,3/12,10.68%,IGF1;SLC9A1;STIMATE
prerank,alpha-amino acid metabolic process (GO:1901605),-0.4092348957910019,-1.2948419250934562,0.09943181818181818,0.5870509327814858,1.0,22/45,22.94%,ASPA;ATP7A;NAALAD2;ASPG;NOX4;MTHFR;MTHFD1;OAT;ALDH18A1;GOT1;GLUL;SLC25A12;GLS;GLS2;KYAT3;DDAH2;GPT2;KYAT1;KMO;GOT2;PYCR3;NAT8L
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5198684911642575,1.2943989608485882,0.16775244299674266,0.6316988176156648,1.0,9/28,15.03%,NOD1;NOD2;IRGM;IRAK2;UBE2V1;CASP8;CYLD;TNFAIP3;INAVA
prerank,muscle organ development (GO:0007517),-0.4080609628298165,-1.2940676320185702,0.08536585365853659,0.5876180114941204,1.0,16/54,9.60%,LAMA2;IGF1;LARGE1;SGCD;COL6A3;FHL1;DMD;SPEG;ITGA11;MKX;MRAS;CHD2;VAMP5;POU6F1;SOX6;EVC
prerank,cellular response to oxidative stress (GO:0034599),-0.34797483924522526,-1.293255715425651,0.04119850187265917,0.5882162183914343,1.0,26/118,11.96%,EGFR;PDGFRA;PRKAA2;MGAT3;CPEB2;TPM1;PLA2R1;PRKCD;PPARGC1A;PKD2;STX2;SOD3;GPX8;SOD2;NOX4;SELENOS;SLC25A24;FOXO3;ARNT;CYBA;PARP1;LRRK2;TMEM161A;CHUK;MPV17;ABL1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.44670409752976437,1.2930233435817062,0.11866859623733719,0.6346783126721718,1.0,11/73,11.35%,KITLG;LMO2;GATA2;TAL1;PSMB3;PSMD11;TCF12;PSMC6;PSME2;CBFB;PSMD8
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.46879928222176015,-1.2929945256023048,0.15151515151515152,0.5873198346214532,1.0,8/24,12.27%,SOX5;ADAMTS12;EFEMP1;TGFBR1;WNT9A;SOX6;PTHLH;PKDCC
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.48411555819079255,-1.2924055531889518,0.1592920353982301,0.5874274508552048,1.0,5/21,6.33%,ROCK2;ERRFI1;BMP4;CTSL;SFRP4
prerank,response to nitric oxide (GO:0071731),0.5870653870440401,1.292217493176793,0.1785063752276867,0.6359860791885064,1.0,4/13,12.80%,FOXO1;KCNC2;CCR7;EGLN1
prerank,negative regulation of cell migration (GO:0030336),0.4018191267205024,1.2921764888449925,0.0801068090787717,0.6349907051812931,1.0,23/137,7.36%,PTPRG;LIMCH1;DACH1;CLDN5;SRGAP3;SRGAP2;DAB2IP;SRGAP1;ENG;MCC;ADGRG1;PTPRJ;ADAM15;ACVRL1;EVL;DUSP3;SMAD7;HYAL2;RHOB;EPHA4;NEXMIF;PTPRR;BST2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5594555949642189,1.2919603380284894,0.18085106382978725,0.6345193249046054,1.0,6/18,6.20%,CD200;LRP8;PRKD1;PRKD2;CRTC1;RPS6KA5
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.4724548375367919,-1.2919431484668855,0.14898989898989898,0.5870507235601767,1.0,3/23,2.20%,TGFBR3;FGFR2;TPM1
prerank,response to X-ray (GO:0010165),-0.5412204733188413,-1.2916190659991178,0.18202764976958524,0.5862591075264713,1.0,5/14,12.49%,ANXA1;IKBIP;ATM;NUCKS1;XRCC5
prerank,negative regulation of developmental process (GO:0051093),0.44579924729948395,1.2913700386893079,0.13381294964028778,0.6350611016466658,1.0,9/69,3.84%,TFRC;NOS3;NOTCH4;ARHGEF15;TBX1;KLF7;NOTCH1;VASH1;RAPGEF3
prerank,regulation of programmed cell death (GO:0043067),0.39700898309782146,1.2908266294565456,0.06674757281553398,0.6356652168471486,1.0,22/161,9.05%,MECOM;HIP1;PPP1R13B;ACER2;FAS;TNFRSF25;LRP8;PHLPP1;JAK3;TGM2;ACTN4;TOX3;CRADD;STAT1;ACTN1;LCMT1;MARK4;BIRC3;PIDD1;TRIM24;BNIP3L;MALT1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.45334628837678165,-1.2902663377533832,0.16209476309226933,0.588289747828975,1.0,6/26,14.97%,ATP1A2;PKD2;THADA;GNB5;FMR1;GSTM2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6045929234372096,1.2899460649695447,0.20696324951644102,0.6371921961067152,1.0,2/13,1.57%,SHANK3;APP
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5383414152500561,1.289865161172197,0.18043844856661045,0.6363415976987123,1.0,5/22,8.89%,PDGFB;PDGFD;CALM1;MRE11;GREM1
prerank,negative regulation of hormone secretion (GO:0046888),0.6336060184349394,1.289387563491188,0.20938628158844766,0.6366072836967761,1.0,1/10,0.73%,RAB11FIP1
prerank,cell part morphogenesis (GO:0032990),-0.545574850316618,-1.2892533256740066,0.17701149425287357,0.5895301547921924,1.0,1/13,0.14%,PID1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4337295636698133,1.288820938263781,0.1378809869375907,0.6371512280375232,1.0,9/75,6.22%,PLCB1;RGS12;RGS3;RASGRP4;GIT2;PPP1R9B;CALM1;RAMP3;GNG7
prerank,Ras protein signal transduction (GO:0007265),0.3977104342822354,1.2887046910184674,0.07702523240371846,0.6364478240975124,1.0,33/137,10.22%,RASGRP3;ARHGEF3;RAPGEF2;NTN1;ELMO1;GRAP;PLEKHG5;ADGRG1;RAPGEF1;TIAM1;PRKD1;RAPGEF3;RIPOR1;GRB2;RREB1;EPS8;GNA12;RHOB;EPS8L2;CDC42EP3;SOS1;DBNL;RASGRP2;NCKAP1;RALB;RAP1B;RGL2;JUN;SHC3;ARHGAP4;PHACTR4;ARHGDIA;CYFIP1
prerank,regulation of transport (GO:0051049),0.48723470572946903,1.2885305495566115,0.16560509554140126,0.6358635905045938,1.0,12/36,14.78%,ICA1;FES;EPB41;ACTB;MYO6;RAB11A;ACTG1;REEP5;ARL6IP5;WWC1;DISP3;DNAJA1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.46404381118371985,1.287887037645843,0.1271860095389507,0.6367249208979633,1.0,14/54,17.70%,IVNS1ABP;CAV1;DCUN1D3;SMAD7;CTNNB1;N4BP1;COPS9;UBXN1;RPL11;TNFAIP3;DNAJA1;BAG2;SIRT7;PRKCG
prerank,regulation of neuron projection development (GO:0010975),0.3945514695859487,1.2875650095902171,0.09876543209876543,0.6365118944047407,1.0,35/163,11.65%,ITGA6;NDNF;MFSD2A;SHANK3;DAB2IP;EFHC2;RAPGEF2;SCARF1;FES;MBOAT1;RAPGEF1;PRAG1;CDH2;PRKD1;NTNG2;LYN;SNX3;EPHA4;CCDC88A;FUT9;CSMD3;RET;KIF1A;LRRC7;TWF2;PTN;SPOCK1;PAK1;SERPINI1;DISC1;PTK6;ACP4;ABI3;PLXNB3;GSK3A
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5562131987213073,-1.2870009221094934,0.17312072892938496,0.5945326022657877,1.0,3/12,8.01%,ROCK2;FLOT2;APOE
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.4711804208830775,-1.286695106438527,0.1561712846347607,0.5937426802816248,1.0,8/24,10.73%,IGF1;ENPP1;IRS1;IRS2;IGF2;SELENOS;PPP1R3B;PPP1R3C
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5297150419996268,1.2865696125316648,0.16447368421052633,0.6383312052942609,1.0,5/24,10.00%,AQP11;BCL2L1;NR1H2;UBXN1;LPCAT3
prerank,vesicle organization (GO:0016050),0.48041433584968474,1.2861211460476194,0.14393939393939395,0.6385699303219284,1.0,10/46,12.19%,CD34;CAV1;FNBP1L;ALS2CL;SRGN;DNAJC13;SORT1;CAV2;HOOK1;EPS15
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5331987643509906,1.2853174814365298,0.20411663807890223,0.6397274307936733,1.0,1/24,0.28%,POLK
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5355995315269517,-1.285127065192042,0.13777777777777778,0.5964923769612087,1.0,6/14,22.70%,CPEB1;CPEB2;YBX3;FMR1;RBM24;CPEB4
prerank,histone acetylation (GO:0016573),0.4478536982909731,1.2849473776665155,0.1278409090909091,0.6397555991684066,1.0,13/69,15.65%,LEF1;TRIM16;PHF20;YEATS2;BRCA2;KAT6A;JADE2;NAA60;BRD1;BRPF1;BRPF3;POLE3;TRRAP
prerank,negative regulation of cell activation (GO:0050866),0.5911932443852448,1.2849306377739822,0.20037453183520598,0.638714430723409,1.0,3/14,2.13%,PDGFB;NOS3;CD200
prerank,mitochondrial fission (GO:0000266),0.5820495717414366,1.284825888678305,0.2,0.6379817363568633,1.0,2/16,7.03%,DNM3;DNM2
prerank,synaptic vesicle endocytosis (GO:0048488),0.5065052439338257,1.2837902777492771,0.17886178861788618,0.6400019262765659,1.0,7/33,8.64%,DNM3;STX1A;ITSN2;PIP5K1C;DNM2;FCHO2;OPHN1
prerank,arachidonic acid secretion (GO:0050482),-0.5951035799926399,-1.283140076612735,0.17660044150110377,0.5990083768937413,1.0,3/10,8.12%,ANXA1;ACE;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.5951035799926399,-1.283140076612735,0.17660044150110377,0.5990083768937413,1.0,3/10,8.12%,ANXA1;ACE;BDKRB2
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5917917925818084,1.2830355783828846,0.2058287795992714,0.6411456854537054,1.0,3/13,4.51%,NOS3;DDAH1;NOS2
prerank,synapse organization (GO:0050808),0.4075335160060583,1.2820943133779468,0.09296482412060302,0.6429110992412532,1.0,23/125,10.22%,SPOCK2;DNM3;SHANK3;APBB2;APP;ADGRL3;UNC13B;AGRN;PLXND1;CDH2;PPFIBP1;DBNL;SLITRK3;CNTN2;GPHN;PIN1;SLITRK1;GPM6A;NRXN1;DNER;LRRC4B;ELFN1;CYFIP1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.49096147295564474,-1.281681034772064,0.13856812933025403,0.6016727540390118,1.0,4/18,14.75%,LBP;THBS1;TNIP2;TLR4
prerank,regulation of actin filament-based movement (GO:1903115),-0.5825422710065583,-1.2816745687431403,0.19222462203023757,0.5999972580126339,1.0,2/10,1.60%,ANK2;PDPN
prerank,gland development (GO:0048732),-0.3834369348284581,-1.2816289630140214,0.09846153846153846,0.5984276870295908,1.0,15/59,9.52%,TGFBR3;GLI2;WNT4;DKK3;FGFR2;COBL;SALL1;TGFBR1;PKD2;ANXA1;SIX1;IGSF3;MET;TGFB3;EZR
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4442789240596835,1.281332629132044,0.14165497896213183,0.644047894767538,1.0,9/67,5.88%,NDNF;UTRN;PDGFB;LIMS2;DOCK1;NEDD9;RREB1;CCR7;RSU1
prerank,protein trimerization (GO:0070206),-0.5310180113162887,-1.2813007748543905,0.18410041841004185,0.5960524715514656,1.0,3/14,5.18%,SCARA5;SLC1A5;CLYBL
prerank,protein homotrimerization (GO:0070207),-0.5310180113162887,-1.2813007748543905,0.18410041841004185,0.5960524715514656,1.0,3/14,5.18%,SCARA5;SLC1A5;CLYBL
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6246300922284762,1.2809562729087143,0.19165085388994307,0.6441172872866324,1.0,3/10,9.05%,SMAD7;FOXP3;MALT1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6035369309143357,1.2807918993257201,0.21042830540037244,0.6435188015754957,1.0,3/12,1.74%,SEMA6A;DAB2IP;XDH
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.4766299285707645,-1.280719078087816,0.16393442622950818,0.5961804864326878,1.0,11/23,25.22%,SELENOS;HSP90B1;SEC16A;SYVN1;AUP1;LMAN1;SURF4;SEC61B;DERL1;TMED9;UFD1
prerank,carboxylic acid catabolic process (GO:0046395),-0.5426539706656748,-1.280587442287852,0.1603563474387528,0.5949061886745347,1.0,8/12,29.12%,ACOT8;PON3;RENBP;NAGK;BCKDK;NPL;GNPDA1;IL4I1
prerank,endothelial tube morphogenesis (GO:0061154),0.6231537296467029,1.2803437469679868,0.20733944954128442,0.6437981815988295,1.0,7/10,12.99%,ACVRL1;PRKD2;STARD13;CTNNB1;RHOB;CCM2;CSNK2B
prerank,response to cAMP (GO:0051591),0.48895023815827815,1.2801752087842302,0.15517241379310345,0.6432022018002714,1.0,11/37,13.66%,PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;KCNQ1;STAT1;RAP1B;AKAP9;ZFP36L1;HCN2;AKAP6
prerank,fatty acid elongation (GO:0030497),0.5978523422252908,1.280051641387479,0.2171628721541156,0.6424996907220197,1.0,5/13,13.45%,ELOVL7;ELOVL5;ABCD1;ELOVL6;HACD2
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5427683846236258,1.2796896391713393,0.19039451114922812,0.6424994047300336,1.0,2/21,0.95%,MFHAS1;PPP1R16B
prerank,chemical synaptic transmission (GO:0007268),0.3777098875604185,1.2795593450721545,0.04861111111111111,0.6417720773484715,1.0,66/284,17.53%,MPZ;SLC1A1;CACNA1A;HCRTR1;SLC6A5;SLC6A2;UNC13B;STX1A;RPS6KA1;CALM1;PDE7B;SLC1A2;CDH8;CAMKK2;TBC1D24;SYPL1;SLC12A6;PRKACB;GRID2;ATXN3;HOMER1;STXBP1;CHRNB1;GABRB1;HTR2A;PRKAR2B;HCRTR2;GRIA4;KCNQ3;APBA2;NRXN1;AKAP9;PRKAR2A;DNAJC5;HSPA8;NPY5R;CHRM3;EXOC4;GRIN2B;SHISA6;GABRQ;PCDHB14;CPNE6;GRIK5;GRIK2;CPLX1;SDCBP;MINK1;GRIK1;MYCBPAP;SLC17A6;SYNJ2BP;GABRG1;HTR4;GRM7;ERC1;AMPH;NLGN1;FCHSD1;MAPK1;GABRG3;CRHBP;MBP;PMP22;GABRA1;SST
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.49910667282127175,1.2788573655069053,0.17944535073409462,0.6428194048099629,1.0,3/30,2.34%,SPTBN1;MACF1;RAB31
prerank,dendritic spine morphogenesis (GO:0060997),0.5736736814966548,1.2788409394965647,0.19708029197080293,0.6418103754630481,1.0,3/15,5.82%,SHANK3;WNT7A;DIP2A
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5065941701135874,1.277219822130009,0.17447495961227788,0.6456818805155978,1.0,6/29,16.15%,CADM1;NOS2;PVR;CD160;CYRIB;AP1G1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.37730906456650953,1.2769353992725219,0.06420927467300833,0.6454218600763196,1.0,40/234,11.71%,TFRC;PRKCH;APP;CAV1;TIRAP;NFKBIA;CD200;TRIM25;LRP8;TNFRSF11A;TRIM14;FZD4;ARHGEF2;RGCC;NOD1;CD40;NOD2;PRKD1;PRKD2;IKBKB;CTNNB1;PPIA;CRTC1;RPS6KA5;LGALS9;AIM2;BUD31;JMY;CRNN;ARHGEF5;PIDD1;IRAK2;MALT1;UBE2V1;AGER;LAMTOR5;S100A8;TNFSF11;PRKCB;ZBTB7A
prerank,cellular sodium ion homeostasis (GO:0006883),-0.530387880984436,-1.2768409949018165,0.1511627906976744,0.603988596860666,1.0,6/15,10.27%,ATP1A2;SLC12A2;ATP1B3;ATP1B2;SLC8A1;SLC9A1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4994267321333177,1.2767838554779056,0.16971713810316139,0.6448211085599466,1.0,2/34,3.20%,SLC7A5;NOD2
prerank,rRNA catabolic process (GO:0016075),0.5635534933711427,1.2759557168738918,0.22144112478031636,0.646078995279737,1.0,8/16,22.45%,DEDD2;TRIR;DIS3L;EXOSC10;XRN1;EXOSC9;PELO;EXOSC8
prerank,thyroid hormone generation (GO:0006590),-0.5734205830571766,-1.2756038518335775,0.203579418344519,0.6060488252544841,1.0,3/10,13.01%,CPQ;SLC5A5;FOXE1
prerank,platelet degranulation (GO:0002576),0.4074915616839162,1.2755343482578967,0.09466666666666666,0.646268621328163,1.0,21/118,9.65%,ABCC4;PECAM1;PDGFB;TGFB2;APP;LHFPL2;SRGN;SELENOP;VWF;LYN;TMSB4X;CALM1;CFD;ACTN4;CTSW;STXBP1;ACTN1;TGFB1;QSOX1;SCG3;CDC37L1
prerank,regulation of myelination (GO:0031641),0.5157566840209695,1.2752033740205782,0.16366612111292964,0.6461538421398699,1.0,6/25,9.55%,JAM2;PARD3;TNFRSF21;CST7;PTN;ZPR1
prerank,acidic amino acid transport (GO:0015800),0.5601938922442601,1.2751067628043373,0.1958041958041958,0.6454131672709764,1.0,2/17,0.40%,SLC6A6;SLC1A1
prerank,epithelial cell differentiation (GO:0030855),-0.35429216944409464,-1.2748656797212763,0.09712230215827339,0.6065508342891741,1.0,17/88,11.04%,FSTL1;MAF;FGFR2;BMP4;DAB2;SCUBE1;ANXA1;ANXA4;SIX1;FZD7;CNN3;GLI1;JAG1;KDM6B;BDH2;GATA6;TAGLN
prerank,regulation of exosomal secretion (GO:1903541),-0.49271559811029586,-1.274545270673741,0.15517241379310345,0.6058796366537763,1.0,5/19,7.96%,ATP9A;SMPD3;TSG101;PRKN;SDC4
prerank,negative regulation of locomotion (GO:0040013),0.5954715704815323,1.274519426682736,0.20964749536178107,0.64625439321852,1.0,3/12,8.04%,FRMD5;DUSP3;PIN1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5310199790621576,-1.2745103347297064,0.1981981981981982,0.6042869298671992,1.0,3/13,3.09%,CACNA1C;ANK2;GJA1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.553068184677676,1.2742616793756585,0.20236087689713322,0.6459326565939706,1.0,6/18,17.88%,CORO2B;CCT3;CCT5;CEP135;PTP4A3;CCT7
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3585725767981072,1.2741663011437014,0.02748414376321353,0.6451845018058282,1.0,106/532,14.05%,PLCB1;PDGFB;MAOA;BCL2L1;ADIPOR2;CXCL12;IL1R1;NFKBIA;IL6R;TNFRSF25;IFNAR1;TRIM25;LRP8;S1PR1;TNFRSF11A;INPP5D;STX3;B2M;PTPRJ;STX1A;NOD1;LAMA5;SP100;IFNAR2;FOXO1;JAK3;RAPGEF1;CD40;NOD2;PELI1;IL10RB;MAP3K8;TMSB4X;SOCS2;IRF2;IKBKB;ADAR;SAMHD1;GRB2;NOS2;OSMR;PITPNA;CD4;ST18;XAF1;PPIA;IRF9;ACTN4;FYN;SOS1;MAPK3;RPS6KA5;AIM2;MCL1;STAT1;PSMB3;HCK;IL13RA2;IRF5;RAP1B;BST2;IL4R;PSMD11;BIRC3;TGFB1;CXCR2;PSMC6;MSN;IRAK2;MAP3K3;LIFR;PSME2;CEBPD;SOCS5;EBI3;UBE2V1;ADAM17;MMP1;OASL;EIF5A;TALDO1;CNTF;TOLLIP;HSPA8;CCL1;PSMD8;TNFSF11;ADIPOR1;IL20RB;TNFRSF4;HIF1A;SYK;MID1;CEACAM1;PIK3CB;IL27RA;TNFSF12;IL15;IL7R;CSNK2B;POU2F1;FSCN1;CFL1;PLVAP;GPR75;PSMB10
prerank,positive regulation of histone methylation (GO:0031062),-0.46783726392026054,-1.2741081475554403,0.16666666666666666,0.6038347930992839,1.0,3/24,5.56%,AUTS2;OGT;CTR9
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4318187553477441,-1.2733261185658433,0.13972602739726028,0.604412258958813,1.0,9/38,12.08%,CACNA1C;ANK2;CAMK2D;CACNA2D1;KCNJ2;CACNA1G;CACNA1D;TRPM4;CACNB2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.501889607254586,-1.2732775952292292,0.15299334811529933,0.6029085480699861,1.0,5/15,17.88%,BMP4;SMO;SIX1;SIX4;PAX2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.573992798946948,1.27317412075209,0.21153846153846154,0.6470954668402238,1.0,2/15,3.26%,DDC;SMOX
prerank,positive regulation of cellular protein localization (GO:1903829),0.4380740983087418,1.2728874825490808,0.14104372355430184,0.6468991522369067,1.0,14/69,12.05%,TFRC;STX3;WWTR1;HSP90AB1;CARD10;CCDC88A;LIMK2;FYN;MARK4;TGFB1;ABCA7;LAMTOR5;FERMT2;ORMDL3
prerank,regulation of cholesterol storage (GO:0010885),0.5650165153373325,1.2728388782604465,0.19507908611599298,0.6460134144204652,1.0,6/15,14.14%,PPARD;SCARB1;ABCG1;NR1H2;PPARG;MSR1
prerank,central nervous system neuron development (GO:0021954),0.5727311116827298,1.2727339870007939,0.19848771266540643,0.6452375050140874,1.0,3/15,5.03%,RAPGEF2;B4GALT5;HSP90AB1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4328347532740232,1.2725603642144991,0.14182344428364688,0.6447133212728645,1.0,11/67,5.98%,MYO10;PPP1R16B;PODXL;CAV1;TBC1D14;TBC1D22A;TBC1D2;CCR7;USP6NL;TBC1D24;TBC1D5
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.4961438347733495,1.272527183617735,0.17696160267111852,0.6437787643573488,1.0,2/32,3.16%,PGLYRP1;DEFA6
prerank,cellular response to zinc ion (GO:0071294),0.573750312288534,1.2723218596181562,0.20517560073937152,0.6433037515068539,1.0,9/15,19.26%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;GLRA2
prerank,regulation of membrane repolarization (GO:0060306),0.5867857786905559,1.2722784410488548,0.21071428571428572,0.6424324016314436,1.0,6/13,13.66%,CAV1;NEDD4L;KCNQ1;KCNH2;AKAP9;AKAP6
prerank,sphingoid metabolic process (GO:0046519),0.5958727255132328,1.272248529732638,0.21937842778793418,0.6415059283254476,1.0,2/12,1.18%,SGPP2;DEGS2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.39438856433290603,1.2718927255669432,0.09113924050632911,0.6414735122698931,1.0,82/168,27.87%,CNOT6L;RPL38;MTPAP;RPL13;RPS29;RPL36A;RPL3;RNPS1;RPL27;RPSA;PAN3;EIF3E;RPS7;RPL9;RPL18;RPLP2;MAGOHB;RPL13A;CNOT9;PDE12;PAN2;HELZ2;RPS11;RPL8;DCP2;NCBP2;RPS27;RPL19;CNOT6;DXO;RPS9;ZFP36L1;DCP1B;RPL11;PNRC2;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;EXOSC10;NBAS;RPL17;RPL23;CNOT11;XRN1;RPL34;RBM8A;RPS18;EXOSC9;UPF2;XRN2;RPL21;PELO;RPS4X;RPL18A;NCBP1;RPS21;DCPS;RPL10A;EXOSC8;CNOT4;PABPC1;RPL24;RPL7A;RPL32;RPL4;UPF3B;UPF1;RPS2;ZC3H12A;RPS20;RPL6;RPS13;AGO1;RPS19;PPP2R1A;NBDY;RPL14;RPL26
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5777356417192652,-1.2718881104287083,0.2033898305084746,0.605209296121731,1.0,5/10,15.13%,DPYD;NT5E;UPB1;UPP2;NT5C1A
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.6179115014322742,1.271859488781266,0.19507575757575757,0.6405675258221002,1.0,3/11,4.69%,SLC19A3;NT5C3A;TPK1
prerank,positive regulation of lipid transport (GO:0032370),-0.5490508610131791,-1.2715194237481426,0.20175438596491227,0.6047595544371052,1.0,3/12,8.01%,LRP1;SPP1;APOE
prerank,positive regulation of DNA recombination (GO:0045911),0.5149125401731236,1.271464120763505,0.16474464579901152,0.6406967505104378,1.0,6/27,17.42%,TFRC;SHLD1;PRDM9;WDR48;ACTR2;FANCB
prerank,negative regulation of cell differentiation (GO:0045596),-0.31896233083274406,-1.270587851492142,0.03827751196172249,0.605812519819958,1.0,41/181,11.19%,RANBP3L;COL5A2;EGFR;LDLRAD4;ADAMTS12;COL5A1;EFEMP1;SMAD3;CRIM1;BMP5;BMP7;ENPP1;BMP4;ZFPM2;OSR1;SMAD6;ADGRV1;ABCA1;TGFBR1;SUFU;WNT9A;RORA;PPARA;CTR9;IGF2;DTX1;MEIS1;RUNX1T1;TMEM64;JAG1;YAP1;LRP3;SPRED1;TWIST2;ANKRD26;ITGAV;TRPM4;VASN;PTK2B;CHRD;PTHLH
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.54763035773805,1.2690970770613141,0.20466786355475763,0.6465560127807111,1.0,5/19,7.11%,TJP1;NOTCH4;RGCC;NOTCH1;NEXMIF
prerank,blood circulation (GO:0008015),-0.40025493764309505,-1.2689310993824645,0.13994169096209913,0.6089577401571769,1.0,18/49,13.67%,ROCK2;SERPING1;COL4A3;SGCD;ELN;MEOX2;MYOF;SCPEP1;GUCY1A1;ACE;BDKRB2;AGTR1;ADORA2A;ITGB1BP1;ADCY6;GCLC;HTR7;GUCY1B1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5812526058232041,1.2684064424266677,0.2099644128113879,0.6475465187788809,1.0,3/14,10.15%,TLR3;ZCCHC3;OASL
prerank,apoptotic process (GO:0006915),0.3748927011964316,1.2682300846560006,0.0842358604091456,0.64705562715174,1.0,23/203,6.76%,HIP1;SEMA6A;BCL2L1;TNFRSF19;APP;FAS;TBX1;PPARD;MAL;ELMO1;NFKBIA;TNFRSF25;MAGI3;FOXO1;ADAM15;ZBTB16;TNFRSF21;RHOB;PPIA;BIK;PAK5;CASP7;NCKAP1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6170588840516099,1.267914000134199,0.22990654205607478,0.6470020672286777,1.0,4/10,16.68%,CAV1;ANK3;KCNRG;SUMO1
prerank,replicative senescence (GO:0090399),-0.5482128773289754,-1.2670695481713148,0.18614718614718614,0.6127861583951222,1.0,5/12,23.64%,PLA2R1;ATM;SERPINE1;WNT16;ATR
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.39007215898071584,-1.2668254806133437,0.12605042016806722,0.6118826301293468,1.0,11/46,16.03%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;EMD;BAG3;PIK3R1;CAMK1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4775836799880136,-1.2668090421868803,0.18795180722891566,0.6086775407703089,1.0,3/21,2.10%,EYA2;EYA1;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4775836799880136,-1.2668090421868803,0.18795180722891566,0.6086775407703089,1.0,3/21,2.10%,EYA2;EYA1;EYA4
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5074762211215742,-1.2662543541904303,0.17096018735362997,0.6088544875345852,1.0,8/17,13.03%,NOTCH2;BMPR1A;BMP4;RBPJ;HEYL;JAG1;BMP2;SNAI1
prerank,sensory organ development (GO:0007423),-0.3875135403942277,-1.2649441242818253,0.12389380530973451,0.6110899198742505,1.0,8/51,6.50%,PBX1;SMOC1;RBP4;SH3PXD2B;FOXC1;PBX4;MEIS1;PBX3
prerank,regulation of endocytic recycling (GO:2001135),-0.5643315633052398,-1.264853471042226,0.2009132420091324,0.609741740589561,1.0,5/11,16.13%,ACTN2;ATP9A;EHD1;RAB11B;EHD2
prerank,regulation of stem cell proliferation (GO:0072091),-0.5081343046784856,-1.263471318834178,0.19305856832971802,0.6119708226171529,1.0,5/17,11.52%,FBLN1;GJA1;ACE;YAP1;KDM1A
prerank,erythrocyte development (GO:0048821),0.6092548842635591,1.2624728338261637,0.2300380228136882,0.6621804877028604,1.0,5/10,18.52%,ALAS1;ZBTB7A;NCKAP1L;LYAR;SH2B3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5220074459146401,1.2619957060686762,0.19148936170212766,0.6625489092843773,1.0,12/23,25.14%,NLRC5;HSP90AB1;STAT1;NR1H2;IRGM;PPARG;SUMO1;IFNGR1;PARP9;SOCS1;IFNGR2;PARP14
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6099063931088904,1.2618359753496748,0.22201492537313433,0.6619885396043258,1.0,6/11,13.39%,TBX1;CTNNBIP1;STAT1;LRP5;TGFBR2;SOX9
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5157354991804333,1.2617510777196301,0.19547657512116318,0.6612197110144482,1.0,4/27,6.88%,PRKCH;NFKBIA;ABCG1;NR1H2
prerank,cellular response to cytokine stimulus (GO:0071345),0.3614245732580361,1.2612840205437215,0.04640883977900553,0.6616147342240198,1.0,81/416,13.66%,LEF1;ST3GAL6;MAOA;LRCH1;BCL2L1;DAB2IP;PDE2A;CXCL12;IL1R1;IL6R;IFNAR1;LRP8;S1PR1;INPP5D;STX3;PTPRJ;ARHGEF2;STX1A;LAMA5;IFNAR2;FOXO1;JAK3;RAPGEF1;CD40;PTPN12;GBP7;GBP4;SIGIRR;GBP5;IL10RB;SOCS2;IKBKB;GRB2;NOS2;TNFRSF21;OSMR;HYAL2;CCR7;CD4;TCF7;FYN;SOS1;LGALS9;AIM2;MCL1;STAT1;HCK;IL13RA2;IRF5;IL4R;CRNN;TGFB1;IRGM;IRAK2;PTPN5;LIFR;CEBPD;SOCS5;EBI3;RPL13A;MMP1;PDE12;CNTF;HSPA8;CCL1;DUSP1;TNFSF11;GSK3A;IL20RB;HIF1A;SYK;PIK3CB;IL27RA;ZFP36L1;RO60;POU2F1;NPR2;SOX9;MT1X;FSCN1;AKAP6
prerank,brain morphogenesis (GO:0048854),0.5952838107928963,1.2612343333564806,0.20658135283363802,0.6607181079373728,1.0,1/12,0.50%,SHANK3
prerank,vasculature development (GO:0001944),0.5634437905720054,1.261163902633241,0.19005328596802842,0.6599107939308382,1.0,9/16,10.09%,BMPR2;NOTCH4;FLT4;ACVRL1;APLNR;FOXF1;FBXW7;SOX18;STRA6
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.37926084316713843,1.259941075651129,0.0815347721822542,0.6624186142231303,1.0,31/214,8.30%,TEK;SEMA7A;SEMA6A;MFHAS1;PDGFB;KDR;DAB2IP;RAPGEF2;PDGFD;APP;CNKSR3;TIRAP;PDE8A;FLT4;NOD2;NOTCH1;PRKD2;DUSP3;LYN;RAMP3;CCR7;CD4;MAPK3;FBXW7;LGALS9;PTPRR;HTR2A;ARHGEF5;PIN1;TGFB1;ABCA7
prerank,response to peptide (GO:1901652),0.4853047202823577,1.2598855377964049,0.1848341232227488,0.661540594712318,1.0,9/33,10.81%,CACNA1A;NOD2;RAMP3;FYN;STAT1;IRF5;EIF2B1;AGER;EIF2B2
prerank,synaptic vesicle cycle (GO:0099504),0.49890177182067,1.2596604621350764,0.18993506493506493,0.6611303500840631,1.0,8/30,15.74%,STX1A;WNT7A;PIP5K1C;SYT7;DNAJC5;CPLX1;SLC17A6;NLGN1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.43224952419030915,1.2591718744484963,0.15052160953800298,0.6615609338045377,1.0,16/66,15.03%,TRIM16;APP;NOD2;GBP5;CCR7;LGALS9;AIM2;P2RX7;MALT1;AGER;CASP8;HSPB1;TLR8;TNFAIP3;GIT1;INAVA
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.48534882513279026,-1.2588505679619575,0.17632850241545894,0.6238399679082295,1.0,1/19,0.34%,IGF1
prerank,establishment of epithelial cell polarity (GO:0090162),0.5344177321995168,1.2587733479759462,0.2009966777408638,0.6616811077654735,1.0,5/19,8.79%,CYTH1;PARD3;CYTH3;OPHN1;MSN
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3911892198913473,1.2586545771671966,0.08564231738035265,0.6610247241744238,1.0,17/152,6.60%,ADGRL4;ADGRE5;WASF2;ADGRL2;PDE2A;ADGRL3;S1PR1;ADGRG1;GNAI2;RAMP2;GNAQ;CALCRL;GNA12;RAMP3;PRKACB;INSL3;ADCY4
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.4359819261755735,-1.2586351986936728,0.1309823677581864,0.6228082138912377,1.0,7/32,5.34%,PID1;IGF1;ZBTB20;PRKAA2;NUPR1;PPARGC1A;PPARA
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5941394094131629,1.2585324350601341,0.22770398481973433,0.660375028858217,1.0,5/11,22.25%,CAV1;ADIPOR1;HGS;SH2B3;SOCS1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5793952777151701,1.2569617795050256,0.21951219512195122,0.663886907052376,1.0,4/13,16.98%,JAK3;PIGU;IL7R;CRLF2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.5271988912830569,1.2568784472005605,0.2058319039451115,0.6630920825789162,1.0,10/21,17.32%,NES;CTNNB1;DLL4;DCT;INSM1;DISC1;LRP2;DISP3;TOX;PROX1
prerank,regulation of DNA binding (GO:0051101),0.46661108308511207,1.2566508847285036,0.17746913580246915,0.6627086447179128,1.0,11/44,13.76%,LEF1;NFKBIA;PLAUR;SP100;JUN;TGFB1;ZBTB7A;PPARG;CSNK2B;EDF1;HMGB2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6021195606542888,1.2564524122165603,0.23308270676691728,0.6623109125207772,1.0,4/11,5.25%,CXCL12;NOD2;MERTK;CCR7
prerank,positive regulation of multicellular organismal process (GO:0051240),0.36647844320708534,1.2564129469607708,0.0655367231638418,0.6614294746711903,1.0,31/308,8.78%,LEF1;IGF1R;TFRC;PRKCH;PLCB1;EPAS1;PDGFB;CADM1;ADIPOR2;GATM;BMPR2;TGFB2;TRIM16;CAV1;B4GALT5;RGCC;UCP2;TIAM1;ZBTB16;RREB1;CTNNB1;WWTR1;OXTR;CCDC88B;SHLD1;YBX2;IL4R;TGFB1;ABCA7;PTN;NPR1
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.517109413412201,-1.2562214580992057,0.17303370786516853,0.6283228727077154,1.0,6/15,15.12%,LARGE1;MGAT3;RENBP;CHST3;CHST1;NAGK
prerank,potassium ion transport (GO:0006813),-0.3414683065894911,-1.2561917407207162,0.0933852140077821,0.6267684207585495,1.0,13/120,5.51%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNK5;KCNMB2;PKD2;SLC9A2;KCNJ2;ABCC9;ATP1B3;KCNQ4
prerank,water transport (GO:0006833),0.6035436589373177,1.2553541665255077,0.2383612662942272,0.6634743132271846,1.0,2/12,4.59%,AQP11;AQP7
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5747689362364038,1.255017514146739,0.21415607985480944,0.6634267278524613,1.0,5/14,19.73%,ENTPD1;ENTPD5;NUDT9;NUDT1;NUDT16
prerank,cellular response to cAMP (GO:0071320),0.48889659781939854,1.2546307763211253,0.1875,0.6635483890701808,1.0,10/30,13.66%,PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;KCNQ1;RAP1B;AKAP9;ZFP36L1;HCN2;AKAP6
prerank,regulation of apoptotic process (GO:0042981),0.34906199875167415,1.2543688694482604,0.015592515592515593,0.6632890115368555,1.0,82/676,9.05%,LEF1;IGF1R;TFRC;MCF2L;TEK;ITGA6;HIP1;RNF144B;ARHGEF3;TJP1;KDR;BCL2L1;DAB2IP;PPP1R13B;RASGRF2;ACER2;FAS;NET1;UNC13B;NFKBIA;SH3RF1;FLT4;TBX3;HIP1R;TNFRSF25;PLEKHG5;LRP8;PHLPP1;PLAUR;DCUN1D3;TNFSF10;ARHGEF2;PTK2;MEF2C;RYBP;KALRN;FOXO1;JAK3;FOXL2;RPS6KA1;TIAM1;ABR;TGM2;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;RHOB;CAT;CD38;MRE11;PPIA;ACTN4;GRID2;SOS1;ADAM10;TOX3;CRADD;MCL1;STAT1;HCK;RNPS1;ARHGEF12;DNM2;ACTN1;EGLN2;IRF5;LCMT1;JMY;JUN;BIRC3;ARHGEF5;RHBDD1;PIDD1;PRDM9;PREX1;ARHGEF7;TRIM24;GREM1;BNIP3L;MALT1
prerank,cellular metal ion homeostasis (GO:0006875),-0.3388678476917854,-1.254057986912403,0.0641025641025641,0.6313338732817307,1.0,16/102,8.19%,ATP1A2;SLC24A3;ANK2;ATP13A5;SLC41A1;STIM1;SLC8A3;SLC12A2;DMPK;ATP13A3;KCNJ2;ATP1B3;SLC8B1;ATP1B2;SLC8A1;PTH1R
prerank,regulation of cellular respiration (GO:0043457),0.5577441426315305,1.2539477646840758,0.2074468085106383,0.6634702853953857,1.0,4/17,8.05%,IFNAR1;IL10RB;NOS2;SHMT2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4038463094326265,1.2537122131382237,0.13212435233160622,0.6631215223349521,1.0,13/110,6.60%,ADGRL4;ADGRE5;ADGRL2;RAPGEF2;ADGRL3;S1PR1;ADGRG1;RAMP2;GNAQ;CALCRL;RAMP3;ADRA2B;ADCY4
prerank,anion transport (GO:0006820),0.4871698675476781,1.2537113501341364,0.19709208400646203,0.6621198281924523,1.0,4/33,2.53%,ABCG2;SLCO2B1;LRRC8B;LRRC8C
prerank,regulation of complement activation (GO:0030449),-0.4094669989384395,-1.2534676665623854,0.13850415512465375,0.631399678816343,1.0,4/40,2.01%,SERPING1;VTN;CD55;CFH
prerank,response to amyloid-beta (GO:1904645),0.4662865382907425,1.2531898445246334,0.15053763440860216,0.6625797221475513,1.0,7/44,6.25%,IGF1R;CACNA1A;APP;RAMP3;EPHA4;FYN;ATP1A3
prerank,negative regulation of protein catabolic process (GO:0042177),-0.4046291681448471,-1.2529122536048203,0.15721649484536082,0.631307874721082,1.0,10/40,11.30%,EGFR;TIMP2;TIMP3;PTPN3;MDM4;SNX12;FLNA;SNRNP70;AZIN1;IRAK3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.4626504386020523,-1.2527604884179235,0.1619718309859155,0.6300678929729998,1.0,5/24,5.39%,SULF1;CCBE1;SULF2;RORA;CYP1B1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5622269072310561,1.2524934734759476,0.21645796064400716,0.663557710051493,1.0,1/15,0.28%,TENT4A
prerank,protein phosphorylation (GO:0006468),0.3522055847303658,1.2524771398978018,0.04520990312163617,0.6625918221871453,1.0,100/478,15.40%,FLT1;IGF1R;PRKCH;TEK;ERG;PDGFB;KDR;INSR;DAB2IP;BMPR2;TGFB2;MAP4K2;APP;CDK17;FES;MAP4K3;FLT4;STK38;PKN3;PTK2;LIPE;SNRK;JAK3;RPS6KA1;ACVRL1;PRAG1;MAP3K1;PRKD1;STK10;PRKD2;CDK19;ZAP70;MERTK;LYN;FNIP2;PRKG1;IKBKB;SMAD7;PPP4R1;CREB1;MAST4;CAMKK2;PKN1;TLR3;EPHA4;LIMK2;PRKACB;PAK5;FYN;MAPK3;RPS6KA5;ADAM10;RET;AATK;EPHB4;PKN2;HCK;PXK;MARK4;TLR7;TGFB1;MARK3;MAP3K6;PAK1;MAP3K3;EIF2AK4;STK33;PTK6;TRIB2;PRKAB1;ABI3;STK32C;SLK;PRKCB;GTF2H4;GSK3A;SYK;MAP4K4;TGFBR2;EPHB1;HIPK2;CSNK2B;STK24;STK3;MINK1;PIM2;VRK1;SGK1;TBCK;CAMK2B;STK26;CTBP1;GRK6;NEK3;HIPK3;SRMS;ERC1;PLK2;SGK3;SGK2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.5230909228281735,-1.2524465009945316,0.19148936170212766,0.6293061929137446,1.0,7/14,21.13%,DPYD;NT5E;UPB1;UPP2;NT5C1A;UMPS;ERH
prerank,regulation of cell adhesion (GO:0030155),0.3985854264806168,1.252394178822567,0.11819389110225764,0.6618293197285369,1.0,30/129,11.99%,FRMD5;PODXL;CXCL12;FES;STX3;CYTH1;ADGRG1;PTPRJ;PTK2;PLXND1;SIPA1;ACVRL1;PRKD2;LYN;TGM2;CCR7;EPHA4;RSU1;ATXN3;ADAM10;RET;PKP4;EFNA1;PPP1CB;ARHGDIA;CBLL1;DUSP1;PLXNB3;PPP3CA;RND1
prerank,neuromuscular process controlling balance (GO:0050885),0.5901629252572469,1.2523553603062847,0.22242647058823528,0.6609492963848491,1.0,4/12,11.92%,PCDH15;NRXN1;CLRN1;CDH23
prerank,mitotic chromosome condensation (GO:0007076),0.49686468804530814,1.252211350043347,0.19078947368421054,0.6603853632175462,1.0,8/26,18.75%,TENT4A;NCAPH;MCPH1;NCAPG;CSNK2B;TTN;NCAPH2;SET
prerank,regulation of immune effector process (GO:0002697),-0.4081669426111737,-1.2521061461136853,0.15254237288135594,0.6286289459938394,1.0,4/41,2.01%,SERPING1;VTN;CD55;CFH
prerank,regulation of calcium ion transport (GO:0051924),-0.381421740081138,-1.2511049528964684,0.1305732484076433,0.6298657722469203,1.0,13/54,8.87%,ANK2;MYLK;STIM1;IL16;CACNA2D1;PKD2;EFHB;SLC8B1;P2RX4;BCL2;CACNA1D;TRPC6;SARAF
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5913655238761109,1.2510580273319993,0.22994652406417113,0.6627639825663929,1.0,3/11,7.93%,CAV1;NEDD4L;KCNH2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5403811756801059,-1.2509780765745833,0.2188235294117647,0.6285519691715677,1.0,6/11,14.53%,P4HA1;EGLN3;P4HTM;P3H2;OGFOD1;P4HB
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.34835577842226334,-1.2506345000900991,0.08992805755395683,0.6279892200097625,1.0,28/104,14.36%,BMPR1A;LDLRAD4;NBL1;SMAD3;CRIM1;BMPER;MAGI2;SMAD6;HTRA3;SNX6;TGFBR1;PPARA;RBPMS2;ASPN;SMAD9;EMILIN1;TGFB1I1;CD109;CCN3;SMURF2;PDPK1;SPRED1;VASN;CHRD;BMP2;SKI;HTRA4;SLC2A10
prerank,regulation of protein metabolic process (GO:0051246),0.47057910991036717,1.250336847382084,0.18086696562032886,0.6640243204451428,1.0,8/44,8.30%,LTBP4;APP;PLAUR;NEDD4L;KLF2;HSP90AB1;KLF4;ABCA7
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.57928866263949,1.2503130672293432,0.2116788321167883,0.6631191367793441,1.0,4/14,9.05%,TIRAP;CARD10;TLR3;MALT1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4643877846301972,1.2502975038118969,0.16978193146417445,0.662200089212688,1.0,9/41,9.89%,PDGFB;LRP8;NEDD9;EPHA4;FYN;FBXW7;EFNA1;TGFA;ADAM17
prerank,positive regulation of protein kinase activity (GO:0045860),0.39099171062477533,1.2493811358553848,0.11234567901234568,0.6638960337277039,1.0,29/148,13.54%,PDGFB;INSR;DAB2IP;TGFB2;RAPGEF2;IL6R;LRP8;NEDD9;PTK2;MMD;CALM1;HSP90AB1;CCR7;CD4;EPHA4;CCDC88A;PAK5;RALB;EFNA1;IRGM;IQGAP1;PAK1;PDCD10;RPTOR;MAP4K4;TGFBR2;MAPRE3;STK3;MINK1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5636026633279008,1.2491923450122224,0.22105263157894736,0.6634678204500654,1.0,8/15,26.07%,ARPC4;JMY;ARPC3;ACTR2;ARPC1B;ARPC2;ARPC5;WHAMM
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.43600087530482773,-1.249136418291048,0.1497005988023952,0.6307654982184902,1.0,10/33,13.57%,OGN;IGFBP5;TPM1;APOD;SOD2;IGFBP3;EFEMP2;TGFB3;MFN2;PTEN
prerank,response to glucagon (GO:0033762),-0.48894689757035825,-1.2488472097906032,0.18990384615384615,0.629976323727281,1.0,8/19,13.39%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6;CYSLTR2
prerank,glycine transport (GO:0015816),0.6159076791443141,1.2488191822569488,0.23954372623574144,0.6635653766996775,1.0,2/10,1.98%,SLC6A5;SLC38A5
prerank,positive regulation of protein polymerization (GO:0032273),0.4318533577860069,1.2488081980481887,0.14831130690161526,0.6626107055341375,1.0,24/65,21.32%,OCLN;FES;EVL;CLIP1;CCR7;CDC42EP3;BAIAP2;NCKAP1;HCK;CDK5RAP2;PAK1;AKAP9;RAC1;NCKAP1L;FCHSD1;NCK1;PRKCE;TENM1;BIN1;TPPP;DCTN1;CDC42EP1;CLASP1;BAIAP2L1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5090608316186096,1.2486175564029036,0.2157190635451505,0.6621593937324692,1.0,7/25,14.70%,ETS1;TAL1;STAT1;HIF1A;BRD1;HMGB2;NCKAP1L
prerank,negative regulation of response to stimulus (GO:0048585),0.4433619772493162,1.2481871311713506,0.16029411764705884,0.6623986907646223,1.0,15/60,10.12%,AQP11;CD34;DDAH1;KLF7;YBX1;LYN;KIF26A;KLF4;NR1H2;TERF2;FOXP3;MAP3K3;SOCS5;LPCAT3;PTK6
prerank,negative regulation of neurogenesis (GO:0050768),0.47476314217117327,1.2480888073615612,0.19155844155844157,0.6616957638259581,1.0,7/34,9.68%,RAPGEF2;B2M;NOTCH1;WNT7A;YWHAH;PTN;ARHGDIA
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5183733311949138,1.2478246006891913,0.20903010033444816,0.6604788036809763,1.0,8/23,17.11%,PPP1R13B;PPP3CC;YWHAH;YWHAQ;CASP8;PPP3R1;YWHAZ;YWHAB
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5183733311949138,1.2478246006891913,0.20903010033444816,0.6604788036809763,1.0,8/23,17.11%,PPP1R13B;PPP3CC;YWHAH;YWHAQ;CASP8;PPP3R1;YWHAZ;YWHAB
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3515858480381271,-1.247804226295652,0.0873015873015873,0.6314098001476498,1.0,17/80,15.71%,SAMD4A;PLD1;ROCK2;SLC2A13;THBS1;PRKCD;SMPD3;PLXNB2;SIRT3;FXR2;NSMAF;EIF3C;FMR1;DDX3X;CASP3;LARP6;YTHDF1
prerank,potassium ion transmembrane transport (GO:0071805),-0.3362346765034046,-1.2477958372937454,0.11504424778761062,0.6298514924973223,1.0,17/135,7.22%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNT2;KCNK5;SLC12A2;PKD2;SLC9A2;KCNJ2;ABCC9;ATP1B3;KCNQ4;SLC12A7;ATP1B2;KCNB2
prerank,positive regulation of biosynthetic process (GO:0009891),-0.40365535611774067,-1.2476274333851718,0.15013404825737264,0.6287252532716838,1.0,13/40,16.85%,ZBTB20;WNT4;BMP4;PPARA;APOE;CREB3L1;TGFB3;SLC5A3;CYBA;TLR4;LARP6;RUNX1;SUCO
prerank,regulation of axon regeneration (GO:0048679),0.5911190018606683,1.2475786035347225,0.22719141323792486,0.6602445398806389,1.0,6/12,13.36%,SCARF1;EPHA4;INPP5F;PTN;CNTF;STK24
prerank,diol biosynthetic process (GO:0034312),0.5525481446495881,1.2474618653141667,0.23550087873462214,0.6596407068837966,1.0,6/15,14.82%,ACER2;GCH1;ACER1;SPTLC2;SPTLC1;QDPR
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.47007070102862014,-1.2469865141100867,0.17782909930715934,0.629004579584594,1.0,2/22,1.81%,ALDH1A2;RBP1
prerank,rRNA metabolic process (GO:0016072),0.38277317081377865,1.2468199897361445,0.11153846153846154,0.660442073340653,1.0,69/160,28.18%,RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;DEDD2;PDCD11;RPL13A;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;NOL9;MRM2;RPL11;RPS15;TRIR;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;RPL37A;DIS3L;NOL8;LYAR;RPL15;RRP12;EXOSC10;RPL17;RPL23;XRN1;RPL34;WDR75;EXOSC9;XRN2;NVL;RPL21;DDX54;RPL18A;RPL10A;EXOSC8;RPL24;RPL7A;RPL32;RPL4;RPS2;TBL3;BYSL;RPL6;RPS19;HEATR1;RPL14;RPL26;DDX10;UTP4;SBDS
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.44300745165449124,-1.2464973368395607,0.18873239436619718,0.6287916760748765,1.0,14/27,25.66%,DDX5;PLA2R1;ATM;SPRED1;KDM1A;SNAI1;TWIST1;CD44;HIC1;KMT5A;ATR;YJU2;MSX1;SMYD2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.5056466234545047,-1.2464338723833153,0.22297297297297297,0.6274047724245085,1.0,2/15,1.85%,GLI3;CD55
prerank,potassium ion import across plasma membrane (GO:1990573),-0.40184074979959,-1.2463275125030326,0.15503875968992248,0.6261664022504191,1.0,11/41,15.79%,ATP1A2;SLC12A2;KCNJ2;ABCC9;ATP1B3;SLC12A7;ATP1B2;KCNJ13;SLC12A4;KCNJ8;KCNJ15
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.4651404308814081,1.24621491317742,0.171875,0.6611879389646584,1.0,10/39,9.22%,KDR;TIE1;ENG;RASIP1;NOTCH4;CTNNB1;DLL4;COL4A1;LRP5;PAK1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5890990239887267,1.24571766765649,0.22980251346499103,0.6616514667012787,1.0,6/12,21.73%,CTNNB1;AXIN2;CTCF;RAD21;DDX11;WAPL
prerank,positive regulation of response to external stimulus (GO:0032103),0.39262465253443574,1.2455700265780028,0.1400523560209424,0.6610814942904368,1.0,22/128,12.73%,ETS1;PDGFB;PDE2A;APP;SCARF1;NFKBIA;STX3;GBP5;HYAL2;MGST2;TLR3;ZCCHC3;TLR7;TGFB1;PTN;OASL;CNTF;CCL1;TLR8;S100A8;IL15;DDT
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.4986622332156304,1.245019284212679,0.19561815336463223,0.6617746597052198,1.0,10/30,13.45%,ELOVL7;TECRL;ABCD4;ACOX1;ACSL6;ELOVL5;ABCD1;ELOVL6;SLC27A2;HACD2
prerank,actin polymerization or depolymerization (GO:0008154),-0.3870323485758567,-1.2448161626260315,0.11849710982658959,0.629048407410718,1.0,10/50,7.33%,ARHGAP6;MICAL3;GAS7;GSN;MICAL2;COBL;SVIL;VILL;DIAPH1;ABI2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5304968375770727,1.244796191054619,0.2138047138047138,0.6614807020982244,1.0,2/22,1.74%,MFHAS1;XDH
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6057838875862827,1.2436977703017937,0.24431818181818182,0.6636431396365405,1.0,3/10,8.06%,LRCH1;CD200;CD200R1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5301473609527136,1.2435831966791087,0.21548821548821548,0.6630062461078498,1.0,5/20,15.22%,BCL2L1;FAS;MCL1;GSK3A;DCC
prerank,inhibitory synapse assembly (GO:1904862),0.5945359063861172,1.2434416989961843,0.22634508348794063,0.6624457430155394,1.0,6/11,25.87%,FGF13;GABRA1;GABRB2;GABRA2;CBLN4;GABRG2
prerank,epithelial to mesenchymal transition (GO:0001837),0.4526411912173881,1.2432022265317944,0.17262830482115085,0.6621846260500062,1.0,8/47,5.99%,LEF1;ENG;TGFB2;NOTCH4;TBX3;NOTCH1;CTNNB1;SNAI2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4689432293079053,1.2428706774199185,0.17674418604651163,0.6621691293669136,1.0,6/35,6.89%,DAB2IP;RASIP1;TGFB2;HEG1;STMN1;STMN3
prerank,histone modification (GO:0016570),-0.33622242818019854,-1.2427896136332215,0.10606060606060606,0.633439672004859,1.0,22/109,15.83%,EYA2;EYA1;EYA4;HDAC4;PRKCD;BAZ1B;EHMT2;TBL1XR1;MIER3;MAP3K12;KAT6B;SGF29;MORF4L2;HUWE1;USP3;SIRT2;PRMT8;BRD8;EP300;MRGBP;UBE2B;MTA3
prerank,negative regulation of heart contraction (GO:0045822),-0.5572284946167012,-1.2427862595463852,0.20915032679738563,0.6318877427700584,1.0,1/11,0.02%,ATP1A2
prerank,positive regulation of protein binding (GO:0032092),0.44387167818450046,1.2419934572001163,0.15441176470588236,0.6635814728891025,1.0,12/56,8.28%,CLDN5;RAPGEF2;APP;CAV1;HIP1R;B2M;EPB41;TIAM1;MEN1;RALB;PIN1;MARK3
prerank,protein targeting (GO:0006605),0.39496762064462376,1.2407367609627014,0.13581890812250333,0.6661379107584273,1.0,39/118,21.23%,AQP11;RASSF9;ZDHHC14;PARD3;PIKFYVE;TOMM22;ZDHHC9;ZDHHC20;ZFAND2A;ZDHHC19;SRP14;TIMM13;RTP4;AP1S3;ZDHHC18;ZDHHC22;TIMM10;AP4S1;DNAJC19;SPCS2;RPL11;SDCBP;NACAD;EDEM1;AKAP6;HACL1;MFF;NLGN1;RTP3;ZDHHC21;PEX16;TOMM7;VPS37A;MYO1C;LONP2;VPS37B;TOMM5;SPCS1;GABARAP
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.41578086381120305,1.240648744204849,0.1370851370851371,0.6654332594199777,1.0,26/86,18.12%,OCLN;APP;FES;EVL;VIL1;CLIP1;CCR7;CDC42EP3;BAIAP2;NCKAP1;HCK;CDK5RAP2;PAK1;AKAP9;RAC1;NCKAP1L;FCHSD1;EDN1;NCK1;TRPV4;PROX1;PRKCE;TENM1;BIN1;WDR1;COLGALT1
prerank,negative regulation of cell motility (GO:2000146),0.4008333109543283,1.24027449344323,0.13706293706293707,0.6654827586349003,1.0,15/108,5.52%,LIMCH1;DACH1;FRMD5;CLDN5;SRGAP3;SRGAP2;SRGAP1;ENG;PTPRJ;ADAM15;ACVRL1;DUSP3;SMAD7;RHOB;EPHA4
prerank,ear morphogenesis (GO:0042471),-0.46092093179140925,-1.2401720615299965,0.17560975609756097,0.6377905827850527,1.0,5/20,7.23%,ZIC1;FGFR2;OSR1;SIX1;EPHB2
prerank,miRNA metabolic process (GO:0010586),-0.4837820029442923,-1.2400247184910551,0.19471153846153846,0.6366046189167255,1.0,8/20,25.60%,TUT4;AGO2;XPO5;DDX17;BCDIN3D;TARBP2;PARN;DROSHA
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5314055104039737,1.2399839529274663,0.22182468694096602,0.665371485857458,1.0,3/17,2.51%,CAV1;APOLD1;KLF7
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4713401870251028,1.2399400497568396,0.19334389857369255,0.664548119834322,1.0,7/38,6.45%,INSR;CD34;CAV1;DDAH1;KLF2;HSP90AB1;KLF4
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.5124590682682806,-1.2398277545364615,0.22787610619469026,0.635609734065948,1.0,4/13,11.43%,CYFIP2;ASPH;PERP;TBC1D10A
prerank,protein localization to cell periphery (GO:1990778),0.39116629811565073,1.23973803426251,0.13421052631578947,0.6641758733366219,1.0,25/133,10.90%,EFR3B;BSG;SPTBN1;RAPGEF2;CAV1;TSPAN5;F11R;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;DENND4C;MAP7;STXBP1;RAB11A;FCHO2;RAB34;TMEM88;ZDHHC22;SMURF1;RAB3B;PACS1;EHD4;RAB40C
prerank,granulocyte chemotaxis (GO:0071621),0.4461482298163115,1.2397366127978535,0.17189835575485798,0.6632398404117645,1.0,10/55,11.85%,BSG;TGFB2;PIKFYVE;PIP5K1C;PPIA;PDE4B;CXCR2;CCL1;S100A8;SYK
prerank,response to ketone (GO:1901654),0.5052211663999436,1.2396697990366048,0.22895622895622897,0.6625151089852878,1.0,5/24,8.09%,ABHD2;TGFB2;CAV1;CCR7;TGFB1
prerank,canonical Wnt signaling pathway (GO:0060070),0.42419370309867094,1.2394796852986574,0.1635036496350365,0.6620927365478751,1.0,8/68,5.83%,LEF1;FZD6;CAV1;FZD4;WNT7A;CTNNB1;FRAT2;TCF7
prerank,atrial septum morphogenesis (GO:0060413),0.5905601318290334,1.2390495773980972,0.24909090909090909,0.6623875297634365,1.0,3/10,3.19%,BMPR2;TGFB2;ZFPM1
prerank,male gonad development (GO:0008584),0.4780202479155488,1.2390113371177547,0.1945337620578778,0.6615452995362958,1.0,6/34,10.83%,KITLG;TGFB2;BIK;COL9A3;NCOA4;LRP2
prerank,neuron projection extension (GO:1990138),-0.42356887862205195,-1.2386904902878757,0.19331742243436753,0.63725269222469,1.0,9/32,13.78%,ALCAM;AUTS2;IMPACT;ULK2;FLRT1;SPG11;PPP3CB;CDKL3;USP9X
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5092189663832467,1.238372823906255,0.21926910299003322,0.6624080391467885,1.0,2/24,2.72%,ABCG2;ALAS1
prerank,negative regulation of growth (GO:0045926),0.39051566272828814,1.236724796868774,0.13685636856368563,0.6660186368711843,1.0,30/121,13.52%,APBB2;BMPR2;TGFB2;SH3BP4;SOX17;DCUN1D3;PTPRJ;SMARCA2;ADAM15;SIPA1;ACVRL1;CCDC85B;NOTCH1;PPP1R9B;HYAL2;WFDC1;BST2;TGFB1;NPR1;BTG1;AGTR2;NAIF1;MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5825571880278002,1.236121035774247,0.24293785310734464,0.6668726334399904,1.0,2/12,1.96%,CSGALNACT1;FUT8
prerank,fatty acid transport (GO:0015908),0.5407575769352234,1.2360515570569781,0.2513089005235602,0.6661470812425934,1.0,2/17,1.88%,MFSD2A;PPARD
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.4714927948770454,1.2356928792202033,0.1848341232227488,0.6661946714397711,1.0,12/39,21.63%,POLK;NTHL1;GTF2H2;GTF2H4;FAN1;RBX1;RPA1;POLD1;GTF2H3;RFC2;DDB1;ERCC4
prerank,neuropeptide signaling pathway (GO:0007218),0.43569657713701004,1.235631783163338,0.17630057803468208,0.6654252264618566,1.0,14/58,19.26%,RAPGEF2;HCRTR1;NPPA;SORT1;SORCS1;HCRTR2;CYSLTR1;PPY;RXFP3;OPRD1;SSTR1;NTS;CPE;GLRA2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5555699457439134,1.2342166947874231,0.2420494699646643,0.6685012135225675,1.0,1/16,0.25%,ETS1
prerank,negative regulation of viral process (GO:0048525),0.43201787287212295,1.234184752131053,0.17925925925925926,0.6676570240289667,1.0,16/57,18.45%,TRIM14;IFIH1;BTBD17;PPIA;STAT1;N4BP1;BST2;BANF1;OASL;SLPI;ZC3HAV1;MBL2;TRIM26;PROX1;TNIP1;TRIM11
prerank,negative regulation of cell projection organization (GO:0031345),-0.39222596483802785,-1.2337550126306804,0.18128654970760233,0.6497554010959954,1.0,13/48,13.57%,DPYSL3;LPAR1;PTPN9;EFNB2;KANK1;PTPRS;APOE;CBFA2T2;STX1B;MYLIP;RAB29;ADCY6;PTEN
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.4579920670547596,-1.2335712196160336,0.18564356435643564,0.6486951769359162,1.0,7/22,13.75%,MDFIC;APOD;SUFU;ITGB1BP1;LRRK2;DMTN;LMAN1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5141939815998414,-1.2326796021625566,0.22,0.6498202566301212,1.0,3/13,8.74%,TNRC6A;AGO2;TNRC6B
prerank,autonomic nervous system development (GO:0048483),0.541104295951323,1.232050858489887,0.225130890052356,0.6728377325058617,1.0,5/17,12.63%,KIF26A;PHOX2A;PHACTR4;SOX10;SOX11
prerank,regulation of ERAD pathway (GO:1904292),0.5889396464947059,1.2314569814263903,0.2413793103448276,0.6735862648634358,1.0,5/11,19.23%,AQP11;ATXN3;UBXN1;BAG6;USP25
prerank,cardiac ventricle development (GO:0003231),0.5145509220206318,1.2313955183429888,0.22164948453608246,0.6728146981362556,1.0,6/20,10.09%,ENG;PDE2A;NOTCH1;DLL4;HECTD1;STRA6
prerank,carbohydrate homeostasis (GO:0033500),0.42496022829915714,1.2306868816571923,0.15994236311239193,0.6739880518415963,1.0,5/67,4.99%,IGF1R;INSR;ADIPOR2;KLF7;CYP11B1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5449480495620014,1.2304530071556201,0.23720136518771331,0.6737020346664101,1.0,6/17,12.47%,NTHL1;TERF2;SMUG1;ACD;MPG;TERF1
prerank,positive regulation of dephosphorylation (GO:0035306),0.49641302194378084,1.22938709831829,0.21122112211221122,0.6759428450460816,1.0,8/27,13.45%,PPP1R16B;CALM1;PPIA;PPP2R5A;PIN1;TGFB1;NSMF;CDH5
prerank,response to cytokine (GO:0034097),0.3827086940357979,1.2292225454943133,0.1274131274131274,0.6755230314056416,1.0,30/141,10.45%,LEF1;BCL2L1;APP;IL1R1;MAP4K3;IL6R;GCH1;TNFRSF11A;SP100;IFNAR2;JAK3;CD40;PTPN12;SIGIRR;ADAR;OSMR;CCR7;XAF1;ADAM10;LGALS9;MCL1;STAT1;BST2;CRNN;SHMT2;IRAK2;PTPN5;LIFR;KLHL20;CASP8
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.37386580880026765,1.228525501591308,0.140485312899106,0.676513807800474,1.0,29/158,11.70%,TFRC;TNFRSF19;TIRAP;PLEKHG5;TRIM25;TNFSF10;TRIM14;NOD1;CD40;NOD2;PELI1;PRKD1;ATP2C1;IKBKB;CCR7;CD4;LGALS9;BST2;BIRC3;MALT1;MAP3K3;NDFIP2;UBE2V1;SHARPIN;CASP8;BRD4;LAMTOR5;PRKCB;GPR89A
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5338783710942291,1.2282197770481065,0.2291296625222025,0.6764525310566751,1.0,5/19,4.57%,SEMA6A;JCAD;DAB2IP;XDH;TSPAN12
prerank,cellular response to amyloid-beta (GO:1904646),0.47856880990269596,1.2281281213254294,0.18441971383147854,0.6757585142882319,1.0,6/35,6.25%,IGF1R;CACNA1A;APP;EPHA4;FYN;ATP1A3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.44927156906772525,1.2280993739095911,0.20094936708860758,0.6749087517749515,1.0,8/43,8.09%,ETS1;PDGFB;TGFB2;PPARD;GATA2;KLF4;JUN;TGFB1
prerank,phagolysosome assembly (GO:0001845),0.5689033126121767,1.227969449977611,0.2523364485981308,0.6743218776543146,1.0,4/12,7.82%,PIKFYVE;SYT7;RAB34;RAB39A
prerank,activin receptor signaling pathway (GO:0032924),-0.49683258071930764,-1.227964882586586,0.20309050772626933,0.6620258250576091,1.0,7/15,30.22%,SMAD3;TGFBR1;ACVR1B;INHBB;INHBA;SMAD2;AMHR2
prerank,entry into host (GO:0044409),0.5669375808640184,1.22764285048664,0.24368231046931407,0.6744003088587087,1.0,6/13,10.31%,GRB2;CTNND1;CTNNB1;CD4;PPIA;CBLL1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.45780559562253487,1.2264855843265672,0.20251177394034536,0.6767933884672853,1.0,12/37,21.62%,ENTPD1;ENTPD5;DFFB;NUDT9;PPP1R8;SND1;NUDT1;RNASEH2C;NUDT16;XRN2;NCBP1;RNASE6
prerank,regulation of cellular protein localization (GO:1903827),-0.3827239161403319,-1.2263374547462385,0.1729106628242075,0.6651738208835946,1.0,5/45,4.60%,GPC6;PRKAA2;GPC3;GBF1;GPC4
prerank,regulation of embryonic development (GO:0045995),0.4818749825363719,1.2258215295254917,0.20064205457463885,0.6777909470173891,1.0,4/34,2.11%,PLCB1;INSR;B4GALT5;SOX17
prerank,T cell proliferation (GO:0042098),0.5773843286188275,1.2257316483164182,0.2478031634446397,0.6771285143965555,1.0,3/13,11.80%,CADM1;MSN;TNFRSF4
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.43400357085800884,-1.2252035315760743,0.215,0.6670032765452351,1.0,3/26,2.10%,EYA2;EYA1;EYA4
prerank,protein polyglutamylation (GO:0018095),0.5864260037762108,1.2249854227433932,0.2419047619047619,0.67833736982222,1.0,2/11,5.28%,TTLL7;TTLL5
prerank,stem cell development (GO:0048864),0.5524436426946715,1.2245890930114025,0.2176360225140713,0.6785382946157518,1.0,6/16,17.63%,CDH2;WNT7A;SNAI2;SOX11;PDCD6;KBTBD8
prerank,response to fatty acid (GO:0070542),-0.47601815744884735,-1.2244791094307523,0.2052505966587112,0.6675992135442637,1.0,2/17,2.41%,PID1;IRS1
prerank,negative regulation of proteolysis (GO:0045861),-0.4106277475444551,-1.224356818251729,0.1693548387096774,0.6663443112532043,1.0,9/34,13.65%,TIMP2;TIMP3;PTPN3;GAS1;SNX12;ECM1;CLN3;LRRK2;SERPINE2
prerank,regulation of defense response (GO:0031347),0.4161092176427828,1.2241934428125407,0.1839080459770115,0.6786682913813096,1.0,16/76,11.38%,SEMA7A;IL1R1;TIRAP;LRP8;BCL6B;NOD2;TMSB4X;SAMHD1;XIAP;HCK;N4BP1;BIRC3;NLRP6;CASP8;BRD4;USP18
prerank,positive regulation of lamellipodium organization (GO:1902745),0.47481507057293004,1.2239220428722557,0.21955128205128205,0.6785608979776099,1.0,11/32,11.43%,OCLN;WASF2;VIL1;RREB1;NCKAP1;TWF2;ARHGEF7;ENPP2;CYFIP1;CLRN1;RAC1
prerank,Golgi organization (GO:0007030),-0.3290060870348807,-1.2238928508950537,0.08,0.6661428372181499,1.0,43/112,24.15%,RAB30;GBF1;OBSL1;TANGO2;ARHGAP21;GOLGB1;FBXW8;FAM174B;DYNC2H1;GOLGA2;SEC16B;PI4K2B;STX5;COG4;CUL7;ARL1;HUWE1;LRRK2;GORASP2;PRMT5;ATP8B2;RAB29;ATP8B1;BCAS3;PLEKHM2;SEC16A;LMAN1;STX16;PLK5;SURF4;OPTN;BLZF1;GOLGA5;GOLGA8B;ATL3;TMED4;LMAN2L;SEC23IP;TMED9;MYO18A;UBXN2A;HTT;TJAP1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5851022238815142,1.2235603470357117,0.2646502835538752,0.678634084375469,1.0,4/11,8.89%,TGFB2;MEF2C;TGFB1;GREM1
prerank,regulation of immune response (GO:0050776),0.38644276200752825,1.2233694842021927,0.14120667522464697,0.678276893732037,1.0,26/135,12.66%,CD34;TGFB2;CLEC2D;TIRAP;CD200;LRP8;B2M;CD40;LYN;ICAM2;SAMHD1;CD19;PILRA;XIAP;PVR;N4BP1;CD160;BIRC3;CD200R1;FOXP3;CD8B;CASP8;DENND1B;KIR3DL2;SYK;IL15
prerank,cobalamin metabolic process (GO:0009235),0.535120682047148,1.2231884557382597,0.2376599634369287,0.6778589096141143,1.0,8/17,24.20%,ABCD4;AMN;MMAA;LMBRD1;TCN2;MMACHC;MMADHC;CD320
prerank,keratan sulfate biosynthetic process (GO:0018146),0.49253510901427444,1.223153566128334,0.2233502538071066,0.6770473120375503,1.0,5/26,4.22%,ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;B3GNT2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5164776922170691,1.2231514881200884,0.2328767123287671,0.6761366203414522,1.0,8/21,11.08%,PDE2A;XDH;HPRT1;PDE4D;HINT1;NT5C2;NUDT3;PNP
prerank,negative regulation of MAPK cascade (GO:0043409),0.40237488514257,1.2229146173628231,0.16689847009735745,0.6759350990408387,1.0,16/87,8.57%,SEMA6A;DAB2IP;CAV1;CNKSR3;STK38;PTPRJ;DUSP7;FOXO1;DUSP3;LYN;HYAL2;PPIA;PTPRR;PIN1;ABCA7;P2RX7
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.43939485223593655,-1.2227594913082962,0.18382352941176472,0.6677814850399902,1.0,11/26,19.78%,ADCY5;EFNA5;STXBP4;ANO1;CDK16;TRPM4;PPP3CB;STX4;NR1H4;PLA2G6;ADRA2A
prerank,microvillus organization (GO:0032528),0.5562199359902154,1.221586838261585,0.22759856630824374,0.6786922876701,1.0,5/13,14.58%,RAPGEF2;RAP1B;MAP4K4;MINK1;STK26
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3648844676306601,-1.2212555651654469,0.14375,0.6708427579337762,1.0,8/57,6.15%,LPAR1;ADCY5;ADCY1;ADCY9;AKAP12;ADCY2;ADCY7;FLNA
prerank,protein catabolic process (GO:0030163),0.42673120605729775,1.221219670099258,0.1915204678362573,0.6788327694362681,1.0,20/59,18.29%,DAB2IP;DENND3;OGA;NEU4;STT3B;UBE2G1;TRIM24;HSPA8;CEACAM1;FBXO6;MANBA;NEU2;CLN8;PSMA8;ATE1;UBE2G2;BAG6;USE1;FBXO2;SIAH1
prerank,urogenital system development (GO:0001655),-0.5404479624379132,-1.2194733660941328,0.24330357142857142,0.6745656952100536,1.0,3/11,7.23%,OSR1;ANXA1;EPHB2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.48594633420438194,-1.2194492890354245,0.21149425287356322,0.6730346587879483,1.0,6/17,10.12%,ATP1A2;CACNA1C;GJA1;ATP1B2;SLC8A1;PRKACA
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5238160844076103,1.219444925211567,0.21428571428571427,0.6828447595550752,1.0,6/20,13.17%,EPAS1;DCUN1D3;HSP90AB1;UBQLN1;HIF1A;DCUN1D1
prerank,proteoglycan biosynthetic process (GO:0030166),0.4819839482538808,1.219284096931403,0.20134228187919462,0.6823620272030944,1.0,4/31,2.89%,CSGALNACT1;BMPR2;EXTL3;CHST11
prerank,protein localization to plasma membrane (GO:0072659),0.3876604356807924,1.2191879800624281,0.1581769436997319,0.6817149430816679,1.0,25/129,10.90%,EFR3B;BSG;SPTBN1;RAPGEF2;TSPAN5;F11R;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;CCDC88A;DENND4C;MAP7;STXBP1;RAB11A;FCHO2;RAB34;TMEM88;ZDHHC22;SMURF1;RAB3B;PACS1;EHD4;RAB40C
prerank,ncRNA 3'-end processing (GO:0043628),-0.5077399377116752,-1.2189270990375327,0.23132530120481928,0.6729705968982339,1.0,9/14,37.23%,INTS8;INTS2;ERI1;TOE1;PTCD1;INTS6L;INTS5;SSB;ELAC2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.46681198351058306,1.2188030459066508,0.21337579617834396,0.681976722934917,1.0,11/37,21.63%,POLK;NTHL1;GTF2H2;GTF2H4;RBX1;RPA1;POLD1;GTF2H3;RFC2;DDB1;ERCC4
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.4968359205204872,-1.2185842455834033,0.2164705882352941,0.6724090582434777,1.0,2/13,3.28%,AXL;IL18
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.4771872659231565,-1.218317752021451,0.21158690176322417,0.6716515190438905,1.0,4/19,11.34%,IGF1;FLOT2;APOE;RTN1
prerank,regulation of protein processing (GO:0070613),-0.45591998667557687,-1.218313205369347,0.2141119221411192,0.6700817854291076,1.0,8/21,16.03%,CCBE1;GAS1;SNX12;CLN3;LRRK2;NKD2;SERPINE2;RUNX1
prerank,positive regulation of protein depolymerization (GO:1901881),0.5955721146021419,1.2181825628750647,0.25142857142857145,0.6827984128585393,1.0,4/11,18.01%,NES;VIL1;TRPV4;WDR1
prerank,positive regulation of embryonic development (GO:0040019),0.5191370697652893,1.217753276237546,0.23378839590443687,0.6831026709158525,1.0,2/19,2.10%,PLCB1;B4GALT5
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.4481655191213012,-1.217466764721752,0.20199501246882792,0.671126452621257,1.0,4/22,7.13%,UGGT2;MAN1C1;AMFR;MAN1A2
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4844188643147991,-1.2173705233822656,0.2288329519450801,0.6697808806269695,1.0,4/16,10.98%,PID1;PPARGC1A;PPARA;PARP1
prerank,negative regulation of apoptotic process (GO:0043066),0.3459988686456194,1.2172599683907566,0.08225108225108226,0.6836289518229686,1.0,59/444,10.86%,LEF1;IGF1R;TFRC;PRKCH;TEK;NDNF;RNF144B;TJP1;KDR;BCL2L1;CAV1;FAS;TBX1;NFKBIA;SH3RF1;FLT4;TBX3;PLAUR;PTK2;MEF2C;FOXO1;RPS6KA1;NOTCH1;MERTK;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;CAT;CD38;MRE11;SNAI2;MAPK3;ADAM10;KLF4;TOX3;RETREG1;MCL1;HCK;POU3F4;BIRC3;RHBDD1;PIDD1;PRDM9;GREM1;BNIP3L;MALT1;FOXQ1;ARHGDIA;PTRH2;KLHL20;PDCD10;MGMT;CNTF;THOC6;HSPB1;LRP2;LAMTOR5
prerank,negative regulation of cell growth (GO:0030308),0.3808846358959063,1.2165831312164301,0.15816993464052287,0.6846960132295487,1.0,22/121,10.36%,APBB2;BMPR2;TGFB2;SH3BP4;SOX17;DCUN1D3;PTPRJ;SMARCA2;ADAM15;SIPA1;ACVRL1;FGF13;CCDC85B;DIP2B;PPP1R9B;HYAL2;WFDC1;BST2;TGFB1;NPR1;BTG1;AGTR2
prerank,negative regulation of hydrolase activity (GO:0051346),0.43684065885466117,1.21650553796457,0.20121028744326777,0.6839984611582516,1.0,11/49,13.03%,LRCH1;DAB2IP;SH3BP4;F11R;FICD;CST7;TERF2;PLXNB3;HRAS;EGLN1;PPP1R35
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5062518693209603,1.215881628032477,0.2391653290529695,0.6848133443655358,1.0,8/24,19.97%,PECAM1;F11R;MSN;SYK;VCAM1;ITGA4;TNIP1;SEMA4D
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5388801089691246,-1.215665596358881,0.24568965517241378,0.6729014133477205,1.0,5/11,9.04%,WNT5B;RSPO3;DAB2;PLEKHA4;MLLT3
prerank,sterol transport (GO:0015918),0.5245194655668447,1.2151907197491536,0.244122965641953,0.6858718949473179,1.0,4/19,14.14%,CAV1;OSBP;NPC1;MSR1
prerank,nucleotide metabolic process (GO:0009117),-0.4415754076316787,-1.2148115159633213,0.1925,0.6738500488671918,1.0,4/23,5.27%,FHIT;NMNAT2;ME1;ENPP3
prerank,gluconeogenesis (GO:0006094),-0.39979215936234946,-1.213981933775369,0.16806722689075632,0.6747760611799439,1.0,12/39,22.43%,RBP4;SLC39A14;PPARGC1A;PER2;MDH2;GOT1;SLC25A12;ALDOA;ENO2;GOT2;ENO3;PGK1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5873628265727838,1.2136394619669622,0.2695984703632887,0.689396110336135,1.0,3/10,7.63%,DAB2IP;EPHA4;EFNA1
prerank,response to alcohol (GO:0097305),-0.4230856069678558,-1.2134663194758852,0.19559902200489,0.6747161200165299,1.0,3/27,3.86%,TGFBR3;SLIT2;TGFBR1
prerank,negative regulation of nuclear division (GO:0051784),-0.53182062086537,-1.213126551270711,0.25260960334029225,0.6741690232184041,1.0,6/11,22.74%,BMP7;BMP4;TOM1L2;NME6;AURKAIP1;TOM1L1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.38840268297291597,1.2129236240971233,0.18013245033112582,0.6906266578037783,1.0,25/114,15.92%,NFKBIA;TNFRSF25;TNFRSF11A;CD40;TMSB4X;IKBKB;ST18;ACTN4;AIM2;STAT1;PSMB3;PSMD11;BIRC3;PSMC6;PSME2;ADAM17;EIF5A;PSMD8;TNFSF11;TNFRSF4;TNFSF12;PLVAP;PSMB10;EDARADD;PSMA8
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3558902918287035,-1.2127197901522961,0.12292358803986711,0.6738099237403947,1.0,18/79,9.03%,SULF1;BMPR1A;ADAMTS12;NBL1;CRIM1;BMPER;SLIT2;SMAD6;HTRA3;SULF2;CASK;THBS1;FGF2;RBPMS2;SMAD9;EMILIN1;SMURF2;CREB3L1
prerank,positive regulation of inflammatory response (GO:0050729),0.3998530951321976,1.212459262881802,0.16288951841359772,0.6910257203586734,1.0,13/86,12.73%,ETS1;PDE2A;APP;NFKBIA;OSMR;HYAL2;MGST2;TLR3;TLR7;CCL1;S100A8;IL15;DDT
prerank,endothelial cell differentiation (GO:0045446),0.5805260517089577,1.212374874000059,0.2593283582089552,0.6903721040941564,1.0,5/12,7.19%,KDR;TIE1;BMPR2;ACVRL1;SOX18
prerank,endocardial cushion morphogenesis (GO:0003203),0.5250004874151356,1.2120645487569763,0.24731182795698925,0.690328736082047,1.0,5/18,3.41%,ENG;TGFB2;NOS3;ACVRL1;NOTCH1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5825791558715072,1.2118948062163226,0.2689393939393939,0.6898936616303849,1.0,2/10,5.97%,RNF125;SEC14L1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3723867001342942,1.2113630034761875,0.16091954022988506,0.6904726002366858,1.0,26/182,6.45%,SLC7A5;OCLN;CLDN5;PDGFB;KDR;CD34;ENG;TGFB2;APP;XDH;MEF2C;ANKRD13A;ACVRL1;APLNR;RIN3;NOTCH1;NOS2;GATA2;NOCT;DLL4;HSP90AB1;DIP2A;ADAM10;FBXW7;LGALS9;KLF4
prerank,protein polymerization (GO:0051258),-0.3714744603237905,-1.2111983032800673,0.16666666666666666,0.6767743440634086,1.0,9/55,9.18%,ARHGAP6;GAS7;GSN;COBL;HDGFL3;DIAPH1;PRKN;RNF135;MAP7D3
prerank,protein O-linked mannosylation (GO:0035269),0.5246627846104938,1.2111886997954797,0.2430939226519337,0.6900650645864084,1.0,1/18,0.08%,TMTC2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4796987651137851,1.2109946378431364,0.24444444444444444,0.6896838206385594,1.0,1/31,0.15%,TFRC
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5165282405815448,-1.2099549402631706,0.2570093457943925,0.6789258735462832,1.0,2/13,1.89%,GLI2;BMP4
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5642111655592035,1.209756418682045,0.24067164179104478,0.6922944381719021,1.0,7/14,10.41%,MMRN2;NOTCH1;STARD13;DLL4;CARD10;KLF4;PDCD10
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5337092124997095,1.2097382612398784,0.26481481481481484,0.691446549685854,1.0,8/16,27.42%,CAV1;INPP5F;ADIPOR1;HGS;SH2B3;SOCS1;PARP14;PPP2R1A
prerank,negative regulation of viral genome replication (GO:0045071),0.45476031378100296,1.2094243239705478,0.20923076923076922,0.6914669652699545,1.0,13/40,18.09%,IFIH1;BTBD17;N4BP1;BST2;BANF1;OASL;TASOR;SLPI;SETDB1;ZC3HAV1;HMGA2;PROX1;TNIP1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.45293384669684134,-1.2092190916597092,0.2199074074074074,0.679499585652294,1.0,13/21,30.58%,DCDC2;SMO;GLI1;EVC;ARMC9;KIF7;SFRP1;TTC23;STK36;PDCL;TXNDC15;SHH;ULK3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5724937903173117,1.2092106811202723,0.28,0.691134742144367,1.0,4/11,6.44%,FAS;PLAUR;ST18;LGALS9
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5647701703982528,1.2090051563967852,0.26014760147601473,0.6908310805918061,1.0,1/14,0.33%,SEMA7A
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5620253147346336,1.2084542522576425,0.27697841726618705,0.691467306167893,1.0,4/13,7.16%,CAV1;CALM1;PDE4D;SRI
prerank,B cell differentiation (GO:0030183),0.4471020809710272,1.2084072768667027,0.20458015267175572,0.6906851988865532,1.0,16/46,17.84%,TPD52;PTPRJ;JAK3;HDAC9;HHEX;SLC25A5;CD79A;KLF6;ADAM17;ZBTB7A;VCAM1;HDAC5;DNAJB9;MSH2;ITGA4;ADGRG3
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5298199775175076,1.208358068416073,0.25215889464594127,0.689920887268104,1.0,9/18,20.23%,SAMHD1;OGA;NEU4;STT3B;FBXO6;MANBA;NEU2;FBXO2;AOAH
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5016916470703388,-1.2081838219500745,0.25165562913907286,0.6810254494810754,1.0,4/14,4.34%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,protein neddylation (GO:0045116),0.5545572425143561,1.2077224214516624,0.24199288256227758,0.6907513029255505,1.0,4/13,14.26%,DCUN1D3;UBA3;DCUN1D1;RBX1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4540296260032497,1.2068844955329725,0.24673202614379086,0.6922425695794269,1.0,3/35,2.84%,FAR2;FASN;HMGCS2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5176846251922755,1.2060961240509689,0.26352530541012215,0.6936056621543161,1.0,6/19,11.01%,IFIH1;TLR3;STAT1;IRF5;TLR7;TLR8
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.4576901329758319,-1.206073572441846,0.20785219399538107,0.6856280017228268,1.0,5/20,18.64%,WNT4;C1QTNF3;EP300;BCKDK;NCOR1
prerank,negative regulation of catabolic process (GO:0009895),-0.3794758658183237,-1.2060507931140207,0.17015706806282724,0.6841411501830659,1.0,10/47,13.67%,EGFR;NUPR1;HDAC4;MDM4;SNX12;PPARA;FLNA;AZIN1;IRAK3;SIRT2
prerank,cellular response to interferon-gamma (GO:0071346),0.40077616198526833,1.2059389287843691,0.1874125874125874,0.693157795981316,1.0,17/88,11.89%,TRIM25;B2M;SP100;GBP7;GBP4;GBP5;IRF2;IRF9;LGALS9;STAT1;HCK;IRF5;RPL13A;OASL;PDE12;CCL1;MID1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.44554644686319783,-1.2057786996727455,0.24705882352941178,0.6834267860322635,1.0,5/22,8.92%,NOTCH2;FGFR2;CASK;STXBP4;SRSF6
prerank,negative regulation of mitochondrion organization (GO:0010823),0.472627634519902,1.2054358635276718,0.24838709677419354,0.6936612779133108,1.0,5/33,10.14%,TFRC;BCL2L1;SLC25A5;VAT1;GHITM
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.4796656304673628,1.2052604598211085,0.22937293729372937,0.6932092802557308,1.0,4/29,5.03%,IFNAR2;NLRC5;SAMHD1;HSP90AB1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5849049649866699,1.2041403908690178,0.2629558541266795,0.6955248764851913,1.0,5/10,22.39%,SVIP;DERL2;UBAC2;UBE2G2;UBE2J1
prerank,positive regulation of programmed cell death (GO:0043068),0.34899635073580904,1.204020526843897,0.11507479861910241,0.6949572298906972,1.0,37/272,8.96%,MCF2L;ITGA6;ARHGEF3;DAB2IP;RASGRF2;FAS;NET1;UNC13B;HIP1R;PLEKHG5;DCUN1D3;TNFSF10;ARHGEF2;RYBP;KALRN;FOXO1;FOXL2;TIAM1;ABR;TGM2;NOS2;CTNNB1;RHOB;SOS1;CRADD;RNPS1;ARHGEF12;DNM2;IRF5;JMY;MARK4;JUN;ARHGEF5;PIDD1;PREX1;ARHGEF7;BNIP3L
prerank,regulation of erythrocyte differentiation (GO:0045646),0.46535300738375096,1.203769041976284,0.253125,0.6947689062812712,1.0,10/35,14.70%,ETS1;ZFPM1;LYN;TAL1;STAT1;HIF1A;ZFP36L1;BRD1;HMGB2;NCKAP1L
prerank,positive regulation of insulin secretion (GO:0032024),-0.4088870080157774,-1.2035132543029305,0.18051575931232092,0.6886589557431579,1.0,9/36,11.28%,MCU;NLGN2;RBP4;IRS2;NNAT;ANO1;TRPM4;AACS;PPP3CB
prerank,cognition (GO:0050890),0.43769163400979827,1.2033732678981517,0.23390894819466249,0.6949454782972878,1.0,7/42,10.22%,MFSD2A;SHROOM4;APP;GPR155;FAM107A;STRA6;CYFIP1
prerank,inorganic cation transmembrane transport (GO:0098662),-0.29324681205677494,-1.2032780143075514,0.0547945205479452,0.687884435677165,1.0,31/268,5.61%,ATP1A2;SLC24A3;TRPM3;CACNA1C;KCNK2;NALCN;SLC6A13;SLC1A3;SLC41A1;SCN7A;SCARA5;SLC6A12;PKD1;SLC30A10;KCNK5;SLC8A3;SLC6A9;SLC12A2;ANO6;SLC39A14;PKD2;SLC9A2;KCNJ2;TRPC3;CACNA1G;ABCC9;ATP6V0A4;TRPM6;ATP1B3;KCNQ4;SLC6A1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5404618381559638,1.2027555942179498,0.2809611829944547,0.6957238577821409,1.0,9/15,24.76%,ZFAND2A;SRP14;SPCS2;EDEM1;SPCS1;RAB3GAP1;RYR2;SRPRA;ZFAND2B
prerank,synaptic vesicle recycling (GO:0036465),0.46958193490575884,1.2027235387230155,0.24213836477987422,0.6949389609174268,1.0,10/31,15.89%,STX1A;WNT7A;PIP5K1C;TBC1D24;SYT7;FCHO2;OPHN1;AMPH;NLGN1;SYNJ1
prerank,B cell receptor signaling pathway (GO:0050853),0.4665601993147828,1.2026505428347798,0.24222585924713586,0.6942387488185691,1.0,11/32,16.40%,MEF2C;CD19;CD38;PLEKHA1;CD79A;PRKCB;SYK;SH2B2;RFTN1;NCKAP1L;LAT2
prerank,protein localization to membrane (GO:0072657),0.36572967616602287,1.2026379516180565,0.14532019704433496,0.6933919469892821,1.0,35/187,11.87%,EFR3B;BSG;SHANK3;SPTBN1;RAPGEF2;CAV1;TSPAN5;F11R;AGRN;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;DENND4C;ABHD17A;MAP7;STXBP1;LRRC7;RAB11A;FCHO2;RAB34;TMEM88;PTN;NRXN1;NPC1;ZDHHC22;SMURF1;RAB3B;PACS1;EHD4;RAB40C;FERMT2;NUP54;SH3GLB1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3771022810363359,-1.2024251731164703,0.1729106628242075,0.6889131261408618,1.0,8/45,4.67%,BMP6;BMPR1A;BMP5;BMP7;BMP4;TGFBR1;TWSG1;DAB2
prerank,cellular component assembly (GO:0022607),0.3558522203644815,1.2022958298145325,0.12515337423312883,0.6935034307305139,1.0,60/253,17.36%,OCLN;SLC2A1;PARVB;SPTBN1;LIMS2;SHROOM1;FAS;MAGI1;NEDD9;CD40;PARD3;CD2AP;PLS3;ACTB;VIL1;WNT7A;EPS8;CARD10;RP1;BAIAP2;ABCA3;FAM107A;PARVG;NCKAP1;CLDN14;TTLL3;TGFB1;OPHN1;QSOX1;CAPG;ACTG1;RSPH4A;CYFIP1;DCX;PDCD10;FERMT2;ACD;PEX14;RAC1;FSCN3;CHAF1A;RANBP9;RSPH1;SOX9;FSCN1;FOXJ1;RHOV;SH3BGR;NCKAP1L;ELOB;NLGN1;APC;HAS3;CHAF1B;ANK3;GAS6;IL1RAP;YWHAZ;RAD21;BAG6
prerank,striated muscle contraction (GO:0006941),-0.3644400913947053,-1.2019517360901337,0.167192429022082,0.6886643359676733,1.0,10/53,16.46%,ATP1A2;TPM1;DMD;SLC8A1;GAA;ARHGEF11;DTNA;STAC3;TNNT3;ALDOA
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4775372480579614,1.2014901598235705,0.24310344827586206,0.6948771218277535,1.0,6/29,11.00%,CXCL12;JAM2;CCR7;LGALS9;AGER;CCL1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4577774446988716,-1.2014447221735296,0.23732718894009217,0.6886829879751656,1.0,8/19,16.85%,WNT4;BMP4;EMILIN1;CREB3L1;TGFB3;LARP6;RUNX1;SUCO
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5766964141404741,1.2013090832534905,0.29704797047970477,0.6944877357359999,1.0,6/11,20.96%,PLAUR;LYN;TNFSF11;SYK;ANK3;RDX
prerank,regulation of AMPA receptor activity (GO:2000311),0.48030425249560876,1.201249635257266,0.24671052631578946,0.693793822904694,1.0,6/25,15.74%,SHANK3;MEF2C;SHISA6;CNIH3;MINK1;NLGN1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4970437561431701,1.2008448982828672,0.25901639344262295,0.6940811549558686,1.0,6/25,10.36%,INSR;DDAH1;KLF2;HSP90AB1;KLF4;AGTR2
prerank,cellular response to glucose stimulus (GO:0071333),0.4746855757534208,1.200502162928544,0.23622047244094488,0.6941539283120687,1.0,2/30,2.00%,IGF1R;UNC13B
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5874741428906994,1.200413605329437,0.2807017543859649,0.6935359613262337,1.0,5/11,24.10%,NPPA;AKAP6;KCNIP2;ALG10B;LRRC55
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.46396292350112917,1.200058367246929,0.24121405750798722,0.6935811410328147,1.0,8/33,14.70%,ETS1;FES;TAL1;STAT1;HIF1A;BRD1;HMGB2;NCKAP1L
prerank,response to interferon-alpha (GO:0035455),0.5347902785246129,1.1998912564322604,0.263254113345521,0.6931657214046415,1.0,8/16,16.47%,IFNAR1;IFNAR2;ADAR;BST2;KLHL20;PDE12;RO60;GAS6
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5022041408632199,1.1997318366384253,0.24416517055655296,0.6918506982329578,1.0,6/22,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5022041408632199,1.1997318366384253,0.24416517055655296,0.6918506982329578,1.0,6/22,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,axoneme assembly (GO:0035082),0.4675544388164018,1.1994236520373491,0.24483306836248012,0.6918113553487216,1.0,10/30,17.66%,RP1;TTLL3;DRC1;RSPH4A;DCX;DNAAF2;RSPH1;FOXJ1;DNAAF3;TTC12
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3825086992834886,-1.1985984423837555,0.20273972602739726,0.6957379303278833,1.0,15/43,12.61%,BMP6;IGF1;BMPR1A;WNT4;BMP7;BMP4;RUNX2;CCN1;YAP1;CCN4;LRP3;FBN2;IFITM1;BMP2;NPNT
prerank,positive regulation of translation (GO:0045727),-0.3279524650146615,-1.198476623202073,0.1407942238267148,0.694588128283203,1.0,39/94,29.51%,SAMD4A;PLD1;THBS1;PLXNB2;AGO2;YBX3;FXR2;MRPS27;RMND1;EIF3C;FMR1;HABP4;DDX3X;LARP6;YTHDF1;JMJD4;RPUSD4;C1QBP;RCC1L;USP16;RPS6KB1;FASTKD3;CIRBP;PIWIL2;FASTKD2;EIF4A3;BCL3;RPS27L;POLDIP3;ERBB2;CDC123;HNRNPD;LARP4;MPV17L2;RPUSD3;VIM;BOLL;DHX36;EIF5A2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4049337381776461,-1.1980617945800947,0.2222222222222222,0.694311424585501,1.0,15/35,22.39%,DDX5;PPARGC1B;AR;NR3C2;YAP1;UBR5;DDX17;ESR1;PGR;CALCOCO1;RNF14;ZMIZ1;ESR2;NEDD4;GPER1
prerank,cell proliferation in forebrain (GO:0021846),-0.5322946104767852,-1.1980488568057628,0.24423963133640553,0.6928055954830802,1.0,4/10,13.87%,DOCK7;NUMBL;PCM1;AKNA
prerank,T cell receptor signaling pathway (GO:0050852),0.37766818403212893,1.1973487817860435,0.16047745358090185,0.6967054172427062,1.0,45/138,23.35%,INPP5D;PTPRJ;PRKD2;ZAP70;PLCG1;IKBKB;PDE4D;TNFRSF21;MOG;CD4;FYN;PSMB3;PSMD11;PDE4B;PSMC6;MALT1;PAK1;PSME2;EIF2B1;EIF2B2;DENND1B;PSMD8;PIK3CB;PSMB10;BCL10;RFTN1;LCP2;CARD11;PSMA8;NCK1;PAK2;SKP1;PSMD9;SPPL3;SKAP1;RBCK1;FYB2;PLCG2;CUL1;PSMC3;PSMD1;TRAT1;PSMD10;TRAF6;NFKBID
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.3824848012679533,-1.197334297205761,0.209366391184573,0.6933960222233324,1.0,6/44,5.81%,PRKAG2;CYP7B1;INSIG2;CYP27A1;PER2;ACOT8
prerank,protein mannosylation (GO:0035268),0.49946513101553225,1.1973078975055265,0.2580071174377224,0.6959464359478819,1.0,1/22,0.08%,TMTC2
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3629804682277839,-1.1973014575962446,0.16339869281045752,0.6919531770149827,1.0,13/59,11.96%,EGFR;PDGFRA;TPM1;MAP3K5;IMPACT;PRKCD;PKD2;ANXA1;CYP1B1;FXN;CHUK;MPV17;ABL1
prerank,protein targeting to membrane (GO:0006612),0.39805730633439373,1.1968238458504037,0.18775510204081633,0.6964211763234608,1.0,25/83,19.69%,AQP11;ZDHHC14;PARD3;SEC62;PIKFYVE;ZDHHC9;ZDHHC20;ZDHHC19;SRP14;SGTB;RTP4;ZDHHC18;ZDHHC22;ABCD1;PEX14;GET3;SDCBP;NACAD;RTP3;ZDHHC21;PEX16;VPS37A;ABCD2;ACBD5;MYO1C
prerank,regulation of cell differentiation (GO:0045595),0.3692141086573199,1.1966223761875403,0.16839378238341968,0.6961284904529954,1.0,20/148,9.60%,SPOCK2;SLC6A6;LTBP4;NOTCH4;FES;TBX1;BCL6B;PTK2;RPS6KA1;TIAM1;SMAD7;HSP90AB1;SNAI2;KLF4;INSM1;TGFB1;YWHAH;CDK5RAP2;GREM1;CEBPD
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.26965615334330156,-1.1965942167039092,0.020833333333333332,0.6926360611932458,1.0,126/572,16.57%,BMP6;FOXP2;PRDM6;FHL2;ZEB2;NR2F2;AEBP1;GLI3;RARB;GLI2;ZFHX3;GLIS3;SMAD3;FOXP4;FGFR2;BMP4;KANK2;ZFPM2;OSR1;DDX5;FNIP1;NR6A1;THRB;FRK;HDAC4;CUX1;MXI1;PER3;WWOX;SALL1;IMPACT;NR1D2;ZHX2;FOXC2;DNMT3A;FOXC1;BCOR;KCNIP3;SUFU;RBPJ;HOXA7;DAB2;EHMT2;TBL1XR1;MIER3;MDM4;AR;DLG1;PER2;PHF21A;GLIS2;PPARA;CTR9;ZNF25;ZMYM5;BCL6;CBX7;IGF2;DACT1;ZEB1;ZNF568;LCOR;NFATC4;ATN1;CHD3;CHD8;PRKN;CBX5;MITF;YAP1;KDM2B;MED25;POU6F1;SMURF2;USP2;FOXO3;CXXC5;PCGF2;EZR;CEBPB;EZH1;GATA6;NR2F1;URI1;PARP1;ZNF148;CRY2;WWP2;KDM1A;RXRA;NFX1;ESR1;PSEN1;BMP2;ZNF219;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;ZNF3;ZBTB4;BAG3;SIRT2;USP9X;PAF1;PEX2;GZF1;IFI27;ZBTB1;EP300;CBX6;ZBTB7B;PHF12;MAP2K5;NFIB;MTA3;NFIL3;RUNX1;LDB1;LDB2;MDFI;ZFP37;NR1H4;JDP2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5237731248551624,-1.1958378157916132,0.2546583850931677,0.693389453936786,1.0,4/11,7.70%,BMPR1A;BMP4;ZFPM2;JAG1
prerank,vasoconstriction (GO:0042310),-0.5297656915580199,-1.1957529645210931,0.2719298245614035,0.6921265796033804,1.0,3/11,9.85%,EDNRA;SLC8A1;ACTA2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4227399615706877,1.1954308288088962,0.2018348623853211,0.6985503847552921,1.0,23/59,23.36%,DAB2IP;NFKBIA;IKBKB;TLR3;TLR7;BIRC3;FAIM;IRAK2;SHARPIN;TLR8;BCL10;ERC1;CARD11;NKIRAS1;RELB;TBK1;RBCK1;AZI2;TICAM2;TBKBP1;PRDX4;TRAF6;RIPK1
prerank,heart trabecula morphogenesis (GO:0061384),0.5157314518535803,1.1954158721334793,0.2787456445993031,0.6977184736169599,1.0,6/18,5.01%,TEK;ENG;TGFB2;S1PR1;NOTCH1;DLL4
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.45107454466277996,1.1952960200242304,0.23853211009174313,0.6972035588809817,1.0,8/39,8.09%,PODXL;NOTCH4;RGCC;PTK2;NOTCH1;KLF4;NEXMIF;TGFB1
prerank,regulation of multicellular organismal development (GO:2000026),0.49579209674458424,1.1948372667988634,0.2545757071547421,0.6976284905968587,1.0,4/25,10.17%,INSR;SOX17;PTN;MYSM1
prerank,regulation of glycolytic process (GO:0006110),-0.35243031276414544,-1.1947704460258868,0.16025641025641027,0.6935688267433353,1.0,9/68,5.34%,IGF1;PRKAG2;ZBTB20;PRKAA2;NUPR1;HDAC4;OGT;SEH1L;PPARA
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.4671177982436011,-1.1942691850072114,0.22624434389140272,0.6934946713429962,1.0,9/18,30.18%,EHMT2;SETD7;SETD4;SETD2;EEF1AKMT2;SMYD2;SETMAR;KMT2A;SETD1B
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.49036729792384803,1.1940822656379324,0.26580226904376014,0.6989332206759675,1.0,6/26,10.36%,INSR;DDAH1;KLF2;HSP90AB1;KLF4;AGTR2
prerank,positive regulation of dendritic spine development (GO:0060999),0.5251361948427358,1.194029224934507,0.2727272727272727,0.6981978338032947,1.0,3/20,6.37%,SHANK3;LRP8;DBNL
prerank,fluid transport (GO:0042044),0.5683525133423727,1.1939621191045113,0.2926829268292683,0.6975181679608836,1.0,2/12,4.59%,AQP11;AQP7
prerank,negative regulation of programmed cell death (GO:0043069),0.3437373929433961,1.1935607145068707,0.11855104281009879,0.6978129126399051,1.0,43/355,10.83%,LEF1;IGF1R;MECOM;TFRC;TEK;RNF144B;TJP1;KDR;BCL2L1;FAS;NFKBIA;SH3RF1;FLT4;TBX3;PLAUR;PTK2;FOXO1;RPS6KA1;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;CAT;CD38;MRE11;ADAM10;MCL1;HCK;BIRC3;RHBDD1;PIDD1;PRDM9;GREM1;BNIP3L;MALT1;ARHGDIA;KLHL20;PDCD10;MGMT;THOC6;HSPB1;LRP2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5405250349576358,-1.1919409319009067,0.27479338842975204,0.6989336038152075,1.0,4/10,10.30%,GFPT1;PFKP;HK2;GFPT2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.39115380206607336,1.1918764622747715,0.20273972602739726,0.701617925356746,1.0,16/85,8.18%,SGPP2;TIE1;AQP11;DAB2IP;TGFB2;TBX1;MCC;B2M;MTSS1;ACVRL1;NOD2;PRKD1;FGF16;CDKN2B;TGFB1;TGFA
prerank,phosphorylation (GO:0016310),0.339534167979855,1.1917990321424907,0.10961968680089486,0.700946544950404,1.0,101/384,18.24%,PRKCH;ERG;PDGFB;INSR;BMPR2;TGFB2;MAP4K2;DGKH;APP;CDK17;MAP4K3;STK38;PKN3;LIPE;SNRK;JAK3;ACVRL1;PRAG1;MAP3K1;PRKD1;STK10;PRKD2;CDK19;ZAP70;MERTK;LYN;FNIP2;PRKG1;IKBKB;PPP4R1;CREB1;CAMKK2;DGKI;PKN1;LIMK2;PRKACB;PAK5;FYN;MAPK3;RPS6KA5;ADAM10;RET;AATK;DGKE;PKN2;HCK;PXK;MARK4;CERKL;TGFB1;MARK3;MAP3K6;PAK1;EIF2AK4;PTK6;TRIB2;PRKAB1;TOLLIP;HK1;PRKCB;GSK3A;SYK;DGKZ;PIK3CB;TNK2;MAP4K4;TGFBR2;PANK3;HIPK2;CERK;STK24;STK3;MINK1;PIM2;VRK1;SGK1;TBCK;CAMK2B;STK26;CTBP1;GRK6;NEK3;HIPK3;PLK2;SGK3;SGK2;MAPK1;ACVR1;GAS6;ALK;YWHAZ;SIK2;MAP3K11;PRKG2;PRKCG;PRKCE;TBK1;PAK2;WNK2;RSKR;CDK11B
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.45251836749162766,1.1915337693898882,0.23174603174603176,0.700769492456686,1.0,7/40,5.02%,LEF1;TGFB2;RGCC;TIAM1;NOTCH1;CTNNB1;WWTR1
prerank,positive regulation of behavior (GO:0048520),0.574593350131399,1.1913477142539737,0.27915869980879543,0.7004184730950515,1.0,3/10,15.74%,MEF2C;STRA6;NLGN1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5223548043581403,1.1911289628987183,0.265625,0.7001765629231222,1.0,8/19,21.66%,TERF2;HNRNPC;ACD;DCP2;TERF1;EXOSC10;XRN1;PINX1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.41004187324095515,1.19101249031191,0.20664739884393063,0.6996444612598102,1.0,19/72,11.43%,ARHGEF3;RASIP1;HEG1;NET1;F11R;ADGRG1;ARHGEF2;LPAR6;PRAG1;STARD13;STMN1;EPS8;EPS8L2;GPR17;OPHN1;ARHGDIA;KCTD10;PDCD10;RAC1
prerank,positive regulation of metabolic process (GO:0009893),0.39144190138500523,1.1909275912584998,0.1864864864864865,0.6990156145266351,1.0,12/103,7.53%,IGF1R;EPAS1;INSR;ADIPOR2;GATM;CAV1;FASN;UCP2;OXTR;ACACB;YBX2;IL4R
prerank,membrane fusion (GO:0061025),0.46826485814354846,1.1906999301064323,0.2491961414790997,0.6988358151053633,1.0,2/33,2.16%,DNM3;DYSF
prerank,positive regulation of interleukin-10 production (GO:0032733),0.47469366187826123,1.19047283448165,0.24155405405405406,0.6985784548004459,1.0,5/30,15.03%,CD34;NOD2;LGALS9;SYK;INAVA
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3810143920245388,1.1901351841989494,0.176158940397351,0.698655605195441,1.0,32/119,17.20%,EFR3B;PIK3R6;ITPKB;INPP5D;PIK3R3;SOCS2;PIKFYVE;PIGU;PIP5K1C;OCRL;INPP5F;PLEKHA1;PIGM;MTMR6;PGAP4;PIGF;SOCS5;PIK3C3;PIK3C2A;RAB4A;PIP4K2A;PIK3CB;MTMR12;CDIPT;MTMR2;PIK3R5;DPM3;PLEKHA3;SYNJ1;TTC7B;INPP5E;INPPL1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.48854810878956834,1.1901003115811133,0.25569176882662,0.6978976476322654,1.0,4/21,6.47%,DAB2IP;TGFB2;CD2AP;ARHGAP25
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5313250185521187,1.1893993404505956,0.25886524822695034,0.69902151755657,1.0,7/16,14.66%,GCH1;SCARB1;TERF2;AGTR2;HIF1A;PIK3CB;NUS1
prerank,organelle fusion (GO:0048284),-0.43953753677222984,-1.1893699689549893,0.2318840579710145,0.7050417782108704,1.0,7/22,16.25%,MIGA2;EEA1;MIEF1;AFG3L2;MFN2;MIEF2;STX4
prerank,regulation of interleukin-8 production (GO:0032677),0.40926020705331495,1.188924686328957,0.23098591549295774,0.6994822551360941,1.0,17/69,14.07%,TIRAP;AFAP1L2;NOD1;NOD2;PRKD2;TMSB4X;NOS2;HYAL2;TLR3;LGALS9;KLF4;TLR7;LAMTOR5;TLR8;SYK;RAB1A;BCL10
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3015849004424878,-1.1887246112833256,0.08411214953271028,0.705295284697019,1.0,35/173,15.17%,ANK2;CD55;SEC24D;CAPZB;SEC24A;GBF1;USO1;GOLGB1;COPA;NRBP2;KDELR3;COPZ2;COPB1;ARFGAP1;ARFGAP3;GOLGA2;ERGIC3;SAR1A;SEC31A;TRAPPC3;SEC16B;STX5;COG4;CUL3;SEC23A;DYNC1I1;GOLT1A;ERGIC1;RAB29;SCFD1;SEC16A;LMAN1;CTSZ;COPB2;DCTN6
prerank,positive regulation of response to wounding (GO:1903036),0.49640296532418227,1.1883388750236443,0.2635024549918167,0.7002950482976119,1.0,8/24,11.49%,OCLN;SCARF1;PTK2;INSL3;PTN;ACTG1;CNTF;HRAS
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5325304412535877,1.1881577667849728,0.27902946273830154,0.6999566715606051,1.0,8/15,18.73%,KCNQ1;ATP1A1;KCNH2;KCNN2;KCNJ3;KCNJ5;KCNA5;KCNIP2
prerank,small GTPase mediated signal transduction (GO:0007264),0.3818451033242711,1.187911909772761,0.20305980528511822,0.6997713377371002,1.0,24/103,13.28%,RASGRP3;ARHGAP31;RAPGEF2;NTN1;GRAP;TIAM1;PRKD1;ABR;GRB2;RREB1;CCDC88A;SOS1;RASGRP2;RALB;RGL2;JUN;SHC3;RAC1;HRAS;RAPGEF5;TNK2;GNB1;RIN2;SETDB1
prerank,protein export from nucleus (GO:0006611),-0.42289109404272435,-1.1878500929397748,0.20863309352517986,0.7063036383690293,1.0,7/27,16.48%,RANBP3L;PKD1;RANBP17;XPO5;XPO6;STRADA;XPO1
prerank,regulation of biomineral tissue development (GO:0070167),0.4811651062091269,1.1874364419182641,0.2585034013605442,0.7002522285717167,1.0,6/26,8.09%,SGMS2;NOS3;S1PR1;NOTCH1;NOTUM;TGFB1
prerank,O-glycan processing (GO:0016266),0.42455753101798316,1.1872105025889268,0.22904191616766467,0.6999984068909982,1.0,6/54,4.22%,ST3GAL1;B4GALT5;ST6GALNAC2;MUC3B;MUC3A;B3GNT2
prerank,gliogenesis (GO:0042063),0.5323178109263208,1.1869566163264311,0.2826086956521739,0.6998185874747015,1.0,4/15,10.01%,TGFB2;CDH2;MMP24;METRN
prerank,ventricular septum morphogenesis (GO:0060412),-0.4188516499389768,-1.186803310507218,0.2400990099009901,0.708015191603602,1.0,8/27,6.34%,ROBO1;TGFBR3;BMPR1A;BMP4;ZFPM2;SLIT2;TGFBR1;HEYL
prerank,negative regulation of signal transduction (GO:0009968),-0.28948751355287905,-1.1867111149216372,0.0440251572327044,0.7068252378876982,1.0,53/249,11.50%,PID1;TRABD2B;SULF1;LRP1;EGFR;LGR4;GLI3;ADAMTS12;DCN;IGFBP5;BMP5;DKK3;ENPP1;GPC3;KANK2;RNF43;CYP26B1;IRS1;TULP3;MMP14;APOD;KANK1;NOTCH3;SULF2;WWOX;THBS1;PRKCD;ARRB1;SUFU;FGF2;GLIS2;SFRP4;DACT1;MGRN1;EMILIN1;BCL2;IGFBP3;GRB10;TNS2;NXN;IFT122;CREB3L1;BEND6;VGLL4;PIP4K2C;QARS1;BTRC;NIBAN2;RPGRIP1L;LRRK2;IRAK3;CXXC4;WWP2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.472418361177535,-1.1865315425242913,0.2404255319148936,0.7058625576148009,1.0,5/17,5.02%,ATP1A2;TFPI;BMP7;BMP4;AR
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.4930172636117537,-1.1860820965723853,0.23390557939914164,0.7056682399029256,1.0,7/13,24.32%,IRS1;IGF2;SNX5;ECHDC3;ZBTB7B;PRKCZ;C1QTNF12
prerank,negative regulation of phosphorylation (GO:0042326),-0.3386202074115931,-1.1859800881031182,0.16065573770491803,0.7044509581861376,1.0,16/85,8.16%,PID1;PTPN13;NTRK3;PLPP3;FBLN1;BMP7;BMP4;NUPR1;SLIT2;HDAC4;IMPACT;PPARA;IRS2;EPHB2;PRKN;IGFBP3
prerank,regulation of multicellular organism growth (GO:0040014),0.5387831121700427,1.1859747967966217,0.2751798561151079,0.7016354001242477,1.0,2/15,1.57%,MFSD2A;APP
prerank,regulation of peptide hormone secretion (GO:0090276),0.4067797148938198,1.1849014409952443,0.229901269393512,0.7037113905786624,1.0,9/67,6.34%,SLC2A1;CACNA1A;STX1A;RAPGEF3;NOS2;KCNC2;SYT7;RAPGEF4;KCNG2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.49382036817166053,1.1841460616309083,0.24871355060034306,0.7049304937409909,1.0,7/22,8.14%,KANK3;HIP1R;SSH2;VIL1;TMSB4X;TMSB10;TWF2
prerank,regulation of protein binding (GO:0043393),0.38679035494340824,1.183957797537076,0.18972332015810275,0.7046372692512856,1.0,14/114,3.87%,CLDN5;PDGFB;RAPGEF2;APP;CAV1;HIP1R;CTNNBIP1;B2M;NES;EPB41;ZFPM1;TIAM1;MEN1;ACTB
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5693522759023356,1.1838724130686913,0.2841726618705036,0.7040347232163755,1.0,3/10,9.89%,FBXW7;TGFA;ADAM17
prerank,protein localization to organelle (GO:0033365),-0.3123200773935337,-1.1837063310536171,0.0975609756097561,0.7095682204522491,1.0,37/133,17.84%,ANK2;COL1A1;BMP7;BMP4;TULP3;LMNA;LAMP2;WDR35;GBF1;OBSL1;ARL3;ZNF423;SIX1;DCP1A;DDX1;IFT122;BICD1;STX5;EHD1;BBS9;ARL1;LRRK2;TOR1AIP1;RAB6A;EMD;TRAM2;AUP1;PAF1;DDX3X;DDRGK1;OPTN;SNX10;SEC61B;SIX4;VAMP2;TULP1;GET1
prerank,positive regulation of axonogenesis (GO:0050772),0.43755742775405854,1.1835683348721735,0.23270440251572327,0.7040165024234726,1.0,11/43,11.16%,SEMA7A;MACF1;NTN1;PLXND1;TIAM1;DBNL;SLITRK1;TWF2;ARHGDIA;METRN;PLXNB3
prerank,lymphocyte differentiation (GO:0030098),0.40918769893682744,1.1833238144492668,0.21726618705035972,0.7038382259196491,1.0,25/68,17.84%,JAG2;TPD52;PTPRJ;JAK3;HDAC9;ZAP70;HHEX;DLL4;SLC25A5;CD4;CD79A;KLF6;ADAM17;GPR89A;GPR89B;ZBTB7A;TOX;VCAM1;HDAC5;IKZF1;DNAJB9;MSH2;ITGA4;RELB;ADGRG3
prerank,regulation of axonogenesis (GO:0050770),-0.36806650820262726,-1.1827397782202773,0.18611111111111112,0.7108690959452887,1.0,13/51,14.09%,ROBO1;PLXNA2;TIAM2;SLIT2;SIPA1L1;KIF13B;NGF;PLXNB2;ROBO2;MAP6;CHN1;PTEN;BRSK1
prerank,phosphate ion homeostasis (GO:0055062),-0.5279536240349926,-1.1826639038983922,0.2837022132796781,0.7095899044852352,1.0,2/10,6.33%,ENPP1;SFRP4
prerank,glycogen biosynthetic process (GO:0005978),0.5589152546104814,1.1824925666611723,0.27692307692307694,0.704407371531185,1.0,4/12,16.04%,GBE1;PGM2L1;NHLRC1;UGP2
prerank,glucan biosynthetic process (GO:0009250),0.5589152546104814,1.1824925666611723,0.27692307692307694,0.704407371531185,1.0,4/12,16.04%,GBE1;PGM2L1;NHLRC1;UGP2
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.5388731527571671,-1.182453097071605,0.2765957446808511,0.7072708282565248,1.0,4/10,25.20%,TULP1;CEP250;CNGB1;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.5388731527571671,-1.182453097071605,0.2765957446808511,0.7072708282565248,1.0,4/10,25.20%,TULP1;CEP250;CNGB1;CACNA2D4
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.4618224236216982,-1.1820525481618698,0.2315035799522673,0.7069433014448304,1.0,6/18,11.96%,POR;ATP7A;SIRT3;AGTR1;FXN;ABL1
prerank,regulation of humoral immune response (GO:0002920),-0.3806110665642905,-1.1817016877260975,0.18888888888888888,0.7064698057969678,1.0,12/44,21.20%,SERPING1;VTN;CD55;CFH;GATA6;C2;C1QB;CD81;C1QBP;C4B;C3AR1;C6
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.35033597393927257,1.1815459750131325,0.15356265356265356,0.7061387397892557,1.0,36/208,11.88%,TFRC;DAB2IP;TNFRSF19;TIRAP;PLEKHG5;TRIM25;TNFSF10;TRIM14;NOD1;CD40;NOD2;PELI1;PRKD1;ATP2C1;IKBKB;CCR7;CD4;LGALS9;STAT1;BST2;BIRC3;PIDD1;MALT1;MAP3K3;NDFIP2;ZMYND11;UBE2V1;OTUD7A;SHARPIN;CASP8;BRD4;HSPB1;LAMTOR5;PRKCB;GPR89A;TLE1
prerank,regulation of microtubule-based process (GO:0032886),-0.3917505147896121,-1.1805522442774885,0.20253164556962025,0.708431763715125,1.0,11/36,14.87%,PHLDB2;EPHA3;PRKAA2;EFNA5;DIAPH1;ATF5;PHLDB1;BICD1;MAP6;MEMO1;KLHL42
prerank,positive regulation of neuron projection development (GO:0010976),0.39314647369934486,1.180085167248961,0.21187584345479082,0.7091165158711061,1.0,19/85,10.12%,ITGA6;NDNF;DAB2IP;RAPGEF2;SCARF1;FES;LRP8;RAPGEF1;PRKD1;LYN;SNX3;FUT9;DBNL;RET;LRRC7;TWF2;PTN;SERPINI1;PTK6
prerank,chondroitin sulfate metabolic process (GO:0030204),0.46705210352512644,1.1789910804366397,0.2590759075907591,0.7113445155050416,1.0,3/30,2.89%,CSGALNACT1;NDNF;CHST11
prerank,microvillus assembly (GO:0030033),0.5296306110159027,1.1787112493413,0.25457875457875456,0.7111949149066932,1.0,5/14,14.58%,RAPGEF2;RAP1B;MAP4K4;MINK1;STK26
prerank,lymphocyte chemotaxis (GO:0048247),-0.3874943237476955,-1.1783451626636647,0.1969309462915601,0.7135970598269392,1.0,15/34,33.66%,CYP7B1;SLC12A2;CXCL16;CCL13;CKLF;ADAM8;PIK3CD;CCL19;CCL2;CXCL10;CCL15;CX3CL1;CCL5;GPR183;CCL11
prerank,inner ear morphogenesis (GO:0042472),-0.43142091338193456,-1.1781878082207011,0.21495327102803738,0.712613487422957,1.0,6/22,7.23%,ZIC1;FGFR2;SIX1;TBX18;TTC39C;EPHB2
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.4467798260480385,-1.178178449225787,0.2523809523809524,0.7096462168995865,1.0,7/20,12.03%,ACADSB;IVD;MCCC2;AUH;HIBADH;BCKDHB;HIBCH
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.4467798260480385,-1.178178449225787,0.2523809523809524,0.7096462168995865,1.0,7/20,12.03%,ACADSB;IVD;MCCC2;AUH;HIBADH;BCKDHB;HIBCH
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.45702048086732644,1.1778259794838888,0.24437299035369775,0.712811349677084,1.0,12/32,14.34%,PPP1R16B;ITGA1;CALM1;HSP90AB1;PPIA;PPP2R5A;PIN1;TGFB1;AGTR2;NSMF;CDH5;PPP1R15B
prerank,dopamine metabolic process (GO:0042417),0.5172748441079492,1.177797179214557,0.28595317725752506,0.7120428681633245,1.0,3/18,2.19%,MAOA;TGFB2;GCH1
prerank,lymphocyte mediated immunity (GO:0002449),-0.5191903390649129,-1.1776550179552203,0.26973684210526316,0.7097222507900166,1.0,2/12,7.70%,CD55;JAG1
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.42946647930013204,-1.1774854148871117,0.2350230414746544,0.7087201799905275,1.0,5/25,13.00%,ITPR1;P2RX4;CDH13;LRRK2;CMKLR1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.39996799940851,-1.176748722427522,0.21025641025641026,0.709330494327658,1.0,7/31,4.56%,TGFBR3;BMPR1A;FGFR2;ZFPM2;TPM1;TGFBR1;RBPJ
prerank,heterocycle biosynthetic process (GO:0018130),0.5420829298741929,1.1767365378047387,0.2902654867256637,0.714062436753394,1.0,2/14,7.20%,GCH1;GPHN
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4970418433591782,1.1767273565627394,0.2597173144876325,0.7132367657757708,1.0,4/23,12.54%,MBOAT1;PLA2G4B;LPCAT3;PNPLA8
prerank,glycogen catabolic process (GO:0005980),-0.47898935321825775,-1.1765089992785887,0.2689075630252101,0.7085431694522775,1.0,10/15,23.04%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PYGL;PHKG1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3675490430448227,-1.1765039738067826,0.21739130434782608,0.7070924658531156,1.0,16/48,18.49%,EGFR;MDM4;SNX12;FLOT2;FLNA;PFDN5;APOE;LDLR;ITGAV;AZIN1;IRAK3;SIRT2;CRYAB;INHBB;ITGB3;MAD2L1
prerank,negative regulation of lipid storage (GO:0010888),0.494779904606773,1.1757345847106628,0.2673611111111111,0.7152058492657964,1.0,4/19,6.88%,PPARD;NFKBIA;ABCG1;NR1H2
prerank,translation (GO:0006412),0.35444031689167027,1.1756626948746796,0.16826923076923078,0.7145577378962351,1.0,96/208,28.90%,SARS2;SARS1;ZAR1L;RPL38;MRPL13;RPL13;RPS29;MRPL10;RPL36A;RPL3;YARS2;RPL27;RPSA;RPS7;RPL9;RPL18;RPLP2;GTPBP1;RPL13A;GARS1;RPS11;RPL8;RPS27;RPL19;MRPL57;RPS9;MRPL28;RPL11;EEFSEC;RPL22L1;RPS15;SRBD1;RPL37;GATC;RPS28;RPS10;EEF1D;RPS25;RPL37A;MRPS2;MRPL9;COPS5;RPL15;TNIP1;MRPL16;RWDD1;MRPL23;RPL17;RPL23;RPL34;FARSB;RPS18;APEH;RPL21;RPS4X;MRPS18A;RPL18A;DHPS;RPS21;RPL10A;GTPBP2;EEF1B2;CARS1;ABCE1;RPL24;RSL24D1;PTCD3;RPL7A;MRPL41;MRPL27;NARS1;IARS2;MRPL51;HARS1;RPL32;RPL4;RPS2;MRPS33;MRPL37;MRPL2;NDUFA7;RPS20;RPL6;RPS13;MRPS18C;RPS19;QRSL1;RPL14;VARS1;EEF1G;RPL26;MARS2;LARS2;MRPS34;MRPS12;RPS6
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.469282665150235,-1.1755422782582698,0.2819277108433735,0.7083919606469583,1.0,3/16,7.73%,PDK1;RORA;PRKN
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.4857528124835671,1.175356744961634,0.28691275167785235,0.714571581980741,1.0,3/24,5.99%,BCL2L1;CXCL12;SNAI2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.45126964270387016,-1.1752397219725959,0.24078624078624078,0.7078259907093348,1.0,8/20,16.19%,HOXA5;CTR9;MEIS1;PTK2B;MAFB;PAF1;HOXA9;LDB1
prerank,cellular glucose homeostasis (GO:0001678),0.4318597922790148,1.1746182672832068,0.24024024024024024,0.715793750888482,1.0,3/41,2.99%,IGF1R;UNC13B;FOXO1
prerank,neuromuscular process (GO:0050905),0.529599085716663,1.1744494133797598,0.29553264604810997,0.7154462900000218,1.0,3/16,10.09%,GCH1;NRXN1;STRA6
prerank,regulation of viral genome replication (GO:0045069),0.4146487504985054,1.1741314909975977,0.23858615611192932,0.7154923610915743,1.0,17/56,18.09%,IFIH1;FKBP6;ADAR;BTBD17;PPIA;PKN2;N4BP1;BST2;BANF1;OASL;PDE12;NR5A2;SLPI;ZC3HAV1;RAD23A;PROX1;TNIP1
prerank,determination of bilateral symmetry (GO:0009855),0.48022261294785057,1.1737111812888044,0.27638190954773867,0.7158235987813384,1.0,6/24,15.27%,ZIC3;TBX1;NOTCH1;KIF3B;FOXJ1;DNAH5
prerank,synaptic vesicle exocytosis (GO:0016079),0.4365595804155816,1.1734889299461966,0.2542113323124043,0.7156102983343816,1.0,9/40,13.18%,UNC13B;STX3;STX1A;PIP5K1C;SYT7;DNAJC5;STX19;SNAP29;CPLX1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.4017017659613614,1.1734296091211451,0.23201174743024963,0.7149338273987844,1.0,17/72,15.84%,KANK3;SHANK3;HIP1R;ARHGEF2;FGF13;SSH2;STMN1;TWF2;PFDN4;PFDN2;HSPA8;CYRIB;ATXN7;CDH5;SSH1;PFDN1;APC
prerank,negative regulation of macroautophagy (GO:0016242),-0.41120155103143013,-1.1733908913436828,0.25790754257907544,0.7116798485856703,1.0,11/26,20.40%,NUPR1;NRBP2;TMEM39A;LRRK2;CLEC16A;SCFD1;PHF23;FEZ1;SMG1;SMCR8;TSC1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3948731096044748,1.1727014004208671,0.2302158273381295,0.7160794706897642,1.0,13/75,8.64%,MFSD2A;APP;KLF7;MEF2C;PARD3;NTNG2;DSCAML1;ACTB;WNT7A;BAIAP2;SLITRK3;SLITRK1;OPHN1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4487203096802518,1.1721666737972376,0.26156299840510366,0.7167101585716132,1.0,5/35,5.17%,CAV1;JAK3;NOTCH1;IL10RB;PIGU
prerank,sphingosine metabolic process (GO:0006670),0.5052991307265562,1.1711346418892596,0.2864493996569468,0.7187987752046013,1.0,4/17,6.96%,SGPP2;ACER2;ACER1;SPTLC2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5654280798891714,1.1708618150538295,0.29961832061068705,0.7187484928761362,1.0,3/11,15.78%,RTP4;LPO;RTP3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3880338163870587,-1.170819512027849,0.2066326530612245,0.717906533868713,1.0,8/37,11.87%,PHLDB2;EPHA3;PRKAA2;EFNA5;PHLDB1;BICD1;MAP6;SKA2
prerank,regulation of innate immune response (GO:0045088),0.4133366195241426,1.170521062344763,0.2529411764705882,0.718848054118037,1.0,12/57,11.38%,TIRAP;LRP8;IFNAR2;GBP5;SAMHD1;HSP90AB1;XIAP;N4BP1;BIRC3;CASP8;TLR8;USP18
prerank,tetrapyrrole metabolic process (GO:0033013),0.5112618434433335,1.1704285812790693,0.28102189781021897,0.7182891189777832,1.0,8/18,24.20%,ABCD4;AMN;MMAA;LMBRD1;TCN2;MMACHC;MMADHC;CD320
prerank,negative regulation of gene expression (GO:0010629),0.3402200731149253,1.1699226575646104,0.15555555555555556,0.7188159456136048,1.0,58/302,13.44%,SLC7A5;OCLN;CLDN5;PDGFB;KDR;CD34;ENG;TGFB2;NANOS3;APP;XDH;RGCC;MEF2C;SRGN;ACVRL1;APLNR;NOTCH1;YBX1;HDAC9;NANOS2;NOS2;GATA2;NOCT;DLL4;ENC1;MRPL13;DIP2A;NANOS1;RPS6KA5;ATP2B1;ADAM10;FBXW7;LGALS9;KLF4;PTBP3;N4BP1;HINFP;TGFB1;TERF2;FOXP3;NDFIP2;KDM4A;PPP1R11;RPL13A;CNOT9;GRB7;PTRH2;PDCD10;TASOR;DCP2;HRAS;HIF1A;BTG2;DXO;SOX11;HELLS;SETDB1;PAIP2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5215037058345231,1.1697455025913772,0.2931937172774869,0.7184639430877001,1.0,3/15,11.38%,NLRC5;SAMHD1;USP18
prerank,lipoprotein transport (GO:0042953),-0.527742207465106,-1.1691290203510116,0.27824267782426776,0.7214825470221651,1.0,1/10,0.53%,LRP1
prerank,liver development (GO:0001889),-0.4133583913741025,-1.169035990456397,0.24296675191815856,0.7202078723620227,1.0,7/32,10.02%,TGFBR3;WNT4;COBL;PKD2;ANXA1;MET;CEBPB
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4481315641809277,-1.1690032660253982,0.2535885167464115,0.7188482474205021,1.0,6/20,6.33%,GSN;PLA2R1;THBS1;ANO6;PRKCI;SFRP4
prerank,glutamate metabolic process (GO:0006536),-0.4525663797810856,-1.1686995763840708,0.23990498812351543,0.7182738956743218,1.0,11/19,22.68%,PRODH;OAT;ALDH18A1;GOT1;GCLC;GLUL;GLS;GLS2;GOT2;FPGS;MTHFS
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.23751575041735198,-1.1686233243646964,0.0,0.7170015435284792,1.0,343/1668,16.32%,BMP6;AUTS2;PID1;FOXP2;PBX1;PRDM6;IGF1;SOX5;MAF;FHL2;ZIC1;NFIA;ZEB2;EGFR;NR2F2;ZIC4;AEBP1;BMPR1A;GLI3;ZBTB7C;DCN;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;SSBP2;BMP5;HOXC4;FGFR2;HOXC6;ZNF462;BMP4;KANK2;ARNT2;ZFPM2;OSR1;HOXB3;TEAD1;FGF1;DDX5;PPARGC1B;FNIP1;SMAD6;NR6A1;RGMA;HOXA3;HOXA5;NFAT5;PKD1;MEOX2;THRB;TNRC6A;FRK;HDAC4;GABPB2;CUX1;TRAK1;MXI1;PER3;IKZF2;HOXB4;WWOX;PRRX2;CREB3L2;TEF;IL18;SALL1;RHOQ;IMPACT;NR1D2;HOXB6;ZHX2;CCNT2;KIT;FOXC2;DNMT3A;FOXC1;CAMK2D;BCOR;ARRB1;TBX15;KCNIP3;HIVEP2;MLXIP;OGT;SUFU;VGLL3;PLAGL1;CDK8;PPARGC1A;RBPJ;HOXA7;BAZ1B;PKD2;DAB2;FGF2;PIAS1;MKX;ZNF367;KDM7A;EHMT2;RORA;TBL1XR1;MIER3;MDM4;AR;DLG1;PER2;PHF21A;GLIS2;ANXA4;HDGFL3;PPARA;KAT6B;PBX4;HIF3A;RUNX2;KLF3;PURG;MED23;CTR9;SIX1;TBX18;EBF4;ZNF25;CRTC3;ZMYM5;IKZF4;BCL6;TEAD3;CBX7;IGF2;TSHZ1;SSBP3;CHD2;HEYL;HOXC8;NR3C2;PAXBP1;DACT1;MEIS1;PBX3;SMARCC2;GLI1;CCN1;ZEB1;SMAD9;KDM2A;CCNL1;ZNF568;KDM3B;LCOR;FOXJ2;NFATC4;ATF5;EBF2;AGO2;ELF4;ZSCAN29;SOD2;KLF15;ATN1;CHD3;JAG1;CHD8;PRKN;CBX5;RFX7;SMARCD3;FHOD1;MITF;FBXL19;KDM5B;APOE;FOXL1;MET;KDM6B;ATM;AKAP8L;TNIP2;YAP1;SMARCB1;RBBP8;KDM2B;MED25;POU6F1;RBAK;CHD4;TNRC6B;HSF2;ATOH8;SMURF2;CREB3L1;USP2;STAT5A;ZNF23;FOXO3;CXXC5;SOX6;PCGF2;MGA;TGFB3;EZR;SLC30A9;PPM1D;BRD9;TWIST2;DDX17;ZNF483;ZKSCAN7;ARNT;ELP3;CDH13;ITGB1BP1;CEBPB;ELK1;SLC9A1;CCNC;SP140;ZNF507;NOP2;EZH1;GATA6;ZNF697;SMARCA1;ZNF182;RNF10;ZBTB38;CCNH;NR2F1;URI1;ARID3A;PARP1;ZNF148;CRY2;PPP3CB;NUCKS1;CHUK;ETV1;MED14;WWP2;KDM1A;CAPRIN2;CREBRF;TFCP2L1;RXRA;PHF8;NFX1;RFXAP;ABL1;CDK7;ESR1;PIAS2;PGR;PSEN1;BMP2;BCAS3;ZNF219;HOXB5;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;HOXC5;MED15;ZNF3;DVL2;SP3;PTEN;ZBTB4;SIRT2;MAFB;CAMTA2;USP9X;PAF1;PEX2;AKNA;SMARCA5;PSIP1;BRD8;MTF1;PIK3R1;GZF1;HOXA9;MAPK14;DDX3X;ATF2;IFI27;NR4A1;ZBTB1;EP300;DDRGK1;AHI1;MRGBP;CBX6;TSHZ3;TLR4;LAGE3;ZBTB7B;PHF12;ZFP64;E2F3;RFX5;ZSCAN20;CD81;LRP6;ELP4;MAP2K5;SAP18;SREBF1;GTF2F1;NFIB;IKBKG;MYBL2;ZSCAN2;PROX2;MTA3;NFIL3;RUNX1;CAMK1;HIVEP3;FOXJ3;ATMIN;LDB1;LDB2;MDFI;ZSCAN21;ATAD2B;MED30;ZBTB26;ZFP37
prerank,neuron apoptotic process (GO:0051402),0.5088442504227346,1.1684168827364605,0.29948364888123924,0.7212224712653632,1.0,3/19,4.54%,APP;FAS;TNFRSF21
prerank,epidermis development (GO:0008544),-0.35268339669862214,-1.1678223186554963,0.18181818181818182,0.7179824288059867,1.0,11/56,13.22%,SVEP1;CCN2;FGFR2;EMP1;FLOT2;CRABP2;GLI1;GATA6;PTHLH;SCEL;LAMC2
prerank,COPII-coated vesicle budding (GO:0090114),-0.3434962620502085,-1.1678138866109784,0.16,0.7165647923000602,1.0,16/68,14.56%,SEC24D;SEC24A;USO1;GOLGA2;SAR1A;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,muscle cell migration (GO:0014812),-0.5273658727805103,-1.167706677148336,0.272,0.7153948296762168,1.0,4/10,10.00%,DDR1;SIX1;CCN3;ITGB1BP1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4537414103858395,-1.167345710619871,0.26570048309178745,0.7150529177382847,1.0,3/20,1.29%,BMPR1A;GLI2;NBL1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.46800064340611136,-1.1671747312302791,0.2897196261682243,0.7141395783819611,1.0,7/17,7.70%,ROBO1;NOTCH2;BMP4;SLIT2;SMAD6;HEYL;JAG1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.49979209040274375,1.1669541003900716,0.2891566265060241,0.724335618663725,1.0,6/22,12.02%,PTPRJ;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1
prerank,regulation of gluconeogenesis (GO:0006111),-0.41066097359286335,-1.1667059047806057,0.2494061757719715,0.7140775306381407,1.0,5/27,8.84%,OGT;PPARGC1A;C1QTNF3;SELENOS;NNMT
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4270752009186588,1.166289736402949,0.24923076923076923,0.7253810210527765,1.0,15/45,18.79%,TRIM25;B2M;SP100;IRF2;IRF9;STAT1;HCK;IRF5;OASL;MID1;CAMK2B;VCAM1;TRIM26;TRIM68;CAMK2G
prerank,positive regulation of neurogenesis (GO:0050769),-0.3348173191927506,-1.1655493016462972,0.19817073170731708,0.7161167730578435,1.0,18/68,11.66%,ROBO1;PLXNA2;TIAM2;SLIT2;CUX1;OBSL1;NGF;FBXW8;SERPINF1;PLXNB2;FZD3;SMARCD3;CUL7;NUMBL;ROBO2;KDM1A;CAPRIN2;MAP6
prerank,lymphocyte migration (GO:0072676),0.4545401340694106,1.165203482425794,0.28503937007874014,0.7274846585805995,1.0,5/32,11.00%,S1PR1;ZAP70;RET;MSN;CCL1
prerank,cation transmembrane transport (GO:0098655),0.4324555297255888,1.1649633879763346,0.26275115919629055,0.7273010549116299,1.0,4/44,1.98%,SLC7A5;SLC7A1;SLC6A5;SLC38A5
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.4232807779335842,1.1647432653914334,0.25744047619047616,0.7270980407186679,1.0,12/46,18.70%,PLCB1;PITPNA;PPIA;RAP1B;MSN;PSME2;TALDO1;CFL1;RALA;HSPA9;PAK2;BOLA2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.565310114409458,1.164667329479183,0.31309297912713474,0.7265027661651821,1.0,6/10,17.33%,CORO2B;SNX3;NDFIP2;TERF1;DNAJA1;PPM1F
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.36771102902795144,1.1640081583598278,0.2261904761904762,0.7275082310828428,1.0,13/113,4.45%,TEK;EGFL7;PDGFB;KDR;PPP1R16B;BMPR2;TBX1;FLT4;NOD2;PRKD1;PRKD2;WNT7A;RREB1
prerank,regulation of ruffle assembly (GO:1900027),0.4790438378032892,1.1640011138510487,0.28695652173913044,0.7266871296482857,1.0,9/23,15.74%,CAV1;EVL;EPS8;EPS8L2;ABI3;PLEKHM1;HRAS;FAM98A;NLGN1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5228941935396441,1.1634301473369821,0.296229802513465,0.7274810308675947,1.0,3/13,10.00%,AQP11;NR1H2;LPCAT3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.506475758786909,-1.163370348841049,0.27400468384074944,0.7210005810143244,1.0,2/12,7.33%,IL18;IL17D
prerank,postsynaptic membrane organization (GO:0001941),0.500723164831989,1.1632973524254067,0.3050259965337955,0.7270295701226022,1.0,4/17,8.93%,SHANK3;CHRNB1;GPHN;NRXN1
prerank,regulation of mast cell degranulation (GO:0043304),0.526619781500113,1.1632850120578775,0.31016042780748665,0.7262222668548964,1.0,5/14,11.85%,FES;LYN;LGALS9;UNC13D;SYK
prerank,peptide biosynthetic process (GO:0043043),0.3617147861442916,1.1631204588401773,0.1997471554993679,0.7258496655352463,1.0,64/153,26.76%,SARS1;ZAR1L;RPL38;MRPL13;RPL13;RPS29;MRPL10;RPL36A;RPL3;YARS2;RPL27;RPSA;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;MRPL28;RPL11;RPS15;SRBD1;RPL37;RPS28;RPS10;RPS25;RPL37A;MRPL9;COPS5;RPL15;TNIP1;MRPL23;RPL17;RPL23;RPL34;FARSB;RPS18;RPL21;RPS4X;MRPS18A;RPL18A;DHPS;RPS21;RPL10A;RPL24;RSL24D1;RPL7A;MRPL41;MRPL27;MRPL51;HARS1;RPL32;RPL4;RPS2;MRPS33;MRPL37;RPS20;RPL6;RPS13;MRPS18C
prerank,regulation of viral entry into host cell (GO:0046596),0.46606786826908647,1.1627119879988115,0.2706270627062706,0.7261461084194548,1.0,6/30,6.44%,LY6E;TRIM25;TRIM14;SNX3;CD4;LGALS9
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.42772684723818355,-1.1623703714784626,0.2634146341463415,0.7225671990765329,1.0,4/23,7.57%,NUPR1;HDAC4;PPARA;C1QTNF3
prerank,establishment of protein localization to membrane (GO:0090150),0.3988693752034375,1.1621274409021534,0.2590448625180897,0.7269453336254926,1.0,19/66,16.36%,AQP11;REEP1;ZDHHC14;PARD3;PIKFYVE;ZDHHC9;ZDHHC20;RAB11A;GRIN3B;ZDHHC19;RTP4;NPC1;ZDHHC18;ZDHHC22;SDCBP;NACAD;RFTN1;RTP3;ZDHHC21
prerank,regulation of protein modification process (GO:0031399),0.4188523837621095,1.1620420621576806,0.2687224669603524,0.7263148194374404,1.0,12/50,13.45%,PPP1R16B;PTK2;LYN;FNIP2;CCDC88A;PIN1;ASPSCR1;HPF1;PARG;HSPB1;PUM3;CDH5
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.48515825046239,-1.1618342805483863,0.271689497716895,0.7227215634238554,1.0,7/15,19.26%,STXBP4;GLI1;KLHL18;CUL3;PAF1;DDRGK1;EZH2
prerank,response to chemokine (GO:1990868),0.5326328278637407,1.1617836910291905,0.31666666666666665,0.726146578473167,1.0,2/13,1.41%,LRCH1;CXCL12
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.3208361543677285,-1.161293816458113,0.15753424657534246,0.7228187169286804,1.0,26/95,14.57%,TGFBR3;ZEB2;LDLRAD4;SMAD3;DKK3;SMAD6;HTRA3;THBS1;SNX6;TGFBR1;DAB2;PPARA;ASPN;EMILIN1;TGFB1I1;CD109;SMURF2;PDPK1;SPRED1;STK11;VASN;SKI;GIPC1;HTRA4;SLC2A10;EP300
prerank,cellular response to organic substance (GO:0071310),0.36672000722989273,1.1612503496971505,0.22178988326848248,0.726730180790247,1.0,19/116,8.14%,LEF1;SLC1A1;PDGFB;BMPR2;NCOA1;PTPN12;ACVRL1;SIGIRR;RAMP2;SOCS2;CTNNB1;RAMP3;CYP11B1;CCR7;KLF4;NCOA2;CRNN;TGFB1;TWF2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.42176426915611115,-1.1607030254537023,0.25,0.7231316852378828,1.0,7/25,6.63%,SULF1;BMPR1A;FOXD1;BMP4;RBPJ;ZNF423;CCN1
prerank,cardiac cell development (GO:0055006),-0.5143673380381972,-1.1606450964507633,0.3125,0.7218669161757538,1.0,4/11,7.89%,CXADR;SLC8A1;JAG1;MYH11
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.41508753794463027,-1.1605016889130026,0.24938271604938272,0.7208826336045067,1.0,12/26,30.18%,OGT;CTR9;SETD4;KMT5C;EEF2KMT;SETD5;KMT5B;SETD2;ANTKMT;METTL21C;KMT2A;SETD1B
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.513408792668496,-1.160494579875818,0.27828054298642535,0.7194801366226858,1.0,6/12,33.09%,UCK2;UPP2;UMPS;UCK1;UCKL1;DCK
prerank,mucosal immune response (GO:0002385),0.5283756680546776,1.1599594318600306,0.29930795847750863,0.7295068026809022,1.0,2/15,4.51%,DEFA6;NOS2
prerank,organelle disassembly (GO:1903008),-0.39213108406593344,-1.1598889475042982,0.24331550802139038,0.7196754705322725,1.0,10/33,14.77%,GBF1;ULK2;ATG2B;MCTS1;GOLGA2;TEX264;STX5;PLK5;DDRGK1;UFC1
prerank,transcription preinitiation complex assembly (GO:0070897),0.5435077098034449,1.1595295949441367,0.3473282442748092,0.7298785955578146,1.0,9/12,34.01%,TAF1B;TAF7L;GTF2B;BDP1;GTF2A2;TAF7;DR1;TAF11;TAF12
prerank,ion homeostasis (GO:0050801),-0.40248278830725703,-1.1594011689903536,0.24873096446700507,0.7197639629510223,1.0,8/30,15.37%,SLC4A10;FHL1;WNK4;CAMK2D;SLC4A7;SLC4A2;WNK1;SLC4A3
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4878666915382027,1.159307637057056,0.30716723549488056,0.7296497336524688,1.0,6/20,5.99%,ENG;TGFB2;TBX3;ACVRL1;NOTCH1;SNAI2
prerank,cGMP metabolic process (GO:0046068),0.5486002572665382,1.159009315012036,0.326007326007326,0.729590934287087,1.0,4/12,13.27%,PDE2A;NPPA;NPR1;NPR2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3935519891635292,1.1589257409111196,0.25333333333333335,0.7290093352823156,1.0,16/75,12.15%,DAB2IP;RASIP1;HEG1;STK38;PTPRJ;DUSP7;MEN1;PKIG;LYN;HHEX;HYAL2;PRKAR2B;LRP5;PRKAR2A;DUSP1;PIK3CB
prerank,chromosome condensation (GO:0030261),0.43522647423015876,1.1586898333281959,0.2640901771336554,0.7288610970037541,1.0,10/36,18.75%,TENT4A;NCAPH;MCPH1;DFFB;NCAPG;BANF1;CSNK2B;TTN;NCAPH2;SET
prerank,negative regulation of cilium assembly (GO:1902018),0.5312512871283096,1.158529909934647,0.30783582089552236,0.7284643049743027,1.0,5/12,11.60%,MAP4;LIMK2;CCP110;ODF2L;TBC1D30
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3497476536360447,1.1585167790117743,0.20297029702970298,0.7276829515306269,1.0,46/190,14.19%,BCL2L1;DAB2IP;PDE2A;SH3BP4;XDH;CAV1;PHLPP1;PLAUR;PTPRJ;TNFAIP8L1;APLNR;PIK3IP1;CD2AP;HDAC7;DUSP3;LYN;TMSB4X;PDE4D;HYAL2;PLEKHA1;ARHGAP25;RFFL;MCL1;STAT1;MARK3;ABCA7;P2RX7;ZMYND11;OTUD7A;DEPDC5;DDIT4;CASP8;DUSP1;ADIPOR1;GSK3A;TLE1;PIK3CB;CYRIB;WWC1;TMEM127;CYLD;TRIM39;TNFAIP3;PDE3B;PDCD6;EPM2A
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.44625114988127923,-1.158208977427433,0.27107061503416857,0.7219501796279673,1.0,11/19,33.48%,GFPT1;RENBP;GFPT2;SLC35D1;PGM3;NAGK;UAP1;UAP1L1;GNPDA1;PMM1;GMPPB
prerank,mitochondrion localization (GO:0051646),-0.4531869149459935,-1.1582057751566102,0.2398989898989899,0.7205469666187356,1.0,10/19,28.49%,TRAK1;MARK1;LRRK2;MFN2;MUL1;TLE6;HAP1;MFN1;MARK2;ATCAY
prerank,pancreas development (GO:0031016),0.5501680973157104,1.1581605636753924,0.30956848030018763,0.7278704694289536,1.0,2/12,4.36%,ZIC3;FOXF1
prerank,mammary gland development (GO:0030879),0.49049566439030545,1.157585154711959,0.30244755244755245,0.7285320435229433,1.0,4/21,5.76%,NOTCH4;CAV1;TBX3;OXTR
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5238338223741361,1.1573171697882145,0.30612244897959184,0.727615364434537,1.0,3/15,5.88%,NANOS3;NANOS2;NANOS1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5238338223741361,1.1573171697882145,0.30612244897959184,0.727615364434537,1.0,3/15,5.88%,NANOS3;NANOS2;NANOS1
prerank,organelle transport along microtubule (GO:0072384),-0.39680357547747147,-1.1572369625940755,0.2541436464088398,0.7219255101472707,1.0,13/31,24.75%,TRAK1;ARHGAP21;MAP1S;BICD1;DYNC1I1;CLN3;RAB6A;FBXW11;RHOT1;BORCS5;COPG1;HTT;HAP1
prerank,positive regulation of nuclear division (GO:0051785),0.4747589920471989,1.1563361035736763,0.29797979797979796,0.7294600402212995,1.0,6/25,8.59%,PDGFB;INSR;RGCC;NPM2;TGFA;LRP5
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5048362989489893,-1.1560609544253495,0.2922077922077922,0.724048802476461,1.0,4/11,9.52%,DAB2;RAB21;PRKN;EZR
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3803966627044173,-1.1558955545185894,0.23163841807909605,0.7230832339904234,1.0,7/39,9.51%,STEAP3;ABCA1;TANGO2;RCN3;ARFGAP3;TANGO6;CANX
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.4949231210050069,-1.1558091788013833,0.29896907216494845,0.7219098328219706,1.0,2/14,5.56%,AUTS2;CTR9
prerank,regulation of histone modification (GO:0031056),-0.4977412381074565,-1.1557442610862239,0.2850877192982456,0.7206705889135918,1.0,7/13,18.58%,IGF2;AKAP8L;MTHFR;NNMT;SETD5;MYOCD;FLCN
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5626069068176432,1.1555523885862167,0.3196078431372549,0.7307410108498656,1.0,4/10,14.06%,ACER2;SNAI2;NEXMIF;PDE3B
prerank,positive regulation of response to stimulus (GO:0048584),0.42729676850194503,1.15547209880989,0.2676282051282051,0.7301238979478859,1.0,10/40,16.60%,TGFB2;B2M;IFIH1;HOMER1;HMGA1;ABI3;IL15;NSMCE4A;HMGA2;CDKN2AIP
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4484859522176581,1.154516852454613,0.2752442996742671,0.7318499573492478,1.0,7/35,12.17%,HIP1;HIP1R;B2M;MKLN1;RAC1;PIK3CB;TNK2
prerank,histone H3-K36 demethylation (GO:0070544),-0.5227411624113159,-1.1544377223045172,0.3051948051948052,0.7230798871234257,1.0,5/10,16.92%,KDM7A;KDM2A;KDM2B;PHF8;RIOX2
prerank,regulation of myoblast fusion (GO:1901739),-0.5156644349773483,-1.1541422575745466,0.2915811088295688,0.7225310936595005,1.0,4/11,16.13%,RIPOR2;EHD1;MAPK14;EHD2
prerank,epithelial structure maintenance (GO:0010669),-0.5104684411394053,-1.1539332538040423,0.291220556745182,0.7218198582142323,1.0,2/11,3.27%,CXADR;RBP4
prerank,megakaryocyte differentiation (GO:0030219),0.5389954003546886,1.153837579499155,0.31589147286821706,0.7329873690215647,1.0,3/11,6.68%,ZFPM1;TAL1;CDKN2B
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.44367012066597195,-1.1537612499640784,0.2800925925925926,0.7209697717924853,1.0,8/19,24.07%,ENPP1;SLC26A2;PAPSS2;PAPSS1;TPST1;ABHD14B;SLC35B2;SULT1A1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.47939815445196166,1.1536963430612315,0.3153310104529617,0.7325626505834453,1.0,4/23,9.22%,DAB2IP;TNFRSF11A;ARHGEF5;PAK1
prerank,regulation of focal adhesion assembly (GO:0051893),0.4081627973385295,1.1536000693680715,0.2519201228878648,0.7319924417296169,1.0,8/54,3.74%,TEK;LIMCH1;KDR;MACF1;PTPRJ;PTK2;ACVRL1;DUSP3
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3550677671013581,-1.1530630570874625,0.22186495176848875,0.7216190006879194,1.0,18/52,24.25%,CELF2;DDX5;FXR2;SRRM4;NOVA1;SRSF6;DDX17;RBM5;FMR1;NSRP1;RBFOX1;SAP18;TRA2B;MBNL2;ZC3H10;RBM24;KHDRBS3;CELF6
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5375587875997392,1.1528677890972348,0.3099099099099099,0.7331832835193093,1.0,7/13,22.00%,ATF6B;ABCA7;PPP1R15B;DNAJB9;NCK1;BFAR;RACK1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.44000619686237313,1.1526548226848732,0.28317152103559873,0.7329800534403527,1.0,3/36,2.34%,SPTBN1;MACF1;RAB31
prerank,monosaccharide transmembrane transport (GO:0015749),-0.4729554458082291,-1.1525633927579095,0.2826086956521739,0.7217241330779068,1.0,4/16,14.36%,SLC2A12;SLC5A3;SLC45A3;SLC2A10
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5200804113206219,1.151791132701079,0.3064798598949212,0.7345129420097656,1.0,5/13,12.34%,NOTCH1;FOXF1;NPY5R;GSK3A;TGFBR2
prerank,negative regulation of receptor internalization (GO:0002091),0.5492799506411866,1.1516237819840012,0.30978260869565216,0.7341561728493822,1.0,5/12,19.35%,ANKRD13A;RIN3;SDCBP;MTMR2;LRPAP1
prerank,regulation of postsynapse organization (GO:0099175),0.4590738434522212,1.151455069445328,0.3169129720853859,0.7337833909326219,1.0,5/28,6.87%,SHANK3;EPHA4;ABHD17A;HOMER1;KIF1A
prerank,negative regulation of potassium ion transport (GO:0043267),0.5302072118212146,1.1514447561601393,0.32142857142857145,0.7330063713097017,1.0,3/13,7.93%,CAV1;NEDD4L;KCNH2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3113876613857134,-1.1513893242748159,0.1828793774319066,0.7237884422138969,1.0,16/112,4.40%,COL1A2;COL3A1;SOX5;TGFBR3;BMPR1A;APPL2;WNT4;SMAD3;PDE3A;ITGB5;SMAD6;WWOX;CLEC3B;TGFBR1;TWSG1;ADAM9
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.4137004872889819,-1.1513741902279002,0.26128266033254155,0.7224408879250884,1.0,5/26,5.39%,SULF1;CCBE1;SULF2;RORA;CYP1B1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.33752403303812245,-1.1506523799837105,0.2,0.7232282157654586,1.0,21/73,11.96%,ITGBL1;COL3A1;PLPP3;FBLN1;ITGB5;ITGB8;ITGA10;TEC;ADAM9;ITGA11;DAB2;COL16A1;ITGA5;FYB1;ITGB4;CUL3;ITGB1BP1;ITGAV;PTK2B;ADAMTS1;ABL1
prerank,cellular response to interleukin-12 (GO:0071349),0.4150573543022272,1.1504776184338759,0.26686656671664166,0.734852123695972,1.0,12/48,18.70%,PLCB1;PITPNA;PPIA;RAP1B;MSN;PSME2;TALDO1;CFL1;RALA;HSPA9;PAK2;BOLA2
prerank,negative regulation of cellular component organization (GO:0051129),-0.33193633800218064,-1.1503845813778402,0.16271186440677965,0.722648294972721,1.0,19/74,17.67%,BMP6;EPHA3;CARMIL1;IMPACT;AR;FAP;LRSAM1;RTEL1;IRAK3;TMEFF2;XRCC5;SCAMP5;DDX3X;SNX33;EP300;CRYAB;NR1H4;DNAJB2;PACSIN3
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.4230829143916369,1.1501461250154366,0.26881720430107525,0.7349152379000206,1.0,11/45,17.80%,NANOS3;APP;NANOS1;TDRD7;CYFIP1;EIF4E;PUM3;ZC3H7A;GCNT2;ATG14;TRIM71
prerank,long-chain fatty acid import into cell (GO:0044539),0.5570399663445231,1.1499723961532353,0.32264150943396225,0.7345744902753922,1.0,3/10,12.91%,SLC2A1;ACSL3;SLC27A2
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4783488831924265,1.1497329408974413,0.2991304347826087,0.7344517285984772,1.0,4/21,3.74%,LIMCH1;MACF1;PTK2;DUSP3
prerank,protein autoubiquitination (GO:0051865),-0.35128932626815584,-1.1495334490369225,0.20962199312714777,0.7238308686253236,1.0,12/61,11.84%,RNF220;SH3RF3;AMFR;SH3RF2;PRKN;LRSAM1;DDB2;CUL3;RNF10;WWP2;RNF181;NFX1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.4317247096081612,1.1494067172113311,0.26952526799387444,0.7345740534974806,1.0,2/42,2.24%,POLK;TRIM25
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4246024591616342,1.1492344177491074,0.27035330261136714,0.7342081262415888,1.0,11/39,12.42%,DAB2IP;ITGA1;PTPRJ;PTPN12;DUSP3;GRB2;TGFA;ARHGEF7;ACP4;EPS15;HGS
prerank,response to interferon-beta (GO:0035456),0.47771216354905693,1.148599182172663,0.30272108843537415,0.7351065910133492,1.0,6/22,8.17%,IFNAR2;XAF1;AIM2;STAT1;BST2;IRGM
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4546222737532607,1.148583594909957,0.2825719120135364,0.7343515735990164,1.0,10/31,15.74%,SHANK3;LRP8;EPHA4;DBNL;KIF1A;EFNA1;ABI3;CFL1;CAMK2B;NLGN1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4548491793695546,1.1485775904177173,0.2946127946127946,0.7335583247468295,1.0,6/29,7.79%,MFSD2A;SCARB1;CREB1;NR1H2;SORBS1;ELOVL5
prerank,postreplication repair (GO:0006301),0.42296488508558644,1.1485743117345621,0.2668711656441718,0.7327668116689364,1.0,5/45,9.77%,POLK;TRIM25;UBE2V2;USP43;UBE2V1
prerank,regulation of dephosphorylation (GO:0035303),0.5107782522013129,1.1484477397458042,0.32092198581560283,0.7323440563633934,1.0,1/15,0.95%,PPP1R16B
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.43316477881535875,-1.1481596366849742,0.29357798165137616,0.7265242243880158,1.0,7/19,17.10%,IL34;CAMK1D;THBS1;CMKLR1;MPP1;RARRES2;MDK
prerank,regulation of actin filament polymerization (GO:0030833),0.3931117915183977,1.1479751111368413,0.24774774774774774,0.7327946196858655,1.0,13/69,8.14%,KANK3;ESAM;HIP1R;EVL;SSH2;VIL1;CCR7;CDC42EP3;BAIAP2;DBNL;NCKAP1;HCK;TWF2
prerank,positive regulation of T cell differentiation (GO:0045582),0.43180471875761467,1.1475091373397328,0.2804878048780488,0.733208901311922,1.0,5/36,11.81%,LEF1;ZAP70;SOX12;PNP;VSIR
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5713147742563524,1.147374949592018,0.3257443082311734,0.732796963011467,1.0,3/10,7.45%,CD40;LYN;BTLA
prerank,protein localization to vacuole (GO:0072665),0.5390275990537886,1.1464047313873016,0.32849364791288566,0.7345476828715346,1.0,5/13,15.55%,SH3BP4;LAMTOR5;SH3GLB1;LMBRD1;LAMTOR4
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.33478978225583156,1.1460500749592952,0.18417945690672963,0.7347091222776928,1.0,47/259,13.59%,DNM3;ABCC4;FGD5;PARVB;ABLIM1;SRGAP2;RAPGEF2;FNBP1L;NTN1;EXOC6;S1PR1;SPATA13;MTSS1;NOTCH1;CD2AP;CNGA2;CEP83;PPP1R9B;POC1B;CDC14A;CFAP52;OCRL;CCDC88A;DYNLL1;RAB11A;RAP1B;TTLL3;ARHGEF7;P2RX7;OPHN1;FGD6;DISC1;CYFIP1;KIF3B;EHD4;CFAP54;EXOC4;EXOC2;RAC1;MAP4K4;SNAP29;RAB1A;FGD2;BBIP1;SDCBP;MINK1;FSCN1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5041005534243463,1.1457029804546124,0.3103448275862069,0.7348877839592817,1.0,5/18,9.89%,MTUS1;IL6R;LYN;PTN;ADAM17
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5282120939500958,1.145665890460406,0.30639097744360905,0.7341861743590082,1.0,7/13,22.39%,SVIP;DERL2;EDEM1;UBAC2;UBE2G2;BRSK2;UBE2J1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.39297687019399663,-1.145448467064583,0.2819843342036554,0.7330208650349099,1.0,5/28,8.01%,PDK1;RORA;PPARA;PRKN;APOE
prerank,ion transport (GO:0006811),-0.31502431117127583,-1.1452267979591044,0.17391304347826086,0.732328677667925,1.0,21/111,9.09%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC26A7;SLC26A2;SLC8A3;SLC12A2;ANO6;WNK4;SLC9A2;SLC5A5;SLC8B1;SLC12A7;ANO1;SLC8A1;SLC20A2;TRPC6;SLC4A2;SLC9A9;GLRB
prerank,COPII vesicle coating (GO:0048208),-0.34643985534854205,-1.1450728188170154,0.20364741641337386,0.7286266774842869,1.0,15/61,14.56%,SEC24D;SEC24A;USO1;GOLGA2;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,vesicle coating (GO:0006901),-0.34643985534854205,-1.1450728188170154,0.20364741641337386,0.7286266774842869,1.0,15/61,14.56%,SEC24D;SEC24A;USO1;GOLGA2;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.34643985534854205,-1.1450728188170154,0.20364741641337386,0.7286266774842869,1.0,15/61,14.56%,SEC24D;SEC24A;USO1;GOLGA2;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,negative regulation of histone methylation (GO:0031061),-0.5227828370491181,-1.145072768467214,0.31736526946107785,0.7272622080507957,1.0,6/10,33.38%,BCOR;KDM1A;BRCA1;AASS;MTF2;JARID2
prerank,L-glutamate transmembrane transport (GO:0015813),0.557057674615312,1.1446591796247538,0.332089552238806,0.7360954782862112,1.0,3/10,10.83%,SLC1A1;SLC1A2;ARL6IP5
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4081634866802273,-1.1444393522114065,0.26097560975609757,0.727684518048914,1.0,9/28,9.88%,PID1;APPL2;ENPP1;IRS1;KANK1;PRKCD;GRB10;TNS2;PIP4K2C
prerank,positive regulation of chemotaxis (GO:0050921),0.4284470290645821,1.1439357063528404,0.29780564263322884,0.7372551335006629,1.0,11/43,10.75%,PDGFB;KDR;IL6R;STX3;PRKD1;PRKD2;TMSB4X;TGFB1;PTN;ADAM17;HSPB1
prerank,dicarboxylic acid transport (GO:0006835),-0.4068439521289722,-1.143661469244184,0.28255528255528256,0.7285448043748567,1.0,6/28,4.51%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5522230031101425,1.1433780648245686,0.33090909090909093,0.7379147144274715,1.0,3/11,14.90%,PXDN;CAT;PRDX5
prerank,keratan sulfate metabolic process (GO:0042339),0.44762695440592104,1.143334601561638,0.2953020134228188,0.7372554692515908,1.0,5/31,4.22%,ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;B3GNT2
prerank,response to cholesterol (GO:0070723),-0.4545629904815986,-1.1425629385044138,0.3080357142857143,0.7303963494330609,1.0,10/17,26.79%,SMO;TGFBR1;GRAMD1B;GRAMD1C;LRP6;GRAMD1A;PTCH1;MLC1;PMVK;SMAD2
prerank,positive regulation of binding (GO:0051099),0.37997785632928316,1.1420775427063836,0.2513812154696133,0.739851587923952,1.0,12/84,4.05%,CLDN5;RAPGEF2;APP;CAV1;HIP1R;PLAUR;B2M;EPB41;TIAM1;MEN1;HMBOX1;STMN1
prerank,regulation of cell morphogenesis (GO:0022604),0.45504085573913816,1.1414483190080138,0.3194888178913738,0.7407449527298522,1.0,7/30,11.20%,MFSD2A;MACF1;NTNG2;VIL1;STRIP1;FERMT2;PDZD8
prerank,positive regulation of apoptotic process (GO:0043065),0.3286764350886256,1.141000271218387,0.19542857142857142,0.7410767278399369,1.0,36/293,8.52%,MCF2L;ITGA6;ARHGEF3;DAB2IP;TGFB2;RASGRF2;FAS;NET1;UNC13B;HIP1R;PLEKHG5;TPD52L1;DCUN1D3;TNFSF10;ARHGEF2;RYBP;KALRN;FOXO1;FOXL2;TIAM1;ABR;TGM2;CTNNB1;RHOB;SOS1;CRADD;RNPS1;ARHGEF12;DNM2;IRF5;JMY;JUN;ARHGEF5;PIDD1;PREX1;ARHGEF7
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.4462147289747832,-1.1406694859195865,0.28699551569506726,0.7345072375330565,1.0,7/16,16.85%,WNT4;BMP4;CREB3L1;TGFB3;LARP6;RUNX1;SUCO
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5457914120257833,1.1403067220142624,0.3419593345656192,0.7421898273203527,1.0,6/11,18.73%,KCNQ1;ATP1A1;KCNH2;KCNJ3;KCNJ5;KCNIP2
prerank,neurotrophin signaling pathway (GO:0038179),0.48394122012115,1.1398853938807032,0.31175468483816016,0.7425747495519277,1.0,6/21,10.22%,RAPGEF2;RAPGEF1;GRB2;SORT1;SOS1;DDIT4
prerank,circulatory system development (GO:0072359),0.36277564946757224,1.1397486280026459,0.24088541666666666,0.7421079389785858,1.0,17/118,4.36%,TEK;RBM20;PDGFB;TGFB2;NOTCH4;HEG1;TBX1;SOX17;FLT4;MEF2C;ACVRL1;ZFPM1;APLNR;NOTCH1;HDAC9;RAMP2;FOXF1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4479347733203263,1.139627513895824,0.304857621440536,0.7416312873008432,1.0,10/33,16.30%,PTPRJ;PRKD2;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1;BCL10;CARD11;TESPA1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3628252159277037,1.1393821076683162,0.24468085106382978,0.741507636564014,1.0,28/118,13.84%,ETS1;SHANK3;TBX1;FLT4;NEDD4L;MEF2C;PLXND1;SP100;CDH2;VASH1;LZTS1;CTNNB1;TSPAN12;EPHA4;KIF1A;INF2;TGFB1;PAK1;STRIP1;FERMT2;ABI3;PDZD8;CEACAM1;CYRIB;EGLN1;NSMF;TNFAIP3;CFL1
prerank,positive regulation of cellular respiration (GO:1901857),0.5362241805703838,1.138767993472411,0.34392523364485983,0.7422973384052685,1.0,2/11,3.56%,IFNAR1;IL10RB
prerank,nervous system development (GO:0007399),0.32505559992805677,1.1385935010937025,0.1673960612691466,0.7419646647831886,1.0,68/429,12.79%,SPOCK2;ST8SIA4;MPZ;DNM3;SLC2A1;SHANK3;SEMA6A;ZIC3;ADGRL3;MAL;PCDH1;TBX3;SEMA6B;NAV1;NES;MEF2C;PLXND1;KALRN;FGF13;CDH2;DSCAML1;EVL;MERTK;ZBTB16;PCDHA11;MOG;PCDHAC1;WWTR1;SEMA4F;ATXN3;DBNL;NCKAP1;STMN3;FAT4;DCHS1;PCDHA1;NAV2;MARK4;NFASC;DPYSL2;TGFB1;SLITRK1;GPM6A;PTN;CDK5RAP2;OPHN1;APBA2;NRXN1;SPOCK1;CAPG;DNER;SERPINI1;RITA1;DCX;THOC6;EIF2B2;VXN;CHRM3;MOBP;PCDHB12;RAPGEF5;RBM45;HMGCR;SOX10;EPHB1;PCDHB14;CPNE6;FEZ2
prerank,response to iron ion (GO:0010039),-0.4862335274276778,-1.1380322728231513,0.30861244019138756,0.7407100852395817,1.0,4/12,11.49%,BMP6;BCL2;FXN;ACO1
prerank,amyloid-beta metabolic process (GO:0050435),-0.4498777660210197,-1.1380191258139079,0.2799097065462754,0.7393820295135288,1.0,5/16,12.41%,MGAT3;BACE2;ACE;IDE;PSEN1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3434739440841482,1.1377904870013769,0.21291866028708134,0.7432628198181822,1.0,51/198,18.95%,PLCB1;PTPRB;PLCB4;ITPKB;GPD2;INPP5D;DUSP23;PLA2G4B;DUSP3;PLCG1;CALM1;PLD4;OCRL;LIMK2;MAPK3;CERKL;PGM2L1;TGFB1;PLCH2;PAK1;PFKFB3;NUDT3;ACP4;TOLLIP;HK1;DUSP12;PPP3CA;IPMK;PLCH1;PIP4K2A;PIK3CB;TNK2;PANK3;DUSP16;INPP1;CERK;G6PC3;PFKL;DUSP8;CLN8;PLPPR4;SYNJ1;ALK;PLPP2;INPPL1;MINPP1;PRKCG;PAK2;NUDT10;GPX4;PGP
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5483729363666473,1.1373847791628238,0.33707865168539325,0.7435175530355955,1.0,4/10,25.65%,LGALS9;FOXP3;SCRIB;PRKAR1A
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.3962840588737864,1.1373102502337917,0.26132930513595165,0.7429476479247829,1.0,13/69,12.73%,APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;SYK;C1QTNF4;DDT
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5316612875724506,1.1372237924641673,0.3292894280762565,0.7423692704478257,1.0,4/12,3.95%,DOCK4;PDGFB;MEF2C;PRKG1
prerank,negative regulation of protein modification process (GO:0031400),0.38047642339882415,1.137052671294354,0.2460202604920405,0.7420372130838887,1.0,13/79,8.09%,OCLN;MFHAS1;PPP1R16B;DAB2IP;PRR5L;XDH;NIBAN1;MEN1;LYN;WWTR1;PPIA;INSM1;TGFB1
prerank,glucose homeostasis (GO:0042593),0.380891291914509,1.13696327324452,0.2323943661971831,0.7415136471890995,1.0,6/83,4.99%,IGF1R;INSR;ADIPOR2;KLF7;FOXO1;CYP11B1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5339256380873285,1.1367926215244528,0.3267148014440433,0.7411617478260973,1.0,4/12,19.71%,UNC13B;SYT7;RIMS2;UNC13A
prerank,organelle fission (GO:0048285),0.470014562666387,1.1362750420555738,0.2917341977309562,0.7417749832495938,1.0,1/24,0.16%,DNM3
prerank,negative regulation of mRNA processing (GO:0050686),-0.4671126635778411,-1.135507256549115,0.33112582781456956,0.7451609947321931,1.0,7/15,21.28%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;SRSF10
prerank,positive regulation of ERAD pathway (GO:1904294),0.5297446185149061,1.1354632565480887,0.3393177737881508,0.7432122066898671,1.0,4/13,17.36%,CAV1;ATXN3;UBQLN1;BAG6
prerank,regulation of dendritic spine development (GO:0060998),0.4999251879001486,1.1350437995788616,0.33157894736842103,0.7435653513660362,1.0,3/19,6.87%,SHANK3;MEF2C;KIF1A
prerank,positive regulation of wound healing (GO:0090303),-0.370572731380881,-1.1350163237675788,0.2557471264367816,0.745149986966526,1.0,9/36,5.24%,PLPP3;VTN;MYLK;ST3GAL4;KANK1;SMOC2;THBS1;FOXC2;ANXA1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.3596807459750366,-1.13456055147872,0.2694300518134715,0.7451516747445169,1.0,15/40,27.39%,FBH1;RTEL1;NUCKS1;TIPIN;ZRANB3;TRAIP;PRIMPOL;DONSON;WRN;ATR;BOD1L1;THOC1;CDK9;MCM9;SETMAR
prerank,ketone body metabolic process (GO:1902224),-0.5101188404912975,-1.1343293426936627,0.32553191489361705,0.7444116929294752,1.0,6/10,15.67%,OXCT1;ACSS3;BDH2;AACS;BDH1;HMGCLL1
prerank,prostaglandin metabolic process (GO:0006693),-0.40098646842675967,-1.1341237472689587,0.26463104325699743,0.7436185887397256,1.0,5/26,9.44%,PTGDS;PTGIS;PTGS1;PTGES;PTGR2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4477289719184017,-1.1340568159275692,0.30472103004291845,0.742441836081519,1.0,7/17,10.59%,SLC12A2;SLC9A2;SLC6A1;SLC8A1;SLC9A9;SLC9A1;TRPM4
prerank,calcium ion transport into cytosol (GO:0060402),-0.42776252270469706,-1.133537258453397,0.2709832134292566,0.7425669084682729,1.0,4/21,12.16%,CACNA1C;CACNA2D1;SLC8A1;JPH1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4550407408701189,-1.1334930041614428,0.31808278867102396,0.7413247151719328,1.0,5/16,12.11%,DDX5;PPARGC1B;AR;DDX17;ESR1
prerank,outflow tract septum morphogenesis (GO:0003148),0.4605613350226486,1.1331365202188675,0.30338983050847457,0.7479457403115944,1.0,5/24,1.88%,SEMA3C;ENG;BMPR2;TGFB2;TBX1
prerank,mitochondrial fusion (GO:0008053),-0.43156392310022473,-1.1329308919587953,0.2947845804988662,0.7416319647549174,1.0,5/18,14.16%,MIGA2;MIEF1;AFG3L2;MFN2;MIEF2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.319694869931005,-1.1327700342801035,0.21766561514195584,0.7407297549926928,1.0,30/80,23.65%,PLPP3;ATP9A;GBF1;COPA;KDELR3;COPZ2;COPB1;ARFGAP1;ARFGAP3;ERGIC3;COG4;ERGIC1;RAB6A;STX18;SCFD1;COPB2;SURF4;RACGAP1;ATP9B;ERGIC2;KIF18A;KIF15;CENPE;SCYL1;COPZ1;TMED9;KIF3C;COPG1;RER1;HTT
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5381385870410065,1.1320513202066536,0.3579136690647482,0.750099615558303,1.0,3/12,9.59%,SERINC3;SERINC5;CBS
prerank,SNARE complex assembly (GO:0035493),0.5471876470611813,1.1318726518886673,0.3430127041742287,0.7497984521638913,1.0,5/10,22.15%,STXBP6;STXBP1;UVRAG;VAMP8;SNCA
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.472246689741981,-1.1318385388212557,0.34279475982532753,0.7418743251938488,1.0,7/14,21.28%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;SRSF10
prerank,regulation of phagocytosis (GO:0050764),0.4060297878480603,1.1317521427889305,0.2927536231884058,0.7493414007326022,1.0,14/53,17.30%,DYSF;SCARB1;MERTK;TGM2;SNX3;GATA2;SYT7;HCK;ABCA7;SYK;IL15;GAS6;DOCK2;LYAR
prerank,positive regulation of leukocyte migration (GO:0002687),0.4613802766926387,1.1315945636522362,0.30377668308702793,0.7489746576334941,1.0,5/27,14.70%,IL6R;PTN;ADAM17;PLVAP;NCKAP1L
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.36563714196742814,1.1315277225811127,0.26666666666666666,0.7483643010264969,1.0,24/107,13.52%,SLC39A10;SLC39A8;CXCL12;CAV1;SLC30A1;CD40;ATP2C1;SLC24A2;SLC24A4;ATP2B1;SLC10A7;HTR2A;CALCB;CCL1;CSRP3;CDH5;MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,embryonic digit morphogenesis (GO:0042733),-0.43895452035116667,-1.1312937854465857,0.2957393483709273,0.742098882121097,1.0,4/18,4.36%,GLI3;OSR1;SALL1;WDPCP
prerank,positive regulation of autophagy (GO:0010508),0.3753631700336561,1.1312905542563239,0.2767203513909224,0.7481861635152471,1.0,21/81,15.35%,KDR;SH3BP4;TRIM14;FOXO1;PRKD1;CAMKK2;SESN3;IRGM;BNIP3L;EIF2AK4;PIK3C2A;GSK3A;SH3GLB1;ORMDL3;PIK3CB;SVIP;TFEB;EPM2A;PIM2;TMEM59;PLK2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4709978976968552,-1.1309258180616772,0.33624454148471616,0.7417652250196979,1.0,4/12,6.13%,IGF1;IRS1;IRS2;IGF2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5527723829347861,1.1308828212419884,0.3321100917431193,0.7485194695929441,1.0,2/11,8.30%,ITM2A;ABCA7
prerank,negative regulation of secretion by cell (GO:1903531),0.43026757207432065,1.1308583130428633,0.31211180124223603,0.747786521230493,1.0,8/38,14.46%,RHBDF2;SLC30A1;NOTCH1;STXBP6;PNKD;SYT4;HMGCR;GRM7
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4097311438351902,1.130634060274476,0.3194444444444444,0.7476190699396689,1.0,7/46,8.04%,SEMA6A;DAB2IP;CNKSR3;DUSP3;LYN;PTPRR;PIN1
prerank,tryptophan metabolic process (GO:0006568),-0.5041396739436438,-1.1299801465546178,0.33189655172413796,0.7431586624496944,1.0,6/11,30.36%,ATP7A;KYAT1;KMO;KYNU;IL4I1;HAAO
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5603901280091621,1.1297791420435137,0.35583941605839414,0.7483664416322645,1.0,4/10,12.65%,ALKBH2;MGMT;MPG;ASCC3
prerank,DNA dealkylation (GO:0035510),0.5603901280091621,1.1297791420435137,0.35583941605839414,0.7483664416322645,1.0,4/10,12.65%,ALKBH2;MGMT;MPG;ASCC3
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.4822269179460079,1.1296213063641538,0.31186440677966104,0.7480132676033237,1.0,5/20,8.57%,ENTPD1;APP;HSP90AB1;ENTPD5;P2RX7
prerank,oligosaccharide biosynthetic process (GO:0009312),0.4792769484529304,1.1296078336484376,0.3447098976109215,0.7472667513368753,1.0,3/20,5.93%,ST3GAL6;FUT8;FUT9
prerank,inorganic anion transport (GO:0015698),-0.36107107413353723,-1.129520615751606,0.24096385542168675,0.7431585954025223,1.0,9/53,6.46%,SLC13A4;SLC4A10;ENPP1;SLC26A7;ANO6;CLCN2;ENPP3;SLC5A5;ANO1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.41925254557568464,-1.1289316389412236,0.30279898218829515,0.7434992868910419,1.0,7/24,7.46%,COL5A1;PDPN;ARHGAP24;DDR1;FLNA;CCN1;ITGA5
prerank,rRNA processing (GO:0006364),0.3404843316997769,1.128862170785856,0.23803680981595093,0.7484932861883501,1.0,79/172,29.83%,RPL38;RPL13;RPL36A;MAK16;RPL3;RPL27;SNU13;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;PDCD11;RPL13A;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;NOL9;RIOK1;MRM2;RPL11;RPS15;RRP15;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;RPL37A;NHP2;NOL8;LYAR;RPL15;RRP12;EXOSC10;RPL17;RPL23;RPL34;WDR75;EXOSC9;THUMPD1;XRN2;NVL;RPL21;DDX54;RPL18A;RPL10A;EXOSC8;RIOK3;RPL24;MRPL1;RPL7A;RPL32;RPL4;RPS2;TBL3;BYSL;RPL6;RPS19;HEATR1;RPL14;RPL26;DDX10;UTP4;SBDS;DCAF13;RPS6;LSM6;POP5;TFB1M;DDX27;RPS14
prerank,regulation of insulin secretion (GO:0050796),-0.31175599068163506,-1.1287096067549813,0.20075757575757575,0.742823602761821,1.0,22/101,11.28%,CACNA1C;ADCY5;ITPR1;MCU;IRS1;EFNA5;NLGN2;RBP4;PER2;STXBP4;IRS2;SLC8B1;NNAT;PRKN;CACNA1D;CCN3;DPP4;CDK16;PRKCA;ITPR2;AACS;PPP3CB
prerank,B cell mediated immunity (GO:0019724),0.5613206544224859,1.12847909560661,0.3590664272890485,0.7487772355029223,1.0,3/10,15.56%,CD19;TLR8;MSH2
prerank,ribosomal small subunit assembly (GO:0000028),0.5045514308986355,1.1280103072214582,0.328719723183391,0.7492990363601877,1.0,6/16,14.11%,ABT1;RPSA;RPS27;PWP2;RPS15;RPS28
prerank,fibrinolysis (GO:0042730),0.5294963372309216,1.1280014898359056,0.3407821229050279,0.7485395935129667,1.0,2/13,9.25%,PLAUR;PLAT
prerank,negative regulation of ion transport (GO:0043271),-0.4019058849044873,-1.1279098399686964,0.2857142857142857,0.7437266362789138,1.0,10/24,25.25%,ACTN2;WNK4;PTK2B;WNK1;HTR1B;PACSIN3;WNK3;ADRA2A;NEDD4;STC1
prerank,negative regulation of protein binding (GO:0032091),0.3925213277015911,1.1273295235042133,0.2768361581920904,0.7496024915200166,1.0,14/71,12.78%,PDGFB;CAV1;CTNNBIP1;B2M;NES;ADAM15;ZFPM1;ACTB;RALB;PIN1;DISC1;PEX14;MITD1;SLPI
prerank,regulation of B cell activation (GO:0050864),0.46092013238083474,1.1268165165376742,0.32741935483870965,0.7502181544473592,1.0,8/25,19.85%,NOD2;CD19;ZFP36L1;TNFAIP3;FOXJ1;SH3KBP1;SAMSN1;ZFP36L2
prerank,cholesterol transport (GO:0030301),0.41059327949029456,1.1267703550368673,0.3119266055045872,0.7495678610700925,1.0,9/45,14.49%,CAV1;SCARB1;OSBP;ABCG1;ABCA7;NPC1;LIPC;MSR1;STARD4
prerank,transcription by RNA polymerase III (GO:0006383),0.4545401429194381,1.1266187579162952,0.3056910569105691,0.7492397190290011,1.0,6/27,15.25%,IVNS1ABP;GTF3A;GTF3C5;RO60;SNAPC1;CRCP
prerank,positive regulation of reproductive process (GO:2000243),0.44218598679153337,1.1259883014094114,0.3278955954323002,0.7500887273058184,1.0,2/31,1.70%,PLCB1;LHFPL2
prerank,lipoprotein localization (GO:0044872),-0.5008741559935406,-1.1257656695086555,0.3333333333333333,0.7485987633368549,1.0,1/11,0.53%,LRP1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.4897789123925578,-1.125721791795187,0.32119914346895073,0.7460559513098305,1.0,3/12,15.92%,FHL2;DYRK2;HOMER3
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.4897789123925578,-1.125721791795187,0.32119914346895073,0.7460559513098305,1.0,3/12,15.92%,FHL2;DYRK2;HOMER3
prerank,regulation of secretion (GO:0051046),0.5073336393847551,1.1254132830684247,0.3247706422018349,0.7508400454436287,1.0,4/13,14.50%,MYO6;KCNQ1;ACSL3;SGK1
prerank,myeloid leukocyte differentiation (GO:0002573),0.3934085362575138,1.125293339544856,0.28699551569506726,0.7503761798305154,1.0,12/65,13.47%,LEF1;TNFRSF11A;CCR7;CD4;PIR;LGALS9;CASP8;TNFSF11;TGFBR2;IL15;PPARG;MT1G
prerank,negative regulation of cellular process (GO:0048523),0.31646460671717386,1.1251620909187803,0.17822838847385272,0.7500069295211048,1.0,78/521,11.25%,ETS1;SRGAP2;PODXL;AQP11;DAB2IP;CD34;APBB2;BMPR2;PPP1R13B;TGFB2;NOS3;NOTCH4;RAPGEF2;JAM2;SH3BP4;APP;TBX1;DDAH1;PDE8A;ITGA1;SOX17;CD200;DYSF;CTTNBP2NL;DCUN1D3;ADGRG1;PTPRJ;RGCC;SMARCA2;PLXND1;SP100;ADAM15;SIPA1;ACVRL1;CCDC85B;PRKD1;NOTCH1;MEN1;LYN;PPP1R9B;SNX3;CTNNB1;TNFRSF21;SOX7;PIWIL1;DLL4;HYAL2;IGFBP7;BTG4;RHOB;ST18;WFDC1;ADAM10;KLF4;CDKN2B;NR1H2;ACTN1;INSM1;BST2;TGFB1;TMEM115;FOXP3;ADAMTS8;NPR1;BNIP3L;HMGA1;ARHGDIA;LPCAT3;AXIN2;BTG1;CBLL1;AGTR2;PDE12;CDC6;FERMT2;DUSP1;PLXNB3;CTCF
prerank,negative regulation of MAP kinase activity (GO:0043407),0.41346896516938025,1.124911240196516,0.31336405529953915,0.749929528033986,1.0,7/44,5.07%,DAB2IP;STK38;PTPRJ;DUSP7;LYN;NPPA;HYAL2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3887101773429533,-1.1248140972977925,0.29876543209876544,0.747207069895109,1.0,7/30,8.91%,FSTL1;TGFBR3;SMAD3;DKK3;TWSG1;SFRP4;SMURF2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4529301407536357,1.1246984352616314,0.3221476510067114,0.7496975431452672,1.0,10/26,11.81%,LYN;EPHA4;FYN;AIM2;EFNA1;PSME2;AGER;APH1A;GRIN2B;VSIR
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5013956030828085,1.1244296936691631,0.34991423670668953,0.749621655223795,1.0,4/15,11.82%,NOD2;GBP5;CD6;HIF1A
prerank,cellular response to radiation (GO:0071478),0.4199724872965824,1.1236284659930103,0.3115264797507788,0.7511254132044236,1.0,13/40,22.80%,NET1;GRB2;RHOB;OPN5;GPR52;OPN3;EEF1D;HUS1;RRH;NSMCE3;RAD9B;RAD1;INO80
prerank,microtubule anchoring at centrosome (GO:0034454),-0.49922143224553117,-1.1235912301088082,0.3181818181818182,0.7493811001356299,1.0,4/10,21.67%,NINL;PCM1;CEP19;BBS4
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.3593840379314098,-1.1235877298071817,0.29085872576177285,0.7480645940443874,1.0,12/43,11.73%,PID1;ENPP1;IRS1;KANK1;PRKCD;OGT;IGF2;GRB10;TNS2;PIP4K2C;NUCKS1;SNX5
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3778962294726611,1.1234277877879935,0.28714285714285714,0.7508515026077062,1.0,13/75,9.42%,SLC39A10;SLC39A8;SLC24A2;SLC9A5;SLC12A6;ATP1A4;ATP1A1;ATP1A3;SLC9A3;SLC12A9;KCNH2;SLC9A7;SLC9A6
prerank,epithelium development (GO:0060429),-0.30587373683281777,-1.1230738276539831,0.19844357976653695,0.7482886651106345,1.0,22/107,8.99%,ALDH1A2;ERRFI1;WNT4;FGFR2;KANK2;OSR1;PKD1;MEOX2;SMO;SALL1;VCL;LOXL3;DAG1;PKD2;ANXA4;SIX1;RCN3;DACT1;CNN3;BDH2;MTHFD1;IFT122
prerank,negative regulation of inflammatory response (GO:0050728),0.34027510643213654,1.122615859863157,0.2512019230769231,0.7523447221565591,1.0,36/182,14.39%,TEK;MFHAS1;PPARD;CD200;RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;KLF4;ADCY4;YES1;HCK;PRKAR2B;CD200R1;NPS;CALCB;ADAM17;LPCAT3;PRKAR2A;SHARPIN;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1;PPARG;CDH5;TNFAIP3;GIT1;HTR4
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.551636967525494,1.1226053791439292,0.3278985507246377,0.7516020701715997,1.0,3/10,6.45%,SIGIRR;PALM3;KLF4
prerank,extracellular matrix disassembly (GO:0022617),-0.34560084389477097,-1.1221332013288703,0.24338624338624337,0.7496566437211756,1.0,12/53,8.62%,GSN;TIMP2;MMP14;MMP16;SH3PXD2B;ADAMTS5;SCUBE1;CTSL;ADAMTS15;TLL1;MMP2;KLK2
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.35731747650741463,-1.1211698647097004,0.28285714285714286,0.7511790797390088,1.0,10/45,8.19%,SMAD3;BMP7;BMP4;PTPN3;GAS1;FOXC1;BCL6;FZD3;PRCC;ZWINT
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5132862352607697,1.1210891047485734,0.33907056798623064,0.7547987034430332,1.0,6/13,23.90%,ARID1A;SMARCD1;SPI1;ZMIZ2;SERTAD2;PADI2
prerank,homeostasis of number of cells (GO:0048872),0.5290569695849354,1.1207504858615427,0.3582089552238806,0.754903682856094,1.0,3/12,10.00%,NOS3;NOTCH1;LPCAT3
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.28558085738129185,-1.1205164380033323,0.17567567567567569,0.7516436289632674,1.0,35/150,13.67%,PID1;PTPN13;PRKAG2;NTRK3;LDLRAD4;PLPP3;ERRFI1;PPM1E;FBLN1;ENPP1;SLIT2;SMAD6;DEPTOR;IMPACT;DMD;RASSF2;PRKCD;DTNBP1;EMILIN1;EPHB2;PRKN;IGFBP3;PDPK1;SPRED1;QARS1;ITGB1BP1;PPEF2;LRRK2;IBTK;GPD1L;DMTN;TWIST1;NF1;PTEN;SIRT2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.28409221383758054,-1.1204269811995198,0.17543859649122806,0.7506107548979805,1.0,26/166,8.84%,SAMD4A;IGF1;ZEB2;EGFR;PLD1;PDGFRB;GLI2;SMAD3;IRS1;SMOC2;THBS1;SLC6A9;PPARGC1A;PKD2;FGF2;IRS2;IGF2;GLI1;PLXNB2;ATP7A;P2RX4;PTH1R;LPGAT1;FXR2;LDLR;NNMT
prerank,lytic vacuole organization (GO:0080171),-0.374365398903208,-1.119427692519498,0.2900763358778626,0.7522061708581146,1.0,12/32,18.25%,ABCA1;HOOK2;ARSB;GAA;CLN3;LRRK2;AKTIP;ACP2;GNPTAB;GRN;CLN6;MBTPS1
prerank,focal adhesion assembly (GO:0048041),0.46732807295978007,1.1191269423479562,0.31956912028725315,0.7584375800196795,1.0,5/21,10.91%,THSD1;ACTN1;SORBS1;ARHGEF7;FERMT2
prerank,cellular response to glucose starvation (GO:0042149),-0.3630903402975283,-1.1188158616788573,0.2849604221635884,0.7526681998154563,1.0,7/41,10.34%,PRKAG2;PRKAA2;IMPACT;FOXO3;NUAK1;MTMR3;PRKAG3
prerank,arachidonic acid metabolic process (GO:0019369),-0.3725969166651049,-1.1186958267232734,0.2883116883116883,0.7517161807126506,1.0,6/35,5.75%,PTGDS;PTGIS;PTGS1;DAGLA;CYP1B1;PTGES
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.48264506804225643,1.1180754178090182,0.3463497453310696,0.7605215861497008,1.0,4/18,11.65%,HIP1R;SLC25A5;ZNF205;GSK3A
prerank,RNA destabilization (GO:0050779),-0.44176494196120764,-1.1178282938357014,0.3303370786516854,0.7528918585593065,1.0,5/18,24.65%,ROCK2;YTHDF1;RBM24;ZC3H18;MEX3D
prerank,peptidyl-lysine modification (GO:0018205),-0.30793941184021817,-1.1176379123541749,0.21509433962264152,0.7521137889646443,1.0,20/99,14.57%,EYA1;LOXL1;PLOD2;HDAC4;LOXL3;PIAS1;SEH1L;P3H3;NNAT;LOX;ATP7A;SIRT3;NUP205;TRPM4;SENP3;SENP6;PIAS2;SENP7;SIRT2;EP300
prerank,protein dephosphorylation (GO:0006470),0.35003810191266477,1.1176322237707663,0.2706964520367937,0.7609288250400282,1.0,21/135,11.40%,PTPRG;PTPRM;PTPRB;CTTNBP2NL;PTPRJ;PPM1L;DUSP7;PTPN12;SSH2;DUSP3;PPP3CC;PPP4R1;PPP2R5A;PTPRR;MTMR6;PTPN5;PPP1CB;SSU72;DUSP12;DUSP1;PPP3CA
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4521863173176108,1.117603184102201,0.3164128595600677,0.7602333290619613,1.0,4/27,12.52%,ETS1;CCDC88B;TNFSF11;CYRIB
prerank,ethanol metabolic process (GO:0006067),-0.48612045273326887,-1.1171881639416148,0.3273942093541203,0.7521186370670617,1.0,1/12,0.31%,ALDH1A1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.43836379890262034,1.1167067093393521,0.3360258481421648,0.7617993009794128,1.0,9/33,16.12%,IGF1R;PLEKHA1;CD160;HTR2A;PIK3C2A;PIK3CB;ZFP36L1;PIK3R5;EDN1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.4097357250649356,-1.1166370922385,0.3385012919896641,0.7524114919791569,1.0,3/20,3.84%,ACTN2;OSR1;CAMK2D
prerank,vitamin transport (GO:0051180),0.44971209720839356,1.1165962557180367,0.31921824104234525,0.7613011055584133,1.0,5/29,10.98%,ABCG2;SLC52A2;SLC25A32;SLC52A3;AMN
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.5305378544191772,1.1164134988384917,0.36178107606679033,0.7610271120510652,1.0,6/11,21.34%,UQCRB;CYC1;UQCRC1;CYCS;UQCRQ;UQCR11
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.45950607389506515,-1.1160051676105833,0.3302540415704388,0.7529159978235598,1.0,7/15,19.98%,PRKCD;SMPD3;SIRT3;NSMAF;SPHK1;PLA2G6;ORMDL2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.380869135672345,1.1159729749368417,0.2853146853146853,0.7614256442242192,1.0,7/73,2.77%,HIP1;ACER2;XDH;FAS;HIP1R;TNFSF10;NOD1
prerank,positive regulation of DNA binding (GO:0043388),-0.38313936540723226,-1.1157541386745815,0.28350515463917525,0.7522978240418523,1.0,8/31,13.67%,IGF1;FOXC1;NGF;PRKN;NIBAN2;SKI;TWIST1;SIRT2
prerank,blood vessel diameter maintenance (GO:0097746),-0.3795238029919616,-1.115442959360314,0.2892561983471074,0.7518920215536631,1.0,12/34,15.39%,ROCK2;EDNRA;KCNMB2;PER2;SCPEP1;ACE;BDKRB2;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,cellular component disassembly (GO:0022411),-0.3449408101417836,-1.115086168111409,0.25935828877005346,0.7515248540057895,1.0,12/53,8.62%,GSN;TIMP2;MMP14;MMP16;SH3PXD2B;ADAMTS5;SCUBE1;CTSL;ADAMTS15;TLL1;MMP2;KLK2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.47462413514810975,-1.114951027026291,0.31497797356828194,0.7505743435437684,1.0,5/12,21.67%,NINL;BICD1;PCM1;CEP19;BBS4
prerank,translesion synthesis (GO:0019985),0.42162551138340126,1.1142505284325483,0.32,0.7652820109490798,1.0,2/42,2.24%,POLK;TRIM25
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4444128364820862,1.1133077157102331,0.3273905996758509,0.7670452564412115,1.0,6/30,3.23%,ARHGEF3;NET1;F11R;ADGRG1;LPAR6;PRAG1
prerank,positive regulation of DNA replication (GO:0045740),-0.44909581227409673,-1.1128509836394551,0.3294663573085847,0.7553737272137511,1.0,3/16,6.56%,EGFR;GLI2;GLI1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.46169440198118294,1.112389899900482,0.3240418118466899,0.7686438352382681,1.0,5/24,8.66%,TTLL7;TTLL5;TTLL10;TTLL3;AGBL5
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.3491247104429116,-1.1119831866163505,0.28700906344410876,0.7566677738149441,1.0,9/49,16.16%,LDLRAD4;SMAD6;IMPACT;DACT1;ANKRD27;DDX3X;EP300;NLRP2B;CRYAB
prerank,negative regulation of multicellular organismal process (GO:0051241),0.33239528897534903,1.1118840969262607,0.25851197982345525,0.7692877585865819,1.0,35/199,12.68%,PTPRG;RAB11FIP1;DAB2IP;BMPR2;NOS3;NOVA2;MCC;ID1;KLF7;RGCC;MEF2C;SRGN;NOTCH1;HDAC9;EVL;SMAD7;IL17RD;RPS6KA5;ATP2B1;NR1H2;N4BP1;PTPRR;BRCA2;EFNA1;TGFB1;FOXP3;PPP1R11;ADAM17;AGER;ADIPOR1;GSK3A;HMGCR;GDF15;IL15;WWC1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.48048547981563,1.1115254566784039,0.33060556464811786,0.769492799818743,1.0,5/19,10.94%,IFIH1;KLF4;IRAK2;LIFR;CBFB
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4531953211438403,-1.1111716080073848,0.3355119825708061,0.7576161588257709,1.0,4/13,6.13%,IGF1;IRS1;IRS2;IGF2
prerank,rRNA transcription (GO:0009303),0.49757720721073695,1.111059827355623,0.34965034965034963,0.769982082579554,1.0,6/17,22.62%,TAF1B;GTF3A;GTF3C5;SIRT7;SPIN1;GTF3C1
prerank,regulation of cell cycle process (GO:0010564),0.35961533145448465,1.1107797682914284,0.2862903225806452,0.7699575050703601,1.0,26/104,17.15%,BCL2L1;DCUN1D3;CALM1;CTNNB1;CDKN2B;CCP110;INSM1;RAB11A;MARK4;PIN1;CETN2;CAV2;RAB11FIP4;PIK3C3;SH3GLB1;SOX9;GIT1;TTL;SPAG5;PLK2;SND1;RPRD1B;APC;PRPF40A;HMGA2;CEP85
prerank,positive regulation of telomerase activity (GO:0051973),0.4402926283956405,1.1107462061665256,0.3295819935691318,0.7692856742512024,1.0,15/33,27.17%,HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;ACD;MAPK1;NAF1;MAP2K7;NVL;PTGES3;MYC;PNKP;NEK7
prerank,positive regulation of hemostasis (GO:1900048),-0.49770696514636315,-1.1106208865301201,0.35683760683760685,0.7565582192743154,1.0,5/10,22.31%,ST3GAL4;THBS1;DMTN;SERPINE1;HPSE
prerank,positive regulation of coagulation (GO:0050820),-0.49770696514636315,-1.1106208865301201,0.35683760683760685,0.7565582192743154,1.0,5/10,22.31%,ST3GAL4;THBS1;DMTN;SERPINE1;HPSE
prerank,lymphocyte proliferation (GO:0046651),0.4626899414604299,1.1100835380111687,0.3261231281198003,0.7702237163048172,1.0,6/22,12.86%,MEF2C;CD40;CD79A;MSN;TNFRSF4;HELLS
prerank,membrane depolarization (GO:0051899),0.4234648600574565,1.1100267210690087,0.3232830820770519,0.7696238424939394,1.0,6/32,8.57%,CACNA1A;CAV1;SCN1A;KCNH2;YWHAH;P2RX7
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.40028354874435296,-1.1097746479677186,0.32805429864253394,0.7576675061102507,1.0,6/24,11.45%,ITPR1;PKD2;FGF2;ANXA6;ITPR2;IBTK
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3752783988603784,1.1097405492448111,0.2906110283159464,0.7696250099637493,1.0,30/80,17.99%,OCLN;WASF2;FNBP1L;PALM;AGRN;EPS8;CCR7;EPS8L2;CCDC88A;CDC42EP3;CCP110;NCKAP1;MARK4;GPM6A;TWF2;P2RX7;CYFIP1;CLRN1;PLEKHM1;RAC1;HRAS;FSCN1;FAM98A;ANLN;NLGN1;APC;RALA;ACTR2;TENM1;KCTD17
prerank,glycosphingolipid metabolic process (GO:0006687),0.407985889961378,1.1093569694614345,0.30745341614906835,0.7698646593853077,1.0,9/42,13.92%,ST6GALNAC3;ESYT2;NEU4;ESYT1;GLB1;GLTP;B4GALNT1;CERK;NEU2
prerank,cellular response to lectin (GO:1990858),0.3612700594170513,1.1088090159903832,0.29499323410013534,0.769818098590078,1.0,25/104,18.28%,MUC3B;MUC3A;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;PAK2;SKP1;PSMD9
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3612700594170513,1.1088090159903832,0.29499323410013534,0.769818098590078,1.0,25/104,18.28%,MUC3B;MUC3A;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;PAK2;SKP1;PSMD9
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.49395546292527165,1.108652650832707,0.3410714285714286,0.7694603953893242,1.0,5/16,10.26%,PDGFB;PDGFD;PTPRJ;PLAT;PIK3C2A
prerank,oligodendrocyte development (GO:0014003),0.49958202596323104,1.1084986132970767,0.35111876075731496,0.769112462577425,1.0,9/15,28.61%,B4GALT5;EIF2B1;EIF2B2;SOX10;TPPP;EIF2B4;PLP1;MYRF;HES5
prerank,cellular protein modification process (GO:0006464),0.30326703003064304,1.1083821895705368,0.16905737704918034,0.7686455664893315,1.0,221/982,18.28%,PTPRG;ST8SIA4;PRKCH;PTPRM;ST3GAL6;PTPRB;ERG;EPAS1;PDGFB;INSR;ST8SIA6;BMPR2;TGFB2;LMO7;MAP4K2;KLHL5;KLHL2;APP;CDK17;ST3GAL1;MAP4K3;B4GALT5;CTTNBP2NL;DCUN1D3;ST6GALNAC2;STK38;PKN3;SPARCL1;PTPRJ;VWA1;PPM1L;LIPE;SNRK;DUSP7;JAK3;PTPN12;ACVRL1;PRAG1;MAP3K1;CDH2;PRKD1;STK10;PRKD2;MEN1;CDK19;ZAP70;SSH2;MERTK;LYN;FNIP2;PRKG1;ZBTB16;TGM2;SOCS2;B3GNT2;PPP3CC;IKBKB;OGA;NOTUM;PPP4R1;CREB1;PIGU;IGFBP7;CAMKK2;PKN1;STT3B;LIMK2;PRKACB;FUT9;KLHL25;PAK5;FYN;MAPK3;RPS6KA5;ADAM10;FBXW7;RET;PPP2R5A;YES1;AATK;PSMB3;GOLM1;PKN2;HCK;RAB11A;COG3;LCMT1;PTPRR;PXK;MARK4;FBXO41;PDIA6;MTMR6;PSMD11;TGFB1;RHBDD1;MARK3;ABCA7;MAP3K6;QSOX1;PIGK;PSMC6;FEM1C;NPC1;PTPN5;KLHL3;PAK1;PGGT1B;PLAT;PPP1CB;PSME2;SCG3;EIF2AK4;SOCS5;PIK3C3;PTK6;TRIB2;KLHL20;PRKAB1;FBXL2;JMJD7;CHRM3;DUSP12;DUSP1;PSMD8;PPP3CA;PRKCB;GSK3A;WSB1;UBA3;HIF1A;SYK;B3GALT4;FBXO6;MAP4K4;TGFBR2;DUSP16;HIPK2;ASB13;RAB1A;EVA1A;DCUN1D1;B3GALT2;MANBA;STK24;STK3;MINK1;FBXW2;SSH1;METAP2;ASB5;PSMB10;FBXO21;SERP2;RBX1;PIM2;MAN2B1;DUSP8;VRK1;SGK1;TBCK;CAMK2B;STK26;SERPINC1;NUS1;FBXL8;CTBP1;DAD1;UBE2D3;GRK6;FBXL15;MTMR2;NEK3;HIPK3;ELOB;ASB15;LOXL2;LORICRIN;PLK2;SGK3;SGK2;GCNT2;MMP15;MCRS1;ZC3HAV1;PROC;DCAF5;PSMA8;ASB7;MAPK1;B3GNT3;ATE1;COPS5;ACVR1;SIRT7;GAS6;SEPHS1;YWHAZ;PTPRZ1;TMEM132A;SIK2;GPS1;FN3K;PPM1F;MAP3K11;SCG2;PRKG2;KBTBD8;WDR45;FBXO2;PRKCG;PRKCE;RCE1;TBK1;PAK2;SKP1;WNK2;PTPRK;RSKR;CDK11B;PSMD9
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.379974553458006,-1.108096446674129,0.3247422680412371,0.7611487192864799,1.0,12/30,21.83%,DDX5;DAB2;AR;HEYL;KLK2;KDM1A;PIAS2;EP300;SFRP1;NCOR1;RNF14;SAFB2
prerank,negative regulation of cell death (GO:0060548),0.36792989411489535,1.1077369782637247,0.2962962962962963,0.7695969551264016,1.0,12/88,11.17%,MECOM;SRGAP2;CD34;PDE8A;CD200;PRKD1;FYN;CD200R1;BNIP3L;PDE12;FERMT2;KIR3DL2
prerank,neural crest cell differentiation (GO:0014033),0.47932114725877367,1.1075627877745633,0.354014598540146,0.7693021048251887,1.0,6/18,17.63%,MEF2C;CDH2;SNAI2;SOX11;PDCD6;KBTBD8
prerank,substrate-dependent cell migration (GO:0006929),0.5138792779266365,1.1070005483171,0.3738819320214669,0.7699612302774438,1.0,4/14,8.64%,NTN1;ANKS1A;CD2AP;OPHN1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3598037088838457,1.1069542831540495,0.2959459459459459,0.7693210781018631,1.0,25/105,18.28%,MUC3B;MUC3A;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;PAK2;SKP1;PSMD9
prerank,excitatory postsynaptic potential (GO:0060079),0.47161551570264726,1.106126813118428,0.335042735042735,0.7707502905200132,1.0,4/19,11.65%,MEF2C;GRID2;GRIN2B;GSK3A
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.4832231567646173,1.106025595602054,0.37305699481865284,0.7702345670513101,1.0,3/17,4.26%,CLDN5;F11R;IKBKB
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4024765673667196,-1.105985406546024,0.29850746268656714,0.7647580438677248,1.0,11/23,18.58%,ZEB2;THBS1;DAB2;TGFB1I1;STK11;GIPC1;SLC2A10;EP300;CDKN1C;CITED2;FLCN
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4024765673667196,-1.105985406546024,0.29850746268656714,0.7647580438677248,1.0,11/23,18.58%,ZEB2;THBS1;DAB2;TGFB1I1;STK11;GIPC1;SLC2A10;EP300;CDKN1C;CITED2;FLCN
prerank,sterol metabolic process (GO:0016125),-0.33102072627856033,-1.1059177972585046,0.266025641025641,0.7636583770705017,1.0,15/60,18.11%,PRKAG2;CYP7B1;CYP26B1;INSIG2;CYP27A1;ABCA1;CYP1B1;APOE;OSBPL5;RXRA;TSKU;FDX1;ANGPTL3;SQLE;CLN6
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.45584963134824263,1.105661734969397,0.33442088091353994,0.770437823505179,1.0,6/25,15.12%,APP;ANKRD13A;RIN3;RAC1;SDCBP;MTMR2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.38583649397248043,-1.1056508022552949,0.3157894736842105,0.7631494353287968,1.0,10/29,23.27%,COPA;COPZ2;COPB1;TRAPPC3;RAB6A;TRAPPC10;COPB2;GOLGA5;COPZ1;COPG1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4693484718832234,-1.1055189315351086,0.3482905982905983,0.7622366312259832,1.0,6/12,24.32%,IRS1;IGF2;SNX5;ZBTB7B;PRKCZ;C1QTNF12
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.36500384928447505,1.105242666479885,0.30266666666666664,0.77080926858462,1.0,14/90,12.19%,IGF1R;EPAS1;ADIPOR2;GATM;CAV1;UCP2;OXTR;YBX2;IL4R;FABP5;PRKAB1;ADIPOR1;SYK;ELOVL6
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.4250661886600109,-1.1051300934883388,0.3133971291866029,0.7620838082868383,1.0,6/20,11.06%,GRK3;MGRN1;MET;BICD1;GPRASP1;RPGRIP1L
prerank,exit from mitosis (GO:0010458),0.5286359985525108,1.104916225276259,0.34990791896869244,0.7709408005533025,1.0,5/12,25.97%,EPS8;SIRT7;SPAST;CLASP1;CLASP2
prerank,negative regulation of leukocyte migration (GO:0002686),-0.4946503218886875,-1.1047148322111169,0.36065573770491804,0.761967795946492,1.0,5/10,11.81%,BMP5;SLIT2;HOXA7;EMILIN1;CD300A
prerank,regulation of cell aging (GO:0090342),-0.4796064345043153,-1.1045366755219974,0.3283261802575107,0.7611834538637592,1.0,3/11,9.41%,LMNA;NEK6;NUAK1
prerank,long-term memory (GO:0007616),-0.4199063311186563,-1.1044075934020443,0.3304535637149028,0.7602570381504373,1.0,5/19,15.20%,NFATC4;APOE;PJA2;LDLR;RASGRF1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.45898213742052246,-1.104406399541563,0.3471615720524017,0.7577218950059689,1.0,5/15,15.61%,ITGB5;ARRB1;PHACTR1;CUL3;ZYX
prerank,stress fiber assembly (GO:0043149),-0.45898213742052246,-1.104406399541563,0.3471615720524017,0.7577218950059689,1.0,5/15,15.61%,ITGB5;ARRB1;PHACTR1;CUL3;ZYX
prerank,acute inflammatory response (GO:0002526),0.4578680687484104,1.1040760617128562,0.33098591549295775,0.772385279809232,1.0,4/23,4.95%,IL6R;CTNNBIP1;SIGIRR;CD6
prerank,positive regulation of endocytosis (GO:0045807),-0.3536811451315182,-1.1037646107408883,0.28654970760233917,0.7583503690771878,1.0,11/45,9.19%,LRP1;APPL2;VTN;AXL;GPC3;ANO6;DAB2;RAB21;APOE;CLIP3;BICD1
prerank,negative regulation of receptor binding (GO:1900121),0.5425126237801188,1.1037572102235855,0.3726937269372694,0.7724980947604106,1.0,2/10,3.05%,B2M;ADAM15
prerank,Golgi ribbon formation (GO:0090161),-0.4695425244613834,-1.103719341138708,0.34615384615384615,0.7572371931565492,1.0,6/13,29.07%,GOLGA2;PRMT5;STX16;OPTN;MYO18A;TRIP11
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.35257640384157,-1.1036549402048825,0.2915601023017903,0.7561701130461707,1.0,14/44,10.00%,LPAR1;ROCK2;PPM1E;CCN2;ARHGEF10L;TPM1;CARMIL1;TGFBR1;S100A10;FHOD1;PFN2;MYOC;TGFB3;ITGB1BP1
prerank,mesenchyme development (GO:0060485),-0.4621998595488282,-1.1031618559277723,0.3470319634703196,0.756325922289744,1.0,5/15,4.66%,BMP7;FGFR2;BMP4;TGFBR1;PKD2
prerank,ribosome biogenesis (GO:0042254),0.3321878100704478,1.1030355380527639,0.27667493796526055,0.7737315268837155,1.0,78/187,28.90%,RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;NOP16;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;PDCD11;RPL13A;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;GTF3A;NOL9;RIOK1;MRM2;RPL11;RPS15;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;RPL37A;NOL8;LYAR;RPL15;NAF1;RRP12;EXOSC10;RPL17;RPL23;RPL34;WDR75;EXOSC9;NOC2L;PAK1IP1;XRN2;NVL;RPL21;DDX54;RPL18A;RPL10A;EXOSC8;SURF6;ABCE1;RPL24;RPL7A;MRPL22;RPL32;RPL4;RPS2;TBL3;BYSL;RPL6;RPS19;HEATR1;RPL14;RPL26;DDX10;UTP4;SBDS;DHX29;RAN;DCAF13;RPS6
prerank,mRNA metabolic process (GO:0016071),-0.31173904547572673,-1.102252602526981,0.27364864864864863,0.7577050480353926,1.0,27/90,22.91%,DDX5;PPARGC1A;SON;SRSF5;SRSF11;PCF11;AKAP8L;SRRM4;CPSF3;PRKACA;SRSF4;RNASE4;HNRNPR;NONO;HNRNPA2B1;PRMT9;PCBP2;PRPF18;LSM10;PRPF3;U2AF2;U2AF1;LSM3;TCERG1;CSTF3;AURKAIP1;TBRG4
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3855596270885716,1.1020463628144541,0.3168604651162791,0.7756236605586915,1.0,15/64,13.75%,CYP2E1;PLA2G4B;ACSL5;CPT1A;ACOX1;ACSL6;ELOVL5;ACSL3;AIG1;ABCD1;ELOVL6;PNPLA8;SLC27A2;LTA4H;HACL1
prerank,macrophage activation (GO:0042116),0.432852691590344,1.1017006111179448,0.3564516129032258,0.7757508194737835,1.0,11/34,22.15%,APP;DYSF;CD93;AGER;SYK;NMI;SBNO2;PLCG2;FOXP1;IFNGR1;SNCA
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3791094629485457,1.101400090089312,0.31547619047619047,0.7757717210005872,1.0,14/73,14.07%,APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;SYK;C1QTNF4;DDT;BCL10
prerank,potassium ion export across plasma membrane (GO:0097623),-0.4648383005060893,-1.1013932784228755,0.33407572383073497,0.7588654329315669,1.0,2/13,3.08%,KCNT2;KCNK5
prerank,negative regulation of blood coagulation (GO:0030195),0.4122898011756849,1.1011550017283018,0.3262518968133536,0.7757005337226041,1.0,4/38,2.28%,PDGFB;CD34;NOS3;PLAUR
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4535563795558135,1.1000512452540856,0.3683304647160069,0.777927444903435,1.0,8/24,13.59%,OCLN;WASF2;NCKAP1;TWF2;CYFIP1;CLRN1;RAC1;FSCN1
prerank,cell-cell junction maintenance (GO:0045217),0.5249240985982715,1.0999467024925595,0.35778175313059035,0.7774324883728733,1.0,5/11,19.90%,TJP1;FERMT2;INAVA;CSF1R;F2R
prerank,hydrogen peroxide metabolic process (GO:0042743),0.48369313549558374,1.0997867356296622,0.3527336860670194,0.7771013304215095,1.0,5/19,14.90%,PXDN;CAT;ACOX1;MAOB;PRDX5
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.47171381636220855,1.099645668277457,0.36115843270868825,0.7767096919752892,1.0,7/20,12.53%,PDGFB;CCNY;RGCC;HSP90AB1;CCND3;ADAM17;MAPRE3
prerank,neural tube closure (GO:0001843),-0.37259114728069487,-1.0992050438911891,0.3252032520325203,0.7637510244974789,1.0,15/34,17.88%,LMO4;COBL;PLXNB2;KDM2B;MTHFR;MTHFD1;IFT122;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;MTHFD1L;PAX2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3869088234482403,1.0990680908033723,0.3047337278106509,0.7773904349329722,1.0,13/64,12.23%,LIMCH1;UTRN;MACF1;ACER2;PTK2;ADAM15;DUSP3;CCR7;NEXMIF;ACTG1;SLK;PIK3CB;MAP4K4
prerank,negative regulation of viral transcription (GO:0032897),0.5040819271720677,1.0988198632995814,0.3723021582733813,0.7772866009825838,1.0,1/13,2.37%,TRIM14
prerank,regulation of biosynthetic process (GO:0009889),0.5185883165226189,1.0981837953048046,0.37725631768953066,0.7782760974350559,1.0,2/11,6.23%,PIKFYVE;SLC25A33
prerank,sphingosine biosynthetic process (GO:0046512),0.5158057467566399,1.0978536637392966,0.37477148080438755,0.7776601499603386,1.0,3/11,6.96%,ACER2;ACER1;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),0.5158057467566399,1.0978536637392966,0.37477148080438755,0.7776601499603386,1.0,3/11,6.96%,ACER2;ACER1;SPTLC2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3532993062442628,1.0977055605456492,0.3125845737483085,0.7772829892216345,1.0,25/110,16.68%,TFRC;DAB2IP;TIRAP;FNIP2;TAL1;BIK;HCK;STXBP1;RALB;INSM1;LCMT1;TGFB1;IRGM;MMP1;HSPA8;SYK;SH3GLB1;SVIP;CDH5;BBS10;GFAP;MPP7;OPRD1;HCFC1;SUMO1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.45815649536249736,-1.0976173432242688,0.34210526315789475,0.7670841378983971,1.0,4/14,23.09%,IL18;IL17D;CD84;CD80
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5424300836558611,1.0972950100979022,0.37572254335260113,0.7775880977777361,1.0,3/10,4.53%,PDE2A;APLNR;PDE4D
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.38743802188882576,-1.0970647499079416,0.3292079207920792,0.7674419129697354,1.0,4/27,7.09%,IGF1;PDGFRA;S100A6;PDGFC
prerank,nerve growth factor signaling pathway (GO:0038180),0.5253556460451299,1.096970799188342,0.36678832116788324,0.7777135917143756,1.0,2/10,3.02%,RAPGEF2;RAPGEF1
prerank,cardiac myofibril assembly (GO:0055003),-0.44702407372962905,-1.0966693487340355,0.3400447427293065,0.767290754608377,1.0,3/15,3.88%,PDGFRB;PDGFRA;OBSL1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4399523286548095,-1.0963069956762057,0.3589108910891089,0.7670515809448969,1.0,7/17,16.50%,ARRB1;ANXA1;ANXA4;SSC5D;PTPN22;MAP2K5;MAPKBP1
prerank,negative regulation of cell development (GO:0010721),-0.4040597785319024,-1.0962872824815397,0.3333333333333333,0.7658556236211552,1.0,3/25,1.30%,IGF1;FBN1;APPL2
prerank,cristae formation (GO:0042407),0.4431111125433575,1.0958168892490747,0.3608768971332209,0.7800085170488812,1.0,9/27,19.22%,ATP5F1E;ATP5MC2;LETM1;ATP5PO;SAMM50;ATP5F1A;ATP5MF;ATP5PF;CHCHD3
prerank,activation of protein kinase activity (GO:0032147),-0.30161288296451777,-1.0956886369004621,0.27692307692307694,0.7663253497721351,1.0,26/106,13.69%,IGF1;NTRK3;ADCY5;ANGPT1;ADCY1;FGF1;ADCY9;NRK;IL18;PRKCD;ADCY2;OSBPL8;ADCY7;CARD14;PDPK1;AXIN1;ITGB1BP1;STK11;PRKACA;PTK2B;ABL1;ADCY6;PRLR;PIBF1;GHR;STRADA
prerank,regulation of lamellipodium organization (GO:1902743),-0.46677447112583853,-1.095618048496602,0.3475177304964539,0.7652722006942057,1.0,3/14,2.69%,PDPN;CARMIL1;CAPZB
prerank,defense response to tumor cell (GO:0002357),-0.4970110698863881,-1.0954835411003565,0.363013698630137,0.7644367219637693,1.0,1/10,0.11%,RBMS3
prerank,negative regulation of synaptic transmission (GO:0050805),0.4644727865883675,1.0954606006819358,0.3926174496644295,0.7801714642830314,1.0,7/23,15.35%,SLC30A1;SLC24A2;STXBP1;PNKD;TMEM25;MTMR2;PLK2
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4089262623456153,-1.0952226662090456,0.3219178082191781,0.7639678950911958,1.0,6/21,12.43%,CXADR;AKAP13;SLC8A1;MYH11;KDM6B;BMP2
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.40275929787465314,-1.0952090677465591,0.3704663212435233,0.7627802767397656,1.0,1/23,0.34%,IGF1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.41959787131720416,-1.0951013585831109,0.33569739952718675,0.7618606192572748,1.0,8/19,20.57%,PLCE1;NFAT5;NFATC4;PPP3CB;INPP5A;NFATC2;NFATC3;HRH1
prerank,regulation of protein secretion (GO:0050708),0.35095464144618727,1.0947314009607692,0.2975871313672922,0.7813641678734788,1.0,15/119,6.34%,SLC2A1;CACNA1A;TGFB2;UNC13B;STX1A;RHBDF2;CD2AP;RAPGEF3;ABCG1;NOS2;KCNC2;SYT7;PPIA;RAPGEF4;KCNG2
prerank,monocyte differentiation (GO:0030224),-0.4871329174778264,-1.0946349386664216,0.3773987206823028,0.7619510197055813,1.0,2/10,1.89%,IL31RA;BMP4
prerank,protein-containing complex subunit organization (GO:0043933),0.3498170779717187,1.0946122130770983,0.2963951935914553,0.7809115563859498,1.0,10/109,6.92%,OCLN;SLC2A1;FAS;MAGI1;CD40;PARD3;CD2AP;VIL1;CARD10;CLDN14
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.46761657884523705,1.0944459346603357,0.36460176991150445,0.780572750031226,1.0,3/18,8.93%,SHANK3;NPS;NRXN1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4002432394826192,-1.0941823799782773,0.3316062176165803,0.7620665023206363,1.0,7/24,10.21%,SEC24D;SEC24A;ACE;SEC31A;CANX;SEC23A;IDE
prerank,modulation by symbiont of host process (GO:0044003),0.5376800715709629,1.093884912537311,0.3711151736745887,0.7813550671530044,1.0,2/10,12.42%,B2M;HGS
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4448599526681178,1.0936902268910507,0.34904013961605584,0.7810971365771743,1.0,8/26,16.18%,SHANK3;APP;WNT7A;NRXN1;TMEM25;MTMR2;NLGN1;RIMS2
prerank,negative regulation of protein polymerization (GO:0032272),0.4385983400428776,1.093687513333357,0.37456445993031356,0.7803543185575097,1.0,8/27,13.85%,KANK3;HIP1R;SSH2;STMN1;TWF2;CYRIB;CDH5;SSH1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3859767191530514,-1.0935440259844613,0.3384223918575064,0.7626233622830835,1.0,3/26,5.14%,LGR4;APPL2;FLOT2
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.4316716716694936,-1.0933480187746503,0.35377358490566035,0.7619058983203516,1.0,3/17,11.34%,IGF1;APOE;RTN1
prerank,cellular protein catabolic process (GO:0044257),0.3775821006361074,1.093246651439991,0.31085043988269795,0.78073987235994,1.0,23/59,23.75%,DAB2IP;DENND3;CTSC;CTSW;CTSK;CTSO;UBE2G1;AP2M1;BNIP3L;MALT1;CASP8;AP2B1;AFG1L;CTSS;UBE2G2;CAPN2;RSPRY1;PISD;AP2S1;BNIP3;LGMN;RIPK1;LONP1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3809549554928053,1.0930451257102256,0.3445255474452555,0.7805084637693179,1.0,14/63,14.07%,ITGA6;CAV1;FAS;SH3RF1;TNFSF10;SP100;HYAL2;DEDD2;ZMYND11;AGTR2;CASP8;TNFSF12;CYLD;BCL10
prerank,embryonic organ development (GO:0048568),0.38200877820950496,1.0922649057956066,0.3358208955223881,0.7817323692088667,1.0,8/61,3.19%,KITLG;MFSD2A;KDR;TGFB2;TEAD4;SOX17;NES;ZFPM1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4447687781047486,1.0920702849878738,0.34527687296416937,0.7814733767558978,1.0,5/25,11.65%,MEF2C;GRID2;INSYN2A;GRIN2B;GSK3A
prerank,neutrophil activation involved in immune response (GO:0002283),0.3085990059102855,1.0917018670101482,0.2571743929359823,0.7816940790631122,1.0,98/428,17.92%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;ATP11B;PTPRJ;CD93;TSPAN14;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CAT;CMTM6;DYNLL1;PPIA;DBNL;ADAM10;LRRC7;RAP1B;ENPP4;BST2;UNC13D;SRP14;SCAMP1;PSMD11;PKM;NFASC;CXCR2;SPTAN1;IQGAP1;PDXK;TUBB;QSOX1;PDAP1;GLB1;FABP5;VAT1;CYFIP1;DNAJC5;NBEAL2;TOLLIP;HSPA8;CYBB;MGAM;PNP;S100A8;RAC1;KCNAB2;SYK;CEACAM1;ORMDL3;SVIP;SNAP29;SLPI;SLC27A2;CSNK2B;MANBA;LTA4H;SDCBP;DEGS1;PGAM1;PTGES2;MAN2B1;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;PRDX6;TUBB4B;TMEM179B;MAPK1;CPNE3;ARMC8;CTSS;RAB24;STOM;CSTB;PRG2;DGAT1;DOCK2;TTR;ACTR2;SLCO4C1;ADGRG3;VAMP7;NEU1;CPNE1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4287733175157748,1.0916063848416038,0.36236391912908245,0.7811846635325532,1.0,11/35,15.74%,ATP2C1;CDH20;PCDHGB4;CDH8;DCHS1;CDH19;CDH10;CDH23;PCDHB14;CDH5;NLGN1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3085514747382945,1.0912265436580864,0.25460455037919827,0.7814264345967026,1.0,83/476,14.38%,LEF1;MECOM;PLCB1;ETS1;FLI1;PDGFB;NOTCH4;TRIM16;ZIC3;TBX1;PPARD;SOX17;AFAP1L2;FZD4;MEF2C;RYBP;NCOA1;SMARCA2;SP100;FOXO1;FOXL2;RPS6KA1;ACVRL1;NOTCH1;KLF2;ZBTB16;WNT7A;IKBKB;HHEX;FOXF1;RREB1;CTNNB1;CREB1;MRPL12;KLF1;TAL1;CD4;CAMKK2;CD38;KLF4;RET;STAT1;NR1H2;DNM2;SOX18;BRCA2;HINFP;KAT6A;JUN;KCNH2;TGFB1;YWHAH;KLF6;FOXP3;LRP5;CDK5RAP2;ARID1A;HMGA1;UBE2V1;ELF2;SMAD5;BRD4;NR5A2;CTCF;HIF1A;SOX10;RNF187;RAI1;TFEB;MAPRE3;SOX11;NAA16;PPARG;HIPK2;EDF1;BRPF1;SOX9;HMGB2;NAT14;BCL10;SP1;PIM2;BICRA
prerank,hexose biosynthetic process (GO:0019319),-0.3521079467301893,-1.0911696953694228,0.29213483146067415,0.7668897723540525,1.0,14/42,22.43%,RBP4;SLC39A14;CHST15;PPARGC1A;AKR1B1;PER2;MDH2;GOT1;SLC25A12;ALDOA;ENO2;GOT2;ENO3;PGK1
prerank,regulation of platelet activation (GO:0010543),0.46534663613366123,1.0911054207838882,0.366723259762309,0.7810251782087728,1.0,3/21,3.88%,PDGFB;NOS3;LYN
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4288920163117061,1.0910019516629634,0.3568,0.7805553888404412,1.0,4/34,5.43%,MFHAS1;DAB2IP;LYN;TLR3
prerank,regulation of protein autophosphorylation (GO:0031952),0.4131843301444558,1.090954372073918,0.35062893081761004,0.7799480312481362,1.0,6/36,6.60%,PDGFB;ENG;PDGFD;CALM1;MRE11;PPP2R5A
prerank,actomyosin structure organization (GO:0031032),0.37482720594773866,1.0908860442467003,0.3333333333333333,0.7793658428334816,1.0,6/75,3.01%,FLII;FRMD5;TJP1;PGM5;F11R;EPB41
prerank,cellular amino acid catabolic process (GO:0009063),-0.3017527282253873,-1.0904431231304539,0.2673611111111111,0.7677938946260049,1.0,30/87,21.62%,DDO;ACADSB;ASPA;ALDH7A1;IVD;HNMT;MCCC2;AUH;HIBADH;ABAT;ALDH4A1;BCKDHB;PRODH;GOT1;HIBCH;GLUL;GLS;GLS2;HMGCLL1;KYAT1;PHYKPL;HYKK;SARDH;PIPOX;BCKDK;FAH;KMO;KYNU;GOT2;AASS
prerank,RNA catabolic process (GO:0006401),0.3977424858820129,1.090295095400423,0.3390625,0.7801561885475631,1.0,16/46,24.14%,NANOS2;ZPR1;DNA2;DCP2;DXO;PPP1R8;SND1;RNASEH2C;NUDT16;ZFP36L2;XRN2;METTL3;NCBP1;RNASE6;RIDA;NUDT12
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.4268679952106903,-1.0900754093642644,0.3477272727272727,0.7677040135882086,1.0,6/18,12.43%,HDAC4;FRS2;FZD7;CCN3;SOX6;BMP2
prerank,proteolysis (GO:0006508),-0.26589725918235163,-1.0896336450019464,0.20382165605095542,0.7677039481437832,1.0,46/252,15.77%,TRABD2B;CPQ;AEBP1;ADAMTS12;PCSK5;MMP14;HTRA3;ADGRV1;MMP16;F3;ANPEP;OGT;SUFU;FAP;GGT5;BACE2;CTSL;MMP2;NAALAD2;ACE;ENPEP;ADAM19;NPEPPS;CPXM1;DPP4;CPXM2;ADAM33;CUL7;IDE;ATG4A;CLN3;MMP19;AFG3L2;SENP6;PSEN1;HTRA1;CTSH;HTRA4;HTRA2;CTSZ;CAPN1;CASP3;SDE2;ADAMTS9;HM13;ZMPSTE24
prerank,phagosome maturation (GO:0090382),0.41813808188962,1.089530690282029,0.3468118195956454,0.7814234786683211,1.0,6/35,7.82%,RAB31;ATP6V0A1;MCOLN1;PIKFYVE;RAB34;RAB39A
prerank,artery morphogenesis (GO:0048844),0.4335851407942973,1.0894844936654728,0.35139573070607555,0.7808223890933624,1.0,7/30,4.36%,ENG;BMPR2;TGFB2;TBX1;NOTCH1;SMAD7;FOXF1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.45685365264372546,1.0892908383830069,0.3620689655172414,0.7806100173301613,1.0,10/22,17.80%,SLC16A2;NES;GATA2;DLL4;INSM1;DISP3;TOX;PTPRZ1;PROX1;TRIM71
prerank,negative regulation of cholesterol transport (GO:0032375),-0.49224879181572834,-1.0885184687189642,0.36622807017543857,0.7696201709578983,1.0,8/10,50.80%,APOC1;SHH;NFKB1;ABCA2;SREBF2;ABCG5;APOA2;PLA2G10
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.29748113424293005,-1.0880035092181317,0.2918454935622318,0.7698941707816632,1.0,22/101,15.71%,SAMD4A;PLD1;CYFIP2;THBS1;ASPH;OGT;ATG10;DACT1;PLXNB2;AGTR1;FXR2;PERP;EZR;VGLL4;BTRC;TBC1D10A;EIF3C;FMR1;FBXW11;DDX3X;LARP6;YTHDF1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.34092813462036425,-1.0879582414589926,0.31024930747922436,0.768796404018212,1.0,15/51,10.00%,LPAR1;ROCK2;PPM1E;CCN2;ARHGEF10L;TPM1;CARMIL1;TGFBR1;S100A10;SYNPO;FHOD1;PFN2;MYOC;TGFB3;ITGB1BP1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.4767164756130252,1.0875010689490288,0.3888888888888889,0.7845407601579274,1.0,3/17,1.88%,ADIPOR2;CAV1;PPARD
prerank,regulation of cellular amide metabolic process (GO:0034248),0.4256960420624116,1.0874511292034952,0.35294117647058826,0.7839078639713228,1.0,6/32,14.00%,NANOS3;APP;CYFIP1;EIF4E;PUM3;PGAM1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4819302034666857,1.0871130018551591,0.3669064748201439,0.7840825288116646,1.0,4/18,6.44%,CD34;TGFB2;CD200;LGALS9
prerank,regulation of amyloid-beta formation (GO:1902003),-0.3649874173961123,-1.0871029093465607,0.31536388140161725,0.7699697927186012,1.0,3/34,2.04%,IGF1;ROCK2;SLC2A13
prerank,response to glucocorticoid (GO:0051384),-0.3871153998472061,-1.087078946269331,0.33007334963325186,0.7688068300674934,1.0,4/26,11.70%,SLIT2;ADAM9;ANXA1;GOT1
prerank,mesenchymal cell differentiation (GO:0048762),0.3865652668075681,1.0870035294609903,0.31164901664145234,0.7835971248102376,1.0,8/51,5.99%,LEF1;ENG;TGFB2;NOTCH4;MEF2C;NOTCH1;CTNNB1;SNAI2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.37127405477988185,1.0869865835633639,0.3485714285714286,0.7829002311877006,1.0,23/76,18.01%,TEK;FES;NES;EVL;VIL1;CCR7;CDC42EP3;BAIAP2;NCKAP1;HCK;P2RX7;PFDN2;HRAS;NCKAP1L;SPAG5;FCHSD1;EDN1;NCK1;PROX1;PRKCE;TENM1;BIN1;WDR1
prerank,mononuclear cell differentiation (GO:1903131),-0.38833799833366317,-1.08653888507559,0.3511450381679389,0.7691192752179598,1.0,3/24,1.89%,IL31RA;AXL;BMP4
prerank,negative regulation of nervous system development (GO:0051961),0.4755954769431159,1.0865237869344184,0.3615916955017301,0.7834531311069685,1.0,3/17,4.25%,B2M;NOTCH1;WNT7A
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3875881168963351,-1.0864013849682772,0.32439024390243903,0.7682813121198911,1.0,4/27,5.09%,CACNA1C;ANK2;CAMK2D;DLG1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.509250295066094,1.085890313775805,0.397212543554007,0.7843605508535171,1.0,3/13,8.30%,STX3;HSP90AB1;ABCA7
prerank,neutrophil degranulation (GO:0043312),0.3072032465064617,1.085800609645985,0.26600441501103755,0.7838501145080683,1.0,97/425,17.92%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;ATP11B;PTPRJ;CD93;TSPAN14;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CAT;CMTM6;DYNLL1;PPIA;DBNL;ADAM10;LRRC7;RAP1B;ENPP4;BST2;UNC13D;SRP14;SCAMP1;PSMD11;PKM;NFASC;CXCR2;SPTAN1;IQGAP1;PDXK;TUBB;QSOX1;PDAP1;GLB1;FABP5;VAT1;CYFIP1;DNAJC5;NBEAL2;TOLLIP;HSPA8;CYBB;MGAM;PNP;S100A8;RAC1;KCNAB2;CEACAM1;ORMDL3;SVIP;SNAP29;SLPI;SLC27A2;CSNK2B;MANBA;LTA4H;SDCBP;DEGS1;PGAM1;PTGES2;MAN2B1;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;PRDX6;TUBB4B;TMEM179B;MAPK1;CPNE3;ARMC8;CTSS;RAB24;STOM;CSTB;PRG2;DGAT1;DOCK2;TTR;ACTR2;SLCO4C1;ADGRG3;VAMP7;NEU1;CPNE1
prerank,primary neural tube formation (GO:0014020),-0.37804235013548115,-1.0857928122459044,0.3341708542713568,0.7688898060960014,1.0,14/30,17.88%,LMO4;COBL;PLXNB2;MTHFR;MTHFD1;IFT122;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;MTHFD1L;PAX2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.27240725477411576,-1.0854735850409072,0.2644230769230769,0.7685596168715781,1.0,50/186,17.47%,BICC1;RBMS3;TRABD2B;LRP1;GLI3;IGFBP2;DKK3;RNF43;IGFBP6;WWOX;INVS;AMFR;DAB2;IGFBP4;SFRP4;DACT1;GLI1;PFDN5;TMEM64;CHD8;PRKN;TLE3;APOE;PSME4;GRB10;NXN;MLLT3;AXIN1;VGLL4;CUL3;STK11;FUZ;PSME3;CXXC4;BMP2;EMD;NKD2;DVL2;LMBR1L;WNT11;LRP6;LIMD1;TLE2;MDFI;TSKU;MDK;SFRP1;LATS1;HIC1;DDIT3
prerank,peptidyl-methionine modification (GO:0018206),0.5130500416495053,1.0854385118577503,0.4014466546112116,0.7840760404215434,1.0,3/12,13.94%,NAA60;NAA16;METAP2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.39084803608168717,1.0853592971494448,0.34728682170542635,0.7835696715499358,1.0,6/47,6.44%,CD34;RAPGEF2;CAV1;SNAI2;FYN;FBXW7
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4438053513739549,-1.085081046336512,0.36049382716049383,0.768408249713916,1.0,5/15,8.72%,PDGFRA;FGFR2;TGFBR1;SIX1;MTHFD1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4002720166466476,-1.084580529141731,0.32779097387173395,0.7686061896893918,1.0,8/24,9.33%,PHLDB2;ARHGAP6;ARHGAP28;ARAP1;CGNL1;ARHGEF18;MET;MYOC
prerank,tube closure (GO:0060606),-0.3739429194698297,-1.0842918309594993,0.3350125944584383,0.7681824539475244,1.0,14/31,17.88%,LMO4;COBL;PLXNB2;MTHFR;MTHFD1;IFT122;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;MTHFD1L;PAX2
prerank,histone H2B ubiquitination (GO:0033523),-0.49577417387723466,-1.0840630915842662,0.38197424892703863,0.7675815617341164,1.0,4/10,13.81%,CTR9;UBE2E1;RNF20;PAF1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5072719462262102,1.083744677376556,0.3889943074003795,0.7869844309773364,1.0,2/13,1.88%,PDGFB;PPARD
prerank,aerobic respiration (GO:0009060),-0.41996303465288565,-1.0832649305352395,0.3492462311557789,0.7686094433596724,1.0,9/20,20.26%,SIRT3;SDHC;MDH2;SDHB;MTFR1;SLC25A14;SURF1;MTFR2;UQCRC2
prerank,regulation of blood coagulation (GO:0030193),-0.38679924908104807,-1.0825385685426063,0.3157894736842105,0.7694914644589957,1.0,8/27,8.01%,TFPI;VTN;ST3GAL4;THBS1;FAP;THBD;EPHB2;APOE
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.4784622442095597,-1.0823425204926236,0.36774193548387096,0.7688224266589,1.0,8/11,36.46%,BCL2;KDM1A;CD44;TAF9B;TAF9;SIRT1;MUC1;CD74
prerank,aorta morphogenesis (GO:0035909),-0.43139844300116575,-1.082028969580045,0.39211136890951276,0.7685331547030181,1.0,7/17,9.11%,LRP1;BMPR1A;PDGFRB;MYLK;RBPJ;JAG1;EFEMP2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.517113019504348,1.0815546303409473,0.41621621621621624,0.7920250763485712,1.0,6/12,24.79%,PCGF3;RBM15;RLIM;METTL3;CDYL;PCGF5
prerank,glucan catabolic process (GO:0009251),-0.4421653668049008,-1.0811407545686447,0.37344398340248963,0.7698523947911332,1.0,10/15,23.04%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PYGL;PHKG1
prerank,regulation of fibroblast migration (GO:0010762),0.46829581271402776,1.0811370353665024,0.38275862068965516,0.7924419888735083,1.0,8/20,11.43%,PRR5L;PTK2;GNA12;HYAL2;RFFL;TGFB1;ARHGEF7;RAC1
prerank,bicarbonate transport (GO:0015701),0.4397277562701212,1.0809842576444084,0.3847487001733102,0.7920883723540175,1.0,2/25,1.24%,CA4;SLC39A8
prerank,regulation of macrophage differentiation (GO:0045649),-0.43859838378908167,-1.0809267883347062,0.3416289592760181,0.7692636538366221,1.0,9/15,36.35%,IL34;PRKCA;INHA;ID2;INHBA;FADD;LIF;HSF1;PF4
prerank,negative regulation of protein kinase activity (GO:0006469),0.3636022910917956,1.0808743855415643,0.35465924895688455,0.7916174658052659,1.0,17/88,12.34%,PTPRB;DAB2IP;CAV1;GNAQ;DUSP3;ADAR;WWTR1;HYAL2;PPIA;LRP5;PTK6;TRIB2;ACP4;HSPB1;CEACAM1;PTPRQ;DBNDD1
prerank,neutrophil mediated immunity (GO:0002446),0.3054104124045968,1.080706728079219,0.2830396475770925,0.7913246681085975,1.0,98/432,17.92%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;ATP11B;PTPRJ;CD93;TSPAN14;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CAT;CMTM6;DYNLL1;PPIA;DBNL;ADAM10;LRRC7;RAP1B;ENPP4;BST2;UNC13D;SRP14;SCAMP1;PSMD11;PKM;NFASC;CXCR2;SPTAN1;IQGAP1;PDXK;TUBB;QSOX1;PDAP1;GLB1;FABP5;VAT1;ADAM17;CYFIP1;DNAJC5;NBEAL2;TOLLIP;HSPA8;CYBB;MGAM;PNP;S100A8;RAC1;KCNAB2;CEACAM1;ORMDL3;SVIP;SNAP29;SLPI;SLC27A2;CSNK2B;MANBA;LTA4H;SDCBP;DEGS1;PGAM1;PTGES2;MAN2B1;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;PRDX6;TUBB4B;TMEM179B;MAPK1;CPNE3;ARMC8;CTSS;RAB24;STOM;CSTB;PRG2;DGAT1;DOCK2;TTR;ACTR2;SLCO4C1;ADGRG3;VAMP7;NEU1;CPNE1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3971777264815765,-1.0801393129750239,0.3597122302158273,0.7703113271089513,1.0,6/23,8.93%,CAMK1D;MCU;SLIT2;RIPOR2;DAPK2;DPP4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5130100682342459,1.0801034408395072,0.39106145251396646,0.7922304373177734,1.0,4/11,10.45%,ARHGEF2;PELI1;BIRC3;CASP8
prerank,Notch signaling pathway (GO:0007219),0.37749896555230794,1.0799874762848827,0.3397626112759644,0.7917691814565379,1.0,11/59,6.71%,SORBS2;NOTCH4;JAG2;PLXND1;NOTCH1;YBX1;DLL4;SNAI2;MAML2;ADAM10;STAT1
prerank,ephrin receptor signaling pathway (GO:0048013),0.3544487558335634,1.0792196445981879,0.3333333333333333,0.7930676918863832,1.0,26/82,14.03%,ANKS1A;PTK2;KALRN;ARPC4;TIAM1;ACTB;LYN;EPHA4;FYN;YES1;EPHB4;ANKS1B;EFNA1;AP2M1;ARHGEF7;ARPC3;PAK1;ACTG1;APH1A;GRIN2B;RAC1;HRAS;AP2B1;EPHB1;SDCBP;GIT1
prerank,histone methylation (GO:0016571),-0.385874495852947,-1.0787751772576704,0.34844868735083534,0.7729498249761803,1.0,17/26,39.45%,EHMT2;SMYD3;PRMT5;PRMT8;EZH2;TRMT112;NSD1;SETD6;SMYD2;CREBBP;PRMT2;CARM1;PRMT1;NTMT1;PRMT6;FBLL1;NSD3
prerank,transition metal ion homeostasis (GO:0055076),0.4314452479300614,1.0780243248395334,0.37438423645320196,0.7953696928198662,1.0,3/28,5.15%,SLC40A1;B2M;XIAP
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5259622068522904,1.0779953538855895,0.38593155893536124,0.7947060024139713,1.0,4/10,7.11%,NOTCH4;RGCC;NOTCH1;NEXMIF
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.30211379083179185,-1.0779297363004263,0.3041958041958042,0.7741069085423606,1.0,27/84,24.25%,CELF2;DDX5;SON;RBM39;FXR2;SRRM4;NOVA1;SRSF6;DDX17;SRSF4;RBM5;FMR1;NSRP1;RBFOX1;PCBP4;SAP18;C1QBP;U2AF2;TRA2B;CIRBP;MBNL2;ZC3H10;SRSF10;RBM24;SF1;KHDRBS3;CELF6
prerank,regulation of cellular senescence (GO:2000772),0.4302331896759901,1.0777487198914317,0.3554817275747508,0.794609778016033,1.0,9/28,16.58%,B2M;YBX1;VASH1;TERF2;HMGA1;MAP3K3;ABI3;RBL1;HMGA2
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.4108037091351697,-1.0772630715554925,0.36054421768707484,0.7746892970573159,1.0,7/17,16.85%,WNT4;BMP4;CREB3L1;TGFB3;LARP6;RUNX1;SUCO
prerank,regulation of cellular component movement (GO:0051270),0.3902533828510558,1.077216561878145,0.33178294573643413,0.7952742578948192,1.0,10/49,7.03%,ETS1;FES;SP100;PRAG1;LYN;PKN1;INPP5F;ACTN4;PKN2;ACTN1
prerank,calcium ion import (GO:0070509),-0.38426742472154984,-1.077189817616874,0.3655913978494624,0.7737028548343481,1.0,8/28,12.08%,CACNA1C;MCU;CACNA1G;SLC8A1;CACNA1D;AFG3L2;TRPC4;CACNB2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.44719767022670653,1.0770441672542983,0.3703071672354949,0.7949905374397711,1.0,6/20,9.70%,IMPDH1;HPRT1;NT5C2;AK4;ADSS2;GART
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5060143518596071,1.0767705551835773,0.3929236499068901,0.794943865359205,1.0,4/12,7.36%,PTK2;LYN;MAPK3;BST2
prerank,snRNA processing (GO:0016180),-0.43124403696154556,-1.076735719764083,0.37708830548926014,0.773788709046751,1.0,9/16,30.01%,INTS8;INTS2;INTS4;TUT1;INTS10;INTS3;TOE1;INTS6L;INTS5
prerank,regulation of dendrite development (GO:0050773),0.40865900418283735,1.076601886969381,0.38769230769230767,0.7946338875227564,1.0,7/37,8.49%,MFSD2A;DAB2IP;LRP8;NEDD4L;LZTS1;CSMD3;PTN
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4216024732850106,-1.0765645697490378,0.35402298850574715,0.7730826330609345,1.0,2/17,2.25%,ANK2;SNTA1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5034612410264026,1.0763008211011467,0.38198198198198197,0.7947098735246777,1.0,2/13,2.58%,PALM;GNAI2
prerank,protein-containing complex assembly (GO:0065003),0.3146618918971781,1.076031193503866,0.3123543123543124,0.7946757089677752,1.0,42/259,14.70%,LEF1;OCLN;SLC2A1;CXCL12;FAS;MAGI1;CD40;TIAM1;PARD3;CD2AP;MEN1;CTSC;VIL1;CTNNB1;CARD10;TCF7;DBNL;ADAM10;AIM2;CLDN14;TLE4;AP2M1;TGFA;P2RX7;CAPG;RSPH4A;AXIN2;CASP8;SAMM50;FERMT2;PEX14;TLE1;RANBP9;CSNK2B;RAB1A;CNIH3;SOX9;PDCD6;RBX1;TSPAN33;SH3BGR;NCKAP1L
prerank,negative regulation of lyase activity (GO:0051350),0.4855597006512746,1.0759326743549924,0.3844797178130511,0.7942047648558999,1.0,2/16,2.58%,PALM;GNAI2
prerank,renal filtration (GO:0097205),0.531938481387512,1.075892341902744,0.4074074074074074,0.7935774197403316,1.0,2/10,1.05%,MYO1E;CD34
prerank,negative regulation of phagocytosis (GO:0050765),0.480426026874742,1.0754064422262675,0.39713774597495527,0.7941291851633097,1.0,2/17,4.37%,DYSF;SNX3
prerank,protein monoubiquitination (GO:0006513),-0.3467791541052964,-1.075239308363537,0.32222222222222224,0.7756639929612682,1.0,11/36,15.38%,KLHL22;CTR9;UBE2R2;MGRN1;PRKN;UBE2E1;CUL3;HUWE1;RNF20;PAF1;UBE2B
prerank,hyaluronan metabolic process (GO:0030212),-0.4007096071419364,-1.0750044044462497,0.3530864197530864,0.7751345992130442,1.0,12/23,27.44%,CEMIP;CEMIP2;FGF2;SLC9A1;HEXA;ABCC5;CD44;LYVE1;HAS1;HMMR;GUSB;HYAL3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.42556928247073583,1.074915299216231,0.3669421487603306,0.7947013012049514,1.0,8/29,18.18%,HSP90AB1;MRE11;PPIA;TERF2;ACD;TERF1;NHP2;RPA1
prerank,histone ubiquitination (GO:0016574),-0.39632942092677986,-1.0748371244415413,0.3394919168591224,0.7744297041718625,1.0,7/21,15.79%,CTR9;UBE2E1;HUWE1;RNF20;PAF1;UBE2B;UBR2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.43815209284376766,1.074281025732955,0.3573825503355705,0.79566955822858,1.0,5/27,4.05%,SHANK3;TJP1;WASF2;F11R;STMN1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.37704352789856904,1.074030033516276,0.339568345323741,0.795615231455708,1.0,13/60,12.22%,PDGFB;RGCC;PRKD2;HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;CCT3;CCT5;ACD;POLG2
prerank,nuclear body organization (GO:0030575),0.5062399987762609,1.0739878363592064,0.3985239852398524,0.7949820566347697,1.0,4/12,14.13%,ETS1;ZPR1;HIPK2;SERBP1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.49174276304876496,-1.0737186465540094,0.3847826086956522,0.7765115968071266,1.0,2/10,2.33%,ACTN2;CARMIL1
prerank,myoblast differentiation (GO:0045445),-0.4482188062843807,-1.0733793384382908,0.37813211845102507,0.7762601738791648,1.0,5/14,9.76%,IGF1;DDX5;JAG1;PLEKHM3;DDX17
prerank,negative regulation of cyclase activity (GO:0031280),0.498088194579256,1.0725889828814732,0.38010657193605685,0.7978510880425312,1.0,2/14,2.58%,PALM;GNAI2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.23074464820860552,-1.0724762887072357,0.0,0.7775828720261413,1.0,333/1646,16.32%,FOXP2;BNC2;PBX1;IGF1;SOX5;MAF;ZIC1;NFIA;ZEB2;EGFR;NR2F2;ZIC4;GLI3;DENND4A;COL1A1;ZBTB7C;PRRX1;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;EFEMP1;GLIS3;FOXD1;WNT4;HLF;SMAD3;PKNOX2;FOXP4;SSBP2;IL31RA;HOXC4;DKK3;BMP7;HOXC6;BMP4;ARNT2;ZFPM2;OSR1;HOXB3;TEAD1;DDX5;PPARGC1B;SMAD6;NR6A1;TULP3;MDFIC;HOXA3;HOXA5;NFAT5;MEOX2;RGMB;LBH;HDAC4;CUX1;TRAK1;MXI1;IKZF2;HOXB4;PRRX2;CREB3L2;TEF;SALL1;MAP3K5;FZD2;SNX6;SHC1;NR1D2;HOXB6;ZHX2;CCNT2;KIT;CDH1;FOXC2;LOXL3;FOXC1;CAMK2D;BCOR;TGFBR1;ARRB1;TBX15;HIVEP2;MLXIP;OGT;SUFU;VGLL3;PLAGL1;PPARGC1A;RBPJ;ZNF423;HOXA7;BAZ1B;FGF2;PIAS1;MKX;ZNF367;KDM7A;RORA;TBL1XR1;MDM4;AR;PER2;GLIS2;MAP3K12;ANXA4;HDGFL3;PPARA;KAT6B;PBX4;HIF3A;RUNX2;KLF3;PURG;MED23;CTR9;SIX1;TBX18;EBF4;ZNF25;SPP1;IKZF4;BCL6;TEAD3;NFXL1;IGF2;TSHZ1;CRABP2;POLR2A;CHD2;HEYL;FZD7;HOXC8;NR3C2;MEIS1;PBX3;SMARCC2;GLI1;ZEB1;SMAD9;ILF2;KDM2A;CCNL1;ZFAT;ZNF568;KDM3B;LCOR;FOXJ2;NFATC4;ATF5;EBF2;TGFB1I1;ELF4;ZSCAN29;GPBP1L1;PHC2;SOD2;KLF15;RUNX1T1;PFDN5;CHD3;CHD8;CBX5;VSX1;RFX7;SMARCD3;MITF;FBXL19;KDM5B;APOE;FOXL1;YAP1;SMARCB1;RBBP8;ZMYND15;KDM2B;TP53INP2;POU6F1;ACTR8;RBAK;CHD4;HSF2;ATOH8;SMURF2;SFMBT1;CREB3L1;MLLT3;AXIN1;STAT5A;ZNF23;PML;FOXO3;CDK16;SOX6;MGA;TGFB3;REXO4;VGLL4;BRD9;TWIST2;DDX17;GCFC2;ZNF483;ACTA2;ZKSCAN7;QARS1;ARNT;ELP3;CEBPB;CDK14;ELK1;CCNC;BTRC;SP140;TSC22D4;MBTD1;NIBAN2;ARHGEF11;NOP2;GATA6;ZNF697;SMARCA1;ZNF182;RNF10;CBFA2T2;ZBTB38;CCNH;NR2F1;URI1;NSD2;ARID3A;SETD5;ZNF148;CRY2;PRDM11;PBXIP1;PPP3CB;NUCKS1;CHUK;MTERF3;PRMT5;ETV1;MED14;WWP2;KDM1A;CREBRF;RNF20;TFCP2L1;SNX5;RXRA;PHF8;BCL7A;NFX1;TGFBRAP1;RFXAP;ABL1;ESR1;SBNO1;PIAS2;PGR;ATP8B1;PSEN1;BMP2;XRCC5;ZNF219;HOXB5;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;HOXC5;PCBD2;ZNF3;DVL2;SP3;GCLC;ZBTB4;SIRT2;MAFB;CAMTA2;FBXW11;SMARCA5;ACVR1B;PSIP1;MTF1;GZF1;HOXA9;MAPK14;TCIM;ATF2;WNT11;NR4A1;ZBTB1;SPTY2D1;EP300;NONO;MRGBP;TSHZ3;ZBTB7B;PHF12;E2F3;RFX5;ZSCAN20;LRP6;ELP4;SAP18;SREBF1;NFIB;MYBL2;ZSCAN2;SPINDOC;PROX2;MTA3;LIMD1;TLE2;NFIL3;CCAR1;CDKN1C;RUNX1;MAP3K2;HIVEP3;FOXJ3;CRYAB;ATMIN;LDB1;APBB3;ZSCAN21;PSPC1;MED30;ZBTB26;ZFP37
prerank,cellular response to light stimulus (GO:0071482),0.36917471687844255,1.0722049482056608,0.3528550512445095,0.7981416496460074,1.0,18/66,21.63%,POLK;N4BP1;OPN5;RHBDD1;GPR52;COPS9;EIF2AK4;GNB1;OPN3;TRIAP1;RRH;PTPRK;NSMCE3;BAK1;NOC2L;POLD1;METTL3;ERCC4
prerank,rRNA methylation (GO:0031167),-0.39802814028699973,-1.0717776219205524,0.37583892617449666,0.7783182191826843,1.0,14/22,39.26%,NOP2;MTERF4;NSUN3;NSUN4;EMG1;FDXACB1;TRMT112;DIMT1;MRM3;MRM1;FTSJ3;BUD23;NSUN5;FBLL1
prerank,protein K48-linked deubiquitination (GO:0071108),0.45445764830682633,1.0713567719654844,0.39666666666666667,0.7996168880047204,1.0,8/23,19.24%,MINDY1;ATXN3;OTUD7A;MINDY2;TNFAIP3;OTUD4;USP25;OTUD7B
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4441551331182381,-1.0713168270696225,0.39851485148514854,0.778412283225047,1.0,9/13,30.69%,ABCA1;LDLR;CD9;CDH13;CD81;FCER1G;ITGB1;LPL;CD36
prerank,regulation of telomerase activity (GO:0051972),0.40015171127231425,1.0709855982771708,0.37031484257871067,0.7998268587492862,1.0,19/45,25.84%,MEN1;HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;ACD;TERF1;MAPK1;NAF1;MAP2K7;NVL;ERCC4;PINX1;PTGES3;MYC;NABP2;PNKP
prerank,lipid homeostasis (GO:0055088),-0.32806730249698357,-1.0707162858042607,0.3709677419354839,0.7789418626035883,1.0,10/57,9.80%,ZBTB20;PRKAA2;RBP1;NR1D2;ABCA1;THADA;IRS2;RCN3;APOE;TLCD2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3975113849815984,-1.0704324776630971,0.3891509433962264,0.7784896583649437,1.0,5/23,10.05%,UACA;BMP7;C1QTNF3;CCN3;PPM1B
prerank,aortic valve morphogenesis (GO:0003180),-0.37633965361574256,-1.0703211058248165,0.36538461538461536,0.7776147166990925,1.0,9/30,7.70%,ROBO1;ROCK2;BMP4;ELN;SLIT2;SMAD6;HEYL;EMILIN1;JAG1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3868208024325684,-1.0701192118856357,0.3746958637469586,0.7769793172722638,1.0,8/25,11.13%,SLIT2;CAPZB;ARHGAP24;KANK1;PRKCD;YAP1;PFN2;ARHGAP44
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4283487910993814,1.0697854375922717,0.3904,0.8022282642035605,1.0,3/30,5.99%,BCL2L1;CXCL12;SNAI2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5242632310082164,1.0697075573493018,0.4035714285714286,0.8016984707933984,1.0,3/10,12.54%,ENPP2;LIPC;PNPLA8
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3727533926688903,1.0692479167239213,0.3806734992679356,0.8021443620367708,1.0,7/62,6.64%,BCL2L1;CXCL12;PLAUR;ARHGEF2;PPIA;SNAI2;MCL1
prerank,ventricular septum development (GO:0003281),-0.3510070967238833,-1.0691162275969774,0.3602015113350126,0.7785708436044002,1.0,9/37,6.34%,ROBO1;TGFBR3;BMPR1A;ZFPM2;SLIT2;SALL1;TGFBR1;MDM4;HEYL
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.43906562343818123,1.0689198125194337,0.3752066115702479,0.8021958626574744,1.0,3/25,5.96%,PLAUR;TNFSF10;BIK
prerank,regulation of cellular localization (GO:0060341),-0.33978042114263934,-1.0686318453506307,0.3494897959183674,0.7787684885557176,1.0,14/46,16.50%,ADCY5;GSN;PARD6G;EFNA5;CAMK2D;STXBP4;PRKN;CDK16;PARP1;LRRK2;KDM1A;BRSK1;MAP2;NR1H4
prerank,activation of GTPase activity (GO:0090630),0.3489214057262068,1.0685223213063966,0.3333333333333333,0.8024870619124016,1.0,15/89,6.47%,TBC1D4;ARHGEF15;TBC1D14;TBC1D22A;SIPA1L2;SIPA1;TIAM1;ABR;RALGAPA1;TBC1D12;TBC1D2;CCR7;USP6NL;TBC1D5;ARHGAP25
prerank,response to glucose (GO:0009749),0.39332771424036017,1.0683605339182047,0.3585185185185185,0.8022159715688483,1.0,2/46,2.00%,IGF1R;UNC13B
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4871306510012493,1.068155281673746,0.36313868613138683,0.8020178219469197,1.0,4/13,14.68%,LCMT1;CDK5RAP2;DUSP1;DYNC1LI1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4521338739426605,-1.0681422879110158,0.3858447488584475,0.7788417262007269,1.0,4/13,15.19%,SAR1A;SEC16B;SEC16A;CD81
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.4328017761598114,-1.0679256520028244,0.3912087912087912,0.778309849365461,1.0,6/16,22.50%,KLHL22;SEH1L;CLEC16A;RRAGA;FLCN;LARS1
prerank,positive regulation of cell cycle (GO:0045787),0.37654654641449253,1.0679094367275508,0.38748137108792846,0.8019162372711377,1.0,12/62,10.12%,PDGFB;TGFB2;APP;TBX3;CCNY;RGCC;DUSP3;TAL1;PKN2;CCND3;ADAM17;PTK6
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.41330159928790744,-1.0677381281427072,0.36228287841191065,0.7776443654141993,1.0,7/18,19.78%,IRS1;PRKN;CCN3;KCNB1;SFRP1;INHBB;ADRA2A
prerank,macrophage chemotaxis (GO:0048246),-0.48857644402434036,-1.067694727752146,0.3991683991683992,0.7766110952740093,1.0,7/10,48.45%,CKLF;CCL2;CCL5;TAFA4;CXCL17;CCL3;LGALS3
prerank,glutathione biosynthetic process (GO:0006750),0.5152908802478161,1.0674236271881157,0.42586206896551726,0.8024547138088164,1.0,2/11,5.09%,GCLM;MGST2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3478040077555295,1.0664502202389265,0.3562753036437247,0.8041830135138239,1.0,17/85,10.41%,DAB2IP;TGFB2;DENND3;RASGRP4;ARHGEF2;RAPGEF1;NOTCH1;STARD13;LYN;GRB2;EPS8;EPS8L2;DENND4C;OPHN1;ARHGDIA;ARHGAP17;PDCD10
prerank,endodermal cell fate commitment (GO:0001711),0.5056528576982429,1.0661949993979296,0.4147727272727273,0.8041364016168008,1.0,1/10,2.11%,SOX17
prerank,positive regulation of cell projection organization (GO:0031346),0.3392554310006036,1.066061023876919,0.3393548387096774,0.8037685190926518,1.0,23/115,10.12%,ITGA6;NDNF;DAB2IP;RAPGEF2;SCARF1;FES;FZD4;PLXND1;RAPGEF1;TIAM1;PRKD1;LYN;SNX3;FUT9;RET;LRRC7;SLITRK1;TWF2;PTN;SERPINI1;ARHGDIA;METRN;PTK6
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.47314855670839956,1.0652606683223516,0.3942652329749104,0.8050659125589332,1.0,6/16,18.32%,ATP5F1E;ATP5MC2;ATP5PO;ATP5F1A;ATP5MF;ATP5PF
prerank,second-messenger-mediated signaling (GO:0019932),0.3616719440986558,1.0652560720673465,0.3464788732394366,0.8043533860793067,1.0,9/82,5.27%,NDNF;NOS3;DDAH1;PLA2G4B;PPP1R9B;PLCG1;NOS2;CCR7;CAMKK2
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.5081234707308503,1.0652093213069798,0.4197292069632495,0.8037468468416367,1.0,3/12,9.63%,LAMA5;ACTB;ACTG1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5094528076433429,1.0651066584263955,0.3879003558718861,0.8033078654977496,1.0,5/11,23.90%,ARID1A;SMARCD1;ZMIZ2;SERTAD2;PADI2
prerank,negative regulation of platelet activation (GO:0010544),0.48717284311467846,1.0648204313811895,0.3784722222222222,0.8033068242566166,1.0,3/16,3.95%,PDGFB;NOS3;PRKG1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5239818777788401,1.0646703666668207,0.40636704119850187,0.8029661844395564,1.0,5/10,13.39%,TBX1;STAT1;LRP5;TGFBR2;SOX9
prerank,regulation of extracellular matrix organization (GO:1903053),-0.43781666065891045,-1.064388768117743,0.38716814159292035,0.7847485013923876,1.0,5/15,9.11%,LRP1;AEBP1;DDR1;FAP;EFEMP2
prerank,positive regulation of catabolic process (GO:0009896),0.36793452763579504,1.0642872773990513,0.37337192474674386,0.8032521293012043,1.0,15/65,15.84%,DAB2IP;NKD1;NEDD4L;FOXO1;EGLN2;OAZ1;SMURF1;GSK3A;VSIR;TNFSF12;TNFAIP3;ASB5;AREL1;PLK2;APC
prerank,glycogen metabolic process (GO:0005977),-0.3829764032099437,-1.064269565137207,0.3858093126385809,0.7839023013462736,1.0,9/27,11.70%,PRKAG2;PYGB;PHKB;PER2;PYGM;GAA;PHKA2;PPP1R3C;AGL
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.395753626133172,-1.0641485460780584,0.3629242819843342,0.7830600805657462,1.0,9/22,25.92%,ANK2;PKD2;SLC9A1;GSTM2;STAC3;JPH2;HTT;HAP1;GSTO1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.4488909839600614,-1.063984015385326,0.38716814159292035,0.7824099861912179,1.0,3/13,4.32%,MDFIC;APOD;SUFU
prerank,negative regulation of protein secretion (GO:0050709),0.4035258929501013,1.0638945443921375,0.36911764705882355,0.803587413458386,1.0,3/38,2.95%,RAB11FIP1;CD200;RHBDF2
prerank,regulation of establishment of protein localization (GO:0070201),0.5000990571757328,1.063133278894231,0.4117647058823529,0.8048557542303867,1.0,4/13,16.25%,CORO2B;CEP135;DNAJA1;PTP4A3
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.38486619055080934,1.0630716295226545,0.36322188449848025,0.8043023258603834,1.0,16/51,19.88%,CXCL12;IL6R;PTK2;CCR7;MAPK3;LGALS9;PTN;PGF;ADAM17;CCL1;MAPK1;GAS6;CCR2;CSF1R;MOSPD2;AKIRIN1
prerank,tryptophan catabolic process (GO:0006569),-0.4798215509353504,-1.0630498336689993,0.41239316239316237,0.7838052599515136,1.0,6/11,30.36%,AFMID;KYAT1;KMO;KYNU;IL4I1;HAAO
prerank,cellular response to gamma radiation (GO:0071480),-0.412520275755496,-1.0626424070547322,0.3926940639269406,0.7837304444366936,1.0,7/17,23.64%,ATM;YAP1;KDM1A;XRCC5;CRYAB;WRN;ATR
prerank,lysine metabolic process (GO:0006553),-0.4627411774119867,-1.0625308610336415,0.40165631469979296,0.781734145640821,1.0,8/12,34.92%,ALDH7A1;PHYKPL;HYKK;PIPOX;AASS;DLST;OGDH;CRYM
prerank,lysine catabolic process (GO:0006554),-0.4627411774119867,-1.0625308610336415,0.40165631469979296,0.781734145640821,1.0,8/12,34.92%,ALDH7A1;PHYKPL;HYKK;PIPOX;AASS;DLST;OGDH;CRYM
prerank,actin crosslink formation (GO:0051764),-0.4562408422332431,-1.0624630922260867,0.4043956043956044,0.7807997761394347,1.0,2/12,6.15%,DPYSL3;FLNA
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4621039226648541,1.0622410591774059,0.4017094017094017,0.8057187230318313,1.0,2/18,5.07%,BCL2L1;SLC25A5
prerank,sarcomere organization (GO:0045214),-0.36701258256967706,-1.0616868810149522,0.40789473684210525,0.7818690811768774,1.0,7/27,21.24%,ACTN2;TPM1;TNNT3;SIX4;MYOM2;CSRP2;KRT19
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.5235670626645722,1.0609855163964361,0.40186915887850466,0.808194704935633,1.0,4/10,8.10%,CALM1;NPPA;SRI;PDE4B
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.43111949409511374,1.0608336022489677,0.37436762225969644,0.8078473201696558,1.0,8/28,15.10%,DAB2IP;PTK2;CTSC;FBXW7;PSMC6;SMURF1;RNF139;BAG2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.37194216440135874,-1.0607055272960797,0.35,0.7832831553143454,1.0,9/26,22.20%,KANK2;DAB2;HEYL;CRY2;PIAS2;SFRP1;NCOR1;BRCA1;PER1
prerank,catecholamine metabolic process (GO:0006584),0.49256565687905923,1.0606435724937235,0.41824440619621345,0.8076258698369337,1.0,1/14,0.61%,DDC
prerank,inflammatory response (GO:0006954),0.32356659500652657,1.0605197112093976,0.3610421836228288,0.8072084513838379,1.0,26/195,11.80%,MFHAS1;LY75;ADGRE5;AFAP1L2;F11R;NOD1;CD40;PLA2G4B;HDAC9;IL10RB;IKBKB;NOS2;CCR7;NRROS;LGALS9;PXK;TGFB1;CXCR2;SIGLEC1;AGTR2;CYBB;TAC4;CCL1;S100A8;RAC1;TNFRSF4
prerank,muscle cell development (GO:0055001),-0.3778203584068184,-1.059514822501359,0.3925729442970822,0.7854628413457638,1.0,8/30,9.11%,ANK2;IGF1;CXADR;MYOF;DMD;SLC8A1;MYH11;EFEMP2
prerank,aorta development (GO:0035904),-0.4544732790171207,-1.059496028910248,0.39400921658986177,0.7843773484018226,1.0,7/14,10.98%,ROBO1;LRP1;PDGFRB;PKD2;JAG1;EFEMP2;ROBO2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.44250881998041036,-1.059320492238836,0.3813559322033898,0.7836716030098649,1.0,5/12,18.64%,DAB2;HEYL;PIAS2;SFRP1;NCOR1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4568631738020991,-1.058971418607668,0.40444444444444444,0.7834673655006027,1.0,6/12,28.14%,PLK5;SDE2;WAC;RPS27L;CCND1;PLK3
prerank,response to interleukin-1 (GO:0070555),0.3602871433506384,1.058044784565445,0.3897364771151179,0.812803402178077,1.0,11/73,13.39%,DAB2IP;APP;IL1R1;TNFRSF11A;CD40;HYAL2;LGALS9;IRAK2;CCL1;HIF1A;SOX9
prerank,positive regulation of signal transduction (GO:0009967),0.31233165277931596,1.057632670174313,0.35661764705882354,0.8131706729602907,1.0,27/238,6.54%,TEK;SHANK3;JCAD;DAB2IP;MACF1;LIMS2;EPN2;TGFB2;NOS3;NOTCH4;TRIM16;JAG2;TSPAN5;FAS;TPD52L1;NOD2;TSPAN14;NOTCH1;PRKD2;VWF;KLF2;WNT7A;HHEX;DLL4;MAML2;HOMER1;CRADD
prerank,response to steroid hormone (GO:0048545),0.413473589495461,1.0573937903601942,0.3950413223140496,0.8130396079293821,1.0,6/31,8.09%,ABHD2;TGFB2;CAV1;ATP1A1;ATP1A3;TGFB1
prerank,negative regulation of B cell proliferation (GO:0030889),0.5003148136085703,1.0570289255100789,0.40106951871657753,0.8132417659815803,1.0,2/11,4.54%,LYN;TNFRSF21
prerank,positive regulation of glucose import (GO:0046326),0.4482917302935146,1.056679805853315,0.39,0.8134112824968159,1.0,2/21,0.95%,OCLN;INSR
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3949353722166201,-1.0563865857445902,0.38288288288288286,0.7871649780468157,1.0,13/20,33.32%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3949353722166201,-1.0563865857445902,0.38288288288288286,0.7871649780468157,1.0,13/20,33.32%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3949353722166201,-1.0563865857445902,0.38288288288288286,0.7871649780468157,1.0,13/20,33.32%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,regulation of interferon-alpha production (GO:0032647),0.4362215156091264,1.056331296446585,0.42470389170896783,0.8135831865925967,1.0,6/23,11.01%,IFIH1;TLR3;STAT1;IRF5;TLR7;TLR8
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.34172286010488606,-1.0558393748215318,0.38144329896907214,0.7875332940163018,1.0,8/41,11.45%,ITPR1;SLC8A3;CACNA2D1;PKD2;FGF2;SLC8A1;ITPR2;IBTK
prerank,ERBB signaling pathway (GO:0038127),0.36564107198493045,1.0556176676617124,0.3830409356725146,0.8147421541167437,1.0,17/64,10.31%,PTK2;PTPN12;VIL1;PLCG1;GRB2;GAB1;SOS1;RPS6KA5;PTPRR;TGFB1;TGFA;IQGAP1;SHC3;ADAM17;PTK6;PIK3C2A;GRB7
prerank,glial cell development (GO:0021782),0.43387628090547126,1.0552207727321357,0.4134453781512605,0.8150234798990319,1.0,6/25,12.63%,APP;NRROS;EIF2B1;EIF2B2;SOX10;SOX11
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5087440922518617,1.0550731096249522,0.4155844155844156,0.8146957778948425,1.0,1/10,5.03%,HSP90AB1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4928672304920559,1.0549881282650106,0.4048059149722736,0.8141909880796318,1.0,2/13,5.25%,PLCB1;CCR7
prerank,cholesterol efflux (GO:0033344),0.4495533357995374,1.0547368768718413,0.38917089678510997,0.8141125763973016,1.0,4/20,8.94%,SCARB1;ABCG1;ABCA7;NPC1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.5071767383417363,1.0546910356177193,0.4155844155844156,0.8135102642533637,1.0,2/10,8.00%,ST3GAL1;ST6GAL1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4637842591900562,-1.0545052681713472,0.3991228070175439,0.7901174826398496,1.0,3/11,13.15%,GRK3;ARRB1;ADM
prerank,supramolecular fiber organization (GO:0097435),0.30469494959726107,1.054480174000293,0.35129068462401797,0.8133239564568171,1.0,59/333,11.52%,ITGA6;FLII;HIP1;COLGALT2;MYO1D;MYO1E;RHOBTB1;SHROOM4;TGFB2;SHROOM1;PGM5;APP;TSPAN5;ELMO1;HIP1R;B2M;ARHGEF2;COL4A2;FGF13;TSPAN14;CD2AP;EVL;PXDN;ELMO2;PPP1R9B;MYO6;STMN1;CCDC13;NPPA;CLIP1;HSP90AB1;RHOB;TPM3;CCDC88A;NCKAP5;CCDC88B;KIF2A;ADAM10;ARHGAP25;STMN3;ACTN1;COL4A1;STMN4;KLHL24;PIN1;PLOD3;GREM1;COL9A3;TMOD1;MYO1F;ARHGAP17;CLRN1;CRIPT;HOOK1;APH1A;TPM4;RAC1;MAP10;SLK
prerank,actin filament bundle assembly (GO:0051017),-0.3627919762032634,-1.0544427384872501,0.38618925831202044,0.789131727787905,1.0,3/33,0.50%,CALD1;DPYSL3;PAWR
prerank,regulation of JUN kinase activity (GO:0043506),0.4103877535734285,1.054250041757614,0.40032679738562094,0.8131851280664458,1.0,9/33,17.39%,DAB2IP;TNFRSF11A;NPPA;ARHGEF5;PAK1;DNAJA1;HIPK3;EDN1;MAP3K11
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4970309623303034,1.0542195273986992,0.39963503649635035,0.8125647746485113,1.0,4/11,19.12%,STMN1;PAK1;RAC1;NRP1
prerank,regulation of response to external stimulus (GO:0032101),0.3374690301183081,1.0539534161783635,0.3604336043360434,0.8124881349344365,1.0,22/121,13.94%,SEMA7A;IL1R1;CAV1;TIRAP;LRP8;BCL6B;NOD2;TMSB4X;SAMHD1;CALM1;XIAP;HCK;N4BP1;BIRC3;NLRP6;CASP8;BRD4;USP18;CYRIB;CYLD;STK24;METAP2
prerank,organonitrogen compound catabolic process (GO:1901565),-0.31975383770507915,-1.0535892267365792,0.3580645161290323,0.7904857887222132,1.0,10/57,10.79%,CPQ;ANPEP;PDXDC1;ACE;ENPEP;NPEPPS;LRSAM1;RENBP;IDE;GGACT
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4179922667006918,1.0531635727228994,0.38571428571428573,0.8137399376772422,1.0,6/29,8.09%,ENG;S1PR1;ZFPM1;NOTCH1;SMAD7;TGFB1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3409485989681427,1.053035677045369,0.3781624500665779,0.813351228353093,1.0,37/109,21.88%,MAP3K1;LYN;PLCG1;IKBKB;CALM1;GRB2;SOS1;MAPK3;PSMB3;JUN;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;PPP3CA;RAC1;SYK;PPP3R1;PIK3CB;PSMB10;BCL10;LCP2;CARD11;PSMA8;MAPK1;LAT2;PAK2;SKP1;PSMD9;PLCG2;MAP2K7;VAV1;CUL1;PSMC3;PSMD1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4318183715791134,1.0528958151991068,0.4079173838209983,0.8130066019880121,1.0,2/24,1.56%,PRKCH;TRIM16
prerank,ATP synthesis coupled proton transport (GO:0015986),0.46084752670887535,1.0525655771220983,0.4056437389770723,0.8131360452911648,1.0,6/17,18.32%,ATP5F1E;ATP5MC2;ATP5PO;ATP5F1A;ATP5MF;ATP5PF
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.38778299891354845,-1.052407601242742,0.3789954337899543,0.7926502085892837,1.0,13/21,33.32%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.27221208983366363,-1.052182931679001,0.296137339055794,0.7920886136029407,1.0,26/138,12.24%,NOTCH2;RARB;CCN2;TEAD1;NR6A1;THRB;NOTCH3;NR1D2;PPARGC1A;RBPJ;RORA;TBL1XR1;AR;PPARA;MED23;TEAD3;POLR2A;NR3C2;YAP1;CCNH;NR2F1;RXRA;TAF8;CDK7;ESR1;PGR
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3407706839817083,-1.0520916091925523,0.352,0.7911834978568485,1.0,5/41,6.15%,ANK2;ACTN2;KCNMB2;KCNJ2;FLNA
prerank,response to UV-A (GO:0070141),-0.43585453459766454,-1.051936492628557,0.4110169491525424,0.7904646078102795,1.0,2/14,6.54%,EGFR;MMP2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.41368816972835326,1.051871261615123,0.39109697933227344,0.8141477046732839,1.0,13/36,19.23%,AQP11;RYBP;HSP90AB1;N4BP1;OPHN1;UBXN1;F8A1;RPL11;TRIM39;SDCBP;BAG6;PRKCG;USP25
prerank,inositol lipid-mediated signaling (GO:0048017),0.37953046937327695,1.0518312972620827,0.3781763826606876,0.8135426712706264,1.0,3/50,0.56%,IGF1R;PLCB1;PLCB4
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.4257510381297574,-1.0517755390547274,0.4068522483940043,0.7898239473107332,1.0,6/15,16.13%,RIPOR2;ADAM9;EHD1;MAPK14;CAMK1;EHD2
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.41947811422119907,-1.0514465484995907,0.39387755102040817,0.7895710313014331,1.0,10/16,23.04%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PYGL;PHKG1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3336772468862342,1.0512869036714014,0.36828644501278773,0.8142468072666531,1.0,11/122,3.59%,NAMPT;PDGFB;KDR;INSR;TGFB2;BCAR3;RGCC;NIBAN1;NOD2;PRKD2;NLRC5
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.4403342334146654,-1.0499995821267238,0.3912037037037037,0.7924973013317069,1.0,9/12,42.16%,TIPIN;WDR18;NBN;METTL4;GMNN;TICRR;NUGGC;CDT1;KAT7
prerank,organic cation transport (GO:0015695),-0.4031003486677003,-1.0496959289749421,0.38571428571428573,0.7921780870259862,1.0,5/19,18.07%,SLC47A1;SLC22A4;SLC5A7;SLC22A2;SLC25A29
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4509296393071686,-1.0492267268179931,0.4117647058823529,0.7923576298549313,1.0,4/12,19.09%,SEH1L;CENPC;RMDN1;CENPE
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.468235182559554,-1.0491416033734922,0.4057649667405765,0.7914793735338581,1.0,4/11,13.30%,CAMK2D;CACNA2D1;CACNB2;CACNB1
prerank,Rho protein signal transduction (GO:0007266),0.368784783042219,1.0487458066342221,0.378419452887538,0.8200312125012005,1.0,13/53,9.68%,ARHGEF3;NTN1;PLEKHG5;ADGRG1;RIPOR1;EPS8;GNA12;RHOB;EPS8L2;CDC42EP3;ARHGAP4;PHACTR4;ARHGDIA
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.23491162154415596,-1.0486269486643913,0.13793103448275862,0.7917670758204356,1.0,177/807,16.32%,BMP6;FOXP2;PRDM6;FHL2;ZEB2;NR2F2;AEBP1;GLI3;RARB;GLI2;ZFHX3;GLIS3;FOXD1;WNT4;SMAD3;FOXP4;DKK3;BMP7;FGFR2;BMP4;KANK2;ZFPM2;OSR1;DDX5;FNIP1;NR6A1;MDFIC;THRB;LBH;FRK;HDAC4;CUX1;MXI1;PER3;WWOX;SALL1;SNX6;SHC1;IMPACT;NR1D2;ZHX2;FOXC2;LOXL3;DNMT3A;FOXC1;BCOR;KCNIP3;SUFU;RBPJ;ZNF423;HOXA7;DAB2;EHMT2;TBL1XR1;MIER3;MDM4;AR;DLG1;PER2;PHF21A;GLIS2;PPARA;KAT6B;RUNX2;CTR9;ZNF25;ZMYM5;IKZF4;BCL6;CBX7;IGF2;FLNA;HEYL;DACT1;SMARCC2;ZEB1;KDM2A;ZNF568;LCOR;ATF5;PHC2;RUNX1T1;PFDN5;ATN1;CHD3;CHD8;PRKN;CBX5;MITF;YAP1;ZMYND15;KDM2B;MED25;POU6F1;RBAK;ATOH8;SMURF2;SFMBT1;CREB3L1;USP2;PML;FOXO3;CXXC5;PCGF2;EZR;VGLL4;TWIST2;GCFC2;QARS1;CEBPB;BTRC;TSC22D4;MBTD1;NIBAN2;EZH1;GATA6;CBFA2T2;ZBTB38;NR2F1;URI1;PARP1;ZNF148;CRY2;PRDM11;PBXIP1;MTERF3;WWP2;KDM1A;RXRA;BCL7A;NFX1;ESR1;ATP8B1;PSEN1;BMP2;XRCC5;ZNF219;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;ZNF3;SP3;GCLC;ZBTB4;SIRT2;USP9X;PAF1;PEX2;FBXW11;GZF1;WNT11;IFI27;ZBTB1;EP300;NONO;CBX6;TSHZ3;ZBTB7B;PHF12;MAP2K5;SAP18;SPINDOC;MTA3;LIMD1;TLE2;NFIL3;CDKN1C;RUNX1;CRYAB;LDB1;LDB2;MDFI;PSPC1;ZFP37
prerank,calcium ion import across plasma membrane (GO:0098703),-0.43897234868553525,-1.0479711525331061,0.3812785388127854,0.7924631036338831,1.0,3/14,7.24%,SLC8A3;CACNA2D1;SLC8A1
prerank,cardiac muscle cell development (GO:0055013),-0.39283097866287947,-1.0478632258196843,0.4072398190045249,0.7916470053855849,1.0,6/20,7.89%,PDGFRB;PDGFRA;CXADR;OBSL1;SLC8A1;MYH11
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.4400689993722538,-1.047704097885665,0.4152173913043478,0.7910225934131243,1.0,9/14,28.26%,MRPS27;RMND1;RPUSD4;C1QBP;RCC1L;FASTKD3;FASTKD2;MPV17L2;RPUSD3
prerank,regulation of response to biotic stimulus (GO:0002831),0.4138409971249221,1.047612926332822,0.4056291390728477,0.8221611870000329,1.0,7/28,10.45%,TIRAP;LRP8;SAMHD1;XIAP;N4BP1;BIRC3;CASP8
prerank,regulation of myoblast differentiation (GO:0045661),0.40565160747796186,1.0474037402187268,0.4205298013245033,0.8219949885647663,1.0,4/32,3.41%,PLCB1;TBX3;MEF2C;NOTCH1
prerank,regulation of cell development (GO:0060284),-0.3478370417569768,-1.047296873968155,0.3647959183673469,0.7910117537240637,1.0,5/36,8.25%,NOTCH2;DOCK7;PER2;HEYL;YAP1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3995058481213903,-1.047212497062051,0.3914027149321267,0.790120638494848,1.0,8/21,22.96%,SLC30A10;PPARA;PRKN;TRAP1;SIRT2;PAX2;BRCA1;AATF
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.38119077931143774,-1.0470640949999508,0.36519607843137253,0.7894136765516733,1.0,6/23,12.32%,PRKAG2;CEMIP;BMP7;AXIN1;SPHK1;S1PR2
prerank,digestive tract morphogenesis (GO:0048546),-0.42786926509045986,-1.047031304668742,0.40268456375838924,0.7883874865735664,1.0,4/14,6.56%,PDGFRA;FGFR2;RBPMS2;GLI1
prerank,zymogen activation (GO:0031638),-0.34454070936430037,-1.0468013282618187,0.3518005540166205,0.7879476565859007,1.0,8/39,13.45%,CYFIP2;MMP14;ASPH;CTSL;KLK2;PERP;TBC1D10A;CTSH
prerank,cell differentiation in spinal cord (GO:0021515),0.508800550644334,1.0460313393415328,0.437847866419295,0.8247880452487569,1.0,6/10,26.91%,SOX13;MDGA2;LHX1;DRAXIN;ISL1;ZC4H2
prerank,positive regulation of bone resorption (GO:0045780),0.49611393974793455,1.0460185311367074,0.4245810055865922,0.8241004628689781,1.0,4/11,11.85%,TNFRSF11A;PLEKHM1;TNFSF11;SYK
prerank,apical protein localization (GO:0045176),0.5138291801612704,1.045982568844197,0.4042145593869732,0.8234904663375212,1.0,2/10,3.87%,MAL;ACTB
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.42557392915582565,-1.045972971875172,0.37585421412300685,0.7891769301841467,1.0,9/15,32.35%,BCL2;PRKN;KDM1A;CD44;TAF9B;TAF9;ARMC10;SIRT1;MUC1
prerank,endothelial cell migration (GO:0043542),0.39750920292726843,1.0459580276258675,0.38618524332810045,0.822845558244657,1.0,8/37,7.19%,NOS3;PLEKHG5;ID1;PLXND1;STARD13;PXN;STAT1;SOX18
prerank,acute-phase response (GO:0006953),0.48963906526245743,1.0458242193010756,0.42907801418439717,0.82245772005259,1.0,2/12,3.44%,IL6R;SIGIRR
prerank,regulation of type I interferon production (GO:0032479),0.3489968897566095,1.0454375299724776,0.3773049645390071,0.8227764399761239,1.0,15/84,15.25%,TIRAP;TRIM25;LRRFIP1;IFIH1;NLRC5;RNF125;CTNNB1;MRE11;IRF5;PIN1;NLRP4;CYLD;TNFAIP3;G3BP1;CRCP
prerank,reverse cholesterol transport (GO:0043691),0.4851348301496498,1.044738342088246,0.4219858156028369,0.8238121348369082,1.0,3/13,10.76%,SCARB1;ABCG1;LIPC
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4508109543904816,1.0441164287641522,0.4388111888111888,0.8247035324236839,1.0,2/18,3.87%,SPTBN1;ACTB
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.45586165408983376,-1.0440634462490708,0.42391304347826086,0.7933174175248326,1.0,4/12,13.57%,CDC14B;GOLGA2;BTRC;PTEN
prerank,response to reactive oxygen species (GO:0000302),-0.318439812515308,-1.0438097582867516,0.3708206686930091,0.7928849151058217,1.0,10/54,11.92%,EGFR;PDGFRA;TPM1;APOD;ADAM9;PKD2;SOD2;APOE;CHUK;MPV17
prerank,positive regulation of lyase activity (GO:0051349),-0.4328507365942771,-1.0432290178411154,0.4098360655737705,0.7933610468843473,1.0,5/14,13.29%,CACNA1C;STIM1;CACNA1D;FXN;NF1
prerank,cellular response to estradiol stimulus (GO:0071392),-0.40604814147769114,-1.042830367454383,0.37844036697247707,0.7933951266737547,1.0,4/18,17.17%,EGFR;LCOR;ESR1;SFRP1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4528764038507451,1.042502251738881,0.4074074074074074,0.828047984078759,1.0,2/19,1.99%,CSGALNACT1;EXTL3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4742420461009632,1.0424677164220202,0.4195804195804196,0.8274164465858087,1.0,7/15,26.06%,SMAD7;RPS7;RPL11;BAG2;RPL23;BAG5;DTX3L
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4526591125454795,1.0423705811212596,0.41968911917098445,0.8269159281541675,1.0,3/20,5.09%,GATM;GCLM;MGST2
prerank,regulation of cytokinesis (GO:0032465),0.3500284229071717,1.0420529492277575,0.40896358543417366,0.8269834646104969,1.0,20/78,16.46%,BCL2L1;CALM1;CDC14A;CCP110;PKN2;RAB11A;PKP4;PIN1;CETN2;RAB11FIP4;PIK3C3;CDC6;KIF23;MAP10;SH3GLB1;GIT1;PLK2;RXFP3;PRPF40A;SPAST
prerank,cellular response to cadmium ion (GO:0071276),0.43303855448711753,1.0418341866552276,0.4091680814940577,0.8268489255995873,1.0,12/24,16.68%,MAPK3;JUN;MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;MAPK1;SUMO1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.45097828127867645,1.0417368391870456,0.4058721934369603,0.8263858466345382,1.0,7/18,18.53%,CCT3;CCT5;DCP2;NHP2;CCT7;NAF1;EXOSC10
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.40849156925685326,1.0416741453874965,0.40939597315436244,0.8258227572295583,1.0,6/32,8.57%,CAV1;APLNR;PLCG1;CD19;RAMP3;P2RX7
prerank,clathrin-dependent endocytosis (GO:0072583),0.4264161781757762,1.0410809990167378,0.42542372881355933,0.8266142709180131,1.0,9/26,14.60%,FNBP1L;ITSN2;PIP5K1C;INPP5F;FCHO2;AP2M1;SIGLEC1;AP2B1;LMBRD1
prerank,regulation of TORC1 signaling (GO:1903432),-0.3568502316232756,-1.040941787318955,0.39086294416243655,0.7975408675251958,1.0,9/33,18.58%,RNF152;KLHL22;SEH1L;ATM;STK11;CLEC16A;RRAGA;SMCR8;FLCN
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.40439910744455465,-1.0407036582558267,0.4159090909090909,0.7971062566348569,1.0,10/17,34.64%,CPEB1;CTR9;RNF20;NELFE;ZC3H3;CDK9;RNF40;ZC3H14;VIRMA;HSF1
prerank,histone monoubiquitination (GO:0010390),-0.37547523055173376,-1.040623920588353,0.4058679706601467,0.7961956954024831,1.0,13/24,29.88%,BCOR;CTR9;UBE2E1;KDM2B;DDB2;RNF20;PAF1;TRIM37;CUL4B;WAC;RNF40;RNF168;UHRF1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.44999252901609366,1.040023163009327,0.4309090909090909,0.8285920722035229,1.0,5/19,7.63%,BMPR2;TGFB2;ZFPM1;NOTCH1;EFNA1
prerank,positive regulation of protein metabolic process (GO:0051247),0.34105568927923774,1.0395976471691324,0.3832658569500675,0.8288970575819284,1.0,24/110,15.84%,DAB2IP;APP;NFKBIA;NKD1;NEDD4L;FOXO1;KLF2;WNT7A;KLF4;NR1H2;EGLN2;OAZ1;TGFB1;SMURF1;GSK3A;TNFSF12;RANBP9;RAB1A;TNFAIP3;ASB5;BCL10;AREL1;PLK2;APC
prerank,regulation of microtubule nucleation (GO:0010968),0.495665154747262,1.0395825952803277,0.4256505576208178,0.8282272233794968,1.0,6/10,19.94%,ARHGEF7;PAK1;GIT1;CKAP5;DCTN1;MECP2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.45968684014209027,1.0394979058587324,0.42807625649913345,0.8277281342162736,1.0,6/17,12.53%,PDGFB;CCNY;RGCC;CCND3;ADAM17;MAPRE3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4525214126983398,-1.0394256046459036,0.40425531914893614,0.7983487185250333,1.0,3/12,3.43%,APOD;CBLB;F3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.36064944672156407,1.0393778315754114,0.4046242774566474,0.827344884899183,1.0,14/69,12.55%,IGF1R;PLCB1;PLCB4;INPP5F;PLEKHA1;PIRT;CD160;HTR2A;PLCH2;PIK3C3;PIK3C2A;PLCH1;PIK3CB;ZFP36L1
prerank,peptidyl-proline modification (GO:0018208),-0.38191872597974513,-1.039126690529498,0.4034653465346535,0.7980197802639929,1.0,8/25,18.35%,FKBP5;PPIC;FKBP10;PPIL2;P3H2;OGFOD1;PPIH;NKTR
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5146504956132998,1.0386585549294514,0.43545279383429675,0.828499895731526,1.0,3/10,14.70%,SH3RF1;CBFB;NCKAP1L
prerank,axonal fasciculation (GO:0007413),-0.44865727274906436,-1.0384307571664133,0.4436781609195402,0.7987660051818972,1.0,2/12,7.23%,EPHA3;EPHB2
prerank,positive regulation of vasoconstriction (GO:0045907),0.47257237768719285,1.0382108573118236,0.4244604316546763,0.8289512463856384,1.0,2/13,5.76%,CAV1;OXTR
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.43523625227466073,1.0380803316232585,0.42418772563176893,0.8285558616172337,1.0,7/23,11.82%,PDGFB;INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,in utero embryonic development (GO:0001701),-0.36914416382593673,-1.0378392158849734,0.4067796610169492,0.7993361279574915,1.0,8/25,12.43%,FGFR2;ARNT2;PKD1;TGFBR1;IGF2;ZNF568;TGFB3;BMP2
prerank,regulation of mitochondrial fusion (GO:0010635),0.49826873490338247,1.0373733587076301,0.4553734061930783,0.8297275682609149,1.0,1/11,0.15%,TFRC
prerank,cAMP-mediated signaling (GO:0019933),0.4275032328172685,1.0365954991675028,0.4088669950738916,0.8309954211364359,1.0,5/24,5.00%,PDE2A;RAPGEF2;RAPGEF3;PDE4D;PDE7B
prerank,reticulophagy (GO:0061709),-0.44332790340026046,-1.0364674724397953,0.4250559284116331,0.8019752700791307,1.0,5/12,14.77%,ULK2;ATG2B;TEX264;DDRGK1;UFC1
prerank,skeletal muscle tissue development (GO:0007519),0.40465912403754295,1.0364285360148024,0.40129449838187703,0.8307257489032154,1.0,6/32,12.12%,CAV1;MEF2C;FOXL2;MYH14;CAV2;CSRP3
prerank,cellular calcium ion homeostasis (GO:0006874),-0.26966338168141046,-1.03636596900488,0.37,0.8011306126316904,1.0,24/133,12.41%,SLC24A3;ANK2;ATP13A5;MCU;STIM1;SLC8A3;DMPK;ATP13A3;CAMK2D;TRPC3;SLC35G1;ANXA6;SLC8B1;SLC8A1;BCL2;PTH1R;TRPC6;PML;PRKACA;CLN3;SLC24A5;AFG3L2;TRPC4;PSEN1
prerank,hyaluronan catabolic process (GO:0030214),-0.41404105947596065,-1.036113494356176,0.4288990825688073,0.8007500069790083,1.0,10/18,27.44%,CEMIP;CEMIP2;FGF2;SLC9A1;HEXA;CD44;LYVE1;HMMR;GUSB;HYAL3
prerank,cellular response to nutrient levels (GO:0031669),0.35915088226681174,1.0359586903886409,0.4200298953662182,0.8311681345366194,1.0,16/62,17.67%,MFSD2A;BMPR2;FOXO1;RIPOR1;FAM107A;CDKN2B;RALB;MAP1LC3B;HSPA8;RPTOR;TFEB;STK24;STK26;ATG14;MAP1LC3A;WDR45
prerank,cellular response to interleukin-6 (GO:0071354),0.4257681513878807,1.0357671293074713,0.4379310344827586,0.8309193821020342,1.0,4/26,6.71%,ST3GAL6;IL6R;ST18;STAT1
prerank,respiratory electron transport chain (GO:0022904),0.4700162707356351,1.0351887049538109,0.4232142857142857,0.8316825887946024,1.0,3/14,9.78%,GPD2;ETFRF1;ETFB
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3690352658071058,-1.0351186473697203,0.41647597254004576,0.8023283739607939,1.0,6/26,11.45%,ITPR1;PKD2;FGF2;SLC8B1;ITPR2;IBTK
prerank,generation of neurons (GO:0048699),0.31468030919085915,1.0346442684627633,0.38224414303329224,0.8323999257028841,1.0,34/190,12.71%,NDNF;TGFB2;RAPGEF2;ADGRL3;SH3RF1;FZD4;NAV1;MEF2C;FGF13;WNT7A;CTNNB1;BTG4;FUT9;INSM1;PIN1;GPM6A;ACSL3;OPHN1;SPOCK1;DNER;DISC1;DDIT4;ATOH7;DCX;CEP85L;LHX5;VXN;IER2;RAC1;LHX9;LHX6;EML1;SOX11;OLIG1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3342662015558788,1.0343086670430757,0.4147952443857332,0.8324813746299125,1.0,29/107,16.74%,CACNA1A;APP;LRP8;MEF2C;CDH2;ABR;CLSTN1;TPRG1L;DGKI;BTBD9;GRID2;HOMER1;PXK;OPHN1;AKAP9;AGER;DGKZ;GRIK5;GRIK2;CPLX1;GRIK1;GRM7;DLGAP3;LRRC4C;NLGN1;RIMS2;GRM8;LGI1;CNTNAP4
prerank,plasma membrane organization (GO:0007009),-0.3091920010949016,-1.0340698122002794,0.3653250773993808,0.8041657068443001,1.0,13/61,11.08%,ANK2;COL5A1;MYOF;ANO6;AHNAK2;A4GALT;ANXA6;STX2;PLSCR2;EPB41L3;SNX9;TLCD2;CLN3
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3687528177176832,1.0339887571210113,0.41512345679012347,0.8326148885896113,1.0,7/52,8.24%,PRKCH;SPTBN1;STX3;ATP2C1;RAMP3;SORBS1;ACSL3
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.44219130659682104,1.0339586242986214,0.4130052724077329,0.8319854624221704,1.0,9/21,25.97%,ARHGEF2;FGF13;ATXN7;APC;CAMSAP2;CLASP1;CAMSAP1;NAV3;CLASP2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4447316037192894,1.033443268550917,0.42517006802721086,0.8326095601752851,1.0,2/19,2.62%,KDR;PTPRJ
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2909964841668001,1.0333916961139735,0.39762931034482757,0.8320494902552449,1.0,85/497,15.26%,LEF1;MECOM;PLCB1;DACH1;PDGFB;ELK3;DAB2IP;BMPR2;NANOS3;ZHX3;PPARD;TBX3;ID1;SMARCA2;FOXO1;FOXL2;ACVRL1;SOX13;CCDC85B;NOTCH1;MEN1;YBX1;HDAC9;HMBOX1;ZBTB16;HHEX;NANOS2;CTNNB1;SOX7;GATAD2A;ENC1;MRPL13;CD38;NANOS1;RPS6KA5;KLF4;PHC1;NR1H2;SOX18;YEATS2;HINFP;L3MBTL4;KAT6A;JUN;TGFB1;FOXP3;ZBTB14;CIART;DEDD2;HMGA1;KDM4A;ZMYND11;YWHAQ;RPL13A;CNOT9;GRB7;HSPA8;CDC6;PEX14;CTCF;EID2;GSK3A;ZBTB7A;LHX9;TNFRSF4;TLE1;BTG2;RCOR2;TERF1;PPARG;ZBTB33;POU2F1;SOX9;PAIP2;HMGB2;NR3C1;ID3;CIC;CTBP1;RIOX1;HDAC5;YAF2;RNF139;IKZF1;LOXL2
prerank,spermatid development (GO:0007286),0.4063495453481723,1.0333487420036425,0.4100486223662885,0.8314468670004003,1.0,5/32,15.20%,JAM2;PIWIL1;RSPH1;YTHDC2;RNF8
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.47911918716159224,1.0329492808807905,0.41379310344827586,0.831763908699114,1.0,4/12,12.84%,NFKBIA;ABCG1;NR1H2;PPARG
prerank,regulation of T cell cytokine production (GO:0002724),0.4736668766878486,1.032697396660569,0.43613138686131386,0.831708327653515,1.0,4/15,9.05%,B2M;SMAD7;FOXP3;MALT1
prerank,organophosphate biosynthetic process (GO:0090407),0.3916028402924439,1.0321992384806824,0.4199066874027994,0.8323325862623646,1.0,4/37,7.20%,ITPKB;MBOAT1;TPK1;GPHN
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.49153110480744916,1.0320552451868732,0.43119266055045874,0.8320190612894428,1.0,3/11,6.44%,CD34;CD200;LGALS9
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.38256197249736296,1.0320139469895573,0.41910631741140214,0.831422390758243,1.0,15/46,17.12%,SHANK3;MEF2C;CDH2;TPRG1L;DGKI;HOMER1;NPS;OPHN1;NRXN1;DGKZ;GRIK1;GRM7;NLGN1;GRM8;CCR2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3719532359479451,1.0320130396369305,0.43238993710691825,0.8307248887525733,1.0,10/50,17.70%,IVNS1ABP;CAV1;SMAD7;N4BP1;UBXN1;TNFAIP3;DNAJA1;BAG2;SIRT7;PRKCG
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.40799631709231854,-1.031638545039684,0.41834451901565994,0.8100460174934302,1.0,4/17,4.69%,ROBO1;EFNB2;SLIT2;FGF2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.47429628617298186,1.0315292330873003,0.4280442804428044,0.8312334129846468,1.0,5/14,11.18%,ABCG1;ADAM10;ABCA7;ADAM17;APH1A
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3419306606915178,1.0315196957333328,0.4052924791086351,0.8305524869007356,1.0,19/88,16.68%,TFRC;DAB2IP;TIRAP;RGCC;FNIP2;VIL1;TAL1;BIK;TGFB1;MMP1;SYK;SH3GLB1;HGS;SDCBP;CDH5;HAS3;MPP7;PDCD6IP;SUMO1
prerank,RNA metabolic process (GO:0016070),-0.2731655185824513,-1.0314943969565002,0.3815261044176707,0.8093280484482824,1.0,43/127,28.92%,CELF2;RBMS1;HNRNPH1;HNRNPUL1;POLR2A;PABPN1;AGO2;RBM39;NOVA1;BICD1;DDX17;HNRNPH2;RBM5;RNASE4;ALKBH1;HNRNPR;TENT2;DDX3X;SIDT2;LAGE3;HNRNPA2B1;PABPC4;GTF2F1;DDX39B;PCBP2;FASTKD1;TP53RK;PAPOLG;FASTKD2;TBRG4;POLR2L;PARN;THOC1;DROSHA;LSM8;POLR2I;HNRNPD;RNASEH2B;ATXN1;TFIP11;SYNCRIP;POLR2K;DHX36
prerank,signal transduction by p53 class mediator (GO:0072331),0.41104984732284355,1.0313709533988429,0.4288052373158756,0.8302485351675362,1.0,6/30,8.89%,PPP1R13B;ACER2;MYO6;HINT1;JMY;GREM1
prerank,regulation of cholesterol transport (GO:0032374),-0.39580398960359436,-1.0310448338477156,0.4147982062780269,0.8094229297682196,1.0,1/20,0.53%,LRP1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.49370524091302065,1.0310382414021027,0.4288354898336414,0.8304415568570799,1.0,1/10,0.34%,CSGALNACT1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.41235708433142076,1.0304540117229202,0.423728813559322,0.831160728592024,1.0,6/29,14.41%,DCUN1D3;SMAD7;FBXW7;PIN1;DCUN1D1;BMI1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.45319493051812854,1.0299300749381917,0.40250447227191416,0.831810306960486,1.0,2/16,2.75%,PLCB1;MEF2C
prerank,protein insertion into membrane (GO:0051205),0.3981813540522108,1.0297843016030346,0.443217665615142,0.8314658249549103,1.0,5/32,8.56%,APP;REEP1;STX1A;GRIN3B;RTP4
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2832211503531218,1.0296985720370204,0.4016477857878476,0.8309845166224219,1.0,96/834,8.89%,LEF1;ETS1;ITGA6;ERG;LMO2;NAMPT;EPAS1;PDGFB;ELK3;DAB2IP;ENG;BMPR2;TGFB2;LMO7;NOTCH4;MRTFB;APP;ZIC3;TBX1;PPARD;MRTFA;NFKBIA;SOX17;TBX3;KLF7;AGRN;ARHGEF2;RGCC;MEF2C;MOSPD1;NCOA1;SMARCA2;PLXND1;FOXO1;CD40;RPS6KA1;ACVRL1;ZFPM1;NOD2;PRKD1;NOTCH1;PRKD2;MEN1;YBX1;NLRC5;KLF2;MYO6;PRDM2;IRF2;ASXL3;WNT7A;IKBKB;SMAD7;HHEX;FOXF1;RREB1;CTNNB1;GATA2;POU2AF1;CREB1;SPAG8;WWTR1;HYAL2;TAL1;ST18;TLR3;CRTC1;MAML2;MAPK3;RPS6KA5;KLF4;TOX3;NKX2-8;CDKN2B;STAT1;MAX;NR1H2;IRF5;NCOA2;SOX18;PHOX2A;NFIC;SOX12;HINFP;KAT6A;JUN;PIN1;TGFB1;ATF6B;TCF12;KLF6;FOXP3;ELK4;LRP5;NFATC2IP;GREM1
prerank,neuronal action potential (GO:0019228),-0.37608486358903404,-1.0294091386570434,0.4331065759637188,0.8128681091192974,1.0,3/22,4.90%,SCN7A;KCNMB2;CACNA1G
prerank,protein modification by small protein conjugation (GO:0032446),-0.241182372762485,-1.0288348028458494,0.3063063063063063,0.8134138603116553,1.0,94/361,21.38%,RNF220;PDZRN3;EYA1;RNF152;FBXL7;RNF43;SPSB1;AMFR;ARRB1;ASB2;FBXL17;PIAS1;DTX4;DTX3;SEH1L;TRIM23;FBXO10;HIF3A;CTR9;FBH1;ZSWIM8;ATG10;FBXW8;DTX1;UBE2R2;MGRN1;PRKN;SELENOS;PJA2;UBE2E1;KLHL18;SMURF2;RNF135;FBXO45;UBE2M;NUP205;CUL7;CUL3;BTRC;TRIM63;TRPM4;KLHL13;HUWE1;ARRDC4;WWP2;MYLIP;RNF20;DCUN1D5;RNF181;NFX1;UBE2E3;PIAS2;TRPC4AP;UBA1;SYVN1;USP9X;PAF1;PEX2;FBXW11;DDRGK1;LZTR1;UFC1;SDE2;RRAGA;RNF144A;ATG3;UBE2B;SPSB4;DTX2;UBR2;UBR3;MKRN1;RCHY1;FBXO4;TRAIP;NUB1;CAND1;FBXO9;NSMCE2;MUL1;CDC16;HECW2;UBA6;BRCA1;TRIM17;OTULIN;RNF14;BRAP;RAE1;FBXW5;DCAF15;RNF34;UBA2;KLHL21
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.2836611867916017,-1.0286327792768426,0.4043321299638989,0.8128117289317288,1.0,28/102,14.43%,ADCY5;ENPP1;ADCY1;CPEB1;CPEB2;ADCY9;IRS1;SLC30A10;INSIG2;RHOQ;PRKCD;SLC39A14;ADCY2;PRKCI;ADCY7;MYO5A;IRS2;SELENOS;PDPK1;PRKACA;EPRS1;SYAP1;PARP1;GOT1;ADCY6;CYSLTR2;PIK3R1;NR4A1
prerank,metal ion export (GO:0070839),-0.35458571443582104,-1.0282888634716998,0.39841688654353563,0.8126365378410068,1.0,6/31,7.08%,ATP1A2;KCNT2;KCNK5;ATP1B3;ATP7A;ATP1B2
prerank,negative regulation of developmental growth (GO:0048640),0.40536579621209096,1.0281501658563474,0.43174603174603177,0.834174516815548,1.0,9/30,16.95%,NKD1;FGF13;DIP2B;GDF15;WWC1;MAG;SEMA3G;DCC;WWC2
prerank,visual perception (GO:0007601),-0.29066613677207115,-1.0280028977291729,0.40942028985507245,0.8123696670248624,1.0,9/84,5.12%,COL1A1;SLC4A10;EFEMP1;EYA4;COL18A1;ADGRV1;COL11A1;DHRS3;EML2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4003358117584138,1.0278353910011553,0.4299363057324841,0.8343010344607704,1.0,9/34,12.43%,PTPRB;PTPRJ;DUSP7;PTPN12;DUSP3;ACP4;DUSP1;PTPRQ;DUSP16
prerank,nucleocytoplasmic transport (GO:0006913),0.38423003729342525,1.0278188442583365,0.4083850931677019,0.8336470371306259,1.0,22/40,31.72%,BACH2;SNRPF;NXT1;MALT1;SNRPE;RITA1;NCBP2;SNRPB;RSRC1;SNRPD2;NCBP1;NXT2;DDX20;SNRPD1;SMN1;NUTF2;HNRNPA1;GEMIN5;ANP32A;HTATIP2;SNRPG;SNRPD3
prerank,mRNA methylation (GO:0080009),0.45046912933560584,1.027641774250841,0.43137254901960786,0.8333839544472408,1.0,7/15,23.95%,CBLL1;TRMT10C;TRMT61B;ZC3H13;CMTR1;METTL3;PCIF1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.32258186127411187,-1.0274637827579718,0.41025641025641024,0.8127450723927327,1.0,11/51,8.50%,GAS7;DCLK1;NBL1;BMP7;NRK;DTNBP1;NGF;MAP1S;ATP7A;EPB41L3;ANKRD27
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.36062130573704,1.0273907725389249,0.43641618497109824,0.8333269736463487,1.0,12/61,5.48%,ARHGEF3;RASGRP4;NET1;F11R;ADGRG1;LPAR6;RAPGEF1;PRAG1;NOTCH1;LYN;GRB2;MAPRE2
prerank,amyloid fibril formation (GO:1990000),0.37314710136198237,1.0272275919767477,0.43503649635036495,0.8330285262292779,1.0,6/51,6.41%,APP;TSPAN5;B2M;TSPAN14;NPPA;ADAM10
prerank,response to cadmium ion (GO:0046686),0.42116915049174475,1.0271691102473515,0.4383561643835616,0.8325084877175027,1.0,12/26,16.68%,MAPK3;JUN;MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;MAPK1;SUMO1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.40711890657684896,1.026871603696665,0.4098883572567783,0.8325788152937429,1.0,9/29,14.07%,CAV1;TNFSF10;HYAL2;RET;DEDD2;AGTR2;TNFSF12;CYLD;BCL10
prerank,pulmonary valve development (GO:0003177),-0.4101039237080831,-1.0267517201981629,0.4295774647887324,0.813614954128873,1.0,7/18,7.70%,ROBO1;NOTCH2;BMP4;SLIT2;SMAD6;HEYL;JAG1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3563940247185187,-1.0267123933299787,0.4076923076923077,0.8126335404251392,1.0,6/29,8.55%,SNTA1;KCNIP3;CD63;DLG1;CACNA1D;SLMAP
prerank,sensory perception of sound (GO:0007605),0.3444504544096629,1.0259988512816465,0.39944521497919555,0.8341240802972459,1.0,19/88,10.83%,CLIC5;USP53;TBX1;GRAP;HOMER2;PCDH15;CDC14A;KCNQ1;EPS8L2;SNAI2;LHFPL3;MARVELD2;POU3F4;MYH14;TIMM13;SLC52A3;TIMM10;CLRN1;LRP2
prerank,regulation of cilium assembly (GO:1902017),0.3528343421593546,1.0256889883801361,0.4358974358974359,0.8342305755794813,1.0,19/62,17.99%,TBC1D14;TBC1D22A;TBC1D2;USP6NL;TBC1D24;CCDC88A;LIMK2;TBC1D5;CCP110;MARK4;ODF2L;TBC1D10B;TBC1D30;CYLD;TBC1D1;TBC1D22B;TBC1D15;IFT140;KCTD17
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4873513349703528,1.0255452800016214,0.44423791821561337,0.8338749791710313,1.0,3/12,11.84%,SEC62;SGTB;GET3
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.4538960076576085,1.0252812174948975,0.4452296819787986,0.8338554794038594,1.0,3/18,4.05%,RASIP1;HEG1;STMN1
prerank,cellular protein-containing complex assembly (GO:0034622),0.31441245146128055,1.0251172624860525,0.4119897959183674,0.8335766646690453,1.0,39/159,19.02%,HIP1;HIP1R;TIAM1;STXBP6;PXN;POMP;HSP90AB1;RPL38;EIF4H;STXBP1;FCHO2;PSMD11;DRC1;AP2M1;TGFB1;PIK3C2A;SMAD1;SAMM50;DNAAF2;EID2;EPS15;GTF2B;HIGD1A;CSNK2B;BBS10;ANLN;DNAAF3;OMA1;IMMP2L;NCK1;TESPA1;TBCEL;POGZ;TTC12;BIN1;NUP153;CHCHD4;GPX4;FKBP1A
prerank,protein transport (GO:0015031),0.2947554037195899,1.0250995303396566,0.4103139013452915,0.832935855673057,1.0,46/332,11.60%,TFRC;TBC1D4;SPTBN1;MACF1;STX3;RAB31;TBC1D14;ARHGEF2;STX1A;TBC1D22A;RAMP2;TBC1D12;ATP6V0A1;CALCRL;SNX13;MYO6;ABCG1;MCOLN1;TBC1D2;ARF5;RAMP3;USP6NL;CMTM6;TBC1D5;REP15;LRP1B;SLC10A7;STXBP1;DNM2;ARL4A;SCAMP1;RAB34;CHMP1B;YWHAH;RAB3B;KIF3B;ARL6IP5;LRP2;TBC1D10B;ACD;AMN;PPY;STX19;PRKCB;MTTP;TBC1D30
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.3105189627376227,-1.024312767579323,0.3577981651376147,0.8180721444743916,1.0,6/59,5.81%,ALDH1A2;CYP7B1;ABCD3;CYP27A1;PER2;ACOT8
prerank,brain development (GO:0007420),0.3204782251219914,1.0241295924484617,0.4380704041720991,0.8347729105905445,1.0,23/136,13.19%,MFSD2A;SHANK3;ADGRL2;SHROOM4;RAPGEF2;ADGRL3;ADGRG1;NES;CDH2;DSCAML1;AATK;COL4A1;DHX37;CDK5RAP2;TBC1D23;DDIT4;AGTR2;GRIN2B;UFM1;UTP3;TGFBR2;EML1;CNTNAP2
prerank,calcium ion homeostasis (GO:0055074),0.333672870509746,1.0238770678445464,0.4249667994687915,0.8347094800138133,1.0,11/95,7.55%,TMTC2;CXCL12;CAV1;SLC30A1;CD40;ATP2C1;SLC24A2;SLC24A4;ATP2B1;SLC10A7;HTR2A
prerank,motor neuron axon guidance (GO:0008045),0.4558377396778131,1.0234200652341008,0.4386873920552677,0.8351656366048614,1.0,4/15,11.43%,NTN1;TMEFF1;EPHA4;RAC1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.36862089219238897,-1.0233944727119118,0.4172661870503597,0.819538872812861,1.0,8/27,9.88%,PID1;ENPP1;IRS1;KANK1;PRKCD;GRB10;TNS2;PIP4K2C
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.4410389185945554,-1.0233730134303387,0.4576271186440678,0.8185070704438814,1.0,6/12,22.38%,CLN3;LRRK2;GRN;CLN6;ATP6AP2;TMEM9
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.49805391825100087,1.023367427644688,0.43169398907103823,0.8346003716220265,1.0,6/10,29.44%,PDE8A;STK26;TXN;RIPK1;NFE2L2;PARK7
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.49800227939312314,1.0227046386118996,0.46296296296296297,0.8355471162287597,1.0,2/10,3.88%,JAK3;LYN
prerank,protein stabilization (GO:0050821),-0.26174012546484193,-1.0225990656545696,0.36585365853658536,0.8196252790491985,1.0,45/168,18.80%,ANK2;IGF1;PARVA;PLPP3;LAMP2;PER3;RASSF2;PRKCD;PPARGC1A;MDM4;FLOT2;ATP1B3;RAB21;STXBP4;AAK1;FLNA;ATP1B2;PRKN;TNIP2;PFN2;USP2;BAG1;CCNH;CDK7;SEC16A;SYVN1;P3H1;NCLN;PTEN;BAG3;OTUD3;USP9X;MORC3;PIK3R1;EP300;UBE2B;CCT2;CRYAB;GRN;TAF9B;GET1;ATF7IP;CCT6A;USP19;MUL1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.34526277278964845,-1.0223248062256272,0.4293193717277487,0.8192699599283827,1.0,5/32,8.01%,PRKAG2;ZBTB20;PRKAA2;PPARA;APOE
prerank,T cell differentiation in thymus (GO:0033077),-0.4200703908509199,-1.0221807003566787,0.4250559284116331,0.8185250405241429,1.0,1/14,0.65%,GLI3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4385173124414289,1.0221095398176492,0.4537671232876712,0.836333116062524,1.0,4/21,4.53%,CAV1;CNKSR3;SMAD7;PDE4D
prerank,regulation of organelle organization (GO:0033043),0.34609599257759094,1.0220295114586073,0.42461964038727523,0.8358503002966106,1.0,13/80,11.08%,TJP1;PDE2A;F11R;PTK2;USP6NL;MAPK3;STMN3;ARHGEF5;MSN;CLIC4;AKAP9;PDCD10;S100A8
prerank,cochlea morphogenesis (GO:0090103),0.5012615393894301,1.0220088676340424,0.44808743169398907,0.8352184480384144,1.0,3/10,13.39%,TBX1;POU3F4;SOX9
prerank,negative regulation of cellular component movement (GO:0051271),0.45850435779209464,1.021997206064941,0.4490909090909091,0.8345785310180013,1.0,4/15,8.04%,FRMD5;SP100;ACTN1;PIN1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3519340984335598,1.021944853172065,0.41678726483357453,0.8340223015380837,1.0,10/74,6.64%,ITGA6;BCL2L1;NOS3;FAS;SH3RF1;TNFSF10;ARHGEF2;SNAI2;RFFL;MCL1
prerank,protein processing (GO:0016485),-0.28312766952349333,-1.0219167989662339,0.4007352941176471,0.8181840111673617,1.0,27/102,20.74%,AEBP1;PCSK5;MMP14;MMP16;F3;OGT;CTSL;ADAM19;CPXM1;KLK2;CPXM2;FXN;CLN3;AFG3L2;PSEN1;CTSH;HTRA2;SDE2;HM13;ZMPSTE24;PRSS12;PARL;CASP4;PCSK6;PTCH1;EEF1AKMT4-ECE2;XPNPEP3
prerank,protein lipidation (GO:0006497),0.35930239847180734,1.0217029567385427,0.43157894736842106,0.83391701100394,1.0,19/59,21.77%,ZDHHC14;PIGU;ZDHHC9;ZDHHC20;PIGM;PGAP4;PIGF;ZDHHC18;ZDHHC22;PIK3C3;ATG12;DPM3;ZDHHC21;WDR45;ATG7;ZDHHC17;PIGO;PIGV;PIGQ
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.48254991553925075,1.021470752922395,0.4430379746835443,0.8338325190097228,1.0,1/12,1.71%,IL1R1
prerank,peptidyl-threonine modification (GO:0018210),-0.30094535300627945,-1.0214671141999685,0.4186046511627907,0.8183123588759297,1.0,24/66,25.37%,ROCK2;PRKCD;CAMK2D;TGFBR1;MAP3K12;PDPK1;PRKCA;LRRK2;GALNTL6;GALNT16;WNK1;ACVR1B;DYRK2;CDC42BPG;SBK1;WNK3;CSNK2A1;CDK5;MAP2K1;GALNT1;CDK10;TNKS;CIT;GALNT3
prerank,establishment of melanosome localization (GO:0032401),-0.388525064188395,-1.021248030463818,0.4370860927152318,0.8178253430473463,1.0,14/19,40.58%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;BLOC1S3;RAB27B
prerank,regulation of lamellipodium assembly (GO:0010591),0.3910787555355977,1.0200397323001515,0.4431818181818182,0.8367011607352359,1.0,9/34,11.43%,OCLN;WASF2;NCKAP1;TWF2;CYFIP1;CLRN1;ABI3;PLXNB3;RAC1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4376376486952433,1.0198463067428187,0.4377104377104377,0.8365099257569306,1.0,4/20,10.81%,IL1R1;B2M;MALT1;DENND1B
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4793400862546679,1.0196863386565693,0.4442307692307692,0.836257272701581,1.0,4/13,13.39%,TBX3;NOTCH1;TGFB1;SOX9
prerank,positive regulation of organelle assembly (GO:1902117),0.380042751492223,1.019623885282279,0.43567251461988304,0.835732820059013,1.0,16/44,17.99%,CNOT6L;CCDC88A;CCP110;RALB;MARK4;CAPG;SH3GLB1;PIP4K2A;CNOT6;SDCBP;FSCN1;G3BP1;SPAG5;PDCD6IP;IL5;KCTD17
prerank,positive regulation of immune response (GO:0050778),0.3513302446169988,1.0196161304023694,0.4196816208393632,0.8350736357143071,1.0,8/64,12.66%,TGFB2;NOD2;GBP5;CCR7;LGALS9;EIF2AK4;TLR8;IL15
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.42163355347552933,-1.01956493595298,0.44768856447688565,0.8213922841969198,1.0,5/14,19.36%,DMD;WNK4;SLC9A1;WNK1;WNK3
prerank,epithelial cell development (GO:0002064),-0.3880747584513099,-1.0191558924359874,0.4439140811455847,0.8214306430790612,1.0,7/20,19.71%,WNT5B;SLC4A7;ACTA2;DACT2;RILPL2;PDZD7;BFSP1
prerank,negative regulation of transport (GO:0051051),0.36044163207765906,1.0191337661836153,0.42168674698795183,0.8356224692161217,1.0,10/51,10.83%,DYSF;CTTNBP2NL;PRKD1;SNX3;NR1H2;BST2;PXK;ABCA7;NDFIP2;ARL6IP5
prerank,cellular response to organonitrogen compound (GO:0071417),0.33108151497374455,1.0191282912318564,0.4247159090909091,0.8349570601229447,1.0,27/99,18.57%,PDE2A;RAPGEF2;SH3BP4;MEF2C;RAPGEF1;RAPGEF3;ACTB;CTNNB1;KCNQ1;RAP1B;GABRB1;P2RX7;AKAP9;LAMTOR5;RPTOR;ZFP36L1;NSMF;HCN2;SOX9;AKAP6;SSH1;LAMTOR4;CRHBP;CAPN2;SLC26A3;CIB2;GABRB2
prerank,Fc receptor signaling pathway (GO:0038093),0.32973509375519994,1.019075530226162,0.4376657824933687,0.8344042117034313,1.0,37/110,21.88%,MAP3K1;LYN;PLCG1;IKBKB;CALM1;GRB2;SOS1;MAPK3;PSMB3;JUN;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;PPP3CA;RAC1;SYK;PPP3R1;PIK3CB;PSMB10;BCL10;LCP2;CARD11;PSMA8;MAPK1;LAT2;PAK2;SKP1;PSMD9;PLCG2;MAP2K7;VAV1;CUL1;PSMC3;PSMD1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.40848866697284025,-1.0187814436985139,0.4419134396355353,0.8213707330326379,1.0,3/16,3.79%,SOX5;HOXB4;FOXC1
prerank,calcium ion import into cytosol (GO:1902656),-0.42153373219499357,-1.0185646985783845,0.41898148148148145,0.8208874673434501,1.0,3/15,7.24%,SLC8A3;CACNA2D1;SLC8A1
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3772412342039158,-1.0182030207988872,0.4097938144329897,0.8207997199771085,1.0,3/22,3.05%,CACNA1C;STIM1;ADGRV1
prerank,positive regulation of cell death (GO:0010942),0.359418094689688,1.0179529621233925,0.4341906202723147,0.8364544072022028,1.0,8/59,11.28%,SLC6A6;ACER2;RAMP3;FYN;MARK4;DDIT4;AXIN2;GRIN2B
prerank,regulation of feeding behavior (GO:0060259),-0.4591978386709909,-1.0179092049263727,0.4689507494646681,0.8204684186682375,1.0,1/11,1.10%,LEPR
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.36709067905093384,-1.0177253471278063,0.42093023255813955,0.819877607181903,1.0,10/25,16.89%,AMPD3;PAICS;MTHFD1;PRPS2;GMPR2;PRPSAP1;GMPS;DGUOK;PRPSAP2;ADSL
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.33021553668369263,1.017372818713434,0.42275280898876405,0.8371853048557911,1.0,21/87,11.99%,ESAM;RHOBTB1;HIP1R;F11R;CORO2B;RAPGEF3;EPS8;RHOB;CCDC88A;BAIAP2;FAM107A;BST2;ARHGEF5;TWF2;IQGAP1;PAK1;ARHGDIA;ARHGAP17;ABI3;RAC1;RND1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.4137972062570554,1.0173284407732999,0.4382207578253707,0.8366197298745937,1.0,2/26,0.95%,OCLN;INSR
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.44539595804150545,1.0161972748729804,0.4633699633699634,0.8388273994149956,1.0,3/18,8.93%,SHANK3;WNT7A;NRXN1
prerank,negative regulation of cell population proliferation (GO:0008285),0.2936689159159784,1.0158964093179526,0.42761692650334077,0.8388957658583631,1.0,43/351,9.22%,ETS1;AQP11;DAB2IP;BMPR2;TGFB2;NOS3;RAPGEF2;SH3BP4;APP;SLC16A2;DDAH1;MCC;ITGA1;CD200;TBX3;CTNNBIP1;B2M;ADGRG1;PTPRJ;RGCC;MTSS1;SMARCA2;ACVRL1;NOTCH1;MEN1;LYN;CTNNB1;GATA2;SOX7;DLL4;IGFBP7;BTG4;ST18;KLF4;CDKN2B;INSM1;TGFB1;TMEM115;FOXP3;ADAMTS8;GREM1;HMGA1;PAK1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.42595305888739754,1.0156872954149374,0.4375,0.83873397890603,1.0,2/21,2.89%,CSGALNACT1;CHST11
prerank,regulation of endopeptidase activity (GO:0052548),0.3567354050518551,1.015643082123726,0.43529411764705883,0.8381714242611261,1.0,10/59,11.81%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;BIRC3;SPOCK1;SERPINI1;PSME2;APH1A;VSIR
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.45908222536076426,1.0156041827477225,0.44086021505376344,0.837598373311163,1.0,4/14,7.37%,RGCC;CD40;PLCG1;CD160
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.40948477516262405,1.015371646003965,0.43042071197411,0.837571481649953,1.0,6/26,12.22%,PLCB1;RGCC;CCND3;ADAM17;CDC6;RPTOR
prerank,cellular response to metal ion (GO:0071248),-0.2708070479970017,-1.0153474629805364,0.425,0.8254149991598716,1.0,16/123,8.33%,BMP6;EGFR;PRKAA2;SLC41A1;ADCY1;ADGRV1;SLC12A2;CDH1;CAMK2D;PKD2;ADCY7;DLG4;P2RX4;PRKN;SYT9;SLC25A24
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.31791314924221387,1.0153224627132917,0.4296774193548387,0.8370038999365551,1.0,24/136,14.63%,DAB2IP;FZD6;NFKBIA;CD200;CTNNBIP1;ID1;SP100;SIGIRR;MEN1;NLRC5;TMSB4X;SMAD7;KLF4;AIM2;FOXP3;IRAK2;EIF2AK4;PEX14;TNFRSF4;EGLN1;CYLD;TNFAIP3;FOXJ1;ID3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4182614960663916,-1.0151160928798915,0.4176334106728538,0.82499320663873,1.0,7/15,25.22%,SELENOS;HSP90B1;SYVN1;AUP1;SEC61B;DERL1;UFD1
prerank,positive regulation of RNA splicing (GO:0033120),0.4028227432031868,1.014854554749336,0.43986820428336076,0.8374455172376933,1.0,1/29,0.46%,RBM20
prerank,nuclear envelope organization (GO:0006998),-0.38060608782343025,-1.0142392004280705,0.4467120181405896,0.8262648331581648,1.0,9/20,26.04%,DMPK;TMEM170A;TOR1AIP1;EMD;SUN2;VPS4A;TMEM43;LEMD2;NUP155
prerank,regulation of protein sumoylation (GO:0033233),-0.3998249810587585,-1.0141501247791802,0.43529411764705883,0.8254234282930065,1.0,8/17,26.68%,HDAC4;PIAS1;MUL1;UBA2;ZMIZ1;RWDD3;EGR1;GNL3L
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.40672184737854356,-1.0140996589788698,0.4407894736842105,0.8244639573358754,1.0,3/17,12.09%,LPGAT1;LCLAT1;PLA2G12A
prerank,negative regulation of endopeptidase activity (GO:0010951),0.37213702994527575,1.0137236373149185,0.42660550458715596,0.8395880162746346,1.0,6/47,9.50%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;SPOCK1;SERPINI1
prerank,positive regulation of synapse assembly (GO:0051965),0.403298156827383,1.013720933458931,0.4324786324786325,0.8389179746806863,1.0,9/27,16.49%,AGRN;WNT7A;CLSTN1;GRID2;NRXN1;LRRC4B;EPHB1;NLGN1;IL1RAP
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3747631229468262,-1.0134580026536633,0.4410377358490566,0.8251797191508061,1.0,10/22,12.11%,NTRK3;PDGFRB;PDGFRA;FGFR2;KIT;FGF2;AGTR1;PDPK1;ARL1;ESR1
prerank,sprouting angiogenesis (GO:0002040),0.35975067761249413,1.0134119579343068,0.42684766214177977,0.8390060386846508,1.0,7/51,3.52%,TEK;KDR;ENG;FLT4;PIK3R3;ACVRL1;RAMP2
prerank,regulation of B cell apoptotic process (GO:0002902),-0.43337448990252136,-1.0127805068785396,0.45454545454545453,0.8259787378088254,1.0,3/12,6.04%,FNIP1;IRS2;BCL6
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.4113810987006323,1.0127777654747154,0.4647887323943662,0.8399054590549541,1.0,2/25,1.57%,ITGA6;APP
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.43799672831455666,-1.0126642965756383,0.45788336933045354,0.8252438990315907,1.0,8/12,36.46%,BCL2;KDM1A;CD44;TAF9B;TAF9;SIRT1;MUC1;CD74
prerank,acetyl-CoA metabolic process (GO:0006084),0.4569128510287075,1.0125457839689191,0.43947858472998136,0.8398226539269301,1.0,6/15,22.50%,HMGCS2;DIP2A;ACACB;ACAT1;HMGCS1;ACLY
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3110936785114033,1.0119361751892577,0.4292929292929293,0.8406399339020669,1.0,27/175,12.55%,DAB2IP;NFKBIA;TNFRSF25;TNFRSF11A;ARHGEF2;CD40;TMSB4X;IKBKB;TNFRSF21;HYAL2;ST18;ACTN4;AIM2;STAT1;PSMB3;PSMD11;BIRC3;PSMC6;PSME2;ADAM17;EIF5A;CCL1;PSMD8;TNFSF11;TNFRSF4;TNFSF12;ZFP36L1
prerank,male meiosis I (GO:0007141),-0.4068900569090628,-1.0117979660156569,0.4399092970521542,0.8265180631818405,1.0,7/16,28.68%,FOXJ2;FOXJ3;ZSCAN21;HSF2BP;MYBL1;TDRD9;DDX4
prerank,positive regulation of lymphocyte activation (GO:0051251),0.39836404870980857,1.0116968815839467,0.4359805510534846,0.8405889918903523,1.0,7/28,17.12%,NOD2;CCDC88B;TNFSF11;CYRIB;NCKAP1L;SH3KBP1;CCR2
prerank,pigment granule transport (GO:0051904),-0.38936939886652105,-1.0116050111200947,0.45494505494505494,0.8248807870479105,1.0,14/18,40.58%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;BLOC1S3;RAB27B
prerank,melanosome transport (GO:0032402),-0.38936939886652105,-1.0116050111200947,0.45494505494505494,0.8248807870479105,1.0,14/18,40.58%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;BLOC1S3;RAB27B
prerank,macrophage differentiation (GO:0030225),-0.425636991861,-1.0108189578366715,0.47071583514099785,0.8259569211666093,1.0,2/13,1.89%,IL31RA;BMP4
prerank,pore complex assembly (GO:0046931),-0.3883193374847023,-1.0106669302372795,0.4434589800443459,0.8252691371496597,1.0,6/19,14.43%,ANO6;PLEKHA7;AFDN;NUP205;TMEM170A;GSDMD
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4723296182573009,1.0106073257334258,0.47005444646098005,0.8425862315601248,1.0,4/12,12.26%,STX3;STX1A;STX19;SNAP29
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.34174012788008923,1.010330352062711,0.44079885877318115,0.8425596314745136,1.0,16/74,12.34%,LEF1;DAB2IP;TGFB2;RGCC;TIAM1;SMAD7;CTNNB1;WWTR1;IL17RD;EFNA1;TGFB1;GREM1;AXIN2;FERMT2;ADIPOR1;TGFBR2
prerank,secondary alcohol metabolic process (GO:1902652),0.37597118976417593,1.0102815141897779,0.4589905362776025,0.8420051400450612,1.0,6/42,6.49%,PPARD;OSBPL1A;ABCG1;CYP11B1;CYP11A1;IDH3A
prerank,positive regulation of protein transport (GO:0051222),0.35104686876695357,1.0100429965397113,0.44869831546707506,0.8419315284941046,1.0,12/67,8.24%,TGFB2;PRR5L;UNC13B;CD2AP;ATP2C1;RIPOR1;ABCG1;PPIA;OAZ1;ARHGEF5;TGFB1;ACSL3
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.33188084847940513,-1.010039295875094,0.4269340974212034,0.8259917332383563,1.0,5/39,6.29%,MCU;NLGN2;RBP4;IRS2;NNAT
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3401947811161702,1.0100253844568223,0.425,0.8412955324973079,1.0,19/85,10.83%,CLIC5;USP53;TBX1;GRAP;HOMER2;PCDH15;CDC14A;KCNQ1;EPS8L2;SNAI2;LHFPL3;MARVELD2;POU3F4;MYH14;TIMM13;SLC52A3;TIMM10;CLRN1;LRP2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.29349204146828795,-1.0098014563948763,0.40559440559440557,0.8255584494809944,1.0,19/76,20.94%,LPAR1;PLCE1;ACTN2;ADRA1B;ANO1;PTH1R;AGTR1;ESR1;LPAR4;CMKLR1;GNA14;CHRM2;GPR157;OPRK1;HTR2C;CCKBR;ADRA2A;HRH1;C3AR1
prerank,positive regulation of receptor internalization (GO:0002092),-0.3797042397052754,-1.009709801231384,0.48214285714285715,0.8247807955651373,1.0,5/22,6.33%,ANGPT1;MAGI2;ARRB1;CD63;SFRP4
prerank,cholesterol metabolic process (GO:0008203),0.3471879456562187,1.009443723470659,0.4444444444444444,0.8420483958979377,1.0,7/68,5.41%,SCARF1;PPARD;OSBPL1A;PLPP6;ABCG1;CYP11B1;CYP11A1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.37008599287308386,-1.0092234808439402,0.4596774193548387,0.825047940708674,1.0,7/23,13.62%,KIT;CYP1B1;OCIAD1;PTK2B;PRLR;PIBF1;GHR
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.3485471659527702,-1.008567654760721,0.4270833333333333,0.8257937826602086,1.0,10/31,13.13%,RANBP3L;CRIM1;SMAD6;SUFU;TMEM64;TWIST2;TRPM4;CHRD;SKI;TWIST1
prerank,regulation of cytoskeleton organization (GO:0051493),0.3203962959532002,1.0079659104310799,0.4527777777777778,0.844934013037689,1.0,26/108,11.99%,TJP1;RHOBTB1;HIP1R;F11R;CORO2B;PTK2;RHOB;CCDC88A;BAIAP2;FAM107A;MAPK3;STMN3;BST2;MAP6D1;ARHGEF5;TWF2;IQGAP1;TRIM36;P2RX7;CLIC4;PFDN2;PAK1;ARHGAP17;S100A8;RAC1;RND1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3484940808647418,1.0077093880792516,0.45930232558139533,0.8449193240240421,1.0,12/66,12.05%,TFRC;WWTR1;HYAL2;CARD10;LIMK2;TGFB1;CCT3;ZPR1;CCT5;LAMTOR5;FERMT2;ORMDL3
prerank,stem cell differentiation (GO:0048863),-0.3291960797715388,-1.007687612955307,0.40273972602739727,0.8271002798813144,1.0,17/39,21.50%,FGFR2;OSR1;HOXB4;KIT;FBXL17;ACE;MLLT3;LMBR1L;LRP6;SFRP1;PAX2;BATF;PTPRC;SP7;EEF1AKMT4-ECE2;SETD2;SETD6
prerank,axon development (GO:0061564),0.3417058627090446,1.0073952072922077,0.44192634560906513,0.8449608102513908,1.0,21/78,20.79%,APP;KLF7;PARD3;NTNG2;DSCAML1;ACTB;WNT7A;BAIAP2;SLITRK3;SLITRK1;ZPR1;GRM7;DCC;PLPPR4;NRCAM;ANK3;CTNNA2;CAMSAP2;RAB8A;ZDHHC17;BRSK2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.33391218651460947,1.007012618367655,0.4513031550068587,0.845231469738603,1.0,20/91,16.87%,HIP1;FES;HIP1R;SCARB1;DNAJC13;SYT7;INPP5F;MAPK3;HCK;RAB11A;OPHN1;RAB3B;RAB4A;SYK;LGI3;CPLX1;RNF139;MAPK1;RIMS2;RALA
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.46985047574246885,1.0069694634988473,0.47424511545293074,0.8446583525484936,1.0,6/14,17.33%,DUSP1;PPP3CA;PPP1R15B;PPP2R2C;NCK1;PPM1F
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3278562765971692,-1.0066507968742278,0.45103857566765576,0.8288675999724666,1.0,5/41,9.42%,PRKAG2;OGT;SEH1L;LACC1;NUP205
prerank,actin-myosin filament sliding (GO:0033275),-0.3240030743140666,-1.0065088657492505,0.44984802431610943,0.8271057933347917,1.0,5/38,10.36%,ACTN2;TPM1;DMD;TPM2;DES
prerank,muscle filament sliding (GO:0030049),-0.3240030743140666,-1.0065088657492505,0.44984802431610943,0.8271057933347917,1.0,5/38,10.36%,ACTN2;TPM1;DMD;TPM2;DES
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2866517314941186,1.0064148759087808,0.4506578947368421,0.8454121841721791,1.0,69/417,15.46%,LEF1;MECOM;PLCB1;DACH1;PDGFB;ELK3;DAB2IP;ZHX3;PPARD;TBX3;ID1;SMARCA2;FOXO1;FOXL2;SOX13;CCDC85B;NOTCH1;MEN1;HDAC9;HMBOX1;ZBTB16;HHEX;CTNNB1;SOX7;GATAD2A;CD38;RPS6KA5;KLF4;PHC1;NR1H2;SOX18;YEATS2;HINFP;L3MBTL4;KAT6A;JUN;TGFB1;FOXP3;ZBTB14;CIART;DEDD2;HMGA1;KDM4A;ZMYND11;YWHAQ;HSPA8;PEX14;CTCF;EID2;ZBTB7A;LHX9;TNFRSF4;TLE1;RCOR2;PPARG;ZBTB33;POU2F1;SOX9;HMGB2;NR3C1;ID3;CIC;CTBP1;RIOX1;HDAC5;YAF2;IKZF1;LOXL2;ARID4A
prerank,icosanoid metabolic process (GO:0006690),-0.3263890929454732,-1.0062870155414463,0.43466666666666665,0.8266654296275012,1.0,6/40,6.72%,PTGIS;PTGS1;DAGLA;CYP1B1;GGT5;PON3
prerank,regulation of cell death (GO:0010941),-0.27366237380344993,-1.006001527135539,0.458041958041958,0.8263990620921462,1.0,22/94,16.16%,LRP1;CCN2;BMP7;BMP4;ACER3;IMPACT;FGF2;CCN5;CCN1;PRKN;CCN3;PRODH;SLC25A24;SRSF6;CCN4;LRRK2;RAB29;DUS2;WNT11;CTSZ;SARM1;CRYAB
prerank,establishment of vesicle localization (GO:0051650),0.43023253129177597,1.0057769884305499,0.4710017574692443,0.8462815705479749,1.0,6/18,18.50%,LIMK2;DNM2;RAB11A;F8A1;SYNJ1;CCDC186
prerank,water-soluble vitamin metabolic process (GO:0006767),0.34482121742408567,1.005750302872223,0.45480631276901007,0.8456898059321427,1.0,11/68,11.50%,SLC2A1;SLC19A3;ABCD4;TPK1;SLC52A2;SLC25A32;SHMT2;PDXK;SLC52A3;AMN;MMAA
prerank,aortic valve development (GO:0003176),0.38142523577599685,1.0054045227022743,0.45751633986928103,0.8458191068595394,1.0,9/34,8.09%,TIE1;BMPR2;NOS3;NOTCH1;NPPA;DLL4;SNAI2;EFNA1;TGFB1
prerank,translational elongation (GO:0006414),0.327101656850271,1.0053470733007928,0.43561643835616437,0.8452924597242597,1.0,45/101,28.70%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;GTPBP1;GFM1;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;EEFSEC;MRPL19;EEF1D;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;RACK1;GTPBP2;EEF1B2;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2;MRPS18C;EEF1G;MRPL15;MRPS34;MRPS12
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.472181280236456,1.0053272397208288,0.45297504798464494,0.8446685976356104,1.0,1/13,0.77%,NAMPT
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.423620828620329,-1.0049187684833927,0.449438202247191,0.8283109387716614,1.0,5/13,22.65%,SLC4A10;CLN3;SYP;SHISA7;PPFIA3
prerank,response to prostaglandin E (GO:0034695),-0.45956718006192315,-1.0049058285771668,0.46875,0.8272905337099159,1.0,1/10,0.41%,TGFBR3
prerank,regulation of immunoglobulin production (GO:0002637),-0.3739534618965029,-1.004619705286895,0.4538834951456311,0.8270683816955571,1.0,5/23,21.01%,RBP4;EPHB2;STX4;PTPRC;VAMP3
prerank,regulation of fibroblast proliferation (GO:0048145),-0.3142085898361966,-1.004498698884834,0.4380165289256198,0.826342156047457,1.0,12/45,14.01%,IGF1;PDGFRA;S100A6;PDGFC;MED25;SPHK1;CD300A;EMD;SKI;NF1;PEX2;MORC3
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.4685065371074331,1.0043774624594417,0.4438405797101449,0.8462647278609107,1.0,4/12,10.94%,LYN;CD19;ELF2;CBFB
prerank,Notch signaling involved in heart development (GO:0061314),-0.4430589911907388,-1.004300620784459,0.44742729306487694,0.8258008291772451,1.0,4/11,7.70%,NOTCH2;RBPJ;HEYL;JAG1
prerank,vitamin D metabolic process (GO:0042359),0.46422458094404195,1.0041572547209818,0.4417744916820702,0.8461185980690303,1.0,4/13,22.47%,CYP11A1;LRP2;CYP24A1;LGMN
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.42611468589264545,1.0035170484183353,0.49473684210526314,0.8470502395860756,1.0,3/21,5.68%,CAV1;CTNNB1;FRAT2
prerank,negative regulation of response to external stimulus (GO:0032102),0.3261306264581343,1.003450450667194,0.4589308996088657,0.8465620404863393,1.0,9/105,6.45%,TEK;MFHAS1;PPARD;SIGIRR;DUSP3;EPHA4;INPP5F;GRID2;KLF4
prerank,T cell migration (GO:0072678),0.45894832425882026,1.0031833320233823,0.4732965009208103,0.8465478229743038,1.0,3/13,8.79%,S1PR1;ZAP70;MSN
prerank,histone H3-K9 demethylation (GO:0033169),-0.4456884867452122,-1.0029061814913696,0.46835443037974683,0.828562738153214,1.0,6/11,23.80%,KDM7A;KDM3B;KDM1A;PHF8;KDM4D;HR
prerank,myeloid cell development (GO:0061515),0.4345516512796793,1.0029050723954982,0.4568345323741007,0.846539181301571,1.0,3/18,5.46%,APP;ALAS1;NRROS
prerank,regulation of membrane depolarization (GO:0003254),-0.3874744640331512,-1.0028907928681965,0.4611872146118721,0.8275485117232229,1.0,5/18,11.80%,FHL1;PTPN3;CAMK2D;LRRK2;GPD1L
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2742721596354258,1.0026693209317072,0.48580121703853957,0.8464251186583812,1.0,116/1082,8.90%,LEF1;MECOM;PLCB1;ETS1;ITGA6;FLI1;ERG;LMO2;NAMPT;EPAS1;PDGFB;ELK3;DAB2IP;ENG;BMPR2;LMO7;NOTCH4;MRTFB;TRIM16;APP;ZIC3;TBX1;PPARD;MRTFA;NFKBIA;SOX17;TBX3;AFAP1L2;FZD4;KLF7;AGRN;ARHGEF2;RGCC;MEF2C;MOSPD1;RYBP;NCOA1;SMARCA2;SP100;FOXO1;CD40;FOXL2;RPS6KA1;ACVRL1;ZFPM1;NOD2;PRKD1;NOTCH1;PRKD2;MEN1;YBX1;NLRC5;KLF2;ZBTB16;MYO6;PRDM2;IRF2;ASXL3;WNT7A;IKBKB;SMAD7;HHEX;FOXF1;RREB1;CTNNB1;GATA2;POU2AF1;CREB1;MRPL12;SPAG8;KLF1;WWTR1;HYAL2;TAL1;CD4;CAMKK2;ST18;TLR3;CD38;CRTC1;MAML2;MAPK3;RPS6KA5;KLF4;RET;TOX3;NKX2-8;CDKN2B;STAT1;MAX;NR1H2;DNM2;IRF5;NCOA2;SOX18;PHOX2A;NFIC;BRCA2;SOX12;HINFP;KAT6A;JUN;KCNH2;PIN1;TGFB1;ATF6B;YWHAH;TCF12;KLF6;FOXP3;ELK4;LRP5;CDK5RAP2;NFATC2IP;GREM1;ARID1A
prerank,T cell mediated immunity (GO:0002456),0.45996693117594933,1.001932472528688,0.46842105263157896,0.8475524865927713,1.0,1/13,0.97%,CADM1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.42272068982662464,1.0016035985212282,0.4673721340388007,0.8476926726068483,1.0,6/21,17.44%,JAK3;DUSP3;SOX11;TNFAIP3;FOXJ1;SAMSN1
prerank,muscle tissue development (GO:0060537),0.46737915720416573,1.0007985712010126,0.4797047970479705,0.8490094707514882,1.0,4/13,12.12%,ENG;PGM5;STRA6;CSRP3
prerank,response to peptide hormone (GO:0043434),-0.31920304782652126,-1.0006448453432266,0.452991452991453,0.832550509317144,1.0,6/43,5.24%,TGFBR3;ROCK2;IGFBP5;IRS1;OGT;ANXA1
prerank,cellular response to hormone stimulus (GO:0032870),0.3476369414775768,1.0005016090358203,0.4568835098335855,0.849058999691557,1.0,14/69,9.46%,LMO2;CAV1;MEF2C;NCOA1;RAMP2;SOCS2;RAMP3;CYP11B1;CYP11A1;ATP1A1;ATP1A3;NCOA2;TRIM24;NCOA4
prerank,diacylglycerol metabolic process (GO:0046339),0.4176030019807096,1.000119191246847,0.4691780821917808,0.8493500831293833,1.0,7/23,16.94%,DGKH;LIPE;DGKI;DGKE;DGKZ;MOGAT2;DGAT1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3184407384916015,0.9994119420295754,0.4601542416452442,0.8503981817795095,1.0,23/116,12.39%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;ADCY4;YES1;HCK;PRKAR2B;NPS;CALCB;ADAM17;PRKAR2A;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1
prerank,melanosome localization (GO:0032400),-0.3698585400388345,-0.9992594761505924,0.47240618101545256,0.8353294868039312,1.0,15/21,40.58%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;VPS33A;BLOC1S3;RAB27B
prerank,glycerol metabolic process (GO:0006071),-0.43939902949365167,-0.9991855189622431,0.4718162839248434,0.834479959052377,1.0,4/10,17.85%,GK;GOT1;COQ2;ANGPTL3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.33753609397861856,0.9991287927299278,0.4595375722543353,0.8503976307496063,1.0,17/72,20.08%,ACER2;CNOT6L;RGCC;SP100;MYO6;CRADD;PIDD1;CNOT9;CNOT6;BTG2;HIPK2;PLK2;TRIAP1;NDRG1;CNOT11;TFAP4;E2F4
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.31794299818763533,0.9989165594697543,0.46282051282051284,0.8501993423957863,1.0,23/117,12.39%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;ADCY4;YES1;HCK;PRKAR2B;NPS;CALCB;ADAM17;PRKAR2A;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1
prerank,cellular response to organic cyclic compound (GO:0071407),0.30679716407238533,0.9986413499407396,0.4697368421052632,0.8502241369926625,1.0,30/141,13.85%,SLC1A1;PDGFB;PDE2A;RAPGEF2;FES;MEF2C;RAPGEF1;RAPGEF3;ACTB;TGM2;CTNNB1;RAMP3;KCNQ1;ATP1A1;ATP1A3;CASP7;RAP1B;GABRB1;TGFB1;P2RX7;MSN;NCOA4;AKAP9;PDE12;ARL6IP5;GNB1;ZFP36L1;HCN2;AKAP6;SSH1
prerank,epithelial cell migration (GO:0010631),0.37980937881901744,0.9986132368760586,0.4577922077922078,0.8496298574601617,1.0,10/37,6.84%,NOS3;PLEKHG5;PKN3;PLXND1;STARD13;PXN;PKN1;NANOS1;STAT1;PKN2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.44303924521060234,-0.9985187507737597,0.45494505494505494,0.8351952881214223,1.0,5/11,24.87%,FBH1;TIPIN;ZRANB3;DONSON;LIG3
prerank,telomere capping (GO:0016233),0.44542636264964824,0.9983788336550656,0.4639865996649916,0.8495120103581145,1.0,4/16,12.47%,MRE11;TERF2;ACD;TERF1
prerank,ceramide catabolic process (GO:0046514),0.457012716796425,0.9981360622704157,0.4731977818853974,0.8494194776063566,1.0,3/14,5.39%,ACER2;ACER1;NEU4
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4601417375705996,0.9978232415569298,0.46593001841620624,0.8495067951835796,1.0,2/13,6.20%,ENTPD1;ENTPD5
prerank,regulation of viral life cycle (GO:1903900),0.42667441197093403,0.9976156712538213,0.4708904109589041,0.8493187451820051,1.0,3/21,5.94%,TRIM25;TRIM14;PPIA
prerank,peptide hormone secretion (GO:0030072),0.3999519889171753,0.9975532715183801,0.4631217838765009,0.848804254519131,1.0,6/26,19.30%,LTBP4;RAB1A;EDN1;RIMS2;CAMK2G;CYB5R4
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.4066051320475471,-0.9973065843279346,0.46916299559471364,0.8373949745763971,1.0,2/16,8.01%,LRP1;APOE
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.35814818819441385,0.9972264580352396,0.4807121661721068,0.8489396038586032,1.0,13/52,18.88%,PPP1R13B;PPP3CC;FBXW7;YWHAH;YWHAQ;CASP8;GSK3A;SH3GLB1;PPP3R1;UBE2D3;YWHAZ;YWHAB;TOMM7
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.35561032226345374,-0.9971904644071399,0.442159383033419,0.8366403769645695,1.0,8/26,10.27%,ROCK2;ASAP3;ALMS1;SYNPO;PRKN;FHOD1;PFN2;SLC9A1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.37420809620410755,-0.9971041229041664,0.4312796208530806,0.8358120767591989,1.0,5/22,10.42%,NTRK3;MAGI2;NGF;ACAP2;EHD1
prerank,transcription by RNA polymerase II (GO:0006366),-0.24014958312048562,-0.9970585243996851,0.4318181818181818,0.8348719774280469,1.0,65/305,18.64%,NOTCH2;SOX5;MAF;PRRX1;RARB;GLIS3;CCN2;TEAD1;DDX5;NR6A1;THRB;NOTCH3;NR1D2;CCNT2;PHAX;PPARGC1A;RBPJ;RORA;TBL1XR1;AR;PPARA;MED23;CTR9;TEAD3;POLR2A;NR3C2;DTX1;PABPN1;PCF11;RPRD2;YAP1;MLLT3;INTS8;CPSF3;CCNH;NR2F1;PARP1;RXRA;NFX1;TAF8;CDK7;ESR1;PGR;TSC22D1;AFF4;INTS2;PAF1;NR4A1;ZBTB1;ZBTB7B;E2F3;ELP4;NELFE;GTF2F1;INTS4;NR1H4;ERCC6;RARA;INTS10;TAF9B;NRBP1;RPAP1;LSM10;HSF2BP;NCOR1
prerank,protein depolymerization (GO:0051261),-0.36021936252110515,-0.9969031952726978,0.45614035087719296,0.8342359168826642,1.0,3/27,1.66%,MICAL3;GSN;MICAL2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3056769538012645,0.9967330642525558,0.4469413233458177,0.8494150521647087,1.0,48/172,21.29%,MFSD2A;PIK3R6;DGKH;INPP5D;PIK3R3;PLA2G4B;SLC44A5;PIKFYVE;PIP5K1C;OCRL;INPP5F;PLEKHA1;CDS2;DGKE;CHKA;MTMR6;SELENOI;PIK3C3;LPCAT3;PIK3C2A;RAB4A;PIP4K2A;DGKZ;PIK3CB;CEPT1;CPNE6;CSNK2B;LPIN3;MTMR12;CDIPT;MTMR2;PIK3R5;PLEKHA3;SYNJ1;CPNE3;ETNPPL;INPP5E;INPPL1;CPNE1;PIP5K1B;MTMR1;PGS1;PLCG2;ETNK1;MBOAT7;PISD;INPP5K;LPCAT2
prerank,necroptotic process (GO:0070266),0.4455407449460078,0.9965948638270558,0.458259325044405,0.8490853825192153,1.0,5/16,23.36%,TLR3;IPMK;CYLD;TICAM2;RIPK1
prerank,actin filament capping (GO:0051693),0.4342635816130568,0.9964272139697516,0.4426807760141093,0.8481739046807095,1.0,5/18,9.26%,FLII;VIL1;EPS8;TWF2;CAPG
prerank,barbed-end actin filament capping (GO:0051016),0.4342635816130568,0.9964272139697516,0.4426807760141093,0.8481739046807095,1.0,5/18,9.26%,FLII;VIL1;EPS8;TWF2;CAPG
prerank,positive regulation of protein acetylation (GO:1901985),0.4717186655495097,0.9961960278142198,0.4631956912028725,0.8480573088405318,1.0,3/12,5.82%,DIP2B;RAPGEF3;DIP2A
prerank,homotypic cell-cell adhesion (GO:0034109),-0.32627003146628625,-0.9950904728816424,0.46685082872928174,0.8382097318834247,1.0,7/39,8.94%,PLPP3;PDGFRA;MEGF11;VCL;FLNA;GNAS;MYL9
prerank,response to purine-containing compound (GO:0014074),-0.3919174487134564,-0.9949556561803135,0.44772727272727275,0.837522979601525,1.0,3/17,7.23%,TRPC3;ABCC9;P2RX4
prerank,membrane repolarization during action potential (GO:0086011),0.4597109205229839,0.99478140679479,0.4673913043478261,0.850810291580729,1.0,3/13,7.93%,KCNQ1;ATP1A1;KCNH2
prerank,lysosome organization (GO:0007040),-0.3258008000131975,-0.9944047175106384,0.4601063829787234,0.8380117625350954,1.0,12/36,18.25%,ABCA1;HOOK2;ARSB;GAA;CLN3;LRRK2;AKTIP;ACP2;GNPTAB;GRN;CLN6;MBTPS1
prerank,stress granule assembly (GO:0034063),-0.37110698085670724,-0.9943426539882175,0.4909090909090909,0.8371227732287339,1.0,8/20,24.23%,UBAP2L;BICD1;OGFOD1;DDX3X;YTHDF1;ATXN2L;CIRBP;CSDE1
prerank,regulation of vacuole organization (GO:0044088),0.42794332130910273,0.9943036352389824,0.45517241379310347,0.8513000139261047,1.0,3/20,4.82%,TBC1D14;TBC1D12;PIKFYVE
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.38250250407141495,-0.9942844005066364,0.4724770642201835,0.8362310947022022,1.0,9/20,31.16%,TNRC6A;AGO2;TNRC6B;LIMD1;HELZ;AJUBA;MOV10;CNOT1;AGO4
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3391522452864089,0.9936601759019268,0.45626822157434405,0.8522231657237428,1.0,22/72,21.63%,POLK;MRE11;EDC3;GTF2H2;DNA2;PDE12;RNASE1;GTF2H4;DXO;DCP1B;FAN1;PNRC2;RBX1;RPA1;DICER1;POLD1;XRN2;GTF2H3;RFC2;DDB1;RNASE6;ERCC4
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.34656547724526987,0.993401078881791,0.47050147492625366,0.852180011669524,1.0,10/70,11.35%,LMO2;GATA2;TAL1;PSMB3;PSMD11;TCF12;PSMC6;PSME2;CBFB;PSMD8
prerank,apoptotic nuclear changes (GO:0030262),0.40827510755757745,0.9931737625536257,0.4603448275862069,0.85212604716057,1.0,9/24,19.18%,FOXL2;CECR2;DFFB;DEDD2;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.35050332700686876,0.9930305644123788,0.48406676783004554,0.8518105476613608,1.0,5/52,4.91%,PRKCH;SPTBN1;STX3;EPB41;RAMP3
prerank,negative regulation of catalytic activity (GO:0043086),0.41037793286975566,0.9928025871217351,0.452991452991453,0.8516879102890698,1.0,2/24,3.41%,NES;NOTCH1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.46287707483663726,0.9927520592891201,0.4990512333965844,0.8511685972472419,1.0,3/12,12.50%,B4GALT5;HSP90AB1;EPHB1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.4447489581947133,-0.9925322271600022,0.5074946466809421,0.8399395252892681,1.0,4/10,8.87%,STIM1;EFHB;SLC8B1;SARAF
prerank,negative regulation of response to wounding (GO:1903035),-0.3770494857649377,-0.9924822305610826,0.4623115577889447,0.8390318500191746,1.0,8/19,21.79%,CASK;PTPRS;FGF2;CD109;MDK;CERS2;SERPINE1;RTN4R
prerank,protein localization to lysosome (GO:0061462),0.39887625595577797,0.9921558243465884,0.4753289473684211,0.8519722034627669,1.0,8/28,17.46%,SH3BP4;NCOA4;LAMTOR5;HGS;M6PR;LMBRD1;LAMTOR4;AP3M1
prerank,regulation of lymphocyte activation (GO:0051249),0.47112105123936476,0.9921310327150301,0.4882032667876588,0.8513768476929664,1.0,2/12,5.26%,CD19;CD4
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3626910742911014,0.9921283965573099,0.45975232198142413,0.8507321347339061,1.0,14/45,10.31%,PTK2;VIL1;PLCG1;GRB2;GAB1;SOS1;RPS6KA5;TGFB1;TGFA;IQGAP1;SHC3;ADAM17;PIK3C2A;GRB7
prerank,regulation of macroautophagy (GO:0016241),-0.2711301652870415,-0.9917544309817984,0.4745098039215686,0.8399428882922416,1.0,35/105,23.77%,PRKAG2;DCN;PRKAA2;SNX6;NRBP2;PRKACA;PRKAG3;CLN3;LRRK2;ATP6V1C1;SNX5;RHEB;ATP6V1G2;CLEC16A;LAMTOR3;CAPN1;CASP3;RRAGA;GNAI3;IKBKG;SMG1;ATP6V1E1;SNX32;SCOC;SMCR8;GPSM1;TSC1;ATP6V0D2;CDK5;NEDD4;PRKAB2;ATP13A2;VPS26A;WAC;SLC38A9
prerank,regulation of cellular pH (GO:0030641),-0.3549042026261136,-0.9915830006833617,0.47721822541966424,0.8393577641798744,1.0,8/29,11.08%,SLC4A10;SLC9A2;LACC1;SLC4A7;SLC4A2;SLC9A9;SLC9A1;CLN3
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2870065673970684,0.9914275998190795,0.49195402298850577,0.8517513769956443,1.0,50/291,14.07%,PDGFB;DAB2IP;PDE2A;RAPGEF2;SH3BP4;FES;TBX1;TIRAP;FZD4;MEF2C;FOXO1;RAPGEF1;DEFA6;NOD2;PRKD1;PXN;RAPGEF3;ACTB;LYN;TGM2;CREB1;RAMP3;KCNQ1;KCNC2;CAMKK2;MAPK3;RET;RAP1B;JUN;PDE4B;TWF2;IRGM;P2RX7;BRINP3;AKAP9;PTK6;LAMTOR5;BRINP2;RPTOR;GNB1;ZFP36L1;NSMF;HCN2;SOX9;AKAP6;HMGB2;TNFAIP3;SSH1;GIT1;BCL10
prerank,regulation of G0 to G1 transition (GO:0070316),0.37588992073000366,0.9912241314376328,0.4798061389337641,0.8515621680679276,1.0,5/38,6.73%,DAB2IP;RYBP;PHC1;CDKN2B;MAX
prerank,peptidyl-amino acid modification (GO:0018193),-0.44784175945634386,-0.991149649315297,0.48440748440748443,0.8395066824524577,1.0,2/10,10.72%,ATP7A;FKBP10
prerank,axonemal dynein complex assembly (GO:0070286),0.39123805562335245,0.9907617745491729,0.48148148148148145,0.8520491490455184,1.0,9/27,17.66%,ZMYND10;LRRC49;CFAP100;DRC1;DNAAF2;DNAH8;DNAAF3;DNAH5;TTC12
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.4624135894379187,0.9906605991697202,0.47101449275362317,0.8516209950931651,1.0,9/12,31.79%,STK33;CDC6;ORC1;HUS1;RAD17;TOPBP1;HUS1B;CHEK2;NAE1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.35972097803757397,0.9904458824605492,0.48405797101449277,0.8514908682922459,1.0,17/51,21.66%,HMBOX1;CTNNB1;MAPK3;TERF2;HNRNPC;CCT3;CCT5;ACD;DCP2;TERF1;MAPK1;CCT7;NAF1;EXOSC10;XRN1;MAP2K7;PINX1
prerank,skeletal muscle organ development (GO:0060538),0.39497431425458834,0.9899893859706681,0.48859934853420195,0.8519105875966944,1.0,6/26,12.12%,CAV1;MEF2C;FOXL2;MYH14;STRA6;CSRP3
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.29090684119338905,-0.9898253280888817,0.46598639455782315,0.8420417165924631,1.0,10/72,10.29%,FGFR2;FGF1;FRS2;KL;FGF2;HNRNPH1;POLR2A;FLRT1;SPRED1;FGFBP1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3147780158896977,0.9896405203827225,0.4708222811671088,0.8520919765440461,1.0,26/128,15.94%,PLCB1;CCNY;TPD52L1;NES;DYNLL1;CDKN2B;CCP110;DNM2;LCMT1;PRKAR2B;CETN2;TUBB;CDK5RAP2;PPP1CB;AKAP9;HAUS6;CEP78;CEP135;CEP72;FBXL8;TUBB4B;TUBA1A;FBXL15;CKAP5;CEP70;PPME1
prerank,negative regulation of organelle assembly (GO:1902116),-0.33032010102468123,-0.9892067999793317,0.4869791666666667,0.8426875121530066,1.0,14/35,19.93%,NUPR1;TMEM39A;YAP1;LRRK2;SCFD1;MDM1;TESK1;PHF23;FEZ1;SMCR8;TCHP;TRIM37;TBC1D7;BRCA1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.44086327943728,-0.9887922729497997,0.47107438016528924,0.8427259205395479,1.0,6/10,38.04%,PTPRS;PPM1B;PYCARD;LILRB1;NLRC3;REL
prerank,regulation of lipase activity (GO:0060191),-0.4155938055113101,-0.9885231400040443,0.4744186046511628,0.8423620908205736,1.0,4/13,18.62%,PCSK5;LMF1;ANGPTL3;PCSK6
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.4247885307289416,0.9881232336095097,0.496415770609319,0.854901856595558,1.0,4/21,10.00%,MBOAT1;PLA2G4B;OSBPL10;LPCAT3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3394527910162425,0.9878956899833286,0.48652482269503544,0.8547642574222882,1.0,15/74,15.92%,EPAS1;NOTCH1;PSMB3;EGLN2;PSMD11;PSMC6;PSME2;PSMD8;HIF1A;HIGD1A;EGLN1;PSMB10;RBX1;ELOB;PSMA8
prerank,nucleotide biosynthetic process (GO:0009165),-0.3847976836811945,-0.9877886843373334,0.47674418604651164,0.8432392879272733,1.0,8/18,18.64%,NMNAT2;ME1;MTHFD1;PRPS2;PRPSAP1;PRPSAP2;ADSL;NMNAT1
prerank,sterol homeostasis (GO:0055092),0.33991034626444844,0.9876439299034173,0.47,0.8547204994715433,1.0,11/65,11.60%,CAV1;SCARB1;HDAC9;ABCG1;ABCB11;NR1H2;LRP5;NPC1;LIPC;ABCD1;MTTP
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4415820494297774,-0.9872177848352849,0.5,0.8437216525623408,1.0,4/10,9.92%,VTN;ITGA5;GRB10;ARNT
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4513644928689619,0.9871722202697998,0.4818181818181818,0.8552136357774922,1.0,3/14,10.97%,MFSD2A;ABCB11;ABCD1
prerank,ncRNA processing (GO:0034470),0.29549755606042655,0.9868665331084939,0.4823815309842041,0.8553489216387744,1.0,57/200,21.51%,ADAR;SARS1;RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;INTS11;PDCD11;RPL13A;SMAD1;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;NOL9;MRM2;RPL11;RPS15;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;MRPL44;RPL37A;RPP21;NOL8;LYAR;RPL15;RRP12;EXOSC10;RPL17;RPL23;RPL34;DICER1;WDR75;EXOSC9;XRN2;NVL;RPL21;DDX54;RPP30;METTL3;RPL18A
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3907000862389297,-0.986187388116521,0.4439461883408072,0.8454677368522188,1.0,3/16,9.76%,DDX5;SRSF6;DDX17
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.481624790721199,0.9854150123223724,0.5057034220532319,0.858191644902976,1.0,3/10,17.12%,ADAM10;ADAM17;CCR2
prerank,amyloid precursor protein metabolic process (GO:0042982),0.41410950408196134,0.9852855387916952,0.4727592267135325,0.8578592581687644,1.0,5/18,11.18%,ABCG1;ADAM10;TMCC2;ADAM17;APH1A
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.46613803766843925,0.9850688052127325,0.4908424908424908,0.8577422204247985,1.0,2/12,6.45%,TIRAP;KLF4
prerank,response to acidic pH (GO:0010447),-0.428239544821521,-0.9848747358521599,0.4965986394557823,0.8479965460758208,1.0,3/13,15.76%,IMPACT;SLC9A1;RAB11B
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.35953855681673247,-0.9847653900341043,0.4937655860349127,0.8472348384755249,1.0,4/25,13.13%,IGF1;PER2;NIBAN2;TWIST1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4654451864585233,0.9846060806715451,0.4748603351955307,0.8581555760805563,1.0,2/10,12.02%,LGALS9;CEACAM1
prerank,protein heterotetramerization (GO:0051290),-0.4151961191708804,-0.984161657885167,0.48590021691973967,0.8478703193510524,1.0,2/13,4.66%,PKD1;PKD2
prerank,response to interleukin-6 (GO:0070741),0.4736076554331567,0.9839373605720109,0.5027522935779817,0.8591248440947057,1.0,1/10,0.37%,ST3GAL6
prerank,pyruvate metabolic process (GO:0006090),0.35826241633429956,0.9838357409113284,0.4776579352850539,0.8587240998972756,1.0,9/52,14.41%,BSG;PDHB;PKM;HK1;PDHX;PGAM4;PGAM1;TPI1;PFKL
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.31653829970114555,0.9838051170207451,0.4940554821664465,0.8581539726574742,1.0,21/108,14.18%,HIP1;ACER2;XDH;FAS;HIP1R;TNFSF10;NOD1;FOXL2;SOX7;ST18;LGALS9;CRADD;PIDD1;MALT1;CASP8;ARL6IP5;S100A8;SYK;PPARG;BCL10;PDCD6
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.35155550329119933,0.9837076943429,0.46957878315132606,0.8577385673753841,1.0,7/44,12.55%,NANOS3;PRR5L;NANOS2;NANOS1;GTPBP1;BTG2;ZFP36L1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.4747197349233173,0.9836069550861206,0.4934579439252336,0.8573253094859765,1.0,3/11,12.02%,SMAD7;FOXP3;CEACAM1
prerank,female gamete generation (GO:0007292),0.39569395049329614,0.9834526983402465,0.5166666666666667,0.8570336011630832,1.0,5/29,8.49%,NANOS3;NANOS2;NANOS1;PRDM9;PTN
prerank,regulation of signal transduction (GO:0009966),0.2963892962118307,0.9828949717735151,0.5030084235860409,0.8577219490458764,1.0,29/190,10.19%,PLCB1;RGS12;TMEM204;RGS3;APP;RASGRP4;GIT2;SP100;PRAG1;PRKD1;PXN;MFNG;SOCS2;SNX3;KIF26A;TSPAN12;WWTR1;IGFBP7;PPIA;FYN;GNG7;HOMER1;TGFB1;FOXP3;IRAK2;LIFR;SOCS5;PTK6;SHARPIN
prerank,gonad development (GO:0008406),0.36922073184124443,0.9828605949214273,0.4960998439937597,0.8571569925256816,1.0,6/41,10.83%,KITLG;TGFB2;BIK;COL9A3;NCOA4;LRP2
prerank,regulation of coagulation (GO:0050818),0.47494486269181274,0.9826723327074182,0.5089605734767025,0.8569730637832984,1.0,1/11,1.75%,CAV1
prerank,phosphatidylserine metabolic process (GO:0006658),0.3812225331599436,0.9825233757328837,0.46787479406919275,0.8566824942002809,1.0,5/32,10.00%,MBOAT1;PLA2G4B;SERINC5;OSBPL10;LPCAT3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.267084711307164,-0.9825095830207454,0.5019607843137255,0.8513781744916112,1.0,17/94,10.31%,ITPR1;FHIT;PDK1;DDX5;MAP3K5;PRKCD;IKBKE;CYP1B1;TMEM117;BCL2;ATM;PRODH;PML;CUL3;CEBPB;STK11;CRIP1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3656291803951164,-0.9825065770295764,0.5089058524173028,0.8503456460883606,1.0,4/23,3.29%,IL34;BMP5;SLIT2;THBS1
prerank,positive regulation of cell development (GO:0010720),-0.3356462000838002,-0.9823875063932567,0.46194225721784776,0.849643668455155,1.0,7/31,15.19%,PDE3A;BMP4;SERPINF1;NUMBL;NIBAN2;NKX6-1;NAP1L1
prerank,androgen receptor signaling pathway (GO:0030521),-0.4340128147003294,-0.9811961487126236,0.47639484978540775,0.8517587975306699,1.0,5/11,21.53%,DDX5;AR;DDX17;RNF14;ZMIZ1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.37810043895738277,0.9810010226146403,0.4679186228482003,0.859610336180957,1.0,4/31,10.71%,DAB2IP;ATXN3;RHBDD1;HSPA8
prerank,regulation of necroptotic process (GO:0060544),0.4038642966609459,0.9806744736074715,0.496551724137931,0.8597414680474571,1.0,7/23,16.43%,ARHGEF2;PELI1;BIRC3;CASP8;CYLD;SDCBP;PDCD6IP
prerank,metal ion transport (GO:0030001),0.325392533934211,0.9806094496203354,0.5070224719101124,0.8592512579033389,1.0,15/86,11.92%,CACNA1A;SLC39A8;CAV1;SLC30A1;NIPAL3;RAMP2;ATP2C1;CALCRL;RAMP3;FYN;SLC3A2;NIPAL4;NDFIP2;LRP2;CDH23
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.28521858942296396,0.9805712917222906,0.5200445434298441,0.858689959859773,1.0,56/348,13.45%,LEF1;TFRC;ETS1;OCLN;CLDN5;PDGFB;INSR;CD34;NOS3;PDE2A;APP;RGCC;MEF2C;PIK3R3;NOTCH1;RAMP2;KLF2;GATA2;TCF23;FGF16;RAMP3;DLL4;TLR3;INPP5F;TBC1D5;MAPK3;LGALS9;KLF4;HINFP;TGFB1;TERF2;RPS7;P2RX7;MSN;GREM1;ZPR1;ACTG1;PDCD10;SMAD1;PRKAB1;CNTF;LAMTOR5;TASOR;CTCF;GSK3A;VSIR;HIF1A;TLE1;PIK3CB;HGS;SOX11;DNAJA4;SETDB1;RPL11;SOX9;CDH5
prerank,cellular lipid catabolic process (GO:0044242),0.3986467740123393,0.9805067020524487,0.478330658105939,0.8582118434039665,1.0,9/27,20.60%,PPARD;MGST2;ACOX1;ENPP2;LPIN3;SMPDL3B;ACBD5;AOAH;FAAH
prerank,negative regulation of ossification (GO:0030279),-0.366312410532193,-0.9804536831892816,0.49876543209876545,0.8526497691351557,1.0,10/23,17.17%,ENPP1;SMAD6;BCOR;RBPJ;ECM1;TRPM4;PTK2B;CHSY1;MDK;SFRP1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.473169377362099,0.9804533090373981,0.4718045112781955,0.857696696631107,1.0,4/11,22.86%,SP100;HIPK2;TFAP4;ING4
prerank,cellular protein localization (GO:0034613),0.284004494019304,0.9803424325239437,0.4988344988344988,0.8573165863289268,1.0,40/285,11.15%,OCLN;ESAM;TBC1D4;REEP1;STX3;RAB31;ID1;TBC1D14;ARHGEF2;STX1A;TBC1D22A;AMOT;TBC1D12;SNX13;MYO6;TBC1D2;HHEX;CTNNB1;ARF5;CEP68;PIGU;USP6NL;MESD;TBC1D5;GRID2;ABHD17A;STXBP1;CNTN2;COG3;GRIN3B;ARL4A;YWHAH;RTP4;PIGK;SMURF1;AXIN2;FERMT2;TBC1D10B;ACD;STX19
prerank,glycine metabolic process (GO:0006544),0.4641163233020831,0.9801826901269769,0.500945179584121,0.8570440755026411,1.0,5/12,23.81%,GLYAT;SHMT2;SDSL;RIDA;GCSH
prerank,epiboly involved in wound healing (GO:0090505),-0.3968031796840174,-0.9794804444653427,0.4928909952606635,0.8542101711020359,1.0,5/16,11.79%,PDPN;DDR1;FLNA;CCN1;TMEFF2
prerank,protein acylation (GO:0043543),0.3744327406782263,0.9788374008100732,0.48408710217755446,0.859692849940487,1.0,8/38,12.54%,ZDHHC14;FOXO1;ZDHHC9;ZDHHC20;KAT6A;ZDHHC18;ZDHHC22;GTF2B
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4261757008529065,0.977775243605329,0.4835924006908463,0.8615541930334703,1.0,4/17,10.22%,PARD3;SMAD7;CALM1;DDIT4
prerank,negative regulation of defense response (GO:0031348),0.3327572952788758,0.9777482007194775,0.504225352112676,0.8609828229407193,1.0,3/77,1.88%,TEK;MFHAS1;PPARD
prerank,regulation of macrophage activation (GO:0043030),0.39491200584234143,0.9776019449829138,0.49185667752442996,0.8606527861539615,1.0,2/30,2.13%,MFHAS1;CD200
prerank,central nervous system development (GO:0007417),0.28794717173622597,0.9774154125716424,0.5344418052256532,0.8604726795583463,1.0,45/250,14.06%,SLC2A1;MFSD2A;ADGRL2;SHROOM4;ZIC3;ADGRL3;MAL;TBX3;SEMA6B;ADGRG1;NES;CDH2;DSCAML1;ZBTB16;LSR;MOG;AATK;NCKAP1;COL4A1;SOX12;DHX37;CDK5RAP2;SPOCK1;CAPG;DNER;SERPINI1;ZPR1;TBC1D23;DDIT4;AGTR2;DCX;THOC6;EIF2B2;GRIN2B;UFM1;UTP3;SOX10;TGFBR2;EML1;SOX11;CNTNAP2;SOX9;GRIK1;FOXJ1;HAPLN2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4776934646748642,0.9772546130718913,0.47900763358778625,0.8602403122893806,1.0,4/10,22.86%,SP100;HIPK2;TFAP4;ING4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4540886608705046,0.9771745540848531,0.5126353790613718,0.8597728390662177,1.0,2/14,5.76%,NOS3;OXTR
prerank,purine-containing compound catabolic process (GO:0072523),0.45223224183365046,0.9760884142339419,0.502835538752363,0.8617682147605452,1.0,3/13,11.08%,XDH;NT5C2;PNP
prerank,regulation of presynapse organization (GO:0099174),-0.3811009864160131,-0.9760292987283622,0.4939467312348668,0.8614397178661279,1.0,2/18,4.60%,GPC6;GPC4
prerank,regulation of presynapse assembly (GO:1905606),-0.3811009864160131,-0.9760292987283622,0.4939467312348668,0.8614397178661279,1.0,2/18,4.60%,GPC6;GPC4
prerank,cell cycle G2/M phase transition (GO:0044839),0.30889407612529135,0.9748349727894112,0.4980237154150198,0.8640129592705145,1.0,26/129,15.94%,PLCB1;CCNY;TPD52L1;NES;DYNLL1;CDKN2B;CCP110;DNM2;LCMT1;PRKAR2B;CETN2;TUBB;CDK5RAP2;PPP1CB;AKAP9;HAUS6;CEP78;CEP135;CEP72;FBXL8;TUBB4B;TUBA1A;FBXL15;CKAP5;CEP70;PPME1
prerank,endomembrane system organization (GO:0010256),-0.24694109609261117,-0.9744046137843867,0.5518867924528302,0.8648266124280902,1.0,68/178,26.36%,RAB30;MYOF;GBF1;DMPK;OBSL1;TANGO2;ARHGAP21;GOLGB1;A4GALT;FBXW8;FAM174B;DYNC2H1;GOLGA2;HOOK2;SEC31A;SEC16B;PI4K2B;COG4;CUL7;TLCD2;PLEKHF1;TMEM170A;ARL1;ARFGEF2;HUWE1;LRRK2;GORASP2;AKTIP;ATP8B2;RAB29;ATP8B1;SPTSSB;BCAS3;PLEKHM2;SEC16A;LMAN1;SNX33;WASHC5;SURF4;OPTN;SNX10;USP50;SYP;SUN2;BLZF1;GOLGA5;GOLGA8B;RAB22A;VPS4A;ATL3;TMED4;DNM1;LMAN2L;SEC23IP;TMED9;MYO18A;UBXN2A;ALS2;HTT;LEMD2;TJAP1;OTOF;WASHC4;NUP155;ANXA8L1;ANXA8;EIF2AK3;PHETA2
prerank,sensory perception of light stimulus (GO:0050953),-0.2702882780014195,-0.9743545907384091,0.5071942446043165,0.8639224093773515,1.0,9/87,5.12%,COL1A1;SLC4A10;EFEMP1;EYA4;COL18A1;ADGRV1;COL11A1;DHRS3;EML2
prerank,negative regulation of telomere maintenance (GO:0032205),-0.39180397892420843,-0.9741199147523819,0.5049261083743842,0.8634737497177537,1.0,8/15,25.26%,TNKS2;ATM;RTEL1;PARP1;ERCC1;RAD50;NBN;TNKS
prerank,regulation of phospholipase C activity (GO:1900274),0.43458620907346657,0.9739275886459123,0.5102389078498294,0.8654897448591155,1.0,2/15,4.11%,FLT1;PLCG1
prerank,"phagocytosis, engulfment (GO:0006911)",0.3725841544973431,0.9737332180709611,0.4858490566037736,0.8652687330794284,1.0,4/36,6.47%,RHOBTB1;DOCK1;ELMO1;ARHGAP25
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.43295117991730964,0.9736506912934006,0.5072727272727273,0.8648284082273,1.0,3/18,6.71%,IL6R;ST18;STAT1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.35082162535689543,-0.973560064166123,0.46539379474940334,0.8640446849840651,1.0,5/24,4.23%,DPYSL3;DOCK11;ARAP1;RHOQ;RIPOR2
prerank,nucleotide-excision repair (GO:0006289),0.31798704174521847,0.9734202132753055,0.5061898211829436,0.8647269077154184,1.0,35/101,26.34%,POLK;ATXN3;GTF2H2;BRCA2;CETN2;GTF2H4;POLB;FAN1;RBX1;AQR;COPS5;RAD23A;GPS1;ISY1;HUS1;POLR2J;RPA1;TCEA1;POLL;POLD1;ERCC8;GTF2H3;POLA1;COPS6;RFC2;DDB1;ERCC4;RAD23B;PPIE;XPC;RFC4;COPS2;PNKP;POLD4;USP45
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.42619251851633705,-0.973223094827594,0.490280777537797,0.8638865956279148,1.0,5/11,12.43%,EFNB2;FRS2;FZD7;SOX6;BMP2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.31375096132879327,-0.9729156568011607,0.48823529411764705,0.8636221852624905,1.0,18/48,18.36%,DOCK5;CARMIL1;CUX1;OBSL1;S100A10;FBXW8;FLNA;MYOC;CUL7;CAPRIN2;ABL1;DMTN;CDKL3;P4HB;TESK1;MDK;MYADM;C1QBP
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3252857070261907,0.9718870987660702,0.5043352601156069,0.8676668821172504,1.0,10/78,8.09%,PRKCH;SPTBN1;BCL2L1;STX3;ACTB;RAMP3;PPP2R5A;SORBS1;AP2M1;TGFB1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3648598447507891,-0.9717055171079595,0.48148148148148145,0.8657883035301818,1.0,2/20,1.57%,WNT4;BMP5
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.43853836101762456,-0.9713539113950869,0.49795918367346936,0.8656405121419155,1.0,2/10,7.88%,OGT;SELENOS
prerank,positive regulation of protein ubiquitination (GO:0031398),0.32310764967670286,0.9710677830165855,0.4992887624466572,0.8689678138291219,1.0,22/80,19.21%,CAV1;DCUN1D3;SMAD7;XIAP;FAM107A;FBXW7;BIRC3;PIN1;MALT1;NDFIP2;UBQLN1;GSK3A;DCUN1D1;BCL10;PDCD6;RBX1;BMI1;INAVA;PTTG1IP;UBE2D1;FKBP1A;NSMCE3
prerank,positive regulation of nervous system process (GO:0031646),0.42703115798707525,0.9704763514961354,0.5139372822299652,0.8697141340294895,1.0,6/18,19.18%,UNC13B;PARD3;CST7;RIMS2;TPPP;DICER1
prerank,regulation of centriole replication (GO:0046599),-0.3857331879822212,-0.9703802212262183,0.5163551401869159,0.8672378673591561,1.0,8/17,23.20%,ALMS1;MDM1;SPICE1;STIL;CEP295NL;TRIM37;BRCA1;CEP76
prerank,cellular response to acid chemical (GO:0071229),0.3876988083999657,0.9703774700960857,0.4729064039408867,0.8693294711231045,1.0,8/27,19.26%,SH3BP4;KLF2;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2;GLRA2
prerank,protein palmitoylation (GO:0018345),0.38441331498623366,0.9703549720172819,0.49585406301824214,0.8687438102437331,1.0,6/30,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,DNA modification (GO:0006304),0.4074251514499766,0.9702731111540714,0.504302925989673,0.8682905618538834,1.0,6/22,12.47%,NTHL1;TERF2;SMUG1;ACD;MPG;TERF1
prerank,Golgi inheritance (GO:0048313),-0.42446621153973507,-0.9702508782587462,0.5042016806722689,0.8665483005092719,1.0,4/11,14.52%,GBF1;GOLGA2;STX5;PLK5
prerank,mRNA stabilization (GO:0048255),0.36417757712844395,0.9700553204190749,0.5094043887147336,0.8681907544666223,1.0,7/40,14.77%,TIRAP;YBX1;NOCT;HNRNPC;AXIN2;PAIP1;ELAVL1
prerank,primary alcohol metabolic process (GO:0034308),-0.35555460221189017,-0.9700353586121845,0.5308641975308642,0.8660654432442493,1.0,6/25,10.14%,IGF1;RBP4;DHRS3;CYP1B1;NAAA;PECR
prerank,regulation of chemotaxis (GO:0050920),-0.3416559612827014,-0.9699515559841416,0.51010101010101,0.8652576988409548,1.0,6/30,7.23%,PDGFRB;PDGFRA;EFNB2;THBS1;ZSWIM8;P2RX4
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4433542497976478,-0.9696866267521063,0.5220125786163522,0.864933904983143,1.0,6/11,33.17%,UGGT2;AUP1;DERL1;UFD1;UGGT1;POMT2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4378914120330784,0.9695988044491936,0.49376114081996436,0.8686328559114301,1.0,4/14,19.78%,TIRAP;HNRNPC;ELAVL1;DAZL
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.39319674798916493,-0.9695776008965374,0.5145413870246085,0.8641999010224266,1.0,6/18,16.03%,SMAD3;PDPN;EMILIN1;EFEMP2;BMP2;RUNX1
prerank,synaptic vesicle membrane organization (GO:0048499),0.42568748044575105,0.9695202801027084,0.5,0.868210349593217,1.0,4/17,12.26%,STX3;STX1A;STX19;SNAP29
prerank,regulation of filopodium assembly (GO:0051489),0.3658962271691662,0.9694398540896637,0.5136436597110754,0.8677543739002744,1.0,6/38,5.25%,MYO10;PPP1R16B;FNBP1L;PALM;AGRN;CCR7
prerank,iron-sulfur cluster assembly (GO:0016226),0.399981538964577,0.9692864630083121,0.4859504132231405,0.8674716047289719,1.0,15/24,29.82%,CIAO2B;CIAPIN1;HSCB;HSPA9;CIAO3;BOLA2;NUBPL;GLRX3;LYRM4;NFU1;ISCA1;ISCA2;NUBP2;NUBP1;ISCU
prerank,serine family amino acid metabolic process (GO:0009069),0.44154653939177113,0.9692189180226287,0.5061946902654867,0.8669827980097737,1.0,4/16,9.59%,SARS1;GLYAT;SHMT2;CBS
prerank,release of cytochrome c from mitochondria (GO:0001836),0.42554356346752,0.9687111714869857,0.49043478260869566,0.8675483904570053,1.0,1/17,0.99%,BCL2L1
prerank,pharyngeal system development (GO:0060037),0.43217594902513823,0.9686302213842615,0.5076923076923077,0.8670853639357538,1.0,3/15,1.88%,BMPR2;TGFB2;TBX1
prerank,regulation of wound healing (GO:0061041),0.361745242383571,0.968581524541796,0.49853372434017595,0.866557300367951,1.0,5/42,6.30%,OCLN;CAV1;PTK2;VIL1;INSL3
prerank,response to organophosphorus (GO:0046683),0.43804028591131616,0.9684968273000595,0.5144404332129964,0.8661008368687406,1.0,3/16,8.57%,TRIM16;STAT1;P2RX7
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.371866715909,0.9679379140410324,0.5048543689320388,0.8667096595059629,1.0,11/32,24.87%,CDK17;HINFP;ZPR1;BRD4;CDC6;ORC1;CDK18;POLA1;DHFR;KLF11;TYMS
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.42168677421987955,0.9669632256543899,0.5140845070422535,0.8684175406482982,1.0,1/18,0.20%,TEK
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.33693348645619076,0.9669576539854423,0.4836309523809524,0.8678031733637842,1.0,1/60,0.03%,LEF1
prerank,steroid biosynthetic process (GO:0006694),-0.29445153295653426,-0.9669071201387873,0.528125,0.8703569082164624,1.0,5/56,5.81%,PRKAG2;CYP7B1;INSIG2;CYP27A1;ACOT8
prerank,regulation of protein kinase C signaling (GO:0090036),0.44353205685417807,0.9669060357775122,0.5130111524163569,0.8673037275291856,1.0,2/14,3.06%,FLT4;CD40
prerank,toxin transport (GO:1901998),-0.4397826665065468,-0.9667096014277046,0.5066371681415929,0.8698524726102965,1.0,3/10,13.99%,ANTXR2;RAB29;SLC22A2
prerank,histone H3-K4 trimethylation (GO:0080182),-0.42366519034084626,-0.9664681078163108,0.5061224489795918,0.869452203288802,1.0,2/11,5.56%,OGT;CTR9
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4061218414124021,-0.9663769842238122,0.5086580086580087,0.8686730755916552,1.0,7/13,18.28%,PKD1;SUFU;PKD2;FLNA;MDFI;LATS1;DBN1
prerank,basement membrane organization (GO:0071711),0.4422803547985582,0.9663229839058587,0.49094202898550726,0.8679922405589798,1.0,4/14,7.04%,NTNG2;RAMP2;PXDN;COL4A1
prerank,sulfur compound biosynthetic process (GO:0044272),0.30818887167080583,0.9660445609970965,0.5261744966442953,0.8680068646561144,1.0,16/104,10.19%,CSGALNACT1;ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;CHST11;GCLM;B3GNT2;TPK1;MGST2;GSTA4;SLC10A7;MAT2A;CBS;HPGDS;GSTK1
prerank,negative regulation of viral life cycle (GO:1903901),0.43069100144317957,0.9658567090568116,0.49640287769784175,0.8677946424330981,1.0,4/15,7.36%,LY6E;SNX3;PPIA;BST2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4132788622386938,-0.9654880310544094,0.5261958997722096,0.8699174965618519,1.0,4/12,17.88%,SMO;SIX1;SIX4;PAX2
prerank,mRNA destabilization (GO:0061157),-0.3197829163463176,-0.9653155687101568,0.5172413793103449,0.8693658465847214,1.0,2/38,2.78%,ROCK2;TUT4
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2994400460860773,-0.9651924870252165,0.5264797507788161,0.868639667160679,1.0,9/48,12.16%,ANK2;CEMIP;DMD;CAMK2D;DIAPH1;PDPK1;PRKACA;PTK2B;JPH1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3438435427030384,0.9647511993369733,0.5007299270072992,0.8697356370303263,1.0,6/57,5.96%,KDR;HIP1R;PLAUR;TNFSF10;CAMKK2;BIK
prerank,proteoglycan metabolic process (GO:0006029),0.39548549187604864,0.9644472432428354,0.527363184079602,0.8698083388381949,1.0,3/26,2.89%,CSGALNACT1;BMPR2;CHST11
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.4014608652088464,-0.9643455945380102,0.48034934497816595,0.8698657470751113,1.0,2/14,5.27%,ENPP1;ENPP3
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4683757247045989,0.9641309918708252,0.5098743267504489,0.8698889924962386,1.0,4/11,17.88%,CCT3;CCT5;TERF1;CCT7
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.33781034742795646,-0.963674490489904,0.49754901960784315,0.8706974202077626,1.0,2/28,1.34%,PRKAG2;PRKAA2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.34857336519301463,0.9635780757639705,0.5121580547112462,0.8705894802086849,1.0,9/50,12.10%,APP;NOD1;NOD2;TLR3;ACTN4;LGALS9;TLR7;AGER;C1QTNF4
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3205983701040851,0.9635513268166331,0.4950354609929078,0.8700258134435109,1.0,19/88,12.42%,EXOC6B;APP;EXOC6;STXBP6;AP1S2;SORT1;SORCS1;DNM2;SCAMP1;CLINT1;AP1S3;KLHL20;CLVS2;HSPA8;EXOC4;EXOC2;AP4S1;EPS15;HGS
prerank,regulation of cartilage development (GO:0061035),-0.3792974604337285,-0.963098259000359,0.523696682464455,0.8711430473371646,1.0,7/18,17.10%,SOX5;BMP4;SOX6;PTHLH;BMP2;WNT11;MDK
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3566812167022575,0.963002108989202,0.5138888888888888,0.8707456546559391,1.0,12/41,12.63%,ENG;TGFB2;MEF2C;NOTCH1;SMAD7;FOXF1;DLL4;TGFB1;NPY5R;GSK3A;TGFBR2;SOX11
prerank,response to thyroid hormone (GO:0097066),0.4446389891589295,0.9629722611799774,0.49074074074074076,0.870178306978239,1.0,1/13,0.76%,LMO2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.30338904520174015,-0.9627667835631422,0.5079365079365079,0.8710116031015424,1.0,17/47,18.36%,DOCK5;FBLN1;PDPN;CARMIL1;EFNA5;KANK1;S100A10;FLNA;MYOC;ITGB1BP1;ABL1;DMTN;P4HB;TESK1;MDK;MYADM;C1QBP
prerank,cytoskeleton organization (GO:0007010),0.31035510139106104,0.9626347342457978,0.5344827586206896,0.8703445220705466,1.0,24/114,13.84%,FGD5;SEMA6A;ARAP3;RHOBTB1;FMNL3;NEDD9;SIPA1;MAST4;RHOB;PAK5;CECR2;DPYSL2;ARHGAP4;RANBP10;FGD6;STRIP1;KLHL20;PDZD8;RAC1;RND1;RANBP9;FGD2;TNFAIP3;CFL1
prerank,negative regulation of histone acetylation (GO:0035067),0.4741427780764903,0.9625864487612368,0.5247349823321554,0.869811829430397,1.0,6/11,22.35%,CTBP1;SIN3A;SET;NOC2L;SNCA;SPI1
prerank,carbohydrate catabolic process (GO:0016052),0.3641052639377258,0.9625625504521901,0.49304482225656876,0.8692361779688965,1.0,12/38,18.47%,NEU4;PKM;HK1;MANBA;NEU2;PGAM4;PGAM1;TPI1;MAN2B1;PFKL;NEU1;LDHA
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.36371634482481424,0.9620796533214148,0.49612403100775193,0.8697391631472084,1.0,5/38,6.22%,XDH;PHLPP1;PTPRJ;HYAL2;PLEKHA1
prerank,regulation of neuron death (GO:1901214),0.3224056332426446,0.961999774894252,0.5159151193633952,0.869299021284937,1.0,16/82,15.22%,CD34;CD200;MEF2C;GRID2;FYN;EGLN2;CD200R1;DDIT4;KIR3DL2;GRIN2B;EPHB1;NSMF;GPR75;TRIM2;BTBD10;DCC
prerank,actin filament network formation (GO:0051639),-0.421926387220125,-0.9619250974949155,0.5423728813559322,0.8722788804202589,1.0,3/11,7.91%,CARMIL1;COBL;FHOD1
prerank,muscle tissue morphogenesis (GO:0060415),-0.3891303878534365,-0.9618407814711204,0.49539170506912444,0.8714873386788377,1.0,3/16,2.08%,TGFBR3;BMP4;MYLK
prerank,positive regulation of macroautophagy (GO:0016239),0.3509158586102749,0.961496205546307,0.5257410296411856,0.8698354165514045,1.0,13/48,14.19%,KDR;SLC25A5;SESN3;SPTLC2;RALB;IRGM;FYCO1;BNIP3L;VPS13D;SH3GLB1;PIP4K2A;SPTLC1;EPM2A
prerank,nuclear export (GO:0051168),-0.27186587391228767,-0.9614308683809368,0.5314685314685315,0.8715765395259817,1.0,26/80,26.87%,RANBP3L;PKD1;PHAX;RANBP17;SRSF5;SRSF11;XPO5;SRSF6;XPO6;SRSF4;STRADA;DDX39B;XPO1;THOC2;THOC7;U2AF2;U2AF1;RAE1;DDX39A;EIF4A3;POLDIP3;THOC1;WASHC4;NUP155;TPR;ATXN1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.31741288861405564,0.9610781127834777,0.5334242837653479,0.8701486773638197,1.0,33/87,27.05%,NDUFAF3;NDUFA2;NDUFA8;SLC25A33;SCO2;NDUFAF7;DMAC2;SAMM50;TMEM126B;SCO1;OMA1;IMMP2L;NDUFA12;NDUFB3;NDUFAF8;SDHAF4;CHCHD4;COA3;SDHAF1;NDUFC1;SMIM20;NUBPL;SDHAF2;NDUFA10;COX20;COX17;ECSIT;DMAC1;PET100;TIMMDC1;NDUFA7;TIMM21;NDUFS5
prerank,telomere maintenance via telomerase (GO:0007004),0.38491213140003183,0.9609659812398285,0.5217391304347826,0.8697883405706746,1.0,9/28,24.06%,HSP90AB1;MRE11;TERF2;ACD;TERF1;NHP2;RPA1;PINX1;PTGES3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.2904142901939613,-0.960673190862202,0.5434083601286174,0.8724453268274416,1.0,12/63,9.09%,SLC1A3;SLC26A2;GABRA3;SLC12A2;ANO6;SLC5A5;SLC6A1;SLC12A7;SLC5A6;ANO1;SLC20A2;GLRB
prerank,anterior/posterior axis specification (GO:0009948),-0.38523205482615563,-0.9604555138655743,0.5180180180180181,0.8719974252596426,1.0,1/15,0.25%,WLS
prerank,cellular response to interferon-beta (GO:0035458),0.42772772267429704,0.9602100938451225,0.5275310834813499,0.8709175266729153,1.0,3/14,8.17%,AIM2;STAT1;IRGM
prerank,regulation of cell cycle (GO:0051726),0.2806426369112927,0.9601650335922667,0.5368898978433598,0.8703824023312833,1.0,28/271,8.39%,MECOM;DAB2IP;APBB2;PPP1R13B;TGFB2;NANOS3;TBX3;AFAP1L2;DCUN1D3;RGCC;SIPA1;NOTCH1;MEN1;PPP1R9B;HSP90AB1;CDC14A;XIAP;BTG4;RHOB;TTC28;ADAM10;CDKN2B;INSM1;JMY;JUN;BIRC3;TGFB1;IQGAP1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.31138740853758506,0.9596943703231565,0.5175202156334232,0.870841466878288,1.0,25/109,17.29%,PLCB1;PIK3R6;INPP5D;PIK3R3;PLCG1;PIKFYVE;PIP5K1C;OCRL;INPP5F;PLEKHA1;MTMR6;PIK3C3;PIK3C2A;RAB4A;PIP4K2A;PIK3CB;MTMR12;CDIPT;MTMR2;PIK3R5;PLEKHA3;SYNJ1;INPP5E;INPPL1;CSF1R
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.3961296489570047,-0.9592846342220139,0.5225806451612903,0.8740801198360969,1.0,2/15,5.34%,OSBPL8;PPARA
prerank,snRNA 3'-end processing (GO:0034472),-0.37308326594159547,-0.9592581879737316,0.5362318840579711,0.8731255763502556,1.0,7/19,30.01%,INTS8;INTS2;TUT1;EXOSC2;TOE1;INTS6L;INTS5
prerank,cellular protein metabolic process (GO:0044267),0.27519238119384465,0.9589038686365587,0.5941240478781284,0.8720811545186536,1.0,98/396,19.60%,ST8SIA4;ST3GAL6;DAB2IP;DENND3;APP;ST3GAL1;STK38;SPARCL1;VWA1;CDH2;MEN1;SARS1;NOTUM;ZAR1L;RPL38;IGFBP7;MRPL13;RPL13;RPS29;ABCA3;MRPL10;ADAM10;RPL36A;YES1;RPL3;GOLM1;UBE2G1;MSRB2;YARS2;LCMT1;MSRB3;RPL27;RPSA;PDIA6;RPS7;QSOX1;RPL9;RPL18;RPLP2;PLAT;SCG3;ADAM17;RPL13A;MMP1;FBXL2;CHRM3;RPS11;DUSP12;APH1A;RPL8;RPS27;RPL19;UBA3;RPS9;MRPL28;SPCS2;EVA1A;MANBA;RPL11;LTA4H;FBXW2;RPS15;SRBD1;RPL37;RPS28;MAN2B1;SERPINC1;RPS10;OMA1;UBE2D3;LOXL2;MMP15;RPS25;MCRS1;PROC;RPL37A;MRPL9;COPS5;GAS6;SEPHS1;TMEM132A;UBE2G2;SCG2;FBXO2;RPL15;SFTPC;TNIP1;SPPL3;ERO1A;CPE;MRPL23;RPL17;RPL23;RPL34;USP25;LMCD1;FARSB;RPS18
prerank,regulation of spindle organization (GO:0090224),-0.36496179141756246,-0.9585680201516383,0.5158150851581509,0.8739735614891448,1.0,9/18,38.06%,PARP3;GPSM2;SENP6;RAE1;TPX2;NUMA1;PSRC1;TACC3;NUP62
prerank,intracellular lipid transport (GO:0032365),0.4103193260410374,0.958415125932784,0.5025380710659898,0.8725636717975271,1.0,4/21,6.80%,CERT1;ABCD4;CPT1A;ACACB
prerank,vascular process in circulatory system (GO:0003018),-0.41626451346915666,-0.9584036417805202,0.5226244343891403,0.872384118974789,1.0,8/13,15.39%,ROCK2;SCPEP1;ACE;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,regulation of tube diameter (GO:0035296),-0.41626451346915666,-0.9584036417805202,0.5226244343891403,0.872384118974789,1.0,8/13,15.39%,ROCK2;SCPEP1;ACE;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,pentose-phosphate shunt (GO:0006098),-0.4253387041565969,-0.9582243544147817,0.5398230088495575,0.8717655126601095,1.0,4/11,14.58%,PGLS;H6PD;PGD;DERA
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3588490632250583,0.9582095184064287,0.4976671850699845,0.8724215131653626,1.0,2/40,1.98%,SLC7A5;SLC38A5
prerank,regulation of mitotic nuclear division (GO:0007088),0.34189955854316245,0.9580310669548765,0.5253731343283582,0.8721921319056828,1.0,9/55,8.62%,PDGFB;INSR;RGCC;LCMT1;PIN1;TGFA;CAV2;LRP5;CDK5RAP2
prerank,T cell differentiation (GO:0030217),0.36005723035528275,0.9579786490429725,0.5338345864661654,0.8716995441512503,1.0,10/40,12.55%,JAG2;SOX13;ZAP70;DLL4;CD4;TCF7;ADAM17;GPR89A;GPR89B;ZFP36L1
prerank,morphogenesis of an epithelium (GO:0002009),-0.3482358382763462,-0.9579545654190578,0.5257985257985258,0.8714751878331102,1.0,8/25,15.26%,FGFR2;VCL;DAG1;TBX18;KDM2B;ARHGAP12;AHI1;LRP6
prerank,pinocytosis (GO:0006907),-0.43476792583604607,-0.9578493008960457,0.5151515151515151,0.8707221003299608,1.0,7/10,29.49%,CARMIL1;MAPKAPK3;SNX5;SNX33;PYCARD;AHSG;MAPKAPK2
prerank,negative regulation of cellular protein localization (GO:1903828),0.37265540019530785,0.9578109808114257,0.5138662316476346,0.871487599472244,1.0,3/34,3.12%,MFHAS1;NEDD4L;ANKRD13A
prerank,inner dynein arm assembly (GO:0036159),0.4614714069292107,0.957214584611716,0.5295238095238095,0.8722089070870774,1.0,2/10,7.43%,ZMYND10;CFAP100
prerank,secretion (GO:0046903),-0.39423512367971825,-0.9571823619857923,0.494279176201373,0.871448392392713,1.0,4/14,4.51%,FBLN5;SLC22A4;PRKCI;SLC22A6
prerank,phospholipid dephosphorylation (GO:0046839),0.3678382577947106,0.9569820772448117,0.5236593059936908,0.8721172196953572,1.0,10/37,17.06%,SGPP2;PLPP6;OCRL;INPP5F;MTMR6;MTMR12;MTMR2;PLPPR4;SYNJ1;PLPP2
prerank,determination of left/right symmetry (GO:0007368),0.36336869323771126,0.9568893846156437,0.5248447204968945,0.8716901636633771,1.0,7/36,15.27%,ZIC3;TBX1;NOTCH1;KIF3B;FOXJ1;DAND5;DNAH5
prerank,positive regulation of monooxygenase activity (GO:0032770),0.3820726854718539,0.9567191847276482,0.525974025974026,0.8714421370244034,1.0,7/26,14.66%,GCH1;SCARB1;TERF2;AGTR2;HIF1A;PIK3CB;NUS1
prerank,negative regulation of kinase activity (GO:0033673),-0.28771769602746033,-0.9560893993102596,0.5631067961165048,0.8732127457347635,1.0,16/62,20.58%,PRKAG2;PPM1E;DEPTOR;DTNBP1;IRS2;PDPK1;SPRED1;QARS1;ITGB1BP1;NF1;LRP6;CDKN1C;PTPRC;SMCR8;THY1;TARBP2
prerank,positive regulation of nervous system development (GO:0051962),0.3536760048122925,0.9557059139979678,0.5079872204472844,0.8732175372569037,1.0,12/42,16.49%,TGM2;WNT7A;CLSTN1;GRID2;FAIM;NRXN1;LRRC4B;LRP2;EPHB1;SOX11;NLGN1;IL1RAP
prerank,protein K11-linked ubiquitination (GO:0070979),-0.3347114014061484,-0.9554076612333768,0.5181347150259067,0.8739105809915424,1.0,9/27,26.17%,UBE2E2;ANAPC5;PRKN;UBE2E3;UBE2B;CDC16;UBE2S;ANAPC4;ANAPC13
prerank,negative regulation of peptidase activity (GO:0010466),0.3538816700431741,0.9553628245292063,0.5279503105590062,0.8733933651196626,1.0,8/47,9.85%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;CST7;SPOCK1;SERPINI1;UBXN1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.33512000270157477,-0.9553039595550441,0.5248041775456919,0.8731831573972597,1.0,6/29,14.96%,SMAD3;TUT4;ZC3H7B;AGO2;PUS10;HNRNPA2B1
prerank,regulation of actin nucleation (GO:0051125),-0.41295683020107665,-0.9550932593569808,0.5044642857142857,0.8726900649654332,1.0,5/12,21.04%,GSN;ARFIP2;WASHC5;ARF1;CORO1B
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.45202643537942333,0.9549555155123935,0.500945179584121,0.8737469854300991,1.0,1/12,0.76%,LMO2
prerank,mitotic cell cycle phase transition (GO:0044772),0.2866550792020306,0.9548226381775878,0.562962962962963,0.8734300504613667,1.0,54/203,22.49%,PLCB1;CCNY;TPD52L1;NES;EPS8;DYNLL1;CDKN2B;CCP110;MAX;DNM2;LCMT1;CCNI;PRKAR2B;HINFP;CETN2;TUBB;CDK5RAP2;PPP1CB;CCND3;AKAP9;HAUS6;CEP78;EIF4E;CEP135;CEP72;PIM2;FBXL8;TUBB4B;TUBA1A;FBXL15;PLK2;CKAP5;CEP70;PPME1;ACVR1;ANAPC7;SPAST;TRIM71;SKP1;USP29;CDK6;DCTN1;SFI1;BRSK2;TAF2;CLASP1;NDE1;HAUS2;CDK4;NASP;CUL1;CCNJL;CDC23;ENSA
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.32413247576819704,-0.954781368371161,0.5308310991957105,0.8724815023031157,1.0,12/33,21.83%,DDX5;AR;KLK2;AXIN1;KDM1A;ESR1;EP300;DDRGK1;RUNX1;LATS1;RNF14;SAFB2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4368149398644759,0.9547641917006473,0.4921190893169877,0.8729472453650073,1.0,2/15,1.41%,KDR;CXCL12
prerank,inner mitochondrial membrane organization (GO:0007007),0.35335411815507395,0.9541598465640886,0.5245398773006135,0.8736844132491265,1.0,15/47,22.98%,ATP5F1E;TIMM13;ATP5MC2;LETM1;ATP5PO;GHITM;TIMM10;SAMM50;ATP5F1A;HSPA9;ATP5MF;ATP5PF;CHCHD3;TMEM11;MTX1
prerank,regulation of astrocyte differentiation (GO:0048710),0.45359780862615395,0.9536948131670901,0.5226860254083484,0.8740819269151255,1.0,2/12,5.52%,NOTCH1;EPHA4
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.30147385205253063,0.9536597734784977,0.5729442970822282,0.8735488936722402,1.0,18/121,10.58%,PECAM1;PDGFB;IL6R;LRP8;NEDD9;ARL2BP;PTPRJ;ARHGEF2;CD40;LYN;EPHA4;STAP2;EFNA1;TGFB1;ENPP2;GREM1;PTK6;CNTF
prerank,cellular response to calcium ion (GO:0071277),0.3265425668381085,0.9535247759119857,0.5238784370477568,0.8732425118834509,1.0,17/67,17.95%,ITPKB;MEF2C;MCOLN1;ACER1;SYT7;CPNE8;RASGRP2;IQGAP1;CLIC4;CPNE5;SYT4;CPNE6;NLGN1;CPNE3;CRHBP;CPNE1;NEUROD2
prerank,positive regulation of cell aging (GO:0090343),0.4560345365872396,0.9533952680464445,0.5245283018867924,0.8729351341125059,1.0,4/11,16.58%,B2M;HMGA1;ABI3;HMGA2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4019915081961463,0.9532513258334403,0.5287958115183246,0.8726196238854412,1.0,4/23,10.56%,TOMM22;TIMM13;TIMM10;SAMM50
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4467445104205521,0.9530001260466806,0.5365384615384615,0.8725613664061523,1.0,1/11,1.47%,NOVA2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.4098550015205121,-0.9527556032791312,0.5308370044052864,0.8746771726307223,1.0,7/12,32.28%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.4098550015205121,-0.9527556032791312,0.5308370044052864,0.8746771726307223,1.0,7/12,32.28%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.4098550015205121,-0.9527556032791312,0.5308370044052864,0.8746771726307223,1.0,7/12,32.28%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3264324964868062,0.9525331271352853,0.5168869309838473,0.8730000489636291,1.0,21/72,23.22%,TIRAP;CARD10;TLR3;PSMB3;PSMD11;BIRC3;PSMC6;MALT1;PSME2;PSMD8;PSMB10;PSMA8;RELB;SKP1;PSMD9;DICER1;CUL1;PSMC3;PSMD1;PSMD10;TRAF6
prerank,detection of mechanical stimulus (GO:0050982),0.414492564143653,0.9523139324961806,0.5266903914590747,0.8728774941223031,1.0,4/19,4.52%,PTK2;CDH2;PIEZO1;CTNNB1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4260395746640997,0.9520750614335057,0.5256410256410257,0.8728341269895737,1.0,6/18,20.96%,DAB2IP;MSN;RGP1;PTTG1IP;NELL1;RDX
prerank,copper ion transport (GO:0006825),0.46584935831325847,0.9520407758591973,0.5171171171171172,0.8723014132826182,1.0,2/11,4.15%,ATOX1;SLC31A1
prerank,blood vessel endothelial cell migration (GO:0043534),0.4032936742872491,0.9519943470549381,0.5352839931153184,0.8717936171376395,1.0,6/22,8.89%,KDR;ID1;PIK3R3;EPHB4;SOX18;GREM1
prerank,response to muscle stretch (GO:0035994),0.42848290741628386,0.9515224177112789,0.5311942959001783,0.8722767608709712,1.0,4/15,4.86%,PTK2;CDH2;CTNNB1;NPPA
prerank,regulation of tumor necrosis factor production (GO:0032680),0.30826397098211183,0.9514466309502905,0.543978349120433,0.8718406797858007,1.0,16/112,13.79%,CD34;APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;VSIR;SYK;C1QTNF4;DDT;TNFAIP3
prerank,embryonic heart tube development (GO:0035050),0.42984068405944265,0.9510454990027987,0.532258064516129,0.8721372624498539,1.0,2/14,7.19%,SOX17;SOX18
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3577151920596834,0.9505371308115037,0.5411585365853658,0.8726588455694381,1.0,4/40,5.96%,BCL2L1;PLAUR;TNFSF10;BIK
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3601708178088777,0.9505161397168124,0.5306451612903226,0.8720923665744881,1.0,11/38,19.24%,DAB2IP;STAT1;ZMYND11;OTUD7A;CASP8;TLE1;TRIM39;TNFAIP3;TRIM59;TNIP1;OTUD7B
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.37359771189239765,0.9500524904992175,0.5303776683087028,0.8725042401123557,1.0,15/28,30.46%,STMN1;MAPRE2;STMN3;STMN4;MAPRE3;CAMSAP2;CLASP1;GAS2L1;CAMSAP1;ARL2;CLASP2;PRUNE1;STMN2;SKA3;FKBP4
prerank,negative regulation of interleukin-17 production (GO:0032700),0.45605838358390316,0.9497523033494668,0.5169172932330827,0.8725526574909777,1.0,3/10,14.70%,FOXP3;VSIR;NCKAP1L
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.4509527324701603,0.9495892540651112,0.5123809523809524,0.872292103121449,1.0,1/12,0.22%,PLCB1
prerank,triglyceride metabolic process (GO:0006641),-0.29458306150896996,-0.9495035194371511,0.5702247191011236,0.8822867653375026,1.0,8/48,15.29%,AGMO;MOGAT3;GK;APOE;LPGAT1;LMF1;GPAT3;PNPLA3
prerank,dendritic cell migration (GO:0036336),0.425258019349859,0.9493373378541909,0.5224719101123596,0.8722374694369192,1.0,3/16,8.20%,EPS8;CCR7;CXCR2
prerank,extracellular matrix assembly (GO:0085029),-0.35539920649407086,-0.9487795370664467,0.519280205655527,0.8831221799199925,1.0,8/23,11.27%,TNXB;FBLN5;ATP7A;EMILIN1;MYH11;LAMB1;EFEMP2;MFAP4
prerank,neuron differentiation (GO:0030182),-0.23937106219801219,-0.9487170134756893,0.6150234741784038,0.8822794155206587,1.0,19/165,8.81%,PBX1;GLI2;WNT4;WNT5B;WNT6;FZD2;TGFBR1;WNT9A;PBX4;RUNX2;NRBP2;FZD7;TDP2;PBX3;HS6ST1;FZD3;VSX1;MET;ATOH8
prerank,limb morphogenesis (GO:0035108),-0.3668712773080594,-0.948606765926492,0.5476190476190477,0.8815892614580987,1.0,3/20,2.40%,GLI3;CYP26B1;PCSK5
prerank,detection of calcium ion (GO:0005513),-0.39642174239862615,-0.9484187298476361,0.5406593406593406,0.8810759040359699,1.0,2/13,4.49%,STIM1;KCNMB2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.4133110888172304,-0.9482079728064028,0.5522388059701493,0.8806310342684371,1.0,2/12,4.68%,BMP4;PTPN14
prerank,regulation of water loss via skin (GO:0033561),0.4223550772764172,0.9481296030220747,0.5206896551724138,0.873721213712679,1.0,6/15,24.27%,LSR;STMN1;FA2H;HRNR;TMEM79;SFN
prerank,establishment of skin barrier (GO:0061436),0.4223550772764172,0.9481296030220747,0.5206896551724138,0.873721213712679,1.0,6/15,24.27%,LSR;STMN1;FA2H;HRNR;TMEM79;SFN
prerank,mesenchymal cell development (GO:0014031),0.4131016508798933,0.9480893484434902,0.5295202952029521,0.8732011666519467,1.0,6/18,17.63%,CDH2;NOTCH1;SNAI2;SOX11;PDCD6;KBTBD8
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3633452394221098,-0.9477991401413868,0.5523809523809524,0.8806768927526444,1.0,2/18,3.76%,UGGT2;AMFR
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3696011821409172,0.9474727903303967,0.5135135135135135,0.8739575359437821,1.0,2/28,1.41%,ESAM;CXCL12
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.31506569135668866,0.9469015723729628,0.5542691751085383,0.8746530190861531,1.0,21/88,17.96%,DAB2IP;NANOS3;YBX1;NANOS2;ENC1;MRPL13;NANOS1;PLAT;RPL13A;CNOT9;GRB7;BTG2;PAIP2;CLN8;RNF139;EDN1;CSTB;RGP1;BAG6;TRIM71;NELL1
prerank,plasma membrane repair (GO:0001778),-0.4006473378440485,-0.9466729669001291,0.5368663594470046,0.8825538966008073,1.0,3/13,5.39%,MYOF;AHNAK2;ANXA6
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.22479521819503356,-0.9461073678033833,0.6583333333333333,0.8830357444272611,1.0,72/327,16.52%,BNC2;NFIA;DENND4A;ZFHX3;EFEMP1;SSBP2;ARNT2;PPARGC1B;TULP3;PRRX2;NR1D2;FOXC1;TGFBR1;SUFU;PPARGC1A;ZNF423;RORA;KAT6B;MED23;CTR9;SIX1;NFXL1;IGF2;CRABP2;POLR2A;FZD7;ZFAT;ATF5;GPBP1L1;PFDN5;CHD3;VSX1;MITF;ACTR8;RBAK;PML;SOX6;REXO4;GCFC2;CEBPB;ZBTB38;NSD2;PRMT5;RNF20;NFX1;TGFBRAP1;ABL1;ESR1;SBNO1;BMP2;ZNF219;DVL2;SP3;ZBTB4;MAFB;ACVR1B;GZF1;ATF2;SPTY2D1;EP300;NONO;PHF12;MYBL2;LIMD1;NFIL3;CCAR1;LDB1;APBB3;ZSCAN21;PSPC1;ZFP37;NFATC2
prerank,regulation of protein kinase A signaling (GO:0010738),-0.3571595204640636,-0.9460430113090507,0.5265588914549654,0.8821986729971035,1.0,6/20,14.29%,ADGRV1;AKAP12;AKAP7;PJA2;LRRK2;TCIM
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3679416775678187,0.9455351816389259,0.5413907284768212,0.8771103389077886,1.0,5/34,8.59%,PDGFB;INSR;RGCC;TGFA;LRP5
prerank,peptide cross-linking (GO:0018149),0.3912520270850974,0.9454684504160211,0.5428571428571428,0.8766547560711611,1.0,3/25,8.30%,NDNF;TGM2;ABCA7
prerank,response to tumor necrosis factor (GO:0034612),0.3096847227831415,0.9454199199248803,0.552054794520548,0.8761337750908387,1.0,10/91,6.41%,DAB2IP;MAP4K3;GCH1;TNFRSF11A;ARHGEF2;CD40;IKBKB;TNFRSF21;HYAL2;ADAM10
prerank,genitalia development (GO:0048806),0.4483981006026525,0.9449890248079785,0.53125,0.8764923822301129,1.0,4/12,16.48%,TBX3;STRA6;DNAJC19;FOXF2
prerank,regulation of cellular component size (GO:0032535),0.3778979734016034,0.944700667076186,0.5463258785942492,0.8765355265420727,1.0,9/30,15.55%,RIN3;EPS8;AP2M1;MSN;RAB3B;LAMTOR5;RAC1;RPTOR;LAMTOR4
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.36283949909789176,-0.9446338502982632,0.548235294117647,0.8848116071692311,1.0,1/16,1.30%,APPL2
prerank,negative regulation of hemostasis (GO:1900047),-0.4009325089426277,-0.9446212373631924,0.5398230088495575,0.8838395943632293,1.0,4/12,8.01%,TFPI;VTN;THBD;APOE
prerank,Wnt signaling pathway (GO:0016055),0.30991867608146084,0.9442505188916134,0.5501355013550135,0.8769263050469512,1.0,7/92,5.83%,LEF1;FZD6;FZD4;WNT7A;SNX3;CTNNB1;TCF7
prerank,immunoglobulin mediated immune response (GO:0016064),0.4688482851369746,0.9442077348788219,0.5186500888099467,0.876421990404829,1.0,2/10,11.01%,CD19;TLR8
prerank,cholesterol homeostasis (GO:0042632),0.32654498613764277,0.9441993277898076,0.539454806312769,0.875832970639069,1.0,10/64,11.60%,CAV1;SCARB1;HDAC9;ABCG1;ABCB11;NR1H2;LRP5;NPC1;LIPC;MTTP
prerank,substantia nigra development (GO:0021762),0.35555074245969115,0.9438692919305703,0.5270700636942676,0.875962495244555,1.0,16/37,24.35%,ACTB;CALM1;INA;DYNLL1;YWHAH;YWHAQ;MAOB;SYPL2;GNB4;MBP;ATP5PF;BASP1;SUDS3;RAD1;PADI2;TTBK1
prerank,mitochondrial membrane organization (GO:0007006),0.37650224339289984,0.9436756016040919,0.5351882160392799,0.8758164119105935,1.0,11/32,24.74%,BCL2L1;SLC25A5;GHITM;SAMM50;HSPA9;CHCHD3;BAK1;BNIP3;TMEM11;MTX1;PMAIP1
prerank,mitochondrial translational elongation (GO:0070125),0.31080107480734054,0.9436369333166843,0.5511921458625526,0.8752905053405888,1.0,35/88,26.76%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;GFM1;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2;MRPS18C
prerank,microtubule-based transport (GO:0099111),-0.4204358247718956,-0.9433815347582598,0.5279642058165548,0.8861397809407846,1.0,9/12,33.83%,DYNC1I1;ROPN1L;HTT;ADCY10;SPAG17;SPA17;DYNC1I2;CCDC40;DNAAF4
prerank,regulation of intracellular transport (GO:0032386),-0.305625120773405,-0.9433782645710274,0.5459610027855153,0.8851473425295506,1.0,9/38,16.16%,ATP9A;GAS1;GRIPAP1;LRRK2;SCFD1;NEFH;MAP2;RAB11B;CRYAB
prerank,cellular response to unfolded protein (GO:0034620),0.3768143468110178,0.9429267845730268,0.5629984051036683,0.8762355090963987,1.0,3/26,10.71%,DAB2IP;RHBDD1;HSPA8
prerank,protein localization to centrosome (GO:0071539),-0.3699323480962145,-0.9429077304985028,0.5408653846153846,0.885367575196755,1.0,11/17,29.48%,GOLGB1;CCDC14;PIBF1;PCM1;SNX10;STIL;BBS4;CEP131;C2CD3;CEP192;NEDD1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.46361009302309153,0.9427959407437593,0.5416666666666666,0.8758921155701702,1.0,2/10,1.75%,ENG;CAV1
prerank,regulation of sensory perception of pain (GO:0051930),-0.41211449371880193,-0.9427305602827909,0.5395033860045146,0.8848285985185262,1.0,2/11,8.15%,TMEM100;CCN3
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4558685125504284,0.9423952992772627,0.5415094339622641,0.8761856760134797,1.0,1/11,1.17%,ITPKB
prerank,indolalkylamine catabolic process (GO:0046218),-0.43593675347807637,-0.9423199653980306,0.5808510638297872,0.8849500839742944,1.0,5/10,30.36%,KYAT1;KMO;KYNU;IL4I1;HAAO
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3578708611880501,0.9421088556044328,0.526984126984127,0.8761897219662127,1.0,20/39,31.33%,RPSA;SNU13;RPS7;RPS27;PWP2;RIOK1;RPS15;RPS28;RPS25;SURF6;RIOK3;ERAL1;RPS19;UTP4;RPS6;LSM6;RPS14;RPS24;WDR3;RPS16
prerank,striated muscle tissue development (GO:0014706),0.3663429688571286,0.9415632805734407,0.5242718446601942,0.876813354963867,1.0,4/29,2.75%,BMPR2;PGM5;CAV1;MEF2C
prerank,negative regulation of cell cycle (GO:0045786),-0.2731508978808039,-0.941454274437479,0.5789473684210527,0.8861669547146093,1.0,8/73,3.79%,NR2F2;SMAD3;BMP7;BMP4;NUPR1;PTPN3;GAS1;FOXC1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4213334567975228,-0.9413594863322735,0.5621181262729125,0.8854277013122475,1.0,3/11,8.15%,NBL1;SLIT2;CCN3
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3773658390453196,0.9406395703378874,0.5162337662337663,0.8782438293447778,1.0,5/28,10.45%,DAB2IP;SORT1;CRADD;DEDD2;CASP8
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3804262113709894,0.940600469719075,0.5427631578947368,0.8777306032285155,1.0,3/27,8.88%,TIRAP;MAP3K1;IRAK2
prerank,regulation of lipid kinase activity (GO:0043550),0.4462343330913572,0.9400222576906433,0.5419847328244275,0.8784526298437912,1.0,3/11,15.45%,PIK3R3;PPP2R5A;RBL1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3658347012595378,0.9399366276494268,0.5465116279069767,0.8780420211699146,1.0,13/32,25.97%,ARHGEF2;FGF13;STMN1;ATXN7;CDH5;APC;CAMSAP2;DYRK1A;CLASP1;SNCA;CAMSAP1;NAV3;CLASP2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.40989640796084464,-0.9399198296613441,0.5536105032822757,0.8880569285689476,1.0,4/12,16.49%,GLI2;EPHB2;NFIB;TSKU
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.37093294525631515,0.9388766207493966,0.5568561872909699,0.8797882565947195,1.0,8/28,13.13%,EGFL7;GATA2;DLL4;FBXW7;RITA1;DLK2;ZBTB7A;ARRDC1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.37424804540729173,0.9388617205564392,0.5338983050847458,0.8792115946038387,1.0,10/29,25.85%,PLA2G4B;NR1H2;LPCAT3;PNPLA8;MBOAT7;LPCAT2;MBOAT2;LPCAT4;TMEM86B;LPCAT1
prerank,positive regulation of sodium ion transport (GO:0010765),0.4409840543622989,0.9388485719977803,0.5383177570093458,0.878632951226219,1.0,1/12,2.01%,CNKSR3
prerank,positive regulation of macrophage migration (GO:1905523),-0.3569852955326949,-0.9383189789259426,0.545662100456621,0.8910883559457298,1.0,6/19,17.10%,IL34;THBS1;P2RX4;CMKLR1;RARRES2;MDK
prerank,regulation of protein ubiquitination (GO:0031396),0.29860905314232095,0.9381519977096621,0.5566166439290586,0.8795914455859463,1.0,28/108,19.64%,IVNS1ABP;CAV1;SMAD7;HSP90AB1;XIAP;FAM107A;FBXW7;N4BP1;BIRC3;MALT1;NDFIP2;UBXN1;UBQLN1;GSK3A;DCUN1D1;TNFAIP3;BCL10;DNAJA1;INAVA;BAG2;SIRT7;FOXF2;PTTG1IP;PRKCG;UBE2D1;FKBP1A;NSMCE3;PRR7
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3911373351267621,-0.9375034592051319,0.5468409586056645,0.8921353231534107,1.0,3/13,10.04%,RNF152;ATM;STK11
prerank,regulation of mast cell activation (GO:0033003),0.4538052529355193,0.9373916061595484,0.5245901639344263,0.8806800870529096,1.0,3/10,16.98%,LYN;MILR1;CRLF2
prerank,cation transport (GO:0006812),0.28727320589982613,0.9371420560206007,0.5826086956521739,0.8806748078170459,1.0,19/166,10.86%,SLC6A6;SLC7A1;SLC1A1;SLC38A5;NEDD4L;FGF13;PIEZO1;MCOLN1;ATP1A4;KCNK6;KCNG2;CHRNB1;SCN1A;KCNN2;SLC3A2;NDFIP2;KCNV1;LRP2;KCNA4
prerank,microglial cell activation (GO:0001774),0.4033858797149671,0.9362704900068997,0.5493934142114385,0.8820679997292057,1.0,8/21,30.78%,APP;AGER;IFNGR1;SNCA;ITGB2;CX3CR1;CLU;AIF1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.34445686887950394,-0.9356993877701061,0.5699745547073791,0.8957177485928927,1.0,6/24,12.29%,PID1;RHOQ;DAB2;ITGB1BP1;LZTFL1;DMTN
prerank,cellular response to superoxide (GO:0071451),0.45924707116270946,0.9350313433547587,0.5599250936329588,0.8843092570709176,1.0,1/10,1.35%,NOS3
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4265926286396369,-0.9347223606998126,0.5541125541125541,0.8971815129970329,1.0,3/10,11.81%,APPL2;ANO6;CD300A
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.4049605115342708,-0.9346201331907423,0.5550755939524838,0.8964392927352308,1.0,11/12,53.58%,CDC45;MCM3;MCM4;MCM5;CDC7;MUS81;MCMDC2;MCM2;MCM7;GINS4;GINS2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.38822607272885823,0.9346115795408367,0.5588752196836555,0.8846478921049226,1.0,8/23,19.18%,FOXL2;CECR2;DFFB;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3391928701344319,0.9346060483959614,0.5440494590417311,0.8840593402222746,1.0,10/43,12.42%,DAB2IP;ITGA1;PTPRJ;DUSP3;GRB2;TGFA;ARHGEF7;SOCS5;EPS15;HGS
prerank,positive regulation of cyclase activity (GO:0031281),-0.38163999405517335,-0.9342186227916073,0.5698198198198198,0.8964983230131978,1.0,5/14,14.21%,CACNA1C;STIM1;CACNA1D;NF1;MAPK14
prerank,negative regulation of cellular catabolic process (GO:0031330),0.32707669635869535,0.9341436862122023,0.5688073394495413,0.8845382519772961,1.0,4/63,2.62%,MFSD2A;DAB2IP;RASIP1;TBC1D14
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.34654488793367605,-0.9338512097112699,0.5564102564102564,0.8964838156704519,1.0,9/21,28.92%,MITF;MED14;TWIST1;MED30;BCLAF1;MED4;MED24;MED16;DHX36
prerank,positive regulation of gene expression (GO:0010628),0.26787148915137116,0.9330890896349112,0.6544671689989235,0.8863475541323154,1.0,31/442,6.45%,LEF1;TFRC;ETS1;OCLN;TENT4A;RBM20;CLDN5;PDGFB;CADM1;CD34;NOS3;PDE2A;APP;RGCC;MEF2C;NIBAN1;PIK3R3;NOTCH1;RAMP2;ACTB;GATA2;TCF23;FGF16;RAMP3;DLL4;TLR3;TAF1B;MAPK3;CCDC88B;LGALS9;KLF4
prerank,activation of protein kinase B activity (GO:0032148),0.3677019700175719,0.9330489075268178,0.5582922824302134,0.8858312997972335,1.0,5/29,6.32%,PDGFB;INSR;CCDC88A;PPIA;ADRA2B
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3187919624451822,0.9326273011330027,0.5604075691411936,0.8861732503168576,1.0,28/72,25.38%,IFNAR2;SIGIRR;IKBKB;PALM3;HSP90AB1;STAT1;BIRC3;IRAK2;LIFR;SHARPIN;CASP8;CBFB;USP18;SYK;CYLD;TNFAIP3;GAS6;SUMO1;SPPL2A;RBCK1;IFNGR1;RACK1;SOCS1;ABCE1;RIPK1;IFNGR2;TRAF1;TRADD
prerank,actin nucleation (GO:0045010),0.39986763264387726,0.9325096089996311,0.552901023890785,0.8858488534149593,1.0,8/21,26.07%,ARPC4;JMY;ARPC3;ACTR2;ARPC1B;ARPC2;ARPC5;WHAMM
prerank,sphingolipid catabolic process (GO:0030149),0.41973493882476753,0.9322292379373479,0.5553539019963702,0.8858813041555463,1.0,3/15,8.63%,ACER2;ACER1;ENPP2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.31189441424621767,0.93208568167439,0.5848275862068966,0.8855973481593264,1.0,20/87,12.34%,CLDN5;ENG;TGFB2;F11R;ID1;PTK2;ACVRL1;PARD3;PXN;SMAD7;NRROS;JUN;TGFB1;SMURF1;SMAD5;SMAD1;FERMT2;EID2;GDF15;TGFBR2
prerank,presynaptic endocytosis (GO:0140238),0.3816485761810995,0.9320095582920347,0.5413907284768212,0.8851471307280324,1.0,7/24,15.89%,STX1A;PIP5K1C;FCHO2;OPHN1;AMPH;NLGN1;SYNJ1
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.36385947034966093,-0.931675681613568,0.5533980582524272,0.9009749376586952,1.0,2/18,2.04%,ROCK2;SLC2A13
prerank,protein methylation (GO:0006479),-0.3032579830963286,-0.9316436253248309,0.5505952380952381,0.9000623578948397,1.0,13/40,23.33%,PCMT1;EHMT2;EEF2KMT;PRMT5;RAB6A;PRMT8;METTL22;FAM98B;EZH2;TRMT112;GSPT1;NSD1;EEF1AKMT2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4289397514563071,0.9316268028347879,0.5495495495495496,0.885373252097513,1.0,1/14,0.99%,BCL2L1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3499508832350513,-0.9313987808827194,0.5552825552825553,0.89962790015783,1.0,9/22,19.83%,DMD;CACNB4;CACNB2;GNB5;FMR1;CACNB1;STAC3;AHNAK;CACNB3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.37436318604822477,0.9313238052418453,0.5591216216216216,0.8854559316875846,1.0,6/29,4.44%,RASGRP4;RAPGEF1;NOTCH1;LYN;TGM2;GRB2
prerank,positive regulation of phospholipid transport (GO:2001140),0.455639425522661,0.9310484021007803,0.5514705882352942,0.8854591094717092,1.0,4/10,17.31%,ABCA3;ABCA7;TMEM30A;TRIAP1
prerank,regulation of neuron apoptotic process (GO:0043523),-0.2538525012911029,-0.9309795614398625,0.6273764258555133,0.8997495947585715,1.0,20/96,11.14%,EPHA7;NUPR1;SLC30A10;SNX6;PRKCI;PPARGC1A;NGF;SIX1;NRBP2;EGLN3;NFATC4;BCL2;SOD2;PRKN;APOE;KDM2B;FOXO3;TGFB3;CLN3;PTK2B
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.40593051149092696,0.9309174304112818,0.5277280858676208,0.8851401504365688,1.0,5/17,6.71%,NOTCH4;PLXND1;NOTCH1;MAML2;STAT1
prerank,neuron projection morphogenesis (GO:0048812),0.2903205671531248,0.9307900010579035,0.6007957559681698,0.8848339249060667,1.0,23/137,9.61%,SHANK3;SRGAP2;DAB2IP;APP;KLF7;PARD3;NTNG2;DSCAML1;ACTB;WNT7A;CTNNB1;BAIAP2;DIP2A;DBNL;NCKAP1;SLITRK3;DNM2;SLITRK1;GPM6A;IQGAP1;PAK1;SLC9A6;EIF2AK4
prerank,regulation of leukocyte migration (GO:0002685),-0.37216036663452146,-0.9306256749832241,0.5511111111111111,0.8996640085581972,1.0,4/16,19.98%,HOXA7;ANXA1;CD81;RHOH
prerank,female gonad development (GO:0008585),-0.3561727903685298,-0.9303305443007267,0.5619047619047619,0.8994240704134094,1.0,5/19,17.72%,NR2F2;KIT;CEBPB;INHBB;INHA
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.31832674536681616,0.9297353980758317,0.5714285714285714,0.8865252328617392,1.0,6/77,6.64%,ITGA6;BCL2L1;SH3RF1;PLAUR;SLC25A5;MCL1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4085135959498547,-0.9294692707961115,0.5673289183222958,0.9006142221565338,1.0,3/12,10.59%,CACNA1C;DLG1;TRPM4
prerank,positive regulation of myelination (GO:0031643),0.45241193505463895,0.9294525191652945,0.5503731343283582,0.8865611254287902,1.0,4/11,19.18%,PARD3;CST7;TPPP;DICER1
prerank,regulation of muscle cell differentiation (GO:0051147),0.3657939200524377,0.9294326965947021,0.5483870967741935,0.8860035526484336,1.0,6/31,7.40%,MEF2C;CDH2;HDAC9;CTNNB1;TCF23;SPAG9
prerank,regulation of exit from mitosis (GO:0007096),0.35497118450584103,0.9294199470159998,0.5637795275590551,0.8854392333969537,1.0,15/38,23.33%,RGCC;PPP1R9B;CDC14A;NPM2;BUB3;ANLN;ANAPC16;ANAPC7;ANAPC10;UBE2D1;ZW10;ANAPC2;CDC23;CDC26;CDC27
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3638860724566547,0.9289182887465175,0.5664556962025317,0.8859389802315714,1.0,3/33,3.70%,SLC39A8;DDAH1;GCLM
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3447272568083416,-0.9287989239422441,0.5424164524421594,0.9012522682659835,1.0,8/23,18.36%,AXL;TLR4;NR1H4;RARA;DDIT3;INHA;LAPTM5;C1QBP
prerank,response to growth factor (GO:0070848),0.34550939704801165,0.9286564091728884,0.5307443365695793,0.8859220752106358,1.0,8/41,12.34%,PDGFB;BMPR2;ACVRL1;CTNNB1;KLF4;TWF2;LRP2;TGFBR2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3399112105402735,-0.9285480074429054,0.5541237113402062,0.9008985602327818,1.0,10/23,19.75%,ERRFI1;CBLB;SNX6;TSG101;ZFYVE28;SRCIN1;GPRC5A;MVP;PTPRC;THY1
prerank,regulation of monocyte differentiation (GO:0045655),0.4208630342674301,0.9283271005693889,0.5618181818181818,0.8860691340528194,1.0,3/14,5.26%,FES;CTNNBIP1;CD4
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.4256992610312457,0.9282437280546382,0.5383177570093458,0.8856640004973211,1.0,7/14,24.01%,PRKD2;BCL10;CARD11;TESPA1;KCNN4;TRAT1;NECTIN2
prerank,regulation of response to interferon-gamma (GO:0060330),0.4221451785093971,0.9281701844358338,0.5343228200371057,0.885223406094195,1.0,7/14,24.59%,HSP90AB1;STAT1;SUMO1;IFNGR1;PARP9;SOCS1;IFNGR2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.41639312319844735,0.9278833831587605,0.5543672014260249,0.885240292022809,1.0,1/15,1.82%,REEP1
prerank,negative regulation of bone mineralization (GO:0030502),-0.38266044650739933,-0.9278176777631668,0.5584415584415584,0.9017559214765126,1.0,5/13,11.14%,ENPP1;BCOR;ECM1;TRPM4;PTK2B
prerank,cellular response to chemokine (GO:1990869),0.33901196115777216,0.927757448019603,0.5703125,0.8849382938234369,1.0,2/46,1.41%,LRCH1;CXCL12
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.2338265570634547,-0.9277187839621327,0.6831683168316832,0.9009738384438996,1.0,36/166,17.91%,NOTCH2;RARB;CCN2;TEAD1;NR6A1;THRB;NOTCH3;NR1D2;PPARGC1A;RBPJ;RORA;TBL1XR1;AR;PPARA;MED23;TEAD3;POLR2A;NR3C2;YAP1;CCNH;NR2F1;RXRA;TAF8;CDK7;ESR1;PGR;SMARCA5;TAF1D;NR4A1;E2F3;GTF2F1;NR1H4;POLR1C;RARA;TAF9B;NRBP1
prerank,ganglion development (GO:0061548),0.45513965597315614,0.9261370498547069,0.5756457564575646,0.8878435173001721,1.0,4/11,19.12%,CTNNB1;INSM1;NRP2;NRP1
prerank,negative regulation of coagulation (GO:0050819),-0.3827649961227676,-0.9261310297244579,0.5859728506787331,0.9040509512455265,1.0,4/14,8.01%,TFPI;VTN;THBD;APOE
prerank,positive regulation of phosphatase activity (GO:0010922),0.3875088619744206,0.9256559211166845,0.5733788395904437,0.8883030673981461,1.0,4/21,5.03%,ITGA1;MEF2C;CALM1;HSP90AB1
prerank,protein K63-linked deubiquitination (GO:0070536),0.36429843244096527,0.9256482460667399,0.5387045813586098,0.8877294760891871,1.0,10/31,19.24%,ATXN3;SHMT2;OTUD7A;BABAM1;CYLD;TNFAIP3;BRCC3;OTUD4;USP25;OTUD7B
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.32111809313673173,-0.9252172679955365,0.5696821515892421,0.9043294100367056,1.0,8/29,18.14%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,CENP-A containing chromatin organization (GO:0061641),-0.32111809313673173,-0.9252172679955365,0.5696821515892421,0.9043294100367056,1.0,8/29,18.14%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,central nervous system neuron differentiation (GO:0021953),0.36276028179718306,0.9251658486379549,0.5592417061611374,0.8881905175266133,1.0,10/33,19.34%,CTNNB1;MDGA2;GRID2;OPHN1;SPOCK1;TOX;LHX1;PROX1;SIN3A;DRAXIN
prerank,fatty acid transmembrane transport (GO:1902001),0.4028402255986592,0.9250306117951438,0.5655172413793104,0.8879024321500412,1.0,4/19,6.80%,SLC2A1;ABCD4;CPT1A;ACACB
prerank,respiratory chain complex IV assembly (GO:0008535),0.3919927264961548,0.9249498670711588,0.5689948892674617,0.8874883739763555,1.0,14/21,31.34%,SCO2;SCO1;COA6;COA3;SMIM20;COX10;COX20;COX17;COX15;PET100;TIMM21;COA5;BCS1L;COA8
prerank,regulation of hormone secretion (GO:0046883),-0.37495768778079824,-0.9244106673076277,0.5772727272727273,0.9053367024573296,1.0,7/15,33.59%,SNX6;ANXA1;VAMP2;VAMP3;SCG5;IL11;LIF
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.4162178288968835,0.924309284435826,0.5478723404255319,0.8882538698677038,1.0,5/15,18.10%,CCT3;CCT5;NHP2;CCT7;NAF1
prerank,meiosis I (GO:0007127),-0.3384542485283736,-0.9242397520383958,0.5402843601895735,0.9047304322037395,1.0,10/23,30.21%,FOXJ2;FOXJ3;ZSCAN21;HSF2BP;MYBL1;ZCWPW1;SGO1;TDRD9;DDX4;MEIOB
prerank,renal absorption (GO:0070293),-0.41283347466140724,-0.9240297271119611,0.5648351648351648,0.9042846210575555,1.0,2/10,3.67%,GSN;WNK4
prerank,chromatin organization (GO:0006325),0.29363039016846193,0.9239982258312534,0.5972972972972973,0.8883766020322814,1.0,24/132,16.58%,MECOM;SMARCA2;NPM3;BAZ2B;NPM2;PWWP3A;FOXP3;ARID1A;CHD1;HCFC2;PAK1;KDM4A;MYSM1;ZBTB7A;TADA2B;SMARCD1;SETDB1;SOX9;HMGB2;HDAC5;LOXL2;SMARCAD1;HCFC1;HMGA2
prerank,regulation of gene silencing by RNA (GO:0060966),-0.2841576020709692,-0.9239526451700253,0.6174698795180723,0.9024925744735232,1.0,17/50,29.32%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;EIF4G1;RAE1;POLR2L;NUP155;POLR2I;NUP35;NDC1;IPO8;TPR;POLR2K;NUP43
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.2841576020709692,-0.9239526451700253,0.6174698795180723,0.9024925744735232,1.0,17/50,29.32%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;EIF4G1;RAE1;POLR2L;NUP155;POLR2I;NUP35;NDC1;IPO8;TPR;POLR2K;NUP43
prerank,negative regulation of autophagy (GO:0010507),-0.28171498352590474,-0.9235520293077174,0.5778443113772455,0.9024814851360545,1.0,18/54,20.40%,LEPR;NUPR1;KLHL22;NRBP2;SNRNP70;DAPL1;BCL2;GOLGA2;MET;PTPN22;LRRK2;SIRT2;RRAGA;SMG1;CTSA;SMCR8;EIF4G1;TSC1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4135639624407811,0.9232999864445536,0.544256120527307,0.8893205387240395,1.0,7/14,20.67%,CHKA;SELENOI;CEPT1;LPIN3;ETNPPL;ETNK1;PISD
prerank,regulation of fat cell differentiation (GO:0045598),0.313690442168806,0.9232258333653038,0.6048850574712644,0.888900574015859,1.0,16/74,12.84%,PPARD;FOXO1;ZFPM1;CCDC85B;ZBTB16;GATA2;NOCT;CREB1;WWTR1;TGFB1;LRP5;TRIB2;FERMT2;PTPRQ;ZFP36L1;PPARG
prerank,regulation of receptor binding (GO:1900120),0.45592996639863526,0.9230701683498549,0.5454545454545454,0.8886508804744829,1.0,2/10,3.05%,B2M;ADAM15
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.30025509832553865,-0.9228657609877953,0.5897435897435898,0.9032133605181825,1.0,9/38,21.33%,BMP6;PRKCA;CYBA;SLC15A4;POLR3G;GRN;PLSCR1;ADAM8;USP15
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.32955148939599205,-0.9227846127151021,0.5777777777777777,0.9024283676930815,1.0,2/25,1.47%,ANK2;CEMIP
prerank,response to ATP (GO:0033198),-0.3626885102307125,-0.9227355179934662,0.565121412803532,0.9015938101229403,1.0,4/18,12.78%,TRPC3;ABCC9;P2RX4;HSP90B1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.27243613662027255,-0.9225109400131081,0.6253968253968254,0.9011761409634375,1.0,10/66,6.43%,EGFR;APPL2;KANK2;FHL1;UBE2E2;PKD1;PKD2;DLG1;ANXA1;DACT1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4134012900221294,-0.9224116366282915,0.5868131868131868,0.9004737256018815,1.0,2/10,2.82%,LRP1;APOD
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3697240133106442,0.922378752167239,0.5633116883116883,0.8895665031026532,1.0,9/29,19.02%,CD40;IKBKB;TLR3;BIRC3;CASP8;UBE2D3;TBK1;UBE2D1;TRAF3
prerank,regulation of intracellular pH (GO:0051453),-0.3170853561506852,-0.9218389722802963,0.5739348370927319,0.900952537118979,1.0,8/34,11.11%,SLC4A10;SLC9A2;SLC4A7;SLC4A2;SLC9A9;SLC9A1;CLN3;LRRK2
prerank,cell projection assembly (GO:0030031),0.38307828713761594,0.921822682267879,0.5385934819897084,0.8902562715718397,1.0,8/22,14.70%,PARVB;PARVG;NCKAP1;CAPG;CYFIP1;RAC1;RHOV;NCKAP1L
prerank,positive regulation of cilium assembly (GO:0045724),0.4071258305729023,0.9212722121675765,0.563573883161512,0.8908994194008301,1.0,6/18,17.99%,ZMYND10;CCDC88A;CCP110;MARK4;CEP135;KCTD17
prerank,regulation of hippo signaling (GO:0035330),0.3899441218607593,0.9212481206610741,0.5555555555555556,0.8903615864347074,1.0,6/17,16.95%,MOB3B;MARK3;SCHIP1;SOX11;WWC1;WWC2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2855477751859286,0.9209875941946367,0.6221374045801527,0.8903648039502783,1.0,34/161,14.80%,DAB2IP;FZD6;CAV1;ANKRD6;MCC;SOX17;NKD1;FZD4;SOX13;ZNRF3;CTNND1;NOTUM;WWTR1;SNAI2;PSMB3;TLE4;PSMD11;TMEM88;PSMC6;GREM1;PSME2;AMER2;AXIN2;PSMD8;GSK3A;SHISA6;TLE1;CYLD;STK3;SOX9;PSMB10;RBX1;TPBG;TMEM131L
prerank,protein autoprocessing (GO:0016540),-0.36835380611037416,-0.920904904066684,0.5562770562770563,0.9022907316047717,1.0,5/17,17.71%,CTSL;FXN;AFG3L2;HTRA2;CASP4
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.25680001534215396,-0.9206990697041302,0.6386861313868614,0.9018326823221662,1.0,29/107,19.12%,ITPR1;CREB3L2;THBS1;MAP3K5;ATG10;TMEM117;RCN3;BCL2;TMEM259;PRKN;SELENOS;CREB3L1;CEBPB;GORASP2;HSP90B1;SCAMP5;SEC16A;SYVN1;PIK3R1;P4HB;DDRGK1;UFC1;RASGRF1;ATP2A3;DDIT3;CASP4;MBTPS1;USP19;ATP2A2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.43884005531447073,0.9206965988516022,0.5578583765112263,0.8904062516931824,1.0,2/12,5.09%,GCLM;MGST2
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4134599369162643,-0.9204217088762947,0.5490196078431373,0.9015061585136868,1.0,4/10,26.10%,DDIT3;QRICH1;CCL2;EIF2AK3
prerank,response to sterol (GO:0036314),-0.4023408930750211,-0.9198943548937708,0.5802469135802469,0.9018248897893862,1.0,2/11,4.86%,TGFBR1;RORA
prerank,cellular response to chemical stress (GO:0062197),-0.25373067979416797,-0.9195405894058891,0.622895622895623,0.9017055782620981,1.0,22/96,14.30%,PRKAA2;MGAT3;CPEB2;PPARGC1A;PKD2;STX2;SOD3;GPX8;SOD2;NOX4;SELENOS;ATM;SLC25A24;FOXO3;CYBA;PARP1;LRRK2;TMEM161A;ABL1;SIRT2;HTRA2;DDX3X
prerank,regulation of Golgi organization (GO:1903358),0.4100216184159451,0.9194369024523559,0.5769881556683587,0.8925344007408053,1.0,6/17,17.98%,USP6NL;MAPK3;AKAP9;PDCD10;MAPK1;CAMSAP2
prerank,cellular respiration (GO:0045333),-0.2952429277064035,-0.9188908182931734,0.5837988826815642,0.902374607335821,1.0,17/41,25.63%,PPARGC1A;SIRT3;SDHC;MDH2;SDHB;COQ10A;UQCRFS1;MTFR1;SLC25A14;NDUFS1;SURF1;MTFR2;COQ10B;UQCRC2;NR4A3;LYRM7;NDUFS8
prerank,B cell activation involved in immune response (GO:0002312),0.42597521561106555,0.9182281278236715,0.5561797752808989,0.8945800138814277,1.0,3/13,15.56%,CD19;RNF8;MSH2
prerank,peptidyl-serine modification (GO:0018209),0.28332768198465264,0.9178372769127686,0.6391752577319587,0.8948214326401372,1.0,33/166,18.02%,PRKCH;NDNF;PDGFB;STK38;PKN3;RPS6KA1;PRKD1;PRKD2;IKBKB;MAST4;PKN1;RPS6KA5;PKN2;MARK3;HPF1;STK32C;PRKCB;TGFBR2;HIPK2;NAA11;VRK1;SGK1;HIPK3;PLK2;SGK3;SGK2;MAPK1;GAS6;POGLUT1;PRKCG;PRKCE;TBK1;PAK2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.34338158846434685,-0.917814011269006,0.5691056910569106,0.9039858215775641,1.0,7/22,19.75%,BMP7;FLOT2;WNK1;MAP2K5;CD44;MYADM;THY1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3230315555587809,0.9177630742288158,0.5699404761904762,0.8943975400431325,1.0,1/59,0.03%,LEF1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.44420175844469323,0.9176751982034422,0.5431861804222649,0.8939929275687589,1.0,3/10,11.99%,ATP5MC2;ATP5PO;ATP5F1A
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3298453044426537,0.9173874067152218,0.5803981623277182,0.8940217928364947,1.0,6/50,6.48%,SH3RF1;PLAUR;RPS6KA1;XIAP;KLF4;RFFL
prerank,cellular response to misfolded protein (GO:0071218),-0.35692939459062123,-0.917218643595971,0.5531914893617021,0.9044778489436187,1.0,8/20,25.22%,UGGT2;CUL3;KLHL15;AUP1;DNAJC18;DNAJB14;DERL1;UFD1
prerank,"phototransduction, visible light (GO:0007603)",0.41958022559521424,0.9171862021327234,0.5711678832116789,0.8938656722807711,1.0,3/14,12.39%,GNAQ;RP1;GNB1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.419806246170307,0.9171667138499958,0.5658362989323843,0.8933120821317626,1.0,4/15,10.22%,GRB2;SORT1;SOS1;DDIT4
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3061298358915183,0.9169547937715928,0.6063218390804598,0.8931659704567179,1.0,13/78,12.53%,PDGFB;CCNY;RGCC;MEN1;ACTB;HHEX;CDKN2B;CCNI;CCND3;ADAM17;CDC6;CCNK;MAPRE3
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.30748121027863506,-0.9165411376637453,0.611731843575419,0.9051807580369291,1.0,10/37,13.67%,PRKAG2;CEMIP;BMP7;AXIN1;SPRED1;PPEF2;SPHK1;DMTN;S1PR2;SIRT2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.34377253491646736,-0.9163712719301886,0.5904761904761905,0.904627690221121,1.0,2/22,1.89%,BMP7;BMP4
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.4050444271122109,-0.9163250387935207,0.5783132530120482,0.9037706812314815,1.0,2/10,13.81%,CPEB1;PAF1
prerank,regulation of vasoconstriction (GO:0019229),0.36443769319657726,0.9158521208709455,0.5645161290322581,0.8949505013127149,1.0,4/27,6.35%,BMPR2;CAV1;OXTR;ATP2B1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.38314394677105695,0.9156744479329507,0.5606326889279437,0.8947349133224483,1.0,6/23,12.63%,ENG;LTBP4;SMAD7;TGFB1;EID2;SOX11
prerank,toll-like receptor signaling pathway (GO:0002224),0.30611317072413124,0.9152680761183053,0.5914285714285714,0.8950247120932464,1.0,24/84,20.16%,TIRAP;MAP3K1;IKBKB;TLR3;TRIL;LGALS9;CTSK;TLR7;BIRC3;IRAK2;PIK3C3;CASP8;TLR8;S100A8;BCL10;RFTN1;UBE2D3;CTSS;TNIP1;UBE2D1;TRAF3;NMI;PLCG2;RPS6KA3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.30526775017622065,0.9150829872633831,0.6042553191489362,0.8948326354544813,1.0,28/85,25.04%,RNF144B;DAB2IP;SMAD7;ATXN3;FBXW7;PSMC6;HECTD1;SOCS5;TRIB2;GSK3A;RBX1;BAG2;ELOB;RAD23A;SUMO1;BAG6;RNF19A;CBFA2T3;GABARAP;PSMC3;RACK1;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;OSBPL7;KEAP1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.26528500039281105,0.9150648282264918,0.681044267877412,0.8942898968809615,1.0,104/306,26.51%,B4GALT5;ALAS1;PTMA;SARS1;ZAR1L;RPL38;TAF1B;MRPL13;RPL13;RPS29;MRE11;FUT9;MRPL10;RPL36A;NKX2-8;RPL3;RNPS1;YARS2;RPL27;RPSA;RPS7;PWP1;RPL9;RPL18;RPLP2;GTPBP1;MCM10;DNA2;RPL13A;CDC6;RPS11;RECQL4;RPL8;RPS27;RPL19;RPS9;MRPL28;ORC1;RPL11;EEFSEC;RPS15;SRBD1;RPL37;RPS28;RPS10;POLE3;EEF1D;RPS25;RPL37A;MRPL9;COPS5;HUS1;RPL15;POLR2J;TNIP1;RPA1;SET;MRPL23;RPL17;RPL23;RPL34;FARSB;RPS18;RAD9B;POLL;POLD1;GRWD1;RPL21;POLA1;RPS4X;MRPS18A;RFC2;RPL18A;RAD1;DHPS;RPS21;RPL10A;GTPBP2;EEF1B2;ING4;RAD17;RPL24;RSL24D1;RPL7A;ING5;TOPBP1;MRPL41;MRPL27;MRPL51;TYMS;HARS1;RFC4;RPL32;RMI1;RPL4;UPF1;RPS2;MRPS33;BLM;MEF2A;MRPL37;RPS20;RPL6;RPS13
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3530270702321018,0.9150063878096918,0.5957792207792207,0.8938401912304406,1.0,7/34,11.43%,LIMS2;DOCK1;NEDD9;RREB1;ARHGEF7;FERMT2;RAC1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.38466863152802416,0.9150026871663929,0.5625,0.8932603193015182,1.0,8/22,14.25%,LYN;ABCG1;EPHA4;EFNA1;AGER;GSK3A;RANBP9;SP1
prerank,mammary gland epithelium development (GO:0061180),-0.3799396038235457,-0.9149809138413377,0.5444444444444444,0.9060644072512938,1.0,6/14,32.42%,WNT4;LATS1;ID2;WNT2;WNT3;IRF6
prerank,signal peptide processing (GO:0006465),-0.4064953707000391,-0.9147758291654138,0.5704697986577181,0.9055888123767994,1.0,3/11,17.16%,PCSK5;HM13;PARL
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.23177525711543703,-0.9147500279227953,0.7216494845360825,0.904696815760492,1.0,22/170,11.19%,PRDM6;IGF1;ROCK2;AFF3;AFF2;ZNF462;CDH1;SLC8A1;YBX3;AFF1;APOE;KDM6B;FUBP1;LDLR;NOVA1;MTMR3;CRIP1;ZNF507;STX1B;IGF2BP2;PRDM11;PTHLH
prerank,mitochondrion distribution (GO:0048311),-0.3951316699803622,-0.9145439768913795,0.5810185185185185,0.9042676976942036,1.0,2/12,11.11%,TRAK1;LRRK2
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.31135188792834373,-0.9145175163152359,0.5897435897435898,0.9033706390063163,1.0,7/33,11.96%,MAP3K5;IMPACT;PRKCD;ANXA1;CYP1B1;FXN;ABL1
prerank,signal release from synapse (GO:0099643),0.33378877283759745,0.9142650286237352,0.5746951219512195,0.8942412966401471,1.0,7/43,13.18%,STX1A;PIP5K1C;STXBP1;NRXN1;DNAJC5;HSPA8;CPLX1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.43777840846666727,0.9139881480199289,0.5865724381625441,0.8942425945581779,1.0,2/12,3.96%,TRIM16;KLF2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3118662890790431,0.9137337222416274,0.6111888111888112,0.8941902335990565,1.0,9/76,8.88%,DAB2IP;NFKBIA;CD200;NLRC5;TMSB4X;KLF4;AIM2;FOXP3;IRAK2
prerank,intestinal lipid absorption (GO:0098856),-0.3985739028065959,-0.9136597657665634,0.5736263736263736,0.904643729619712,1.0,7/11,49.31%,LDLR;CD36;SOAT2;AKR1C1;ABCG5;UGCG;NPC1L1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3479212242004456,-0.913644537982918,0.6024096385542169,0.9037126724514609,1.0,2/21,2.78%,SAMD4A;TUT4
prerank,regulation of actin filament-based process (GO:0032970),0.3091422012690978,0.9136336526365281,0.6128550074738416,0.8938281248213874,1.0,16/70,11.99%,RHOBTB1;HIP1R;F11R;CORO2B;RHOB;CCDC88A;BAIAP2;FAM107A;BST2;ARHGEF5;TWF2;IQGAP1;PAK1;ARHGAP17;RAC1;RND1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.44064972213965753,0.9131837804810863,0.5421245421245421,0.8936441526478781,1.0,1/11,1.39%,NOTCH4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.44064972213965753,0.9131837804810863,0.5421245421245421,0.8936441526478781,1.0,1/11,1.39%,NOTCH4
prerank,primary miRNA processing (GO:0031053),-0.42797520256983096,-0.9130823439592226,0.5995525727069351,0.9041627258799225,1.0,3/10,14.96%,SMAD3;PUS10;HNRNPA2B1
prerank,melanosome organization (GO:0032438),-0.327779528287616,-0.9130414775889787,0.5679012345679012,0.9032945984019474,1.0,16/26,38.32%,DTNBP1;AP3B1;RAB29;BLOC1S2;LYST;BLOC1S6;BLOC1S5;HPS4;HPS1;BLOC1S4;KIF13A;RAB38;PMEL;GPR143;AP1M1;RAB32
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.41854649556999374,0.9129665337929259,0.5863874345549738,0.8935077493176753,1.0,7/15,23.12%,HOMER2;HOMER1;GRM7;GRM8;GRM2;GRM3;GRIK3
prerank,nuclear membrane organization (GO:0071763),-0.356442562273318,-0.9129488809889743,0.6051401869158879,0.9025501095471581,1.0,7/19,23.94%,AKAP8L;TOR1AIP1;EMD;VPS4A;GPER1;UBXN2A;TMEM43
prerank,positive regulation of interferon-beta production (GO:0032728),0.34844483102082396,0.9119163295931897,0.5774877650897227,0.8951707660623602,1.0,14/33,27.40%,IFIH1;TLR3;IRF5;TLR7;TLR8;TBK1;POLR3F;FLOT1;RIOK3;POLR3B;ISG15;POLR3C;IRF7;TOMM70
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2738961187700421,-0.9117000281454625,0.6655948553054662,0.9046991622033871,1.0,20/59,25.33%,ROCK2;PRKCD;CAMK2D;TGFBR1;MAP3K12;PDPK1;PRKCA;LRRK2;WNK1;ACVR1B;DYRK2;CDC42BPG;SBK1;WNK3;CSNK2A1;CDK5;MAP2K1;CDK10;TNKS;CIT
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.42509694642646245,0.9116424442870534,0.5612052730696798,0.8951820092117255,1.0,1/13,0.30%,ABHD2
prerank,endochondral bone morphogenesis (GO:0060350),0.4464541561747545,0.9116393760146726,0.552734375,0.8946017456371261,1.0,2/11,2.75%,BMPR2;MEF2C
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.32850826507930037,-0.9114573328897597,0.6197916666666666,0.9043183428170128,1.0,5/26,6.49%,ERRFI1;CBLB;SNX6;SHC1;TSG101
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.2998441013254997,-0.9113494535694018,0.5988023952095808,0.9036197539374675,1.0,11/38,18.52%,PRKN;NPEPPS;RNF31;HUWE1;LRRK2;LMAN1;ATP5IF1;HTRA2;SREBF1;PARL;ABLIM3
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3467794470035216,0.9112350390849917,0.5746140651801029,0.8949210893634493,1.0,8/39,9.03%,ACER2;FZD4;CORO2B;ADAM15;NOTCH1;ACTN4;NEXMIF;SPOCK1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.36300803279382493,0.9108679848198686,0.5864297253634895,0.895153088303349,1.0,9/30,19.02%,CD40;IKBKB;TLR3;BIRC3;CASP8;UBE2D3;TBK1;UBE2D1;TRAF3
prerank,mitotic cytokinesis (GO:0000281),0.3328194960867095,0.9106547421984956,0.5862595419847328,0.8950392700640761,1.0,13/47,17.09%,SPTBN1;EFHC2;STMN1;RHOB;TRIM36;KIF23;MITD1;ANLN;APC;PDCD6IP;ANK3;SPAST;MYH10
prerank,mitochondrial translation (GO:0032543),0.2949499448421575,0.9106072979527654,0.5977496483825597,0.8945572898153991,1.0,45/104,28.70%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MTIF3;GFM1;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;GATC;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;IARS2;MRPL51;HARS1;MRPL49;MRPS33;MRPL37;MRPL2;NDUFA7;MRPS18C;QRSL1;MRPL15;LARS2;MRPS34;MRPS12
prerank,positive regulation of cell communication (GO:0010647),-0.32033785789119407,-0.9105046036430164,0.5989847715736041,0.9046517001193212,1.0,3/28,7.03%,WLS;CLSTN2;DLG4
prerank,positive regulation of viral transcription (GO:0050434),-0.335711321277687,-0.9100827713940706,0.6098191214470284,0.904727761670055,1.0,8/25,28.83%,MDFIC;POLR2A;NELFE;GTF2F1;POLR2L;CDK9;POLR2I;POLR2K
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.37372633261385646,-0.9100588182125536,0.577922077922078,0.9038282030717415,1.0,7/14,26.81%,IL18;ANXA1;RARA;CD80;PRKCZ;CCL19;CD86
prerank,proteasome assembly (GO:0043248),0.44453239259337535,0.9098522313608405,0.5667311411992263,0.8956369500502996,1.0,5/11,27.30%,POMP;PSMD11;PSMD9;PSMD10;ADRM1
prerank,neurotransmitter transport (GO:0006836),0.31176563777303784,0.9096237421104524,0.5884892086330935,0.8955256667081645,1.0,9/73,10.71%,SLC1A1;SLC6A2;UNC13B;STX1A;SLC1A2;STXBP1;NRXN1;DNAJC5;HSPA8
prerank,DNA conformation change (GO:0071103),-0.3685755685119651,-0.9093403159946625,0.5773672055427251,0.9046407044519698,1.0,4/17,11.96%,TOP2B;TOP1;HAT1;ABL1
prerank,antibacterial humoral response (GO:0019731),0.4081944512536238,0.9091437109693782,0.5860215053763441,0.8959711686186833,1.0,4/16,21.62%,DEFA6;SLPI;JCHAIN;RNASE6
prerank,negative regulation by host of viral transcription (GO:0043922),0.4268966083755104,0.9090708394939175,0.5792349726775956,0.8955305057020853,1.0,5/12,21.70%,JUN;HMGA2;TFAP4;INPP5K;PSMC3
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.29628142419453674,-0.9089546654278449,0.6335078534031413,0.9046576995749791,1.0,8/39,13.21%,ANK2;FHL1;PTPN3;CACNA1D;TRPC6;WWP2;GPD1L;FXYD1
prerank,snRNA metabolic process (GO:0016073),-0.3554266991932893,-0.9088549387627886,0.5868544600938967,0.9039476896668492,1.0,5/17,17.37%,INTS8;INTS2;INTS4;TUT1;INTS10
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3339100590166519,0.9086068766876799,0.5996932515337423,0.8959675602446986,1.0,4/42,8.17%,IL6R;DEFA6;NOS2;IRGM
prerank,negative regulation of immune system process (GO:0002683),-0.36462650821474113,-0.9084911516953398,0.5682819383259912,0.9038541276600259,1.0,3/16,7.33%,COL3A1;HOXA7;IL17D
prerank,cilium organization (GO:0044782),-0.22773371510189164,-0.9081663701886161,0.7151162790697675,0.9036753547667218,1.0,41/209,14.69%,PARVA;GSN;CYS1;CC2D2A;DCDC2;PKD1;WDR35;IFT80;GBF1;DYNC2I1;IFT81;WDPCP;ARL3;PKD2;CDC14B;DZIP1;DZIP1L;IFT74;CCDC57;TTC39C;FLNA;PTPDC1;DYNC2H1;CFAP44;TTC8;IFT122;CEP164;FUZ;ARMC9;EHD1;BBS9;LZTFL1;TRAPPC14;CLUAP1;MKKS;PIBF1;PCM1;RILPL2;WDR19;AHI1;DYNC2I2
prerank,regulation of inclusion body assembly (GO:0090083),-0.40323196928135774,-0.9081483641694466,0.5911016949152542,0.9027856336109629,1.0,1/11,0.93%,SNCAIP
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3764826097196658,0.9080813734748304,0.58,0.8965167328453552,1.0,9/24,21.66%,TERF2;HNRNPC;ACD;DCP2;TERF1;EXOSC10;XRN1;ERCC4;PINX1
prerank,GTP metabolic process (GO:0046039),0.40882155610373266,0.9079877968901318,0.5771230502599654,0.8961243667810915,1.0,3/15,9.07%,IMPDH1;AK4;GTPBP1
prerank,superoxide metabolic process (GO:0006801),0.36340171121890874,0.9075216151458495,0.5879478827361564,0.896526820146716,1.0,7/29,12.57%,NOS3;NOS2;NRROS;PREX1;CYBB;NCF4;NOX3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3510919253538186,-0.9073837535095935,0.5915492957746479,0.9037235089716588,1.0,4/19,6.81%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.32216942288640216,-0.9073418421145104,0.581453634085213,0.9028797052062216,1.0,6/27,11.15%,PER3;FBXL17;PER2;USP2;PML;CRY2
prerank,regulation of axon guidance (GO:1902667),-0.4035041592147587,-0.9071988704085064,0.6040268456375839,0.9022589990880394,1.0,3/10,16.70%,ZSWIM8;YTHDF1;TUBB2B
prerank,GPI anchor biosynthetic process (GO:0006506),0.3608378432473565,0.9071661605003168,0.5739837398373984,0.8967090528330279,1.0,10/30,21.77%,PIGU;PIGM;PGAP4;PIGK;PIGF;DPM3;PIGS;PIGO;PIGV;PIGQ
prerank,regulation of glycogen metabolic process (GO:0070873),-0.3864878137022911,-0.9070256929204354,0.5838926174496645,0.9017767546043108,1.0,3/12,19.11%,PPP1R3B;PPP1R3C;PPP1R3F
prerank,negative regulation of cation channel activity (GO:2001258),-0.3208998686248631,-0.9066869233913311,0.5944584382871536,0.9017239712696219,1.0,7/26,15.68%,SLC6A9;PKD2;EPHB2;GNB5;FMR1;GSTM2;KCNAB1
prerank,ERBB2 signaling pathway (GO:0038128),0.3517101707792707,0.9062127637933471,0.6058631921824105,0.8981750749539018,1.0,7/31,10.31%,PTPN12;GRB2;GAB1;SOS1;PTPRR;PTK6;GRB7
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.36943378433229607,0.9061533942208543,0.5817555938037866,0.8977101656345803,1.0,4/24,6.64%,TGFB2;CTNNB1;FBXW7;MCL1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3273243416540147,0.9059129158365717,0.6255707762557078,0.8976485132465043,1.0,14/56,17.09%,SPTBN1;EFHC2;STMN1;RHOB;CECR2;TRIM36;KIF23;MITD1;ANLN;APC;PDCD6IP;ANK3;SPAST;MYH10
prerank,mitochondrial translational termination (GO:0070126),0.29676301239201364,0.9053478714905056,0.620979020979021,0.898258689726699,1.0,34/88,26.76%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2;MRPS18C
prerank,UV protection (GO:0009650),-0.4107369919893366,-0.9050931221948973,0.5781584582441114,0.9045212969596989,1.0,2/10,11.27%,SCARA3;MFAP4
prerank,chemical homeostasis (GO:0048878),-0.27229213651795275,-0.9050769082716077,0.6213592233009708,0.903618802530571,1.0,14/61,15.37%,ZBTB20;SLC4A10;RBP1;NR1D2;WNK4;THADA;IRS2;SLC4A7;SLC4A2;TLCD2;WNK1;DDX3X;PNPLA3;SLC4A3
prerank,negative regulation of chemokine production (GO:0032682),0.42110984261890544,0.9050196471642616,0.5959409594095941,0.8983935959736555,1.0,3/14,6.45%,SIGIRR;LGALS9;KLF4
prerank,regulation of nervous system process (GO:0031644),0.39544215679138617,0.9049950938226794,0.5905096660808435,0.8978607009349525,1.0,2/18,1.57%,NOS3;APP
prerank,atrial septum development (GO:0003283),0.4120322848728483,0.9047557281200759,0.5785714285714286,0.8977971575962884,1.0,3/13,3.19%,BMPR2;TGFB2;ZFPM1
prerank,actin filament bundle organization (GO:0061572),0.34836993330260124,0.9046166542301562,0.5912897822445561,0.8975242329860393,1.0,7/33,6.17%,SHROOM1;NEDD9;PLS3;RFLNB;EPS8;BAIAP2;FAM107A
prerank,keratinocyte differentiation (GO:0030216),-0.3105613001686757,-0.904253384434708,0.6312056737588653,0.9046274878756689,1.0,9/29,19.51%,ADAM9;ANXA1;TXNIP;JAG1;SCEL;BCR;CASP3;DSP;WNT16
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3600932924772414,0.9042181365021414,0.5562805872756933,0.8977957829568752,1.0,2/27,2.89%,CSGALNACT1;CHST11
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.34626694427245897,0.9040385617636716,0.6141215106732348,0.8976213100706489,1.0,4/36,6.73%,DAB2IP;RYBP;PHC1;MAX
prerank,regulation of oxidative phosphorylation (GO:0002082),0.40091139542545096,0.903504115608633,0.5888501742160279,0.898167083430218,1.0,5/16,10.97%,AK4;SLC25A33;SHMT2;PDE12;ABCD1
prerank,AMP metabolic process (GO:0046033),0.4155412579509605,0.9028159097221288,0.5700389105058365,0.8990502007995167,1.0,3/13,7.35%,XDH;AK4;ADSS2
prerank,positive regulation of neuron death (GO:1901216),-0.2857983239679706,-0.9027117380276969,0.6115702479338843,0.9072735855698668,1.0,10/46,17.47%,EPHA7;EFNB2;NUPR1;MAP3K5;FOXO3;NF1;TLR4;SARM1;GRN;DDIT3
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.29322241966633666,-0.9024444899191469,0.6039325842696629,0.9069519063727297,1.0,9/44,11.14%,GSN;FCHSD2;CARMIL1;CDC42EP4;CDC42EP5;SNX9;PFN2;LMOD1;PTK2B
prerank,regulation of protein localization to cell surface (GO:2000008),0.35381526233155797,0.9022729216459031,0.6066350710900474,0.8995872258602681,1.0,6/33,11.56%,STX3;NEDD4L;CTNNB1;HSP90AB1;ABCA7;KCNAB2
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.29320374531482524,-0.9021270534541318,0.6477611940298508,0.9067823096283162,1.0,4/41,9.42%,PRKAG2;OGT;SEH1L;NUP205
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.24083153474883282,-0.9020328138304312,0.6785714285714286,0.9060567521973296,1.0,19/117,9.79%,IGF1;ALDH1A2;CYP26B1;ACADSB;ME1;PER2;PPARA;CPT1C;GGT5;ME2;MCCC2;SLC5A6;SCPEP1;ACOT11;ABAT;CKB;ALDH4A1;NAAA;AMACR
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3446672856520116,0.9019969545217887,0.5987558320373251,0.8995747019007619,1.0,13/40,20.02%,PTK2;GNA12;FBXW7;RPS7;SMURF1;HIPK2;RPL11;TRIM39;RNF139;RAD23A;FOXF2;RPL23;DESI1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3459976040469059,0.9016913340470745,0.6276422764227643,0.899640552489082,1.0,7/34,8.10%,SMAD7;CALM1;PDE4D;NPPA;KCNQ1;SRI;PDE4B
prerank,T cell activation (GO:0042110),0.31490779530928376,0.9015839978093767,0.6088888888888889,0.8992875955018259,1.0,14/69,11.80%,JAG2;ZAP70;DLL4;CCR7;CD4;FOXP3;CD8B;MSN;EIF2AK4;CASP8;PPP3CA;GPR89A;GPR89B;TNFRSF4
prerank,central nervous system myelination (GO:0022010),0.4363184002036132,0.9010135586951092,0.5794392523364486,0.8999026471451547,1.0,2/11,12.11%,B4GALT5;SOX10
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.35732027201413014,-0.90087556006146,0.6085011185682326,0.9078304668882825,1.0,4/17,6.81%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,apoptotic cell clearance (GO:0043277),-0.3120153851799011,-0.900448446348161,0.6164383561643836,0.9079279394468603,1.0,7/30,10.36%,LRP1;THBS1;XKR4;ANXA1;RHOBTB2;TXNDC5;ITGAV
prerank,long-chain fatty acid transport (GO:0015909),0.35310513746216604,0.8999018293448496,0.6,0.9017398062609782,1.0,9/30,12.91%,MFSD2A;ABCD4;CPT1A;ACACB;ACSL3;FABP5;ABCD1;PPARG;SLC27A2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.34540620915657905,-0.8996901963336801,0.6148148148148148,0.9088267365719603,1.0,3/23,2.73%,IGF1;EFNB2;MMP14
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.396274540588774,0.8995636111469775,0.5934819897084048,0.9018383407334076,1.0,5/17,15.44%,HDAC9;SORT1;NR1H2;LIPC;ANGPTL4
prerank,motile cilium assembly (GO:0044458),0.42393550752229286,0.8994666316427233,0.585635359116022,0.9014668074853712,1.0,3/12,20.08%,ZMYND10;DNAAF3;E2F4
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.34628699743002134,-0.8994269674809837,0.6,0.9085216213153944,1.0,6/21,15.69%,DAG1;ADAM9;BACE2;ADAM19;PSEN1;HM13
prerank,positive regulation of heart contraction (GO:0045823),-0.34803606023380923,-0.8994035683688121,0.6023809523809524,0.9076323758070408,1.0,1/19,0.02%,ATP1A2
prerank,regulation of T cell chemotaxis (GO:0010819),0.4279372304843352,0.8988404063792196,0.6131528046421664,0.9022343725444265,1.0,3/11,17.12%,ADAM10;ADAM17;CCR2
prerank,nuclear pore organization (GO:0006999),-0.37040152715669017,-0.8980742038388825,0.5798687089715536,0.9097414115380807,1.0,7/14,31.05%,SEH1L;NUP205;TMEM170A;NUP35;NDC1;TPR;RTN4
prerank,positive regulation of calcium ion transport (GO:0051928),0.3350975982827282,0.8979650903340555,0.5756097560975609,0.9035044713116624,1.0,3/36,1.75%,PDGFB;CXCL12;CAV1
prerank,oxoacid metabolic process (GO:0043436),-0.3220717037836813,-0.8975301531691023,0.6525,0.910081334428706,1.0,2/27,1.67%,DDO;ENPP1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2969547984012279,0.8974134518766305,0.6386913229018493,0.9040603660717356,1.0,7/86,2.67%,PECAM1;PDGFB;APP;IL6R;LRP8;PTPRJ;ARHGEF2
prerank,positive regulation of transmembrane transport (GO:0034764),-0.38082454359306905,-0.897377646509815,0.6049382716049383,0.9095174269700509,1.0,4/13,10.71%,ACSL1;ANO6;CLIP3;AZIN1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.409715803452544,0.8972314547674091,0.5945945945945946,0.9038783093153949,1.0,4/15,10.42%,TJP1;KLF4;PKM;SMAD1
prerank,response to insulin (GO:0032868),0.3031228998690682,0.8971729491011147,0.6404011461318052,0.9034230088074825,1.0,17/80,14.97%,TBC1D4;INSR;RAB31;FOXO1;HDAC9;SORT1;DENND4C;SLC25A33;SORBS1;PKM;GSK3A;CEACAM1;ZFP36L1;PPARG;LPIN3;PDE3B;HDAC5
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.27802533105654886,-0.897080031712415,0.6473988439306358,0.9092855851411467,1.0,10/47,15.39%,PID1;PDGFRB;THBS1;PRKCD;AGTR1;SLC5A3;CYBA;MAPK14;TLR4;ACE2
prerank,cell differentiation in hindbrain (GO:0021533),0.4449948074617552,0.8969879844742498,0.603202846975089,0.9032338719652637,1.0,4/11,17.32%,GRID2;OPHN1;LHX1;PROX1
prerank,photoperiodism (GO:0009648),-0.31464852551685757,-0.8969773314625379,0.6218905472636815,0.9086010638294574,1.0,6/28,11.15%,PER3;FBXL17;PER2;USP2;PML;CRY2
prerank,cellular response to lipopolysaccharide (GO:0071222),0.28680554388382634,0.896961427998849,0.6506024096385542,0.9027043689104655,1.0,10/101,8.17%,DAB2IP;MEF2C;DEFA6;NOD2;LYN;CD6;HCK;TGFB1;PDE4B;IRGM
prerank,positive regulation of organelle organization (GO:0010638),-0.31038251523128374,-0.896891238477293,0.6433915211970075,0.9078496874345768,1.0,11/32,20.23%,ANXA2;PPARGC1A;ANXA1;STX18;LMAN1;HTRA2;SURF4;RAB3GAP2;SMCR8;C2CD5;ATL3
prerank,response to retinoic acid (GO:0032526),0.3176982271476989,0.8968379326511121,0.6108663729809104,0.9024061044873151,1.0,11/59,11.20%,ACER2;TRIM16;TBX1;FZD4;LYN;CREB1;RET;TWF2;BRINP3;PTK6;BRINP2
prerank,sterol biosynthetic process (GO:0016126),-0.3045536740156061,-0.8965377881650833,0.6337662337662338,0.9077967389134114,1.0,2/33,2.95%,PRKAG2;INSIG2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.34551569432981766,0.8962827048421531,0.6,0.903011285055465,1.0,9/33,24.06%,HSP90AB1;MRE11;TERF2;ACD;TERF1;NHP2;RPA1;PINX1;PTGES3
prerank,regulation of hemopoiesis (GO:1903706),0.4353857767526471,0.8962411678255463,0.603082851637765,0.9025143605781438,1.0,4/10,11.53%,PTN;MYSM1;CBFB;PRKCB
prerank,B cell homeostasis (GO:0001782),0.4310073836436539,0.8961526987435027,0.5911602209944752,0.9021353734572017,1.0,4/10,14.70%,MEF2C;LYN;TNFAIP3;NCKAP1L
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3622618993139679,0.895812070234918,0.6013513513513513,0.902275127015704,1.0,2/26,2.10%,ST8SIA6;B4GALT5
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.33801980262784365,0.8957960251001871,0.6142208774583964,0.9017431198254855,1.0,5/37,11.08%,BCL2L1;CAV1;RPS7;EIF5A;S100A8
prerank,embryonic appendage morphogenesis (GO:0035113),0.4250750433649443,0.8954591419289442,0.5959409594095941,0.9018458358074602,1.0,1/12,1.32%,TGFB2
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.26027846582535796,-0.8952279584880724,0.686411149825784,0.9099466376078956,1.0,16/69,11.14%,SLC30A10;SNX6;PRKCI;PPARGC1A;NGF;SIX1;NRBP2;NFATC4;BCL2;SOD2;PRKN;APOE;KDM2B;TGFB3;CLN3;PTK2B
prerank,positive regulation of viral life cycle (GO:1903902),-0.3309740187143728,-0.8949019587355584,0.6267942583732058,0.9098096037692325,1.0,6/22,18.69%,AXL;LGALS1;TSG101;FMR1;P4HB;VPS4A
prerank,positive regulation of cell cycle process (GO:0090068),0.2974788189456549,0.894735211617788,0.6391184573002755,0.9027822047720441,1.0,21/91,18.30%,PDGFB;INSR;RGCC;CDC14A;PKN2;PKP4;NPM2;TGFA;LRP5;CDC6;KIF23;MAP10;DYNC1LI1;SPAG5;RXFP3;RCC2;EDN1;SPAST;RAD21;PRKCE;DDX11
prerank,negative regulation of type I interferon production (GO:0032480),0.33358292476066204,0.8943634643415623,0.6022364217252396,0.902988930593912,1.0,9/40,17.96%,TRIM25;IFIH1;NLRC5;RNF125;PIN1;CYLD;TNFAIP3;RELB;TBK1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.32808291449197136,-0.8941921991427969,0.6054590570719603,0.9105765419031955,1.0,5/25,13.44%,UGGT2;FBXL17;CUL3;KLHL15;AUP1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.40772232762035054,-0.8940694412259064,0.6016949152542372,0.9099068691852943,1.0,5/10,30.70%,GALNT16;POGLUT2;GALNT1;GALNT3;MGAT5B
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.3668638667987031,-0.8938295451586872,0.6058394160583942,0.9095059220119514,1.0,5/15,13.15%,IRS1;PPARA;IRS2;SLC45A3;ADM
prerank,regulation of gene expression (GO:0010468),0.2463568747019284,0.8938009238119379,0.8108941418293937,0.90355620252757,1.0,122/903,13.45%,LEF1;SLC7A5;TFRC;ETS1;OCLN;RBM20;CLDN5;PDGFB;KDR;INSR;CD34;APBB2;SLC39A8;ENG;TGFB2;NOS3;PDE2A;NOVA2;APP;XDH;SOX17;TRIM14;BCL6B;RGCC;MEF2C;RYBP;SMARCA2;PIK3R3;ACVRL1;SOX13;APLNR;NOTCH1;YBX1;RAMP2;LYN;PRDM2;IRF2;RREB1;NOS2;GATA2;SOX7;NOCT;MOG;HINT1;TCF23;FGF16;RAMP3;DLL4;KLF1;WWTR1;SORT1;TLR3;DIP2A;TCF7;NANOS1;CAVIN4;SNAI2;MAPK3;RPS6KA5;ADAM10;FBXW7;LGALS9;KLF4;PTBP3;DNM2;INSM1;NCOA2;SOX18;YBX2;BRCA2;SOX12;HINFP;CRNN;TDRD7;PIN1;TGFB1;TERF2;FOXP3;RPS7;PRDM9;P2RX7;MSN;HCFC2;HMGA1;NDFIP2;KDM4A;ZPR1;ACTG1;UBE2V1;BTG1;PTRH2;PDCD10;SMAD1;CASP8;PRKAB1;CNTF;ZNF205;NR5A2;LAMTOR5;ADNP;CTCF;HRAS;GSK3A;ONECUT1;VSIR;HIF1A;TLE1;PIK3CB;RNF187;HGS;TFEB;ZFP36L1;SOX11;WWC1;RO60;EDF1;DNAJA4;SETDB1;RPL11;TRIM39;SOX9;CDH5
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3588232730698836,-0.8934887405995225,0.5947242206235012,0.9094117499387704,1.0,3/17,7.70%,CD55;IL18;JAG1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3384647830171264,-0.8934344781024519,0.6302325581395349,0.9086158674647249,1.0,6/18,15.19%,DACT1;APOE;EZR;VGLL4;ATP5IF1;CD81
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3928812107752312,0.8932155326243078,0.5954063604240283,0.9041974273339706,1.0,5/17,16.68%,NPPA;AKAP6;ANK3;KCNRG;SUMO1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3299273131127225,-0.892479659487679,0.6267605633802817,0.9098853846946904,1.0,6/22,17.83%,DDX5;PLA2R1;ATM;SPRED1;HIC1;CHD5
prerank,leukocyte tethering or rolling (GO:0050901),0.39366508796601357,0.8924328052043067,0.593065693430657,0.9052951399655317,1.0,1/17,1.49%,JAM2
prerank,ERK1 and ERK2 cascade (GO:0070371),0.37472541578356167,0.8921647371401519,0.5979557069846678,0.9053021705406387,1.0,6/21,15.98%,KDR;MAPK3;LGALS9;ZFP36L1;SOX9;MAPK1
prerank,autophagosome maturation (GO:0097352),0.3428342430472411,0.8919851129650753,0.5861486486486487,0.9050989861772167,1.0,15/32,23.67%,CALM1;TECPR1;MAP1LC3B;UBQLN1;SNAP29;ATG14;VPS16;MAP1LC3A;VAMP7;UVRAG;GABARAP;VMP1;RUBCNL;VAMP8;GABARAPL2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4189079153856481,0.8918400401701984,0.5790408525754884,0.9048476769207345,1.0,3/13,4.51%,NOS3;TMSB4X;NOS2
prerank,cellular response to purine-containing compound (GO:0071415),-0.4005009922499029,-0.8916712344672028,0.5926680244399185,0.9108651846990545,1.0,5/10,33.72%,SLC8A1;GSTM2;RYR3;P2RY1;CASQ2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.3898657449147946,0.8913980545753013,0.6169491525423729,0.905194699453216,1.0,4/18,7.93%,CAV1;NEDD4L;SLC43A2;KCNH2
prerank,mitochondrial transport (GO:0006839),0.3209531001068832,0.8911708792982013,0.6298507462686567,0.9050943274758239,1.0,11/53,21.97%,BCL2L1;TOMM22;SLC25A5;TIMM13;TIMM10;DNAJC19;MFF;TOMM7;BAK1;TOMM5;BNIP3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.37937793594570934,-0.8910562496403414,0.6137931034482759,0.9113467109005151,1.0,5/13,21.90%,SAR1A;SEC16B;SEC16A;CD81;EDEM2
prerank,cortical cytoskeleton organization (GO:0030865),0.33357147809289417,0.8906862324004182,0.6224,0.9055328903298454,1.0,11/41,16.62%,RHOBTB1;FMNL3;IKBKB;RHOB;NCKAP1;STRIP1;RAC1;RND1;NCKAP1L;NLGN1;TRPV4
prerank,protein localization to synapse (GO:0035418),-0.38040639850601604,-0.8904987723252223,0.6024844720496895,0.9117142239504958,1.0,2/12,7.03%,NLGN2;DLG4
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3486122648982724,0.8904081776050201,0.5993537964458805,0.9055467300542888,1.0,7/29,12.66%,IFNAR1;IFNAR2;JAK3;SOCS2;STAT1;PTK6;IL15
prerank,positive regulation of cartilage development (GO:0061036),0.38176602343824045,0.8903833272656984,0.601010101010101,0.905037649894555,1.0,3/17,3.97%,BMPR2;ACVRL1;ZBTB16
prerank,smooth muscle tissue development (GO:0048745),-0.4025799940659841,-0.8903105487125694,0.5961538461538461,0.9112082928947722,1.0,5/10,13.29%,BMP4;MYLK;SMO;EFEMP2;NF1
prerank,regulation of T cell activation (GO:0050863),0.33080781688349203,0.8903091513659808,0.6067961165048543,0.904614189884742,1.0,6/42,12.52%,JAK3;DUSP3;CD4;CCDC88B;TNFSF11;CYRIB
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.4032226466386156,-0.8901167531448142,0.5918367346938775,0.9107261422714081,1.0,3/10,10.12%,ABCA1;APOE;PRKACA
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2841304105308674,-0.8899455629389925,0.6358695652173914,0.9101955334226063,1.0,9/41,12.70%,RNF152;UBE2E2;TRAF3IP2;PRKN;RNF135;WWP2;UBE2E3;PRPF19;PELI3
prerank,regulation of microtubule depolymerization (GO:0031114),0.3649657700788776,0.8898202637299814,0.5962837837837838,0.9050620951451913,1.0,10/25,25.97%,ARHGEF2;FGF13;ATXN7;APC;TRPV4;CAMSAP2;CLASP1;CAMSAP1;NAV3;CLASP2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.40547672100041976,0.8897941679354433,0.590566037735849,0.9045479407862316,1.0,3/14,9.46%,LIMS2;PRKD1;PHACTR4
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.36677673157024093,-0.889644090796713,0.6369565217391304,0.9100076990063124,1.0,4/14,15.19%,CD55;IL18;PTPN22;CD81
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.36008998257399283,0.8883616517499445,0.6056572379367721,0.9069386429836073,1.0,3/25,5.93%,CSGALNACT1;B3GNT2;FUT9
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3741655609269301,0.8882099992199407,0.5951972555746141,0.9066839592510946,1.0,7/20,14.85%,BCL2L1;PPP2R5A;AP2M1;TGFB1;ABI3;MRAP;TMEM59
prerank,regulation of translation (GO:0006417),0.2727150014708451,0.8881226325350964,0.6825,0.9063094738360609,1.0,30/173,13.59%,NANOS3;APP;NIBAN1;RPS6KA1;YBX1;MTG1;NANOS2;EIF4H;ENC1;MRPL13;NANOS1;KLHL25;YBX2;SHMT2;EIF3E;EIF2AK4;RPL13A;CNOT9;EIF3D;CYFIP1;GRB7;HSPB1;EIF2B2;NCBP2;BTG2;EIF4E;PUM3;PAIP2;PAIP1;EIF3B
prerank,negative regulation of cellular senescence (GO:2000773),0.4149648291593488,0.8880024644630455,0.5922509225092251,0.9059853696865459,1.0,7/13,23.01%,YBX1;TERF2;MAP3K3;RBL1;HMGA2;CDK6;AKT3
prerank,fatty acid catabolic process (GO:0009062),0.3073556733389508,0.8870064459305577,0.6458635703918723,0.907477638237911,1.0,12/67,15.66%,ABHD2;PPARD;ABCD4;ACOX1;AIG1;ABCD1;MMAA;SLC27A2;LPIN3;HACL1;ECI2;ACAT1
prerank,polyol biosynthetic process (GO:0046173),-0.35401201152244255,-0.8867941816712236,0.6430155210643016,0.9158187663710807,1.0,5/16,11.06%,CYP27A1;ACER3;FGF2;ISYNA1;PPIP5K2
prerank,neurotransmitter secretion (GO:0007269),0.32307117752024855,0.8867134438934617,0.6152671755725191,0.9075065851494313,1.0,12/44,24.10%,STX1A;PIP5K1C;STXBP1;NRXN1;DNAJC5;HSPA8;CPLX1;RIMS2;UNC13A;SNCA;PTPRN2;SYN1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.29210201456613166,-0.8866478173733411,0.6640211640211641,0.9152176212657147,1.0,10/38,19.99%,CENPC;HAT1;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4;UBN1
prerank,icosanoid biosynthetic process (GO:0046456),0.44365293103237546,0.8863385816983891,0.6111111111111112,0.9077171185989128,1.0,2/10,13.41%,MGST2;LTA4H
prerank,negative regulation of stem cell differentiation (GO:2000737),0.41755886784751733,0.8860604588564794,0.5910780669144982,0.9077547036076228,1.0,1/12,3.41%,NOTCH1
prerank,electron transport chain (GO:0022900),0.40342720280471983,0.8859022174273399,0.6090750436300174,0.9074999919724626,1.0,4/15,9.78%,ETFRF1;ENOX2;CYB561;ETFB
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.34868867899787803,0.885683703107847,0.6142857142857143,0.9073834483897424,1.0,13/34,25.87%,MEF2C;GRID2;INSYN2A;GRIN2B;GSK3A;GABRG1;GABRG3;GABRA1;RAB3GAP1;GABRA2;GRIN1;GLRA1;GABRG2
prerank,proteasomal protein catabolic process (GO:0010498),0.2664605688801353,0.8855764908124922,0.6986634264884569,0.9070361827617405,1.0,65/201,24.82%,ZNRF1;NEDD4L;PELI1;CTNNB1;ENC1;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;PSMD11;RHBDD1;PSMC6;FEM1C;PSME2;SMURF1;UBXN1;KCTD10;SHARPIN;KLHL20;UBE3D;PSMD8;GSK3A;RNF187;MAEA;PSMB10;NHLRC1;RBX1;TRIM2;UBE2D3;AREL1;RNF139;PSMA8;ATE1;ARMC8;RAD23A;BAG6;GID8;BFAR;TRIM71;TRIM3;KCTD17;PSMD9;SIAH1;RNF4;RBCK1;NSFL1C;PLAA;ANKRD9;BRSK2;ERCC8;DDB1;PSMC3;PSMD1;RAD23B;RNF126;PSMD10;HECW1;CRBN;RNF216;PMAIP1;UBXN2B;ZFAND2B;MTA1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.3457334058203313,-0.8854060152355568,0.6616161616161617,0.9171934486235901,1.0,6/18,14.16%,DCN;MCU;PRKN;MIEF1;DDHD1;MIEF2
prerank,protein kinase B signaling (GO:0043491),0.36505886451565506,0.885382522096177,0.5993150684931506,0.9068829805116593,1.0,3/23,8.09%,KDR;PIK3R3;TGFB1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.357341830048585,-0.8845798814505249,0.6023529411764705,0.918129550174758,1.0,8/17,25.22%,SELENOS;HSP90B1;SYVN1;AUP1;HM13;SEC61B;DERL1;UFD1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.3346680567159901,-0.8845780079457348,0.6234413965087282,0.9172134495230778,1.0,4/22,11.15%,ROCK2;PPP4R4;PTPA;CRY2
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.38806671923555763,-0.8844464911120813,0.6283924843423799,0.9166074243166886,1.0,2/11,10.12%,IL34;PRKCA
prerank,negative regulation of endocytosis (GO:0045806),0.3616226648638873,0.8841860695848424,0.6306156405990017,0.9087078064412305,1.0,5/24,11.43%,CAV1;PRKD1;NR1H2;ABCA7;RAC1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.38815059459484147,0.8832339629568158,0.628731343283582,0.9100914690415766,1.0,5/17,18.27%,STX1A;UNC13D;SYT4;NLGN1;CACNA1I
prerank,positive regulation of vacuole organization (GO:0044090),-0.39990254319906904,-0.8828428034364496,0.6451612903225806,0.9193830335454642,1.0,5/10,16.97%,ANXA2;LRSAM1;PIP4K2C;RAB3GAP2;GRN
prerank,chloride transport (GO:0006821),0.30326826105940763,0.8828151384369168,0.6417033773861968,0.910374654666705,1.0,18/74,19.47%,CLIC5;SLC1A1;SLC12A6;GABRB1;SLC12A9;CLCN3;CLIC4;TTYH3;GABRQ;GABRG1;CLIC1;GABRG3;PACC1;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,dendrite morphogenesis (GO:0048813),0.33432607642131024,0.8827470567577339,0.6323777403035413,0.9099444589423142,1.0,5/35,8.49%,SHANK3;KLF7;WNT7A;DIP2A;PTN
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.38767371073424395,0.8825782958328807,0.6129032258064516,0.9097316437923763,1.0,4/16,18.18%,HMGA1;RECQL4;TWNK;RPA1
prerank,regulation of autophagy (GO:0010506),-0.21518059766897263,-0.8823499301128888,0.8452380952380952,0.9195803921375935,1.0,49/216,18.58%,PRKAG2;DCN;ITPR1;LEPR;PRKAA2;RNF152;NUPR1;SNX6;KLHL22;DAPK2;DAPL1;BCL2;GOLGA2;PRKN;MET;ATM;FOXO3;PTPN22;PLEKHF1;PIP4K2C;MTMR3;STK11;PRKACA;PRKAG3;LRRK2;ATP6V1C1;SNX5;ABL1;RHEB;ATP6V1G2;TPCN1;SIRT2;HTRA2;LAMTOR3;EP300;CAPN1;CASP3;RRAGA;WDR41;SREBF1;OPTN;CISD2;ATP6V1E1;SNX32;DDIT3;CTSA;PSAP;SMCR8;FLCN
prerank,intracellular sterol transport (GO:0032366),0.4148179481847557,0.8823251386253792,0.5855513307984791,0.9096969724086252,1.0,4/13,14.49%,OSBP;ABCG1;NPC1;STARD4
prerank,negative regulation of RNA splicing (GO:0033119),-0.3454280612308285,-0.8822785417695815,0.6438679245283019,0.9188230952563861,1.0,8/19,21.28%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;PTBP2;SRSF10
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.37019221973873706,0.882088650628042,0.6188811188811189,0.9096279166184563,1.0,4/24,7.40%,MEF2C;CDH2;CTNNB1;SPAG9
prerank,positive regulation of signaling (GO:0023056),-0.2905181434361672,-0.8819187811216315,0.6330532212885154,0.9187272918031638,1.0,4/37,7.03%,WLS;ANXA2;CLSTN2;DLG4
prerank,positive regulation of neutrophil migration (GO:1902624),-0.34468235315294765,-0.8816189366558974,0.6269662921348315,0.9184880919805227,1.0,4/18,6.81%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.41852707300510616,0.8814666598449945,0.5981308411214953,0.9103584171647099,1.0,1/11,0.99%,BCL2L1
prerank,protein destabilization (GO:0031648),-0.2965328440244118,-0.8814124092063588,0.6497326203208557,0.9180259068677609,1.0,8/32,14.57%,GSN;PRKN;CUL3;BTRC;CTSH;PEX2;FBXW11;EP300
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3600534819361947,0.8813113724981149,0.6215334420880914,0.9101196148342137,1.0,4/26,10.75%,PDE8A;PPIA;FYN;HSPB1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.29903023875520346,0.8812482858689922,0.6539007092198581,0.9096942948973183,1.0,25/76,25.04%,RNF144B;PTK2;SMAD7;FBXW7;HECTD1;SOCS5;SMURF1;TRIB2;GSK3A;RBX1;RNF139;BAG2;ELOB;RAD23A;SUMO1;RNF19A;CBFA2T3;GABARAP;RACK1;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;KEAP1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2881271483197525,0.8811601117012419,0.6982408660351827,0.9093113352254081,1.0,13/98,11.94%,PRKCH;SPTBN1;PPP1R13B;STX3;PPP3CC;RAMP3;FYN;SORBS1;YWHAH;YWHAQ;CASP8;HRAS;PPP3R1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3890918968913578,-0.8811467648561516,0.6034858387799564,0.9177059918598984,1.0,3/11,11.85%,SLC30A10;PPARA;TRAP1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3806813179742776,-0.8809088388906074,0.6219239373601789,0.9173204880782575,1.0,3/12,14.17%,PRCC;ZWINT;ZWILCH
prerank,regulation of phosphatase activity (GO:0010921),-0.326143051104524,-0.8806696938744305,0.6715686274509803,0.9169503420798624,1.0,10/24,28.68%,SH3RF2;PTPA;URI1;BMP2;HSP90B1;SH2D4A;TSC1;HTT;ZCCHC9;MTMR9
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.30346405382315556,-0.8804930098920567,0.6507177033492823,0.9164011188649361,1.0,5/31,6.43%,KANK2;FHL1;PKD2;DLG1;DACT1
prerank,regulation of interferon-beta production (GO:0032648),0.3181917784770766,0.8802693167733453,0.6424148606811145,0.9105263404127173,1.0,18/46,27.40%,TIRAP;IFIH1;TLR3;IRF5;TLR7;TLR8;RELB;TBK1;TRAF3;POLR3F;FLOT1;RIOK3;POLR3B;RNF216;ISG15;POLR3C;IRF7;TOMM70
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.33653565639404126,-0.8802251449328138,0.6405867970660146,0.9161219451398998,1.0,5/20,12.41%,CAMK2D;THADA;BCL2;PML;PSEN1
prerank,purine nucleotide metabolic process (GO:0006163),0.3659809878800283,0.8797941721533958,0.6188811188811189,0.9109359809862797,1.0,5/24,11.08%,XDH;HPRT1;NT5C2;GART;PNP
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2842232448354332,0.8797742651406075,0.684931506849315,0.9104170953088743,1.0,12/95,14.07%,DAB2IP;TIRAP;MEF2C;DEFA6;NOD2;PDE4B;IRGM;CYRIB;HMGB2;TNFAIP3;GIT1;BCL10
prerank,regulation of aerobic respiration (GO:1903715),0.4055197021119345,0.8795320193343762,0.6163636363636363,0.9103454447987547,1.0,4/15,10.97%,AK4;SLC25A33;SHMT2;ABCD1
prerank,sympathetic nervous system development (GO:0048485),0.4028008551058087,0.8787740588826949,0.6220183486238532,0.9112978693171973,1.0,5/15,19.12%,CTNNB1;INSM1;SOX11;NRP2;NRP1
prerank,polyamine metabolic process (GO:0006595),0.40861586507206404,0.8786865634561505,0.6079854809437386,0.910901028236333,1.0,8/13,29.42%,SMOX;AMD1;SMS;OAZ2;DHPS;AOC1;SRM;HDAC6
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2938564642146206,0.8782699059084549,0.6592489568845619,0.9112196520667804,1.0,15/86,15.92%,EPAS1;KLF2;PSMB3;EGLN2;PSMD11;PSMC6;PSME2;PSMD8;HIF1A;HIGD1A;EGLN1;PSMB10;RBX1;ELOB;PSMA8
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.4005709319171392,0.8779983619610724,0.6029143897996357,0.9112383998797257,1.0,7/16,28.81%,SNRPC;NCBP2;DCPS;WBP11;SRSF12;SFSWAP;SRSF1
prerank,neutrophil activation (GO:0042119),0.4188618474505515,0.8776570548841928,0.6254612546125461,0.9113552357067313,1.0,4/12,12.66%,CXCR2;PREX1;SYK;IL15
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.37618723625102846,0.8765299065075337,0.6037414965986394,0.913118313497685,1.0,2/18,3.74%,JAK3;DUSP3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3087100778011357,-0.8761835194562431,0.6550802139037433,0.9240545938181677,1.0,2/26,1.34%,PRKAG2;PRKAA2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.43102798848798807,0.875879285792806,0.6030245746691871,0.9138707931463794,1.0,3/10,17.78%,SACS;DNAJA4;DNAJB6
prerank,neuromuscular junction development (GO:0007528),-0.31872280120992696,-0.8757056998315343,0.6430317848410758,0.9242074040453523,1.0,7/24,13.30%,PDZRN3;UNC13C;PPFIBP2;CACNB4;LRRK2;CACNB2;CACNB1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3306627633784919,0.8752493808181526,0.6314102564102564,0.9146291685974086,1.0,3/40,2.47%,HIP1;INSR;B2M
prerank,monocarboxylic acid catabolic process (GO:0072329),0.37154439404027967,0.8751051295040811,0.6040955631399317,0.9143763169503839,1.0,7/21,20.60%,PPARD;ACOX1;LDHD;LPIN3;AGXT;ACBD5;FAAH
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.403557655180665,-0.8749293172755745,0.6285714285714286,0.9250085484496275,1.0,4/10,18.39%,IMPACT;BAG3;SIRT2;CITED2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3007450143015136,0.8749083530455553,0.6734397677793904,0.9142036329877666,1.0,18/72,21.63%,POLK;GTF2H2;GTF2H4;RBX1;AQR;COPS5;GPS1;ISY1;POLR2J;RPA1;TCEA1;POLD1;ERCC8;GTF2H3;COPS6;RFC2;DDB1;ERCC4
prerank,DNA methylation (GO:0006306),-0.318390912705823,-0.8745195037191035,0.6229116945107399,0.9249879634146404,1.0,10/23,30.13%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15;PICK1;ZFP57;METTL4;FOS;BAZ2A
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.42058783770217667,0.8744864849297361,0.6045197740112994,0.91446299691646,1.0,2/11,10.44%,TIMM13;TIMM10
prerank,mitotic DNA replication (GO:1902969),-0.39509721944144405,-0.8743736146156935,0.6231578947368421,0.9243954243165151,1.0,6/10,34.70%,CDC45;LIG1;MCM3;MCM4;GINS1;GINS3
prerank,C-terminal protein amino acid modification (GO:0018410),0.4215360279039009,0.8739736941214116,0.592391304347826,0.9149223726486039,1.0,7/11,31.34%,LCMT1;ATG12;TTL;ATG7;AGBL4;FOLH1;AGTPBP1
prerank,gene expression (GO:0010467),0.2508354279475299,0.8737966794392718,0.7806524184476941,0.9147076529313333,1.0,112/348,26.77%,TSPAN5;AGFG1;TSPAN14;ADAR;PTMA;HHEX;SARS1;ZAR1L;RPL38;TAF1B;MRPL13;RPL13;RPS29;MRPL10;RPL36A;NKX2-8;RPL3;RNPS1;YARS2;RPL27;RPSA;RPS7;PWP1;RPL9;RPL18;RPLP2;NXT1;DEDD2;CPSF1;MAGOHB;RPL13A;THOC6;RPS11;RPL8;NUP54;MPHOSPH10;RBPMS;NCBP2;RPS27;RPL19;RPS9;MRPL28;EIF4E;NOL9;ADAD1;ZC3H11A;RPL11;RPS15;SRBD1;RPL37;RPS28;TSPAN33;RPS10;NUP160;RPS25;MRPL44;RPL37A;MRPL9;COPS5;PRPF4;RPL15;POLR2J;TNIP1;NUP153;NUP50;MRPL23;RPL17;RPL23;RPL34;RBM8A;RBMS2;FARSB;RPS18;UPF2;XRN2;RPL21;RPS4X;MRPS18A;DDX54;RPL18A;NCBP1;DHPS;RPS21;NUP42;DUSP11;RPL10A;ADARB2;RPL24;RSL24D1;RPL7A;NUP85;MRPL41;MRPL27;NUP210;MRPL51;HARS1;RPL32;DHX38;RPL4;UPF3B;UPF1;RPS2;MRPS33;MEF2A;NUP188;MRPL37;CHTOP;RPS20;RPL6;RPS13;MRPS18C;DNAJB11
prerank,nuclear pore complex assembly (GO:0051292),-0.39566607014760125,-0.8736564414003473,0.6346555323590815,0.9249768377577005,1.0,8/10,45.00%,NUP205;TMEM170A;NDC1;TPR;RTN4;NUP98;NUP107;AHCTF1
prerank,regulation of ion transmembrane transport (GO:0034765),0.34055283624009475,0.8734073589291202,0.6209262435677531,0.9148983042844421,1.0,10/33,18.38%,NEDD4L;KCNQ1;KCNH2;P2RX7;AKAP9;CHRM3;AKAP6;KCNJ3;KCNJ5;KCNJ6
prerank,programmed necrotic cell death (GO:0097300),0.3878481680650404,0.8728698535453314,0.625,0.9154386568360395,1.0,5/18,23.36%,TLR3;IPMK;CYLD;TICAM2;RIPK1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.38722068146296207,0.8727713381954189,0.6486013986013986,0.9150735180999165,1.0,4/15,4.06%,PRKD1;NOTCH1;PRKD2;TMSB4X
prerank,response to UV (GO:0009411),0.28449832118495416,0.8726234916701504,0.6795977011494253,0.9148271760799919,1.0,10/95,9.61%,POLK;MAP4K3;DCUN1D3;MEN1;CAT;GTF2H2;N4BP1;RHBDD1;COPS9;EIF2AK4
prerank,positive regulation of dendrite development (GO:1900006),0.427509917509693,0.8726075433039677,0.615530303030303,0.9143076124931409,1.0,3/10,8.49%,DAB2IP;LRP8;PTN
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3842259815764759,-0.8725510765242598,0.6353211009174312,0.9265339537708024,1.0,4/12,19.86%,AR;SELENOS;TMEFF2;AP2A1
prerank,regulation of amyloid fibril formation (GO:1905906),0.39524579672552584,0.8724729865255294,0.610909090909091,0.9140238652912446,1.0,3/15,9.20%,APP;PFDN4;PFDN2
prerank,mitotic recombination (GO:0006312),-0.3533601083307313,-0.8721115939650682,0.6414253897550112,0.9266304461644906,1.0,7/15,19.24%,SMC6;TEP1;ERCC1;RAD50;NSMCE2;DMC1;TPRKB
prerank,negative regulation of translation (GO:0017148),-0.24709933574096046,-0.8720656849923764,0.7127659574468085,0.9258220764170167,1.0,5/87,2.18%,SAMD4A;ROCK2;IGFBP5;CPEB1;CPEB2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.38171607777270394,0.8720263922198791,0.6113074204946997,0.9143871333232753,1.0,1/18,0.69%,MFHAS1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.3205702254665721,-0.871944194419172,0.6407035175879398,0.9251623958918348,1.0,9/23,28.14%,PRCC;ZWINT;ZWILCH;PLK5;CHMP4C;VPS4A;INTS3;SETMAR;PLK3
prerank,response to organic cyclic compound (GO:0014070),0.31264024136007595,0.8718448057052743,0.6461086637298091,0.9141916157789931,1.0,7/52,11.91%,SLC1A1;SOCS2;CTNNB1;TLR3;TGFB1;ARL6IP5;PAQR7
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3697941382517395,0.8715783372001185,0.6350877192982456,0.9141886876421733,1.0,7/20,14.85%,BCL2L1;PPP2R5A;AP2M1;TGFB1;ABI3;MRAP;TMEM59
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.36447899057203254,-0.870694840210437,0.6442105263157895,0.9269581722818991,1.0,6/13,26.85%,CBLB;KPNA3;KPNB1;KPNA6;NUP35;KPNA1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4211317598179312,0.8705892536911081,0.6029411764705882,0.9156229196750977,1.0,3/10,9.62%,CTNNB1;DCT;DISC1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.34534546909702585,-0.8705012213742719,0.6428571428571429,0.926472357719914,1.0,3/17,12.48%,NSA2;WDR12;LAS1L
prerank,alcohol catabolic process (GO:0046164),0.42609001345107067,0.8703018574046671,0.6373831775700934,0.915627105940824,1.0,1/10,1.76%,SCARF1
prerank,positive regulation of synaptic transmission (GO:0050806),0.29191064365708375,0.8702432516256426,0.662704309063893,0.9151865542986721,1.0,15/72,17.12%,SHANK3;APP;SLC24A2;CLSTN1;NPS;NRXN1;EIF2AK4;AGER;GRIN2B;GRIK2;PLK2;NLGN1;RIMS2;LGI1;CCR2
prerank,homocysteine metabolic process (GO:0050667),-0.3927176996517033,-0.8701804255870735,0.6329670329670329,0.9262655030016206,1.0,2/11,8.66%,NOX4;MTHFR
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3745064801358736,0.8700587183273203,0.6418685121107266,0.9150328323260889,1.0,6/20,12.14%,DIP2B;DIP2A;MAPK3;RPS6KA5;FOXP3;TADA2B
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.27730865082498846,-0.8694136184305359,0.6785714285714286,0.9270732808766029,1.0,9/41,18.90%,IGF1;LBP;SELENOS;PTPN22;IRAK3;TLR4;NR1H4;RARA;PTPN6
prerank,receptor signaling pathway via STAT (GO:0097696),-0.31495356353944476,-0.869385880709489,0.654911838790932,0.9262261512817381,1.0,6/25,9.16%,IL31RA;PKD1;PKD2;PIAS1;CTR9;STAT5A
prerank,metallo-sulfur cluster assembly (GO:0031163),0.36766292664005323,0.8692571248733258,0.6209262435677531,0.9160850537608257,1.0,13/22,29.82%,CIAO2B;CIAPIN1;HSCB;HSPA9;CIAO3;NUBPL;LYRM4;NFU1;ISCA1;ISCA2;NUBP2;NUBP1;ISCU
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.28757444541504334,0.8687332157036963,0.7031900138696255,0.9165769617175865,1.0,36/100,25.71%,RNF144B;RYBP;SMAD7;GNA12;HSP90AB1;N4BP1;HECTD1;SOCS5;UBXN1;TRIB2;GSK3A;RPL11;TRIM39;SDCBP;RBX1;BAG2;ELOB;RAD23A;FOXF2;SUMO1;BAG6;RNF19A;CBFA2T3;DESI1;GABARAP;EIF3H;RACK1;RAD23B;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;KEAP1;BAG5;CAMLG
prerank,regulation of myotube differentiation (GO:0010830),0.35422058344681207,0.8683642212296415,0.6134751773049646,0.9167708715658373,1.0,4/24,4.77%,NOTCH1;HDAC9;PIEZO1;ATP11A
prerank,adrenergic receptor signaling pathway (GO:0071875),0.37289133515862893,0.8678233329385617,0.6272577996715928,0.9172574890789429,1.0,3/20,6.32%,RAPGEF2;PDE4D;ADRA2B
prerank,protein-containing complex disassembly (GO:0032984),0.3073725618606798,0.8678043267645309,0.6687598116169545,0.9167442053933375,1.0,20/54,24.72%,CAV1;CTNNB1;TECPR1;FRAT2;MAP1LC3B;HSPA8;UBQLN1;SNAP29;APC;VPS16;MAP1LC3A;VAMP7;RPL23;UVRAG;GABARAP;RUBCNL;VAMP8;CSNK1A1;GABARAPL2;MYC
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3151183054899065,0.8676001076722216,0.650381679389313,0.9166236955127106,1.0,6/47,4.72%,PPARD;SOX13;ZBTB16;RREB1;NOCT;CREB1
prerank,histone H2A acetylation (GO:0043968),-0.3486851779077164,-0.8675181887915477,0.6295454545454545,0.9294402012234632,1.0,6/16,30.24%,MORF4L2;BRD8;NAA40;EPC1;MSL3;SPHK2
prerank,cellular amide metabolic process (GO:0043603),-0.23751107646573189,-0.867379721043716,0.7969348659003831,0.9288387888128701,1.0,22/102,18.30%,AEBP1;PLPP3;ACOT8;SMPD3;MCCC2;SLC5A6;ACOT11;CPXM1;MTHFR;MTHFD1;NNMT;NAAA;CPXM2;ACSF2;NSMAF;PCCB;NIT1;BTD;DBI;MTHFD1L;OXSM;MTHFD2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.29229364364384725,0.8670254139113897,0.685472496473907,0.9171925437902272,1.0,23/78,25.04%,RNF144B;CAV1;SMAD7;HECTD1;SOCS5;TRIB2;UBQLN1;GSK3A;RBX1;BAG2;ELOB;RAD23A;SUMO1;RNF19A;CBFA2T3;GABARAP;RACK1;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;KEAP1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.36493505268981896,-0.8664035108442094,0.6277056277056277,0.9300702260412493,1.0,1/13,0.65%,GLI3
prerank,regulation of establishment of planar polarity (GO:0090175),0.2907753283386385,0.8657931596144836,0.698005698005698,0.9190913226099959,1.0,13/88,12.31%,FZD6;FZD4;TIAM1;WNT7A;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;PSMD8;RAC1;AP2B1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3366148495630824,0.8654239785775582,0.6540880503144654,0.9192756988441145,1.0,6/33,12.22%,PLCB1;RGCC;CRNN;CCND3;ADAM17;RPTOR
prerank,translational termination (GO:0006415),0.2821085362086879,0.865405948263541,0.6964285714285714,0.9187682296422804,1.0,35/95,26.04%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;APEH;MRPL21;MRPS18A;ABCE1;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.28844469524223804,0.8650798962049859,0.690856313497823,0.918884371185918,1.0,20/76,19.21%,CAV1;DCUN1D3;SMAD7;XIAP;FAM107A;FBXW7;BIRC3;MALT1;NDFIP2;UBQLN1;GSK3A;WDR48;DCUN1D1;BCL10;INAVA;PTTG1IP;TNIP1;UBE2D1;FKBP1A;NSMCE3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.39949546939072555,0.8649059916040571,0.6263736263736264,0.918708840900161,1.0,3/12,9.70%,IMPDH1;ADSS2;GART
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.31627222669347577,-0.864904186010688,0.6683417085427136,0.9324953801969209,1.0,4/25,10.36%,PARVA;CXADR;ITGA5;ITGAV
prerank,pseudouridine synthesis (GO:0001522),-0.35978987295847464,-0.8648637230654256,0.6369565217391304,0.9316575734719471,1.0,3/13,15.09%,PUS7;PUS10;GAR1
prerank,epidermal cell differentiation (GO:0009913),-0.27800070801963833,-0.8643844975492817,0.7142857142857143,0.9317678613823074,1.0,11/41,19.51%,ADAM9;ANXA1;GLI1;TXNIP;JAG1;GATA6;SCEL;BCR;CASP3;DSP;WNT16
prerank,regulation of protein targeting to membrane (GO:0090313),-0.30187720445936184,-0.8643488182128355,0.6852367688022284,0.9309409337761172,1.0,7/28,18.24%,CEMIP;MIEF1;ITGB1BP1;DMTN;MIEF2;KCNB1;C2CD5
prerank,positive regulation of keratinocyte migration (GO:0051549),0.4224977927523368,0.8639877582430496,0.6137667304015296,0.9200486985364182,1.0,3/10,12.23%,MAPRE2;IQSEC1;MAP4K4
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.42258857616668866,0.8634210960341704,0.6379928315412187,0.9206301165851971,1.0,3/11,19.40%,ABCG1;LIPC;AGT
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3573733167524803,0.8632866314598655,0.6430976430976431,0.9203517890642301,1.0,4/24,12.54%,PLA2G4B;ABCA3;CDS2;PNPLA8
prerank,negative regulation of T cell activation (GO:0050868),0.32942715241129145,0.863185839016019,0.6628664495114006,0.9200112576585395,1.0,6/35,14.70%,JAK3;DUSP3;TNFRSF21;FOXP3;CEACAM1;NCKAP1L
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3844191206027219,-0.8629216299247291,0.6399132321041214,0.9331460496389383,1.0,2/10,3.84%,OSR1;CAMK2D
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.28715220872571845,0.8628820805702125,0.6818181818181818,0.9200121569331515,1.0,8/87,7.78%,NDNF;TBX1;GRB2;FGF16;DLL4;HYAL2;MAPK3;TIAL1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2728489618900655,-0.8622870596688241,0.6931506849315069,0.9336794942635926,1.0,9/43,18.90%,IGF1;LBP;SELENOS;PTPN22;IRAK3;TLR4;NR1H4;RARA;PTPN6
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.35194427584100246,-0.862174957962622,0.6339869281045751,0.9330236758260511,1.0,5/14,17.10%,IL34;THBS1;CMKLR1;RARRES2;MDK
prerank,regulation of microglial cell activation (GO:1903978),-0.3542941534726647,-0.8619944508054439,0.6658986175115207,0.9325092250465902,1.0,4/15,17.98%,LDLR;SPHK1;GRN;PTPRC
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.32745843425382287,-0.8614990965496987,0.6563981042654028,0.9326719615164346,1.0,15/19,46.12%,APOE;SLC5A7;NQO1;CHRNA4;CHRNB2;ACHE;COLQ;CHRFAM7A;CHRNA7;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3;RAPSN
prerank,zinc ion transport (GO:0006829),0.36156857770059125,0.8610149249466527,0.6413793103448275,0.9231671347125165,1.0,2/21,3.02%,SLC39A8;SLC30A1
prerank,cellular glucan metabolic process (GO:0006073),-0.3830562328340415,-0.8606798355064872,0.6496945010183299,0.9335004817461047,1.0,4/11,10.73%,PRKAG2;PHKB;PYGM;PPP1R3C
prerank,response to estradiol (GO:0032355),-0.2987558026596394,-0.8602728317818309,0.6725,0.9334514602035902,1.0,4/31,6.99%,EGFR;ANXA1;GGT5;LCOR
prerank,oligodendrocyte differentiation (GO:0048709),0.3719541927124941,0.860172094681716,0.6454388984509466,0.9243122275671061,1.0,7/19,18.48%,SOX13;EIF2B1;EIF2B2;SOX10;SOX9;PTPRZ1;TPPP
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3024610147043593,0.8601043829020257,0.6804564907275321,0.9233385005664277,1.0,18/56,27.05%,NDUFAF3;NDUFA2;NDUFA8;NDUFAF7;DMAC2;TMEM126B;NDUFA12;NDUFB3;NDUFAF8;NDUFC1;NUBPL;NDUFA10;ECSIT;DMAC1;TIMMDC1;NDUFA7;TIMM21;NDUFS5
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3024610147043593,0.8601043829020257,0.6804564907275321,0.9233385005664277,1.0,18/56,27.05%,NDUFAF3;NDUFA2;NDUFA8;NDUFAF7;DMAC2;TMEM126B;NDUFA12;NDUFB3;NDUFAF8;NDUFC1;NUBPL;NDUFA10;ECSIT;DMAC1;TIMMDC1;NDUFA7;TIMM21;NDUFS5
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3885759659506481,0.8599923496659149,0.6480446927374302,0.9229865150986184,1.0,6/14,25.56%,CSTF2;CPSF1;NCBP2;NCBP1;CPSF4L;CSTF2T
prerank,regulation of mitochondrion organization (GO:0010821),-0.26811680410272865,-0.8599333656990242,0.7008547008547008,0.9332544813326331,1.0,12/47,18.93%,PID1;PPARGC1A;PRKN;LRRK2;HTRA2;MIEF2;EP300;SREBF1;PARL;FLCN;MUL1;RHOT1
prerank,regulation of neuroblast proliferation (GO:1902692),0.3856120021916394,0.8597412981990986,0.6425992779783394,0.9229233564054605,1.0,4/15,9.62%,CTNNB1;DCT;PTN;DISC1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4217536899245933,0.8590126229476728,0.6484962406015038,0.9238107797090775,1.0,3/11,11.65%,FOXO1;NOTCH1;GSK3A
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3028387887305341,0.8584729058234948,0.6710914454277286,0.9243800944436703,1.0,9/57,12.66%,IL6R;ARL2BP;CD40;LYN;INPP5F;STAP2;PTK6;CNTF;IL15
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3773004196786136,-0.8584647432942195,0.6230936819172114,0.9354338523402391,1.0,4/10,31.50%,TLR4;TLR6;CD36;CD68
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3657635516141905,0.8580475416148452,0.6467486818980668,0.9246463550349149,1.0,3/21,6.18%,MTUS1;PTK2;MAPK3
prerank,GPI anchor metabolic process (GO:0006505),0.349900681173991,0.8580126199599541,0.6505823627287853,0.924167970801612,1.0,8/26,21.77%,PIGU;PIGM;PGAP4;PIGF;DPM3;PIGO;PIGV;PIGQ
prerank,negative regulation of protein depolymerization (GO:1901880),0.3579945510845365,0.8576645983339086,0.6490630323679727,0.9243436169883101,1.0,9/24,25.97%,ARHGEF2;FGF13;ATXN7;APC;CAMSAP2;CLASP1;CAMSAP1;NAV3;CLASP2
prerank,"transcription, DNA-templated (GO:0006351)",0.2563021971035582,0.8573645760935648,0.7796817625458996,0.9243816921423871,1.0,50/207,19.85%,IVNS1ABP;PTMA;RREB1;NOCT;MRPL12;PIR;TAF1B;IRF9;SLC25A33;NKX2-8;GTF2H2;ABT1;RNPS1;YBX2;NFIC;PWP1;KLF13;TRIM24;CEBPD;PKNOX1;CBFB;NCBP2;GTF2H4;NELFCD;CCNK;GTF2B;GTF3A;MLLT1;GTF3C5;RO60;NAT14;HIPK3;ELOB;CRCP;TWNK;UBTF;TAF4B;LHX1;TAF4;MNT;POLR2J;DEK;TAF5;TCEA1;CCNT1;TBPL1;EAF1;THRA;GTF2E2;BRF2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.33199821831941584,0.8570223105921954,0.6521060842433697,0.9244739114593596,1.0,6/35,5.00%,PDE2A;RAPGEF2;RAPGEF3;PDE4D;NPPA;PDE7B
prerank,glycolipid biosynthetic process (GO:0009247),-0.2800799334730839,-0.8569476542152037,0.7195467422096318,0.9378349311040246,1.0,10/38,15.65%,LARGE1;ST3GAL4;A4GALT;ST3GAL5;PIGN;GBGT1;B4GALT6;ST6GALNAC5;PIGA;PIGP
prerank,positive regulation of immune effector process (GO:0002699),-0.30044558143284866,-0.8569086295300231,0.6878306878306878,0.9370137258475401,1.0,2/27,2.68%,APPL2;LBP
prerank,manganese ion transport (GO:0006828),0.39334054776586536,0.8566352549751745,0.6375711574952562,0.9246905827409388,1.0,2/14,3.60%,SLC39A8;ATP2C1
prerank,positive regulation of type I interferon production (GO:0032481),0.2904758346797838,0.8565701715680135,0.7083333333333334,0.9242821526866842,1.0,8/73,7.61%,LRRFIP1;IFIH1;CTNNB1;TLR3;MRE11;STAT1;IRF5;TLR7
prerank,positive regulation of cell division (GO:0051781),-0.28400125808632526,-0.8564765668811877,0.676056338028169,0.9370085465851379,1.0,9/38,16.08%,FGFR2;FGF1;SVIL;CDC14B;CUL3;CDC25B;GIPC1;SIRT2;RACGAP1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.39908438127122975,0.8563309534529305,0.6292335115864528,0.9242071798184781,1.0,1/13,2.06%,PDE8A
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.3074148375228516,-0.8558937922970288,0.6568627450980392,0.9373656365216129,1.0,9/24,17.51%,PKD1;APOE;PRKACA;PSME3;PTK2B;ATP5IF1;RHBDF1;LATS1;NUB1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3431838826899486,-0.8558225932957151,0.680089485458613,0.9366100516643208,1.0,7/17,24.38%,EMC8;EMC7;GET1;EMC1;EMC2;EMC3;EMC4
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3427003545712017,-0.8558097000073888,0.6728538283062645,0.9357416308061652,1.0,5/17,19.66%,GJA1;KDM1A;PTPRC;PDCD2;LTBP3
prerank,response to calcium ion (GO:0051592),0.27742525951527613,0.8557145703761551,0.7071823204419889,0.9248645191462287,1.0,23/102,17.95%,ITPKB;CAV1;MEF2C;MCOLN1;CALM1;ACER1;SYT7;CPNE8;RASGRP2;HOMER1;IQGAP1;CLIC4;CPNE5;PPP3CA;SYT4;CPNE6;PDCD6;NLGN1;CPNE3;CRHBP;TTN;CPNE1;NEUROD2
prerank,regulation of mitochondrial fission (GO:0090140),-0.30945123426862364,-0.8555291352458896,0.6824146981627297,0.935450389801893,1.0,7/24,14.16%,DCN;MCU;PRKN;MIEF1;LRRK2;DDHD1;MIEF2
prerank,response to estrogen (GO:0043627),0.3400644419923016,0.8553836184235021,0.6593220338983051,0.9250006018613616,1.0,4/31,9.46%,CAV1;TRIM25;TRIM24;NCOA4
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.40074964554991216,0.8551846231890015,0.6192236598890942,0.9248407415260967,1.0,5/13,18.60%,STAT1;EBI3;OASL;IL27RA;IL27
prerank,regulation of phosphorylation (GO:0042325),0.2759086124445925,0.8549451414390371,0.7539473684210526,0.9247584200252706,1.0,23/120,15.38%,ITGA6;APP;PTK2;NLRC5;LYN;FNIP2;IKBKB;CCDC88A;DYNLL1;CDKN2B;PIN1;HSPB1;NUP54;ZBTB7A;HIF1A;KCTD20;SDCBP;CDH5;PGAM1;BCL10;NCKAP1L;BTBD10;NUP160
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.39215059479411074,0.8547764848000977,0.6358595194085028,0.9245227875832458,1.0,6/13,25.56%,CSTF2;CPSF1;NCBP2;NCBP1;CPSF4L;CSTF2T
prerank,establishment of mitotic spindle localization (GO:0040001),-0.30244174170410343,-0.8545149578166038,0.648,0.9366929729392348,1.0,14/28,32.62%,GJA1;GPSM2;FBXW11;NUSAP1;MAD2L1;MISP;HTT;KPNB1;SPDL1;NUMA1;ITGB1;PLK1;ESPL1;PKHD1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.41535081994141493,0.8543574798541551,0.6304347826086957,0.9247779308635641,1.0,1/10,2.03%,TIRAP
prerank,cellular response to amino acid stimulus (GO:0071230),0.32871516056209926,0.8543454509147329,0.6309904153354633,0.9242522725243484,1.0,9/33,19.26%,SH3BP4;SESN3;FYN;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2;GLRA2
prerank,nucleosome organization (GO:0034728),0.30315545358672424,0.8543431426088808,0.6774668630338734,0.9237080938585275,1.0,24/55,25.82%,PRDM9;ARID1A;HMGA1;CTCF;CHAF1A;NAA60;SMARCD1;SOX9;HMGB2;VPS72;POLE3;RNF8;CHAF1B;SET;SRCAP;GRWD1;NASP;DAXX;LIN54;INO80;NAP1L4;ARID2;SMARCA4;SART3
prerank,positive regulation of exosomal secretion (GO:1903543),-0.3538818509605364,-0.8541878591153147,0.7016317016317016,0.9364891798700676,1.0,3/15,7.96%,SMPD3;TSG101;SDC4
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.39010116813978224,-0.8540699915702862,0.6617954070981211,0.9358257347664427,1.0,7/10,32.90%,GAR1;RPUSD4;RPUSD1;TSR3;RPUSD2;RPUSD3;NOP10
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.36728565043410555,-0.853734952926472,0.6547884187082406,0.9356604426275662,1.0,2/13,6.78%,PLXNA2;PLXNB2
prerank,membrane raft organization (GO:0031579),-0.34461175540044386,-0.8535545524438845,0.6528735632183909,0.9351527191373192,1.0,4/15,11.08%,ANXA2;S100A10;FLOT2;CLN3
prerank,positive regulation of translational initiation (GO:0045948),-0.32942191719391584,-0.8532142748933672,0.6629464285714286,0.9350181539407508,1.0,7/18,32.92%,HABP4;DDX3X;YTHDF1;RPS6KB1;CDC123;BOLL;CCL5
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3365189968704194,-0.8532030262496115,0.6725888324873096,0.9341596787240282,1.0,1/18,0.45%,FBN1
prerank,positive regulation of transporter activity (GO:0032411),-0.36425718245229755,-0.852914980027166,0.6644736842105263,0.9338507778837365,1.0,7/13,31.29%,TRPC6;RXRA;KCTD7;WNK3;SYNGR3;KMT2A;PDZK1
prerank,negative regulation of cell aging (GO:0090344),0.3794102233460216,0.8525587355918369,0.6577540106951871,0.9266642856798164,1.0,7/16,23.01%,YBX1;TERF2;MAP3K3;RBL1;HMGA2;CDK6;AKT3
prerank,protein localization to nucleus (GO:0034504),-0.23283470486466457,-0.852270987580959,0.8048780487804879,0.9342968038585193,1.0,29/102,27.08%,COL1A1;APPL2;BMP7;BMP4;LMNA;RANBP17;SIX1;PML;TOR1AIP1;TAF8;PAF1;MORC3;E2F3;FAM53B;SIX4;CNEP1R1;IPO7;BBS4;WRN;GBP2;BCL3;STAT3;KPNB1;MSX1;HIKESHI;NUP155;IPO8;TPR;NOP53
prerank,regulation of tissue remodeling (GO:0034103),0.36692809534495463,0.8517228520556474,0.6606822262118492,0.9277420864929362,1.0,5/18,12.66%,FLT4;SYT7;TGFB1;CEACAM1;IL15
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.3559824789622731,0.8515891157066886,0.6497545008183306,0.9274792536337646,1.0,9/23,27.37%,CYP2E1;ELOVL6;LTA4H;GPX4;HPGD;GSTM1;LTC4S;ACSBG1;ASAH2
prerank,long-term synaptic potentiation (GO:0060291),-0.3153708815902559,-0.851155908463602,0.6982968369829684,0.9356745241944626,1.0,9/21,27.37%,SLC8A3;NFATC4;PTK2B;TSHZ3;STX4;VAMP2;PRKCZ;GRIN2D;SLC8A2
prerank,proton transmembrane transport (GO:1902600),-0.286315953876847,-0.8508611585298566,0.7002652519893899,0.9354021125167515,1.0,2/36,5.04%,ATP1A2;ATP6V0A4
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.2775866039154355,-0.8507065289185748,0.7418478260869565,0.9348332163100048,1.0,5/41,5.81%,ACSL1;PTGS1;DAGLA;CYP1B1;ACOT8
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3002969177519057,-0.8502900840141348,0.7039800995024875,0.9348338705904718,1.0,8/28,17.71%,ITPR1;MAP3K5;TMEM117;BCL2;CEBPB;ATP2A3;DDIT3;CASP4
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.4181389466463016,0.8501603594280808,0.6383763837638377,0.9297584044972752,1.0,4/11,8.63%,VIL1;RREB1;ARHGEF7;ENPP2
prerank,mesoderm formation (GO:0001707),0.36958584604548195,0.8499333439524845,0.6374570446735395,0.9296861452080039,1.0,1/17,1.29%,BMPR2
prerank,response to laminar fluid shear stress (GO:0034616),0.4152488898298506,0.8498821326909409,0.6581818181818182,0.9292402328381396,1.0,3/10,6.45%,KLF2;SMAD7;KLF4
prerank,regulation of response to stress (GO:0080134),0.42629799725929635,0.8498471311993341,0.636697247706422,0.9287495707632933,1.0,1/10,2.60%,CORO2B
prerank,protein deubiquitination (GO:0016579),0.25183647168811274,0.8495935201905958,0.7920560747663551,0.9286964893806815,1.0,86/242,27.39%,MINDY1;NFKBIA;IFIH1;ACTB;SMAD7;SNX3;ATXN3;CCP110;EIF3F;PSMB3;PSMD11;BIRC3;SHMT2;PSMC6;PSME2;OTUD7A;MYSM1;BABAM1;SMAD1;MINDY2;PSMD8;USP18;HIF1A;TADA2B;POLB;HGS;ATXN7;WDR48;CYLD;TNFAIP3;PSMB10;WDR20;TRRAP;MCRS1;APC;PSMA8;COPS5;HCFC1;RAD23A;USP49;RCE1;TNIP1;PSMD9;JOSD2;USP32;USP29;UBE2D1;BRCC3;TRAF3;OTUD4;ASXL1;USP25;USP21;OTUD7B;DESI2;JOSD1;SUDS3;KAT2B;MBD5;PSMC3;PSMD1;STAMBP;RAD23B;INO80;PSMD10;TRAF6;ENY2;RIPK1;USP30;VCPIP1;FOXO4;MYC;KEAP1;KDM1B;ZC3H12A;USP38;PSME1;USP45;TAB1;ACTR5;ADRB2;UBB;PSMD2;PSMA1;ADRM1;NFRKB
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2874434820886604,0.8489806919141983,0.699290780141844,0.9293426211275927,1.0,13/85,12.31%,FZD6;FZD4;TIAM1;WNT7A;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;PSMD8;RAC1;AP2B1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.37278176460944734,0.8485834845114798,0.6453382084095064,0.9295604239632037,1.0,1/18,1.02%,DAB2IP
prerank,regulation of receptor internalization (GO:0002090),0.3259150602574438,0.8485131397924334,0.6612641815235009,0.9291622525928718,1.0,6/35,8.89%,INSR;ANKRD13A;RIN3;TBC1D5;MKLN1;GREM1
prerank,cardiocyte differentiation (GO:0035051),0.41630152564447875,0.8484126908067553,0.6597744360902256,0.9288043450699519,1.0,1/10,1.32%,TGFB2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.38483996004464566,0.8480834658659631,0.6513274336283186,0.9288891083191625,1.0,4/15,12.84%,PPARD;NR1H2;ELOVL5;PPARG
prerank,peroxisome organization (GO:0007031),-0.30447422307338984,-0.8477867975441906,0.6675,0.9391481301036273,1.0,7/25,18.06%,ABCD3;ACOT8;SEC16B;PEX7;PEX2;TMEM135;PEX11A
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3336576663083577,-0.8477352923461248,0.6718403547671841,0.9383678827712141,1.0,4/18,15.47%,FCHSD2;DTNA;SLC5A7;STAC3
prerank,plasma membrane tubulation (GO:0097320),0.3958077594160136,0.846904711910142,0.63016157989228,0.930595197972368,1.0,2/13,9.16%,FNBP1L;CAVIN2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.27149465281411295,0.8467820945068116,0.7171314741035857,0.9302886647224239,1.0,16/104,12.42%,DAB2IP;ACTB;CALM1;FGF16;CDKN2B;RALB;CCNI;IRGM;LRP5;CCND3;TRIB2;PDCD10;CDC6;CCNK;RPTOR;HGS
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.37835343562959445,-0.8467339446063115,0.6510067114093959,0.9395810077828746,1.0,3/10,12.27%,SOX5;SOX6;PKDCC
prerank,acyl-CoA metabolic process (GO:0006637),0.32425240791297333,0.8467198609258468,0.6527545909849749,0.9298669371673977,1.0,5/35,7.77%,HMGCS2;ACBD6;GLYAT;ACACB;ACSL6
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.3015313371035135,-0.8463450727560665,0.7018970189701897,0.939497088532535,1.0,8/26,18.80%,TRAFD1;PPM1B;IRAK3;SIRT2;MAPKBP1;PCBP2;C1QBP;MUL1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2627476500427175,-0.8461999348897501,0.7546583850931677,0.9389017928342466,1.0,11/52,13.05%,LMNA;SHC1;KDELR3;ARFGAP1;GFPT1;TSPYL2;SEC31A;CUL7;FKBP14;TLN1;SYVN1
prerank,nucleoside salvage (GO:0043174),0.4145804625293379,0.8456852789906514,0.6451016635859519,0.9312751169470851,1.0,1/10,3.05%,HPRT1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.26247193903251553,0.845237539872723,0.7587096774193548,0.9315973093493674,1.0,13/153,6.84%,PRKCH;PDGFB;STK38;PKN3;RPS6KA1;PRKD1;PRKD2;IKBKB;PIKFYVE;MAST4;PKN1;RPS6KA5;PKN2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.336248440555303,0.8443460452368006,0.6736,0.9327378193177708,1.0,8/30,13.42%,RYBP;HSP90AB1;N4BP1;UBXN1;SVIP;RPL11;TRIM39;SDCBP
prerank,positive regulation of neuron differentiation (GO:0045666),0.3114645793133175,0.8442015229580768,0.696969696969697,0.9324705397407116,1.0,12/40,17.95%,ARHGEF2;MEF2C;MMD;ADRA2B;BRINP3;BRINP2;SOX11;NRCAM;PROX1;SIN3A;CPNE1;NEUROD2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.31176836971827193,0.8437456538794001,0.7113884555382215,0.9328038771665103,1.0,20/46,30.85%,TOMM22;TIMM13;TIMM10;HK1;DNAJC19;MFF;TOMM20L;RALA;CHCHD4;TOMM7;TOMM5;TIMM21;TIMM50;TOMM70;BCAP31;TIMM9;AIFM1;FIS1;GRPEL2;AKT1
prerank,myofibril assembly (GO:0030239),0.3132470157549977,0.8434967674994651,0.6754250386398764,0.9327529963636066,1.0,2/42,1.54%,FLII;PGM5
prerank,cell projection organization (GO:0030030),0.3304625653069739,0.842977705865554,0.6700167504187605,0.9331902386581364,1.0,8/30,14.70%,PARVB;PARVG;NCKAP1;CAPG;CYFIP1;RAC1;RHOV;NCKAP1L
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.37313223260326794,0.8425950169762476,0.6521739130434783,0.9333656818597412,1.0,4/16,18.03%,VPS36;TMEM50A;VPS25;LEPROTL1
prerank,methylguanosine-cap decapping (GO:0110156),0.4149102544755851,0.8423488175936662,0.6340996168582376,0.9333098468263442,1.0,4/10,13.62%,EDC3;DCP2;DCP1B;PNRC2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4119812452729489,0.8416980521045756,0.6509803921568628,0.9339946139328549,1.0,6/10,31.00%,INPP5F;SH2B3;SOCS1;PARP14;PPP2R1A;NF2
prerank,protein maturation (GO:0051604),-0.2330110384692354,-0.8413989222957334,0.7985611510791367,0.9476931881652486,1.0,15/95,12.41%,AEBP1;PCSK5;MMP14;MMP16;F3;OGT;NAA35;NNAT;ADAM19;CPXM1;CPXM2;CLN3;AFG3L2;LMF1;PSEN1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.38801289251931637,-0.8409931444398566,0.6688453159041394,0.9476349747775142,1.0,2/10,6.13%,DNMT3A;IGF2
prerank,myotube differentiation (GO:0014902),0.37276840343366713,0.8402626683275769,0.6780575539568345,0.9361900017281459,1.0,3/17,5.10%,JAM2;MEF2C;SORT1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.28457685196641525,-0.8398040563623624,0.6855036855036855,0.9491787295486278,1.0,5/33,6.43%,KANK2;FHL1;PKD2;DLG1;DACT1
prerank,cellular response to nitrogen compound (GO:1901699),-0.3183802624212448,-0.8396606698398487,0.678082191780822,0.9485692846539998,1.0,1/20,0.65%,ROCK2
prerank,rRNA 3'-end processing (GO:0031125),-0.38519581425336713,-0.8395740183580622,0.6738197424892703,0.9478748978282796,1.0,4/10,25.05%,ERI3;ERI2;EXOSC2;ERI1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2732908705154118,-0.8394292108478368,0.7506925207756233,0.9472641445049295,1.0,7/40,13.91%,PID1;SLC25A36;BCL2;PPA2;LRRK2;ABL1;ATP5IF1
prerank,protein complex oligomerization (GO:0051259),0.28276889452476284,0.8392295138072021,0.7517337031900139,0.9375772538974139,1.0,17/85,16.56%,AQP11;LRRC8C;KCNC2;HOMER1;SHMT2;MAT2A;LETM1;EHD4;LRRC8D;BCL10;ELAVL1;TRMT61B;CARD11;TWNK;PDCD6IP;SPAST;NLRC4
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.32395719560574876,-0.8388839662737209,0.6707317073170732,0.9474552173057772,1.0,2/19,2.73%,AXL;MMP14
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.357023066684805,0.8383725136947322,0.6468531468531469,0.9385800379315603,1.0,1/21,0.99%,BCL2L1
prerank,fatty acid metabolic process (GO:0006631),0.2683047812295718,0.8382142298249878,0.7710526315789473,0.9383385415174609,1.0,19/115,15.00%,ADIPOR2;FASN;PPARD;ACSL5;CPT1A;CRAT;ACOX1;ABCB11;ACSL6;ACSL3;LIPC;ADIPOR1;PNPLA8;PPARG;SLC27A2;LPIN3;HACL1;HSD17B8;FA2H
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.3641101492035918,0.8378782664908685,0.6564625850340136,0.9383980846018041,1.0,3/19,6.44%,TIRAP;TRIL;LGALS9
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3599971139140552,0.8375843834888553,0.6642728904847397,0.9378510153588205,1.0,6/20,11.82%,INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,positive regulation of glycolytic process (GO:0045821),0.3599971139140552,0.8375843834888553,0.6642728904847397,0.9378510153588205,1.0,6/20,11.82%,INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,cellular response to inorganic substance (GO:0071241),0.3522669263044734,0.8370274421502251,0.6773648648648649,0.9383511226753386,1.0,2/21,5.21%,FOXO1;KCNC2
prerank,negative regulation of bone remodeling (GO:0046851),0.40895287277633074,0.8369663246209098,0.6424581005586593,0.9379053379605369,1.0,4/11,21.75%,P2RX7;GREM1;TNFAIP3;GPR137
prerank,macrophage activation involved in immune response (GO:0002281),0.38770493984232046,0.8368791622341726,0.6410256410256411,0.9375449987911556,1.0,5/13,20.06%,DYSF;SYK;NMI;SBNO2;PLCG2
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.3511432993028455,-0.8357912755412403,0.6586433260393874,0.9527926059987727,1.0,5/13,21.27%,ATG10;SENP6;UBA1;UBA6;UBA2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2402162713285772,0.8356200136759139,0.851685393258427,0.9394194732791498,1.0,95/341,23.33%,RNF144B;ZNRF1;TRIM25;NEDD4L;PELI1;RNF125;ZNRF3;CTNNB1;KLHL25;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;RNF215;PSMD11;PSMC6;FEM1C;KLHL3;NDFIP2;PSME2;PPP1R11;SMURF1;UBXN1;KCTD10;OTUD7A;SHARPIN;KLHL20;RNF130;TOLLIP;UBE3D;UBQLN1;PSMD8;GSK3A;RNF187;ARRDC1;MAEA;BUB3;TNFAIP3;PSMB10;FBXO21;NHLRC1;RBX1;PTTG1;ANAPC16;TRIM2;UBE2D3;AREL1;RNF8;PSMA8;ATE1;ARMC8;RAD23A;ANAPC7;UBE2G2;BAG6;GID8;BFAR;RNF19A;TRIM71;TRIM3;KCTD17;ANAPC10;PSMD9;SIAH1;CBL;RNF4;UBE2D1;VPS37A;OTUD7B;RBCK1;RNF166;FBXO8;ANAPC2;NSFL1C;PLAA;ANKRD9;VPS37B;ERCC8;MIB1;RLIM;DDB1;PSMC3;UBL7;PSMD1;CDC23;RAD23B;RNF126;VPS37C;CNOT4;PSMD10;CDC26;FBXL14;CDC27
prerank,negative regulation by host of viral process (GO:0044793),0.4091220563334294,0.8350346825290967,0.6684981684981685,0.9399713403013341,1.0,5/10,25.68%,EIF2AK4;CCNK;PSMC3;PTX3;ZC3H12A
prerank,regulation of TOR signaling (GO:0032006),0.2887385774758361,0.834951066085599,0.7130434782608696,0.9395870436342405,1.0,16/67,16.47%,SH3BP4;TNFAIP8L1;GNA12;WDR59;RFFL;DEPDC5;DDIT4;LAMTOR5;GSK3A;RPTOR;TMEM127;PDCD6;EPM2A;TBCK;LAMTOR4;GAS6
prerank,regulation of DNA replication (GO:0006275),-0.25752741835220644,-0.8341843420734718,0.7465181058495822,0.9551997076410523,1.0,7/49,11.32%,EGFR;GLI2;EHMT2;GLI1;TSPYL2;ZBTB38;NUCKS1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2632654681644485,0.8338190993327192,0.7826666666666666,0.9412046437609538,1.0,23/132,12.44%,INSR;SH3BP4;APP;PRR5L;TRIM14;FOXO1;PRKD1;ENTPD5;IRGM;P2RX7;MSN;GTPBP1;PFKFB3;PIK3C2A;ABCD1;GSK3A;HIF1A;SH3GLB1;ORMDL3;PIK3CB;SVIP;DXO;TFEB
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3781468704868536,0.833807917775677,0.660482374768089,0.9406787439173606,1.0,3/14,9.70%,IMPDH1;ADSS2;GART
prerank,macrophage migration (GO:1905517),-0.35775120974514635,-0.8337541447206661,0.6894273127753304,0.9552115213319854,1.0,8/13,44.82%,P2RX4;CKLF;CCL2;CCL5;P2RY12;TAFA4;CXCL17;CCL3
prerank,regulation of cation channel activity (GO:2001257),-0.23254640571004564,-0.8333693555633939,0.8581818181818182,0.9551249643395683,1.0,22/89,18.42%,ANK2;ACTN2;NLGN2;DMD;CAMK2D;DLG1;DLG4;SLMAP;CACNB4;PRKACA;PRRT1;PTK2B;GRIA3;CACNB2;JPH1;CACNB1;CAPN1;FGF11;KCNAB1;VAMP2;AHNAK;JPH2
prerank,response to hexose (GO:0009746),-0.3023762881643677,-0.8332821014376564,0.7525510204081632,0.954416269542342,1.0,3/25,7.88%,THBS1;IRS2;SELENOS
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.33897476052078107,-0.8331491486257018,0.7142857142857143,0.9537888747740245,1.0,3/16,11.39%,SLC39A14;PRKCA;PRMT5
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.32870405011631043,0.8331219450459294,0.6766561514195584,0.9414007994693044,1.0,2/31,7.20%,GCH1;GPHN
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.3330435292103457,-0.8328089246972508,0.6863636363636364,0.9535885441340637,1.0,7/16,17.12%,AMPD3;PAICS;LHPP;IMPDH2;GMPS;ADSL;ATIC
prerank,protein homotetramerization (GO:0051289),0.30149150051208917,0.8328056255159958,0.7057010785824345,0.9414610812565383,1.0,7/49,8.05%,B2M;HPRT1;GBP5;SAMHD1;MCOLN1;ACACB;SHMT2
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.26619795466601887,-0.832782155554198,0.7594202898550725,0.9527680109579716,1.0,10/46,15.57%,PLD1;AGPAT4;LCLAT1;GPD1L;PLA2G12A;ACP6;GPAT3;DDHD1;PNPLA3;SLC27A1
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.33066500477118743,-0.8327667078177361,0.7071583514099783,0.9519308644288874,1.0,8/16,40.93%,TOP2B;TOP2A;HFM1;MEIOB;EME1;SHOC1;CENPS;MUS81
prerank,NAD biosynthetic process (GO:0009435),0.3548808315937277,0.8325796232468381,0.6942003514938488,0.9413697087360257,1.0,1/20,0.77%,NAMPT
prerank,positive regulation of TOR signaling (GO:0032008),-0.27883765418811174,-0.8323911468506768,0.7416879795396419,0.9518124947150264,1.0,9/40,18.58%,FNIP1;KLHL22;SEH1L;RHEB;CLEC16A;LAMTOR3;RRAGA;SMCR8;FLCN
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2374319926292875,-0.8319556992045135,0.8548895899053628,0.9517757717420123,1.0,27/80,26.63%,DENND2A;SGSM2;SNX6;GBF1;SNX12;STX5;ARL1;TBC1D10A;SNX5;SNX8;RAB29;RAB6A;LMAN1;STX16;TRAPPC10;SURF4;SNX32;VPS54;BET1L;VAMP3;TMED9;VPS26A;RAB9A;BAIAP3;PHETA2;VPS26B;RHOBTB3
prerank,negative regulation of biosynthetic process (GO:0009890),-0.33613734742560664,-0.8317617306096136,0.68,0.951264553921236,1.0,4/16,11.85%,SLC30A10;PPARA;EMILIN1;TRAP1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3484558121264046,0.831660518836709,0.6722972972972973,0.9424939175812395,1.0,9/22,26.98%,GTF2H2;CETN2;GTF2H4;RBX1;GTF2H3;DDB1;RAD23B;XPC;UBB
prerank,heart process (GO:0003015),-0.34085224375823886,-0.8314445587609397,0.7060185185185185,0.9510134655276091,1.0,3/14,7.82%,SGCD;ACE;NOX4
prerank,glycoprotein catabolic process (GO:0006516),0.37095649235688066,0.8313293064704101,0.6742160278745645,0.9425837479974888,1.0,7/17,13.92%,OGA;NEU4;STT3B;FBXO6;MANBA;EDEM1;NEU2
prerank,ubiquinone metabolic process (GO:0006743),-0.33686205617744247,-0.8310216394755459,0.6808510638297872,0.9509613374105033,1.0,5/15,19.93%,COQ10A;AIFM2;COQ2;COQ8B;COQ10B
prerank,multivesicular body organization (GO:0036257),0.32386335960775736,0.830957254379671,0.694078947368421,0.9427526286969843,1.0,13/31,28.32%,RAB11A;CHMP1B;VPS36;HGS;VPS25;PDCD6IP;VPS37A;VPS37B;VPS37C;CHMP2B;VPS4B;RAB27A;VPS28
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.32733651637902766,0.830610695438837,0.6791862284820032,0.9428573306451993,1.0,10/32,20.09%,HMBOX1;CTNNB1;MAPK3;CCT3;CCT5;ACD;MAPK1;CCT7;NAF1;MAP2K7
prerank,regulation of proteolysis (GO:0030162),0.29958304847467293,0.8303023224616256,0.7254038179148311,0.9429119167317772,1.0,3/48,2.28%,LTBP4;CAV1;PLAUR
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.33660377677431474,-0.8298611620887024,0.6768558951965066,0.9522650683337568,1.0,2/14,4.11%,NMNAT2;ME1
prerank,DNA methylation or demethylation (GO:0044728),-0.3159163085008264,-0.8298322819379133,0.7219626168224299,0.9505751812384534,1.0,5/19,19.69%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15
prerank,DNA alkylation (GO:0006305),-0.3159163085008264,-0.8298322819379133,0.7219626168224299,0.9505751812384534,1.0,5/19,19.69%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.3699009648464409,-0.8293294670546442,0.6865342163355408,0.9506944481848656,1.0,5/11,37.06%,SIRT1;CIITA;TMEM106A;PF4;IL4
prerank,transport along microtubule (GO:0010970),-0.34769742194723846,-0.8291216090346375,0.6870748299319728,0.9502171323210084,1.0,8/13,23.27%,ARHGAP21;CLIP3;DYNC1I1;SPG11;BAG3;APBA1;BORCS5;COPG1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.31599361843019447,-0.8287549168065337,0.7020316027088036,0.9500933352139181,1.0,6/20,17.34%,NR2F2;CDK5RAP1;PTEN;CDKN1C;LATS1;MYOCD
prerank,negative regulation of transposition (GO:0010529),-0.3331680221599225,-0.8285380937508862,0.6868008948545862,0.9496622650704308,1.0,8/16,28.68%,TUT4;UBR2;TEX15;PIWIL2;MYBL1;TDRD9;MOV10;DDX4
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.3355323466704865,0.8283166417803236,0.6945337620578779,0.9460603145240162,1.0,2/27,2.59%,UTRN;NEDD4L
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3167441180661925,-0.8281977366540065,0.7070217917675545,0.9494791895088354,1.0,3/20,5.80%,MCU;SLC8A3;SLC8B1
prerank,cellular senescence (GO:0090398),0.3393640620035393,0.8280139059516616,0.7015873015873015,0.9460816427676345,1.0,6/27,11.49%,TBX3;CDKN2B;KAT6A;TERF2;HMGA1;HRAS
prerank,regulation of protein polymerization (GO:0032271),-0.2755523240973118,-0.8279076520960286,0.7598039215686274,0.9491335823789413,1.0,10/35,18.28%,ARHGAP28;FCHSD2;PLEKHG2;ARHGAP18;PFN2;ABL1;MAP2;CTTN;LATS1;DBN1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3735502720964881,0.8277334584664556,0.6537102473498233,0.946042590907619,1.0,4/13,26.57%,PVR;CYRIB;NECTIN2;IL12A
prerank,regulation of lipid storage (GO:0010883),0.3424105585048886,0.8277143858428895,0.671957671957672,0.9455418960018109,1.0,2/22,6.44%,NFKBIA;FBXW7
prerank,cellular response to decreased oxygen levels (GO:0036294),0.2875680202751122,0.8270407217918645,0.7466863033873343,0.946274169223156,1.0,11/65,12.89%,NDNF;EPAS1;RGCC;AK4;EGLN2;BNIP3L;UBQLN1;HIF1A;ZFP36L1;EGLN1;HIPK2
prerank,macromolecule catabolic process (GO:0009057),0.33079211575111345,0.8269417303301165,0.6967071057192374,0.9459193309252889,1.0,13/26,27.66%,TGFB1;TRIM24;SMURF1;SH3GLB1;CLN8;USE1;SIAH1;UVRAG;LGMN;SNX25;MTOR;PPT1;BECN1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3339100236651131,-0.8268155150628909,0.7,0.9503469330981408,1.0,5/16,14.96%,TNKS2;ATM;RTEL1;PARP1;HNRNPA2B1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3157256091018927,0.8267451724530138,0.6873065015479877,0.9457606055267186,1.0,9/37,13.42%,RYBP;HSP90AB1;N4BP1;RPS7;UBXN1;HIPK2;RPL11;TRIM39;SDCBP
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.32283330057708176,-0.826488432425887,0.7139364303178484,0.9501003145388441,1.0,5/20,18.35%,FKBP5;PPIC;PPIL2;PPIH;NKTR
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.29962721693096717,0.8263429554456788,0.7276785714285714,0.9459481139208481,1.0,8/49,12.66%,IL6R;ARL2BP;CD40;LYN;STAP2;PTK6;CNTF;IL15
prerank,positive regulation of actin nucleation (GO:0051127),-0.37062368608444884,-0.8258420039010168,0.6756756756756757,0.9504458214781545,1.0,3/11,7.33%,GSN;FCHSD2;ABI2
prerank,bone morphogenesis (GO:0060349),-0.3435016564682468,-0.8256296783023652,0.6928104575163399,0.9499980564578024,1.0,5/14,15.26%,FGFR2;CYP26B1;SFRP4;SKI;LRP6
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.32523151253538907,-0.8254430199570297,0.7186046511627907,0.949506563861166,1.0,4/20,7.91%,ROCK2;RHOQ;DLG1;FHOD1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3079811947891411,-0.8234240178751989,0.7085308056872038,0.9524718197205468,1.0,6/22,17.34%,NR2F2;CDK5RAP1;PTEN;CDKN1C;LATS1;MYOCD
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.32511838109908253,0.823100143196176,0.679549114331723,0.9513718043543624,1.0,9/32,22.58%,TAF1B;MAPK3;GTF2H2;GTF2H4;RRN3;UBTF;POLR1A;GTF2H3;TAF1C
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.32420299452102214,-0.8221734360967276,0.7217194570135747,0.9540383421265675,1.0,6/19,13.53%,CUX1;OBSL1;FBXW8;CUL7;CAPRIN2;CDKL3
prerank,RNA 3'-end processing (GO:0031123),0.278350207416153,0.8220019947617893,0.7615499254843517,0.9528627980584429,1.0,9/69,13.09%,TENT4A;MTPAP;RNPS1;CSTF2;CPSF1;MAGOHB;THOC6;NCBP2;ZC3H11A
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.37095099191521447,0.8216655808958604,0.6895910780669146,0.9529367454930879,1.0,5/15,23.40%,FAM107A;ZFP36L1;NR3C1;ZFP36L2;ISL1
prerank,positive regulation of viral genome replication (GO:0045070),0.328697086236494,0.8216295580014447,0.6993569131832797,0.9524569189398574,1.0,6/29,10.78%,FKBP6;ADAR;PPIA;PKN2;PDE12;NR5A2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.303662699424205,-0.8211707876498843,0.7382075471698113,0.9550023687382471,1.0,8/22,25.47%,ERI3;ERI2;WDR12;NOP14;EXOSC2;NOP9;ERI1;UTP20
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.3876387102094367,0.8211322831391294,0.6544789762340036,0.9528004875015721,1.0,5/11,16.32%,TGFB2;SMAD7;TGFB1;TGFBR2;ACVR1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.33548216956784177,0.8211228638154308,0.679465776293823,0.9522716892925527,1.0,4/26,6.84%,APP;DUSP3;TAL1;PKN2
prerank,spliceosomal snRNP assembly (GO:0000387),0.30849682037757215,0.8210215224737054,0.7218543046357616,0.9519054549223048,1.0,21/38,31.72%,SNRPF;SNRPC;SNRPE;SNRPB;AAR2;PRMT7;LSM4;SNRPD2;WDR77;PRPF8;SART3;DDX20;SNRPD1;SRSF12;SMN1;PRPF31;COIL;GEMIN5;PRPF6;SNRPG;SNRPD3
prerank,regulation of urine volume (GO:0035809),-0.3806367659295288,-0.821014300213867,0.6887417218543046,0.9544300217261305,1.0,3/10,13.15%,NPR3;ADCY6;ADM
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3680879016321206,0.8208441511134695,0.6835205992509363,0.9516652157505685,1.0,5/14,16.18%,CRAT;ACOX1;ABCD1;ECI2;DECR2
prerank,protein import into peroxisome membrane (GO:0045046),-0.30030707803811263,-0.8206648992928748,0.7265822784810126,0.9541965722619941,1.0,6/22,23.80%,ABCD3;PXMP2;PEX2;ALDH3A2;ATAD1;PEX13
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.3580222890720245,-0.8198138735466002,0.7033898305084746,0.9548973676224863,1.0,3/11,24.32%,C1QTNF3;EP300;C1QTNF12
prerank,cell junction maintenance (GO:0034331),-0.34534904257825927,-0.8196390939869876,0.7095238095238096,0.954362070833487,1.0,5/14,25.83%,NLGN2;CLDN1;MYADM;CBLN2;PRTN3
prerank,positive regulation of cation channel activity (GO:2001259),0.3058877548943964,0.8191288569008007,0.7149532710280374,0.9542514514641406,1.0,4/40,6.96%,SHANK3;TMSB4X;CALM1;PIRT
prerank,cytoplasmic microtubule organization (GO:0031122),0.29588982733890573,0.8188322634979973,0.7340764331210191,0.9542564184267901,1.0,18/54,21.14%,CCDC13;CLIP1;CCDC88A;LIMK2;CCDC88B;STMN3;RAB11A;CRIPT;HOOK1;MAP10;SLK;SPAST;TRPV4;CLIP2;CAMSAP2;TPPP;DCTN1;CLASP1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2927240709603658,0.8187294907171438,0.7419825072886297,0.9539019648914525,1.0,18/57,19.90%,TNFSF10;NOD1;FOXL2;SOX7;FYN;AIM2;MALT1;CASP8;ARL6IP5;GRIN2B;SYK;BCL10;PDCD6;NLRC4;PPM1F;BAK1;CYCS;F2R
prerank,tRNA wobble base modification (GO:0002097),-0.34192096607061423,-0.8186875267840756,0.696969696969697,0.9552047246305669,1.0,4/14,15.34%,TRMT9B;ELP3;ALKBH1;ELP4
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.28516130654310023,0.8185411797901453,0.7355491329479769,0.9537306805165932,1.0,20/70,23.04%,B2M;IKBKB;PSMB3;PSMD11;MFSD6;TAP2;PSMC6;PSME2;CYBB;PSMD8;NCF4;PSMB10;PSMA8;PSMD9;TAP1;PSMC3;PSMD1;VAMP8;PSMD10;CALR
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.3019458073274385,-0.8179750252493725,0.7242268041237113,0.955713632372495,1.0,11/23,32.62%,GJA1;GPSM2;FBXW11;MAD2L1;MISP;HTT;SPDL1;NUMA1;ITGB1;PLK1;PKHD1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.377146840354864,-0.8173851995074666,0.6946236559139785,0.9559373653027968,1.0,4/10,17.48%,ALDH7A1;HNMT;COMT;SARDH
prerank,lipoprotein catabolic process (GO:0042159),0.3923132775261775,0.8172095914957932,0.6928838951310862,0.9556429781013346,1.0,3/11,8.87%,NOTUM;ABHD17A;LYPLA1
prerank,RNA splicing (GO:0008380),0.2664533884134762,0.8169339995465342,0.7782485875706214,0.9555839947339241,1.0,34/95,29.87%,IVNS1ABP;PPP1R9B;RNPS1;SNRPF;HNRNPC;MAGOHB;SNRPN;ZCRB1;MPHOSPH10;NCBP2;SNRPB;PRPF4;RSRC1;SCNM1;SMU1;LSM4;SNRPD2;RBM8A;SF3B3;NCBP1;PRPF8;SMNDC1;USB1;SCAF11;SNRNP48;PPP2R1A;NOL3;SNRPD1;SRSF7;LSM6;PPIG;BCAS2;PRPF6;ZRSR2
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2913232800288269,-0.8166979116819394,0.7216494845360825,0.9563459162693843,1.0,6/24,18.24%,CEMIP;MIEF1;ITGB1BP1;MIEF2;KCNB1;C2CD5
prerank,negative regulation of axonogenesis (GO:0050771),0.32566205471727955,0.8165883042424883,0.714759535655058,0.9556748293836754,1.0,6/27,15.22%,FGF13;DIP2B;ARHGDIA;MAG;SEMA3G;DCC
prerank,global genome nucleotide-excision repair (GO:0070911),0.33307690218899016,0.816414882763454,0.6872909698996655,0.9554450115736272,1.0,11/26,26.98%,GTF2H2;CETN2;GTF2H4;RBX1;GTF2H3;DDB1;ERCC4;RAD23B;XPC;USP45;UBB
prerank,neurogenesis (GO:0022008),-0.26240922843913617,-0.8163904677884629,0.7528409090909091,0.9560796091711069,1.0,5/43,5.68%,LPAR1;TRAK1;DAGLA;ANXA1;SIX1
prerank,regulation of platelet aggregation (GO:0090330),0.3666137143644312,0.8161987199337473,0.7125645438898451,0.9553094440350131,1.0,5/17,12.02%,F11R;LYN;PRKG1;SYK;CEACAM1
prerank,cGMP-mediated signaling (GO:0019934),0.3748137402270644,0.8160453345385321,0.6742160278745645,0.9550525997456423,1.0,3/13,5.21%,PDE2A;NPPA;KCNC2
prerank,tRNA modification (GO:0006400),-0.24456402838973573,-0.8159815449833062,0.8111455108359134,0.956018917212948,1.0,18/62,20.25%,THADA;TRMT9B;THUMPD3;NSUN2;OSGEP;ALKBH1;METTL6;PUS7;ELP5;DUS2;PUS10;TRIT1;TPRKB;DTWD1;TRMT112;ANKRD16;TYW5;BCDIN3D
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3036908851758331,0.8154246282971797,0.7192982456140351,0.955631838045547,1.0,18/50,28.17%,PSMB3;OAZ1;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMC3;PSMD1;PSMD10;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3262008874461274,-0.8153604651082494,0.7218390804597701,0.9562873154078634,1.0,10/15,29.48%,CCDC14;PIBF1;PCM1;SNX10;STIL;BBS4;CEP131;C2CD3;CEP192;NEDD1
prerank,microtubule anchoring (GO:0034453),-0.3460552281314003,-0.8150296466493504,0.7291196388261851,0.9560806584168007,1.0,3/12,13.57%,DAG1;BICD1;PCM1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3099938340064639,-0.8144724450382639,0.7434052757793765,0.9562255934354273,1.0,7/20,18.67%,RBPJ;RUNX2;SMAD9;BMP2;EP300;CHD6;CREB3
prerank,regulation of protein catabolic process (GO:0042176),0.26610804017557815,0.8141169030733736,0.7675070028011205,0.9575578023205785,1.0,19/99,15.84%,DAB2IP;NKD1;NEDD4L;FOXO1;SNX3;EGLN2;OAZ1;PIN1;SMURF1;GSK3A;HMGCR;HGS;TNFSF12;TNFAIP3;ASB5;AREL1;PLK2;GFAP;APC
prerank,kinetochore organization (GO:0051383),-0.344736281672629,-0.8138731840255109,0.6997792494481236,0.9564299238463213,1.0,8/13,41.13%,CENPC;CENPE;CENPF;DLGAP5;NUF2;CENPW;CENPH;CDT1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.364822028017631,-0.8138530756108198,0.7050209205020921,0.95561102807082,1.0,6/10,27.79%,MTHFR;MTHFD1;MTHFD1L;MTHFD2;MTHFS;SHMT1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.36805355406959006,-0.8132194220021002,0.7066381156316917,0.9559066155809859,1.0,2/10,6.79%,ZEB2;ATP7A
prerank,axonal transport of mitochondrion (GO:0019896),-0.3566968758331893,-0.8131433716127214,0.7084233261339092,0.9551850127960979,1.0,1/11,2.97%,TRAK1
prerank,DNA packaging (GO:0006323),0.36006897792673154,0.8130572491415468,0.6862416107382551,0.9588920499559169,1.0,5/16,20.07%,KAT6A;BANF1;CHAF1A;CHAF1B;NOC2L
prerank,prostanoid metabolic process (GO:0006692),-0.3361588891275761,-0.8129497223939194,0.700218818380744,0.9546876024715945,1.0,5/13,20.54%,PTGS1;PTGES;PTGR2;CYP2S1;PTGR1
prerank,cellular response to UV (GO:0034644),0.27630762337618625,0.8127394963189114,0.7603550295857988,0.9588857890884126,1.0,19/76,21.63%,POLK;HYAL2;N4BP1;OPN5;RHBDD1;COPS9;EIF2AK4;MMP1;OPN3;TRIAP1;PTPRK;NSMCE3;BAK1;NOC2L;POLD1;HYAL1;METTL3;DDB1;ERCC4
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.27904164287291905,0.8121303195955225,0.7562408223201175,0.9594638393623878,1.0,14/76,13.08%,APP;NFKBIA;NOD1;NOD2;HDAC7;TMSB4X;TLR3;ACTN4;LGALS9;TLR7;AGER;ADIPOR1;C1QTNF4;CYLD
prerank,chromatin assembly or disassembly (GO:0006333),0.38441999198446913,0.8117639120724595,0.6849557522123894,0.9596153869171938,1.0,4/11,20.07%,CHAF1A;CHAF1B;HIRIP3;NOC2L
prerank,detection of visible light (GO:0009584),0.36243830330996585,0.8113224797512747,0.7158469945355191,0.9598631818967761,1.0,2/16,5.49%,GNAQ;RP1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.2952584411597588,-0.8112063949906408,0.7373493975903614,0.9570828008765102,1.0,6/25,16.99%,CCNT2;WDR43;SETD5;DDX39B;LDB1;ERCC6
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.27067460969282414,0.8106113133384139,0.7841726618705036,0.9606267297148848,1.0,21/80,20.16%,SH3RF1;TNFSF10;NOD1;FOXL2;RPS6KA1;SOX7;XIAP;KLF4;MALT1;ARL6IP5;LAMTOR5;SYK;BCL10;PDCD6;GAS6;TRIAP1;PPM1F;DNAJB6;CYCS;F2R;RPS6KA3
prerank,regulation of nervous system development (GO:0051960),-0.2694995436613961,-0.8104463690549638,0.7807486631016043,0.9575173891253944,1.0,6/37,13.98%,DOCK7;PER2;HEYL;YAP1;SIRT2;LGI4
prerank,cellular response to heat (GO:0034605),-0.2750131185297958,-0.8104222019296992,0.7769028871391076,0.9567114811292693,1.0,14/35,26.78%,FGF1;THBS1;ANO1;PRKACA;BAG3;HTRA2;TCIM;HSBP1;CLPB;RBBP7;HIKESHI;HSPA1A;HMOX1;TPR
prerank,plasma membrane invagination (GO:0099024),0.32620962195763004,0.8103421186231833,0.7147335423197492,0.9605345970662231,1.0,3/29,6.47%,DOCK1;ELMO1;ARHGAP25
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.4018618893886221,0.8102340369070173,0.7095588235294118,0.9601936707961939,1.0,3/10,17.88%,CCT3;CCT5;CCT7
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3671380659374965,-0.8099067097615745,0.7221095334685599,0.9567806602647007,1.0,5/10,36.76%,KDM1A;BRCA1;SIRT1;JARID2;MYB
prerank,regulation of mitochondrial depolarization (GO:0051900),0.39032011288957047,0.8098261882144091,0.6908396946564885,0.9604280593147673,1.0,1/10,0.90%,KDR
prerank,regulation of protein kinase activity (GO:0045859),-0.22157123415970803,-0.809799720091043,0.9196787148594378,0.9561160777703424,1.0,18/106,13.29%,PRKAG2;PLCE1;PPM1E;DEPTOR;RASSF2;DTNBP1;CCN1;TSPYL2;SNX9;PDPK1;SPRED1;QARS1;ITGB1BP1;PTK2B;JTB;XRCC5;ANKRD54;NF1
prerank,chromatin remodeling at centromere (GO:0031055),-0.2786972188032745,-0.8097597951406482,0.7425,0.9553300729598715,1.0,8/31,18.14%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.36778774603134395,0.8097095138611524,0.7092592592592593,0.9600995237480855,1.0,3/15,12.17%,HIP1R;PIK3CB;TNK2
prerank,positive regulation of catalytic activity (GO:0043085),0.3091538470937485,0.8095544249952692,0.7451612903225806,0.9598134338366158,1.0,9/37,17.11%,CAV1;NOD2;MAPK3;PHACTR4;APH1A;B3GAT3;MSH3;MSH2;YWHAB
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.2857401161308416,0.8092271153957311,0.748159057437408,0.9598697695135089,1.0,20/57,24.02%,APP;MEF2C;LRRC7;GRIA4;AKAP9;GRIN2B;SHISA6;CNIH3;MINK1;CAMK2B;DLGAP3;NLGN1;CRHBP;NPTX1;GRIA2;NPTXR;CACNG2;OPRM1;GSG1L;GRIN1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.38412919541017526,0.8090653090323014,0.6802325581395349,0.9595943531578237,1.0,3/11,11.81%,LGALS9;CBFB;VSIR
prerank,positive regulation of lipid metabolic process (GO:0045834),0.34391637980077006,0.809036207971179,0.7277227722772277,0.9591001362919156,1.0,5/22,14.02%,PPARD;CREB1;SORBS1;PPARG;DISP3
prerank,regulation of mitotic cell cycle (GO:0007346),0.2507615732973488,0.8088962915256543,0.8169191919191919,0.9588158160294965,1.0,53/171,23.55%,APP;AFAP1L2;DUSP3;TAL1;BTG4;TTC28;PSMB3;PKN2;PSMD11;HECA;PIN1;TGFB1;IQGAP1;CAV2;PSMC6;PSME2;BRINP3;BTG1;BRINP2;PSMD8;BTG2;EIF4E;CYLD;SDCBP;MAEA;BUB3;PSMB10;PIM2;TTL;ANAPC16;PSMA8;ANAPC7;SKP1;ANAPC10;CDK11B;PSMD9;UBE2D1;PIM3;TFAP4;ANAPC2;BTG3;ASNS;DDB1;CUL1;PSMC3;PSMD1;CDC23;SCRIB;LGMN;PSMD10;CDC26;CDC27;CDKN1B
prerank,response to unfolded protein (GO:0006986),0.29295112091485276,0.8085734480918372,0.7677224736048266,0.958831760226525,1.0,6/48,10.75%,DAB2IP;HSP90AB1;STT3B;RHBDD1;HSPA8;HSPB1
prerank,regulation of stem cell differentiation (GO:2000736),0.2713885925164839,0.8081403793405919,0.7907647907647908,0.9590494273024758,1.0,12/89,11.35%,LMO2;NOTCH1;GATA2;TAL1;PSMB3;PSMD11;TCF12;PTN;PSMC6;PSME2;CBFB;PSMD8
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.3402502967324283,-0.8075848433339008,0.7366167023554604,0.9583053284250299,1.0,1/12,1.67%,BMP7
prerank,mitotic nuclear division (GO:0140014),-0.2381989009441464,-0.807509675963254,0.852760736196319,0.9575899508491308,1.0,31/71,32.28%,KLHL22;FLNA;GOLGA2;ZWINT;SMC4;PIBF1;CENPK;TUBG1;KLHDC8B;STAG2;SPICE1;KIF18A;NUSAP1;CCDC61;MISP;TPX2;KNSTRN;KIFC1;NSL1;UBE2S;KPNB1;KIF11;SGO1;CDCA8;CEP192;ABRAXAS2;BCCIP;PLK1;ABRAXAS1;TOGARAM2;ESPL1
prerank,multivesicular body assembly (GO:0036258),0.31607556715512825,0.8074111408390605,0.7248764415156508,0.9598037695682524,1.0,12/30,28.32%,RAB11A;CHMP1B;VPS36;HGS;VPS25;PDCD6IP;VPS37A;VPS37B;VPS37C;CHMP2B;VPS4B;VPS28
prerank,regulation of lipid metabolic process (GO:0019216),0.26789999493977523,0.807053516210366,0.7975708502024291,0.9598983815971812,1.0,18/88,14.25%,CAV1;FASN;PPARD;NCOA1;ACACB;NCOA2;ZFP69;ABCA7;OPA3;HELZ2;LACTB;ADIPOR1;HMGCR;ELOVL6;PPARG;EDF1;DISP3;SP1
prerank,transcription by RNA polymerase I (GO:0006360),0.3130950200886239,0.8069244378770812,0.7066246056782335,0.9595991350779471,1.0,9/34,22.58%,TAF1B;MAPK3;GTF2H2;GTF2H4;RRN3;UBTF;POLR1A;GTF2H3;TAF1C
prerank,negative regulation of cell communication (GO:0010648),0.3553811763238852,0.806662881985071,0.7365684575389948,0.9595167791252313,1.0,5/21,16.32%,KIF26A;SOCS5;PTK6;SRMS;ACVR1
prerank,negative regulation of signaling (GO:0023057),0.34094920496823705,0.8058056619124627,0.7283333333333334,0.9604528336002659,1.0,9/25,24.90%,KIF26A;SOCS5;PTK6;SRMS;AP1AR;ACVR1;TRAT1;OPRM1;GLRA1
prerank,positive regulation of secretion by cell (GO:1903532),0.27807484883456585,0.8054975686167313,0.7655571635311144,0.9604587648316695,1.0,9/70,8.09%,TGFB2;UNC13B;RGCC;STX1A;CD2AP;ABCG1;PPIA;UNC13D;TGFB1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.28939633372164586,-0.8053568383987891,0.7751322751322751,0.9605709612673917,1.0,6/26,17.72%,FBN1;HOXA7;MAFB;TLR4;RARA;INHA
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3675737241306975,-0.8052405179360898,0.7274633123689728,0.9599137641295279,1.0,5/10,18.58%,PRKAA2;KLF15;SETD5;MYOCD;FLCN
prerank,positive regulation of protein maturation (GO:1903319),-0.3518274470696869,-0.8052311233044277,0.7048458149779736,0.9590819956677701,1.0,1/11,1.62%,CCBE1
prerank,negative regulation of neuron death (GO:1901215),0.26647473923803605,0.8050777795564322,0.7953929539295393,0.9606684645064794,1.0,18/93,18.75%,NDNF;CD34;CD200;MEF2C;TOX3;RETREG1;CD200R1;FOXQ1;CNTF;KIR3DL2;MAG;BTBD10;UNC5B;MSH2;PTPRZ1;PRKCG;PM20D1;SET
prerank,protein N-linked glycosylation (GO:0006487),0.2756671550211328,0.8050060376668767,0.7910216718266254,0.960261304443396,1.0,7/66,8.00%,SLC39A8;ST3GAL1;FUT8;STT3B;ENTPD5;GAL3ST1;ST6GAL1
prerank,nuclear membrane disassembly (GO:0051081),-0.33387835530816123,-0.8048462591489353,0.7360178970917226,0.958916804285112,1.0,5/14,22.47%,NEK6;AKAP8L;PRKCA;CNEP1R1;CCNB2
prerank,RNA polyadenylation (GO:0043631),0.33119659277171914,0.8047772736965672,0.7405498281786942,0.9595790843620189,1.0,4/26,10.84%,APP;MTPAP;CPSF1;SSU72
prerank,mRNA polyadenylation (GO:0006378),0.33119659277171914,0.8047772736965672,0.7405498281786942,0.9595790843620189,1.0,4/26,10.84%,APP;MTPAP;CPSF1;SSU72
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2533603135065089,-0.8046950730800801,0.808695652173913,0.9583518055502013,1.0,10/48,15.57%,PLD1;AGPAT4;LCLAT1;GPD1L;PLA2G12A;ACP6;GPAT3;DDHD1;PNPLA3;SLC27A1
prerank,cellular response to retinoic acid (GO:0071300),0.30377748407856503,0.8040906424540736,0.746875,0.9602759892267315,1.0,9/42,11.20%,TBX1;FZD4;LYN;CREB1;RET;TWF2;BRINP3;PTK6;BRINP2
prerank,ether lipid metabolic process (GO:0046485),-0.33771877948150086,-0.8038524153468729,0.6960556844547564,0.9590189847030488,1.0,5/14,23.05%,AGMO;PEX7;PLA2G6;AGPS;GNPAT
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.31204138097181555,0.8037939006834839,0.6998341625207297,0.960266237774016,1.0,4/29,7.63%,DAB2IP;SMAD7;IL17RD;EFNA1
prerank,piRNA metabolic process (GO:0034587),0.34446934816861174,0.8036758549546432,0.6972318339100346,0.9599436970246288,1.0,2/19,4.89%,FKBP6;PIWIL1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.3439870389889534,0.8031043569875698,0.6827586206896552,0.960437379451324,1.0,4/18,17.36%,LYN;CD19;SH2B2;BAG6
prerank,regulation of cellular response to stress (GO:0080135),-0.21623443498621486,-0.8030258657235178,0.9079497907949791,0.9596496237153227,1.0,35/115,26.78%,ROCK2;NUPR1;AMFR;CAMK2D;NEK6;SEH1L;PRKN;ATM;NUAK1;NUP205;BAG1;CEBPB;CLN3;AIFM2;ABL1;ARMT1;BAG3;EP300;CRYAB;SMG1;SLC38A2;HSBP1;USP19;EIF4G1;RAE1;AJUBA;CASP9;ATR;HIKESHI;HSPA1A;NUP155;CREBBP;NUP35;NDC1;TPR
prerank,protein K48-linked ubiquitination (GO:0070936),0.28579398075455104,0.8027508162159962,0.7651403249630724,0.960546129222993,1.0,16/54,18.63%,ZNRF1;NEDD4L;PELI1;RFFL;UBE2G1;KLHL3;RNF187;TNFAIP3;RBX1;UBE2D3;RNF8;UBE2Q2;UBE2G2;BFAR;RNF4;UBE2D1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.3376278884993861,0.8025028419144592,0.6878216123499142,0.9604531247812921,1.0,8/21,16.47%,NOS3;SRGN;NOTCH1;TGFB1;GREM1;SOX9;HEY1;GAS6
prerank,ether lipid biosynthetic process (GO:0008611),-0.3576593117970208,-0.8020193453834288,0.7311827956989247,0.9605308205024481,1.0,4/10,30.33%,PEX7;AGPS;GNPAT;FAR1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2857096548985444,0.8018431917826329,0.7654320987654321,0.9610826699110092,1.0,14/56,20.16%,NOD1;NOD2;TLR3;CTSK;TLR7;IRAK2;TLR8;S100A8;BCL10;INAVA;CTSS;TRAF3;PLCG2;RPS6KA3
prerank,mitochondrion organization (GO:0007005),0.24825069059675778,0.8014022430129483,0.8429447852760736,0.9613294552553756,1.0,24/165,15.54%,DNM3;BCL2L1;NOS3;ALAS1;TOMM22;BIK;SLC25A33;DNM2;MYH14;TIMM13;CAV2;BNIP3L;FANCG;TIMM10;SAMM50;VPS13D;DNAJC19;POLG2;HIGD1A;AFG1L;OMA1;MFF;IMMP2L;TWNK
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.34208594555037614,-0.8013878649421914,0.7083333333333334,0.9607560270755476,1.0,4/12,16.16%,PFDN5;APOE;LDLR;CRYAB
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.3411915800928548,0.801131374858657,0.6962025316455697,0.9612642072133727,1.0,10/20,25.99%,ADAM10;TGFB1;RHBDD1;ADAM17;APH1A;SPPL2A;APH1B;TRAF6;MBTPS2;NCSTN
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.36388835056601493,-0.8006078387415125,0.7158590308370044,0.9612785221281118,1.0,2/10,1.67%,BMP5;BMP7
prerank,engulfment of apoptotic cell (GO:0043652),0.3590672085616485,0.8002799422744461,0.7195571955719557,0.962237468226644,1.0,1/15,1.07%,RHOBTB1
prerank,positive regulation of protein catabolic process (GO:0045732),0.26885644457797664,0.8001641175235592,0.8011126564673157,0.961903502679517,1.0,15/84,15.84%,DAB2IP;NKD1;NEDD4L;FOXO1;EGLN2;OAZ1;MSN;SMURF1;GSK3A;TNFSF12;TNFAIP3;ASB5;AREL1;PLK2;APC
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.27625892869565205,0.7999327624416454,0.7842857142857143,0.9617742294360768,1.0,24/69,27.64%,NDUFA2;UQCRB;NDUFA8;CYC1;NDUFA4;UQCRC1;AFG1L;COA6;COX6C;NDUFA12;NDUFB3;CYCS;NDUFC1;UQCRQ;COX10;UQCR11;SDHAF2;NDUFA10;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;COX5B
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3533159991307898,-0.7993227472654738,0.7278761061946902,0.9626046903361619,1.0,2/12,5.81%,ACSL1;ACOT8
prerank,protein import into peroxisome matrix (GO:0016558),0.38207865657156503,0.7992994686609113,0.6936936936936937,0.9623438878593399,1.0,5/12,23.89%,PEX5L;PEX14;PEX16;PEX6;PEX1
prerank,mRNA catabolic process (GO:0006402),0.29041616860386027,0.7992201946527289,0.7299843014128728,0.9619427578463328,1.0,18/44,27.44%,NANOS2;PDE12;DCP2;DXO;EXOSC10;NBAS;XRN1;NUDT16;ZFP36L2;EXOSC9;XRN2;METTL3;RIDA;NUDT12;UPF1;NUDT16L1;AGO1;NBDY
prerank,protein polyubiquitination (GO:0000209),0.23232409514664062,0.7991232399761807,0.8887601390498262,0.9615778381305424,1.0,84/297,23.33%,RNF144B;LMO7;ZNRF1;TRIM14;NEDD4L;PELI1;RNF125;CTNNB1;UBE2V2;FBXW7;RFFL;PSMB3;UBE2G1;FBXO41;PSMD11;TRIM36;PSMC6;KLHL3;PSME2;HECTD1;UBE2V1;SMURF1;SHARPIN;KLHL20;UBOX5;HERC6;CBFB;UBE3D;PSMD8;ZNRF2;WSB1;FBXO6;RNF187;TRIM69;FBXW2;TNFAIP3;PSMB10;FBXO21;NHLRC1;RBX1;FBXL8;TRIM2;UBE2D3;AREL1;FBXL15;RNF8;UBE2Q2;PSMA8;ANAPC7;UBE2G2;BFAR;TRIM68;FBXO2;RNF19A;TRIM71;TRIM3;SKP1;ANAPC10;PSMD9;SIAH1;FBXW9;RNF4;UBE2D1;FBXO28;TRAF3;TMEM129;RBCK1;RNF166;ANAPC2;ERCC8;RLIM;CUL1;PSMC3;PSMD1;CDC23;UBE2J1;RNF126;UNKL;PSMD10;FBXO32;CDC26;TRAF6;FBXL14;CDC27
prerank,cGMP biosynthetic process (GO:0006182),0.394397114105429,0.7991048899810234,0.6881918819188192,0.9610876472825044,1.0,3/10,13.27%,NPPA;NPR1;NPR2
prerank,fatty acid oxidation (GO:0019395),0.28427695647669005,0.7989543620783364,0.7751824817518248,0.9608369256862018,1.0,14/57,19.06%,ADIPOR2;PPARD;ABCD4;ACOX1;ABCD1;ADIPOR1;SLC27A2;HACL1;ADH5;ECI2;ACAT1;CYP24A1;ACAD11;ABCD2
prerank,mitochondrial gene expression (GO:0140053),0.2955155095002183,0.7989008884338158,0.7456828885400314,0.9603956667132284,1.0,21/42,30.68%,MRPL12;SLC25A33;MRPL57;GATC;TWNK;MRPS2;MRPL16;MRPL23;MRPS18A;PTCD3;IARS2;MRPL51;HARS1;MRPL2;NDUFA7;QRSL1;LARS2;MRPS34;MRPS12;MRPS28;MRPS24
prerank,organelle organization (GO:0006996),0.229292695836361,0.7985875522107156,0.9301310043668122,0.9603987661159596,1.0,53/388,13.84%,FGD5;SEMA6A;ARAP3;SYNE1;NOS3;CAV1;FNBP1L;FMNL3;RAB31;NEDD9;ALAS1;SIPA1;PRKD1;MCOLN1;ABCD4;PIKFYVE;SORT1;MAST4;USP6NL;PPIA;ABCA3;PAK5;SLC25A33;CECR2;COG3;MARK4;RAB34;CHMP1B;DPYSL2;CAV2;ARHGEF7;ARHGAP4;FANCG;RANBP10;FGD6;STRIP1;REEP5;KLHL20;ABCD1;PEX14;CEP78;VPS13D;PDZD8;EPS15;POLG2;ATXN7;RANBP9;RAB1A;FGD2;TSGA10IP;AFG1L;TNFAIP3;CFL1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2667917967975311,0.7985334467535784,0.7880986937590712,0.9599621360342276,1.0,14/79,12.31%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;MFSD6;AP1S3;KIF3B;KIF23;DCTN4;AP2B1
prerank,regulation of cell killing (GO:0031341),-0.32700275156404,-0.7983386258334748,0.7351598173515982,0.9634424285278519,1.0,5/16,13.37%,CD55;CFH;FZD7;CYBA;DVL2
prerank,cellular response to hypoxia (GO:0071456),0.25406738323225697,0.7981488282344514,0.8401048492791612,0.9601164215057626,1.0,22/126,16.11%,NDNF;EPAS1;RGCC;AK4;PSMB3;EGLN2;PSMD11;PSMC6;BNIP3L;PSME2;UBQLN1;PSMD8;HIF1A;ZFP36L1;HIGD1A;EGLN1;HIPK2;PSMB10;RBX1;ELOB;PSMA8;OPRD1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.27527093958413684,0.7980449319908558,0.7905604719764012,0.9597700572945695,1.0,10/68,9.07%,HPRT1;HINT1;NT5C2;ACBD6;GLYAT;AK4;TPST2;ADSS2;ACSL6;GTPBP1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.36159212437742344,0.7976846155975666,0.6962962962962963,0.9598586233620764,1.0,3/14,11.01%,JAK3;CCR7;TLR8
prerank,intracellular protein transport (GO:0006886),-0.18834413684954898,-0.7975079201894416,0.9926470588235294,0.9640049682472678,1.0,72/304,21.28%,RANBP3L;WLS;APPL2;SGSM2;PKD1;LAMP2;TRAK1;SNX6;USO1;KIF13B;SIL1;RANBP17;COPA;TRIM23;RAB21;STX2;COPZ2;ARFGAP3;GRTP1;GGA2;AP3B1;SAR1A;XPO5;SNX9;SEC31A;CLIP3;STX5;SNX15;AP4M1;XPO6;EHD1;ARL1;STX1B;TBC1D10A;SNX8;RAB29;RAB6A;SCFD1;SEC16A;ARFIP2;GIPC1;BAG3;STRADA;LMAN1;STX16;RABGAP1;COPB2;E2F3;SURF4;RAB3GAP2;CTTN;HOMER3;STX4;XPO1;TBC1D2B;FAM53B;LAPTM5;CTSA;C2CD5;RAB22A;VPS26C;RPGR;LTBP2;AP2A1;TBC1D9B;ARL5C;COX18;ARF1;RAB14;SNX17;COPZ1;IPO7
prerank,organelle assembly (GO:0070925),0.22609801435718593,0.7974832224045135,0.9152542372881356,0.959693512642925,1.0,41/384,11.25%,ABCC4;FLII;ABLIM1;CD34;PGM5;FNBP1L;EXOC6;STARD9;NOTCH1;CNGA2;CEP83;POC1B;CDC14A;MAPRE2;CFAP52;OCRL;DYNLL1;ABCA3;DBNL;EDC3;CDS2;RAB11A;SAC3D1;TTLL3;CHMP1B;IRGM;MAP1LC3B;DHX37;TMOD1;DISC1;PIK3C3;ATG12;GRB7;VPS36;HAUS6;KIF3B;EHD4;CFAP54;EXOC4;EXOC2;UBQLN1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3493568543148426,0.7963144311571209,0.7092819614711033,0.9612398596833704,1.0,10/17,31.46%,NDUFA4;AFG1L;COX6C;CYCS;COX10;COX15;COX7A2L;COX5B;COX4I1;COX8A
prerank,chloride transmembrane transport (GO:1902476),0.29379315576869725,0.7962283990272989,0.7619047619047619,0.9608675315909969,1.0,13/48,19.47%,SLC1A1;SLC12A6;GABRB1;SLC12A9;CLCN3;GABRQ;GABRG1;GABRG3;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.2798490741161913,-0.7959232989397587,0.7729468599033816,0.965806254262854,1.0,6/26,14.75%,SLC30A10;PPARA;SLC5A3;CYBA;TRAP1;TLR4
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.280329298019601,0.7956348459473638,0.7728613569321534,0.9613628026713412,1.0,19/67,23.04%,B2M;IKBKB;PSMB3;PSMD11;TAP2;PSMC6;PSME2;CYBB;PSMD8;NCF4;PSMB10;PSMA8;PSMD9;TAP1;PSMC3;PSMD1;VAMP8;PSMD10;CALR
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2737261826839237,-0.7953239849889506,0.8101604278074866,0.9659340219388448,1.0,22/33,44.92%,FBN1;CEBPB;MAFB;TLR4;FSTL3;CAMK4;LILRB3;CARTPT;LRRC17;POU4F1;BGLAP;CCR1;IL4;UBASH3B;OCSTAMP;IL23A;TNF;IL23R;PRXL2A;TCTA;CCL3;IL12B
prerank,cilium assembly (GO:0060271),0.22794864455316483,0.7949394371601805,0.9027149321266968,0.9620223282733256,1.0,49/296,15.76%,ABCC4;ABLIM1;FNBP1L;EXOC6;NOTCH1;CNGA2;CEP83;POC1B;CCDC13;ZMYND10;CDC14A;RP1;CFAP52;OCRL;DYNLL1;CCP110;RAB11A;PRKAR2B;MARK4;TTLL3;CETN2;TUBB;CDK5RAP2;DISC1;AKAP9;RSPH4A;DCX;HAUS6;KIF3B;EHD4;TBC1D32;CFAP54;CEP78;EXOC4;EXOC2;SNAP29;RAB1A;RSPH1;BBIP1;BBS10;CEP135;FOXJ1;CEP72;DNAAF3;TUBB4B;TUBA1A;DNAH5;CKAP5;CEP70
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.35831395631856805,-0.7948556362045502,0.7292929292929293,0.9658621524723882,1.0,6/10,41.13%,DBF4;E2F7;E2F8;WIZ;CDC7;CDT1
prerank,nucleus organization (GO:0006997),0.2899583686379538,0.7948531957069376,0.7589285714285714,0.961651292719328,1.0,10/47,18.00%,SYNE1;CHMP1B;LEMD3;NUP54;ATXN7;SUN1;REEP3;PDCD6IP;PITPNB;BIN1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3267409070854782,0.7947963724217132,0.7181663837011885,0.96122302001846,1.0,5/23,9.41%,SLC12A6;SLC12A9;KCNH2;CLCN3;SLC9A7
prerank,myoblast fusion (GO:0007520),0.3778237188729914,0.7945487875440932,0.7020109689213894,0.9611131913879741,1.0,3/12,13.82%,JAM2;PTGFRN;ADAM12
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.35007614526276787,0.7945462167057239,0.7040998217468806,0.9605915598093502,1.0,5/17,22.47%,CXCL12;CCL1;CCR2;MOSPD2;LGMN
prerank,regulation of NMDA receptor activity (GO:2000310),0.30768109489916723,0.7943643688127041,0.7440381558028617,0.9604041733990936,1.0,9/32,17.12%,APP;MEF2C;LRRC7;GRIA4;GRIN2B;CAMK2B;NLGN1;CRHBP;CCR2
prerank,mitotic metaphase plate congression (GO:0007080),-0.24774133765057396,-0.7942128677078671,0.839541547277937,0.9661119296075101,1.0,11/51,19.09%,EML4;SEH1L;CENPC;CUL3;PIBF1;RMDN1;CHMP4C;KIF18A;EML3;VPS4A;CENPE
prerank,negative regulation of immune response (GO:0050777),0.24691534046621968,0.7935331449968537,0.8458692971639951,0.9613468827685008,1.0,32/154,17.44%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;ADCY4;YES1;HCK;PRKAR2B;NPS;FOXP3;CALCB;ADAM17;PRKAR2A;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1;TNFAIP3;HTR4;PLK2;RXFP2;GLP1R;CCR2;LYAR;SAMSN1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.34912386116909677,0.7931167818883182,0.7068062827225131,0.961550637208398,1.0,6/18,15.98%,SNX3;DNAJC13;MAPK3;MSN;MTMR2;MAPK1
prerank,negative regulation of transferase activity (GO:0051348),0.3185962343876251,0.7928933377872555,0.7252931323283082,0.9614072300740847,1.0,14/28,31.41%,MEN1;SMAD7;GSK3A;TERF1;INPP5K;ERCC4;PINX1;CDKN1B;BAG5;DTX3L;PARK7;TP53;GSK3B;SRC
prerank,leukotriene metabolic process (GO:0006691),-0.29973149675496125,-0.7927327349678095,0.7534562211981567,0.967721422431121,1.0,10/19,33.57%,GGT5;ABCC10;MGST3;PTGR1;ABCC1;PLA2G5;MAPKAPK2;ALOX12;DPEP1;GGT1
prerank,DNA metabolic process (GO:0006259),0.22971767678906882,0.7925769711671166,0.8946759259259259,0.9614379064649753,1.0,61/270,21.64%,POLK;SP100;MEN1;SAMHD1;NTHL1;MRE11;UBE2V2;HINFP;TERF2;PWWP3A;DFFB;FANCG;CBS;MCM10;DNA2;AXIN2;PARG;SMUG1;MGMT;CDC6;ACD;RECQL4;GTF2H4;MPG;FBXO6;BTG2;POLB;TERF1;HELLS;ORC1;FAN1;HMGB2;NSMCE4A;POLE3;MSH3;SMARCAD1;MSH2;TSN;TRRAP;DNASE2;SIRT7;SUMO1;RAD21;UHRF2;HUS1;NUDT1;ENDOG;RPA1;ADPRS;NSMCE3;RAD9B;POLL;POLD1;UVRAG;GTF2H3;POLA1;PARP2;RFC2;DDB1;ERCC4;RAD1
prerank,regulation of organelle assembly (GO:1902115),0.27337289624545624,0.7919354974615355,0.7988252569750367,0.9619795605170682,1.0,19/72,18.50%,TBC1D14;TBC1D22A;TBC1D12;TBC1D2;PIKFYVE;USP6NL;TBC1D24;TBC1D5;HCK;MSN;TBC1D10B;CYLD;PLK2;TBC1D1;PDCD6IP;TBC1D22B;TBC1D15;IFT140;RNF4
prerank,negative regulation of cell division (GO:0051782),-0.3493318968898663,-0.7917879371837518,0.74375,0.9684497381305108,1.0,7/11,39.90%,TXNIP;CHMP4C;VPS4A;E2F7;E2F8;ORC6;AURKB
prerank,mitochondrial genome maintenance (GO:0000002),-0.3510805776447068,-0.7917181860790848,0.7435897435897436,0.9677243314318474,1.0,3/11,11.92%,SLC25A36;PARP1;MPV17
prerank,regulation of synapse assembly (GO:0051963),0.28602884828940633,0.7916848787308306,0.7439759036144579,0.9618758654728709,1.0,9/46,9.94%,APP;MEF2C;WNT7A;CLSTN1;GRID2;SLITRK3;SLITRK1;NRXN1;LRRC4B
prerank,regulation of protein acetylation (GO:1901983),0.3785932726871779,0.7915848627457436,0.6901669758812616,0.9615005189695714,1.0,1/12,3.84%,RAPGEF3
prerank,glutathione derivative metabolic process (GO:1901685),0.33129362233136206,0.7905692768951538,0.714527027027027,0.9622642278038323,1.0,4/20,10.19%,MGST2;GSTA4;HPGDS;GSTK1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.33129362233136206,0.7905692768951538,0.714527027027027,0.9622642278038323,1.0,4/20,10.19%,MGST2;GSTA4;HPGDS;GSTK1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.3937808110140848,0.7903908982212232,0.753731343283582,0.9620356748590078,1.0,3/10,10.97%,NR1H2;ELOVL5;ABCD1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.20614961663076609,-0.790004335985286,0.9601990049751243,0.9698335528008623,1.0,52/148,29.19%,PRKAG2;PRKAA2;EHMT2;MDM4;CHD3;ATM;RBBP8;CHD4;PDPK1;USP2;PML;NUAK1;STK11;PRKAG3;NOP2;PRMT5;DYRK2;MAPK14;EP300;RAD50;ATRIP;TAF9B;CHD5;RBBP4;BOP1;TP53RK;RFC3;CSNK2A1;BRCA1;KMT5A;RNF34;CDK5;TBP;WRN;PRKAB2;TPX2;PIP4K2B;NBN;RBBP7;ATR;MAPK11;TAF9;PPP1R13L;SMYD2;EXO1;RFC5;NOP53;PRR5;PLK3;TTC5;PRDM1;HDAC1
prerank,calcineurin-mediated signaling (GO:0097720),-0.3556370046904064,-0.7895175054224646,0.7126696832579186,0.9689540576763914,1.0,5/10,19.56%,NFAT5;NFATC4;PPP3CB;NFATC2;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3556370046904064,-0.7895175054224646,0.7126696832579186,0.9689540576763914,1.0,5/10,19.56%,NFAT5;NFATC4;PPP3CB;NFATC2;NFATC3
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3031298340552435,-0.7893947218576042,0.7582938388625592,0.9683267683876233,1.0,5/18,17.10%,IL34;DAAM2;SLC45A3;NF1;MDK
prerank,glial cell differentiation (GO:0010001),0.31848826718337125,0.7893707352699795,0.7438825448613376,0.9632468445031936,1.0,8/28,18.48%,CDH2;MMP24;METRN;SOX10;SOX11;SOX9;PTPRZ1;TPPP
prerank,negative regulation of fat cell differentiation (GO:0045599),0.31006036725778285,0.7892627608802187,0.7397034596375618,0.9629075065154257,1.0,8/34,10.91%,FOXO1;ZFPM1;CCDC85B;GATA2;WWTR1;TGFB1;TRIB2;FERMT2
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.36185122878719256,-0.7888804709595891,0.722567287784679,0.9683620852322926,1.0,3/10,8.93%,FAP;EMILIN1;DPP4
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.33846348619537636,0.7888615423268727,0.729235880398671,0.9630993057182885,1.0,6/19,14.21%,PARD3;LRRC7;CLIC4;FSCN1;FOXJ1;SYNJ2BP
prerank,lipoprotein biosynthetic process (GO:0042158),-0.34170401211591583,-0.7887370507209577,0.7270742358078602,0.9677584518440923,1.0,2/11,8.01%,ATG10;APOE
prerank,maturation of SSU-rRNA (GO:0030490),0.3016209392916951,0.7880401687488934,0.7641509433962265,0.9639141836794618,1.0,7/34,14.11%,SNU13;DHX37;PWP2;NOL10;UTP3;RIOK1;RPS28
prerank,placenta development (GO:0001890),0.3742427734895938,0.7878393311453237,0.6981132075471698,0.9637171890438359,1.0,2/12,12.84%,PTK2;PPARG
prerank,bile acid biosynthetic process (GO:0006699),-0.2898688454616423,-0.7869872135942985,0.7793427230046949,0.9697058199621188,1.0,4/24,9.79%,CYP7B1;CYP27A1;ACOT8;AMACR
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.36796249957833044,0.7868612894493893,0.7061068702290076,0.9648391365505649,1.0,3/12,15.03%,NOD2;SOX9;INAVA
prerank,mitochondrial protein processing (GO:0034982),0.3802796499285733,0.7867227336059855,0.7292817679558011,0.9645508431987483,1.0,3/11,15.12%,PMPCA;OMA1;IMMP2L
prerank,regulation of cellular catabolic process (GO:0031329),-0.23549361346652553,-0.7864166674775979,0.858433734939759,0.9698457298142574,1.0,27/62,29.24%,ITPR1;NUPR1;DAPK2;PRKN;ATM;PIP4K2C;MTMR3;LRRK2;ABL1;EP300;RRAGA;WDR41;CISD2;DDIT3;PSAP;SMCR8;USP13;RAB39B;PIP4K2B;TYSND1;USP10;KAT8;WDR91;MTMR4;WDR24;USP33;PIK3R2
prerank,regulation of protein transport (GO:0051223),0.3168016017102609,0.7854522158292709,0.75,0.9661549736734737,1.0,6/27,17.33%,RHBDF2;SNX3;NDFIP2;HSPA8;DNAJA1;PPM1F
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3299140377128232,0.7852092185001227,0.7342419080068143,0.9660579628088902,1.0,4/20,8.09%,LYN;CD6;HCK;TGFB1
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.228432199728025,-0.7849203456738048,0.8738170347003155,0.9714223549225558,1.0,22/64,28.83%,CCNT2;CTR9;POLR2A;MLLT3;CCNH;CDK7;AFF4;PAF1;ELP4;NELFE;GTF2F1;SETD2;GTF2H1;POLR2L;CDK12;EAF2;CDK9;POLR2I;ELOA;TCEA2;ERCC2;POLR2K
prerank,positive regulation of telomere maintenance (GO:0032206),-0.26703411400166066,-0.7848169041426616,0.8172043010752689,0.9707454493164398,1.0,13/31,26.59%,TNKS2;ATM;PML;RTEL1;HNRNPA2B1;ERCC1;RAD50;NBN;SIRT6;TNKS;PKIB;HNRNPD;MAP3K4
prerank,protein alkylation (GO:0008213),-0.28968091050937256,-0.7845788164996014,0.7737789203084833,0.9703163925870816,1.0,9/22,28.73%,PCMT1;EEF2KMT;PRMT8;METTL22;FAM98B;GSPT1;EEF1AKMT2;PRMT2;METTL21C
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.311989292182437,0.7844081274061532,0.7512953367875648,0.9668653098459352,1.0,11/29,29.64%,RNF212B;PRDM9;SIRT7;RAD21;BAG6;SYCP2;REC8;TEX12;IHO1;TERB1;P3H4
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.3778044897722611,0.7842648554485269,0.7293666026871402,0.9665710736215167,1.0,1/10,4.52%,CTNNB1
prerank,protein targeting to mitochondrion (GO:0006626),0.2857127376654497,0.7842211130120433,0.7642526964560863,0.9661235111980834,1.0,20/52,30.77%,TOMM22;TIMM13;PMPCA;TIMM10;SAMM50;DNAJC19;MFF;IMMP2L;TOMM20L;CHCHD4;TOMM7;TOMM5;TIMM21;TIMM50;TOMM70;BCAP31;TIMM9;AIFM1;FIS1;GRPEL2
prerank,ncRNA catabolic process (GO:0034661),0.3155450688705921,0.7840911888892466,0.7560975609756098,0.9658436556867811,1.0,9/28,22.45%,DEDD2;TRIR;SND1;DIS3L;EXOSC10;XRN1;NUDT16;EXOSC9;EXOSC8
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2618722360673255,0.7840046448335549,0.829971181556196,0.9654767125762251,1.0,25/87,21.88%,DCUN1D3;RGCC;FAM107A;KLF4;CDKN2B;PSMB3;PSMD11;PSMC6;PSME2;PSMD8;ZFP36L1;PSMB10;RBX1;RBL1;APC;PSMA8;SKP1;PSMD9;CDK6;ZFP36L2;CDK4;PINX1;CUL1;PSMC3;PSMD1
prerank,protein targeting to peroxisome (GO:0006625),-0.27428480070097566,-0.7823323684772022,0.7817679558011049,0.9730896735196853,1.0,5/29,13.81%,ABCD3;ZFAND6;PXMP2;PEX7;PEX2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3113795263809493,0.7818537002583956,0.7648953301127214,0.9684996065316134,1.0,4/32,4.79%,APLNR;PLCG1;CALM1;CD19
prerank,regulation of primary metabolic process (GO:0080090),0.25142314759413553,0.7818296520300528,0.847167325428195,0.9680154145112985,1.0,30/126,18.72%,FASN;PPARD;NCOA1;PSMB3;ACACB;NCOA2;OAZ1;PSMD11;ZFP69;ABCA7;PSMC6;OPA3;PSME2;PRKAB1;HELZ2;LACTB;PSMD8;ADIPOR1;HMGCR;ELOVL6;PPARG;EDF1;PSMB10;SP1;PSMA8;IDI1;SIN3A;DHCR7;PSMD9;HMGCS1
prerank,aggrephagy (GO:0035973),0.3144165953198571,0.7818161257815094,0.7391304347826086,0.9675099324089516,1.0,12/27,29.53%,DYNLL1;WDFY3;UBE2V1;UBQLN1;DYNC1LI1;ACBD5;ARL13B;UBB;PCNT;HDAC6;PARK7;DYNC1H1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3128120954885845,-0.7814845830285018,0.7505773672055427,0.9735845015931172,1.0,8/18,28.83%,FLNA;WDR43;PHF8;POLR2L;RASL11A;ERBB2;EIF2AK3;POLR2K
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.2328554153512125,-0.7807802410804505,0.8920634920634921,0.9738467563521873,1.0,20/62,29.32%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;LIMD1;EIF4G1;RAE1;AJUBA;POLR2L;STAT3;NUP155;POLR2I;NUP35;NDC1;IPO8;TPR;POLR2K;NUP43
prerank,post-translational protein modification (GO:0043687),0.2244679483568746,0.7804286007889578,0.9390519187358917,0.9692722334585777,1.0,67/332,18.43%,EPAS1;LMO7;KLHL5;KLHL2;APP;DCUN1D3;SPARCL1;VWA1;CDH2;MEN1;ZBTB16;SOCS2;NOTUM;IGFBP7;STT3B;KLHL25;ADAM10;FBXW7;PSMB3;GOLM1;RAB11A;FBXO41;PDIA6;PSMD11;RHBDD1;QSOX1;PSMC6;FEM1C;KLHL3;PSME2;SCG3;SOCS5;KLHL20;PSMD8;WSB1;UBA3;HIF1A;FBXO6;ASB13;RAB1A;EVA1A;DCUN1D1;FBXW2;ASB5;PSMB10;FBXO21;RBX1;SERPINC1;FBXL8;FBXL15;ELOB;ASB15;PROC;DCAF5;PSMA8;ASB7;COPS5;GAS6;TMEM132A;GPS1;FN3K;SCG2;KBTBD8;FBXO2;SKP1;PSMD9;FBXW9
prerank,triglyceride homeostasis (GO:0070328),-0.28478990806433213,-0.7800861711391055,0.7892030848329049,0.9741144546405515,1.0,4/26,8.01%,IL18;RORA;C1QTNF3;APOE
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.36906075750569123,0.7800463356870421,0.7377049180327869,0.9694093835524923,1.0,2/12,5.41%,CYP11B1;CYP11A1
prerank,regulation of cellular response to heat (GO:1900034),0.2594237620869904,0.779342402034085,0.8354253835425384,0.970066854001754,1.0,25/77,26.36%,CD34;HSP90AB1;MAPK3;HSPA8;NUP54;RPTOR;CAMK2B;BAG2;NUP160;DNAJC7;MAPK1;DNAJB6;RPA1;NUP153;NUP50;CAMK2G;IER5;NUP42;PTGES3;NUP85;MTOR;NUP210;BAG5;NUP188;BAG4
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.27757977800832406,-0.7790949683277303,0.8084577114427861,0.9749065954532253,1.0,8/26,19.68%,ANAPC5;NEK6;RIOK2;CUL3;NSMCE2;CENPE;CDC16;HECW2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.35645167140188494,0.7776276074379093,0.727112676056338,0.9723712419148196,1.0,2/14,4.06%,NFKBIA;TMSB4X
prerank,lipid biosynthetic process (GO:0008610),-0.22171037934355126,-0.777402808561991,0.9046052631578947,0.9767454431981643,1.0,4/77,3.79%,ABCD3;PRKAA2;ACSL1;PAM
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.2855829507183253,0.777387800044492,0.779874213836478,0.9722340422380241,1.0,18/53,28.17%,PSMB3;OAZ1;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMC3;PSMD1;PSMD10;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,regulation of defense response to virus (GO:0050688),-0.322727768579269,-0.7773467722035827,0.7692307692307693,0.9760005967705093,1.0,4/14,18.36%,PPM1B;ZMPSTE24;PCBP2;C1QBP
prerank,membrane assembly (GO:0071709),-0.25700594553769485,-0.777323657433152,0.8312655086848635,0.9751924181902317,1.0,5/34,5.95%,ANXA2;NLGN2;S100A10;FLOT2;STX2
prerank,platelet aggregation (GO:0070527),0.3036445682186693,0.7772696327130926,0.7724358974358975,0.9718801155727317,1.0,8/33,12.38%,ACTB;PPIA;STXBP1;ACTN1;ACTG1;HSPB1;PIK3CB;MYL12A
prerank,ncRNA metabolic process (GO:0034660),-0.26185437143074786,-0.7772567535050325,0.8235294117647058,0.9744568766719879,1.0,14/37,28.68%,TUT4;AGO2;XPO5;DDX17;EXD1;DTD1;BCDIN3D;TARBP2;PIWIL2;PARN;DROSHA;TDRD9;DTD2;DDX4
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.330319592657943,-0.7772490909989143,0.748868778280543,0.9736379928145305,1.0,1/13,1.94%,GAB2
prerank,positive regulation of cell killing (GO:0031343),0.3583922767811829,0.7769718112903264,0.7490636704119851,0.9718557804055137,1.0,3/13,11.85%,NOS2;RAC1;SYK
prerank,regulation of cell cycle phase transition (GO:1901987),0.2595419533677241,0.7763817768117577,0.8125894134477826,0.9722636686660557,1.0,29/91,24.44%,FBXW7;PSMB3;PSMD11;PSMC6;PSME2;PSMD8;TRIM39;BUB3;PSMB10;ANAPC16;PSMA8;ANAPC7;SKP1;ANAPC10;PSMD9;UBE2D1;TFAP4;ANAPC2;ATP2B4;DDB1;CUL1;PSMC3;PSMD1;CDC23;PSMD10;CDC26;CDC27;CDKN1B;XPC
prerank,DNA replication checkpoint signaling (GO:0000076),0.34588258719668946,0.7763202850710551,0.7365591397849462,0.9718462606537932,1.0,9/16,29.22%,DNA2;CDC6;ORC1;HUS1;RAD9B;RAD17;TOPBP1;TIMELESS;HUS1B
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.33922690419028134,-0.7761657618870065,0.7528868360277137,0.9745352830275678,1.0,2/11,8.17%,SCARA3;TNIP2
prerank,mitochondrial transcription (GO:0006390),0.3786137029378675,0.776110414226864,0.7330827067669173,0.9716489638286099,1.0,3/10,15.54%,MRPL12;SLC25A33;TWNK
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3088881773930674,0.7760888913106423,0.7611940298507462,0.9711596927627879,1.0,8/29,23.50%,YBX1;NOCT;AXIN2;PAIP1;ELAVL1;NBAS;TENT5C;PABPC1
prerank,sensory perception of smell (GO:0007608),0.37078270685117287,0.775929725259147,0.7145522388059702,0.9709109624050051,1.0,1/11,4.01%,SLC24A4
prerank,osteoclast differentiation (GO:0030316),-0.28773020183435416,-0.775653464375192,0.765661252900232,0.9744953677363253,1.0,2/22,2.21%,GAB2;ANXA2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.36389365377268584,0.7745112768461514,0.720353982300885,0.9726936952860202,1.0,7/12,32.99%,TASOR;SETDB1;SETDB2;DNMT1;MPHOSPH8;TRIM28;PPHLN1
prerank,extracellular transport (GO:0006858),-0.3387399020031922,-0.7741927194798426,0.7601713062098501,0.975940969600829,1.0,8/12,33.83%,TSG101;WWP2;ROPN1L;ADCY10;SPAG17;SPA17;CCDC40;DNAAF4
prerank,cellular response to UV-A (GO:0071492),0.3710660581757279,0.7741234460553507,0.7131782945736435,0.9728389585314332,1.0,3/11,15.23%,OPN5;MMP1;OPN3
prerank,regulation of endocytosis (GO:0030100),0.26856162979340203,0.773771991525283,0.8167388167388168,0.9728769624810005,1.0,4/61,3.37%,HIP1;HIP1R;NEDD4L;PRKD1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.2762720192095955,0.7734205407298512,0.8239757207890743,0.9729208728446825,1.0,15/54,19.16%,CAV1;NEDD4L;KCNQ1;KCNH2;KCNN2;KCNN3;KCNAB2;GNB1;AKAP6;KCNJ3;KCNJ5;BIN1;KCNJ6;KCNIP2;KCNN4
prerank,regulation of interleukin-1 production (GO:0032652),0.3500513237609295,0.7734133097012671,0.7223264540337712,0.9724097957729088,1.0,5/15,20.10%,CCR7;CEACAM1;GAS6;F2R;FOXP1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.29643876747530346,-0.7728788061673071,0.805045871559633,0.9771128191031561,1.0,3/20,5.14%,NUPR1;OGT;FLOT2
prerank,ribosome assembly (GO:0042255),0.28308197581144906,0.7727832907201372,0.8089368258859785,0.9728746173965609,1.0,19/47,28.37%,RPL3;RPSA;DHX37;RPS27;PWP2;MRPL20;RPL11;RPS15;RPS28;MRPS2;RPL24;RSL24D1;ERAL1;MRPL22;RPL6;RPS19;TRAF7;SBDS;DHX29
prerank,tyrosine metabolic process (GO:0006570),0.3688823289281308,0.7722417877281551,0.7397003745318352,0.9732029198065677,1.0,3/11,23.83%,DCT;HGD;THAP4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.28319834089279367,0.7721498487109544,0.8141025641025641,0.9728203683294866,1.0,6/44,10.86%,SH3RF1;RPS6KA1;XIAP;KLF4;CST7;LAMTOR5
prerank,ruffle organization (GO:0031529),-0.30830230333305847,-0.7717978340722785,0.7681818181818182,0.9778981844073823,1.0,2/16,2.33%,TPM1;CARMIL1
prerank,negative regulation of neuron differentiation (GO:0045665),0.3213541857093424,0.7711674894318415,0.7447916666666666,0.9738487690384924,1.0,5/22,16.14%,B2M;EIF2AK4;SOX9;DISP3;HEY1
prerank,insulin secretion (GO:0030073),-0.29440077261341885,-0.7711381608755393,0.7766990291262136,0.9780447165087779,1.0,2/19,5.24%,RAB11FIP2;ANXA1
prerank,centromere complex assembly (GO:0034508),-0.2593853859395179,-0.770454627645994,0.8213399503722084,0.9782784257992492,1.0,11/36,23.99%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4;CENPE;RBBP7;CENPF
prerank,regulation of myeloid cell differentiation (GO:0045637),0.2688569308926295,0.7704225350791665,0.8181818181818182,0.974449255933764,1.0,5/62,3.97%,FES;MEF2C;ZFPM1;LYN;ZBTB16
prerank,early endosome to late endosome transport (GO:0045022),-0.29042045675656286,-0.7703207511515593,0.7834549878345499,0.9776615160548786,1.0,12/20,35.75%,EEA1;ANKRD27;HOOK2;AKTIP;WDR81;WDR91;EMP2;SNF8;PTPN23;SNX16;RILP;RAB5A
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.32665162334328623,-0.770082066563505,0.75,0.9771844641473445,1.0,1/13,1.61%,AXL
prerank,positive regulation of cytokinesis (GO:0032467),0.30128294479674395,0.7698850814863196,0.7845911949685535,0.9748029518526021,1.0,9/32,17.83%,CDC14A;PKN2;PKP4;CDC6;KIF23;MAP10;RXFP3;SPAST;PRKCE
prerank,regulation of chromatin organization (GO:1902275),-0.31147487554370024,-0.769807371179327,0.7657004830917874,0.9767854571445082,1.0,3/14,10.99%,IGF2;MLLT3;SETD5
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.22005501913372494,0.7692560978594393,0.9575418994413408,0.9752601705384049,1.0,47/366,13.22%,INSR;APBB2;SLC39A8;ENG;NANOS3;APP;SOX17;MEF2C;RYBP;SMARCA2;ACVRL1;SOX13;NOTCH1;YBX1;PRDM2;IRF2;RREB1;SOX7;HINT1;KLF1;WWTR1;CCDC88A;TCF7;SNAI2;RPS6KA5;DNM2;NCOA2;SOX18;BRCA2;SOX12;HINFP;FOXP3;HCFC2;HMGA1;UBE2V1;CYFIP1;BTG1;ZNF205;NR5A2;ONECUT1;HIF1A;TFEB;SOX11;WWC1;EIF4E;EDF1;PUM3
prerank,thymus development (GO:0048538),0.3606695951319504,0.7692061493709424,0.7320143884892086,0.9748172804151881,1.0,1/13,1.88%,TBX1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3353223906178321,0.7688954073940618,0.7545126353790613,0.9747744210663468,1.0,5/18,23.40%,FAM107A;ZFP36L1;NR3C1;ZFP36L2;ISL1
prerank,body fluid secretion (GO:0007589),-0.3112318614455991,-0.768870854973633,0.7681498829039812,0.9773696209028234,1.0,4/15,14.82%,SLC22A4;PRLR;SLC22A2;ZBTB7B
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.29360616904903675,0.7688307081022859,0.8048780487804879,0.974350534021237,1.0,3/39,3.22%,UTRN;NEDD4L;FGF13
prerank,chromatin remodeling (GO:0006338),0.2535984561628341,0.7688012438838014,0.8518518518518519,0.973877675311659,1.0,22/100,16.58%,SMARCA2;NPM3;ACTB;BAZ2B;CECR2;NPM2;FOXP3;ARID1A;HNRNPC;HCFC2;PAK1;KDM4A;MYSM1;ZBTB7A;TADA2B;SMARCD1;SOX9;POLE3;HDAC5;SMARCAD1;HCFC1;HMGA2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.28945083849260245,0.7681520889400173,0.7987421383647799,0.9744088020907167,1.0,7/37,11.82%,NOD2;GBP5;NOS2;CD6;PLD4;ABCD1;HIF1A
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.22332745970573512,0.7671118836763532,0.9523255813953488,0.9755586299963555,1.0,93/314,24.82%,ZNRF1;TRIM25;NEDD4L;PELI1;CTNNB1;STT3B;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;PSMD11;SGTB;PSMC6;FEM1C;DMAC2;PSME2;SMURF1;UBXN1;KCTD10;SHARPIN;KLHL20;FBXL2;UBE3D;UBQLN1;PSMD8;GSK3A;FBXO6;RNF187;DERL2;MAN1B1;MAEA;EDEM1;BUB3;PSMB10;NHLRC1;RBX1;PTTG1;FBXL8;ANAPC16;TRIM2;UBE2D3;AREL1;FBXL15;DNAJB9;TMUB2;PSMA8;ARMC8;RAD23A;ANAPC7;UBE2G2;BAG6;GID8;BFAR;FBXO2;TRIM71;TRIM3;KCTD17;SKP1;ANAPC10;PSMD9;SIAH1;RNF4;UBE2D1;TMEM129;RBCK1;ANAPC2;NSFL1C;PLAA;ANKRD9;ERCC8;ANKZF1;DDB1;CUL1;PSMC3;TMUB1;PSMD1;CDC23;RAD23B;UBE2J1;RNF126;PSMD10;CDC26;FBXL14;CDC27;HECW1;CRBN;FBXL3;RNF216;UBXN2B;ZFAND2B;MTA1
prerank,negative regulation of protein transport (GO:0051224),0.3082064654726559,0.7669891327517699,0.7739837398373983,0.9752483938945166,1.0,4/25,12.09%,RHBDF2;SNX3;NDFIP2;HMGCR
prerank,DNA catabolic process (GO:0006308),-0.34158985642301154,-0.7665479574573093,0.76875,0.979984117692128,1.0,2/11,9.55%,FBH1;REXO4
prerank,dendritic cell differentiation (GO:0097028),0.3204319401948163,0.7663936417742389,0.7555938037865749,0.9756471522767528,1.0,5/22,16.47%,LYN;CCR7;LGALS9;TGFBR2;GAS6
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.24136624476616025,-0.7663415107658671,0.8611111111111112,0.9794437568908819,1.0,3/48,5.17%,PRKAG2;OGT;SEH1L
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.33458924560947423,0.7661592384787507,0.7626527050610821,0.975502215641938,1.0,11/18,31.34%,SCO2;SCO1;COA3;SMIM20;COX20;COX17;PET100;TIMM21;COA5;BCS1L;COA8
prerank,nucleic acid-templated transcription (GO:0097659),0.286681425662794,0.7656829206766707,0.797752808988764,0.9757349516210586,1.0,5/42,8.47%,PTMA;TAF1B;NKX2-8;RNPS1;PWP1
prerank,positive regulation of transport (GO:0051050),-0.21798480005824844,-0.7656142087009974,0.9114391143911439,0.9797030493614349,1.0,13/85,12.85%,LRP1;GPC3;CAMK1D;ANXA2;DAB2;ANXA1;IL15RA;APOE;CLIP3;BID;CYBA;RXRA;FMR1
prerank,protein import (GO:0017038),-0.2134457554534343,-0.7654907784575365,0.9397163120567376,0.9790877504664884,1.0,21/84,26.78%,ABCD3;APPL2;LAMP2;RANBP17;HSPA4;APOE;PXMP2;PEX2;SNX33;E2F3;FAM53B;ALDH3A2;IPO7;ATAD1;PEX13;STAT3;KPNB1;HIKESHI;NUP155;IPO8;TPR
prerank,regulation of protein localization to Cajal body (GO:1904869),0.36889219204366996,0.7653432370263218,0.7428571428571429,0.9752266623411812,1.0,3/11,17.88%,CCT3;CCT5;CCT7
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.36889219204366996,0.7653432370263218,0.7428571428571429,0.9752266623411812,1.0,3/11,17.88%,CCT3;CCT5;CCT7
prerank,aerobic electron transport chain (GO:0019646),0.2651368844868574,0.7651043111885825,0.8318965517241379,0.9750881354025518,1.0,24/68,28.50%,NDUFA2;UQCRB;NDUFA8;CYC1;NDUFA4;UQCRC1;AFG1L;COX6C;NDUFA12;NDUFB3;CYCS;NDUFC1;UQCRQ;COX10;UQCR11;SDHAF2;NDUFA10;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;COX5B;NDUFAB1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3329899977325039,-0.7651001068143621,0.739406779661017,0.9788411991623128,1.0,2/11,9.99%,P2RX4;CDH13
prerank,regulation of cell division (GO:0051302),0.2591824970230851,0.7647213011272898,0.8543543543543544,0.9751576195612657,1.0,13/72,16.22%,BCL2L1;CALM1;TAL1;CCP110;RAB11A;PIN1;CETN2;RAB11FIP4;PIK3C3;SH3GLB1;GIT1;PLK2;PRPF40A
prerank,regulation of response to oxidative stress (GO:1902882),-0.33573551796869644,-0.7644209430567098,0.7861915367483296,0.979078877969604,1.0,9/11,43.54%,PRKN;AIFM2;ACOX2;HEBP2;STOX1;MCTP1;SELENON;ALOX5;PINK1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.268507439781837,-0.7643140552573713,0.8346456692913385,0.9784161589781442,1.0,6/27,20.94%,LPAR1;AGTR1;LPAR4;GPR157;HTR2C;C3AR1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.36982174240522214,0.7642063946705047,0.7445255474452555,0.9754278423694297,1.0,11/11,63.04%,MALT1;NFKBID;PRKCQ;NFKBIZ;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1
prerank,response to metal ion (GO:0010038),0.26293733429411337,0.7641444982200332,0.8255813953488372,0.9750182618824722,1.0,13/67,17.64%,CAV1;NEDD4L;CALM1;HOMER1;GPHN;PPP3CA;HIF1A;MT1A;MT1X;PDCD6;LOXL2;TTN;NDRG1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.2672440502989054,0.7640522183717815,0.806015037593985,0.9746629980693833,1.0,7/56,12.22%,PLCB1;RGCC;RAB11A;CCND3;ADAM17;BRD4;RPTOR
prerank,negative regulation of cell cycle process (GO:0010948),0.266986303050165,0.763719006275831,0.8314121037463977,0.9746509756471506,1.0,7/61,8.29%,DAB2IP;RYBP;NANOS2;PHC1;CCP110;MAX;TERF2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.22346117679649072,-0.7635813759811727,0.9138461538461539,0.978648850114803,1.0,21/62,28.83%,CCNT2;CTR9;POLR2A;MLLT3;CCNH;CDK7;AFF4;PAF1;ELP4;NELFE;GTF2F1;SETD2;GTF2H1;POLR2L;CDK12;EAF2;CDK9;POLR2I;ELOA;ERCC2;POLR2K
prerank,termination of RNA polymerase II transcription (GO:0006369),0.297471118767949,0.7634457263106643,0.7799671592775042,0.9745702154756118,1.0,7/33,13.02%,CSTF2;SNRPF;SNRPE;CPSF1;SSU72;NCBP2;SNRPB
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3158474772099227,-0.7633783506733046,0.7907488986784141,0.9781210182204422,1.0,7/15,38.23%,CPEB2;DDX3X;GSTO1;DHX36;ZFAND1;HSF1;VCP
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3407925532784304,0.7629947921689295,0.7542087542087542,0.9747659952218825,1.0,2/17,6.32%,RAPGEF2;ADRA2B
prerank,regulation of lipid catabolic process (GO:0050994),0.32405700057025305,0.7629870209506872,0.7419928825622776,0.974264673023037,1.0,6/19,22.21%,ABCB11;ABCD1;PDE3B;ALK;LONP2;PRKAA1
prerank,neuron cell-cell adhesion (GO:0007158),0.3453601243180069,0.762838509993349,0.7424511545293073,0.9739719324507577,1.0,4/14,15.74%,RET;NCAM2;NRXN1;NLGN1
prerank,response to zinc ion (GO:0010043),0.3129023189478905,0.7627866681282776,0.776595744680851,0.9735321833028416,1.0,10/25,20.32%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;GLRA2;SLC30A4
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.37241862786542934,0.7627301784609412,0.7419962335216572,0.9731210683995523,1.0,3/11,12.20%,STAT1;EBI3;IL27RA
prerank,cellular response to starvation (GO:0009267),0.23545375496209264,0.7624313618216402,0.8913324708926261,0.9730562417934673,1.0,20/147,12.44%,MFSD2A;BMPR2;FAS;FOXO1;PRKD1;RIPOR1;WDR59;XPR1;SESN3;MAPK3;RALB;MAP1LC3B;EIF2AK4;PIK3C3;DEPDC5;HSPA8;LAMTOR5;SH3GLB1;RPTOR;TFEB
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3217319332730898,-0.7620518763049582,0.7858719646799117,0.9791797133857166,1.0,1/13,1.67%,ENPP1
prerank,outer dynein arm assembly (GO:0036158),0.3427339367435594,0.7613437415284394,0.7393715341959335,0.9741920530672993,1.0,4/14,15.27%,ZMYND10;LRRC49;DNAH8;DNAH5
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.2438177053185421,-0.760957331535456,0.8390092879256966,0.9798880367450014,1.0,13/42,18.14%,SMARCC2;CHD3;CHD8;SMARCB1;ACTR8;CHD4;SMARCA1;SMARCA5;SPTY2D1;ERCC6;MBD2;SMARCC1;RBBP4
prerank,regulation of neuron differentiation (GO:0045664),0.2572519057054537,0.7606158047445092,0.8503496503496504,0.9747773855487726,1.0,20/76,18.00%,ARHGEF2;MEF2C;TIAM1;MMD;ADRA2B;YWHAH;CDK5RAP2;EIF2AK4;BRINP3;BRINP2;SOX11;DISP3;NLGN1;HEY1;NRCAM;ALK;SIN3A;CPNE1;NEUROD2;BIN1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.35195360660714337,0.7605364233750479,0.7477477477477478,0.9743908799619535,1.0,3/13,9.98%,TLR7;IRAK2;PIK3C3
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.24798389630479092,0.7599699865421617,0.8611500701262272,0.9747305627277114,1.0,24/94,21.27%,CEP83;DYNLL1;CCP110;RAB11A;PRKAR2B;MARK4;CETN2;TUBB;CDK5RAP2;AKAP9;HAUS6;CEP78;CEP135;CEP72;TUBB4B;TUBA1A;CKAP5;CEP70;CEP97;DCTN1;SFI1;CLASP1;NDE1;HAUS2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.31106305907981074,0.7591945356283585,0.7582608695652174,0.9753825176548461,1.0,5/24,11.06%,CXCL12;LYN;GREM1;CCL1;DUSP1
prerank,regulation of stem cell population maintenance (GO:2000036),0.33089273022368204,0.7589833353458445,0.762962962962963,0.9751668337165329,1.0,7/18,25.12%,PTN;ELAVL1;LOXL2;ZC3H13;HMGA2;MYC;TAF5L
prerank,protein localization to Golgi apparatus (GO:0034067),-0.2746633891147571,-0.7589295202975455,0.828125,0.9819497920853796,1.0,6/27,15.78%,GBF1;OBSL1;VPS13A;ARL1;RAB6A;OPTN
prerank,serine family amino acid catabolic process (GO:0009071),0.3693853287212264,0.7587683059660368,0.7339622641509433,0.9749953093552802,1.0,2/10,9.59%,SHMT2;CBS
prerank,striated muscle cell differentiation (GO:0051146),0.3406206851643483,0.7584828718340553,0.7750439367311072,0.9749340061117134,1.0,2/16,5.10%,MEF2C;SORT1
prerank,glycolytic process (GO:0006096),0.30453267019563707,0.7583576349259735,0.797716150081566,0.9746110257717725,1.0,7/28,18.47%,PKM;HK1;PGAM4;PGAM1;TPI1;PFKL;LDHA
prerank,regulation of RNA metabolic process (GO:0051252),0.26338232501792525,0.7580754340504985,0.8215339233038348,0.9745325470652734,1.0,2/59,1.47%,RBM20;NOVA2
prerank,response to gamma radiation (GO:0010332),0.30779632773880783,0.7578892155969882,0.7521514629948365,0.9743157572479314,1.0,2/24,3.46%,DCUN1D3;MEN1
prerank,regulation of dopamine secretion (GO:0014059),-0.2721609353936387,-0.75675013229963,0.824,0.9841049530465018,1.0,5/25,16.89%,DTNBP1;PRKN;SYT9;SYT13;SYT3
prerank,negative regulation of insulin secretion (GO:0046676),-0.30319048014937056,-0.7565820004045172,0.8192488262910798,0.9835116196860728,1.0,7/17,19.78%,IRS1;PRKN;CCN3;KCNB1;SFRP1;INHBB;ADRA2A
prerank,protein insertion into ER membrane (GO:0045048),0.28777117360997406,0.7556954130220059,0.8143322475570033,0.977124302231864,1.0,2/37,2.69%,APP;STX1A
prerank,mRNA modification (GO:0016556),0.31141266395034817,0.7554596401379425,0.7594501718213058,0.9769612639474458,1.0,7/22,23.95%,CBLL1;TRMT10C;TRMT61B;ZC3H13;CMTR1;METTL3;PCIF1
prerank,covalent chromatin modification (GO:0016569),0.34265931071814737,0.7552730620801905,0.7569573283858998,0.976703992569064,1.0,5/14,21.06%,CHD1;HELLS;SIRT7;HLCS;PARP2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.26555249777374085,-0.7551288216993871,0.8384615384615385,0.9846507134810301,1.0,8/29,19.93%,KANK2;YAP1;AXIN1;ESR1;DDRGK1;RUNX1;LATS1;BRCA1
prerank,import into nucleus (GO:0051170),0.25422813072853034,0.7549169510259303,0.8700564971751412,0.9767158188936197,1.0,30/73,31.72%,BACH2;IPO11;SNRPF;NXT1;SNRPE;RANBP6;SYK;SNRPB;PTTG1IP;SNRPD2;NUP153;NUP50;IPO4;CSE1L;NXT2;NUP85;FAM53A;NUP188;DDX20;RAN;SNRPD1;SMN1;NUTF2;HNRNPA1;GEMIN5;HTATIP2;AKT1;RPAIN;SNRPG;SNRPD3
prerank,hexose metabolic process (GO:0019318),0.2808669130456827,0.7548749611240114,0.7909516380655226,0.976271387494686,1.0,6/39,14.75%,SORD;PPARD;HK1;BRAT1;HECTD4;OMA1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.3170994654188447,-0.7543705080349405,0.7924107142857143,0.9849192266095774,1.0,4/12,18.25%,CLCN2;H6PD;SREBF1;MBTPS1
prerank,pre-miRNA processing (GO:0031054),-0.3100850524772417,-0.7542756359305464,0.7613882863340564,0.9842309855489897,1.0,2/14,7.30%,TUT4;AGO2
prerank,modification-dependent protein catabolic process (GO:0019941),0.22660022930524576,0.754273175227997,0.9246411483253588,0.9766862512352722,1.0,51/193,23.33%,RNF144B;TRIM25;NEDD4L;RNF125;ZNRF3;KLHL25;ATXN3;RFFL;UBE2G1;RNF215;PSMD11;FEM1C;KLHL3;NDFIP2;PPP1R11;SMURF1;KCTD10;RNF130;TOLLIP;UBQLN1;ARRDC1;BUB3;FBXO21;RBX1;PTTG1;ANAPC16;AREL1;RNF8;ANAPC7;UBE2G2;BAG6;BFAR;RNF19A;ANAPC10;PSMD9;SIAH1;CBL;UBE2D1;RNF166;FBXO8;ANAPC2;MIB1;RLIM;DDB1;UBL7;CDC23;RNF126;CNOT4;CDC26;FBXL14;CDC27
prerank,histone H4-K8 acetylation (GO:0043982),0.34351856802523006,0.7541751000110241,0.7583187390542907,0.9758151125016395,1.0,4/15,16.34%,PHF20;JADE2;MCRS1;HCFC1
prerank,histone H4-K5 acetylation (GO:0043981),0.34351856802523006,0.7541751000110241,0.7583187390542907,0.9758151125016395,1.0,4/15,16.34%,PHF20;JADE2;MCRS1;HCFC1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.34196812118870673,-0.753928709972835,0.755741127348643,0.9838896398770451,1.0,3/10,15.19%,CD55;ZBTB7B;CD81
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2900609974252123,0.7539161233602051,0.7649918962722853,0.97572642667164,1.0,13/35,25.97%,NTHL1;PARG;SMUG1;MPG;POLB;RPA1;ADPRS;POLL;POLD1;RFC2;RFC4;PNKP;POLD4
prerank,histone exchange (GO:0043486),-0.2517787225391055,-0.753662037089015,0.8492063492063492,0.9834426919269537,1.0,9/37,18.14%,CENPC;CENPP;CENPK;SMARCA5;SPTY2D1;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,regulation of intracellular protein transport (GO:0033157),0.2960121154419242,0.7531221962053378,0.8041958041958042,0.9764365532300281,1.0,9/32,19.68%,PRR5L;RIPOR1;OAZ1;TGFB1;PDCD10;B3GAT3;SIRT7;TENM1;OAZ2
prerank,regulation of autophagosome assembly (GO:2000785),0.295450224486638,0.753070396474947,0.8085443037974683,0.9760073065767298,1.0,7/33,12.79%,TBC1D14;TBC1D12;PIKFYVE;RALB;SH3GLB1;PIP4K2A;FEZ2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.321604202992213,0.7529209829144127,0.7641196013289037,0.97574753239738,1.0,2/20,5.41%,CYP11B1;CYP11A1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.31443644398574655,0.7525782989742954,0.7477954144620811,0.9757372393887275,1.0,12/22,33.78%,ENC1;PSMB3;PSMB10;PSMA8;PSMA1;NFE2L2;PSMB8;PSMA7;PSMB9;PSMB1;PSMA4;PSMB7
prerank,establishment of spindle localization (GO:0051293),0.349345385194162,0.7516590450479376,0.7724665391969407,0.9766142151476785,1.0,2/14,13.84%,MAP4;CFL1
prerank,synaptic vesicle localization (GO:0097479),0.3442404912838577,0.7516020263401185,0.7527272727272727,0.9761889107470368,1.0,3/13,15.89%,DNM2;NLGN1;SYNJ1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.31943629308763416,0.7514861909911605,0.7742998352553542,0.9758588620863756,1.0,5/21,11.20%,MCUB;TGM2;RAP1GDS1;LETM1;PDZD8
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.29906654930886223,-0.7512811292604481,0.8251748251748252,0.985933326026048,1.0,8/19,24.68%,CDIP1;PML;DYRK2;EP300;PHLDA3;PYCARD;BCL3;RPS27L
prerank,response to hydrogen peroxide (GO:0042542),0.2734393682158306,0.7510304150114515,0.8475336322869955,0.976016598720157,1.0,9/45,14.58%,NET1;RHOB;CAT;FYN;PLEKHA1;PDCD10;STK24;TNFAIP3;STK26
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.22801261683627683,0.7507551967425266,0.9506172839506173,0.9759020566193289,1.0,54/184,23.33%,RGCC;PPP1R9B;CDC14A;DYNLL1;CCP110;PSMB3;NPM2;PRKAR2B;PSMD11;CETN2;TUBB;CDK5RAP2;PSMC6;PSME2;AKAP9;HAUS6;CDC6;CEP78;PSMD8;ZFP36L1;BUB3;CEP135;PSMB10;CEP72;ANLN;ANAPC16;TUBB4B;TUBA1A;CKAP5;CEP70;PSMA8;ANAPC7;SKP1;ANAPC10;PSMD9;UBE2D1;ZW10;ZFP36L2;TFAP4;DCTN1;ANAPC2;SFI1;CLASP1;NDE1;HAUS2;DDB1;CUL1;PSMC3;PSMD1;CDC23;INO80;PSMD10;CDC26;CDC27
prerank,regulation of protein localization to centrosome (GO:1904779),0.3649121881353755,0.7505376450407636,0.7571942446043165,0.9757206853190847,1.0,5/10,24.76%,MARK4;CEP72;APC;NSFL1C;UBXN2B
prerank,negative regulation of macrophage activation (GO:0043031),0.3272216993101793,0.7505334909064819,0.7526690391459074,0.9752248010344156,1.0,2/16,8.24%,CD200;CST7
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.25185546296901123,0.750195656879365,0.8688046647230321,0.9747003873686366,1.0,13/78,12.31%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;AP1S3;KIF3B;KIF23;DCTN4;AP2B1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.25185546296901123,0.750195656879365,0.8688046647230321,0.9747003873686366,1.0,13/78,12.31%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;AP1S3;KIF3B;KIF23;DCTN4;AP2B1
prerank,regulation of keratinocyte migration (GO:0051547),0.35614545966821587,0.7496977332110468,0.7495327102803738,0.9749281745874122,1.0,3/12,12.23%,MAPRE2;IQSEC1;MAP4K4
prerank,cellular response to catecholamine stimulus (GO:0071870),0.3152710603684925,0.7494244364522694,0.7874149659863946,0.974822895132908,1.0,9/23,22.85%,TGM2;KCNQ1;MAPK3;PDE4B;GNB1;MAPK1;ATP2B4;SNCA;RYR2
prerank,cellular response to pH (GO:0071467),-0.29000739713195534,-0.7487573247013064,0.7907488986784141,0.9885649529389465,1.0,3/17,15.76%,IMPACT;SLC9A1;RAB11B
prerank,glutathione metabolic process (GO:0006749),0.28612903606678725,0.7486711997913833,0.8093023255813954,0.9754044223755065,1.0,5/38,10.19%,GCLM;MGST2;GSTA4;HPGDS;GSTK1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.300118595918654,-0.7486341904479196,0.8065268065268065,0.9878887620648366,1.0,1/16,0.93%,SNCAIP
prerank,regulation of protein export from nucleus (GO:0046825),0.3097260767821416,0.7483480084401919,0.8035087719298246,0.9753860367984101,1.0,2/23,3.84%,SP100;RAPGEF3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.23138059498811106,0.7483234334130738,0.910828025477707,0.97492023945756,1.0,39/145,21.88%,DYNLL1;CCP110;PSMB3;RAB11A;PRKAR2B;PSMD11;CETN2;TUBB;CDK5RAP2;PSMC6;PSME2;AKAP9;HAUS6;BRD4;CEP78;PSMD8;CEP135;PSMB10;CEP72;RBX1;TUBB4B;TUBA1A;RCC2;CKAP5;CEP70;PSMA8;SKP1;PSMD9;DCTN1;MECP2;SFI1;CLASP1;NDE1;HAUS2;CDK4;PINX1;CUL1;PSMC3;PSMD1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2754810874405079,0.7483187006274704,0.8255451713395638,0.9744226440163786,1.0,6/48,6.88%,SIGIRR;NLRC5;SAMHD1;PALM3;RFFL;NR1H2
prerank,negative regulation of viral entry into host cell (GO:0046597),0.3524009423426655,0.7481559118972286,0.7554347826086957,0.9741680380326205,1.0,2/12,4.37%,LY6E;SNX3
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2700886184612983,0.7480096471616711,0.8459214501510574,0.9738960114569286,1.0,12/53,17.70%,DAB2IP;GNA12;HSP90AB1;FBXW7;OPHN1;PSMC6;PSME2;F8A1;BAG2;RAD23A;FOXF2;PRKCG
prerank,neuron projection regeneration (GO:0031102),0.35909746990282104,0.7479057346057171,0.7574626865671642,0.9735530514089251,1.0,2/10,23.20%,PTN;DHFR
prerank,response to light stimulus (GO:0009416),0.2691762909276678,0.7471646997142789,0.8348082595870207,0.9741191126267847,1.0,6/55,8.66%,MAP4K3;MEN1;DCT;GTF2H2;OPN5;GPR52
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.234990637567556,-0.747142595583059,0.88268156424581,0.9890345778893694,1.0,16/45,25.08%,EGFR;BMP4;DDX5;POLR2A;RIOK2;WDR43;HABP4;PIK3R1;SLC38A2;U2AF2;TRMT112;DIMT1;MAP2K1;ZC3H18;GRSF1;HSPA1A
prerank,negative regulation of T cell proliferation (GO:0042130),0.3033882652247226,0.7470985400895259,0.809931506849315,0.973712000736725,1.0,3/28,8.41%,TNFRSF21;LGALS9;FOXP3
prerank,protein tetramerization (GO:0051262),0.2552040592113372,0.7468444600194458,0.8542274052478134,0.9735689602159056,1.0,8/67,8.05%,B2M;HPRT1;GBP5;SAMHD1;MCOLN1;HOMER1;ACACB;SHMT2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2619531642693282,0.746595995494443,0.8472834067547724,0.9734234727182993,1.0,15/57,20.82%,RPL38;NOP16;RPS7;DHX37;WDR74;GTF3A;RIOK1;RPL11;RPS15;RPS28;RPS25;NAF1;NOC2L;PAK1IP1;NVL
prerank,response to ionizing radiation (GO:0010212),0.2513798087614538,0.7465344072593001,0.8686131386861314,0.9730308236378835,1.0,26/70,27.79%,NET1;DCUN1D3;MEN1;GRB2;RHOB;BABAM1;BRAT1;RNF8;MSH2;EEF1D;HUS1;BRCC3;RAD9B;RAD1;PRKAA1;INO80;TOPBP1;MYC;MTA1;SMPD1;NABP2;BLM;CLOCK;XRRA1;GADD45A;RFWD3
prerank,embryonic axis specification (GO:0000578),0.3328010745246516,0.7464191042723627,0.8037383177570093,0.9726960976734482,1.0,3/15,10.96%,TBX3;WNT7A;TASOR
prerank,intracellular cholesterol transport (GO:0032367),0.33705692875679616,0.7462847491604764,0.7966417910447762,0.9723731091741151,1.0,4/15,14.49%,OSBP;ABCG1;NPC1;STARD4
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.32758547285870976,0.745921063552507,0.7968197879858657,0.9724350838699471,1.0,5/17,14.34%,ITGA1;CALM1;HSP90AB1;AGTR2;PPP1R15B
prerank,phospholipid homeostasis (GO:0055091),-0.32603813151528466,-0.7455907866502338,0.7880794701986755,0.9903801962251848,1.0,3/11,9.80%,ABCA1;RCN3;TLCD2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.33112490818849016,0.7455488786578457,0.7430683918669131,0.9724633634944323,1.0,3/16,12.52%,AGER;CEACAM1;CYRIB
prerank,regulation of autophagosome maturation (GO:1901096),-0.32088843254942456,-0.7452772977129586,0.8235294117647058,0.9899967315322844,1.0,5/13,18.21%,TMEM39A;CLN3;CLEC16A;PHF23;SMCR8
prerank,rRNA modification (GO:0000154),-0.2814318180103018,-0.7452278091344203,0.8418604651162791,0.9892436448866432,1.0,7/21,22.12%,MTERF4;GAR1;NSUN3;NSUN4;TRMT112;DIMT1;TSR3
prerank,histone H2A ubiquitination (GO:0033522),-0.30273219335744356,-0.7452143378358165,0.8221153846153846,0.9884447479295376,1.0,7/17,21.71%,BCOR;KDM2B;DDB2;UBE2B;UBR2;TRIM37;CUL4B
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.2652993059492204,0.7447700759864626,0.8358433734939759,0.9730940890425485,1.0,5/55,6.23%,PDGFB;XDH;GRB2;PIKFYVE;SLC25A33
prerank,negative regulation of transmembrane transport (GO:0034763),0.366162647775261,0.7446271041366681,0.7565543071161048,0.9727937832515976,1.0,2/10,11.53%,CTTNBP2NL;PRKCB
prerank,negative regulation of microtubule polymerization (GO:0031115),0.3403311767730923,0.7445218656846746,0.7858472998137802,0.9724669200957381,1.0,5/12,22.15%,STMN1;ARHGEF7;CDH5;DYRK1A;SNCA
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.26395867218536156,-0.7444757039014066,0.8690176322418136,0.9885947905220763,1.0,13/27,33.08%,KAT6B;SGF29;MORF4L2;BRD8;EP300;MRGBP;TAF6L;NAA50;CREBBP;KAT8;MSL3;KAT5;TAF6
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.26692578053181976,0.7424959060169579,0.84399375975039,0.9748435029501225,1.0,7/50,12.11%,ACTB;HSP90AB1;CDKN2B;CCNI;CCND3;CDC6;CCNK
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.280839765507194,-0.7420319228094934,0.8516746411483254,0.9910246109863134,1.0,4/22,11.97%,PPM1E;PPM1D;PPM1B;DUSP10
prerank,protein ubiquitination (GO:0016567),0.20842251180890653,0.7420285961907933,0.9902386117136659,0.975001052514953,1.0,95/471,18.63%,RNF144B;EPAS1;LMO7;ZNRF1;KLHL2;SH3RF1;TRIM25;TRIM14;NEDD4L;KLHL7;PELI1;RNF125;ZNRF3;CTNNB1;ENC1;KLHL25;UBE2V2;ABCB11;FBXW7;PHC1;PSMB3;UBE2G1;FBXO41;PSMD11;KLHL24;TRIM36;TRIM24;PSMC6;KLHL3;PSME2;UBE2V1;SMURF1;KCTD10;CBLL1;KLHL20;FBXL2;UBOX5;HERC6;CBFB;PEX14;UBE3D;PSMD8;ZNRF2;WSB1;HIF1A;FBXO6;RNF187;TRIM69;ARRDC1;TRIM39;FBXW2;RNF38;RNF208;ASB5;PSMB10;BCL10;FBXO21;NHLRC1;RBX1;FBXL8;ANAPC16;TRIM2;UBE2D3;AREL1;FBXL15;RNF139;ELOB;RNF8;UBE2Q2;PSMA8;MSL2;ANAPC7;HERC2;UBE2G2;TRIM26;TRIM47;UHRF2;UBE2Z;BFAR;KBTBD8;TRIM68;FBXO2;RNF19A;TRIM71;TRIM3;NEUROD2;SKP1;HLTF;PSMD9;SIAH1;CBL;FBXW9;TRIM11;RNF4;UBE2D1
prerank,histone mRNA catabolic process (GO:0071044),-0.3036479177477826,-0.7410956213061173,0.8060046189376443,0.9913705549105744,1.0,4/15,16.24%,TUT4;ATM;TENT2;TUT1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.3119327404592364,-0.7404208016920312,0.7962085308056872,0.9913908631071061,1.0,5/15,17.74%,EGFR;RBPJ;CDH13;RHBDF1;MVB12A
prerank,protein deacylation (GO:0035601),0.30894392783528973,0.7396989386148962,0.7916666666666666,0.9777602738349963,1.0,7/23,17.62%,HDAC7;NOTUM;ABHD17A;LYPLA1;HDAC5;SIRT7;SIN3A
prerank,Golgi to endosome transport (GO:0006895),-0.2982264152021686,-0.7395642071474821,0.8066666666666666,0.991739167957753,1.0,7/16,23.45%,GBF1;VPS13A;AP4M1;MON2;AP2A1;RAB14;CORO7
prerank,regulation of synapse organization (GO:0050807),0.29899853968546497,0.7384818777477797,0.7950413223140496,0.9789297755798549,1.0,6/26,17.93%,MEF2C;EPHA4;ABHD17A;CAMK2B;YWHAZ;CTNNA2
prerank,protein-DNA complex assembly (GO:0065004),0.2378311399626006,0.7384504011612197,0.8918205804749341,0.9784728243490836,1.0,37/116,28.17%,GTF2H2;PSMB3;PSMD11;CETN2;PSMC6;PSME2;CDC6;PSMD8;GTF2H4;CHAF1A;NAA60;ORC1;SOX9;HMGB2;PSMB10;RBX1;PSMA8;CHAF1B;RPA1;PSMD9;GRWD1;GTF2H3;DDB1;PSMC3;DAXX;PSMD1;RAD23B;PSMD10;NAP1L4;XPC;SART3;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.2895230329147967,0.7376048265410039,0.8251192368839427,0.9791520000683107,1.0,5/29,11.86%,ABT1;DHX37;PWP2;NOL10;UTP3
prerank,regulation of smooth muscle contraction (GO:0006940),-0.2830555622066594,-0.7374319863227337,0.8366336633663366,0.993701482803918,1.0,6/20,17.34%,PLCE1;KCNB2;SPHK1;CHRM2;CTTN;MYOCD
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.33953595568047473,0.7367502602783843,0.7824497257769653,0.9798376913950366,1.0,7/13,29.62%,CIAO2B;BOLA2;GLRX3;YAE1;NFU1;ISCA1;ISCA2
prerank,microtubule nucleation (GO:0007020),-0.28492534631964744,-0.7363395089697071,0.8283062645011601,0.9943135039049374,1.0,5/19,16.29%,CCDC57;GOLGA2;TUBGCP2;TUBGCP4;TUBG1
prerank,protein modification by small protein removal (GO:0070646),0.21865306365875237,0.7362806889911935,0.9728453364817001,0.9800143440177725,1.0,86/252,27.39%,NFKBIA;IFIH1;ACTB;SMAD7;SNX3;ATXN3;CCP110;EIF3F;PSMB3;PSMD11;BIRC3;PSMC6;PSME2;OTUD7A;MYSM1;BABAM1;SMAD1;PSMD8;USP18;HIF1A;TADA2B;POLB;HGS;ATXN7;WDR48;CYLD;TNFAIP3;PSMB10;WDR20;TRRAP;MCRS1;APC;PSMA8;COPS5;HCFC1;RAD23A;GPS1;USP49;RCE1;TNIP1;PSMD9;JOSD2;USP32;USP29;UBE2D1;BRCC3;TRAF3;OTUD4;ASXL1;USP25;USP21;OTUD7B;DESI2;DESI1;JOSD1;SUDS3;COPS6;KAT2B;MBD5;PSMC3;PSMD1;STAMBP;RAD23B;INO80;PSMD10;TRAF6;RIPK1;USP30;VCPIP1;FOXO4;MYC;KEAP1;COPS2;KDM1B;ZC3H12A;USP38;PSME1;USP45;TAB1;ACTR5;ADRB2;UBB;PSMD2;PSMA1;ADRM1;NFRKB
prerank,DNA repair (GO:0006281),0.21418121615285016,0.7359741664809398,0.9766081871345029,0.9799218623052548,1.0,63/284,22.36%,TENT4A;POLK;MEN1;MRE11;UBE2V2;ATXN3;GTF2H2;ALKBH2;BRCA2;HINFP;CETN2;PWWP3A;FANCG;KDM4A;HPF1;UBE2V1;UBXN1;DNA2;BABAM1;SMUG1;MGMT;RECQL4;GTF2H4;MPG;FBXO6;BTG2;POLB;ASCC3;WDR48;FAN1;NSMCE4A;FANCF;MSH3;RNF8;MSH2;TRRAP;RAD23A;HERC2;HMGA2;SUMO1;RAD21;FANCB;HUS1;NUDT1;RPA1;ADPRS;BRCC3;NSMCE3;RAD9B;POLL;POLD1;UVRAG;ERCC8;GTF2H3;POLA1;PARP2;RFC2;DDB1;ERCC4;RAD1;DCLRE1C;PARP9;RAD23B
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.3610920852653469,0.7358959149828354,0.7601476014760148,0.9795313589531933,1.0,4/10,16.06%,TBX1;ACTN4;PPARG;RXRB
prerank,receptor catabolic process (GO:0032801),0.30656895982027293,0.7355397008481346,0.8207705192629816,0.9795450451444198,1.0,6/24,12.31%,ZNRF3;AP2M1;TGFB1;SMURF1;SH3GLB1;AP2B1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.30470810717499935,-0.7355060190617242,0.8175675675675675,0.9937467573498597,1.0,6/15,21.85%,DTNBP1;AP3B1;BLOC1S2;AP3S2;BLOC1S6;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.30470810717499935,-0.7355060190617242,0.8175675675675675,0.9937467573498597,1.0,6/15,21.85%,DTNBP1;AP3B1;BLOC1S2;AP3S2;BLOC1S6;BLOC1S5
prerank,regulation of RNA export from nucleus (GO:0046831),-0.3255587407345975,-0.7348654303881252,0.8161434977578476,0.9937239810897465,1.0,4/11,26.78%,AKAP8L;NSUN2;SETD2;TPR
prerank,regulation of chromatin binding (GO:0035561),0.35710389808841286,0.7342160034400749,0.7750439367311072,0.9808526634467417,1.0,5/10,26.06%,HMBOX1;DDX11;WAPL;PARP9;DTX3L
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.2810223045413744,-0.7339190796749842,0.8337349397590361,0.994145846157918,1.0,7/19,22.68%,MTHFR;MTHFD1;MTHFD1L;MTHFD2;GGH;FPGS;MTHFS
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.31911162009655203,-0.7334540502526982,0.831140350877193,0.9939540817828014,1.0,1/12,1.07%,B3GALT1
prerank,vacuolar acidification (GO:0007035),-0.2783739528441648,-0.7331414715467738,0.8486997635933806,0.993499354983656,1.0,8/21,22.38%,ATP6V0A4;CLN3;GRN;CLN6;ATP6AP2;TCIRG1;ATP6V0D2;TMEM9
prerank,positive regulation of heart rate (GO:0010460),0.32843175979861183,0.7329206419264892,0.7867383512544803,0.982130215124356,1.0,3/17,5.16%,PDE4D;NPPA;KCNQ1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.290635932779055,-0.7328528462839548,0.815668202764977,0.9930509853072829,1.0,7/16,24.26%,PIGN;PIGA;PIGP;PIGX;PIGB;PIGH;PIGL
prerank,positive regulation of ATPase activity (GO:0032781),-0.24244807014372408,-0.7324852845926109,0.880466472303207,0.9927059217829627,1.0,8/41,17.81%,TPM1;ATP1B3;ATP1B2;PFN2;TOR1AIP1;TNNT3;DNAJB2;PLSCR1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.34236094125911165,0.7320460378507511,0.8180147058823529,0.982791957159298,1.0,4/13,17.62%,TMSB4X;SOX11;HEY1;SIN3A
prerank,regulation of peptidase activity (GO:0052547),0.3143982310471676,0.7319983747050727,0.7860780984719864,0.9823640750676156,1.0,2/19,8.24%,CAV1;CST7
prerank,negative regulation of ATPase activity (GO:0032780),-0.2942661438911871,-0.7319545037220906,0.8337236533957846,0.992558395009908,1.0,3/16,20.40%,THADA;ATP5IF1;TSC1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3324322948246702,-0.7317015650432843,0.8134171907756813,0.9920566847374762,1.0,6/10,37.06%,IL18;RARA;PRKCZ;SPHK2;GATA3;IL4
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3070109997212004,0.7314987228122856,0.7954144620811288,0.9825356573622935,1.0,5/22,16.57%,ASXL3;PPP2R5A;CEACAM1;PDE3B;ALK
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2613552756951557,0.7314250829390369,0.8556390977443609,0.9821406050958069,1.0,23/54,27.87%,MAK16;RPL3;SNU13;NOP16;WDR74;MRPL20;GTF3A;RPL11;RRP15;NHP2;NOC2L;PAK1IP1;NVL;RPL10A;SURF6;RPL24;RSL24D1;MRPL1;RPL7A;RPL6;TRAF7;RPL14;RPL26
prerank,regulation of exocytosis (GO:0017157),0.26712964645000187,0.7312385521438735,0.8405572755417957,0.9818954308424108,1.0,13/46,22.15%,STXBP6;UNC13D;RAB3B;LGI3;CPLX1;CADPS;RIMS2;RALA;CADPS2;RAB8A;CLASP1;ATP6AP1;SNCA
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.31078288780235325,0.7312168365733964,0.790893760539629,0.9814299823525919,1.0,5/17,19.17%,CTCF;BUB3;BOD1;ZW10;IK
prerank,endoplasmic reticulum organization (GO:0007029),0.24949177445386703,0.7310891919436154,0.8760932944606414,0.9810923415718924,1.0,6/72,10.33%,APP;REEP1;STX1A;CAV2;LPCAT3;REEP5
prerank,positive chemotaxis (GO:0050918),-0.28553449326221475,-0.730553970803816,0.8285714285714286,0.9926853474442697,1.0,2/17,8.05%,ANGPT1;MET
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.3085089497728276,-0.7304651985812076,0.8195652173913044,0.9919782722747852,1.0,1/13,1.07%,B3GALT1
prerank,response to nutrient levels (GO:0031667),-0.2800640245903737,-0.7304267555175089,0.8,0.9912132872175462,1.0,4/17,19.95%,PRKAA2;KCNB1;RPS6KB1;EIF4G1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3306802348723632,0.7303240007946697,0.7857142857142857,0.9816081271649577,1.0,3/14,8.24%,CD200;CD200R1;CST7
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3296234727988231,0.7300551284943259,0.7894736842105263,0.9814791754226888,1.0,3/14,17.12%,ADAM10;ADAM17;CCR2
prerank,autophagosome assembly (GO:0000045),0.2616301516611714,0.7298143514890335,0.8599397590361446,0.9813151211260394,1.0,23/52,27.66%,IRGM;MAP1LC3B;SMURF1;PIK3C3;ATG12;UBQLN1;RAB1A;ATG14;ATG9B;MAP1LC3A;WDR45;ATG7;NSFL1C;GABARAP;VMP1;ATG2A;GABARAPL2;UBXN2B;ULK1;RAB1B;UBQLN2;RAB7A;BECN1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3263293992070364,0.7295419532857733,0.7661870503597122,0.9811726675706178,1.0,1/15,0.99%,BCL2L1
prerank,snRNA transcription (GO:0009301),-0.2117598345778297,-0.7294358133057103,0.9377049180327869,0.9916704477339453,1.0,23/70,30.57%,CCNT2;PHAX;POLR2A;RPRD2;INTS8;TAF8;CDK7;INTS2;GTF2F1;INTS4;INTS10;USPL1;TBP;POLR2L;TAF9;SNAPC2;CDK9;POLR2I;INTS3;POLR2K;ZC3H8;INTS5;SNAPC4
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.24367358906052142,0.7289278182147996,0.9127324749642346,0.981509855887637,1.0,15/84,13.44%,NANOS3;YBX1;NANOS2;ENC1;MRPL13;NANOS1;PIN1;ABCA7;RPL13A;CNOT9;GRB7;ORMDL1;ORMDL3;BTG2;PAIP2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.29472660135122447,0.7288001916738454,0.8285229202037352,0.9811935898334291,1.0,3/25,10.72%,SORT1;CHMP1B;TMEM50A
prerank,regulation of centrosome duplication (GO:0010824),-0.255870004063382,-0.728597640864545,0.8441558441558441,0.9918447963832135,1.0,8/29,23.20%,ALMS1;SPICE1;STIL;CHMP4C;CEP295NL;FBXW5;CEP131;CEP76
prerank,membrane protein proteolysis (GO:0033619),-0.2406513574936445,-0.7274919711237892,0.8952879581151832,0.9923612114128676,1.0,10/37,18.25%,DAG1;ADAM9;BACE2;ADAM19;AFG3L2;PSEN1;CTSH;HM13;PARL;MBTPS1
prerank,regulation of nuclear division (GO:0051783),-0.2775249168300576,-0.7274669541395916,0.8403755868544601,0.9915729392218056,1.0,3/20,11.39%,OBSL1;CUL7;PRMT5
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.26504406311806117,-0.7272865244019706,0.8236658932714617,0.9909870460907113,1.0,2/21,5.31%,EPHA7;NGF
prerank,regulation of histone acetylation (GO:0035065),0.29335153291446586,0.727066656321035,0.8502415458937198,0.9830362678204128,1.0,11/33,22.35%,RAPGEF3;MAPK3;RPS6KA5;FOXP3;TADA2B;CTBP1;HDAC5;SET;NOC2L;SNCA;SPI1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3129063220335929,-0.7267281647513637,0.8091286307053942,0.9908563996884503,1.0,1/13,1.74%,MOGAT3
prerank,protein homooligomerization (GO:0051260),0.23322846507258013,0.7265673411158053,0.9183400267737617,0.9832202269141356,1.0,19/114,16.56%,AQP11;B2M;HPRT1;GBP5;SAMHD1;MCOLN1;SLC1A2;KCNC2;ACACB;SHMT2;LETM1;EHD4;BCL10;ELAVL1;TRMT61B;CARD11;PDCD6IP;SPAST;NLRC4
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3420503905109391,0.7265231955138372,0.7662835249042146,0.982781908040114,1.0,4/11,22.42%,NCBP2;ZFP36L1;NCBP1;PAPOLA
prerank,regulation of neurogenesis (GO:0050767),0.256256071124487,0.726150403311588,0.8687315634218289,0.9828090929878481,1.0,9/55,13.76%,B2M;NOTCH1;TGM2;WNT7A;CTNNB1;FAIM;LRP2;SOX11;HMGB2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.30870029340410365,0.7259791865703681,0.782608695652174,0.9825489109860528,1.0,6/18,20.06%,DYSF;SYK;DOCK2;NMI;SBNO2;PLCG2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2973213059720017,0.7255615425611255,0.8153310104529616,0.9826260000887486,1.0,4/24,11.82%,NOTCH1;KLF2;ATF6B;HIF1A
prerank,regulation of transferase activity (GO:0051338),0.31958077564383797,0.7252656561346102,0.8003300330033003,0.9825155395236923,1.0,2/17,3.77%,NLRC5;HMBOX1
prerank,positive regulation of phagocytosis (GO:0050766),0.2645887349915466,0.7248858763632159,0.8622222222222222,0.9825346788058851,1.0,10/47,17.30%,RAB31;PTPRJ;MERTK;GATA2;ABCA7;IL15;NCKAP1L;GAS6;DOCK2;LYAR
prerank,carnitine metabolic process (GO:0009437),0.34175962002753146,0.7246963035094702,0.7883211678832117,0.9823071320188264,1.0,2/12,5.58%,CPT1A;CRAT
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2589785188066102,-0.7246703652697798,0.8676844783715013,0.9925305800006262,1.0,6/24,14.97%,DMD;CAMK2D;PKD2;PRKACA;JPH1;GSTM2
prerank,positive regulation of rRNA processing (GO:2000234),-0.33379447841528387,-0.7240821371831504,0.8160676532769556,0.9924234791692382,1.0,4/10,21.58%,RIOK2;WDR43;TRMT112;DIMT1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2868246012255555,0.7240505627729806,0.8352553542009885,0.9826718214172019,1.0,6/30,16.02%,FUT8;STT3B;ST6GAL1;DAD1;DPM3;MGAT2
prerank,DNA duplex unwinding (GO:0032508),0.2619087297629841,0.7235884054731134,0.8768996960486323,0.9827740075132901,1.0,14/50,22.36%,MRE11;GTF2H2;CETN2;HMGA1;RECQL4;GTF2H4;ASCC3;RBX1;TWNK;RPA1;DDX11;GTF2H3;DDB1;RAD23B
prerank,triglyceride catabolic process (GO:0019433),0.31040648337203536,0.722908744580677,0.8128342245989305,0.9831593824358288,1.0,2/19,10.76%,FABP5;LIPC
prerank,regulation of pH (GO:0006885),0.34713957952519886,0.7224356707949103,0.7829313543599258,0.9832627416306927,1.0,3/11,9.41%,ATP1A4;CLCN3;SLC9A7
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3072902396924907,0.7224115719459958,0.8186440677966101,0.9823098543286461,1.0,7/21,21.63%,GTF2H2;GTF2H4;RBX1;RPA1;GTF2H3;DDB1;ERCC4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3072902396924907,0.7224115719459958,0.8186440677966101,0.9823098543286461,1.0,7/21,21.63%,GTF2H2;GTF2H4;RBX1;RPA1;GTF2H3;DDB1;ERCC4
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.3433961699526441,0.721909065665816,0.7833333333333333,0.9824761985523972,1.0,3/12,17.88%,CCT3;CCT5;CCT7
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2853924937624305,0.7218965896897237,0.8461538461538461,0.982000371424014,1.0,6/31,14.41%,DCUN1D3;FBXW7;PIN1;RAB1A;DCUN1D1;BMI1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3097866338513799,-0.7218721877461521,0.8114035087719298,0.9942236303018849,1.0,6/12,30.07%,ESR1;NCOR1;BCDIN3D;ZC3H10;STAT3;TERT
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3220187439427963,-0.7218209530625259,0.8113636363636364,0.9934851703666173,1.0,5/11,30.73%,STX4;TYROBP;MAVS;CAMK4;ITGAM
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.27663768293506164,0.7208839182299962,0.8443759630200308,0.9828700305901081,1.0,9/35,15.74%,ITGA1;CALM1;HSP90AB1;PPP1R2;PPP1R11;AGTR2;CSNK2B;PPP1R15B;BOD1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.34484547937385246,0.7207191615967466,0.8035363457760314,0.9826187068661942,1.0,1/11,4.52%,CTNNB1
prerank,regulation of ion transport (GO:0043269),0.2437293751877207,0.7197839854929193,0.8939179632248939,0.9833150667190568,1.0,16/76,18.53%,B2M;NEDD4L;NKAIN2;SYT7;ATP1A1;PXK;YWHAH;P2RX7;NKAIN1;SYT4;ANK3;KCNJ3;KCNJ5;CA2;KCNJ6;KCNA5
prerank,response to amino acid (GO:0043200),0.28393042045900124,0.7190529678539506,0.8132045088566827,0.9837176132018902,1.0,10/31,24.90%,SH3BP4;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2;GLRA2;GRIN1;MTOR;GLRA1
prerank,negative regulation of TOR signaling (GO:0032007),0.27929182009824904,0.719025120089407,0.8355263157894737,0.983260002185883,1.0,9/36,14.19%,SH3BP4;TNFAIP8L1;SESN3;DEPDC5;DDIT4;GSK3A;TMEM127;PDCD6;EPM2A
prerank,telomere organization (GO:0032200),0.26499078565836226,0.7190122452006753,0.8643815201192251,0.9827831910069347,1.0,14/43,25.97%,SP100;MRE11;TERF2;DNA2;ACD;RECQL4;TERF1;HUS1;RPA1;POLD1;ERCC4;PTGES3;BLM;POLD4
prerank,peptidyl-asparagine modification (GO:0018196),0.28255744631636037,0.7188927821166426,0.850328947368421,0.9824474019837004,1.0,6/31,16.02%,FUT8;STT3B;ST6GAL1;DAD1;DPM3;MGAT2
prerank,sensory perception of chemical stimulus (GO:0007606),-0.29409028016034094,-0.7185826051985985,0.8329411764705882,0.9965218975618833,1.0,5/15,22.35%,GNAS;MKKS;UBR3;BBS4;GNAL
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2800798524945405,0.7177597448271349,0.8406940063091483,0.9834578102695958,1.0,10/35,20.09%,HMBOX1;CTNNB1;MAPK3;CCT3;CCT5;ACD;MAPK1;CCT7;NAF1;MAP2K7
prerank,non-motile cilium assembly (GO:1905515),-0.2458455473955557,-0.7176941028333088,0.8880208333333334,0.9967604907403838,1.0,11/30,24.39%,TTC8;IFT122;FUZ;RPGRIP1L;IFT57;PIBF1;PCM1;CEP250;BBS4;TMEM17;C2CD3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.28256354963704555,-0.7173725216662824,0.8411214953271028,0.9963495208034665,1.0,3/16,14.02%,FBH1;KLHL15;HELB
prerank,cardiolipin metabolic process (GO:0032048),0.3312162831610756,0.7171388217499696,0.7937956204379562,0.9837465558575328,1.0,2/13,12.54%,PTPMT1;PNPLA8
prerank,regulation of cytoplasmic transport (GO:1903649),0.3475150048443343,0.7165432198137444,0.7760910815939279,0.9840269662462356,1.0,2/11,6.18%,DNAJC13;MAPK3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.2763979968688847,0.7164912238677343,0.8540706605222734,0.9836102835345609,1.0,13/36,26.64%,NLRC5;IRGM;ADAM17;HIF1A;C1QTNF4;EDN1;GAS6;CPNE1;PARP9;TICAM2;RIPK1;PARP14;AGPAT2
prerank,dopaminergic neuron differentiation (GO:0071542),0.30576404656600614,0.7164527856609216,0.8183361629881154,0.9831628596712705,1.0,2/19,7.32%,CTNNB1;PHOX2A
prerank,regulation of mitotic spindle organization (GO:0060236),-0.23737794185485253,-0.7150945541693146,0.8885941644562334,0.9982323968845003,1.0,12/35,31.68%,PARP3;GPSM2;CHMP4C;EML3;RAE1;TPX2;HSPA1A;CCSAP;TPR;NUMA1;PLK1;PSRC1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.31019258922797444,0.7147279725205853,0.8344947735191638,0.9848479432914861,1.0,3/17,10.22%,WASF2;NCKAP1;CYFIP1
prerank,DNA replication (GO:0006260),-0.19545967379800394,-0.7146595087268285,0.9831223628691983,0.9979352355091395,1.0,40/105,32.26%,TOP1;RBMS1;REV1;ATM;RBBP8;TIPIN;HELB;IGHMBP2;NAP1L1;RAD50;BAZ1A;CLSPN;DUT;ATRIP;POLD2;RFC3;BRCA1;PCLAF;DONSON;CDC45;DBF4;WRN;NBN;MCM3;ATR;MCM4;POLE2;MCM5;MCM9;EXO1;RFC5;ORC2;ORC5;TOP1MT;TBRG1;PIF1;FEN1;KAT5;TICRR;MCMBP
prerank,action potential (GO:0001508),0.2599857390718945,0.7146275634200957,0.8628389154704944,0.9844856899018247,1.0,7/44,8.33%,GNAQ;KCNQ1;SRI;SCN1A;MYH14;KCNH2;YWHAH
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.25347820664643206,0.7144526964439356,0.8989441930618401,0.9842075888989228,1.0,7/54,12.16%,CNOT6L;RGCC;CRADD;PIDD1;CNOT9;CNOT6;BTG2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.35462336415883855,0.7140922085501935,0.7902621722846442,0.9841599548054246,1.0,4/10,20.44%,AKAP9;DLGAP3;NPTX1;NPTXR
prerank,protein deacetylation (GO:0006476),-0.2336454038455673,-0.7137316354407456,0.9216216216216216,0.9981947762112521,1.0,6/41,9.15%,HDAC4;TBL1XR1;MIER3;FLNA;SIRT3;MORF4L2
prerank,DNA-dependent DNA replication (GO:0006261),0.22692196595506864,0.7129130485570431,0.9427083333333334,0.9851499704540293,1.0,39/128,28.65%,PSMB3;PSMD11;PSMC6;HMGA1;PSME2;MCM10;DNA2;CDC6;RECQL4;PSMD8;POLB;POLG2;ORC1;PSMB10;POLE3;TWNK;PSMA8;SIRT7;RPA1;PSMD9;REV3L;POLD1;POLA1;RFC2;PSMC3;PSMD1;PSMD10;TOPBP1;RFC4;PNKP;BLM;POLD4;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7;WRNIP1
prerank,regulation of pseudopodium assembly (GO:0031272),0.34337596934599,0.7124343290657061,0.768361581920904,0.9848015271755493,1.0,2/10,5.77%,CCR7;CDC42EP3
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.34337596934599,0.7124343290657061,0.768361581920904,0.9848015271755493,1.0,2/10,5.77%,CCR7;CDC42EP3
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.34770351503894187,0.711520847254649,0.7861163227016885,0.9854574150208859,1.0,1/10,4.35%,CALM1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.28603981765096426,0.7105211993407459,0.8246753246753247,0.9861856929003354,1.0,6/27,16.47%,CD200;CD200R1;TNFAIP3;FOXJ1;NCKAP1L;GAS6
prerank,cellular response to estrogen stimulus (GO:0071391),-0.2936009165619176,-0.7103919961031229,0.8643326039387309,1.0,1.0,6/14,21.80%,AR;BCAS3;SFRP1;RARA;PELP1;SRA1
prerank,regulation of oxidoreductase activity (GO:0051341),0.33416843863051116,0.7101997751127962,0.8166666666666667,0.9860977208262612,1.0,1/13,3.20%,NOD2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.2794115795570021,0.7099229479457565,0.8496732026143791,0.9859543610643979,1.0,4/31,11.78%,STX1A;SYT7;STXBP1;SYT4
prerank,nuclear transport (GO:0051169),0.31807981999339224,0.7091927605402989,0.8112874779541446,0.9863446350809718,1.0,4/16,17.07%,NXT1;HMGA1;BANF1;RSRC1
prerank,regulation of adaptive immune response (GO:0002819),-0.28549700342504464,-0.7090083039351464,0.8574712643678161,1.0,1.0,8/18,30.76%,ADCY7;PYCARD;IL6ST;AHR;IRF1;FADD;IL4I1;SIRT1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.2745230679550462,0.7088248574201723,0.853225806451613,0.9863061433387889,1.0,4/31,12.63%,LYN;TNFRSF21;FOXP3;SOX11
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.30058508302155595,0.7087287212509296,0.831973898858075,0.985929845148346,1.0,2/22,3.56%,NOTCH1;IL10RB
prerank,myelination in peripheral nervous system (GO:0022011),-0.299130891566494,-0.7085783670134744,0.8224719101123595,1.0,1.0,8/13,27.75%,MYOC;SKI;NF1;SIRT2;LGI4;NCMAP;PRX;CNTNAP1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.30648601512846796,-0.7084504576522475,0.8464912280701754,1.0,1.0,4/12,22.47%,NEK6;PRKCA;CNEP1R1;CCNB2
prerank,mRNA 3'-end processing (GO:0031124),-0.2043185888114176,-0.708411696750924,0.9642857142857143,1.0,1.0,27/78,25.41%,SRSF5;PABPN1;SRSF11;PCF11;RPRD2;SRSF6;CPSF3;SRSF4;TENT2;PAF1;DDX39B;PAPOLB;TUT1;THOC2;THOC7;U2AF2;U2AF1;CPSF2;CSTF3;PAPOLG;FIP1L1;DDX39A;EIF4A3;GRSF1;POLDIP3;THOC1;SYMPK
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.29646197727269213,-0.7078471601541341,0.8441860465116279,0.9998687663597501,1.0,5/15,19.68%,NEK6;RIOK2;CENPE;CDC16;HECW2
prerank,protein sumoylation (GO:0016925),-0.2197212381271352,-0.7078170748684826,0.9250720461095101,0.999102124611087,1.0,6/49,12.17%,EYA1;PIAS1;SEH1L;NUP205;TRPM4;PIAS2
prerank,N-terminal protein amino acid modification (GO:0031365),0.32359907392266996,0.7069271915019865,0.8241563055062167,0.9875839753692768,1.0,4/14,13.94%,NAA60;NAA16;NAA11;METAP2
prerank,lysosome localization (GO:0032418),0.2668626582728625,0.7062999225578717,0.8646362098138748,0.9878545229116436,1.0,7/37,14.10%,SPAG9;RAB34;MILR1;PLEKHM1;TFEB;KXD1;FAM98A
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.32414743532475365,0.7061047835684275,0.7925233644859813,0.9876055813846212,1.0,3/13,18.27%,STX1A;SYT4;CACNA1I
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.33690038729422084,0.7060640605785229,0.7907407407407407,0.9871606537639915,1.0,4/11,20.97%,NEDD4L;GOPC;LEPROTL1;GPM6B
prerank,Golgi localization (GO:0051645),0.33793833969932147,0.7056138317098745,0.8287292817679558,0.9872164568009761,1.0,6/11,27.10%,RIPOR1;PDCD10;YWHAZ;UVRAG;CDC42;HOOK3
prerank,histone H3-K4 methylation (GO:0051568),-0.2500673696704229,-0.7056130162336732,0.8976190476190476,1.0,1.0,3/26,6.37%,OGT;CTR9;SETD4
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.23378291401100532,0.7053663603538678,0.9325681492109039,0.9870194450416286,1.0,24/83,24.87%,CDK17;MAX;HINFP;BRD4;CDC6;EIF4E;ORC1;PIM2;PLK2;ACVR1;TRIM71;USP29;CDK18;CDK6;POLA1;CDK4;NASP;CUL1;DHFR;CDKN1B;KLF11;MYC;CDKN2C;TYMS
prerank,nucleic acid metabolic process (GO:0090304),-0.20659902267872648,-0.7049635172189821,0.9715189873417721,1.0,1.0,11/69,17.09%,ENPP1;NT5E;HNRNPH1;POLR2A;DDX1;HNRNPH2;HNRNPR;HNRNPA2B1;GTF2F1;RAD50;PCBP2
prerank,lipid catabolic process (GO:0016042),0.3032054532167442,0.7049382664071251,0.8324324324324325,0.9870697921759293,1.0,2/18,10.76%,LIPE;LIPC
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2409540416337127,-0.7045953137423415,0.8945945945945946,1.0,1.0,7/30,16.99%,FBH1;UBR5;KLHL15;TWIST1;HELB;TRIP12;ERCC6
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.22597348415094354,-0.7041376864574229,0.9329446064139941,0.9998971060909544,1.0,11/42,27.38%,FBH1;RTEL1;PARP1;KDM1A;KLHL15;HELB;ERCC6;SETD2;SIRT6;SPIDR;RAD51AP1
prerank,regulation of ATP metabolic process (GO:1903578),-0.2158947590044113,-0.7038167133847544,0.9525423728813559,0.999435480048885,1.0,5/54,9.42%,PRKAG2;OGT;SEH1L;ATP7A;NUP205
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.2828980225052507,0.7036371240128517,0.8291873963515755,0.9882022109037039,1.0,8/27,21.66%,MAP3K8;IKBKB;MAPK3;CCM2;MAPK1;SKP1;MAP2K7;CUL1
prerank,steroid hormone biosynthetic process (GO:0120178),0.2823529275154803,0.7035173270787957,0.8663282571912013,0.9878490020001646,1.0,6/29,19.63%,CYP11B1;CYP11A1;HSD17B7;HSD17B8;DHCR7;STARD3NL
prerank,pre-replicative complex assembly (GO:0036388),0.2480716732242687,0.7033113663265358,0.8813314037626628,0.9876019118162502,1.0,19/64,28.17%,PSMB3;PSMD11;PSMC6;PSME2;CDC6;PSMD8;ORC1;PSMB10;PSMA8;PSMD9;PSMC3;PSMD1;PSMD10;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.23681406803138394,-0.7030462736289949,0.9109195402298851,0.999439299928842,1.0,5/31,9.52%,PRKCI;PARD3B;DLG1;MYO9A;EZR
prerank,bile acid metabolic process (GO:0008206),0.28477802333206803,0.7022478904554055,0.8524871355060034,0.9883834767677897,1.0,5/27,12.91%,OSBPL1A;OSBP;ABCB11;NPC1;SLC27A2
prerank,cellular response to virus (GO:0098586),0.2739179373006499,0.7019586522144827,0.85,0.9882425310943339,1.0,6/30,11.82%,IFIH1;POU2AF1;LGALS9;IRGM;EIF5A;HIF1A
prerank,positive regulation of intracellular protein transport (GO:0090316),0.21714076772747098,0.7018482621567116,0.975,0.9878899949924727,1.0,27/144,17.11%,PPP1R13B;PRR5L;RAPGEF3;RIPOR1;PPP3CC;HYAL2;FYN;FBXW7;OAZ1;TGFB1;YWHAH;ZPR1;YWHAQ;PDCD10;CASP8;HRAS;GSK3A;SH3GLB1;PPP3R1;B3GAT3;TMEM30A;MFF;UBE2D3;ANK3;GAS6;YWHAZ;YWHAB
prerank,signal transduction in response to DNA damage (GO:0042770),0.25588268272266584,0.7015569486853487,0.8929712460063898,0.9877494292176558,1.0,10/49,19.36%,ACER2;MYO6;GRB2;HINFP;STK33;FBXO6;TRIAP1;HUS1;NDRG1;CDC5L
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.3189319419033059,0.7012796060846541,0.8385964912280702,0.9875966169701006,1.0,3/14,10.96%,BRCA2;TERF2;ACD
prerank,maturation of LSU-rRNA (GO:0000470),-0.24831608900463914,-0.7012342585964089,0.8980582524271845,1.0,1.0,4/26,12.48%,NSA2;WDR12;NOP2;LAS1L
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.323809188033105,0.7011319407560519,0.7974217311233885,0.9872785830948607,1.0,2/13,4.45%,SOX13;RREB1
prerank,glycerolipid metabolic process (GO:0046486),0.3355772071319205,0.7011198457876789,0.8037383177570093,0.9868089318816009,1.0,3/11,18.95%,GAL3ST1;DGKZ;PGP
prerank,sensory perception (GO:0007600),-0.2235452868054867,-0.7011006674888925,0.9155313351498637,0.9999124540243872,1.0,6/45,8.63%,ADGRV1;PTGES;GNAS;P2RX4;TTC8;ADORA2A
prerank,acylglycerol homeostasis (GO:0055090),-0.27261976422018364,-0.7008908502087624,0.8728606356968215,0.9993324876759688,1.0,3/20,8.01%,IL18;RORA;APOE
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.29789380107967883,-0.7007218695254686,0.8398268398268398,0.998720017984926,1.0,3/12,14.75%,SLC5A3;CYBA;TLR4
prerank,DNA geometric change (GO:0032392),-0.24936009402295173,-0.700524609361049,0.8839506172839506,0.9981287098961913,1.0,14/24,32.82%,ANXA1;DDX1;RTEL1;ZRANB3;HNRNPA2B1;RAD50;WRN;NBN;MCM9;HMGB1;RECQL;DHX36;PIF1;SUPV3L1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2801777135196131,0.6981885893099563,0.8597972972972973,0.9897032865158499,1.0,4/30,10.12%,CAV1;HYAL2;INPP5F;PTK6
prerank,regulation of T cell differentiation (GO:0045580),0.2688161700372305,0.6980319656247683,0.8725165562913907,0.9893921052747298,1.0,4/33,10.94%,ZAP70;TCF7;FOXP3;CBFB
prerank,chromatin assembly (GO:0031497),0.2678636525300707,0.697862668799426,0.8755980861244019,0.9891014884624554,1.0,14/38,24.05%,PRDM9;CTCF;CHAF1A;NAA60;SOX9;HMGB2;POLE3;CHAF1B;HMGA2;NOC2L;GRWD1;DAXX;LIN54;NAP1L4
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.27564855835145097,-0.6977176840143517,0.8852459016393442,1.0,1.0,8/18,34.70%,POLD2;RFC3;LIG1;MCM3;MCM4;LIG3;GINS1;GINS3
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.23723356036225757,0.69731376826643,0.9185714285714286,0.9892201167664775,1.0,17/71,17.36%,CTSC;ATXN3;CTSW;CTSK;CTSO;RHBDD1;MALT1;OTUD7A;CASP8;TNFAIP3;OMA1;PSMA8;ATE1;PDCD6IP;CTSS;CAPN2;BAG6
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.27278149492052284,-0.6966962275037213,0.8853658536585366,1.0,1.0,5/18,14.61%,SOD2;PRKN;TRAP1;HTRA2;NONO
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.2824144108569609,-0.6965462082944636,0.8355555555555556,0.9998810585087903,1.0,4/15,13.94%,MAGI2;DACT1;SKI;ACVR1B
prerank,regulation of dendrite morphogenesis (GO:0048814),0.2735211891374087,0.6958935351501807,0.8781645569620253,0.9903165966312368,1.0,3/32,4.12%,RAPGEF2;NEDD4L;LZTS1
prerank,autophagosome organization (GO:1905037),0.2527761967406904,0.6958431650754214,0.8869969040247678,0.9898872995352815,1.0,22/50,27.66%,IRGM;MAP1LC3B;PIK3C3;ATG12;UBQLN1;RAB1A;ATG14;ATG9B;MAP1LC3A;WDR45;ATG7;NSFL1C;GABARAP;VMP1;ATG2A;GABARAPL2;UBXN2B;ULK1;RAB1B;UBQLN2;RAB7A;BECN1
prerank,regulation of histone deacetylation (GO:0031063),0.3236303319572332,0.6956835432936396,0.8387096774193549,0.9895851714510727,1.0,3/13,14.86%,APLNR;FOXP3;CTBP1
prerank,tRNA methylation (GO:0030488),-0.23056325446656423,-0.6949683812738868,0.9085872576177285,1.0,1.0,7/34,12.54%,THADA;PRORP;DALRD3;THUMPD3;TRMT1L;NSUN2;METTL6
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2928173219458226,0.6948150001910156,0.8481228668941979,0.9900957224545965,1.0,8/23,21.28%,OCRL;INPP5F;MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1;INPP5K
prerank,positive regulation of peptidase activity (GO:0010952),-0.2604670210760769,-0.6936270389315242,0.86810551558753,1.0,1.0,5/20,16.97%,RCN3;PSME3;CTSH;DDRGK1;GRN
prerank,glucose metabolic process (GO:0006006),0.24710147311717015,0.6935425638618965,0.8975535168195719,0.9910595635789106,1.0,10/58,14.75%,SORD;PPARD;LRP5;BRAT1;SLC25A1;G6PC3;HECTD4;PGAM1;TPI1;OMA1
prerank,protein-DNA complex disassembly (GO:0032986),0.30552846493367986,0.6934232848382318,0.8464285714285714,0.9907124911125601,1.0,9/16,25.09%,ARID1A;HMGA1;SMARCD1;SET;RPL23;GRWD1;ARID2;MYC;SMARCA4
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2925287923260663,0.6932577958710027,0.8527508090614887,0.99042433206052,1.0,10/23,26.98%,CETN2;RBX1;COPS5;GPS1;COPS6;DDB1;RAD23B;XPC;COPS2;UBB
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3365394583634218,0.6926233752815916,0.8296703296703297,0.990162101521928,1.0,2/11,7.16%,CALM1;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3365394583634218,0.6926233752815916,0.8296703296703297,0.990162101521928,1.0,2/11,7.16%,CALM1;SRI
prerank,midbody abscission (GO:0061952),0.3078137843561778,0.6924799247157478,0.8162544169611308,0.9898426815134521,1.0,6/17,28.96%,CHMP1B;MITD1;PDCD6IP;CHMP2B;VPS4B;CEP55
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.27437018777263644,-0.6924106857340214,0.8606356968215159,1.0,1.0,4/16,21.77%,PARP3;KMT5C;KMT5B;KDM4D
prerank,negative regulation of phosphatase activity (GO:0010923),0.2842962262146321,0.6921989331700337,0.8697829716193656,0.9896822538999079,1.0,6/25,19.97%,TGFB2;PPP1R11;PPP1R35;BOD1;FKBP1A;SEMA4D
prerank,selective autophagy (GO:0061912),-0.2115475236017939,-0.692198547834392,0.9550898203592815,1.0,1.0,11/56,14.77%,LGALS8;ULK2;ATG2B;PRKN;ATM;TEX264;DYNC1I1;AUP1;AMBRA1;DDRGK1;UFC1
prerank,ubiquinone biosynthetic process (GO:0006744),-0.2786436463946593,-0.6917564918835897,0.8417721518987342,1.0,1.0,6/15,28.71%,COQ10A;COQ2;COQ8B;COQ10B;NDUFA9;COQ6
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.20193812457318366,-0.6916008156136295,0.9675324675324676,1.0,1.0,22/69,30.57%,CCNT2;PHAX;POLR2A;RPRD2;INTS8;TAF8;CDK7;INTS2;GTF2F1;INTS4;INTS10;TBP;POLR2L;TAF9;SNAPC2;CDK9;POLR2I;INTS3;POLR2K;ZC3H8;INTS5;SNAPC4
prerank,positive regulation of acute inflammatory response (GO:0002675),0.3134249838448536,0.6913376323904031,0.8162878787878788,0.9901711335555253,1.0,1/14,4.60%,OSMR
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.31719821597378,-0.6908419558808166,0.8264642082429501,1.0,1.0,6/10,40.96%,DDX39B;THOC1;FEM1B;ETAA1;CCAR2;THOC5
prerank,leukotriene biosynthetic process (GO:0019370),-0.29012857481078336,-0.6902901120643536,0.8747203579418344,0.9998406840473152,1.0,3/14,15.64%,GGT5;GGTA1;MGST3
prerank,dendritic cell chemotaxis (GO:0002407),0.31681152769103954,0.688757683883029,0.8370786516853933,0.9926222448096633,1.0,2/14,8.20%,CCR7;CXCR2
prerank,secretory granule organization (GO:0033363),-0.3143149676316648,-0.6887352103804477,0.8660907127429806,1.0,1.0,2/10,5.16%,ABCA1;DTNBP1
prerank,magnesium ion transport (GO:0015693),-0.2994682597739218,-0.6876186825615905,0.851380042462845,1.0,1.0,4/12,19.77%,SLC41A1;NIPAL2;MAGT1;TUSC3
prerank,synaptonemal complex organization (GO:0070193),0.3101474379010005,0.6870875369159787,0.8555555555555555,0.9935368932540133,1.0,6/15,29.64%,RAD21;BAG6;SYCP2;REC8;TEX12;P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.3101474379010005,0.6870875369159787,0.8555555555555555,0.9935368932540133,1.0,6/15,29.64%,RAD21;BAG6;SYCP2;REC8;TEX12;P3H4
prerank,negative regulation of DNA recombination (GO:0045910),-0.2190351161426733,-0.6867007994481522,0.9346590909090909,1.0,1.0,7/43,14.02%,FBH1;PARP3;POLR2A;RTEL1;KLHL15;ZRANB3;HELB
prerank,steroid metabolic process (GO:0008202),-0.20010137437606568,-0.6862986102741572,0.9872611464968153,1.0,1.0,4/72,5.39%,CYP7B1;CYP26B1;CYP27A1;CYP1B1
prerank,histone H4 deacetylation (GO:0070933),0.33625234388923636,0.6861174321847658,0.833641404805915,0.9941185246476627,1.0,3/10,16.90%,HDAC9;SMARCAD1;RCOR1
prerank,regulation of RNA splicing (GO:0043484),0.23849364608793294,0.6858131031256295,0.9354838709677419,0.9939653098144292,1.0,2/69,1.59%,RBM20;QKI
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.2880488600397586,-0.6857916139443313,0.863013698630137,1.0,1.0,4/13,20.90%,RHOQ;LRRK2;GNAI3;ENTPD7
prerank,DNA double-strand break processing (GO:0000729),0.2972676680115688,0.6852382282063488,0.8260135135135135,0.9940756542354034,1.0,4/18,15.43%,MRE11;UBE2V2;DNA2;SMARCAD1
prerank,cellular response to amino acid starvation (GO:0034198),0.23480806350629796,0.6847266446838954,0.9410071942446043,0.994140869431837,1.0,11/71,12.44%,FAS;PRKD1;WDR59;SESN3;MAPK3;EIF2AK4;DEPDC5;LAMTOR5;SH3GLB1;RPTOR;TFEB
prerank,response to amino acid starvation (GO:1990928),0.23407856268506144,0.684234935077134,0.9451659451659452,0.9942025975922554,1.0,11/72,12.44%,FAS;PRKD1;WDR59;SESN3;MAPK3;EIF2AK4;DEPDC5;LAMTOR5;SH3GLB1;RPTOR;TFEB
prerank,histone mRNA metabolic process (GO:0008334),0.2726542172337547,0.6835287022103604,0.882943143812709,0.9944842717476199,1.0,9/27,21.56%,MTPAP;SNRPF;SNRPE;DCP2;NCBP2;SNRPB;EXOSC10;XRN1;NCBP1
prerank,integrated stress response signaling (GO:0140467),-0.2872163555350198,-0.6830328770545944,0.8729792147806005,1.0,1.0,5/14,26.10%,IMPACT;DDIT3;QRICH1;CCL2;EIF2AK3
prerank,regulation of protein localization (GO:0032880),0.24272100778685526,0.6827801975378882,0.9235294117647059,0.9947607871011181,1.0,5/58,6.44%,TRIM25;TRIM14;MMD;HSP90AB1;FBXW7
prerank,cytoplasmic translational initiation (GO:0002183),0.29738530982786193,0.6826546523021714,0.8448844884488449,0.994416730162062,1.0,6/17,23.53%,EIF4H;EIF3D;EIF3M;EIF4A1;EIF4B;EIF2S2
prerank,gastrulation (GO:0007369),-0.27394195737152005,-0.6825740441540732,0.9020044543429844,1.0,1.0,1/15,1.79%,GPC3
prerank,spindle assembly (GO:0051225),0.23494515944478395,0.6825073606913282,0.9213649851632048,0.9940944858430393,1.0,9/67,12.53%,STARD9;MAPRE2;KIF2A;RAB11A;SAC3D1;MZT1;HAUS6;KIF3B;MAPRE3
prerank,regulation of sodium ion transport (GO:0002028),0.2608731016837802,0.6815599328062166,0.8767550702028081,0.9945923220399189,1.0,6/34,11.33%,CNKSR3;NKAIN2;ATP1A1;YWHAH;P2RX7;NKAIN1
prerank,endocytic recycling (GO:0032456),-0.20858562939093772,-0.6812464220871048,0.9591836734693877,1.0,1.0,16/50,24.67%,SNX12;ENTR1;ACAP2;ANKRD27;VPS35L;EHD1;RAB11B;EHD2;VPS26C;RAB13;ANKRD50;RAB14;SNX17;CCDC22;VPS26A;VPS39
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3158071989646899,0.6806341130109506,0.8283582089552238,0.995072120141339,1.0,2/12,9.70%,HPRT1;GART
prerank,cellular response to DNA damage stimulus (GO:0006974),0.19594477880842168,0.6806080893893004,0.9965831435079726,0.9946227915550664,1.0,71/336,21.64%,POLK;BCL2L1;ACER2;FOXO1;MEN1;LYN;FNIP2;SAMHD1;GRB2;CCDC13;RNF169;XIAP;MRE11;MAPK3;MCL1;HINFP;PIDD1;PWWP3A;FANCG;PAK1;HPF1;MCM10;STK33;MGMT;RECQL4;GTF2H4;BRAT1;CCNK;FBXO6;BTG2;POLB;WDR48;FAN1;NSMCE4A;FANCF;POLE3;MSH3;RNF8;MSH2;TRRAP;APC;SIRT7;HERC2;CDKN2AIP;SUMO1;GNL1;ALKBH8;HUS1;NUDT1;CBX1;SLF1;RPA1;DDX11;ADPRS;NSMCE3;BAK1;RAD9B;FOXP1;POLD1;UVRAG;TIGAR;ERCC8;GTF2H3;POLA1;PARP2;RBBP5;RFC2;METTL3;DDB1;ERCC4;RAD1
prerank,sulfur amino acid catabolic process (GO:0000098),0.33427265593473116,0.6803111946293534,0.8429906542056075,0.9944672221328764,1.0,2/10,18.90%,CBS;TXN2
prerank,negative regulation of hippo signaling (GO:0035331),-0.2913885245735876,-0.6801284596399678,0.8505050505050505,1.0,1.0,6/12,25.33%,VGLL4;MAPK14;LIMD1;MAP2K3;AJUBA;CIT
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.1982141709969522,-0.6797509539204859,0.9761092150170648,1.0,1.0,15/73,19.26%,HDAC4;DNMT3A;BAZ1B;IGF2;TDG;PPM1D;SMARCA5;TAF1D;EP300;POLR1C;ERCC6;RBBP4;EED;PHF2;EZH2
prerank,regulation of mitochondrial translation (GO:0070129),-0.25852468595629235,-0.6796188379687575,0.9048723897911833,1.0,1.0,9/21,22.00%,MRPS27;RMND1;ALKBH1;NSUN3;RPUSD4;C1QBP;RCC1L;FASTKD3;FASTKD2
prerank,mRNA processing (GO:0006397),-0.16342994680605125,-0.6794192388391945,1.0,1.0,1.0,80/287,27.74%,DDX5;SRRM2;PPARGC1A;HNRNPH1;HNRNPUL1;SON;SRSF5;POLR2A;RNPC3;PABPN1;SNRNP70;SRSF11;PRCC;RAVER2;PCF11;RPRD2;AKAP8L;SRRM4;NOVA1;SRSF6;CPSF3;GCFC2;PRKACA;SUGP1;CCNH;HNRNPH2;SRSF4;PNN;CDK7;RBM5;PRPF19;HNRNPR;RBM41;NONO;HNRNPA2B1;PRMT9;GTF2F1;PPIH;DDX39B;CCAR1;PSPC1;RAMAC;PCBP2;THOC2;PRPF18;PRPF3;THOC7;U2AF2;U2AF1;TRA2B;LSM3;TCERG1;CPSF2;CSTF3;FIP1L1;SRSF10;DDX39A;RBMX2;AURKAIP1;SF1;TBRG4;RBM10;EIF4A3;GTF2H1;DBR1;PPIL1;POLR2L;POLDIP3;CWF19L1;THOC1;RNMT;SYMPK;LSM8;POLR2I;HNRNPD;SNRPA1;SF3B5;DHX35;CRNKL1;TFIP11
prerank,mitotic sister chromatid segregation (GO:0000070),0.21984163910994303,0.6788458992146689,0.9682320441988951,0.9955312965121315,1.0,17/98,19.15%,TENT4A;NCAPH;RAB11A;MCPH1;CHMP1B;NCAPG;KIF23;CSNK2B;SPAG5;BOD1;PDCD6IP;TTN;RAD21;POGZ;NCAPH2;SET;ZW10
prerank,membrane lipid catabolic process (GO:0046466),-0.3012314435446896,-0.6785783903415104,0.8496732026143791,1.0,1.0,3/10,13.89%,CYP1B1;PDXDC1;NAGA
prerank,linoleic acid metabolic process (GO:0043651),-0.26767422099168664,-0.6768791862181781,0.8986486486486487,1.0,1.0,1/17,1.89%,ACSL1
prerank,regulation of telomere maintenance (GO:0032204),-0.23817606466369337,-0.6768647377380335,0.9015151515151515,1.0,1.0,11/26,31.27%,PML;RTEL1;XRCC5;ERCC1;RAD50;SMG1;NBN;SIRT6;HNRNPD;DHX36;PIF1
prerank,heterochromatin assembly (GO:0031507),0.2899738834573426,0.6768191119385017,0.8573883161512027,0.9971059567438476,1.0,5/20,16.58%,ZNFX1;HMGA1;HELLS;POLE3;HMGA2
prerank,intracellular pH reduction (GO:0051452),0.2592357824596715,0.6761251085571642,0.873581847649919,0.9973508210379455,1.0,5/33,11.70%,ATP6V0A1;RAB39A;CLCN3;GPR89A;GPR89B
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.276495707376983,-0.6761210466662316,0.8736383442265795,1.0,1.0,6/15,30.36%,KYAT1;FAH;KMO;KYNU;IL4I1;HAAO
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.26733116694667974,0.6754301395043483,0.875,0.9975550856625847,1.0,9/29,24.44%,GTF2H2;CETN2;GTF2H4;RBX1;RPA1;GTF2H3;DDB1;RAD23B;XPC
prerank,chromatin disassembly (GO:0031498),-0.2708491856170031,-0.6745651694488852,0.8741721854304636,1.0,1.0,3/14,8.30%,SMARCC2;SMARCD3;SMARCB1
prerank,nucleosome disassembly (GO:0006337),-0.2708491856170031,-0.6745651694488852,0.8741721854304636,1.0,1.0,3/14,8.30%,SMARCC2;SMARCD3;SMARCB1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2605185511958052,0.673819511253186,0.8978583196046128,0.9987211107394098,1.0,7/32,18.11%,MEF2C;SLC30A1;PNKD;CPLX1;RIMS4;RIMS2;PREPL
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.27022337470270136,0.6735276256586266,0.9024390243902439,0.9985202948010701,1.0,8/27,20.67%,CHKA;SELENOI;CEPT1;PNPLA8;LPIN3;ETNPPL;ETNK1;PISD
prerank,cellular response to interleukin-7 (GO:0098761),0.2874897770823778,0.6734877731505645,0.8344709897610921,0.997601823331362,1.0,8/17,25.09%,JAK3;SOCS2;IL7R;CRLF2;CISH;SOCS1;IL2RG;SMARCA4
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.2874897770823778,0.6734877731505645,0.8344709897610921,0.997601823331362,1.0,8/17,25.09%,JAK3;SOCS2;IL7R;CRLF2;CISH;SOCS1;IL2RG;SMARCA4
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3231370306728463,0.6733548387167363,0.8453038674033149,0.9972465852565915,1.0,3/11,14.58%,FYN;UBQLN1;STK26
prerank,mitochondrial RNA metabolic process (GO:0000959),0.30495668445552715,0.6733110802295281,0.8381818181818181,0.9968189502033268,1.0,2/14,6.23%,MRPL12;SLC25A33
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.28449508588056166,0.6731304785975282,0.8614564831261101,0.9965225898515596,1.0,3/22,12.52%,B2M;MALT1;CYRIB
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2242000267280923,0.6725737697089426,0.9569444444444445,0.9965966352025307,1.0,20/82,21.27%,DYNLL1;CCP110;PRKAR2B;CETN2;TUBB;CDK5RAP2;AKAP9;HAUS6;CEP78;CEP135;CEP72;TUBB4B;TUBA1A;CKAP5;CEP70;DCTN1;SFI1;CLASP1;NDE1;HAUS2
prerank,histone H4-K16 acetylation (GO:0043984),0.2893488776716777,0.6708534296269016,0.8532883642495784,0.9978143390839033,1.0,5/19,16.38%,PHF20;JADE2;MCRS1;HCFC1;MSL2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3350604949269972,0.6691739526785775,0.8336283185840708,0.9989834467695928,1.0,2/10,10.96%,TERF2;ACD
prerank,regulation of cellular metabolic process (GO:0031323),0.2459300420453855,0.6690816386567426,0.9236417033773862,0.9986130870382188,1.0,5/45,8.23%,FASN;ABCG1;ABCB11;ACACB;MKLN1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.25875356765671703,-0.6690027452426082,0.8632075471698113,1.0,1.0,4/18,17.76%,PABPN1;DDX19B;MCM3AP;THOC2
prerank,histone H2A monoubiquitination (GO:0035518),-0.2669831161253105,-0.6679880798357,0.8905908096280087,1.0,1.0,4/17,9.81%,BCOR;KDM2B;PCGF2;DDB2
prerank,regulation of steroid metabolic process (GO:0019218),0.2727354766718021,0.6675722392052529,0.8764227642276423,0.9996332196781731,1.0,2/23,6.18%,ABCG1;ABCB11
prerank,regulation of mRNA stability (GO:0043488),-0.17423133931078488,-0.6675240511059262,0.9956521739130435,1.0,1.0,31/145,25.40%,SAMD4A;ROCK2;PRKCD;TENT5A;DCP1A;CSDC2;PSME4;FXR2;PRKCA;PSME3;IGF2BP2;FMR1;PCBP4;YTHDF1;XPO1;FASTKD1;EXOSC2;FASTKD3;EIF4G1;PSMD7;CIRBP;PSMA3;EXOSC1;PSMD14;SAMD4B;RBM24;TBRG4;PARN;MEX3D;HSPA1A;TNFSF13
prerank,anterograde axonal transport (GO:0008089),-0.2215265537068636,-0.6674224875279016,0.9404145077720207,1.0,1.0,4/37,7.83%,TRAK1;DTNBP1;RAB21;AP3B1
prerank,regulation of double-strand break repair (GO:2000779),-0.21726929650562604,-0.6655972032151897,0.9325513196480938,1.0,1.0,13/39,27.38%,UBR5;PML;RTEL1;KDM1A;TWIST1;TRIP12;SETD2;SLF2;OTUB1;SIRT6;ZCWPW1;SPIDR;RAD51AP1
prerank,cellular response to interleukin-2 (GO:0071352),-0.2900866121220503,-0.6653868790583853,0.8646464646464647,1.0,1.0,5/11,21.38%,SHC1;STAT5A;PTK2B;STAT5B;JAK1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.2900866121220503,-0.6653868790583853,0.8646464646464647,1.0,1.0,5/11,21.38%,SHC1;STAT5A;PTK2B;STAT5B;JAK1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2616842034627793,0.664443080657888,0.8887070376432079,1.0,1.0,7/30,18.72%,PLPP6;HMGCR;HSD17B7;LBR;IDI1;DHCR7;HMGCS1
prerank,ncRNA transcription (GO:0098781),0.3073206833793594,0.6640124235930922,0.8442028985507246,1.0,1.0,5/13,27.65%,GTF3A;SIRT7;SPIN1;GTF3C1;SNAPC3
prerank,receptor clustering (GO:0043113),0.26551703636737484,0.6639065882919964,0.8876582278481012,1.0,1.0,7/27,16.54%,AGRN;LRRC7;PTN;NRXN1;SYNJ2BP;NLGN1;ITGA4
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.260934370098912,0.6638573526325002,0.893312101910828,1.0,1.0,16/31,32.21%,PEX14;DNAJC19;TOMM20L;PEX16;CHCHD4;PEX6;PEX1;TIMM21;TIMM50;TOMM70;PEX12;AIFM1;PEX5;GRPEL2;GRPEL1;PEX10
prerank,response to UV-B (GO:0010224),-0.28495823714742236,-0.6631917065651363,0.8954545454545455,1.0,1.0,3/12,11.27%,STK11;CRIP1;MFAP4
prerank,apoptotic mitochondrial changes (GO:0008637),0.2580675211913518,0.6629812549420346,0.9034267912772586,1.0,1.0,2/32,5.96%,BCL2L1;BIK
prerank,regulation of brown fat cell differentiation (GO:0090335),0.295220564409829,0.6610732041153967,0.8553345388788427,1.0,1.0,2/16,4.45%,SOX13;RREB1
prerank,negative regulation of leukocyte activation (GO:0002695),0.29341338992543226,0.6605389921755901,0.851063829787234,1.0,1.0,1/15,2.13%,CD200
prerank,regulation of cholesterol esterification (GO:0010872),0.32189754415185323,0.6598726666327901,0.8342342342342343,1.0,1.0,3/10,19.40%,ABCG1;STARD4;AGT
prerank,microtubule polymerization (GO:0046785),0.26271256166998314,0.6596801055335036,0.8917089678510999,1.0,1.0,10/28,21.21%,FGF13;PIN1;AKAP9;RANBP9;CKAP5;TRPV4;TPPP;CLASP1;TUBG2;NDE1
prerank,protein acetylation (GO:0006473),0.2604009717540667,0.6595420542610095,0.9119086460032626,1.0,1.0,6/30,13.40%,FOXO1;KAT6A;NAA60;GTF2B;NAA16;NAA11
prerank,regulation of viral release from host cell (GO:1902186),0.27582834136614226,0.659460342501489,0.899488926746167,1.0,1.0,6/21,23.50%,TRIM25;TRIM26;TRIM11;VPS37B;DDB1;MID2
prerank,mismatch repair (GO:0006298),-0.23771071377015834,-0.6591534592136946,0.9364303178484108,1.0,1.0,9/27,25.95%,TDG;ABL1;ERCC1;MLH3;POLD2;SETD2;LIG1;MCM9;EXO1
prerank,cholesterol biosynthetic process (GO:0006695),0.25830045721419315,0.6584237963568017,0.8962722852512156,1.0,1.0,7/31,18.72%,PLPP6;HMGCR;HSD17B7;LBR;IDI1;DHCR7;HMGCS1
prerank,quinone biosynthetic process (GO:1901663),-0.2721521746777257,-0.6559446839750952,0.8721174004192872,1.0,1.0,4/14,19.93%,COQ10A;COQ2;COQ8B;COQ10B
prerank,positive regulation of glial cell differentiation (GO:0045687),0.28585765472788205,0.6556136193430971,0.8556521739130435,1.0,1.0,6/17,19.18%,NOTCH1;TGFB1;PTN;PTPRZ1;BIN1;DICER1
prerank,peptidyl-arginine modification (GO:0018195),-0.26956576258486287,-0.6555272763850478,0.8910675381263616,1.0,1.0,10/15,44.77%,PRMT5;PRMT8;ART3;KRTCAP2;PRMT1;ART1;PADI1;PADI4;ART4;ART5
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.22522741099611535,0.6550294159081438,0.9506531204644412,1.0,1.0,18/69,22.39%,TRIM25;STT3B;SGTB;PSMC6;UBQLN1;FBXO6;DERL2;MAN1B1;EDEM1;DNAJB9;TMUB2;UBE2G2;BAG6;FBXO2;TMEM129;ANKZF1;TMUB1;UBE2J1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.28803339992246313,-0.6548014634926388,0.8860759493670886,1.0,1.0,2/12,8.15%,HDAC4;CCN3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.30270471293532863,0.6546318507560367,0.8506375227686703,1.0,1.0,3/12,14.77%,TGFB1;PPARG;ELAVL1
prerank,TOR signaling (GO:0031929),0.26844686288409814,0.6544871378181041,0.8852739726027398,1.0,1.0,4/26,15.35%,PRR5L;CCDC88A;RPTOR;CARD11
prerank,cytosolic transport (GO:0016482),-0.179332098240508,-0.6541246200983725,0.9925093632958801,1.0,1.0,17/108,12.33%,DENND2A;SNX6;GBF1;VPS13A;EEA1;ANKRD27;HOOK2;STX5;AP4M1;ARL1;CLN3;AKTIP;TBC1D10A;MON2;SNX5;RAB29;RAB6A
prerank,positive regulation of defense response to virus by host (GO:0002230),0.2690416086028501,0.654088826863096,0.9019607843137255,1.0,1.0,9/24,27.40%,AIM2;STAT1;EIF2AK4;SIN3A;PARP9;ZC3H12A;CGAS;DTX3L;TOMM70
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.2408562849191207,-0.6536817269387772,0.9313725490196079,1.0,1.0,7/22,28.92%,MED14;ESR1;MED30;MED4;MED24;MED16;DHX36
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.29302584619666266,0.6532884312689478,0.8694852941176471,1.0,1.0,1/17,3.45%,PLA2G4B
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.29031818332069514,0.6523661142196701,0.8779174147217235,1.0,1.0,6/15,23.21%,CSTF2;CPSF1;RTRAF;TSEN15;RTCB;TSEN34
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.28700153110222654,0.6520106582049875,0.8682842287694974,1.0,1.0,5/19,21.77%,TERF2;ACD;TERF1;POLR2J;DAXX
prerank,regulation of DNA recombination at telomere (GO:0072695),0.28700153110222654,0.6520106582049875,0.8682842287694974,1.0,1.0,5/19,21.77%,TERF2;ACD;TERF1;POLR2J;DAXX
prerank,regulation of lymphocyte differentiation (GO:0045619),0.2803685045602282,0.6516884193029029,0.8912280701754386,1.0,1.0,5/18,21.50%,ZFP36L1;NCKAP1L;CCR2;ZFP36L2;METTL3
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.29236364892257516,0.6510650967665389,0.8928571428571429,1.0,1.0,2/17,3.95%,MEF2C;PRKG1
prerank,ERAD pathway (GO:0036503),0.21864179958395383,0.6508850648342439,0.9728571428571429,1.0,1.0,23/83,22.39%,TRIM25;STT3B;ATXN3;SGTB;RHBDD1;PSMC6;UBQLN1;FBXO6;DERL2;MAN1B1;EDEM1;RNF139;DNAJB9;TMUB2;UBE2G2;BAG6;GET4;FBXO2;TMEM129;BRSK2;ANKZF1;TMUB1;UBE2J1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.27162617192032057,-0.6505824190137369,0.9051094890510949,1.0,1.0,5/14,23.16%,PELI3;NLRP2B;TRAIP;GPS2;CCDC3
prerank,vesicle transport along microtubule (GO:0047496),0.2683877480721224,0.6502505114113635,0.9180887372013652,1.0,1.0,5/23,13.02%,KIF1A;FYCO1;BICDL1;KIF3B;RAB1A
prerank,histone deacetylation (GO:0016575),-0.20754598054310133,-0.6499882157080739,0.9659090909090909,1.0,1.0,16/43,30.76%,HDAC4;TBL1XR1;MIER3;PER2;MORF4L2;SIRT2;MTA3;RCOR3;PER1;SIRT6;MIER2;HDAC1;MSL3;BAZ2A;RBM14;SIRT1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.2114413080869999,-0.64892422573706,0.9707446808510638,1.0,1.0,19/42,29.67%,PPA2;QARS1;EPRS1;YARS1;HARS2;VARS2;WARS2;RARS2;DARS2;DARS1;FARS2;EARS2;FARSA;LARS1;TARS1;AIMP1;PPA1;RARS1;KARS1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2806216785555798,-0.6488507254133236,0.8761682242990654,1.0,1.0,3/12,17.10%,PPARA;WNK1;MDK
prerank,negative regulation of JUN kinase activity (GO:0043508),0.320952582759717,0.6488129672684282,0.8435754189944135,1.0,1.0,3/10,15.14%,NPPA;DNAJA1;HIPK3
prerank,inositol phosphate catabolic process (GO:0071545),0.3042423251741004,0.6487588398676394,0.8698884758364313,1.0,1.0,6/12,25.08%,OCRL;NUDT3;INPP1;SYNJ1;INPP5K;IMPA1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.2911780380554349,-0.6468881184621417,0.8888888888888888,1.0,1.0,5/10,28.95%,GATA6;TSKU;CDH3;TYROBP;LILRB1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.23889065098623538,0.6465228385546694,0.9195230998509687,1.0,1.0,13/48,23.90%,ACTB;TAF1B;ARID1A;HMGA1;SMARCD1;DEK;POLR1A;MYO1C;KAT2B;TAF1C;ZMIZ2;SERTAD2;PADI2
prerank,fatty acid beta-oxidation (GO:0006635),0.2328074215966398,0.6460606922578376,0.9374045801526718,1.0,1.0,13/51,19.06%,PPARD;ABCD4;CRAT;ACOX1;ETFB;ABCD1;SLC27A2;ECI2;ACAT1;DECR2;ACAD11;ETFDH;ABCD2
prerank,positive regulation of hormone secretion (GO:0046887),-0.26188433523115395,-0.645505086183192,0.9110576923076923,1.0,1.0,2/17,7.57%,SPP1;C1QTNF3
prerank,presynapse organization (GO:0099172),-0.29193448361943863,-0.6452101003881981,0.890495867768595,1.0,1.0,1/10,2.73%,NLGN2
prerank,protein targeting to lysosome (GO:0006622),-0.2438112594820085,-0.6450723414079368,0.9427207637231504,1.0,1.0,6/20,22.12%,LAMP2;AP4M1;GNPTAB;LAPTM5;VPS4A;NEDD4
prerank,cellular response to osmotic stress (GO:0071470),0.2764081044014136,0.6449313007443116,0.8883333333333333,1.0,1.0,5/21,16.62%,ARHGEF2;RCSD1;ZFP36L1;LRRC8D;TRPV4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2305751732839894,0.6448421781358429,0.9466248037676609,1.0,1.0,9/52,13.07%,CNOT6L;EDC3;PAN3;CNOT9;PDE12;PAN2;DCP2;CNOT6;DCP1B
prerank,chemokine-mediated signaling pathway (GO:0070098),0.23953877954898184,0.6445715298932845,0.9221374045801527,1.0,1.0,7/42,20.92%,CXCL12;CCL1;GPR75;CCR2;SH2B3;CCL25;RBM15
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.29259174930853965,0.6441689892071701,0.875,1.0,1.0,6/14,23.21%,CSTF2;CPSF1;RTRAF;TSEN15;RTCB;TSEN34
prerank,protein heterooligomerization (GO:0051291),-0.2527868419786949,-0.6431193670390731,0.8967889908256881,1.0,1.0,2/17,4.66%,PKD1;PKD2
prerank,regulation of regulated secretory pathway (GO:1903305),0.24702218495587147,0.6431133641525069,0.9250398724082934,1.0,1.0,11/34,26.32%,SYT7;UNC13D;SYT4;RIMS4;RIMS2;PREPL;DOC2A;SYN1;SYT17;RIMS1;SYT15
prerank,negative regulation of B cell activation (GO:0050869),0.2698181495087412,0.6427376359025859,0.8899835796387521,1.0,1.0,5/21,17.44%,LYN;TNFRSF21;TNFAIP3;FOXJ1;SAMSN1
prerank,cellular response to ionizing radiation (GO:0071479),0.23076657661686972,0.6426640458862335,0.9527439024390244,1.0,1.0,3/47,5.30%,NET1;GRB2;RHOB
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.27820232229353925,0.6426438575428366,0.8944543828264758,1.0,1.0,10/19,26.52%,RPTOR;PRDX5;TENM1;BRF2;POLR3F;ZNF76;MAF1;ICE1;MTOR;POLR3C
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.25596291729965676,0.6426008370540583,0.9114331723027376,1.0,1.0,6/29,14.55%,APP;ACP4;SHISA6;NSMF;GRIK2;CAMK2B
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3037895010776082,0.6424957170210855,0.8672727272727273,1.0,1.0,5/11,25.09%,PWP1;SIRT7;DDX11;MTOR;SMARCA4
prerank,folic acid metabolic process (GO:0046655),-0.24817169925403387,-0.6423613543642094,0.9297820823244553,1.0,1.0,9/18,32.80%,MTHFR;MTHFD1;MTHFD1L;MTHFD2;FPGS;MTHFS;SHMT1;ALDH1L1;PM20D2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.31282045741274733,0.6422196871303384,0.8776978417266187,1.0,1.0,7/11,32.99%,TASOR;SETDB1;SETDB2;DNMT1;MPHOSPH8;TRIM28;PPHLN1
prerank,RNA modification (GO:0009451),-0.1964848837166067,-0.6422136623482755,0.9859943977591037,1.0,1.0,16/54,23.95%,TRMT9B;NOP2;NSUN2;ALKBH1;PUS7;ELP5;NSUN3;TRIT1;NSUN4;DTWD1;ANKRD16;TYW5;BCDIN3D;TSR3;LCMT2;PARN
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.2791958282684404,0.6416488966706964,0.8837606837606837,1.0,1.0,3/17,11.25%,PPIA;HSPB1;UBQLN1
prerank,macroautophagy (GO:0016236),0.2033057604543359,0.6412738366881847,0.9917920656634747,1.0,1.0,36/118,22.48%,TOMM22;TECPR1;DYNLL1;TBC1D5;TOMM6;MAP1LC3B;KLHL3;PIK3C3;ATG12;VPS36;PRKAB1;UBQLN1;PLEKHM1;PIP4K2A;SNAP29;HGS;CSNK2B;VPS25;TMEM74;ATG14;VPS16;MAP1LC3A;VAMP7;TOMM7;VPS37A;ATG7;ACBD5;PLAA;UVRAG;VPS37B;TOMM5;GABARAP;RUBCNL;VAMP8;PRKAA1;VPS37C
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.2831436373029367,-0.6403192230350087,0.8769230769230769,1.0,1.0,3/11,19.99%,HAT1;RBBP4;UBN1
prerank,DNA biosynthetic process (GO:0071897),0.28179899558990407,0.6397725902046343,0.8944543828264758,1.0,1.0,7/16,28.65%,PPIA;POLL;POLD1;POLA1;TYMS;POLD4;WRNIP1
prerank,tRNA metabolic process (GO:0006399),0.2807106372307656,0.6397464879521572,0.8900523560209425,1.0,1.0,2/17,7.22%,SARS1;YARS2
prerank,peroxisomal membrane transport (GO:0015919),-0.2264430116577117,-0.6391482150113501,0.9560439560439561,1.0,1.0,7/27,23.80%,ABCD3;PXMP2;PEX7;PEX2;ALDH3A2;ATAD1;PEX13
prerank,protein kinase A signaling (GO:0010737),-0.27033631776535116,-0.6389752231643115,0.8970917225950783,1.0,1.0,4/12,19.00%,EZR;PRKACA;MYOM1;RAB13
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.242577771455832,-0.6387797162510301,0.9414634146341463,1.0,1.0,5/21,18.49%,CDC14B;GOLGA2;BTRC;PTEN;MAD2L1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.27481218856433576,0.6386705982485877,0.8707360861759426,1.0,1.0,8/18,25.82%,RAP1B;RIMS4;NLGN1;RIMS2;PREPL;RAB3GAP1;SYN1;RIMS1
prerank,positive regulation of innate immune response (GO:0045089),0.25698745026878533,0.6383020908166818,0.9107744107744108,1.0,1.0,11/30,27.28%,GBP5;NLRC5;TLR8;NMI;POLR3F;SPI1;RIOK3;POLR3B;POLR3C;IFI35;RPS19
prerank,RNA transport (GO:0050658),-0.18488282227220526,-0.6370710822661811,0.9835526315789473,1.0,1.0,22/71,26.78%,SIDT1;SRSF5;SRSF11;XPO5;SRSF6;SRSF4;FMR1;RBFOX1;SIDT2;HNRNPA2B1;DDX39B;THOC2;THOC7;U2AF2;U2AF1;RAE1;DDX39A;EIF4A3;POLDIP3;THOC1;NUP155;TPR
prerank,regulation of neutrophil migration (GO:1902622),0.31430667506273,0.6367298917502007,0.8667992047713717,1.0,1.0,2/10,14.70%,RAC1;NCKAP1L
prerank,tRNA transport (GO:0051031),0.2457441341873827,0.6365435612899285,0.9331210191082803,1.0,1.0,11/35,26.01%,YBX1;NUP54;NUP160;TOMM20L;NUP153;NUP50;XPOT;NUP42;NUP85;NUP210;NUP188
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.22037567621960436,0.6365329741114504,0.9615952732644018,1.0,1.0,7/63,12.16%,CNOT6L;RGCC;CRADD;PIDD1;CNOT9;CNOT6;BTG2
prerank,sensory perception of taste (GO:0050909),0.30697294922487917,0.6355784148462192,0.8754448398576512,1.0,1.0,10/10,69.32%,TAS1R1;PKD2L1;ASIC2;ASIC1;PKD1L3;TAS1R3;GNAT3;TAS1R2;ASIC3;CD36
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.2774930114005448,0.6351553654705259,0.8966725043782837,1.0,1.0,3/19,11.65%,CAMKK2;FBXW7;GSK3A
prerank,endosome organization (GO:0007032),0.23992557509137286,0.6340989921828137,0.9425465838509317,1.0,1.0,5/41,10.87%,ALS2CL;SNX3;DNAJC13;CLCN3;HOOK1
prerank,homologous chromosome segregation (GO:0045143),0.26729105067580816,0.6338815970689242,0.9036144578313253,1.0,1.0,4/20,16.41%,RNF212B;PRDM9;PTTG1;SIRT7
prerank,skeletal muscle contraction (GO:0003009),0.2751961826586952,0.6333664099670269,0.8622950819672132,1.0,1.0,2/19,8.30%,MYH14;RCSD1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.2659701512630338,-0.6331331654677979,0.9203354297693921,1.0,1.0,2/13,12.68%,ALG1;MPDU1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.26532267903925794,0.6328502888737251,0.9032786885245901,1.0,1.0,4/21,13.44%,PGM2L1;TALDO1;HK1;G6PC3
prerank,lipid droplet organization (GO:0034389),0.26541213720197177,0.6326419923483656,0.9126712328767124,1.0,1.0,2/22,6.74%,PPIA;CDS2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.2918834662185682,-0.6325449385450859,0.8930232558139535,1.0,1.0,3/10,13.65%,PRKCD;CD9;SERPINE2
prerank,gene silencing by miRNA (GO:0035195),0.2488954697832192,0.6323571045429608,0.9395424836601307,1.0,1.0,2/32,4.27%,NOTCH4;ADAR
prerank,aminoglycan metabolic process (GO:0006022),0.3087651099869324,0.6320855449754814,0.8759541984732825,1.0,1.0,6/10,29.59%,XYLT2;B3GAT3;CHST9;B3GAT2;GAL3ST3;XYLT1
prerank,regulation of B cell differentiation (GO:0045577),-0.2575571342088534,-0.6314904538078557,0.9390243902439024,1.0,1.0,4/17,18.74%,MMP14;SFRP1;INHA;ID2
prerank,modulation by host of viral genome replication (GO:0044827),0.2950071897531604,0.6312512702568389,0.8821428571428571,1.0,1.0,4/13,14.87%,EIF2AK4;FBXL2;CCNK;YTHDC2
prerank,mitotic nuclear membrane organization (GO:0101024),-0.19747088210149039,-0.6310858016732965,0.9848484848484849,1.0,1.0,15/51,29.32%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;LEMD2;KPNB1;NUP155;NUP35;NDC1;IST1;NUP43
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.19747088210149039,-0.6310858016732965,0.9848484848484849,1.0,1.0,15/51,29.32%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;LEMD2;KPNB1;NUP155;NUP35;NDC1;IST1;NUP43
prerank,calcium import into the mitochondrion (GO:0036444),0.3123787042318258,0.6306532436072045,0.8681318681318682,1.0,1.0,1/10,2.82%,MCUB
prerank,regulation of catabolic process (GO:0009894),0.2786828550049301,0.6288518574883987,0.9126050420168067,1.0,1.0,1/18,2.59%,NEDD4L
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.21742188589395295,-0.6286246770230673,0.9685863874345549,1.0,1.0,15/32,35.56%,CDC14B;ATM;BRSK1;CLSPN;BRCA1;DONSON;NBN;DTL;TAOK3;NOP53;PLK1;ABRAXAS1;TICRR;TAOK2;UIMC1
prerank,regulation of cell size (GO:0008361),0.2608146859834456,0.6282555268852804,0.9137645107794361,1.0,1.0,10/23,24.53%,MSN;LAMTOR5;RAC1;RPTOR;LAMTOR4;EDN1;RDX;VAV1;RAP1GAP2;MTOR
prerank,superoxide anion generation (GO:0042554),0.2956783057988345,0.6281393646105029,0.8918439716312057,1.0,1.0,3/13,12.57%,CYBB;NCF4;NOX3
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.27566072290870475,-0.6267581711165002,0.8836206896551724,1.0,1.0,4/11,15.58%,SYNJ2;PTEN;INPP5A;INPP5B
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.27566072290870475,-0.6267581711165002,0.8836206896551724,1.0,1.0,4/11,15.58%,SYNJ2;PTEN;INPP5A;INPP5B
prerank,RNA processing (GO:0006396),0.1906570441181351,0.6265227963229438,0.9921259842519685,1.0,1.0,18/176,13.02%,TENT4A;IVNS1ABP;PPP1R9B;ADAR;MTPAP;RNPS1;SNRPF;HNRNPC;DEDD2;MAGOHB;SNRPN;ZCRB1;MPHOSPH10;RBPMS;NCBP2;NOL9;ADAD1;SNRPB
prerank,calcium-ion regulated exocytosis (GO:0017156),0.24971787046536226,0.6248328008556115,0.9351535836177475,1.0,1.0,8/27,26.32%,SYT7;ARHGAP17;SYT4;RIMS2;VAMP7;SYT17;RIMS1;SYT15
prerank,negative regulation of histone modification (GO:0031057),0.28907909258566467,0.6246714603766105,0.8789473684210526,1.0,1.0,5/14,22.15%,FOXP3;CTBP1;SET;NOC2L;SNCA
prerank,production of siRNA involved in RNA interference (GO:0030422),0.305538032892958,0.6243216927691286,0.885036496350365,1.0,1.0,4/10,19.18%,TSNAX;TSN;MRPL44;DICER1
prerank,DNA recombination (GO:0006310),0.23423205216268606,0.6233568590196037,0.9470198675496688,1.0,1.0,9/37,18.18%,RAD54B;MRE11;RECQL4;MSH3;MSH2;TSN;RAD21;ENDOG;RPA1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.26551989801305326,-0.6221413315073918,0.9227373068432672,1.0,1.0,3/13,9.06%,FGF2;IGF2;PDPK1
prerank,positive regulation of viral process (GO:0048524),-0.18572193016605523,-0.6221326969534696,0.99375,1.0,1.0,9/60,15.81%,AXL;MDFIC;PPARA;POLR2A;TMEM39A;DDX3X;NELFE;GTF2F1;PPIH
prerank,regulation of defense response to virus by host (GO:0050691),0.24751065062178124,0.6212074136836605,0.9375,1.0,1.0,11/30,27.40%,AIM2;STAT1;EIF2AK4;TNFAIP3;SIN3A;PARP9;RNF216;ZC3H12A;CGAS;DTX3L;TOMM70
prerank,lipoxygenase pathway (GO:0019372),-0.2500005867424803,-0.6208941203846645,0.9076923076923077,1.0,1.0,7/14,42.31%,PON3;PTGS2;ALOXE3;ALOX12;GPX1;PON1;ALOX5
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.17031433853196318,-0.6195002271212965,0.9965753424657534,1.0,1.0,30/95,27.38%,FBH1;RAD51B;RBBP8;SMC6;PARP1;NUCKS1;XRCC1;NSMCE1;RAD50;SWI5;NSMCE2;BRCA1;CDC45;PSMD14;WRN;KDM4D;SEM1;NBN;MCM3;AP5Z1;MCM4;ZSWIM7;LIG3;SPIDR;RAD54L;MCM5;MCM9;RECQL;ZFYVE26;RAD51AP1
prerank,protein deneddylation (GO:0000338),0.3057518837373562,0.6183998797491463,0.8888888888888888,1.0,1.0,4/10,25.23%,COPS5;GPS1;COPS6;COPS2
prerank,positive regulation of histone modification (GO:0031058),0.24448269337847128,0.6179522037344247,0.9441707717569786,1.0,1.0,6/33,14.86%,APLNR;MAPK3;RPS6KA5;FOXP3;TADA2B;CTBP1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2580358501505703,0.6168984685749095,0.9271186440677966,1.0,1.0,4/22,11.81%,SOX12;FOXP3;CBFB;VSIR
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2855364494523088,0.6168282608035938,0.9,1.0,1.0,2/13,10.50%,NTHL1;SMUG1
prerank,negative regulation of DNA replication (GO:0008156),-0.2593966011446345,-0.6163829197383802,0.9103139013452914,1.0,1.0,7/13,31.03%,TSPYL2;CDAN1;S100A11;ATR;GMNC;PDS5A;GMNN
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.24878975120063218,-0.6162651266116306,0.9431818181818182,1.0,1.0,5/16,20.96%,PLEKHM2;VAMP2;RAET1E;LYST;ULBP1
prerank,regulation of receptor recycling (GO:0001919),0.276773984789122,0.616192114839338,0.91005291005291,1.0,1.0,8/16,27.00%,RAMP3;INPP5F;AP1AR;SNCA;SCRIB;TRAT1;NSF;ECE1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.24256211337123892,0.6160798784432825,0.9567307692307693,1.0,1.0,7/32,17.36%,PPP1R13B;HINT1;JMY;DDIT4;HIPK2;MSH2;BAG6
prerank,'de novo' posttranslational protein folding (GO:0051084),0.24202301600138657,0.6150729891478377,0.9419568822553898,1.0,1.0,7/30,18.69%,ENTPD5;HSPA8;DNAJC7;HSPA9;HSPE1;CHCHD4;ERO1A
prerank,nuclear membrane reassembly (GO:0031468),-0.19004400745743297,-0.6146101636206095,0.9938271604938271,1.0,1.0,15/54,27.62%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;UBXN2A;LEMD2;KPNB1;NUP155;NUP35;NDC1;IST1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.20851519022113577,0.6143779799165706,0.9798561151079137,1.0,1.0,27/84,28.17%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;BUB3;PSMB10;PTTG1;ANAPC16;PSMA8;ANAPC7;ANAPC10;PSMD9;UBE2D1;ANAPC2;PSMC3;PSMD1;CDC23;PSMD10;CDC26;CDC27;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.28163553662917046,0.6143451019404058,0.9040852575488455,1.0,1.0,1/15,3.49%,GBP5
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.2168793381821085,0.6142064433115278,0.9616519174041298,1.0,1.0,20/61,28.17%,CAV1;PSMB3;OAZ1;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMC3;PSMD1;PSMD10;SIRT5;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,cellular response to leucine starvation (GO:1990253),0.29357967254929396,0.6134790680827917,0.8665338645418327,1.0,1.0,2/10,9.61%,SESN3;EIF2AK4
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.2330017553250903,-0.6126146390656393,0.9542168674698795,1.0,1.0,6/22,25.18%,CCNT2;DDX39B;ERCC6;TCERG1;CDK12;THOC1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.28150552738267753,0.6121389857711619,0.9053356282271945,1.0,1.0,4/14,14.04%,OPHN1;MSN;FSCN1;FOXJ1
prerank,purine-containing compound salvage (GO:0043101),-0.26696098214655456,-0.6112344977731464,0.9126637554585153,1.0,1.0,3/12,16.15%,AMPD3;GMPR2;DGUOK
prerank,positive regulation of protein deacetylation (GO:0090312),0.28469663662269906,0.6110599851372754,0.9146567717996289,1.0,1.0,3/14,19.42%,APLNR;CTBP1;DYRK1A
prerank,DNA strand elongation (GO:0022616),-0.244973421625821,-0.6105709221288709,0.9477434679334917,1.0,1.0,8/18,30.26%,RAD50;POLD2;RFC3;NBN;MCM3;MCM4;TERT;GINS1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.22015675291492104,-0.610195451214004,0.9463414634146341,1.0,1.0,4/24,13.47%,NOX4;MTHFR;MTHFD1;GCLC
prerank,myelin assembly (GO:0032288),-0.27734332104561854,-0.6098064921364407,0.9216101694915254,1.0,1.0,2/10,9.73%,EPB41L3;CD9
prerank,tRNA wobble uridine modification (GO:0002098),-0.2504853623019236,-0.6094391431980953,0.9290465631929047,1.0,1.0,3/14,15.34%,TRMT9B;ELP3;ELP4
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.23676413881365996,0.609187108375823,0.9451827242524917,1.0,1.0,8/29,22.45%,EDC3;DCP2;CNOT6;DCP1B;LSM4;EXOSC9;DCPS;EXOSC8
prerank,regulation of DNA recombination (GO:0000018),-0.20624386559337846,-0.6088320921111755,0.9869791666666666,1.0,1.0,11/32,27.38%,RTEL1;KDM1A;ZRANB3;RAD50;SETD2;SIRT6;ZCWPW1;THOC1;SPIDR;KPNA1;RAD51AP1
prerank,maintenance of protein localization in organelle (GO:0072595),0.265339439298259,0.6083876558565661,0.9212880143112702,1.0,1.0,2/19,10.89%,ARL2BP;HK1
prerank,cranial nerve development (GO:0021545),-0.2656359503839749,-0.6078510438084562,0.930648769574944,1.0,1.0,1/11,3.34%,SALL1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.24093029362513732,-0.607633682949387,0.9258373205741627,1.0,1.0,6/16,26.34%,NAA35;NAA80;EP300;NAA40;NAA50;CREBBP
prerank,positive regulation of type 2 immune response (GO:0002830),0.28441740671940413,0.6075353690979913,0.9151943462897526,1.0,1.0,2/14,10.81%,NOD2;DENND1B
prerank,intracellular protein transmembrane transport (GO:0065002),0.22716648612495668,0.6073373574699659,0.9525267993874426,1.0,1.0,20/42,32.21%,SEC62;PEX14;DNAJC19;TOMM20L;PEX16;CHCHD4;PEX6;PEX1;ZFAND2B;TIMM21;TIMM50;TOMM70;SEC63;AKT2;PEX12;AIFM1;PEX5;GRPEL2;GRPEL1;PEX10
prerank,termination of RNA polymerase I transcription (GO:0006363),0.24295654777764628,0.6067830411776144,0.9457735247208932,1.0,1.0,7/30,22.58%,TAF1B;GTF2H2;GTF2H4;UBTF;POLR1A;GTF2H3;TAF1C
prerank,synaptic vesicle transport (GO:0048489),0.28673139871606257,0.6062904436920012,0.888268156424581,1.0,1.0,2/11,15.89%,DNM2;SYNJ1
prerank,base-excision repair (GO:0006284),0.2227489223840972,0.6060940531629055,0.9771341463414634,1.0,1.0,12/48,21.33%,NTHL1;DNA2;PARG;SMUG1;MPG;POLB;HMGA2;RPA1;ADPRS;POLL;POLD1;RFC2
prerank,error-free translesion synthesis (GO:0070987),-0.2245887633776192,-0.6050629730658138,0.9463414634146341,1.0,1.0,7/22,32.74%,REV1;RCHY1;RFC3;UFD1;RFC5;SPRTN;POLDIP2
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.29699200752908417,0.6043384159465969,0.8935018050541517,1.0,1.0,2/10,12.31%,AP2M1;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.29699200752908417,0.6043384159465969,0.8935018050541517,1.0,1.0,2/10,12.31%,AP2M1;AP2B1
prerank,ESCRT complex disassembly (GO:1904896),0.29479842404411494,0.6042818292389682,0.870722433460076,1.0,1.0,1/10,7.83%,CHMP1B
prerank,ESCRT III complex disassembly (GO:1904903),0.29479842404411494,0.6042818292389682,0.870722433460076,1.0,1.0,1/10,7.83%,CHMP1B
prerank,recombinational repair (GO:0000725),-0.17302290683461585,-0.6038069166283523,0.9932885906040269,1.0,1.0,25/77,27.38%,FBH1;RAD51B;RBBP8;SMC6;PARP1;NUCKS1;XRCC1;NSMCE1;RAD50;SWI5;NSMCE2;BRCA1;PSMD14;WRN;KDM4D;SEM1;NBN;AP5Z1;ZSWIM7;LIG3;SPIDR;MCM9;RECQL;ZFYVE26;RAD51AP1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.26012434904120485,-0.6036488956754643,0.92,1.0,1.0,3/11,23.43%,PRKN;NONO;NR4A3
prerank,regulation of mRNA processing (GO:0050684),0.23735441478392277,0.6027551595640483,0.945364238410596,1.0,1.0,1/32,1.59%,QKI
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.1835504077860012,-0.6024907791220959,0.9910714285714286,1.0,1.0,17/57,27.08%,CDC14B;ATM;TIPIN;BRSK1;ATF2;SDE2;CLSPN;FANCD2;BRCA1;DONSON;NBN;WAC;DTL;RPS27L;CCND1;TAOK3;NOP53
prerank,Golgi to lysosome transport (GO:0090160),0.2937604776971248,0.6010187816812602,0.9166666666666666,1.0,1.0,3/11,20.91%,SORT1;AP1G1;ANKFY1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.23101544246573172,-0.6009390446750977,0.9461358313817331,1.0,1.0,9/20,31.82%,HSPA4;MKKS;CCT2;PSMG1;PTGES3L;HSPA1A;HOPX;TMEM35A;PSMG2
prerank,replication fork processing (GO:0031297),0.22163313456667472,0.6008595521737261,0.9516908212560387,1.0,1.0,4/38,9.90%,SAMHD1;MRE11;BRCA2;DNA2
prerank,histone deubiquitination (GO:0016578),0.263981192479981,0.6003599895059284,0.9133448873483535,1.0,1.0,6/18,23.26%,ATXN7;TRRAP;USP49;BRCC3;USP21;ENY2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.26996849055690747,-0.6000539873672821,0.9256198347107438,1.0,1.0,3/11,17.47%,CREB3L1;CEBPB;DDIT3
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.21447411597948363,0.5993326327373506,0.9882697947214076,1.0,1.0,13/54,19.38%,IKBKB;RFFL;BIRC3;ADAM17;SHARPIN;CASP8;SYK;CYLD;TNFAIP3;GAS6;CPNE1;SPPL2A;RBCK1
prerank,regulation of telomere capping (GO:1904353),-0.21528413695862306,-0.5988325553479557,0.9664948453608248,1.0,1.0,9/23,26.59%,TNKS2;ATM;RTEL1;RAD50;NBN;TNKS;PKIB;HNRNPD;MAP3K4
prerank,regulation of cilium movement (GO:0003352),0.2869965425944704,0.597130014659028,0.9049360146252285,1.0,1.0,1/10,7.92%,DRC1
prerank,negative regulation of translational initiation (GO:0045947),0.27479800196073945,0.5959861631282035,0.9,1.0,1.0,3/13,13.44%,EIF3E;EIF2AK4;PAIP2
prerank,regulation of catecholamine secretion (GO:0050433),0.2411202903431504,0.5959008006674047,0.9496753246753247,1.0,1.0,3/29,11.78%,STX1A;SYT7;SYT4
prerank,axonal transport (GO:0098930),0.22827974966817943,0.5958018694611441,0.9630225080385852,1.0,1.0,8/36,19.90%,AP3M2;KIF1A;AP3S1;KIF3B;HIF1A;SPAST;AP3M1;DCTN1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.21579753723645362,0.5955944263031472,0.9686028257456829,1.0,1.0,3/48,6.64%,BCL2L1;FNIP2;MCL1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.291486145353078,0.5955492863339544,0.9072356215213359,1.0,1.0,2/10,12.47%,DNA2;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.291486145353078,0.5955492863339544,0.9072356215213359,1.0,1.0,2/10,12.47%,DNA2;TERF1
prerank,t-circle formation (GO:0090656),0.291486145353078,0.5955492863339544,0.9072356215213359,1.0,1.0,2/10,12.47%,DNA2;TERF1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.17532728605499753,0.5947066724843796,1.0,1.0,1.0,81/241,29.87%,NOVA2;YBX1;EFTUD2;GPATCH1;RNPS1;BUD31;SNU13;CSTF2;SNRPF;HNRNPC;SNRPC;SNRPE;RBM19;CPSF1;MAGOHB;SNRPN;ZCRB1;HSPA8;PPWD1;NCBP2;GPKOW;CTNNBL1;SNRPB;SNRNP27;ELAVL1;FRG1;AQR;PRPF40A;PRPF4;RSRC1;ISY1;USP49;SMU1;SNRPB2;POLR2J;SF3A2;LSM4;SNRPD2;IK;PUF60;CDC5L;RBM8A;HNRNPM;ELAVL2;SF3B3;RBM15;METTL3;NCBP1;PAPOLA;WBP11;PABPC1;PRPF8;PPIE;SNRPA;SMNDC1;DHX38;UPF3B;CSTF2T;SART3;SNW1;PHF5A;CWC27;SNRNP48;HNRNPF;HNRNPA3;CSTF1;CWF19L2;HNRNPL;SNRPD1;SRSF12;SRSF7;SRSF1;LSM6;PRPF31;XAB2;DDX41;HNRNPA1;BCAS2;GEMIN5;PRPF6;ZRSR2
prerank,mRNA export from nucleus (GO:0006406),-0.16444823115520743,-0.5945845714632446,1.0,1.0,1.0,30/102,26.78%,SEH1L;SRSF5;PABPN1;SRSF11;DDX19B;SRSF6;CPSF3;NUP205;SRSF4;MCM3AP;HNRNPA2B1;DDX39B;SMG1;FYTTD1;THOC2;THOC7;U2AF2;U2AF1;CPSF2;RAE1;FIP1L1;DDX39A;EIF4A3;POLDIP3;THOC1;SYMPK;NUP155;NUP35;NDC1;TPR
prerank,regulation of DNA metabolic process (GO:0051052),0.2233521940115619,0.5945370425564378,0.9645608628659477,1.0,1.0,14/44,25.57%,UBE2V2;TERF2;UBE2V1;PARG;IL7R;SMARCAD1;YLPM1;SIRT7;RADX;SUB1;WDR70;MYC;UPF1;KDM1B
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2127240008216423,0.5943881219852584,0.9793205317577548,1.0,1.0,8/53,16.40%,CALCRL;HTR2A;AGTR2;CHRM3;MTNR1A;HTR4;OPRD1;SSTR1
prerank,cilium movement (GO:0003341),0.21662313509717412,0.5943151694664991,0.981651376146789,1.0,1.0,6/47,11.10%,DNHD1;CFAP100;CFAP91;RSPH4A;CFAP54;DNAAF2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.22987697232094004,0.5937939269352275,0.9652317880794702,1.0,1.0,8/31,22.45%,EDC3;DCP2;CNOT6;DCP1B;LSM4;EXOSC9;DCPS;EXOSC8
prerank,histone H3 deacetylation (GO:0070932),0.2723775308718521,0.5936544956999068,0.9382716049382716,1.0,1.0,4/15,16.41%,HDAC9;ELK4;SMARCAD1;SIRT7
prerank,protein localization to chromosome (GO:0034502),0.23200313331462868,0.5935323420059622,0.9446254071661238,1.0,1.0,10/34,21.73%,TERF2;ACD;CTCF;MSH2;BOD1;RAD21;SLF1;RPA1;PINX1;WAPL
prerank,positive regulation of intracellular transport (GO:0032388),0.2237028750350713,0.5929896588657889,0.9706362153344209,1.0,1.0,6/38,15.24%,PRR5L;RIPOR1;OAZ1;PDCD10;B3GAT3;SPAG5
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.21848871417454752,-0.5925920615160329,0.9589371980676329,1.0,1.0,6/20,24.85%,APOE;SREBF1;NR1H4;MBTPS1;EPHX2;KPNB1
prerank,RNA export from nucleus (GO:0006405),-0.16559040410876186,-0.5915363184906329,0.996031746031746,1.0,1.0,30/100,26.78%,SEH1L;SRSF5;SRSF11;DDX19B;XPO5;SRSF6;CPSF3;NUP205;SRSF4;MCM3AP;HNRNPA2B1;DDX39B;SMG1;FYTTD1;THOC2;THOC7;U2AF2;U2AF1;CPSF2;RAE1;FIP1L1;DDX39A;EIF4A3;POLDIP3;THOC1;SYMPK;NUP155;NUP35;NDC1;TPR
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.24916897387946335,-0.5911530691223602,0.9399038461538461,1.0,1.0,1/13,3.61%,PRKCD
prerank,glucose catabolic process to pyruvate (GO:0061718),0.2490827072985476,0.5910062554925881,0.9290657439446367,1.0,1.0,5/24,14.41%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,canonical glycolysis (GO:0061621),0.2490827072985476,0.5910062554925881,0.9290657439446367,1.0,1.0,5/24,14.41%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,cellular response to alkaloid (GO:0071312),0.2564502549968769,0.5909678919211482,0.9326047358834244,1.0,1.0,2/17,6.72%,TGM2;CASP7
prerank,double-strand break repair (GO:0006302),0.18197406345667821,0.5907899676549596,0.9987405541561712,1.0,1.0,25/158,18.81%,TENT4A;SAMHD1;RAD54B;MRE11;UBE2V2;PALB2;BRCA2;KDM4A;HPF1;UBXN1;DNA2;BABAM1;RECQL4;POLB;FAN1;HMGB2;RNF8;SMARCAD1;HERC2;SUMO1;RAD21;HUS1;RPA1;REV3L;BRCC3
prerank,tRNA 5'-end processing (GO:0099116),0.2672396999947823,0.5905777846828827,0.9198542805100182,1.0,1.0,5/15,21.46%,TRMT10C;RPP38;RPP21;HSD17B10;RPP30
prerank,neuron projection fasciculation (GO:0106030),0.2883708974675049,0.5899961586556963,0.8954128440366973,1.0,1.0,2/10,16.29%,EPHA4;NRCAM
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.2897096155977392,0.5898997347333356,0.9057591623036649,1.0,1.0,2/10,8.79%,OPHN1;MSN
prerank,regulation of mRNA metabolic process (GO:1903311),-0.25675632845014706,-0.589085408555445,0.9429824561403509,1.0,1.0,5/11,34.73%,SAFB2;SLTM;SRPK1;PTCD2;SRPK2
prerank,protein localization to chromatin (GO:0071168),-0.22448317108182886,-0.5890161012258107,0.9506726457399103,1.0,1.0,8/18,33.06%,SGF29;ESR1;LEMD2;MCM9;PIH1D1;PLK1;MCM8;LRWD1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.23400276224167593,-0.5888456822641405,0.9399038461538461,1.0,1.0,8/17,26.78%,PRKN;KDM1A;SNAI1;TWIST1;CD44;RNF34;YJU2;ARMC10
prerank,retrograde axonal transport (GO:0008090),0.2650298701839403,0.5864786075954207,0.9336917562724014,1.0,1.0,1/16,6.87%,KIF1A
prerank,regulation of actin filament depolymerization (GO:0030834),0.2774674542101171,0.5857854812385065,0.8998144712430427,1.0,1.0,1/12,3.93%,VIL1
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.2417097971617323,-0.5857682948279567,0.9461206896551724,1.0,1.0,3/13,24.36%,SDAD1;XPO1;NOP9
prerank,phosphate ion transport (GO:0006817),0.2642479640514266,0.5847320292553931,0.9212007504690432,1.0,1.0,5/16,23.80%,XPR1;SLC37A3;SLC37A2;SLC34A3;SLC37A1
prerank,protein localization to kinetochore (GO:0034501),0.25755207060629165,0.5846838775723832,0.9206642066420664,1.0,1.0,4/14,19.17%,BUB3;RCC2;ZW10;IK
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.25103685627556477,0.5842472662711229,0.9147826086956522,1.0,1.0,4/18,19.50%,ATXN3;NCK1;BAG6;BAK1
prerank,autophagy of nucleus (GO:0044804),-0.23137091920695763,-0.5840103866753387,0.9279069767441861,1.0,1.0,2/16,6.27%,ULK2;ATG2B
prerank,telomere maintenance (GO:0000723),0.2101527923086211,0.5839662552624757,0.9718518518518519,1.0,1.0,7/50,12.47%,SP100;MRE11;TERF2;DNA2;ACD;RECQL4;TERF1
prerank,ovarian follicle development (GO:0001541),0.2732926488171095,0.5830533999813291,0.9215328467153284,1.0,1.0,2/13,10.81%,FOXL2;EIF2B2
prerank,RNA biosynthetic process (GO:0032774),-0.1949590516530692,-0.5814777627302543,0.9921052631578947,1.0,1.0,7/31,21.69%,POLR2A;PRMT5;SMARCA5;HELB;PRIM2;BRF1;TBP
prerank,positive regulation of protein export from nucleus (GO:0046827),0.26277891615242904,0.5807378466953862,0.9301075268817204,1.0,1.0,1/15,3.84%,RAPGEF3
prerank,pyroptosis (GO:0070269),0.2583999603139184,0.580320490477388,0.9175438596491228,1.0,1.0,3/15,16.56%,AIM2;CASP8;NLRC4
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.21395628035829697,-0.5796609649754308,0.9619047619047619,1.0,1.0,6/24,23.18%,DNMT3A;PPM1D;RBBP4;EED;EZH2;RBBP7
prerank,autophagy of peroxisome (GO:0030242),0.2707817489221031,0.5785055852122076,0.9314079422382672,1.0,1.0,4/12,23.46%,MAP1LC3B;PIK3C3;ACBD5;USP30
prerank,regulation of acute inflammatory response (GO:0002673),0.24631261310290634,0.5782532620026927,0.9280701754385965,1.0,1.0,1/18,4.60%,OSMR
prerank,regulation of translational initiation (GO:0006446),0.2045163673397532,0.5780887450126705,0.987673343605547,1.0,1.0,17/63,21.56%,EIF4H;KLHL25;EIF3E;EIF2AK4;HSPB1;EIF2B2;NCBP2;PAIP2;PAIP1;EIF3B;PPP1R15B;EIF1B;NCK1;DAZL;EIF4EBP3;EIF3H;NCBP1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2287295930739401,0.5772929083070399,0.965,1.0,1.0,8/27,26.26%,AK4;CMPK1;AK1;GSR;DTYMK;NME2;TYMS;AK2
prerank,chromosome organization (GO:0051276),-0.15544048699496976,-0.5765733704622042,1.0,1.0,1.0,35/99,33.85%,TOP2B;SETD7;HMGN3;MTHFR;DDB2;EZH1;PARP1;NUCKS1;ABL1;COPS4;LDB1;CDAN1;LATS1;TOP2A;EZH2;RAE1;CUL4B;COPS8;NUP155;FAM50A;BAHD1;CDCA8;BRWD1;COPS7B;HMGN2;HDAC1;SIRT1;NUF2;GEM;MTF2;LIG4;SOX2;LRWD1;CENPW;DOT1L
prerank,protein localization to mitochondrion (GO:0070585),-0.2593591844461695,-0.5764279172481358,0.9267241379310345,1.0,1.0,4/11,22.64%,HK2;LRRK2;COX18;MTCH2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.2829784386325604,0.5758191665077993,0.9265536723163842,1.0,1.0,2/10,14.97%,RAPGEF3;HDAC5
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2558259134670674,-0.5754942106143405,0.926530612244898,1.0,1.0,3/11,19.93%,MDM1;TRIM37;BRCA1
prerank,protein import into nucleus (GO:0006606),-0.16874890704718998,-0.5750184538631173,1.0,1.0,1.0,16/66,26.85%,APPL2;CBLB;RANBP17;E2F3;FAM53B;KPNA3;IPO7;STAT3;KPNB1;HIKESHI;KPNA6;NUP155;NUP35;IPO8;TPR;KPNA1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.25062312519646623,0.5746005619558919,0.9273049645390071,1.0,1.0,6/18,26.51%,PTBP3;TGFB1;NUDT16;KAT2B;ZC3H12A;RPS13
prerank,presynapse assembly (GO:0099054),-0.2327501179391247,-0.5743611597420948,0.9480812641083521,1.0,1.0,6/16,31.51%,NLGN2;PTEN;LRRTM3;DVL1;NLGN3;BSN
prerank,autophagy of mitochondrion (GO:0000422),0.21744540614693578,0.5717614047308894,0.9855305466237942,1.0,1.0,14/38,25.03%,CTSK;MAP1LC3B;ATG12;ATG14;ATG9B;MAP1LC3A;WDR45;ATG7;GABARAP;ATG2A;BNIP3;USP30;GABARAPL2;ULK1
prerank,positive regulation of histone acetylation (GO:0035066),0.23878685037952885,0.5711308700447766,0.9575856443719413,1.0,1.0,4/23,12.14%,MAPK3;RPS6KA5;FOXP3;TADA2B
prerank,phagosome acidification (GO:0090383),-0.20002826101668963,-0.5710147925754275,0.9682151589242054,1.0,1.0,7/26,21.50%,ATP6V0A4;ATP6V1C1;ATP6V1G2;ATP6V1E1;TCIRG1;ATP6V1F;ATP6V0D2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.1983301221232475,0.5703454909649671,0.9883040935672515,1.0,1.0,10/68,13.02%,TAF1B;GTF2H2;CSTF2;SNRPF;SNRPE;CPSF1;SSU72;NCBP2;GTF2H4;SNRPB
prerank,receptor recycling (GO:0001881),-0.25209894889647816,-0.5696251246319437,0.9276315789473685,1.0,1.0,5/10,31.00%,ARFGEF2;RAB11B;NSG1;PHETA2;PLEKHJ1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.28884020380789377,0.5682791895241592,0.9344569288389513,1.0,1.0,6/10,25.87%,GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,tRNA aminoacylation (GO:0043039),-0.19250986970057654,-0.5680224643262426,0.9923857868020305,1.0,1.0,17/37,29.67%,PPA2;QARS1;EPRS1;YARS1;HARS2;WARS2;RARS2;DARS2;DARS1;FARS2;FARSA;LARS1;TARS1;AIMP1;PPA1;RARS1;KARS1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.19899594579968036,-0.5673790324168553,0.9872773536895675,1.0,1.0,9/28,23.64%,ATM;PRPF19;CLSPN;ERCC6;ATRIP;DONSON;NBN;CEP63;ATR
prerank,positive regulation of chromosome organization (GO:2001252),0.2546728753946128,0.5661956260111064,0.9356060606060606,1.0,1.0,4/15,18.30%,MRE11;SHCBP1L;RAD21;DDX11
prerank,natural killer cell mediated immunity (GO:0002228),-0.23171178070161336,-0.566006122838292,0.9402654867256637,1.0,1.0,4/15,20.96%,PLEKHM2;RAET1E;LYST;ULBP1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.23919994978234654,0.5648871104397415,0.9534883720930233,1.0,1.0,5/18,21.31%,RAB11A;BRD4;RCC2;MECP2;CDK4
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.17740813805680106,-0.5643571859573553,0.9943977591036415,1.0,1.0,5/49,8.94%,TNRC6A;THBS1;MTURN;TNRC6B;MYL9
prerank,establishment of protein localization to organelle (GO:0072594),-0.16105968266117726,-0.5641348454932025,1.0,1.0,1.0,5/72,9.55%,APPL2;LAMP2;RANBP17;HK2;LRSAM1
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.2534507134021258,-0.5635998926303348,0.9395973154362416,1.0,1.0,3/10,20.05%,ATP7A;KYAT1;KYNU
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.22408347503777332,-0.5625409294144212,0.9529702970297029,1.0,1.0,4/17,18.25%,FGF1;APOE;SREBF1;MBTPS1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.20376607324057952,-0.5619342004918905,0.9826302729528535,1.0,1.0,10/27,27.49%,ZC3H12B;PCF11;CPSF3;RNASE4;LACTB2;CSTF3;PARN;ZC3H12C;TOE1;POP7
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.22306423192288022,0.558393035171808,0.9725557461406518,1.0,1.0,3/29,7.77%,ACBD6;GLYAT;ACSL6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.22306423192288022,0.558393035171808,0.9725557461406518,1.0,1.0,3/29,7.77%,ACBD6;GLYAT;ACSL6
prerank,ncRNA export from nucleus (GO:0097064),-0.18670206939569792,-0.5582392065339936,0.9916434540389972,1.0,1.0,16/36,38.06%,PHAX;SEH1L;NUP205;TSC1;RAE1;NUP155;NUP35;NDC1;TPR;NUP43;AAAS;NOL6;NUP37;SSB;NUP98;NUP62
prerank,negative regulation of cellular metabolic process (GO:0031324),0.21282272309789085,0.558078825522749,0.9665605095541401,1.0,1.0,8/37,19.35%,ANKRD13A;RIN3;SDCBP;MTMR2;EDN1;AP1AR;TFAP2A;LRPAP1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.26912363746138374,0.5580721877853092,0.9299820466786356,1.0,1.0,3/10,21.70%,PSMC6;THRA;PSMC3
prerank,regulation of superoxide anion generation (GO:0032928),-0.22786228865544234,-0.5580413465142928,0.960880195599022,1.0,1.0,1/14,3.61%,PRKCD
prerank,defense response to fungus (GO:0050832),0.2409639023886878,0.5575686732776446,0.9502664298401421,1.0,1.0,3/17,20.06%,S100A8;BCL10;PLCG2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.2770420622339277,0.5570272063326122,0.9255725190839694,1.0,1.0,3/10,15.84%,SPAG5;RCC2;APC
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.16310885774957543,0.5568484673455663,1.0,1.0,1.0,89/264,29.87%,NOVA2;YBX1;EFTUD2;GPATCH1;RNPS1;BUD31;SNU13;CSTF2;SNRPF;HNRNPC;SNRPC;SNRPE;RBM19;CPSF1;MAGOHB;SNRPN;ZCRB1;HSPA8;PPWD1;NCBP2;GPKOW;CTNNBL1;SNRPB;SNRNP27;ELAVL1;FRG1;AQR;PRMT7;PRPF40A;PRPF4;RSRC1;ISY1;SCNM1;USP49;SMU1;SNRPB2;POLR2J;SF3A2;LSM4;SNRPD2;IK;PUF60;CDC5L;RBM8A;WDR77;HNRNPM;ELAVL2;SF3B3;RBM15;METTL3;NCBP1;DCPS;PAPOLA;WBP11;PABPC1;PRPF8;PPIE;SNRPA;SMNDC1;DHX38;UPF3B;CSTF2T;SART3;SNW1;PHF5A;CWC27;SCAF11;SNRNP48;HNRNPF;HNRNPA3;CSTF1;CWF19L2;HNRNPL;DDX20;SNRPD1;SRSF12;SRSF7;SRSF1;LSM6;SMN1;PRPF31;XAB2;DDX41;COIL;HNRNPA1;BCAS2;GEMIN5;PRPF6;ZRSR2
prerank,RNA stabilization (GO:0043489),0.21511498872861248,0.5556286337919579,0.9785478547854786,1.0,1.0,5/33,14.77%,YBX1;NOCT;AXIN2;PAIP1;ELAVL1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.19671874716792068,0.554628507105947,0.9910846953937593,1.0,1.0,23/65,28.17%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;RBX1;PSMA8;SKP1;PSMD9;ZFYVE19;PINX1;CUL1;PSMC3;PSMD1;PSMD10;PABIR1;NABP2;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.2045284864938041,0.5544877395748242,0.9847560975609756,1.0,1.0,13/43,25.86%,MRE11;BABAM1;CDC6;ORC1;TRIM39;HMGA2;HUS1;BRCC3;RAD17;PABIR1;TOPBP1;NABP2;BLM
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2498154633186843,0.553726622036531,0.9393939393939394,1.0,1.0,8/15,31.60%,MRE11;HUS1;RAD9B;RAD17;HUS1B;CHEK2;MDC1;EME2
prerank,positive regulation of lipid storage (GO:0010884),0.23162926442561516,0.5533184507865818,0.9660714285714286,1.0,1.0,1/21,2.93%,SCARB1
prerank,regulation of mRNA catabolic process (GO:0061013),0.1760476299067177,0.5528680818355101,0.9986648865153538,1.0,1.0,28/121,23.50%,PRR5L;PSMB3;PSMD11;PSMC6;GTPBP1;PSME2;HSPA8;HSPB1;PSMD8;DCP2;ZFP36L1;PSMB10;SERBP1;ELAVL1;ZC3HAV1;PSMA8;YWHAZ;YWHAB;PSMD9;SET;XRN1;ZFP36L2;EXOSC9;PSMC3;PSMD1;EXOSC8;PSMD10;PABPC1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.20931582872356136,0.5528429419526475,0.9768518518518519,1.0,1.0,7/38,21.84%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.1823571039044256,0.5497550593601956,0.9958847736625515,1.0,1.0,22/88,23.25%,FBXW7;PSMB3;PSMD11;PSMC6;DMAC2;PSME2;FBXL2;PSMD8;FBXO6;PSMB10;RBX1;FBXL8;FBXL15;PSMA8;FBXO2;SKP1;PSMD9;CUL1;PSMC3;PSMD1;PSMD10;FBXL14
prerank,response to histamine (GO:0034776),0.27224342461444473,0.5496575698955039,0.9264150943396227,1.0,1.0,4/10,25.87%,GABRB1;GABRB2;AOC1;GABRG2
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.20872445140214657,0.5494733578624204,0.9935587761674718,1.0,1.0,8/40,16.58%,UBE2V2;MCL1;UBE2V1;PARG;IER3;NSMCE4A;SIRT7;HMGA2
prerank,mRNA transport (GO:0051028),0.17709565937289098,0.54858166342415,0.9986449864498645,1.0,1.0,12/101,13.09%,AGFG1;HHEX;RNPS1;NXT1;CPSF1;MAGOHB;THOC6;NUP54;NCBP2;ZFP36L1;EIF4E;ZC3H11A
prerank,regulation of secretion by cell (GO:1903530),-0.16896380663543817,-0.547654703483548,0.9914529914529915,1.0,1.0,9/54,19.00%,SNCAIP;ANXA1;RAB21;FMR1;P3H1;STX4;RHBDF1;VAMP2;RAB13
prerank,nucleosome assembly (GO:0006334),0.21847790212984017,0.5450661587458503,0.9736408566721582,1.0,1.0,12/31,25.82%,CHAF1A;NAA60;SOX9;HMGB2;CHAF1B;IPO4;GRWD1;NASP;DAXX;HIRA;NAP1L4;SART3
prerank,mitochondrion disassembly (GO:0061726),0.21032987415414578,0.5429846165874779,0.9904153354632588,1.0,1.0,13/34,25.03%,CTSK;MAP1LC3B;ATG12;ATG9B;MAP1LC3A;WDR45;ATG7;GABARAP;ATG2A;BNIP3;USP30;GABARAPL2;ULK1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.1723444887867132,0.5425543464672861,1.0,1.0,1.0,17/125,16.09%,EFHC2;MAP4;STMN1;CLIP1;DYNLL1;KIF2A;KIF3B;RPS27;EML1;BUB3;CENPU;DYNC1LI1;PLK2;NUP160;RCC2;CKAP5;CENPN
prerank,mitotic spindle assembly (GO:0090307),0.20164332402828575,0.5423557768375685,0.9840255591054313,1.0,1.0,6/42,11.51%,KIF2A;RAB11A;MZT1;KIF3B;KIF23;MAP10
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.24808405629581265,-0.5422077957513779,0.9599109131403119,1.0,1.0,2/10,22.07%,PRKN;AOC3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.22951353792832502,-0.542193053482063,0.9649532710280374,1.0,1.0,4/13,17.01%,KDM1A;SNAI1;TWIST1;CD44
prerank,eye photoreceptor cell development (GO:0042462),-0.22052728826594267,-0.542098838492745,0.963963963963964,1.0,1.0,7/15,35.22%,RPGRIP1L;TULP1;THY1;BBS4;MYO7A;CRB2;NRL
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.17500917233178023,0.5393114998076993,0.9986486486486487,1.0,1.0,25/96,26.16%,AGFG1;HHEX;RNPS1;NXT1;CPSF1;MAGOHB;THOC6;NUP54;NCBP2;EIF4E;ZC3H11A;NUP160;NUP153;NUP50;RBM8A;UPF2;NCBP1;NUP42;NUP85;NUP210;DHX38;UPF3B;UPF1;NUP188;CHTOP
prerank,regulation of rRNA processing (GO:2000232),-0.22414763529815152,-0.5391043895467077,0.9798206278026906,1.0,1.0,5/16,25.71%,RIOK2;WDR43;TRMT112;DIMT1;USP36
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.22481483979642844,0.5389660411652973,0.9705372616984402,1.0,1.0,5/25,14.41%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2411928797788645,-0.5380846888732969,0.9537444933920705,1.0,1.0,5/11,34.84%,MFN2;ATG9A;WIPI1;STX17;WIPI2
prerank,establishment of spindle orientation (GO:0051294),0.21246172623805232,0.5377771061060873,0.9825673534072901,1.0,1.0,7/28,21.21%,MAP4;CDK5RAP2;ZW10;DCTN1;NSFL1C;CLASP1;NDE1
prerank,regulation of phosphate metabolic process (GO:0019220),0.24243320910949878,0.537354784268201,0.9537366548042705,1.0,1.0,4/16,23.45%,IKBKB;PGAM1;TIGAR;RAD17
prerank,isotype switching (GO:0045190),0.26033033540532885,0.5366491452082756,0.9439071566731141,1.0,1.0,2/10,15.56%,RNF8;MSH2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.2535437703854628,0.5344584643000128,0.9438596491228071,1.0,1.0,5/11,25.55%,LPCAT3;ATL1;BNIP1;VCPIP1;VAPB
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.22963893249607542,0.5340825263842577,0.9628975265017667,1.0,1.0,18/18,77.06%,DNAAF2;AQP4;RFX3;CFAP53;ODAD4;CABYR;NPHP3;SPEF2;CCDC39;NEK10;OFD1;DNAAF1;DNAAF4;CCDC40;SPA17;SPAG17;ADCY10;ROPN1L
prerank,phosphate ion transmembrane transport (GO:0035435),0.25205908114859,0.5322592152016346,0.9646182495344506,1.0,1.0,4/12,23.80%,XPR1;SLC37A3;SLC37A2;SLC37A1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.2046001323452661,-0.5320625460942112,0.9759825327510917,1.0,1.0,4/19,18.28%,AMPD3;GMPR2;DGUOK;POLD2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.19711887385814356,-0.5310408084870177,0.9903381642512077,1.0,1.0,7/22,26.10%,SMARCB1;WDR43;PHF8;RASL11A;ERBB2;NCL;EIF2AK3
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.2179064474650884,0.5308858076179676,0.9769911504424779,1.0,1.0,2/23,13.94%,CALM1;METAP2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.23548734096900503,0.5304448540859343,0.9502762430939227,1.0,1.0,4/15,16.74%,STXBP1;NPS;NLGN1;CNTNAP4
prerank,positive regulation of exocytosis (GO:0045921),0.20674317531735015,0.528996983908101,0.9776714513556619,1.0,1.0,13/35,28.28%,UNC13D;HGS;SDCBP;CADPS;PDCD6IP;CADPS2;CLASP1;ATP6AP1;SNCA;CLASP2;RAB7A;VPS4B;RAB27A
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2142383492084785,0.5289148965966016,0.9811965811965812,1.0,1.0,5/25,19.14%,ZMYND11;BRD4;NELFCD;RNF8;EAF1
prerank,phasic smooth muscle contraction (GO:0014821),0.261469905228143,0.5287436758881259,0.9502762430939227,1.0,1.0,10/10,73.87%,EDN1;TIFAB;EDN3;EDNRB;EDN2;DRD2;GDNF;HTR1D;HTR2B;PTGER3
prerank,7-methylguanosine RNA capping (GO:0009452),0.20608432931930906,0.5284294794445283,0.9798319327731092,1.0,1.0,8/31,21.56%,GTF2H2;NCBP2;GTF2H4;CMTR2;CMTR1;POLR2J;GTF2H3;NCBP1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.20608432931930906,0.5284294794445283,0.9798319327731092,1.0,1.0,8/31,21.56%,GTF2H2;NCBP2;GTF2H4;CMTR2;CMTR1;POLR2J;GTF2H3;NCBP1
prerank,lipid droplet formation (GO:0140042),0.25855577419223946,0.5280318217282641,0.9446564885496184,1.0,1.0,1/10,6.74%,CDS2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.18658537495299005,0.5250234202987982,0.994261119081779,1.0,1.0,16/58,21.81%,MRE11;UBE2V2;BABAM1;ZBTB7A;POLB;HMGB2;RNF8;HERC2;SUMO1;BRCC3;POLL;UVRAG;ERCC8;POLA1;ERCC4;DCLRE1C
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.21075693967949494,-0.5236198586333944,0.9752252252252253,1.0,1.0,7/16,37.59%,TRA2B;CIRBP;NCL;CELF4;CELF3;SF3B4;NUP98
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.19139327547101992,0.5233930300868586,0.990726429675425,1.0,1.0,20/55,28.17%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;RBX1;PSMA8;SKP1;PSMD9;PINX1;CUL1;PSMC3;PSMD1;PSMD10;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,RNA methylation (GO:0001510),0.18272898817806724,0.5227436587516657,0.9955555555555555,1.0,1.0,21/60,26.66%,CBLL1;GTPBP3;TRMT10C;MRM2;TRMT12;TRMT61B;METTL2A;METTL2B;ZC3H13;ALKBH8;CMTR1;TRMT5;NSUN6;RBM15;METTL3;ZCCHC4;TRMO;PCIF1;TARBP1;TRMT10A;TYW3
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.2264213085904988,0.5225389943103566,0.9743150684931506,1.0,1.0,6/20,19.18%,TSNAX;ZC3H7A;TSN;MRPL44;TRIM71;DICER1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.24176148250655446,0.522253870715736,0.9638095238095238,1.0,1.0,7/13,29.83%,AAR2;PRPF8;SART3;DDX20;SRSF12;PRPF31;PRPF6
prerank,cellular response to leucine (GO:0071233),0.24983272000114942,0.5209183325300589,0.9680638722554891,1.0,1.0,2/10,12.22%,SESN3;RPTOR
prerank,response to leucine (GO:0043201),0.24983272000114942,0.5209183325300589,0.9680638722554891,1.0,1.0,2/10,12.22%,SESN3;RPTOR
prerank,mitotic spindle organization (GO:0007052),0.16203161755350837,0.5201774831788425,1.0,1.0,1.0,21/153,16.46%,EFHC2;MAP4;STMN1;CLIP1;DYNLL1;KIF2A;RAB11A;MZT1;KIF3B;KIF23;RPS27;EML1;BUB3;CENPU;DYNC1LI1;PLK2;NUP160;RCC2;CKAP5;CENPN;SPAST
prerank,ribonucleoprotein complex assembly (GO:0022618),0.16305423154436857,0.5197177456421612,1.0,1.0,1.0,50/132,29.87%,HSP90AB1;RPL38;EIF4H;RPL3;ABT1;RPSA;SNRPF;SNRPC;SNRPE;RPS27;PWP2;MRPL20;SNRPB;RPL11;RPS15;RPS28;PRMT7;ISY1;NAF1;SF3A2;LSM4;SNRPD2;DICER1;PUF60;WDR77;NCBP1;EIF4B;EIF2S2;RPL24;RSL24D1;ERAL1;PTGES3;SART3;SCAF11;RPL6;RPS19;TRAF7;NOL3;DDX20;DHX29;SNRPD1;SRSF1;SETX;SMN1;XAB2;COIL;GEMIN5;PRPF6;RPS14;ZRSR2
prerank,positive regulation of mRNA processing (GO:0050685),-0.19359782543691736,-0.519247685728551,0.9812206572769953,1.0,1.0,10/21,38.35%,PAF1;TRA2B;CIRBP;NCL;CELF4;DHX36;CELF3;SF3B4;NUP98;CDC73
prerank,RNA interference (GO:0016246),0.2255302400341711,0.5185547625196052,0.9606837606837607,1.0,1.0,4/17,19.18%,TSNAX;TSN;MRPL44;DICER1
prerank,peripheral nervous system development (GO:0007422),0.21613201264677306,0.5166818949981846,0.9820846905537459,1.0,1.0,6/23,24.49%,NFASC;SERPINI1;SOX10;PMP22;BDNF;ADGRG6
prerank,coenzyme A biosynthetic process (GO:0015937),0.25054769745442834,0.5161204600321916,0.9647495361781077,1.0,1.0,2/11,15.66%,PANK3;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.25054769745442834,0.5161204600321916,0.9647495361781077,1.0,1.0,2/11,15.66%,PANK3;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.25054769745442834,0.5161204600321916,0.9647495361781077,1.0,1.0,2/11,15.66%,PANK3;ACAT1
prerank,peptidyl-lysine acetylation (GO:0018394),-0.2293239609594618,-0.5160610172472363,0.9753593429158111,1.0,1.0,5/10,34.56%,EP300;CREBBP;SIRT1;KAT5;ESCO1
prerank,tRNA processing (GO:0008033),0.17905860457744294,0.5159427765680452,0.9939668174962293,0.9998449887920333,1.0,16/61,23.21%,SARS1;CDKAL1;CSTF2;CPSF1;TRMT10C;DTWD2;RTRAF;RPP21;TSEN15;RTCB;THUMPD1;NSUN6;QTRT2;RPP30;CTU2;TSEN34
prerank,polarized epithelial cell differentiation (GO:0030859),0.23756640198497703,0.5159147463023508,0.948943661971831,0.9994168357126245,1.0,2/13,8.79%,OPHN1;MSN
prerank,steroid catabolic process (GO:0006706),-0.23685515649865574,-0.5158046661624293,0.9501084598698482,1.0,1.0,1/10,5.86%,SPP1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.25111404004267884,0.514814610660852,0.9605263157894737,0.9992957438354463,1.0,10/10,74.90%,GNB1;PDE6G;PDE6B;PDE6A;CNGA1;GRK1;GNAT1;RHO;SAG;CNGB1
prerank,regulation of spindle assembly (GO:0090169),-0.1873241970519143,-0.5145375619084188,0.9875930521091811,1.0,1.0,9/25,30.36%,GPSM2;SENP6;CHMP4C;EML3;HSPA1A;CCSAP;TPR;NUMA1;PLK1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.21346845485422195,-0.5133636658917095,0.9863013698630136,1.0,1.0,5/13,25.47%,RCL1;NOP14;NOP9;BMS1;UTP20
prerank,response to organonitrogen compound (GO:0010243),-0.16787887145546754,-0.5129888570183686,0.997134670487106,1.0,1.0,8/38,22.30%,RCN3;PRKN;GLRB;IRAK3;SYVN1;NR1H4;KYNU;DERL1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.20925726990648935,0.5114792572425232,0.9862542955326461,0.9997936064291264,1.0,5/21,21.31%,RAB11A;BRD4;RCC2;MECP2;CDK4
prerank,response to ethanol (GO:0045471),-0.20744906824257608,-0.5087997167814685,0.9839816933638444,1.0,1.0,1/14,4.82%,ADCY7
prerank,negative regulation of innate immune response (GO:0045824),0.19405277177633584,0.5081859237926717,0.9909774436090225,1.0,1.0,11/34,27.28%,NLRC5;SAMHD1;USP18;TNFAIP3;LYAR;NMI;METTL3;STAT2;ISG15;ACOD1;RPS19
prerank,cellular response to ATP (GO:0071318),-0.2111191538070126,-0.506014921298695,0.9764957264957265,1.0,1.0,8/14,38.09%,P2RX4;HSP90B1;RYR3;P2RY1;P2RX3;P2RY12;P2RY2;PDXP
prerank,cellular response to hydroxyurea (GO:0072711),0.24348126205762913,0.5058712218208489,0.9590747330960854,1.0,1.0,6/10,32.68%,DDX11;NSMCE3;BLM;TIMELESS;DDI2;RTF2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2257453709291174,0.5058145001289593,0.9646840148698885,1.0,1.0,5/16,25.68%,ZFP36L1;TRIM71;ZFP36L2;UPF1;ZC3H12A
prerank,myelin maintenance (GO:0043217),0.24682829366958722,0.5048720550123796,0.975609756097561,0.9998264299843347,1.0,3/10,19.06%,ABCD1;DEGS1;ABCD2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.17488479338105217,-0.5040790130972188,0.9919571045576407,1.0,1.0,6/30,18.52%,NPEPPS;RNF31;HUWE1;HTRA2;PDCD5;ABLIM3
prerank,UV-damage excision repair (GO:0070914),-0.22063707651564513,-0.5034507114455697,0.9870410367170627,1.0,1.0,3/12,21.71%,DDB2;ERCC1;CUL4B
prerank,protein prenylation (GO:0018342),0.23656134362157763,0.5021355483067753,0.9731182795698925,1.0,1.0,2/10,17.85%,PGGT1B;RCE1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.2488582178844259,0.5018362434671676,0.9593345656192237,0.9997308953733933,1.0,3/10,18.83%,ETFB;ACAD11;ETFDH
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.24579401576347615,0.4989990893640002,0.9793103448275862,0.999533845120842,1.0,2/10,16.84%,KLF4;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.24579401576347615,0.4989990893640002,0.9793103448275862,0.999533845120842,1.0,2/10,16.84%,KLF4;MBP
prerank,regulation of chromosome organization (GO:0033044),0.2115279642022902,0.4989782665301056,0.9763113367174281,0.999106555989271,1.0,6/22,25.52%,TERF2;SHCBP1L;YLPM1;WAPL;MYC;UPF1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.23431969422337195,0.49730974678293854,0.9563636363636364,0.9990653419287528,1.0,5/12,22.50%,IDH3A;IREB2;ASS1;IDH3B;ACLY
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.24832592994799912,0.49655094951212125,0.9509090909090909,0.9988043598762719,1.0,4/10,22.15%,CTBP1;SET;NOC2L;SNCA
prerank,V(D)J recombination (GO:0033151),-0.22374938019040444,-0.49425846762032283,0.9804347826086957,1.0,1.0,4/11,31.43%,LIG1;LIG3;HMGB1;LIG4
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.20580730804742217,0.4908039235897632,0.9861111111111112,0.9996447827217807,1.0,12/22,30.55%,VPS36;VPS25;VPS37A;PLAA;VPS37B;RNF126;VPS37C;RNF115;VPS4B;VPS28;MVB12B;UBAP1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.18605634614069624,0.48873254640214103,0.9968454258675079,0.9996468720020437,1.0,15/36,29.95%,HINFP;DNA2;CDC6;FBXO6;HUS1;CDC5L;RAD9B;RAD1;RAD17;TIPRL;CLOCK;TIMELESS;HUS1B;CHEK2;MAP3K20
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.20216424491681378,-0.4887257656960453,0.9863013698630136,1.0,1.0,7/15,37.67%,ZC3H12B;LACTB2;ZC3H12C;POP7;ZC3H12D;RPP40;NYNRIN
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.23473294420385377,0.48639200950354056,0.9757009345794393,0.9997257906328314,1.0,10/10,76.54%,NAF1;ZNHIT3;ZNHIT6;RUVBL1;RUVBL2;NUFIP1;SHQ1;PIH1D1;TAF9;PIH1D2
prerank,regulation of centrosome cycle (GO:0046605),0.20512562223540845,0.4862548362166076,0.9808027923211169,0.9993249834727495,1.0,2/21,7.83%,MARK4;CHMP1B
prerank,regulation of transposition (GO:0010528),0.22427730510407187,0.4857956504101144,0.9694244604316546,0.9989767238130125,1.0,1/13,4.89%,PIWIL1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.20826333333248329,-0.485202174606603,0.9847826086956522,1.0,1.0,5/12,37.08%,PIBF1;BRCA1;APOC1;SIRT1;ERLIN1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.22380563751647925,0.48498993137866914,0.979890310786106,0.9987076896440711,1.0,14/14,77.64%,TNFSF11;ATP6AP1;TRAF6;CSF1;IFNG;POU4F2;IL12B;IL23R;TNF;IL23A;OCSTAMP;CCR1;POU4F1;TYROBP
prerank,negative regulation of secretion (GO:0051048),-0.22016713853752937,-0.4809978413089619,0.9894736842105263,1.0,1.0,4/10,36.46%,VAMP3;PTGER3;SPX;CD74
prerank,regulation of T cell mediated immunity (GO:0002709),-0.21872066602739598,-0.48074342392646646,0.9829787234042553,1.0,1.0,2/10,14.46%,TRPM4;ZBTB1
prerank,androgen metabolic process (GO:0008209),-0.18906456597993154,-0.47909805044619985,0.990521327014218,1.0,1.0,1/18,5.86%,SPP1
prerank,cellular response to oxygen levels (GO:0071453),0.22701311742923497,0.47801066097177214,0.9767025089605734,0.9996616739896431,1.0,10/10,77.31%,CCDC115;ATP6AP1;ATP6V1A;ATP6V0D1;NDUFS2;ATP6V1G1;ATP6V0A2;TMEM199;PICK1;CPEB4
prerank,DNA replication initiation (GO:0006270),-0.15664252985439794,-0.4746056641197729,0.9971830985915493,1.0,1.0,14/37,33.06%,POLE4;PRIM2;CDC45;DBF4;MCM3;MCM4;POLE2;MCM5;ORC2;ORC5;GMNN;CDC34;MCM8;LRWD1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.22132443334447258,0.47331800516446465,0.9777777777777777,1.0,1.0,2/12,15.20%,NELFCD;RNF8
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.21254535546139353,0.47285042445865433,0.9837251356238698,0.9997595347660848,1.0,5/14,28.36%,NOL9;DDX18;ZNHIT3;RPL7L1;ZNHIT6
prerank,regulation of microtubule-based movement (GO:0060632),0.22103677107266256,0.4706661623338017,0.9731663685152058,0.9997142949770904,1.0,1/11,7.92%,DRC1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.18640016554437255,-0.47019620588964095,0.987012987012987,1.0,1.0,5/17,26.06%,ALG1;MPDU1;MVD;DHDDS;SRD5A3
prerank,interstrand cross-link repair (GO:0036297),-0.14977969381203954,-0.4698002971503113,1.0,1.0,1.0,17/53,32.97%,FANCE;FANCI;FAAP100;NUCKS1;ERCC1;ATRIP;FANCD2;ATR;MCM9;RAD51AP1;RNF168;USP1;NEIL3;FAAP24;FANCL;UBE2T;MCM8
prerank,mitotic cytokinetic process (GO:1902410),0.20121019601749476,0.46964061468826784,0.9878260869565217,0.9994621492214621,1.0,3/20,16.43%,CHMP1B;MITD1;PDCD6IP
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.2166223479415747,0.46710924535904774,0.9831460674157303,0.9994634337746986,1.0,2/13,15.20%,NELFCD;RNF8
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.18633476285840314,-0.46709239574112416,0.993103448275862,1.0,1.0,8/16,39.91%,PTPN22;TNFSF8;AHR;LST1;IKZF3;FGF10;CD22;TNFSF9
prerank,organophosphate catabolic process (GO:0046434),0.22266900701542827,0.46643619909430273,0.9710144927536232,0.9991368637749758,1.0,1/11,8.63%,ENPP2
prerank,protein import into mitochondrial matrix (GO:0030150),0.2018210361067505,0.4637448658957166,0.9982876712328768,0.9991225575630936,1.0,18/18,79.84%,DNAJC19;TOMM20L;TIMM21;TIMM50;TOMM70;GRPEL2;GRPEL1;PAM16;TOMM20;DNLZ;ROMO1;TIMM17A;DNAJC15;TOMM40;TIMM17B;TIMM23;TIMM44;TOMM40L
prerank,sensory perception of pain (GO:0019233),-0.17364874723280938,-0.4616524872157979,0.9861751152073732,1.0,1.0,2/21,7.23%,PTGES;P2RX4
prerank,mitochondrion transport along microtubule (GO:0047497),0.2152809922146671,0.4601998179844256,0.968421052631579,0.9992537049285531,1.0,5/13,30.69%,HIF1A;SPAST;LRPPRC;UBB;SYBU
prerank,coenzyme A metabolic process (GO:0015936),-0.19283390438882936,-0.4548083114100237,0.9908675799086758,1.0,1.0,2/14,13.43%,DCAKD;CROT
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2093526653196103,0.4535907784814999,0.9946043165467626,0.9998077772869824,1.0,7/13,34.24%,BNIP3L;BNIP3;PMAIP1;BCL2L11;BAX;BAD;BMF
prerank,ribosomal large subunit assembly (GO:0000027),0.18712241628081455,0.4519600050536931,0.9865319865319865,0.9996086098966928,1.0,7/24,27.56%,RPL3;MRPL20;RPL11;RPL24;RSL24D1;RPL6;TRAF7
prerank,neuron fate commitment (GO:0048663),-0.18909325850705805,-0.45101635086156955,0.9908466819221968,1.0,1.0,7/14,34.54%,TGFBR1;ID2;POU3F2;SHH;POU4F1;PAX6;ASCL1
prerank,cell cycle G1/S phase transition (GO:0044843),0.15559051135273505,0.4508260254885435,0.9985074626865672,0.9993372058384462,1.0,16/61,24.78%,MAX;HINFP;EIF4E;PIM2;PLK2;ACVR1;MAP3K11;TRIM71;USP29;CDK6;CDK4;NASP;CUL1;CDKN1B;MYC;CDKN2C
prerank,response to hydroxyurea (GO:0072710),0.21403914276050784,0.45063924710097447,0.9753086419753086,0.9989317454717075,1.0,6/11,32.68%,DDX11;NSMCE3;BLM;TIMELESS;DDI2;RTF2
prerank,P-body assembly (GO:0033962),0.20472192595023014,0.44950851323479346,0.9765342960288809,0.9986578161710892,1.0,3/12,24.18%,EDC3;LSM4;LSM14A
prerank,positive regulation of double-strand break repair (GO:2000781),0.16931765947986907,0.44844621018846686,0.9984917043740573,0.9983706182256766,1.0,12/39,26.06%,SHLD1;MGMT;WDR48;ACTR2;FANCB;SLF1;DDX11;PARP9;FMN2;ARID2;PNKP;DTX3L
prerank,estrogen metabolic process (GO:0008210),-0.18639138867696325,-0.4438637753234743,0.9881796690307328,1.0,1.0,7/15,40.17%,CYP1B1;HSD17B2;SULT1A1;HSD17B14;HSD17B1;HSD17B11;CYP1A1
prerank,regulation of chromosome segregation (GO:0051983),-0.1727812034631282,-0.44269054675009545,0.9907192575406032,1.0,1.0,9/16,44.57%,SMC6;CSNK2A1;NUMA1;RAD18;BUB1;KIF2C;AURKB;MKI67;HORMAD1
prerank,protein localization to condensed chromosome (GO:1903083),0.1999427379048178,0.4414424078681065,0.9797047970479705,0.9988160848911245,1.0,3/12,19.17%,BUB3;ZW10;IK
prerank,tRNA export from nucleus (GO:0006409),-0.1512605732588112,-0.4380958495939945,1.0,1.0,1.0,14/32,38.06%,SEH1L;NUP205;RAE1;NUP155;NUP35;NDC1;TPR;NUP43;AAAS;NOL6;NUP37;SSB;NUP98;NUP62
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.1512605732588112,-0.4380958495939945,1.0,1.0,1.0,14/32,38.06%,SEH1L;NUP205;RAE1;NUP155;NUP35;NDC1;TPR;NUP43;AAAS;NOL6;NUP37;SSB;NUP98;NUP62
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.17710215597524157,-0.4379676597141516,0.9908675799086758,1.0,1.0,5/16,29.90%,PDS5B;NAA50;SGO1;DSCC1;PDS5A
prerank,eosinophil chemotaxis (GO:0048245),0.20145646305480586,0.4375171167753813,0.9895287958115183,0.9984032698165045,1.0,14/14,79.87%,CCL1;SCG2;CCL4;CCL26;CCL24;LGALS3;CCL3;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2;CCL13
prerank,eosinophil migration (GO:0072677),0.20145646305480586,0.4375171167753813,0.9895287958115183,0.9984032698165045,1.0,14/14,79.87%,CCL1;SCG2;CCL4;CCL26;CCL24;LGALS3;CCL3;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2;CCL13
prerank,intermediate filament organization (GO:0045109),0.1891614924371004,0.4343010937297372,0.9932203389830508,0.9983197654177989,1.0,3/17,17.78%,KLHL24;GFAP;DNAJB6
prerank,positive regulation of telomere capping (GO:1904355),-0.1670681997540668,-0.4333236708590348,0.9976359338061466,1.0,1.0,6/17,26.59%,TNKS2;RTEL1;TNKS;PKIB;HNRNPD;MAP3K4
prerank,tRNA 5'-leader removal (GO:0001682),-0.1828451836560389,-0.43150426209443876,0.9934924078091106,1.0,1.0,6/13,36.32%,PRORP;POP4;RPP25L;POP7;RPP40;SSB
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.19506394514650283,0.42720708176420186,0.9964028776978417,0.9986414692861729,1.0,3/14,17.42%,WDR48;ACTR2;FANCB
prerank,regulation of viral transcription (GO:0046782),0.1614403855615274,0.4258258638137639,0.9969183359013868,0.9983432868181512,1.0,1/39,2.37%,TRIM14
prerank,histone lysine methylation (GO:0034968),0.16206656328452562,0.42576667899955345,0.9967266775777414,0.9979215784916874,1.0,8/33,26.11%,MEN1;PRDM9;SETDB1;SMYD1;RBBP5;SETDB2;WDR82;SUV39H1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.18119286792272646,-0.42421405747905405,0.9954545454545455,1.0,1.0,8/12,48.97%,ZBTB1;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,gas transport (GO:0015669),-0.1940495451705771,-0.4231867227748323,0.9912472647702407,0.9994957339500282,1.0,1/10,8.90%,CYGB
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.1854391765032477,-0.41630844415958235,0.9958419958419958,0.9992246986655328,1.0,4/11,40.58%,EXOSC2;PARN;FBLL1;LARP7
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.1685884772623187,0.4140208675787346,0.9983388704318937,0.9985677728611135,1.0,5/25,18.69%,HSPA8;DNAJC7;HSPA9;HSPE1;ERO1A
prerank,T cell activation involved in immune response (GO:0002286),-0.18022663240398384,-0.41397927777451043,1.0,0.9986585105337651,1.0,9/12,46.96%,MDK;FCER1G;ICAM1;LILRB1;CD74;ITGAL;F2RL1;IFNK;TNFSF18
prerank,regulation of mitotic spindle assembly (GO:1901673),0.1791635267520723,0.4121266161709159,0.9930313588850174,0.9983008162111321,1.0,19/19,82.10%,CHMP1B;PDCD6IP;CEP97;CHMP2B;VPS4B;DRG1;CHMP3;CHMP4B;HNRNPU;CHMP5;HSPA1B;CHMP2A;CHMP1A;PLK1;TPR;CCSAP;HSPA1A;EML3;CHMP4C
prerank,phospholipid metabolic process (GO:0006644),0.14107206177694273,0.4089758051979887,1.0,0.9981221425610721,1.0,10/71,20.25%,MBOAT1;PLA2G4B;ENPP2;PIP4K2A;CLN8;PLPPR4;PLPP2;GPX4;PGP;PLAA
prerank,negative regulation of viral release from host cell (GO:1902187),-0.17175141242937852,-0.4081314378194877,0.9977678571428571,0.9982714135445178,1.0,13/13,82.85%,PML;TRIM8;TRIM5;TRIM21;TRIM35;TRIM13;TRIM15;CHMP3;TRIM28;TRIM32;MID2;TRIM11;TRIM26
prerank,myeloid dendritic cell activation (GO:0001773),0.17971251020023865,0.3819298639389798,0.990909090909091,0.9993341062895807,1.0,12/12,82.04%,TGFBR2;DOCK2;BATF2;DHRS2;DCSTAMP;SLAMF1;BATF3;IL4;CAMK4;HMGB1;PYCARD;BATF
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.1472543635023541,0.36082645202412655,1.0,0.9996487766314043,1.0,9/28,27.60%,SHLD1;SIRT7;HMGA2;ACTR2;PARP9;PNKP;DTX3L;NUDT16L1;CYREN
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.1376205163551532,0.340387290776792,1.0,0.9996413050258884,1.0,8/25,29.83%,MPHOSPH10;PRPF4;SF3B3;PRPF8;SMNDC1;SCAF11;BCAS2;PRPF6
